WOC2010 FinalProgram

See you WOC
2010
World Ophthalmology Congress

2010
ICC, Berlin, Germany
XXXII International Congress of Ophthalmology
108
th
DOG Congress
5 - 9 June 2010
AAD Congress 2010
3 - 6 June 2010
www.woc2010.org
F
i
n
a
l

P
r
o
g
r
a
m
WOC
2010
M
a
p

I
C
C
Main Entrance
Hall 7
Roof Garden
Hall 10
Hall 9
Hall 8
Hall 6
Hall 4/5
Hall 3
Rooms 42 - 46
Room 56
Main Lobby
Kids Club (Room 35)
Press Office (Rooms 31-33)
WOC 2010
PCO Counter
BVA
Registration
Registration
Terminals
Registration
Terminals
ICC Lounge
Entrance Level
Lobby Level
Hall 1
Hall 2
Salon 11/12
Salon 13/14
Salon 15/16
Salon 17/18
Salon 19
Salon 20
Salon 21
Salon 22
Hall Level
Media Check
Rooms 31-40
Rooms 23-30
Hall 16
Industrial Exhibition
Hall 17
Hall 15
Abu Dhabi
Hall 17
Congress Bags
Radio Tower
Lounge 1, Lounge 2
Hall 11
Poster Exhibition
VIP Lounge 1
VIP Lounge 2
Rooms
Madrid, Sydney,
Hong Kong, Istanbul
Hall 12
Hall 13
Oslo
Hall 14
Sao Paulo
Stockholm
Lobby Level
When monotherapy is not enough
Control under pressure
GANFORT (bimatoprost 0.03%/timolol 0.5%). Abbreviated
Prescribing Information. Presentation: Eye drop solution, one ml
contains0.3mgbimatoprost and5mgtimolol (asmaleate). Indications:
Reduction of intraocular pressure (IOP) in patients with open-angle
glaucoma or ocular hypertension who are insufficiently responsive to
topical beta-blockers or prostaglandin analogues. Dosage and
Administration: Pleaserefer totheSummaryof Product Characteristics
beforeprescribing. Recommendeddoseisonedropintheaffectedeye(s)
once daily, administered in the morning (evening dosing may be
considered). If more than one topical ophthalmic product is to be used,
each should be instilled at least 5 minutes apart. Not recommended in
childrenor adolescents(under theageof 18). Usewithcautioninrenal or
hepatic impairment. Contraindications: Hypersensitivity to active
substances or to any of the excipients. Reactive airway disease including
bronchial asthma or a history of bronchial asthma, severe chronic
obstructivepulmonarydisease. Sinusbradycardia, secondor thirddegree
atrioventricular block, overt cardiac failure, cardiogenic shock.
Warnings/Precautions: Ganfort may be absorbed systemically. The
same types of cardiovascular and pulmonary adverse reactions as seen
with systemic beta-blockers may occur. Cardiac failure should be
adequatelycontrolledbeforebeginningtherapy. Patientswithahistoryof
severe cardiac disease should be watched for signs of cardiac failure and
havetheir pulserateschecked. Cardiacandrespiratoryreactions, including
deathduetobronchospasminpatientswithasthma, and, rarely, deathin
association with cardiac failures have been reported following
administrationof timolol maleate. Beta-blockersmayalsomaskthesigns
of hyperthyroidismand cause worsening of Prinzmetal angina, severe
peripheral and central circulatory disorders and hypotension. Beta-
adrenergic blocking agents should be administered with caution in
patients subject to spontaneous hypoglycemia or to diabetic patients
(especially those with labile diabetes) as beta-blockers may mask the
signs andsymptoms of acutehypoglycemia. Whiletakingbeta-blockers,
patientswithahistoryof atopyor ahistoryof severeanaphylacticreaction
to a variety of allergens may be unresponsive to the usual dose of
adrenalineusedtotreat anaphylacticreactions. Inpatients withahistory
of mildliverdiseaseorabnormal alanineaminotransferase(ALT), aspartate
aminotransferase(AST) and/or bilirubinat baseline, bimatoprost hadno
adverse reactions on liver function over 24 months. There are no known
adverse reactions of ocular timolol on liver function. Before treatment is
initiated, patientsshouldbeinformedof thepossibilityof eyelashgrowth,
darkening of the eyelid skin and increased iris pigmentation since these
have been observed during treatment with bimatoprost and Ganfort.
Some of these changes may be permanent, andmay leadto differences
in appearance between the eyes if only one eye is treated. After
discontinuationof Ganfort, pigmentationof irismaybepermanent. After
12monthstreatment withGanfort, theincidenceof irispigmentationwas
0.2%. After 12months treatment withbimatoprost eyedrops alone, the
incidence was 1.5%and did not increase following 3 years treatment.
Cystoid macular oedema has been reported with Ganfort. Therefore,
Ganfort should be used with caution in patients with known risk factors
for macular oedema(e.g. aphakicpatients, pseudophakicpatientswitha
torn posterior lens capsule). The preservative in Ganfort, benzalkonium
chloride, may cause eye irritation. Contact lenses must be removedprior
to application, with at least a 15-minute wait before reinsertion.
Benzalkoniumchloride is known to discolour soft contact lenses; avoid
contact. Benzalkoniumchloride has been reported to cause punctate
keratopathy and/or toxic ulcerative keratopathy. Therefore monitoringis
requiredwithfrequent or prolongeduseof Ganfort indryeyepatients or
where the cornea is compromised. Ganfort has not been studied in
patientswithinflammatoryocular conditions, neovascular, inflammatory,
angle-closureglaucoma, congenital glaucomaornarrow-angleglaucoma.
Potential for additive effects resulting in hypotension, and/or marked
bradycardia when eye drops containing timolol are administered
concomitantlywithoral calciumchannel blockers, guanethidine, or beta-
blocking agents, anti-arrhythmics, digitalis glycosides or para-
sympathomimetics. The hypertensive reaction to sudden withdrawal of
clonidine can be potentiated when taking beta-blockers. There are no
adequate data fromthe use of Ganfort in pregnant women. Do not use
duringpregnancyunlessclearlynecessary. Ganfort shouldnot beusedby
breast-feedingwomen. Ganfort hasnegligibleinfluenceonabilitytodrive
and use machines. Adverse Effects: No adverse drug reactions (ADRs)
specific for Ganfort havebeenobservedinclinical studies. TheADRs have
been limited to those earlier reported for bimatoprost and timolol and
themajoritywereocular, mildinseverityandnonewereserious. Basedon
12-month clinical data, the most commonly reported ADR was
conjunctival hyperaemia(mostlytracetomildandthought tobeof anon-
inflammatory nature) in approximately 26% of patients and led to
discontinuationin1.5%of patients. ThefollowingADRs werereported
during clinical trials with Ganfort. Eye disorders: Very common (1/10):
conjunctival hyperaemia, growth of eyelashes. Common (1/100 to
<1/10): superficial punctuatekeratitis, corneal erosion, burningsensation,
eye pruritus, stinging sensation in the eye, foreign body sensation, eye
dryness, eyelid erythema, eye pain, photophobia, eye discharge, visual
disturbance, eyelid pruritus. Skin and subcutaneous tissue disorders:
Common: blepharal pigmentation. Additional adverse events that have
been seen with one of the components and may potentially occur also
with Ganfort. Please refer to Summary of Product Characteristics for full
informationonsideeffects. Basic NHSPrice: 13.95per 3ml bottle.
37.59 for 3x3ml bottle. Marketing Authorisation Number:
EU/ 1 / 06 / 340 / 001-002. Marketing Authorisation
Holder: Allergan Pharmaceuticals Ireland, Castlebar
Road, Westport, Co. Mayo, Ireland. Legal Category:
POM. DateofPreparation: March2009. Further
information is available from: Allergan Ltd,
Marlow International, The Parkway,
Marlow, Bucks, SL71YL.
Allergan Ltd, MarlowInternational, The Parkway, Marlow, Bucks, SL7 1YL
Tel: +44 (0)1628 494026 Fax: +44 (0)1628 494057 www.allergan.co.uk
EU/0201/2010 Date of preparation: April 2010.
Adverse events should be reported to your local regulatory authority and Allergan office.
See you WOC
2010

2010
108
th
DOG Congress
5 - 9 June 2010
AAD Congress 2010
3 - 6 June 2010
Final Program
President WOC 2010
Professor Gerhard K. Lang
Congress Venue
ICC - Internationales Congress Centrum Berlin
Messedamm 22, 14055 Berlin, Germany
www.icc-berlin.com
2010 Alcon, Inc. 3/10 MIX10501JA
AJ7G>86I>C<:N: 9GDEH
Sharing Your Commitment
to Eye Care for 65 Years
The global leader in eye care, Alcon is
dedicated to discovering and developing
breakthrough products that advance the
treatment of eye disease.
3
WOC
2010
Table of contents
Welcome Addresses
Awards
Sponsors
Committees
Supporting
Organizations
WOC History
Program
Social Program
Information
Organizing Societies
Welcome Address from the WOC 2010 Honorary President
Welcome Address from the WOC 2010 Congress President
Welcome Address from the WOC 2010 Scientific Program
Committee Chair
Welcome Address from the WOC 2010 Scientific Program
Committee Co-Chair
Welcome Address from the Federal Minister of Education and Research
Welcome Address from Berlin's Governing Mayor
Awards
DOG Promotions and Awards
Acknowledgement to main Sponsors
WOC 2010 Executive Committee
Professional Congress Organizer
WOC 2010 Scientific Program Committee
WOC 2010 Scientific Program Coordinators
WOC 2010 Submitted Program Reviewing Committee
ICO Roster 2010
ICO Advisory Committee
ICO Foundation Council Board of Directors
DOG Executive Committee
AAD Executive Committee
WOC 2010 Supporting Organizations
Past and future WOCs
Highlights
How to Read the Scientific Program
Subspecialty Days
Scientific Program
Saturday, 5 June 2010
Sunday, 6 June 2010
Monday, 7 June 2010
Tuesday, 8 June 2010
Wednesday, 9 June 2010
Courses and Wetlabs (incl. AAD-Courses Joint Program)
Posters
Administrative Meetings
Company Symposia
Other Symposia
Official Social Program
Program for Accompanying Persons
Information for authors
Travel and accommodation grants France 2010 European Symposium
Sponsors and Exhibitors
Complete ICC, Exhibition Halls
Information from A to Z
Press Office WOC 2010
Adverts
Author Index
Imprint
Page
4
5
7
8
9
10
11
13
18
19
21
21
21
22
24
25
25
26
27
28
29
31
37
50
51
63
63
87
129
171
213
237
263
325
327
335
337
338
339
343
345
349
357
361
368
369
413
4
WOC
2010
Sponsor
International Council of Ophthalmology (ICO)
www.icoph.org
Host
Deutsche Ophthalmologische Gesellschaft e. V.
(DOG, German Society of Ophthalmology)
www.dog.org
Co-Host
Augenrztliche Akademie Deutschland
(AAD, German Academy of Ophthalmology)
www.augeninfo.de
Organizing
Societies
5
WOC
2010
W
e
l
c
o
m
e

A
d
d
r
e
s
s
Welcome Address from the President of the International Council of
Ophthalmology
Dear Colleagues,
On behalf of the International Council of Ophthalmology, the sponsor of the
World Ophthalmology Congress 2010 (WOC 2010), I am most pleased
to welcome you to the exciting international city of Berlin, to the superb
scientific program, organized under the leadership of Stephen Ryan and
Gabriele Lang, and the extraordinary overall program and social events
organized under Congress President Gerhard Lang.
We are thrilled to return the World Ophthalmology Congress 2010 to
Europe this year, following previous successful gatherings in Brussels in 1958,
Munich in 1966, Paris in 1974, Rome in 1986, and Amsterdam in 1998.
As the world comes closer together, it is particularly so in ophthalmology. We held
our first international meeting in 1857 in Brussels and this meeting, 153 years later,
is our 32nd World Congress. As the first true specialty in medicine, ophthalmology
continues to be a leader in diagnostics, surgical innovation, education, certification
and certainly congeniality.
This World Congress is a chance for generalists in ophthalmology and subspecialists
in every field to learn from one another and to maintain a central commitment
to ophthalmology as a specialty. We come together with the mutual goal of preven-
ting and alleviating vision loss, and to face the challenge of 314 million people
visually impaired.
On behalf of the International Council and the worlds ophthalmologists, I welcome
you and wish for you a most successful Congress personally and professionally.
Bruce E. Spivey, M.D., M.S., M.Ed.
President, International Council of Ophthalmology
Lotemax
0.5% Eye Drops, Suspension Abbreviated Prescribing

Information UK (Please refer to full Summary of Product Characteristics
when Prescribing). Presentation: The suspension contains 0.5%
loteprednol etabonate (5 mg/ml). Each drop contains 0.19 mg loteprednol
etabonate. Uses: Treatment of post-operative inammation following ocular
surgery. Dosageandadministration: Ocular: Adults and elderly One to
two drops four times daily beginning 24 hours after surgery and continuing
throughout the post-operative period. The duration of treatment should not
exceed 2 weeks. Children and adolescents: Lotemax should not be used in
the paediatric age group until further data become available.
Contraindications: most viral diseases of the cornea and conjunctiva
including epithelial herpes simplex keratitis (dendritic keratitis), vaccinia,
varicella, and also in mycobacterial infection of the eye and fungal diseases of
ocular structures; untreated purulent acute infections, red eye with unknown
diagnosis and infection caused by amoeba. Hypersensitivity to the active
substance, to any of the excipients, and to other corticosteroids. Warnings
and Precautions: Prolonged use of corticosteroids may result in ocular
hypertension or glaucoma with damage to the optic nerve, defects in visual
acuity and elds of vision, and in posterior subcapsular cataract formation.
Steroids should be used with caution in the presence of glaucoma.
Prolonged use of corticosteroids may suppress the host response and may
increase the possibility of secondary ocular infections. In those diseases
causing thinning of the cornea or sclera, perforations have been known to
occur with the use of topical steroids. In acute purulent conditions of the eye,
steroids may mask infection or enhance existing infection. The use of steroids
after cataract surgery may delay healing and increase the incidence of bleb
formation. Long term treating with corticosteroids can cause fungal disease.
Fungal disease should be considered in the diferential diagnosis when a
corneal ulcer persists. Contains benzalkonium chloride which may cause
eye irritation. In general patients should not wear contact lenses after cataract
surgery, unless contact lens wearing is medically indicated. Contact with soft
contact lenses should be avoided. Known to discolour soft contact lenses. If
signs and symptoms fail to improve after two days, the patient should be re-
evaluated. If this product is used for 10 days or longer, intraocular pressure
should be monitored. Interactions: the low potential of ocular loteprednol
etabonate eye drops to increase the intraocular pressure may be adversely
afected by systemically administered medicinal products with anticholinergic
activity. In patients receiving concomitant ocular hypotensive therapy, the
addition of loteprednol etabonate may increase intraocular pressure and
decrease the apparent ocular hypotensive efect of these medicinal
products. Concurrent administration of cycloplegics may increase the risk of
raised intraocular pressure. Undesirableefects: reactions associated with
ophthalmic steroids include elevated intraocular pressure in steroid
responsive patients, which may be associated with optic nerve damage,
visual acuity and eld defects, posterior subcapsular cataract formation,
secondary ocular infection from pathogens including herpes simplex, and
perforation of the globe where there is thinning of the cornea or sclera. The
most common side-efects (>1/100, <1/10) during clinical trials with
loteprednol included the following: corneal defect, eye discharge, ocular
discomfort, dry eye, epiphora, foreign body sensation in eyes, conjunctival
hyperaemia and ocular itching. Instillation site burning, headache, rise in IOP
(see SPC for full details of adverse events). Useinpregnancyandlactation:
contraindicated. Overdosage: Acute overdosage is unlikely to occur via the
ophthalmic route. Basic NHS price: 5.50 Legal Category: POM
Product Licence number: PL17947/0001. Product Licence Holder:
Bausch & Lomb GmbH, Brunsbtteler Damm 165-173, 13581 Berlin,
Germany. Dateof last revision: September 2009. FurtherInformationis
availablefrom: Bausch& Lomb UK Ltd 106-114 London Road, Kingston-
Upon-Thames, KT2 6QJ. Tel: 01748 828864. Trademark statement:
Lotemax is a registered trademark of Bausch& Lomb Incorporated.
Adverse events should be reported. Reporting forms and
Information can be found at www.yellowcard.gov.uk. Adverse
events should also be reported to Bausch & Lomb UK Ltd on
01748 828864.
* In a summation of controlled, randomized studies of individuals
treated for 28 days or longer with LOTEMAX, LOTEMAX
provided a lower incidence of IOP elevations * 10 mm Hg vs
prednisolone acetate 1% (2.1%, 14/664 for LOTEMAX; 6.7%,
11/164 for prednisolone acetate 1%).
References:
1. Lotemax, German SPC, Dec. 2008.
2. Stewart R, Horwitz B, Howes J, Novack GD, Hart K, and the
Loteprednol Etabonate Post-operative Inammation Study Group
1. Double-masked, placebo-controlled evaluation of loteprednol
etabonate 0.5% for postoperative inammation. J Cataract Refract
Surg. 1998;24:1480-1489.
3. Beehler C, Bodner B, Bowman B, et al, for the Loteprednol
Etabonate Postoperative Inammation Study Group 2. A
double-masked, placebo-controlled evaluation of 0.5%
loteprednol etabonate in the treatment of postoperative
inammation. Ophthalmology. 1998;105:1780-1786.
4. Novack GD, Howes J, Crockett RS, Sherwood MB. Change in
intraocular pressure during long-term use of loteprednol
etabonate. J Glaucoma. 1998;7:266-269.
LOTEMAX is a registered trademark of Bausch + Lomb incorporated.
2009 Bausch + Lomb Incorporated
001-2010-05-Lotemax
Welcome Address from the WOC 2010 Congress President
Dear colleagues and friends,
It is my pleasure and honor to welcome you to the World Congress of
Ophthalmology WOC2010, the 108
th
DOG Congress and the AAD Congress
2010 in Berlin.
For the third time the DOG will be host of this outstanding international
congress. Following Heidelberg in 1888 and Munich in 1966 this year
ophthalmologists from all over the world will be meeting in Berlin.
20 years after the German Reunification, Berlin, the cultural and political
center of Germany, has become a unique symbol of the overcoming of global
frontiers. It is thus predestined to host the World Congress WOC2010:
The necessity of international cooperation as well as responsibility-and
problem-orientated action are essential responsibilities of international ophthal-
mology especially with regard to the discrepancy in quality in the treatment of
eye diseases between industrialized and third world countries. The WOC2010 will
also focus on this aspect.
In an outstanding scientific program with numerous lectures, presentations,
courses, posters, videos in over 3.000 sessions leading experts of all subspecialties
will present the latest scientific knowledge in research and state of the art ophthal-
mology. Subspecialty Days will prioritize retina, glaucoma, pediatric ophthalmology
as well as cataract and refractive surgery.
In addition to the scientific discourse, the social program offers various possibilities
for a personal and cultural exchange: The opening ceremony will commemorate
Albrecht von Graefe, co-founder of the German Society of Ophthalmology and the
ICO. You can look forward to a stunning presentation! On Monday evening we will
invite you to a typical Bavarian-like WOCtoberfest. A further highlight will be
WOC in Concert on Sunday evening in the French Church of Friedrichstadt, where
ophthalmologists will be perform for ophthalmologists.
It is a special pleasure for me that numerous colleagues will be visiting the
WOC2010 with their families and I extent a cordial welcome to all of them.
For those participants travelling with children, I would like to point out to the day
care for children offered free of charge in Room 35.
It is my deep desire to thank everybody involved in the preparation of the congress
and the scientific program. All in all 82 program coordinators, 55 societies and
organizations, more than 1.100 speakers contribute to the success of this congress.
My special thanks go to the coordinators of the scientific program, Prof. Steve Ryan
and Prof. Gabriele Lang.
Special thank also go to the sponsors and exhibitors for their various support. With-
out their contributions this congress would not have been possible.
Last but not least I would like to thank our friends of the ICO Council for their active
and long-standing support and I express my thanks to the members of the organiz-
ing committee for more than eight years of active support and help in the planning
and preparation of this congress.
Let me again welcome you to Berlin also on behalf of the ICO. Lets look forward to
an interesting congress, a manifold collegial exchange, to meeting with old friends
and making new friends with ophthalmologists from all over the world.
Prof. Dr. Gerhard K. Lang
Congress President WOC2010
7
WOC
2010
W
e
l
c
o
m
e

A
d
d
r
e
s
s
Welcome Address from the WOC 2010 Scientific Program Committee Chair
It is with great pleasure that I add my words of welcome to the World
Ophthalmology Congress 2010 (WOC 2010) in Berlin. We are all indebted
to the leading ophthalmologists from around the world who have con-
tributed their time and organizational abilities as coordinators, chairs, mod-
erators, and speakers. Their scientific contributions and active participation
guarantee the success of the scientific program in the 32nd International
Congress of Ophthalmology. Our colleagues have expanded our core pro-
grams including the latest in scientific practice with the newest cutting
edge treatments, ophthalmic drugs and devices. The leaders of industry
from around the world join the leaders of ophthalmology in the outstanding
Congress.
The WOC 2010 provides a unique opportunity for scientific communication and
exchange between the worldss leading specialists in the various fields of ophthal-
mology. The cosmopolitan city of Berlin, Germanys capital, invites you not only for
its science but to show you the dynamics and development of the 20 years follow-
ing reunification making it an ideal setting for our prestigious world congress. We
take pride that ophthalmology has the longest history of any regular international
medical meeting. At the time of the first international meeting in Brussels in 1857,
Berlin was the location for the remarkable contributions of von Helmholtz, von
Graefe, and others who provided the scientific basis for our specialty, ophthalmo-
logy. We are fortunate to pursue the heritage they established in international
ophthalmology.
More than 3,000 international experts will make their presentations in more than
600 sessions. 81 coordinators have organized the chairs, moderators, and speakers
in 31 specialties and separate areas in the scientific program. 58 separate oph-
thalmic organizations from around the world actively participate in the scientific
program. The quality of scientific program is even more impressive to me than
these numbers.
The scientific program makes the WOC 2010 professionally rewarding as well as
enjoyable. Our colleagues of the German Society of Ophthalmology and the
German Academy of Ophthalmology have been delightful colleagues with whom to
work. We welcome you and look forward to an exciting scientific program in this
stimulating environment so that we may exchange the newest cutting edge ideas,
and build stronger and better practices for our patients for the future. I am
delighted to join in welcoming you to Berlin.
Stephen J. Ryan, MD
Scientific Program Committee Chair
8
WOC
2010
W
e
l
c
o
m
e

A
d
d
r
e
s
s
Welcome Address from the President of the BVA
Dear Colleagues,
2010 marks a momentous year in the field of ophthalmology. For the first
time in 44 years, the World Ophthalmology Congress 2010 (WOC 2010)
will once again take place in Germany. The WOC 2010 organizers have put
together a comprehensive and informative program. Top-class speakers
will update delegates on the most up-to-date practices and procedures in
ophthalmology, guaranteed to offer stimulated discussions.
The annual conference of the German Academy of Ophthalmology (AAD),
the leading German-speaking conference in training and continuing
education in the field of ophthalmology, will take place at the same time.
This is being hosted by the German Society of Ophthalmology (DOG) and the
Professional Organisation of German Ophthalmologists (BVA).
The German ophthalmic community is delighted that their international colleagues
are coming to Berlin, Germanys capital, to exchange ideas and share new perspecti-
ves. German and international visitors alike - we cordially welcome you all at WOC
2010 and AAD!
Prof. Dr. Bernd Bertram
President Professional Association of German Ophthalmologists (BVA)
9
WOC
2010
W
e
l
c
o
m
e

A
d
d
r
e
s
s
Welcome Address from the Federal Minister of Education and Research
The field of ophthalmology is facing major challenges as a result of current
demographic developments. We urgently need improved methods for the
diagnosis and treatment of degenerative diseases in particular. Recent
estimates have revealed that about ten million Europeans are at risk of
losing their eyesight as a result of age-related degeneration of the macula.
Such degeneration may lead to blindness, as do cataracts, glaucoma and
retinopathy in patients with a history of diabetes. The growing number of
people suffering from diabetes in old age will exacerbate this negative trend.
Innovative technological solutions are being used in ophthalmology to
improve patients' quality of life. It is not yet possible for blind patients to
regain their eyesight, but impressive progress has already been made in the
development of electronic retinal prostheses.
The enormous progress made in basic biomedical research needs to be transferred
to routine treatment more quickly so that patients can receive even better care in
the future. Smooth cooperation between all players in science, industry and health
care requires the establishment of forums for the exchange of information and
experience forums where researchers and practitioners can meet, discuss their
challenges and visions and work together to find solutions.
The World Ophthalmology Congress 2010 is such a forum. It does not only provide
an excellent opportunity to learn about innovative techniques and new methods for
use in clinical practice; it is also a platform for the generation of promising project
ideas and the creation of new cooperation networks. I wish the participants in this
congress stimulating discussions and a productive exchange of ideas.
Prof. Dr. Annette Schavan, MdB
Federal Minister of Education and Research
10
WOC
2010
W
e
l
c
o
m
e

A
d
d
r
e
s
s
Welcome Address from Berlins Governing Mayor
We are delighted to welcome the participants in the World Ophthalmology
Congress to Berlin. As both a conference venue and a science capital, our city
is honored to be hosting this major international congress and its discus-
sions of the current state of research, study outcomes, and the prospects for
ophthalmology.
A good 20 years after the peaceful revolution and the fall of the Wall, Ger-
manys capital shows the impact of unprecedented change. Not only have
the two halves of the city been visibly reunited, leaving behind the long era
of division, but Berlin has discovered new strengths in many different areas.
A magnet especially for talented and creative people from all over the world,
it owes its national and international appeal in large part to its many cultural insti-
tutions and its renowned scientific landscape.
One of Berlins special strengths lies in medicine and the health care sector.
Tradition and modern medical research are intertwined here. For instance, Berlin is
the birthplace of your discipline, ophthalmology. The festivities surrounding the
Berlin Science Year in 2010 give us an especially vivid impression of the long history
of the sciences in our city. The Charit, for instance, Europes largest university hospi-
tal, is celebrating its 300
th
anniversary this year. However, we are not just looking
back. The spotlight is also on our excellent universities and renowned scientific
institutes, many of which do worldclass research and offer the next generation of
scholars and scientists a bright future. In other words, the World Ophthalmology
Congress is taking place in an exciting environment.
In this spirit, I would again like to say Welcome! and to wish you not only many
new insights and productive professional exchange, but also the opportunity
to round off your stay in Berlin with a cultural or culinary experience you will long
remember.
Klaus Wowereit
Governing Mayor of Berlin
11
WOC
2010
W
e
l
c
o
m
e

A
d
d
r
e
s
s
The Gonin Medal
The Gonin Medal has been instituted in 1937 and is the oldest but also the most
prestigious medal in ophthalmology. It is placed every year at the disposition of the
Board of the International Council of Ophthalmology by the University of Lausanne
and the Swiss Ophthalmological Society.
Honoree: Alan Charles Bird (London/UK)
Laudatio: Bruce E. Spivey (ICO President)
Alan Bird started his ophthalmology residency at St Bartholomews Hospital
in London 1962. His first interest was neuro-ophthalmology and he worked
for one year as Senior House Officer at Guys/Maudsley Neurosurgical Unit.
In 1965 he joined the staff of Moorfields Eye Hospital. In 1968-1969 he com-
pleted a clinical fellowship at the Bascom Palmer Eye Institute, Miami. He
became a close friend of Donald Gass who had a major influence on him. In
August 1969 Alan returned to Moorfields Eye Hospital where he became an
undisputed world leader in medical retina. In 1976 he became Professor of
Clinical Ophthalmology and is since October 2006 Emeritus Professor. He is
still a Honorary Consultant at Moorfields Eye Hospital.
Dr. Birds main interests are age-related macular degeneration and retinal
dystrophies. Together with John Marshall and Daniel Pauleikhoff he studied aging
changes in Bruchs membrane. With A. Hoskins he was the first to recognize tears
of the retinal pigment epithelium. His group described a number of genotype-
phenotype correlations and identified new gene mutations in various retinal dystro-
phies. With Fitzke and Holz he introduced fundus auto-fluorescence as a diagnostic
tool in retinal diseases. Professor Bird also worked on Sickle Cell disease in Jamaica
and on Onchocercosis in Africa.
His scientific production is amazing with over 400 papers in peer-reviewed journals
and over 80 contributions in books. He sits on the Editorial Board of Investigative
Ophthalmology and Vision Science and of a number of other journals. He is a
foreign advisor to INSERM, member of the scientific committee on AMD of the
Deutsche Forschungsgemeinschaft and an Ad Hoc member of the Board of Scienti-
fic Counsellors of the NEI in Bethesda.
Alan Bird has delivered more than 60 named lectures, including the Duke-Elder
Lecture, the Doyne Lecture, the Jackson Memorial Lecture, the Donders Lecture, the
Bowman Lecture, the Jules Franois Lecture to name only some of the most presti-
gious ones. He is a Honorary Fellow of the Royal Society of Medicine, of the Royal
College of Ophthalmology, of the American College of Surgeons, of the South
African College of Ophthalmologists. He was the 2008 Laureate of the American
Academy of Ophthalmology and obtained the 2003 ICO Golden Apple Award for
teaching.
He is a gifted speaker and a superb teacher who trained numerous young ophthal-
mologists from all over the world. The list of speakers at his career celebration in
London in 2005 reads as a Whos Who in world ophthalmology.
13
WOC
2010
A
w
a
r
d
s
Jules Franois Golden Medal
The Jules Franois Golden Medal is awarded every four years by the Board of the In-
ternational Council of Ophthalmology for ophthalmic work of high scientific quality.
Honoree: Gisle Soubrane (Paris-Crteil/F)
Professor Soubrane obtained her MD degree in 1969 in Paris where she also
did her residency under Professor Brgeat and Professor Coscas, followed
by a fellowship in medical retina in Crteil. In 1992 she presented her Ph.D.
thesis: "Ocular angiogenesis in normal and pathologic eyes. Implication of
basic fibroblast growth factor" at the Facult des Sciences Pierre et Marie
Curie, Paris V. In 1987 she became Associate Professor and in 1993 Professor
of Ophthalmology at the Eye University Clinic of Paris XII Crteil. She
succeeded Professor Coscas as chair of the department in 1996.
Professor Soubrane is a world expert on age-related macular degeneration.
Her scientific production is impressive with 243 papers in international
journals, 85 articles in national ophthalmological journals, and more than
50 chapters in books. She co-authored 6 books or reports of the French Oph-
thalmological Societies and was the chief editor of the 2007 report on Age-related
Macular Degeneration. She was instrumental in one of the first randomized study
on laser photocoagulation of subretinal neovascular membranes, studied the
natural history of occult new vessels and was the first to describe reticular pseudo-
drusen. She delivered multiple lectures on her favourite topic all over he world.
She serves on the editorial board of Graefes Archives of Ophthalmology, the
European Journal of Ophthalmology, the Journal Franais d'Ophtalmologie, the
British Journal of Ophthalmology and Investigative Ophthalmology and Vision
Science. She is past president of the European Board of Ophthalmology and of EVER,
she served as Board member of the Gonin Club and as secretary-general of the
French Ophthalmological Society of which she is still a Board member. She is mem-
ber of 17 ophthalmological societies.
Professor Soubrane was made Professor Honoris Causa of the University of Ulm in
2000 and delivered 11 named lectures.
Professor Soubrane is still active in clinical research improving the diagnosis of
age-related macular degeneration and looking for new therapeutic approaches.
14
WOC
2010
A
w
a
r
d
s
International Duke Elder Medal
Lady Phyllis Duke Elder established a gold medal in honor of her late husband, Sir
Stewart Duke Elder. This medal, which is called the International Duke Elder Medal is
awarded every four years by the Board of the International Council of Ophthalmo-
logy to an ophthalmologist who by his/her distinction, leadership and teaching has
contributed most to the development of international relations and friendship bet-
ween ophthalmologists, and who has advanced the field by his/her contributions in
writing and organization in ophthalmology.
Honoree: Mohammad Daud Khan (Peshawar/PK)
Professor Daud Khan graduated in 1969 at the Khyber Medical College,
Peshawar (Pakistan). He obtained his Diploma in Ophthalmology, University
of London in 1971, became a fellow of the Royal College of Surgeons Edin-
burgh in 1976, of the: Royal College of Ophthalmologists, London, in 1989, of
the College of Physicians and Surgeons Pakistan in 1994, of the Pakistan
Academy of Medical Sciences in1990, of the National Academy of Medical
Sciences, Pakistan in 1996 and of the Bangladesh College of Physician &
Surgeons in 2005.
He was Professor of Ophthalmology Post Graduate Medical Institute/Lady
Reading Hospital, Peshawar (1984-1997), Chairman of the National Steering
Committee for Prevention of Blindness (1994-2006), Chief Executive, Hayat
Abad Medical complex, Dean Post Graduate Medical Institute Peshawar,
2002-2003 and is the Founder Vice Chancellor, Khyber Medical University, Peshawar.
He is currently the chairman of CHEF International an NGO which aims at provi-
ding high quality health care and educational opportunities to the needy popula-
tion in Pakistan and other developing countries and. Vice President of the College of
Physicians and Surgeons of Pakistan. Professor Kahn served as President of the Asia-
Pacific Academy of Ophthalmology, of the SAARC Academy of Ophthalmology, of the
Ophthalmological Society of Pakistan, of the Eye Bank Society, Peshawar, of the glau-
coma interest group of Pakistan, was a Board member for 6 years of the ICO and is
still Vice Chairman of the International Agency for Prevention of Blindness (IAPB),
East Mediterranean Region, Advisor to the WHO and Councilor, College of Physician
& Surgeon of Pakistan (CPSP).
He made huge contributions to teaching. He is credited with training over two hun-
dred ophthalmologists and ophthalmic medical assistants. With the help of the
WHO and a consortium of INDGOs, he established the Pakistan Institute of Commu-
nity Ophthalmology (PICO) as a major regional resource centre in Community Eye
Health, Research and HRD and started Masters Course in community eye health.
Professor Kahn published over 80 scientific papers and gave over 280 lectures in
Pakistan and abroad. He served on the editorial board of 8 national and internatio-
nal journals.
He played a key role in initiating a major partnership between the government of
North West Frontier Province (NWFP) and a consortium of highly committed INGOs
to start district comprehensive eye care program in Pakistan. The program started
as a ten district initiative and is now covering over 80 districts. Professor Kahn conti-
nues to serve on the Board of trustees of Layton Rahmatullah Benevolent Trust
(LRBT) since 1984, one of the largest and the finest eye NGO in Pakistan and assisted
LRBT to establish two eye hospitals in NGO sector in NWFP.
Among the many awards received we should mention the President of Pakistan
Award for outstanding position in MBBS, the President of Pakistan Pride of Perfor-
mance Award, the Prevention of Blindness Award APAO, the Prevention of Blindness
Award Saudi Ophthalmological Society, the APAO Jose Rizal Gold medal, the SARC
ophthalmology Life time Achievement Award, the Pakistan Institute of Community
Ophthalmology Life time Achievement Award.
15
WOC
2010
A
w
a
r
d
s
International Council of Ophthalmology Ophthalmic Pathology Award
The Gottfried and Liselotte Naumann Foundation was established in 1997 in Erlangen (Ger-
many) as a non-profit organization to support Ophthalmic Pathology including Clinico-Pathologic
Correlations. The Foundation has provided an amount at the disposition of the Board of the Inter-
national Council of Ophthalmology. An International Committee of experts in Ophthalmic Patho-
logy, selects three candidates from which the ICO Board elects every four years a laureate. The
first laureate TP Drija MD, received his award in 2006 at the Opening Ceremony of the WOC in
Sao Paulo.
Honoree: Ursula Schltzer-Schrehardt
Ursula Schltzer-Schrehardt is Associate Professor and Senior Scientist at the
Department of Ophthalmology, University Erlangen-Nrnberg (Erlangen/D)
She received a PhD (summa cum laude) in Biology (thesis Ultrastructural in-
vestigations on reproduction, development and structural organization of Py-
gospio elegans (Polychaeta, Spionidae)) from the University of
Erlangen-Nrnberg in 1992 and joined the Department of Ophthalmology,
where she graduated 1998 in Experimental Ophthal-mology and became a
member of the Faculty of Medicine. Her thesis on the subject of Pseudoexfo-
liation syndrome: histopathology and pathogenesis of a newly described sys-
temic process of the extracellular matrix was awarded as the best thesis of
the Medical Faculty of this year. Since 2008, she also serves as a representative
for equal opportunities for the Faculty of Medicine.
By means of full integration into the clinical environment, Ursula Schltzer-Schrehardt was, as a
basic researcher, in a position to contribute greatly to the common and clinically relevant disorder
of pseudoexfoliation (PEX) syndrome and to add a growing body of knowledge to this formerly
rather obscure entity. Comprehensive clinical-histopathological correlations helped to explain the
causative mechanisms of the frequent ocular complications including phacodonesis and lens
subluxation, pigment dispersion, poor mydriasis, blood-aqueous barrier dysfunction, and develop-
ment of secondary glaucomas. The combination of clinical and her histopathological observati-
ons led to the original description of a specific PEX-associated keratopathy. These
clinical-pathological correlations not only increased our under-standing of this entity and allo-
wed diagnosis of early stages, but also helped to prevent complications and to improve clinical
management by close follow-up. One of her most outstanding contributions is the documenta-
tion of PEX syndrome as a new systemic process affecting the heart, lungs, liver, kidney, cerebral
meninges and blood vessel walls, which appears to be associated with increased cardio-vascular
and cerebrovascular morbidity. Lately, her pioneering analytic studies have provided new insights
into the underlying molecular pathophysiology and resulted in the commonly accepted pathoge-
netic concept of PEX syndrome as a stress-induced elastosis. This concept was recently substan-
tiated by the identification of the LOXL1 (lysyl oxidase-like 1) gene, coding for a key enzyme in
elastogenesis, as a principal genetic risk factor for both PEX syndrome and PEX glaucoma.
Functional alterations of the LOXL1 risk variant, detected by her group, open new approaches for
specific treatment strategies in the future.
Apart from being dedicated to pseudoexfoliation, her research interests also include corneal bio-
logy/pathology and corneal stem cells, glaucoma basic science, extracellular matrix as well as ge-
neral ophthalmic pathology and ultrastructural research. She also established an improved
culture technique supporting the preferential expansion and preservation of limbal stem cells for
future therapeutic applications in patients with limbal stem cell deficiency.
Her research projects have been continuously supported by the German Research Foundation
since 1990. From 1997 until 2009 she was principal investigator and scientific secretary of a Colla-
borative Research Center Glaucomas including Pseudoexfoliation Syndrome (SFB 539). She is
Editorial Board Member of the journal Experimental Eye Research and Scientific Advisory Board
Member of The Glaucoma Foundation, New York. She has published over 175 scientific articles in
peer-reviewed journals, including many describing the histopatho-logic features of ocular disea-
ses, and 20 book chapters. She also received several awards including poster prizes.
All in all, her work received broad recognition worldwide and substantiated her international posi-
tion as the leading basic researcher in the field of pseudoexfoliation syndrome. Moreover, her per-
sonality is gifted to allow exemplarily smooth cooperation so essential for the combination of basic
and clinical research. In her spare time, she enjoys literature and the arts as well as scuba diving.
These awards will be conferred on Saturday, 5 June 2010 from 18:30 - 19:00 during the
Opening Ceremony in Hall 1, ICC.
16
WOC
2010
A
w
a
r
d
s
Bernardo Streiff Gold Medal
In 1997, on behalf of friends and disciples, Professor Jean-Franois Cuendet was
commissioned by the Academia Ophthalmologica Internationalis to create the
"Bernardo Streiff Gold Medal." honoring the memory of Professor Bernardo Streiff (1908-1988),
Head of the University Eye Clinic, Lausanne, Switzerland, and AOI
member. The Bernardo Streiff Gold Medal is awarded by election of the Academia every four
years to an ophthalmologist who has contributed most, through history, ethics and education,
to the advance of ophthalmology.
Honoree: Gullapalli N. Rao
Laudatio: Peter G. Watson (AOI President)
Gullapalli Rao was educated at the Guntur Medical College, India; All India
Institute of Medical Sciences, New Delhi; and at the Tufts Medical School;
University of Connecticut; University of Rochester, U.S.A. He is a Diplomat of
the American Board, FACS, FRCS, FNAMS, D.Sc.
He is the Founder Director and Distinguished Chair of Eye Health, L V Prasad
Eye Institute of the L. V. Prasad Eye Institute, Hyderabad, India which is a com-
plex of a modern eye hospital with advanced training programs for ophthal-
mologists and paramedical personnel, an eye research centre, and also
provides a rehabilitation program. The L. V. Prasad Eye Institute has develo-
ped high quality eye care models for underserved areas and regularly trains
not only ophthalmologists but also hospital administrators and allied health
personnel from developing countries.
Professor Rao is also Adjunct Professor, University of New South Wales, Australia
(1993 -), Adjunct Professor of Ophthalmology, University of Rochester, USA (2002 -),
formerly Associate Clinical Professor of Ophthalmology, and Director, Cornea Research Labora-
tory, University of Rochester, Rochester, New York and Medical Director,
Rochester Eye Bank.
His main scientific interests are corneal diseases and community eye health. He authored over 240
published papers in journals all over the world, 18 chapters and one
book. He sits on the editorial board of the American Journal of Ophthalmology, Cornea, The Ocular
Surgery, CLAO Journal, Ophthalmic Surgery and Lasers and a number of other journals. He is the
former Editor-in-Chief of the Indian Journal of Ophthalmology.
Professor Rao has been a visiting professor at several Universities in the U.S., Japan, Europe, Hong
Kong , South Korea, Australia, China, South Africa, Africa, South East Asia, South America and
India . He gave lectures at many international ophthalmology research and public health mee-
tings. He was the Academic and Clinical Supervisor for 20 fellows in Cornea at the University of
Rochester and over 200 past and present fellows in Hyderabad, India, from all over the world.
Professor Rao had and still has a wide number of national and international responsibilities:
Medical Advisory Board, Eye Bank Association of America (1983-88 & 1996-99); Castroviejo In-
ternational Corneal Society (Board of Directors, 1985-89 & 2009-); Hyderabad Eye Institute
(Chairman, 1986-); Indo-American Eye Care, Inc. (Chairman, 1986-94); President, Eye Bank Asso-
ciation of India (1995-98). From 2004 till 2004 he was the Chairman of the Board of Trustees
and President of the International Agency for the Prevention of Blindness (2004-2008).
He received grants from many national and international governmental agencies and corporati-
ons and non-governmental organizations as well as several honours and awards from many in-
ternational organisations including All India Ophthalmological Society (1982, 1984, 1986); Ranbaxy
Research Award for excellence in Clinical Research (1995); Senior Honour Award, American Aca-
demy of Ophthalmology (1998); Member, Academia Ophthalmologica Internationalis (1998-),
Doctor of Science honoris causa of the University of New South Wales, Australia (2001), Padma
Shri from the Government of India -2002 (Republic Day Honours given by the President of India),
Fellow qua Surgeon ad eundem of the Royal College of Physicians and Surgeons of Glasgow
(2003);
HRH Prince Abdulaziz bin Ahmed bin Abdulaziz Al-Saud for the Prevention of Blindness Award
(2004), First "G. B. Bietti International Award for Prevention of Blindness" by the Italian Society for
Prevention of Blindness (2005), International Blindness Prevention Award by the American Aca-
demy of Ophthalmology (2006), Pisart Vision Award by Lighthouse International (2007), Honorary
Doctorate of Science from University of Melbourne, Australia (2007), AAO-Essilor Award for Out-
standing International Contributions to global eye care by the American Academy of Optometry
(2009) .
17
WOC
2010
A
w
a
r
d
s
18
WOC
2010
P
r
o
m
o
t
i
o
n
s

a
n
d

A
w
a
r
d
s
European Vision
Award Lecture
2010
DOG Promotions
and Awards
Monday, 7 June 2010, 17:45 - 18:15, Room Stockholm
A systemic view on retinal ciliopathies: inherited retinal degeneration revisited.
Speaker: Dr. Ronald Roepman (Nijmegen/NL)
Welcome & Laudatio: Prof. E. Zrenner, Chairman European Vision Institute
Keynote Lecture Dr. Ronald Roepman
Promotions
Research Funding for Innovative Scientific Projects in Ophthalmology
donated by the DOG
Funding for Research in Tropical Ophthalmology donated by the DOG
The Award will be conferred on Sunday, 6 June 2010 from 16:00 17:30 at Hall 9, ICC.
Awards
Glaucoma Research Award donated by Pharm Allergan GmbH (Ettlingen/D)
Julius Springer Award for Ophthalmology donated by Springer Medizin Verlag
(Heidelberg/D)
Krner Research Award donated by the Krner-Stiftung
Leonhard-Klein-Award donated by the Leonhard-Klein-Stiftung
Poster Award
3 posters a day will be awarded, donated by the DOG
Promotional Award "Innovative developments and therapeutic attempts with
age-related macular degeneration (AMD)" donated by Novartis Pharma GmbH
(Nuremberg/D)
Research Award Bausch & Lomb donated by Bausch & Lomb GmbH (Berlin/D)
Senator-Hermann-Wacker-Award donated by Hermann Wacker Fonds
Three best German participants in the EBO exam
Tropical Ophthalmology Award donated by the German Committee for the Preven-
tion of Blindness, URSAPHARM Arzneimittel GmbH & Co. KG (Saarbrcken/D),
Novartis Pharma GmbH (Nuremberg/D), 1StQ Deutschland GmbH & Co. KG (Mann-
heim/D) and WaveLight AG (Erlangen /D)
The Award will be conferred on Sunday, 6 June 2010 from 16:00 17:30 at Hall 9, ICC.
Uveitis Award 2010 donated by LUX Bioscience, Inc. (Jersey City/USA) Allergan Inc.
(Irvine/USA)
The Award will be conferred on Monday, 7 June 2010 from 14:30 15:30 at Salon 21
(Lilienthal).
Video Award donated by Carl Zeiss Meditec AG (Munich/D)
The award will be conferred on Sunday, 6 June 2010 from 10:30 12:00 at
Radio Tower Lounge.
Von Graefe Award donated by the DOG
Short-term Lectures
Short-term lectureships donated by the DOG
The Awards will be conferred on Sunday, 6 June 2010 from 16:00 17:00 at Hall 9
The DOG Promotions and Awards will be conferred on Wednesday, 9 June 2010
from 11:30 - 13:00 during the session Award Ceremony and Handover of
DOG Presidency" in the Hall Roof Garden, ICC (if not stated differently).
19
WOC
2010
S
p
o
n
s
o
r
s
Acknowledgement to Package Sponsors
We cordially thank the following sponsors for their generous support of the WOC 2010:
Sponsor City Country
Diamond Sponsor
Carl Zeiss Meditec AG Jena D
Gold Sponsors
Alcon Laboratories, Inc. Fort Worth, Texas USA
Bausch & Lomb Zug CH
Pharmaceuticals
Chibret Pharmazeutische GmbH Haar D
Merck, Sharp & Dohme White House Station,
New Jersey USA
Pfizer Ophthalmics New York New York USA
Santen Pharmaceutical Co, Ltd Osaka J
Silver Sponsors
ALLERGAN AG Nordics UK
Novartis Pharma GmbH Basel CH
Bronze Sponsors
AMO Abbott Santa Ana USA
Heidelberg Engineering GmbH Heidelberg D
Sponsors
Aeon Astron Europe Leiden NL
Abbott GmbH & Co. KG Wiesbaden D
Bayer Schering Pharma AG Berlin D
GEUDER AG Heidelberg D
Oculentis GmbH Berlin D
OCULUS Optikgerte GmbH Wetzlar D
Sanofi Pasteur MSD Lyon F
Sixt Pullach D
Ziemer Group Port CH
Adverse events should be reported. Reporting forms and information
can be found at www.yellowcard.gov.uk. Adverse events should
also be reported to Pfzer Medical Information on 01304 616161.
I8
I
0
8
A
8
0
0
1
2
8
I3
5
REFERENCES: 1. European Glaucoma Prevention Study (EGPS) Group. Predictive factors
for open-angle glaucoma among patients with ocular hypertension in the European
Glaucoma Prevention Study. Ophthalmology 2007;114:39. 2. Gordon MO, et al. The
Ocular Hypertension Treatment Study. Baseline factors that predict the onset of primary
open-angle glaucoma. Arch Ophthalmol. 2002;120:71420. 3. Heijl A, et al. Reduction
of intraocular pressure and glaucoma progression: results from the Early Manifest
Glaucoma Trial. Arch Ophthalmol. 2002 Oct;120(10):126879. 4. Advanced Glaucoma
Intervention Study (AGIS) Investigators. AGIS: 7. The relationship between control of
intraocular pressure and visual feld deterioration. Am J Ophthalmol. 2000;130:42940.
*

R
e
g
is
t
r
a
t
io
n

in

t
h
e

U
K

1
6
/
1
2
/
1
9
9
6
.

D
a
t
e

o
f

p
r
e
p
a
r
a
t
io
n
:
M
a
r
c
h

2
0
1
0
.
X
L
U
O
1
0
4
2
A
Start with powerful IOP control for lasting patient success.
14
I N OCUL AR HYPERT ENS I ON AND GL AUCOMA
Protect whats precious
FIND OUT HOW WE CAN HELP YOU PROTECT
JOIN OUR SYMPOSIUM:
FUNCTION, FUNCTIONING & QUALITY OF LIFE
DATE: SATURDAY 05 JUNE TIME: 13:1014:00
LOCATION: THE ICC (HALL SAO PAULO)
Xalatan
0.005% w/v eye drops solution Prescribing Information

Please refer to the SmPC before prescribing Xalatan 0.005% w/v eye drops solution
(latanoprost) Presentation Plastic bottle containing 2.5ml eye drops. Each 1ml
contains latanoprost 50 micrograms (0.005%) and benzalkonium chloride.
Indication Reduction of elevated intraocular pressure in patients with OAG and
ocular hypertension. Dosage and Administration Adults including the Elderly: One
eye drop into the affected eye(s) once daily in the evening. Contact lenses should be
removed before instillation of the eye drops and may be reinserted after 15 minutes
(see Precautions). Children: Not recommended. Contra-indications Known
hypersensitivity to any component. Precautions Xalatan may increase brown
pigment within the iris leading to a gradual change in eye colour usually within the
frst 8 months of treatment, rarely during the second or third year, and has not been
seen after the fourth year of treatment. The rate of progression of iris pigmentation
decreases with time and is stable for fve years. The effect of increased pigmentation
beyond fve years has not been evaluated. In an open 5-year latanoprost safety
study, 33% of patients developed iris pigmentation. This has predominantly been
seen in patients with mixed coloured irides and may be permanent. Patients should
be examined regularly and treatment discontinued if appropriate. Unilateral
treatment can result in permanent heterochromia. Exercise caution in patients with
asthma, infammatory ocular conditions and other types of glaucoma, including
chronic angle closure, OAG of pseudophakic patients and in pigmentary glaucoma.
Also caution is recommended in aphakic patients, pseudophakic patients with torn
posterior lens capsule or anterior chamber lenses or patients with known risk factors
for cystoid macular oedema. Latanoprost may gradually change eyelashes and vellus
hair in the treated eye and surrounding areas; these changes include increased
length, thickness, pigmentation, number of lashes or hairs and misdirected growth
of eyelashes. Eyelash changes are reversible upon discontinuation of treatment.
Xalatan contains the preservative benzalkonium chloride which has been reported to
cause punctate keratopathy and/or toxic ulcerative keratopathy, may cause eye
irritation and is known to discolour soft contact lenses. Close monitoring required
with frequent or prolonged use of Xalatan in dry eye patients/ conditions where the
cornea is compromised. Contact lenses may absorb benzalkonium chloride. These
should be removed before applying Xalatan but may be reinserted after 15 minutes
(see Dosage and Administration). Pregnancy Do not use. Lactation Do not use or
stop breast feeding. Interactions Defnitive data are not available. There have been
reports of paradoxical elevations in intraocular pressure following the concomitant
ophthalmic administration of two prostaglandin analogues. Therefore, the use of two
or more prostaglandins, prostaglandin analogues or prostaglandin derivatives is not
recommended. Any other eye drops should be administered fve minutes apart.
Side Effects Ocular side effects - Very common (1/10): Increased iris pigmentation,
mild to moderate conjunctival hyperaemia, eye irritation (burning, grittiness, itching,
stinging and foreign body sensation), eyelash and vellus hair changes (increased
length, thickness, pigmentation and number); Common (1/100 and <1/10):
transient punctate epithelial erosions (mostly without symptoms), blepharitis, eye
pain. Please refer to SmPC for other ocular side-effects. Non-ocular side-effects
Uncommon (1/1000 and <1/100): Skin rash; Rare (1/10,000 and <1/1000):
Asthma, asthma exacerbation, dyspnoea, localised skin reaction on the eyelids,
darkening of the palpebral skin of the eyelids; Very rare (<1/10,000): Aggravation of
angina in patients with pre-existing disease, chest pain. There have been additional
post-marketing spontaneous reports of: headache, dizziness, palpitations, myalgia
and arthralgia Driving Instillation of eye drops may cause transient blurring of vision.
Overdosage Symptomatic treatment. Pharmaceutical Precautions Store at 2C -
8C. Protect from light. Once opened, store at room temperature (25C) and discard
after 1 month. Legal category POM. Packaging Quantities and Basic NHS
price 2.5 ml 12.48. PL number PL 00032/0220. PL Holder Pharmacia Limited,
Ramsgate Road, Sandwich, Kent, CT13 9NJ, UK. Date of preparation of PI
January 2009. Further information is available on request from:
Pfzer Limited, Walton Oaks, Dorking Road, Tadworth, Surrey, KT20 7NS, UK.
21
WOC
2010
C
o
m
m
i
t
t
e
e
s
WOC 2010 Congress President
Gerhard K. Lang, MD
DOG President
Ulm, Germany
WOC 2010 Executive Committee
President
Gerhard K. Lang, MD
Ulm, Germany
Secretary General
Anselm Kampik, MD
Munich, Germany
Treasurer
Jochen Kammann, MD
Davos, Switzerland
Program Director
Gabriele E. Lang, MD
Ulm, Germany
Executive Director of the DOG
Philip Gass, PhD
German Society of Ophthalmology
Munich, Germany
Professional Congress Organizer
(PCO)
Monika Porstmann
Porstmann Kongresse GmbH
pco@woc2010.de
Berlin, Germany
WOC 2010 Honorary President
Bruce E. Spivey, MD
ICO President
San Francisco, USA
WOC 2010 Scientific Program
Committee
Chair
Stephen J. Ryan, MD
Los Angeles, USA
Co-Chair
Bernd Bertram, MD
Aachen, Germany
Co-Chair
Gabriele E. Lang, MD
Ulm, Germany
Subspecialty Area Coordinators
Cataract Dennis Lam (Kowloon, Hong Kong/CN)
Amar Agarwal (Chennai/IND)
Joseph Colin (Bordeaux/F)
Abhay R. Vasavada (Ahmenabad/IND)
Thomas F. Neuhann (Munich/D)
Contact Lens and Refraction Albert Franceschetti (Meyrin/CH)
Gudrun Bischoff (Hamburg/D)
Evidence Based Ophthalmology Richard L. Abbott (San Francisco/USA)
Klaus Dieter Lemmen (Dsseldorf/D)
External Eye Disease, Cornea, EyeBank Abdulaziz AlRajhi (Riyadh/SA)
Zbigniew Zagorski (Lublin/PL)
Thomas Reinhard (Freiburg/D)
Eye Trauma and Emergencies Ferenc Kuhn (Birmingham/USA)
Wolfgang F. Schrader (Nuremberg/D)
Glaucoma Robert Ritch (New York/USA)
Clive Migdal (London/UK)
Jian Ge (CN)
Norbert Pfeiffer (Mainz/D)
Immunology, Molecular Biology,
Microbiology Robert Nussenblatt (Bethesda/USA)
Arnd Heiligenhaus (Mnster/D)
Low Vision August Colenbrander (Novato/USA)
Susanne Trauzettel-Klosinski
(Tbingen/D)
Neuro-Ophthalmology Christian Luco (Santiago/RCA)
Klara Landau (Zurich/CH)
Eberhart Zrenner (Tbingen/D)
NewTechnology: Bioengineering,
Nanotechnology Shigeru Kinoshita (Kyoto/J)
Friedrich E. Kruse (Erlangen/D)
Oculoplasty, Lacrimal System,Orbit John Richard O. Collin (London/UK)
Artur Klett (Tallinn/EST)
Christoph Hintschich (Munich/D)
Rudolf F. Guthoff (Rostock/D)
Oncology Jerry Shields (Philadelphia/USA)
Tero Kivel (Helsinki/FIN)
Norbert Bornfeld (Essen/D)
Ophthalmic Epidemiology Jialiang Zhao (Beijing/CN)
Paul Mitchell (Sydney/AUS)
Pathology Tatsuro Ishibashi (Kyushu/J)
Miguel N. Burnier Jr. (Montral/CDN)
Hans E. Grossniklaus (Atlanta/USA)
Karin U. Lffler (Bonn/D)
Pediatric Ophthalmology, Genetics Marilyn Miller (Chicago/USA)
Gnther Rudolph (Munich/D)
Pharmacology, Ocular Drug Delivery Mark Blumenkranz (Stanford/USA)
Karl Ulrich Bartz-Schmidt (Tbingen/D)
WOC2010
Scientific
Program Coordi-
nators
22
WOC
2010
C
o
m
m
i
t
t
e
e
s
Subspecialty Area Coordinators
Refractive Surgery Peter McDonnell (Baltimore/USA)
Theo Seiler (Zurich/CH)
Gernot I. W. Duncker (Halle/D)
Retina, Vitreous Xiao Xin Li (Beijing/CN)
Zdenek J. Gregor (London/UK)
Peter Wiedemann (Leipzig/D)
Strabismus Kanxing Zhao (Tianjin/CN)
Eugene Helveston (Indianapolis/USA)
Joachim Esser (Essen/D)
Teleophthalmology and Computers Jorge Valdez (Nuevo Leon/MEX)
Georg Michelson (Erlangen/D)
Uveitis, Intraocular Inflammation Rubens Belfort Jr. (So Paulo/BR)
Shigeaki Ohno (Sapporo/J)
Manfred Zierhut (Tbingen/D)
Vision 2020 (Prevention of Blindness) Nathan Congdon (Baltimore/USA)
Hugh R. Taylor (Melbourne/AUS)
Volker Klauss (Munich/D)
Cataract and Refractive Surgery
Subspecialty Day Douglas D. Koch (Houston/USA)
Jorge L. Ali (Alicante/E)
Thomas Kohnen (Frankfurt/Main/D)
Glaucoma
Subspecialty Day Clement C. Y. Tham (Hong Kong/CN)
Harry Quigley (Baltimore/USA)
Franz Grehn (Wrzburg/D)
Pediatric Ophthalmology
Subspecialty Day Birgit Lorenz (Giessen/D)
Retina
Subspecialty Day Michael T. Trese (Rochester/USA)
Alain Gaudric (Paris/F)
William Aylward (London/UK)
Anselm Kampik (Munich/D)
World Ophthalmic Educational Colloquium Marko Hawlina (Ljubljana/SLO)
Pinar Aydin (Ankara/TR)
Mark Tso (Baltimore/USA)
Klaus Peter Steuhl (Essen/D)
World Forum of Journal Editors Andrew P. Schachat (Baltimore/USA)
Alexander J. Brucker (Gladwyne/USA)
Bernd Kirchhof (Cologne/D)
World Forum of Prevention of Blindness Hilel Lewis (New York/USA)
Bruce Spivey (San Francisco/USA)
WOC2010
Scientific
Program Coordi-
nators
23
WOC
2010
C
o
m
m
i
t
t
e
e
s
WOC 2010
Submitted
Program
Reviewing
Committee
Winfried M. Amoaku (Nottingham/GB)
Rimvydas Asoklis (Vilnius/LT)
Leonid I. Balashevich (St.
Petersburg/RUS)
Kristine Baumane (Riga/LV)
Wolfgang Behrens-Baumann
(Magdeburg/D)
Amarildo Belshi (AL)
Nadija F. Bobrova (Odessa/UA)
Andrej Cernk (Bratislava/SK)
Stefan Cornel (Bukarest/RO)
H. Burkhard Dick (Bochum/D)
Vjekoslav Dorn (Zagreb/HR)
Brigita Drnovsek-Olup (Ljubljana/SI)
Gernot I. W. Duncker (Halle/Saale/D)
Carl Erb (Berlin/D)
Christoph Faschinger (Graz/A)
Michael Grf (Giessen/D)
Rolf Grewe (Mnster/D)
Steffen Heegaard (Copenhagen/DK)
Frank G. Holz (Bonn/D)
Raimond Hoxha (AL)
Tatsiana Imshenetskaya (Minsk/BY)
Antonia M. Joussen (Dsseldorf/D)
Jozef Kaluzny (Bydgoszcz/PL)
Jochen Kammann (Davos/CH)
Gerold H. Kolling (Heidelberg/D)
Lajos Kolozsvri (Szeged/H)
Gnther K. Krieglstein (Cologne/D)
Morten La Cour (Glostrup/DK)
Guna Laganovska (Riga/LV)
Klaus-Dieter Lemmen (Dsseldorf/D)
Wolfgang E. Lieb (Karlsruhe/D)
Birgit Lorenz (Giessen/D)
Dmitry J. Maitchuk (Moscow/RUS)
Hans-Werner Meyer-Rsenberg
(Hagen/D)
Christian Ohrloff (Francfort/Main/D)
Dusica Pahor (Maribor/SI)
Daniel Pauleikhoff (Mnster/D)
Iva Petkova (Sofia/BG)
Duy-Thoai Pham (Berlin/D)
Maria Manuela Pires Carmona
(Lisboa/P)
Susanne Pitz (Mainz/D)
Uwe Pleyer (Berlin/D)
Gisbert Richard (Hamburg/D)
Johann Roider (Kiel/D)
Ahmet Sarici (Cerrahpasa/TR)
Reinier O. Schlingemann
(Amsterdam/NL)
Ursula Schmidt-Erfurth (Vienna/A)
Berthold Seitz (Homburg/Saar/D)
Daniela F. Selaru (Bucharest/RO)
Eric Sellem (Lyon/F)
Halina Sitnik (Minsk/BY)
Nelly Sivkova (Plovdiv/BG)
Heimo Steffen (Wrzburg/D)
Josef Stoiber (Salzburg/A)
Peter Strmen (Bratislava/SK)
Jerzy Szaflik (Warszawa/PL)
Nevbahar Tamcelik (Cerrahpasa/TR)
Susanne Trauzettel-Klosinski
(Tbingen/D)
Antnio Casa Nova Travassos
(Coimbra/P)
Zoran Vatavuk (Zagreb/HR)
Catherine Vignal-Clermont (Paris/F)
Christian K. Vorwerk (Magdeburg/D)
Carroll A. B. Webers (Maastricht/NL)
Helmut Wilhelm (Tbingen/D)
Sebastian Wolf (Bern/CH)
Aleksandra Zborovskaya (Odessa/UA)
Biro Zsolt (Pcs/H)
24
WOC
2010
C
o
m
m
i
t
t
e
e
s
President Bruce E. Spivey, MD (San Francisco/USA)
Vice President Akef El-Maghraby, MD (Jeddah/SA)
Secretary General Jean-Jacques de Laey, MD (Ghent/B)
Treasurer Hugh R. Taylor, AC, MD (Carlton/AUS)
Executive Director William Felch, BA (Stinson Beach/USA)
Immediate Past President Gottfried O. H. Naumann, MD, ML (Erlangen/D)
Honorary Life President Akira Nakajima, MD (Tokyo/J)
Honorary Life Member Benjamin F. Boyd, MD (Panama/PA)
Balder P. Gloor, MD (Zurich/CH)
Bradley R. Straatsma, MD, JD (Los Angeles/USA)
Members Richard L. Abbott, MD (San Francisco/USA)
Jean-Paul Adenis, MD (Limoges /F)
Selwa A. F. Al Hazzaa, MD (Riyadh/SA)
Abdulaziz AlRajhi, MD (Riyadh/SA)
Rubens Belfort Jr., MD, PhD (So Paulo/BR)
Susanne Binder, MD (Vienna/A)
Daniel Etya'ale, MD (Genve/CH)
Veit-Peter Gabel, MD (Regensburg/D)
Enrique L. Graue Wiechers, MD (Mexico City/MEX)
Adekunle Olubola Hassan, MD (Lagos/NGA)
Tero Kivel, MD (Helsinki/FIN)
Volker Klauss, MD (Munich/D)
Dennis S. C. Lam, MBBS (Kowloon/Hong Kong/CN)
Gerhard K. Lang, MD (Ulm/D)
Hilel Lewis, MD (New York/USA)
Frank J. Martin, MBBS (Sydney/AUS)
David W. Parke II, MD (San Francisco/USA)
Jacob Pe'er, MD (Jerusalem/IL)
Mohammed Babar Qureshi, BMBCh, MSc
(Peshawar/(PK)
Serge Resnikoff, MD, PhD (Clermont-Ferrand/F)
Robert Ritch, MD (New York/USA)
Jos A. Roca, MD (Lima/PE)
Stephen J. Ryan, MD (Los Angeles/USA)
Alfred Sommer, MD (Baltimore/USA)
David Taylor, MB, ChB, DSc (Med) (London/UK)
Mark O. M. Tso, MD, DSc (Baltimore/USA)
Gabriel van Rij, MD, PhD (Rotterdam/NL)
Abhay R. Vasavada, MD, MS (Ahmenabad/IND)
Peter G. Watson, MB, BChir (Cambridge/UK)
Zbigniew Zagrski, MD (Lublin/PL)
Jialiang Zhao, MD (Beijing/CN)
Committee Chair Robert Ritch, MD (New York/USA)
Members Pinar Aydin, MD, PhD (Kavaklidere/Ankara/TR)
Emilio Carlo Campos, MD (Bologna/I)
August Colenbrander, MD (Novato/USA)
Joseph Colin, MD (Bordeaux/F)
John Richard O. Collin, MD (London/UK)
Mohamed Alaa, El-Danasoury, MD (Jeddah/SA)
Neeru Gupta, MD PhD (Toronto/CDN)
Marko Hawlina, MD, PhD (Ljubljana/SLO)
Ana Luisa Hofling-Lima, MD, PhD (Sao Paulo/BR)
Tatsuro Ishibashi, MD (Fukuoka/J)
Martine J. Jager, MD, PhD (Leiden/NL)
Ivo Kocur, MD (Geneva/CH)
Anthony Murray, MD (Cape Town/ZA)
Amel Meddeb Ouertani, MD (Tunis/TN)
Ramachandra Pararajasegaram, MD (Geneva/CH)
N. Venkatesh Prajna, MBBS (Tamilnadu/IND)
Stefan Seregard, MD, PhD (Stockholm/S)
Peter Wiedemann, MD (Leipzig/D)
International
Council of
Ophthalmology
Members of the
Board of Trustees
Roster 2010
Members of the
Advisory
Committee to the
Board of Trustees
ICO Advisory
Committee
25
WOC
2010
C
o
m
m
i
t
t
e
e
s
26
WOC
2010
C
o
m
m
i
t
t
e
e
s
International
Council of
Ophthalmology
Foundation
Board of Directors
and ICO Members
President Bradley R. Straatsma, MD, JD (Los Angeles/USA)
Vice President Alfred Sommer, MD, MHS (Baltimore/USA)
Secretary Treasurer Bruce E. Spivey, MD (San Francisco/USA)
Members H. R. H. Prince Abdulaziz Ahmed Abdulaziz Al Saud (Riyadh/SA)
Rubens Belfort Jr., MD PhD (So Paulo/BR)
Kevin J. Buehler (Fort Worth/USA)
Jean-Jacques de Laey, MD, PhD (Ghent/B)
Akef El-Maghraby, MD (Jeddah/SA)
Michael Kaschke, PhD (Oberkochen/D)
Hilel Lewis, MD (New York/USA)
Paul R. Lichter, MD (Ann Arbor/USA)
James V. Mazzo (Santa Ana/USA)
Alice R. McPherson, MD (Houston/USA)
Takakazu Morita (Osaka/J)
David E. I. Pyott (Irvine/USA)
Stephan J. Ryan, MD (Los Angeles/USA)
Timothy R. G. Sear (Fort Worth/USA)
Paul A. Sieving, MD, PhD (Bethesda/USA)
Hugh R. Taylor, AC, MD (Melbourne/AUS)
27
WOC
2010
C
o
m
m
i
t
t
e
e
s
DOG Executive
Committee
President Professor Gerhard K. Lang (Ulm/D)
First Vice President Professor Thomas Reinhard (Freiburg/D)
Second Vice President Professor Peter Wiedemann (Leipzig/D)
Secretary General Professor Anselm Kampik (Munich/D)
Secretary Professor Franz Grehn (Wrzburg/D)
Treasurer Professor Jochen Kammann (Davos/CH)
Executive Director Dr. Philip Gass (Munich/D)
DOG Office
Platenstr. 1, 80336 Munich
T +49 89 5505 768 14
F +49 89 5505 768 11
E geschaeftsstelle@dog.org
For information about DOG membership please visit the DOG
booth located in the main foyer (1
st
floor) of the ICC or go to
www.dog.org and click on membership.
28
WOC
2010
C
o
m
m
i
t
t
e
e
s
AAD Executive
Committee
President of the BVA Professor Bernd Bertram (Aachen/D)
(Berufsverband der
Augenrzte)
Vice President of Dr. Klaus Heckmann (Wiesbaden/D)
the BVA
Secretary General of Professor Anselm Kampik (Munich/D)
the DOG
Secretary of the DOG Professor Franz Grehn (Wrzburg/D)
Scientific Board Professor Norbert Pfeiffer (Mainz/D)
Member of the BVA
Delegate of Professor Joachim Esser (Essen/D)
Strabismology and
Neuroophthalmology
Manager of the BVA Christian Gante (Dsseldorf/D)
Assistant of the Claudia Werner (Dsseldorf/D)
BVA Manager
For information about BVA membership please visit the
BVA booth located in the entrance foyer of the ICC or please go
to www.augeninfo.de/wir/formular.php (This site is only in
German).
29
WOC
2010
S
u
p
p
o
r
t
i
n
g

O
r
g
a
n
i
z
a
t
i
o
n
s
WOC 2010
Supporting
Organizations
Academia Ophthalmologica Internationalis (AOI)
American Association for Pediatric Ophthalmology and Strabismus (AAPOS)
American Society of Ophthalmic Plastic & Reconstructive Surgery (ASOPRS)
American Academy of Ophthalmology (AAO)
American Society of Retina Specialists (ASRS)
Asian Oceanic Glaucoma Society (AOGS)
Asia Pacific Academy of Ophthalmology (APAO)
Asia Pacific Society of Ophthalmic Plastic & Reconstructive Surgery (APSOPRS)
Asia Pacific Intraocular Inflammation Study Group (APIISG)
Association for Research in Vision and Ophthalmology (ARVO)
Barraquer Foundation
Bielschowsky Society
Black Sea Ophthalmological Society (BSOS)
Club Jules Gonin
Contact Lens Association of Ophthalmologists (CLAO)
European Academy of Ophthalmology (EAO)
European Association for Vision and Eye Research (EVER)
European Board of Ophthalmology (EBO)
European Contact Lens Society of Ophthalmologists (ECLSO)
European Glaucoma Society (EGS)
European Ophthalmic Oncology Group (EOOG)
European Paediatric Ophthalmological Society (EPOS)
European Society of Cataract and Refractive Surgery (ESCRS)
European Society of Ophthalmic Plastic and Reconstructive Surgery (ESOPRS)
European Society of Ophthalmology (SOE)
European Society of Retina Specialists (EURETINA)
European Strabismological Association (ESA)
European VitreoRetinal Society (EVRS)
Federation of European Ophthalmology (FEOph)
German Ophthalmic Surgeons (DOC)
German Society of Intraocular Lens Implantation, Interventional and Refractive
Surgery (DGII)
Glaucoma Research Society (GRS)
International Medical Contact Lens Council
International Ocular Inflammation Society (IOIS)
International Organization Against Trachoma (IOAT)
International Society for Clinical Electrophysiology of Vision (ISCEV)
International Society of Geographical and Epidemiological Ophthalmology (ISGEO)
International Society of Low Vision Research and Rehabilitation (ISLRR)
International Society of Ocular Oncology (ISOO)
International Society of Ocular Trauma (ISOT)
International Society for Ophthalmic Pathology
International Society of Refractive Surgery of the American Academy of
Ophthalmology (ISRS/AAO)
International Strabismological Association (ISA)
International Uveitis Study Group (IUSG)
Julius Hirschberg Society
Latin American Society of Cataract and Refractive Surgery (ALACCSA-R)
Lindberg Society
Middle East Africa Council of Ophthalmology (MEACO)
Pan American Oculoplastic Society
Pan American Association of Ophthalmology (PAAO)
Retinological Society
Sociedad Panamericana de Retina y Vtreo (SPRV)
South East Asia Glaucoma Interest Group (SEAGIG)
South East European Ophthalmological Society (SEEOS)
Tear Film & Ocular Surface Society (TFOS)
The Macula Society
The Retina Society
von Graefe Society
World Glaucoma Association (WGA)
31
WOC
2010
WOC History
2002 - 2014 WOC 2002
XXIX International Congress of Ophthalmology
21 - 25 April 2002, Sydney (AUS)
President: Peter Hardy Smith, MD
www.ophthalmology.aust.com
WOC 2006
XXX International Congress of Ophthalmology
19 - 24 February 2006, So Paulo (BR)
President: Rubens Belfort, Jr., M.D., Ph.D.
WOC 2008
XXXI International Congress of Ophthalmology
28 June - 2 July 2008, Hong Kong (CN)
President: Dennis S.C. Lam, MD, FRCOphth
www.woc2008hongkong.org
WOC 2010
5 - 9 June 2010, Berlin (D)
President: Gerhard K. Lang, MD
www.woc2010.org
WOC 2012
XXXIII International Congress of Ophthalmology
16 - 20 February 2012, Abu Dhabi (UAE)
President: Abdulaziz AlRahji, MD
WOC 2014
XXXIV International Congress of Ophthalmology
2 - 6 April 2014, Tokyo (J)
President: Tetsuro Oshika, MD
32
DOG
Deutsche Ophthalmologische
Gesellschaft e.V.
Die wissenschaftliche Gesellschaft
der Augenrzte
Ankndigung
Announcement
Herausforderungen in
der Augenheilkunde
109. DOG-Kongress
29.9.-2.10.2011
Estrel Hotel Berlin
Challenges in Ophthalmology
109
th
DOG Congress
29 September - 2 October 2011
Estrel Hotel Berlin
Prsident
President
Prof. Dr. Thomas Reinhard
Direktor der
Universitts-Augenklinik Freiburg
33
Invitation to the DOG Congress 2011
Einladung zum DOG-Kongress 2011
Dear Colleagues,
It is a special honour and pleasure for me to invite you to the 109
th
Congress of the
German Society of Ophthalmology in Berlin, September 29
th
to October 2
nd
2011.
Our theme is
Challenges in Ophthalmology
and we will be highlighting diagnostic and therapeutic aspects in depth.
We will address what constitutes the cutting edge in clinical and
scientific-research terms, and economic and educational topics will also be
presented. Various symposia will form the backbone of the congress. This
applies in particular to the Subspeciality Day, during which the latest
topics regarding each ophthalmological section may be presented and
discussed critically. Poster sessions will be given particularly close attention.
Two Keynote Lectures and the von Graefe Lecture are further highlights.
The congress offers a perfect forum for ophthalmologists, scientists,
residents and the industry to exchange knowledge. Our congress has
traditionally had an international flair, which is why we express an especially
warm welcome to guests and ophthalmological societies from all over the world.
The congress is taking place in the Hotel Estrel in Berlin for the third time. This
location offers a large number of conference rooms, an excellent infrastructure as
well as more than 2,000 beds.
Together with the board of the German Society of Ophthalmology, I would be
very pleased to welcome you in Berlin at the 109
th
congress.
Sehr geehrte, liebe Kolleginnen und Kollegen,
verehrte Gste, sehr geehrte Damen und Herren,
zum 109. Kongress der Deutschen Ophthalmologischen Gesellschaft vom
29. September bis zum 2. Oktober 2011 mchte ich Sie sehr herzlich nach Berlin
einladen. Unter dem Thema des Kongresses
Herausforderungen in der Augenheilkunde
sollen diagnostische und therapeutische Aspekte unseres Faches umfassend
beleuchtet werden. Dies wird die Cutting Edges in der Klinik und in der Forschung,
aber auch gesundheitskonomische Herausforderungen sowie Bereiche der Aus-,
Weiter- und Fortbildung betreffen.
Das Rckgrat des Kongresses stellen die zahlreichen Symposien dar. Dies gilt ganz
besonders fr den geplanten Subspeciality Day. Hier sollen aktuelle Themen des
jeweiligen ophthalmologischen Schwerpunkts von allen Seiten dargestellt und kri-
tisch hinterfragt werden. Daneben wird den aufgewerteten Postersitzungen beson-
deres Augenmerk gewidmet. Besondere Highlights stellen wiederum zwei Keynote
Lectures sowie die von Graefe-Vorlesung dar.
Der Kongress bietet Klinikrzten, niedergelassenen Augenrzten, Wissenschaftlern,
dem Nachwuchs und der Industrie eine hervorragende Gelegenheit zum Wissens-
austausch. Der Tradition folgend ist der Kongress auch international ausgerichtet.
So sind europische und auereuropische Referenten und Gste, aber auch Fach -
gesellschaften ganz besonders willkommen.
Der Kongress findet zum dritten Mal im Estrel in Berlin statt. Diese Lokalitt hat sich
als Veranstaltungsort mit einer groen Zahl an Tagungs- und Ausstellungsrumen,
mehr als 2.000 Hotelbetten, sowie einer exzellenten Infrastruktur sehr gut bewhrt.
Gemeinsam mit dem Geschftsfhrenden Prsidium der Deutschen Ophthalmolo -
gischen Gesellschaft wrde ich mich sehr freuen, Sie in Berlin zum 109. Kongress
begren zu drfen.
Prof. Dr. Thomas Reinhard
First Vice President of the DOG
Erster Vizeprsident der DOG
34
WOC
2010
The impressive memorial of the founder of the DOG, the German
Society of Ophthalmology, Albrecht von Graefe (May 22
nd
1828 - 20
th
July
1870 in Berlin) is situated in front of the Charit at the corner Luisen-/
Schumannstr. in Berlin-Mitte. On the initiative of the Medical Society
of Berlin, the memorial was built by the sculptor Rudolf Leopold
Siemering. It was originally positioned in the Charits garden which
was von Graefes main place of work.
Later the memorial was reestablished at its current location.
As a founder of the German Society of Ophthalmology Albrecht von
Graefe proved visionary farsightedness. The German Society of
Ophthalmology is the first and oldest scientific medical society of the
world.
The DOG wishes to thank all sponsors for the generous contribution
to the restoration of the memorial:
*Acri.Tec AG
Bausch & Lomb GmbH
Chibret Pharmazeutische GmbH
HOYA Medical Europe GmbH
sowie
Alcon Pharma GmbH, AMO Germany GmbH, Anteis GmbH, DOMILENS GmbH,
GEUDER AG, Pharm-Allergan GmbH, Rayner Surgical GmbH, Santen GmbH,
TECHNOMED GmbH
35
WOC
2010
36
Berlin WOC
2010

2010
108
th
DOG Congress
5 - 9 June 2010
AAD Congress 2010
3 - 6 June 2010
37
3 Congresses under one roof!
108
th
DOG Congress
AAD Congress 2010
Scientific Program
- 738 sessions and courses
- 1,204 invited speakers
- 1,123 papers from the coordinators program
- 1,120 posters
- 618 free papers
Subspecialty Days
The subspecialty days on 6 and 7 June, 2010 provide the
opportunity to discuss in depth new research approaches in
the areas of cataract, retina, glaucoma, refractive surgery and
pediatric ophthalmology.
Symposia sponsored by Supporting Organizations
55 supporting organizations offer 70 Symposia covering
various fields of modern ophthalmology.
From the Academia Ophthalmologica Internationalis (AOI) to
the World Glaucoma Association (WGA) all leading ophthalmic
associations will be represented at the WOC2010.
Submitted Scientific Program
559 free paper presentations
1120 poster presentations
33 video presentations
E-Posters
More than 1,120 posters can be viewed during the entire
congress at e-workstations located within the exhibition area
in Hall 17.
E-Videos
Videos are available for viewing at the e-poster and video
terminals in Hall 17. Headphones will be provided.
E-Papers
Available online immediately after their presentation at
the congress at the e-workstations in Hall 17.
H
i
g
h
l
i
g
h
t
s
At MSD Ophthalmics,
innovative science is in our DNA.
Heritage. Commitment. Vision.
Todays MSD is working to help
the world be well. Through our
medicines, vaccines, biologic
therapies, and consumer and
animal products, we work with
customers and operate in more
than 140 countries to deliver
innovative health solutions.
We also demonstrate our
commitment to increasing access
to health care through far-reaching
programs that donate and deliver
our products to the people who
need them. For over 50 years,
MSD has been committed to
ophthalmic research. And this
commitment continues into our
future of ophthalmic research.
SAFLUTAN and COSOPT are trademarks of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Whitehouse Station, NJ, USA.
Copyright 2010 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. All rights reserved. 3-11 CST-2010-W-1328400-J
Before prescribing SAFLUTAN
and COSOPT
, please read the Prescribing Information available from your local MSD representative.
Visit us at MSD exhibit booth #14/06 or on the Worldwide Web at www.msd.com
TM
(dorzolamide HCI-timolol maleate ophthalmic solution, MSD)
SAFLUTAN is manufactured
by Santen Oy, Finland.
39
WOC
2010
Opening Ceremony
18:30-20:00
ICC, Hall 1
Followed by the WOC Reception
20:00-22:00
ICC, Hall 2
Do not miss the WOC 2010 Opening Ceremony, Saturday 5 June 2010 at 6.30pm
Follow us and discover past, present and future during the Opening Ceremony:
Pay tribute to our ancestor Albrecht von Graefe
Explore the iconic Berlin, the vibrant capital of Germany and its Queen
Look into the future with WOC 2012 to be held in Abu Dhabi, United Arab
Emirates.
Join us in welcoming the Who is Who of ophthalmo-
logy marching in and coming from across the world and
be part of the promotion of scientific excellence
reflected throughout the International Award Ceremony.
Featured in HD sequences, the beauty of the Eye will be
omnipresent during the Opening Ceremony and strives
to represent the vision and mission of our fascinating
profession. Admire the breathtaking pictures of Eyeland
Design. Enjoy phantastic music and entertainment.
The WOC Reception is the perfect get-together for the
international ophthalmologist community and allied
specialties to meet old friends and make new ones in a
friendly atmosphere.
On behalf of the International Council of Ophthalmology, the German Society of
Ophthalmology, the German Academy of Ophthalmology and both, the WOC 2010
Executive Committee and Scientific Programme Committee, we take pleasure in
welcoming you to this key event.
Prof. Dr. Gerhard K. Lang Bruce E. Spivey, MD, MS, Med
President of the DOG International Council of Ophthalmology
President WOC 2010 President
H
i
g
h
l
i
g
h
t
s
Oculus Optikgerte GmbH 35549 Wetzlar GERMANY
Tel. +49-641-2005-0 Fax +49-641-2005-295 www.oculus.de
The future of eye-diagnostics starts now !
OCULUS High tech devices emphasizing
your competence
Reliable - Instruments you can trust on during your daily tasks
Innovative Our philosophy for more than 115 years
Customer-oriented We consult, train and care all over the world
This is OCULUS A family-owned enterprise with outlook
Look for us at the WOC 2010, booth #15A/10
41
WOC
2010
H
i
g
h
l
i
g
h
t
s
WOC in Concert
Sunday, 6 June 2010
20:00 21:30
French Church of Friedrichstadt
(French Cathedral, Franzsische Friedrichstadtkirche)
directly at the Gendarmenmarkt
Ophthalmologists play for Ophthalmologists
The musicians present masterpieces from
Carl Philipp Emmanuel Bach
Lon Bollmann
Leopold Mozart
Wolfgang Amadeus Mozart
Johann Joachim Quantz
Robert Schumann
Louis Vierne
Ludwig van Beethoven
Organizers:
Georg Fischer Varvitsiotis (Conductor)
and Franz Grehn
Entrance open from 19:30
Admission free. Concert attendees are
kindly requested to support the work
of Stiftung Auge (the Eye Foundation)
with a donation.
As the official airline network for World Ophthalmology Congress
2010, wed like to thank you for choosing the Star Alliance network
and hope that all goes really well for you here today.
Whilst you concentrate on the days events, we hope youll consider
us the next time you need to attend a conference.
With over 19,700 flights a day to 1,077 airports across 175 countries,
our 26 member airlines will extend a wide choice of flights to any future
conference youre planning to attend. And no matter which of those
airlines frequent flyer programmes you belong to, you can earn and
redeem miles across all of them.
So the next time you want to concentrate all your energies on your
conference, we hope youll decide to leave the travel arrangements
to us.
YOUVE ONLY JUST
ARRIVED & ALREADY
WERE THINKING OF
YOUR NEXT TRIP
www.staralliance.com
Information correct as at 01/2010
43
WOC
2010
H
i
g
h
l
i
g
h
t
s
WOCtoberfest
Monday, 7 June 2010
19:30-24:00
Hangar II at Tempelhof Airport
WOCtoberfest will be a typical Bavarian-like Oktoberfest
with beer, German food and entertainment. You should not
miss this special social highlight!
We cordially invite you to come and join us for a Bavarian-style
Oktoberfest at the WOCtoberfest. With traditional Oktober-
fest brass band music, beer and Bavarian specialties, we plan
to enjoy a lively, intercultural evening. Of course, there will
also be non-alcoholic drinks and vegetarian food. We are
offering some other attractions for adults and children so as
to celebrate this WOCtoberfest as a family party.
All participants are also most welcome to wear their own
national dress at this event, as wearing different and colorful
national dresses conveys a sense of friendly solidarity.
Our motto for the evening is: meet old friends and make new
friends in a relaxed and friendly atmosphere.
WOC
toberfest c 80
Children from 7 to 14 years c 25
(free up to 6 years)
Discover the Future of
Ophthalmology
ARVO Annual Meeting
May 15, 2011
Fort Lauderdale, Florida
www.arvo.org/am
Diabetic Retinopathy:
Neurovascular
Dysfunction & Protection
August 1114, 2010
Reykjavik, Iceland
www.arvo.org/serc
ARVO Summer Eye
Reseach Conference
Photo courtesy of freefoto.com

VO ARRV
Reseach Conference

VO Summer Eye
Reseach Conference

Neurovascular
August 1114, 2010

Neurovascular
August 1114, 2010

August 1114, 2010
Reykjavik, Iceland
www

August 1114, 2010
Reykjavik, Iceland
vo.org/serc .ar www

Ophthalmology
ARVO Annual Meeting
May 15, 2011

Ophthalmology
ARVO Annual Meeting
May 15, 2011

May 15, 2011
t Lauderdale, Florida For
www

May 15, 2011
t Lauderdale, Florida
vo.org/am .ar www

45
WOC
2010
Academia Ophthalmologica Internationalis (AOI) Lecture
Sunday, 6 June 2010, 17:30-18:15
Hall Oslo
Galileos Blindness
Chair:
Paul R. Lichter (Ann Arbor/USA)
Introduction of the AOI Lecturer:
Juan Verdaguer T. (Santiago/RCH)
Lecturer:
Peter Watson (Cambridge/UK)
He was educated in medicine at the University of Cambridge and University
College London. After posts in general medicine, neurosurgery and plastic
surgery, he trained in Ophthalmology at Moorfields Eye Hospital. He later
became Senior lecturer at Moorfields Eye Hospital and London University.
He was Consultant Ophthalmologist at Addenbrooke's University Hospital
and Moorfields Eye Hospital until 1995. He was Boerhaave Professor of
Ophthalmology University of Leiden The Netherlands from 1999 to 2004.
His specialty interests are in glaucoma transplantation and inflammatory
eye disease, especially scleritis. These interests have led to the development
of Trabeculectomy in 1976 with John Cairns and the unravelling of the types
of Scleral Disease together with the developmentof effective treatments
for these conditions. The third edition of the "Sclera and Systemic Disorders" is
currently in preparation.
He has also initiatited of the Cambridge Symposium now in its 40th year. This 2 day
symposium on a specific, sometimes minor topic, brings together basic scientists
and clinicians. It has been published as a separate issue of EYE since it started.
He was responsible for the initiation and development of the International Council
Assessments for Ophthalmologists. Over 2000 candidates a year from 70 countries
now take this exam.
Whilst Boerhaave Professor he was able to pursue his interest in Transplantation
which led to the successful transplantation of Ciliary Body in the rabbit. His interest
in portraiture has led him to investigate Galileo's blindness.
H
i
g
h
l
i
g
h
t
s
46
A
u
c
t
i
o
n
A
r
t
From above:
Peter Halley
Laurence Weiner
Rosemarie Trockel
From above:
Matt Mullican
Marc Francis
Stiftung Auge
weil Sehen wichtig ist
47
H
i
g
h
l
i
g
h
t
s
WOC 2010 Art Auction
Benefit Art Auction in aid of Stiftung Auge
(the Eye Foundation) as part of the WOC 2010.
3 9 June 2010
Main foyer, ICC Berlin
Join the bidding for some eye-catching pieces of art work!
Exclusive to WOC 2010 you have the opportunity to purchase modern works
centered on the theme of Art in the Art of Healing. In the works of art donated
by Georg Thieme Verlag, renowned contemporary artists have dealt with the
fascination of the human body, and also its fragility and limitations. This has
resulted in the creation of impressive works of art, which are available for purchase
as hand-signed, numbered serigraphs (limited edition of 250).
Art is Seeing Seeing is Art
Founded in 2008 by the German Society of Ophthalmology (DOG), Stiftung Auge
is dedicated to fighting avoidable blindness and serious visual impairment.
Its commitment is to raising awareness, training and the promotion of research
to preserve vision. If you would like to support the work of Stiftung Auge, join the
bidding and see what delights your eye. Stiftung Auge. Because sight is important.
The artists
Peter Halley, New York
Rosemarie Trockel, Cologne
Marc Francis, London
Laurence Weiner, New York
Matt Mullican, New York
Would you like to bid? Its easy:
At WOC 2010, you have the opportunity to see the expression and power of these
works of art for yourself. They will be on exhibition in the main foyer of the ICC next
to the Stiftung Auge stand. The value of each work is estimated at at least 1,300
Euro. Join in by making an opening bid of 300 Euro.
Should you wish to bid in the auction, you can have your name entered on a list of
bidders at the Stiftung Auge stand. Here, we will have some information on the
works of art to be auctioned, the current bidding situation and the foundation
itself. Curious? Then come along during WOC and join the bidding.
48
WOC
2010
49
WOC
2010
H
i
g
h
l
i
g
h
t
s
The Eye Run Because sight is important
Five-kilometer run in aid of Stiftung Auge (the Eye Foundation)
as part of the World Ophthalmology Congress.
Start: Sunday, 6 June 2010, 7.00 a.m.
at Mommsenstadion, near the ICC Berlin
Waldschulallee 34, 14055 Berlin, Germany
Open your eyes to a beautiful route and a good cause!
Make a sporty start to Sunday morning together with some
fellow runners and help to preserve the sense of sight at the
same time: this is the goal of the Eye Run on the occasion of
WOC 2010. This breakfast-time run follows a flat course
leading through city and forest. The start and finish are located
at Mommsenstadion, 10 minutes walk from the Messe Berlin
exhibition grounds and the ICC Berlin. An award ceremony will
take place following the run. Refreshments are provided and
changing rooms and sanitary facilities are available.
Support Stiftung Auge!
Founded in 2008 by the German Society of Ophthalmology
(DOG), Stiftung Auge is dedicated to fighting avoidable blind-
ness and serious visual impairment. Its commitment is to
raising awareness, training and the promotion of research to
preserve vision. If you would like to support the work of
Stiftung Auge, run with us on June 6, 2010 in the Eye Run!
Youd like to join in? Its easy:
All congress attendees and running enthusiasts are most
welcome to take part in the Eye Run. Pay a 15 Euro donation fee
and youre off!
Registrations can be made at the Stiftung Auge stand in
the main foyer of the ICC Berlin during WOC 2010. Would you
like to do something for your health and support the work
of Stiftung Auge? Then pack your running shoes and join in on
June 6, 2010 when the cry goes up: On your marks, get set, go!
WOC
2010
H
o
w

t
o

R
e
a
d

t
h
e

S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m
50
Scientific Program
S
u
b
s
p
e
c
i
a
l
t
y

D
a
y
s
WOC
2010
51
Zwei-Jahres-Abo:
22 Ausgaben fr 166 Euro*. (inkl. jhrl.
aktualisiertem Ophthalmo-Index)
Jahres-Abo:
11 Ausgaben fr 83 Euro*. (inkl. jhrl.
aktualisiertem Ophthalmo-Index)
Test-Abo:
3 Ausgaben fr 20 Euro**.
Das Abonnement verlngert sich nur
dann um ein Jahr, wenn nach Erhalt der
2. Ausgabe keine schriftliche Kndigung
vorliegt.
Ermigtes Abo:
11 Ausgaben fr 47 Euro, fr Assistenzrzte
und Studenten. Nachweis beilegen.
*zzgl. Versand 16 Euro (inkl. MwSt.);
**inkl. Versand und MwSt.
Bestell-Service:
Augenspiegel Leserservice
PressUp GmbH, Postfach 701311
22013 Hamburg, Fax: 040-41448-499
Telefon: 040-41448-460
E-Mail: mediawelt@pressup.de
"#0 "/(&#05
8&// 4*& +&5;5 &*/
;8&*+)3*(&4"#0#&45&--&/
&3)"-5&/ 4*& %*&4&/
(#*10%/"/0
(3"5*4
*MlJ \lLLOKAMLkA, OkOSSLkLM LlSlLA, kALlO UNL \lLLLS MLHkl
WOC
2010
S
u
n
d
a
y
,

6

J
u
n
e

S
u
b
s
p
e
c
i
a
l
t
y

D
a
y
s
53
09:25 IL SU-02-02
What is weak in present conventional perimetry
and what can we do about it
Ulrich Schiefer (Tbingen/D)
09:35 IL SU-02-03
Alternatives presently available (Flicker tests [FDT,
Matrix, etc.], electrophysiology)
Michael Bach (Freiburg/D)
09:45 IL SU-02-04
What we need - the ideal new functional test
Balwantray C. Chauhan (Halifax/CDN)
09:55
Discussion
Stockholm
10:30 - 11:15 SU-03
Decisions for Treatment and Change in Treatment
Subspecialty Day Glaucoma
Glaucoma Care: A Look into the Future
Section 2:
Present and Future Approaches to Glaucoma Care
Chairs:
Augusto Azuara-Blanco (Aberdeen/UK)
10:30 IL SU-03-01
Risk assessment and risk calculation
Steven L. Mansberger (Portland/USA)
10:40 IL SU-03-02
The impact of risk calculation on physician
decisions
Michael Boland (Baltimore/USA)
10:50 IL SU-03-03
Cost/benefit, Cost effectiveness
11:00 IL SU-03-04
Practice patterns, too much or too little
11:10
Discussion
Sunday, 6 June 2010
Stockholm
08:30 - 09:15 SU-01
Present and Future Imaging
Section 1:
Structure and Function in Glaucoma Care
Chairs:
Ted Garway-Heath (London/UK)
Ester M. Hoffmann (Mainz/D)
08:30 IL SU-01-01
What is most useful present imaging (HRT, OCT,
GDx)
Ester M. Hoffmann (Mainz/D)
08:40 IL SU-01-02
Measuring progressive change with imaging:
which stage, which strategy, which consequences
08:50 IL SU-01-03
Ganglion cell visualization: animals and humans
M. Francesca Cordeiro (London/UK)
09:00 IL SU-01-04
Perspectives in retinal imaging: adaptive optics,
en face OCT and full-field doppler
Michel Paques (Paris/F)
09:10
Discussion
Stockholm
09:15 - 10:00 SU-02
Present and Future of Functional Diagnostics
Section 1:
Structure and Function in Glaucoma Care
Chairs:
Anders Heijl (Malm/S)
09:15 IL SU-02-01
Useful strategies in present perimetry
Stockholm
11:15 - 12:00 SU-04
New Approaches to Gathering Information About
Glaucoma
Section 2:
Present and Future Approaches to Glaucoma Care
Chairs:
Alfred Sommer (Baltimore/USA)
Richard Wormald (London/UK)
11:15 IL SU-04-01
The challenge: conduct large-scale research with
many centers
Don Budenz (Miami/USA)
11:25 IL SU-04-02
Insurance database studies: strengths and wea-
knesses
Joshua D. Stein (Ann Arbor/USA)
11:35 IL SU-04-03
Mining our hard drives (Lessons from Cochrane
approach)
11:45 IL SU-04-04
How to do research cheaper and better
12:05
Discussion
Stockholm
14:00 - 14:45 SU-05
Adherence with Medical Therapy, the Dirty Secret
Section 3:
Outlooks to Medical and Surgical Therapy
Chairs:
Jenny Lacey (Norwich/UK)
14:00 IL SU-05-01
How bad is adherence now?
14:10 IL SU-05-02
Barriers to adherence
14:20 IL SU-05-03
How does physician communication affect
adherence?
14:30 IL SU-05-04
How much would be gained if we increased
adherence?
James C Tsai (/USA)
14:40
Discussion
Stockholm
14:45 - 15:40 SU-06
Present and Future of Glaucoma Surgery Surgical
Challenges
Section 3:
Outlooks to Medical and Surgical Therapy
Chairs:
Peng T. Khaw (London/UK)
Tarek M. Shaarawy (Geneva/CH)
George Baerveldt (Irvine/USA)
14:45 IL SU-06-01
Developments making trabeculectomy safer
14:55 IL SU-06-02
Bleb classification and management of complicati-
ons related to blebs
15:05 IL SU-06-03
Non-penetrating glaucoma surgery techniques
has their time come or gone?
15:15 IL SU-06-04
Tubes: When, why, how
Keith Barton (London/UK)
15:25 IL SU-06-05
Angle surgery: status report on newer methods
15:35 IL SU-06-06
Standardized reporting on surgical studies
Mark Sherwood (Gainesville/USA)
Sunday, 6 June 2010
WOC
2010
S
u
n
d
a
y
,

6

J
u
n
e
S
u
b
s
p
e
c
i
a
l
t
y

D
a
y
s
54
WOC
2010
S
u
n
d
a
y
,

6

J
u
n
e
S
u
b
s
p
e
c
i
a
l
t
y

D
a
y
s
55
Stockholm
16:10 - 16:50 SU-07
Childhood Glaucoma Care: the Patient who Lives
up to 2100
Section 4:
Neglected Areas: Where Can We Improve
Chairs:
Jan Eric Jakobsen (Oslo/N)
Jugnoo S. Rahi (London/UK)
16:10 IL SU-07-01
Present and future surgical techniques: Innovation
at the horizon?
16:20 IL SU-07-02
Spontaneous resolution of congenital glaucoma
a natural help for surgery
16:25 IL SU-07-03
Developing vision: Amblyopia is a major challenge
Thomas Klink (Wrzburg/D)
16:35 IL SU-07-04
New aspects of secondary glaucoma after
congenital cataract surgery
16:45
Discussion
Stockholm
16:50 - 17:30 SU-08
Glaucoma Care in Developing Countries
Section 4:
Neglected Areas: Where Can We Improve
Chairs:
Paul Foster (London/UK)
Clement C. Y. Tham (Hong Kong/CN)
16:50 IL SU-08-01
The scope of the problem
16:55 IL SU-08-02
What is done now for OAG in the developing world
Kuldev Singh (Stanford/USA)
17:00 IL SU-08-03
What is done now for ACG in the developing world
What should be done right now: 3 viewpoints
17:05 IL SU-08-04
We should apply the developed country model
17:10 IL SU-08-05
We should use different programs for different
regions
Tin Aung (Singapore/SGP)
17:15 IL SU-08-06
We should use the center of excellence pyramid
model
Garudadri Chandra Sekhar (Hyderabad/IND)
17:25 IL SU-08-07
Where will we make the biggest short-term gains
in reducing impairment
Mingguang He (Guangzhou/CN)
17:25
Discussion
Abu Dhabi
08:30 - 10:00 SU-13
Correcting Presbyopia with IOLs
Subspecialty Day Cataract
Chairs:
Charles Claou (Brentwood/UK)
08:30 IL SU-13-01
Monovision
08:40 IL SU-13-02
Multifocal, refractive
08:50 IL SU-13-03
Mulitfocal, diffractive
Jos F. Alfonso (Miami/USA)
09:00 IL SU-13-04
Accommodating, monooptic
Milind Pande (North Ferriby/UK)
Sunday, 6 June 2010
09:10 IL SU-13-05
Accommodating, dualoptic
Ivan L. Ossma-Gomez (Bucaramanga/CO)
09:20 IL SU-13-06
Managing astigmatism and residual ametropia
Michael C. Knorz (Mannheim/D)
09:30
Discussion
Abu Dhabi
10:30 - 12:00 SU-14
Managing Complex Cases
Chairs:
Boris Malyugin (Moscow/RUS)
Hiroko Bissen-Miyajima (Tokyo/J)
10:30 IL SU-14-01
Incisional issues
10:40 IL SU-14-02
Dense nuclei
10:50 IL SU-14-03
Small pupils
11:00 IL SU-14-05
Ruptured posterior capsule
11:10 IL SU-14-06
Iris defects (aniridia, coloboma, traumatic)
Stephan Kohnen (Aachen/D)
11:20 IL SU-14-07
Dislocated iols
TBA
11:30
Discussion
Abu Dhabi
14:00 - 15:30 SU-15
New Monofocal IOL Designs
Chairs:
Rudy Nuijts (Maastricht/NL)
Liliana Werner (Berlin/D)
Thomas Kohnen (Frankfurt am Main/D)
14:00 IL SU-15-01
Aspheric
14:10 IL SU-15-02
Toric overview
14:20 IL SU-15-03
Surgical pearls for toric IOLs
David Spalton (London/UK)
14:30 IL SU-15-04
Extreme cases
Gerd U. Auffarth (Heidelberg/D)
14:40 IL SU-15-05
Light-adjustable
Fritz Hengerer (Bochum/D)
14:50 IL SU-15-06
New IOL biomaterials
15:00
Discussion
Abu Dhabi
16:00 - 17:30 SU-16
Emerging Technology in Cataract Surgery
Chairs:
Mats Lundstrm (Karlskrona/S)
Douglas D. Koch (Houston/USA)
Oliver Findl (Vienna/A)
16:00 IL SU-16-01
Advances in techniques for patient assessment
16:10 IL SU-16-02
IOL calculations, technology?, formulas - Haigis,
IOL calculations after refractive surgery - DDK
Jaime Aramberri Agesta (Vitoria-Gasteiz/E)
Sunday, 6 June 2010
WOC
2010
S
u
n
d
a
y
,

6

J
u
n
e
S
u
b
s
p
e
c
i
a
l
t
y

D
a
y
s
56
WOC
2010
S
u
n
d
a
y
,

6

J
u
n
e
S
u
b
s
p
e
c
i
a
l
t
y

D
a
y
s
57
16:20 IL SU-16-03
Phaco technology
Barry S. Seibel (Los Angeles/USA)
16:30 IL SU-16-04
Prevention of PCO
Manfred Tetz (Berlin/D)
16:40 IL SU-16-05
Prevention of endophthalmitis
16:50 IL SU-16-06
Small-incision ECCE" to "Modern Manual Cataract
Srinivas K. Rao (Chennai/IND)
17:00
Discussion
Hall 3
08:30 - 10:00 SU-48
Retinal Detachment and PVR
Subspecialty Day Retina
Chairs:
George William Aylward (London/UK)
08:30 IL SU-48-01
Surgical instrumentation for RD and PVR repair
(20, 23, 25 g etc.)
Constantin J. Pournaras (Geneva/CH)
08:40 IL SU-48-02
Which new drugs can treat PVR?
Louisa Wickham (London/UK)
08:50 IL SU-48-03
Is there still place for scleral buckling in primary
surgery for RD?
Heinrich Heimann (Liverpool/UK)
09:00 IL SU-48-04
Management after failure of primary RD-repair
Periklis Brazitikos (Athens/GR)
09:10 IL SU-48-05
Prevention of RD: are there cases in which it is
worthwhile?
Fred Hendrikse (Maastricht/NL)
09:20 IL SU-48-06
Management of second eye in vitreoretinal
dystrophies
Antonio Capone (Oakland/USA)
9:30 IL SU-48-07
Trauma and vitreoretinal surgery timing and
management
Masahito Ohji (Otsu/J)
09:40 IL SU-48-08
Intraocular tamponade whats new?
David Wong (Pok Fu Lam/HK)
09:50 IL SU-48-09
Hot topic (last minute announcement)
TBA
10:00
Discussion
Hall 3
10:30 - 12:00 SU-49
Vitreoretinal Interface Epiretinal Macular
Surgery
Chairs:
Michael T. Trese (Royal Oak/USA)
10:30 IL SU-49-01
Pathology of the vitreoretinal interface: Implicati-
ons for surgery
Arnd Gandorfer (Munich/D)
10:40 IL SU-49-02
Pharmacologic vitreolysis and vitreodynamics
Matthew Benz (Houston/USA)
10:50 IL SU-49-03
Progress in epiretinal surgery: vital stains
Christos Haritoglou (Munich/D)
11:00 IL SU-49-04
Macular hole surgery: is face -down positioning
still necessary?
D. Alistair H. Laidlaw (London/UK)
11:10 IL SU-49-05
Macular hole surgery: is ILM peeling always
useful?
Ramin Tadayoni (Paris/F)
11:20 IL SU-49-06
ERM and VMTS surgery: cases which fail
Thomas J. Wolfensberger (Lausanne/CH)
11:30 IL SU-49-07
Vitreoretinal interface in AMD
Susanne Binder (Vienna/A)
Sunday, 6 June 2010
WOC
2010
S
u
n
d
a
y
,

6

J
u
n
e
S
u
b
s
p
e
c
i
a
l
t
y

D
a
y
s
58
11:40 IL SU-49-08
Vitreoretinal Interface in children therapeutic
implications
11:50 IL SU-49-09
TBA
12:00
Discussion
Hall 3
14:00 - 15:30 SU-50
Retinal Vascular Diseases: Diabetic Retinopathy /
Vein Occlusions
Chairs:
14:00 IL SU-50-01
Retinal oximetry in diabetic retinopathy and reti-
nal vein occlusions
Einar Stefnsson (Reykjavik/IS)
14:10 IL SU-50-02
Steroids vs laser in DME
Pascale Massin (Paris/F)
14:20 IL SU-50-03
Anti VEGFs vs Steroids in DME
Julia A. Haller (Philadelphia/USA)
14:30 IL SU-50-04
Slow release steroids in DME
14:40 IL SU-50-05
Combination of pharmacology and VR surgery in DR
J. Fernando Arevalo (Caracas/Y)
14:50 IL SU-50-06
Does early intravitreal drug therapy change the
course of BRVO and CVRO
Francesco Bandello (Milano/I)
15:00 IL SU-50-07
Is surgery useful in BRVO and CRVO?
Jos Garca Arum (Barcelona/E)
15:10 IL SU-50-08
TBA
15:20 IL SU-50-09
TBA
Hall 3
16:00 - 17:30 SU-51
AMD
Chairs:
16:00 IL SU-51-01
When to stop anti VEGF therapy?
Adnan Tufail (London/UK)
16:10 IL SU-51-02
Update on Clinical Trials of Intravitreal Drugs for
Neovascular AMD
Alexander J. Brucker (Philadelphia/USA)
16:20 IL SU-51-03
Geographic atrophy: Imaging Metrics and
Progression Determinants
16:30 IL SU-51-04
Future drugs for treatment of dry AMD
Salvatore Grisanti (Lbeck/D)
16:40 IL SU-51-05
Genetics and prevention of AMD
Hendrik Peter Nicolas Scholl (Bonn/D)
16:50 IL SU-51-06
Is there a place for surgery in AMD?
Jan van Meurs (Rotterdam/NL)
17:00 IL SU-51-07
Cell therapy for AMD
TBA
17:10 IL SU-51-08
How to prevent endophthalmitis in intravitreal
therapy?
Thierry C. Verstraeten (Pittsburgh/USA)
17:10 IL SU-51-09
TBA
Sunday, 6 June 2010
WOC
2010
M
o
n
d
a
y
,

7

J
u
n
e
S
u
b
s
p
e
c
i
a
l
t
y

D
a
y
s
59
Sao Paulo
08:30 - 10:00 MO-04
Update on Retinopathy of Prematurity: New
Approaches for Research, Diagnosis and Treatment
Subspecialty Day Pediatric Ophthalmology
Chairs:
Andrea Zin (Rio de Janeiro/BR)
Anand Vinekar (Bangalore/IND)
08:30 IL MO-04-01
New research areas in ROP diagnosis and
management
Ann Hellstrom (Gothenburg/S)
08:40 IL MO-04-02
Organizing national screening programs for ROP
08:50 IL MO-04-03
ROP Screening in Vietnam
Nguyen Xuan Tinh (Hanoi/VN)
09:00 IL MO-04-04
Telemedicine as an option for screening:
The experts view on WFDI in ROP
Michael Chiang (New York/USA)
09:10 IL MO-04-05
Telemedicine in ROP: The Indian Experience
09:20 IL MO-04-06
WFDI in ROP. Opportunity for automated image
analysis
Alistair Fielder (London/UK)
09:30 IL MO-04-07
Anti-VEGF and ROP
Helen A. Mintz-Hittner (Houston/USA)
09:40
Discussion
Sao Paulo
10:30 - 12:00 MO-05
Surgical Challenges in Pediatric Anterior Segment
Diseases
Chairs:
Marie-Jos Tassignon (Antwerp/B)
Ken K. Nischal (London/UK)
10:30 IL MO-05-01
Best choice surgery in pediatric cataract
Marie-Jos Tassignon (Antwerb/B)
10:45 IL MO-05-02
Alternatives to penetrating keratoplasty in
pediatric corneal disease
11:00 IL MO-05-03
Pediatric Corneal Transplantation: Experiences
from a large tertiary referral center in India
Pravin V. Krishna (Hyderabad/IND)
11:15 IL MO-05-04
The choice and effectiveness of surgery in different
clinical forms of congenital glaucoma
Anton Gerinec (Bratislava/SK)
11:30 IL MO-05-05
Pediatric perforating injuries of the globe: timing
of surgical steps
Robert Stegmann (Pretoria/ZA)
11:45
Discussion
Sao Paulo
14:00 - 15:30 MO-06
Update on Infantile Nystagmus: Clinics, Genetics,
and Treatment
Chairs:
Irene Gottlob (Leicester/UK)
Christina Zeitz (Paris/F)
14:00 IL MO-06-01
Modern work-up in infantile nystagmus
14:15 IL MO-06-02
Genetics of X-linked idiopathic nystagmus
14:30 IL MO-06-03
Genetics of cone dysfunction disorders
Susanne Kohl (Tbingen/D)
14:45 IL MO-06-04
Genetic and clinical hetereogeneity of congenital
forms of night blindness
15:00 IL MO-06-05
Medical and surgical treatment options
Anil Kumar (Leicester/UK)
Monday, 7 June 2010
15:15 IL MO-06-06
Gene therapy provides cure for achromatopsia
Knut Stieger (Giessen/D)
Sao Paulo
16:00 - 17:30 MO-07
EPOS Symposium: Vision 2020 in Pediatric
Ophthalmology. Dreams and Realities in
Eliminating Avoidable Childhood Blindness
Chairs:
Clare Gilbert (London/UK)
David Taylor (London/UK)
16:00 IL MO-07-01
VISION 2020 and children: achievements and
challenges
16:15 IL MO-07-02
Pediatric cataract: can we improve on what we
have achieved?
Michael OKeefe (Dublin/IRL)
16:30 IL MO-07-03
Pediatric glaucoma. Holes, tubes and more
16:45 IL MO-07-04
Pediatric infectious eye diseases: Prevention and
treatment
Perumalsamy Vijayalakshmi (Madurai/IND)
17:00 IL MO-07-05
Predictions of genotype and phenotype in
pediatric hereditary diseases: present
achievements and future challenges
Josseline Kaplan (Paris/F)
17:15 IL MO-07-06
Retinal dystrophies: hopes for cure
Hall 3
08:30 - 10:00 MO-37
Corneal Approaches for Addressing Presbyopia
Subspecialty Day Refractive Surgery
Chairs:
Emanuel S. Rosen (Manchester/UK)
08:30 IL MO-37-01
Corneal Techniques (Monovision)
08:45 IL MO-37-02
Corneal Pseudoaccommodation
09:00 IL MO-37-03
Presby-Lasik
Damin Gatinel (Paris/F)
09:15 IL MO-37-04
Intracorneal Lenses
09:30 IL MO-37-05
Small Aperture Devices
George Waring (Atlanta/USA)
09:45
Discussion
Hall 3
10:30 - 12:00 MO-38
Corneal Laser Refractive Surgery
Chairs:
Gnther Grabner (Salzburg/A)
J. Bradley Randleman (Atlanta/USA)
10:30 IL MO-38-01
Femtosecond Laser Technology
10:40 IL MO-38-02
Excimer Laser Technology
10:50 IL MO-38-03
Other New Technologies for Ablation and Flap
Creation
Holger Lubatschowski (Hannover/D)
Monday, 7 June 2010
WOC
2010
M
o
n
d
a
y
,

7

J
u
n
e
S
u
b
s
p
e
c
i
a
l
t
y

D
a
y
s
60
WOC
2010
M
o
n
d
a
y
,

7

J
u
n
e
S
u
b
s
p
e
c
i
a
l
t
y

D
a
y
s
61
11:00 IL MO-38-04
Eye-Tracking
Michael Mrochen (Zurich/CH)
11:10 IL MO-38-05
LASIK Techniques and Complications
11:20 IL MO-38-06
Surface Techniques and Complications
Marguerite McDonald (New Orleans/USA)
11:30 IL MO-38-07
Ectasia
11:40
Discussion
Hall 3
14:00 - 15:30 MO-39
Corneal Physiology and Biomechanics
Chairs:
William J. Dupps Jr. (Cleveland/USA)
14:00 IL MO-39-01
Biomechanics
14:10 IL MO-39-02
Accommodation and presbyopia
Adrian Glasser (Houston/USA)
14:20 IL MO-39-03
Normal wavefront error as function of age, pupil
size and anatomy
14:30 IL MO-39-04
Retinal image quality in refractive surgery
Jack T. Holladay (Bellaire/USA)
14:40 IL MO-39-05
Laser tissue interaction
Ronald R. Krueger (Cleveland/USA)
14:50 IL MO-39-06
New advances in corneal imaging
Mitchell P. Weikert (Houston/USA)
15:00
Discussion
Hall 3
16:00 - 17:30 MO-40
Managing High Refractive Errors
Chairs:
Roberto Zaldivar (Buenos Aires/RA)
16:00 IL MO-40-01
Phakic iols vs corneal refractive surgery
Jos L. Gell (Barcelona/E)
16:10 IL MO-40-02
Angle-supported
16:20 IL MO-40-03
Iris-fixated
Camille Budo (Melveren/B)
16:30 IL MO-40-04
Sulcus-fixated
16:40 IL MO-40-05
Phakic IOLs: complications
16:50 IL MO-40-06
Refractive lens exchange
Antonio A. P. Marinho (Porto/P)
17:00 IL MO-40-07
IOL selection for refractive lens exchange
Roberto Bellucci (Verona/I)
17:10
Discussion
Monday, 7 June 2010
EVER
Crete Oct 6-9
2010
www.ever.be
21 CME CREDITS
Join EVER
Largest annual european eye research meeting
Keynote lectures
Special interest symposia
Free paper sessions and posters
Workshops and courses
Commercial Interest Symposia
New attractive location every three years
Become an active member
Reduced fee for annual meeting
Organizing Special Interest Symposia (SIS) during the
annual meeting
Voting rights for the election of Board Members
Free access to Acta Ophthalmologica
Travel grants
Quarterly E-Newsletter
European Association for Vision and Eye Research
23/03/2010
Keynote - Plenary Lectures
Keynote Lectures - David TAYLOR, UK
- Alan BIRD, UK
- Stefan SEREGARD, Sweden
EVER - Acta Lecture - Wolfgang DREXLER, Austria
EVER Lecture - Charles RIVA, Switzerland
European Ophthalmic Heritage Lecture
Ophthalmic Research Lecture
EVI Prize and Lecture
Pre-congress Courses
COS - Optical coherence tomography applications
in anterior segment eye diseases
Edward WYLEGALA
- Corneal infectious disease - Jean-Jacques
GICQUEL, Harminder S DUA
- Facial nerve palsy: anatomy, etiology,
evaluation, and management
Ioannis MAVRIKAKIS
IM - EBO Review Course 1: Intraocular
inammation and infection - Bahram BODAGHI,
Carl P HERBORT
- EBO Review Course 2: Intraocular
inammation and infection - Bahram BODAGHI,
Carl P HERBORT
LC - Anaesthesia in ocular surgery - Kati GOMBOS
NSPH - Common neuro-ophthalmic pitfalls: case-
based studies - Valerie PURVIN, Aki KAWASAKI
PO - Diagnostic of ophthalmic tumors - Laurence
DEJARDINS, Bertil DAMATO
- Proper use of words and numbers in
scientic writing - Bertil DAMATO, Tero KIVEL
- Simple and effective alternatives to
textbook surgical procedures for treatment
of trichiasis, removal of orbital tumors and
evisceration - Mordechai ROSNER, Nachum ROSEN
RV - Retinal detachment: how to improve our
success rate? - Caherine CREUZOT, Constantin
POURNARAS
- Retinal imaging: rst to describe and then
to analyse - Caherine CREUZOT, Gisle SOUBRANE
Special Interest Symposia/workshops
in the following scientic sections:
Anatomy / Cell Biology - ACB
Cornea / Ocular Surface - COS
Glaucoma - G
Immunology / Microbiology - IM
Lens and Cataract - LC
Molecular Biology / Genetics / Epidemiology - MBGE
Neuro-ophthalmology / Strabismology/ Paediatric
Ophthalmology / History of Ophthalmology - NSPH
Pathology / Oncology - PO
Physiology/Biochemistry/Pharmacology - PBP
Retina / Vitreous - RV
Vision Sciences / Electrophysiology / Physiol. Optic - VEP
Dates to remember
Abstract submission deadline: June 14, 2010
Final programme online: July 15, 2010
Early registration deadline: September 1, 2010
EVER 2010 Hosts:
ARVO - ESCRS - EURETINA - FRO - ISCEV - MEACO - OOG - SOIE
S
c
ie
n
c
e

f
o
r

S
ig
h
t
Scientific Program
Scientific Program Schedule
S
a
t
u
r
d
a
y
,

5

J
u
n
e
WOC
2010
63
S
a
t
u
r
d
a
y
,

5

J
u
n
e
H
i
g
h
l
i
g
h
t
S
y
m
p
o
s
i
u
m
F
r
e
e

P
a
p
e
r
W
O
C

C
o
u
r
s
e
I
n
d
u
s
t
r
y

S
y
m
p
o
s
i
u
m
M
e
e
t
i
n
g
s
I
C
C
H
a
l
l

1
H
a
l
l

2
H
a
l
l

6
H
a
l
l

7
H
a
l
l

8
H
a
l
l

9
H
a
l
l

1
0
R
o
o
f

G
a
r
d
e
n
S
a
l
o
n

1
1
/
1
2
S
a
l
o
n

1
3
/
1
4
S
a
l
o
n

1
5
/
1
6
R
o
o
m

3
4
R
o
o
m

4
4
R
o
o
m

5
6
0
7
1
5
3
0
4
5
0
8
1
5
3
0
4
5
0
9
1
5
3
0
4
5
1
0
1
5
3
0
4
5
1
1
1
5
3
0
4
5
1
2
1
5
3
0
4
5
1
3
1
5
3
0
4
5
1
4
1
5
3
0
4
5
1
5
1
5
3
0
4
5
1
6
1
5
3
0
4
5
1
7
1
5
3
0
4
5
1
8
1
5
3
0
4
5
S
A
-
0
0

O
p
e
n
i
n
g

C
e
r
e
m
o
n
y
S
A
-
3
3

B
r
u
c
k
e
r
,

S
o
u
b
r
a
n
e
,

H
o
l
z
U
p
d
a
t
e

o
n

M
a
n
a
g
e
m
e
n
t

o
f

A
M
D
S
A
-
3
4

L
i
,

B
a
n
d
e
l
l
o
,

S
c
h
m
i
d
t
-
E
r
f
u
r
t
h

U
p
d
a
t
e

i
n

D
i
a
b
e
t
i
c
R
e
t
i
n
o
p
a
t
h
y
L
u
n
c
h

S
y
m
p
o
s
i
u
m
A
l
c
o
n
W
O
C
-
A
A
D
-
C
-
1
7

Z
i
e
r
h
u
t

E
p
i
s
c
l
e
r
i
t
i
s

a
n
d

S
c
l
e
r
i
t
i
s
W
O
C
-
A
A
D
-
C
-
1
8

K
i
r
c
h
h
o
f

D
i
a
g
n
o
s
i
s

a
n
d

T
r
e
a
t
m
e
n
t

o
f
P
e
r
i
p
h
e
r
a
l

R
e
t
i
n
a
l

D
e
g
e
n
e
r
.
W
O
C
-
A
A
D
-
C
-
1
9

B
e
h
r
e
n
s
-
B
a
u
m
a
n
n

D
i
a
g
n
o
s
i
s

a
n
d
T
r
e
a
t
m
e
n
t

o
f

K
e
r
a
t
o
m
y
c
o
s
e
s
L
u
n
c
h

S
y
m
p
o
s
i
u
m
B
a
u
s
c
h
&
L
o
m
b
O
c
u
l
u
s

U
s
e
r

M
e
e
t
i
n
g
B
r
e
a
k
f
a
s
t

S
y
m
p
o
s
i
u
m
Z
i
e
m
e
r
W
O
C
-
C
-
1
0

W
o
r
m
a
l
d
,

V
i
r
g
i
l
i

E
v
i
d
e
n
c
e
-
B
a
s
e
d

O
p
h
t
h
a
l
-
m
o
l
o
g
y

W
O
C
-
A
A
D
-
C
-
1
1

C
u
r
s
i
e
f
e
n

C
r
o
s
s
l
i
n
k
i
n
g

o
f

t
h
e

C
o
r
n
e
a
:
W
h
e
n
,

H
o
w

a
n
d

W
h
y
?
W
O
C
-
C
-
1
2

C
h
a
k
r
a
b
a
r
t
i

A
d
v
a
n
c
e
d

B
i
a
x
i
a
l

M
i
c
r
o
p
h
a
c
o
a
n
d

C
o
a
x
i
a
l

P
h
a
c
o
M
i
t
g
l
i
e
d
e
r
v
e
r
s
.
B
i
e
l
s
c
h
o
w
s
k
y
-
G
e
s
e
l
l
s
c
h
a
f
t
S
i
t
z
u
n
g

d
e
r

S
e
k
t
i
o
n

D
O
G
-
G
l
a
u
k
o
m
W
O
C
-
A
A
D
-
C
-
2
0

G
r
e
h
n

G
l
a
u
c
o
m
a

S
u
r
g
e
r
y

F
o
l
l
o
w
-
u
p
C
a
r
e
S
A
-
3
7

K
o
l
l
m
a
n
n
,

I
l
a
k
o
,
N
k
u
m
b
e

A
f
r
i
c
a
:

C
a
n

w
e

s
u
c
-
c
e
e
d

i
n

t
h
e

g
r
e
a
t
e
s
t

c
h
a
l
l
.
S
A
-
3
8

L
a
n
d
a
u
,

Z
r
e
n
n
e
r
,

L
e
e
,
L
u
c
o

P
a
n
e
l
:

N
e
u
r
o
-
O
p
h
t
h
a
l
-
m
o
l
o
g
i
c
a
l

P
r
o
b
l
e
m
s

S
A
-
1
5

F
r
a
n
c
e
s
c
h
e
t
t
i
,

K
h
o
o
,
K
u
h
n

P
a
n
e
l
:

C
o
n
t
a
c
t

L
e
n
s
e
s
a
n
d

C
h
i
l
d
r
e
n
S
A
-
1
6

K
i
n
o
s
h
i
t
a
,

F
i
o
l
-
S
i
l
v
a
,
G
u
t
h
o
f
f

C
o
r
n
e
a
l

I
m
a
g
i
n
g
:
N
e
w

V
e
r
s
u
s

U
s
e
f
u
l
I
C
O

W
o
r
l
d

O
p
h
t
h
a
l
m
o
l
o
g
y

R
o
u
n
d
t
a
b
l
e

o
n

L
e
a
d
e
r
s
h
i
p

D
e
v
e
l
o
p
m
e
n
t

(
W
O
R
L
D
)

a
n
d

I
C
O

G
e
n
e
r
a
l

A
s
s
e
m
b
l
y
S
A
-
4
0

R
o
s
e
n
b
a
u
m
,

M
a
c
k
e
n
s
e
n
,

G
u
l

G
e
n
e
t
i
c
s

a
n
d

U
v
e
i
t
i
s
S
A
-
4
1

A
r
e
v
a
l
o
,

W
i
l
k
i
n
s
o
n
,

R
o
c
a
P
A
A
O

S
y
m
p
o
s
i
u
m
:

R
e
t
i
n
a
l
a
n
d

C
h
o
r
o
i
d
a
l

M
a
n
i
f
e
s
t
.
B
r
e
a
k
f
a
s
t

S
y
m
p
o
s
i
u
m
A
e
o
n
A
s
t
r
o
n
W
O
C
-
C
-
1
3

E
m
m
e
r
i
c
h

T
h
e

A
g
i
n
g

L
i
d

F
u
n
c
t
i
o
n
a
l
E
f
f
e
c
t
s

a
n
d

t
h
e
i
r

T
r
e
a
t
m
e
n
t
W
O
C
-
C
-
1
4

G
e
e
r
l
i
n
g
,

G
r
e
h
n
,
M
l
l
e
r

M
a
n
a
g
e
m
e
n
t

o
f

C
o
m
p
l
e
x

G
l
a
u
c
o
m
a
W
O
C
-
C
-
1
5

S
c
h
m
i
d
t
-
E
r
f
u
r
t
h

M
o
d
e
r
n

O
C
T

i
m
a
g
i
n
g
:

C
l
i
n
i
-
c
a
l

v
a
l
u
e

a
n
d

p
e
r
s
p
e
c
t
i
v
e
s
W
O
C
-
A
A
D
-
C
-
1
6

K
o
h
n
e
n

K
R
C

A
d
v
a
n
c
e
d

C
o
u
r
s
e

f
o
r

t
h
e
R
e
f
r
a
c
t
i
v
e

S
u
r
g
e
r
y
L
u
n
c
h

S
y
m
p
o
s
i
u
m
Z
e
i
s
s
S
A
-
0
5

M
e
n
a
p
a
c
e
,

F
i
s
h
k
i
n
d
,
A
r
t
a
l

A
d
v
a
n
c
e
s

i
n

C
a
t
a
r
a
c
t
a
n
d

I
O
L

T
e
c
h
n
o
l
o
g
y
S
A
-
0
6

O
'
B
r
i
e
n
,

B
a
r
r
y
,

B
a
r
t
z
-
S
c
h
m
i
d
t

E
n
d
o
p
h
t
h
a
l
m
i
t
i
s
S
A
-
0
7

A
g
a
r
w
a
l
,

K
o
h
n
e
n

P
h
a
c
o

N
i
g
h
t
m
a
r
e
s

a
n
d

W
o
r
s
t
C
a
s
e

S
c
e
n
a
r
i
o
s
S
A
-
0
8

W
a
k
e
f
i
e
l
d
,

P
a
v
e
s
i
o
,
T
h
u
r
a
u

U
n
m
e
t

N
e
e
d
s

i
n

D
i
a
g
n
o
s
i
s

o
f

U
v
e
i
t
i
s
A
r
b
e
i
t
s
g
r
u
p
p
e

I
n
t
e
r
n
e
t

u
n
d

m
e
d
i
z
i
n
i
s
c
h
e

I
n
f
o
r
m
a
-
t
i
o
n
s
v
e
r
a
r
b
e
i
t
u
n
g
S
i
t
z
u
n
g

d
e
r

S
e
k
t
i
o
n

D
O
G
-
G
e
w
e
b
e
-
t
r
a
n
s
p
l
a
n
t
a
t
i
o
n

u
n
d

B
i
o
t
e
c
h
n
o
l
o
g
i
e
I
C
O

O
p
h
t
h
a
l
m
o
l
o
g
i
c

S
o
c
i
e
t
y

A
d
v
o
c
a
t
e
s

L
u
n
c
h
W
O
C
-
A
A
D
-
C
-
0
9

V
l
c
k
e
r

C
o
r
n
e
a
l

D
e
g
e
n
e
r
a
t
i
o
n

/

D
y
s
t
r
o
p
h
y
1
9
:
0
0
-
2
0
:
0
0

V
o
r
s
t
a
n
d
s
s
i
t
z
u
n
g

D
G
I
I

D
O
C
H
-
M
e
e
t
i
n
g
S
a
t
u
r
d
a
y
,

5

J
u
n
e
L
u
n
c
h

S
y
m
p
o
s
i
u
m
A
l
l
e
r
g
a
n

O
p
h
t
h
a
l
-
m
o
l
o
g
y
H
i
g
h
l
i
g
h
t
S
y
m
p
o
s
i
u
m
F
r
e
e

P
a
p
e
r
W
O
C

C
o
u
r
s
e
I
n
d
u
s
t
r
y

S
y
m
p
o
s
i
u
m
M
e
e
t
i
n
g
s
M
e
s
s
e
S
t
o
c
k
h
o
l
m
S
a
o

P
a
u
l
o
A
b
u

D
h
a
b
i
O
s
l
o

R
o
o
m

M
a
d
r
i
d
R
o
o
m

S
y
d
n
e
y
R
o
o
m

H
o
n
g

K
o
n
g
R
o
o
m

I
s
t
a
n
b
u
l

V
I
P

L
o
u
n
g
e

1

V
I
P

L
o
u
n
g
e

2

R
a
d
i
o

T
o
w
e
r

L
o
u
n
g
e

1
R
a
d
i
o

T
o
w
e
r
L
o
u
n
g
e

2
H
a
l
l

1
1
0
7
1
5
3
0
4
5
0
8
1
5
3
0
4
5
0
9
1
5
3
0
4
5
1
0
1
5
3
0
4
5
1
1
1
5
3
0
4
5
1
2
1
5
3
0
4
5
1
3
1
5
3
0
4
5
1
4
1
5
3
0
4
5
1
5
1
5
3
0
4
5
1
6
1
5
3
0
4
5
1
7
1
5
3
0
4
5
1
8
1
5
3
0
4
5
S
A
-
0
1

H
o
l
l
a
d
a
y

H
o
t

T
o
p
i
c
s

i
n

R
e
f
r
a
c
t
i
v
e

S
u
r
g
e
r
y
S
A
-
0
2

K
r
u
e
g
e
r
,

S
e
k
u
n
d
o

2
0
1
0

W
O
C

F
e
m
t
o
s
e
c
o
n
d
L
a
s
e
r

R
e
v
i
e
w
L
u
n
c
h

S
y
m
p
o
s
i
u
m
G
e
u
d
e
r

A
G
S
A
-
0
3

Z
a
r
b
i
n
,

M
a
c
L
a
r
e
n
,
B
i
n
d
e
r

S
O
E

S
y
m
p
:

C
e
l
l

D
e
r
i
v
e
d

T
h
e
r
a
p
i
e
s

S
A
-
0
4

R
e
i
n
s
t
e
i
n
,

R
a
b
i
n
o
v
i
t
z
,
P
r
e
u
n
e
r

S
a
f
e
t
y

o
f

R
e
f
r
.

S
u
r
-
g
e
r
y

u
s
i
n
g

N
e
w

D
i
a
g
n
.

T
e
c
h
n
.
S
A
-
2
9

M
i
c
h
e
l
s
o
n
,

C
h
i
a
n
g
,
O
l
s
o
n
,

T
o
s
t

C
l
i
n
i
c
a
l

A
s
p
e
c
t
s
:
S
c
r
e
e
n
i
n
g
,

D
i
a
g
n
o
s
i
n
g
,

S
A
-
3
0

G
o
l
d
b
e
r
g
,

R
o
j
a
n
a
p
o
n
g
-
p
u
n
,

F
a
n
g

S
E
A
G
I
G

S
y
m
p
.
:
A
n
g
l
e
-
C
l
o
s
u
r
e

G
l
a
u
c
o
m
a
L
u
n
c
h

S
y
m
p
o
s
i
u
m
P
f
i
z
e
r
W
O
C
-
A
A
D
-
C
-
0
1

L
a
n
g

D
i
f
f
e
r
e
n
t
i
a
l

D
i
a
g
n
o
s
i
s

o
f
M
a
c
u
l
a
r

D
i
s
e
a
s
e
s
W
O
C
-
A
A
D
-
C
-
0
2

D
i
e
t
l
e
i
n

G
l
a
u
c
o
m
a

w
i
t
h
o
u
t

h
i
g
h

P
r
e
s
-
s
u
r
e

N
o
r
m
a
l
-
t
e
n
s
i
o
n

G
l
a
u
c
.
W
O
C
-
A
A
D
-
C
-
0
3

K
a
m
p
i
k

D
i
a
b
e
t
i
c

R
e
t
i
n
o
p
a
t
h
y
W
O
C
-
A
A
D
-
C
-
0
4

S
c
h
r
o
e
t
e
r

O
p
t
i
c

d
i
s
c

e
l
e
v
a
t
i
o
n

D
i
f
f
e
r
-
e
n
t
i
a
l

D
i
a
g
n
o
s
i
s

a
n
d

W
o
r
k

U
p
S
A
-
3
5

M
i
e
l
e
r
,

J
a
g
e
r
,

F
o
e
r
s
t
e
r

R
e
t
i
n
a
l

S
h
o
w
c
a
s
e
S
A
-
3
6

D
'
A
m
i
c
o
,

v
a
n

M
e
u
r
s
,
W
i
e
d
e
m
a
n
n

W
h
a
t
'
s

N
e
w

o
n
M
a
n
a
g
e
m
e
n
t

o
f

R
e
t
i
.

D
i
s
e
a
s
e
S
A
-
2
5

M
i
e
l
e
r
,

M
u
r
r
a
y
,

R
o
i
d
e
r

R
e
t
i
n
a
:

D
i
a
g
n
o
s
t
i
c
s

1
S
A
-
2
6

K
n
o
r
z
,

E
l

D
a
n
a
s
o
u
r
y
,
N
e
u
h
a
n
n

R
e
f
r
a
c
t
i
v
e

s
u
r
g
e
r
y
/
R
e
f
r
a
c
t
i
o
n

1
S
A
-
0
9

D
e
s
j
a
r
d
i
n
s
,

S
i
l
v
a
,
L
o
h
m
a
n
n

O
c
u
l
a
r

T
u
m
o
r
s

i
n
C
h
i
l
d
h
o
o
d

D
e
v
e
l
o
p
.

E
y
e

D
i
s
.
S
A
-
1
0

D
u
t
t
o
n
,

F
a
z
z
i
,

L
o
r
e
n
z

C
e
r
e
b
r
a
l

V
i
s
u
a
l

I
m
p
a
i
r
m
e
n
t
S
A
-
1
1

K
r
i
e
g
l
s
t
e
i
n
,

G
a
n
d
o
l
f
i
,
F
a
n
t
e
s

T
r
a
b
e
c
u
l
e
c
t
o
m
y
:

P
r
o
b
l
e
m
s

a
n
d

S
o
l
u
t
i
o
n
s
S
A
-
1
2

R
i
t
c
h
,

J
o
n
a
s
,

F
l
a
m
m
e
r

P
r
e
s
s
u
r
e
-
i
n
d
e
p
e
n
d
e
n
t

F
a
c
t
o
r
s

i
n

G
l
a
u
c
o
m
a
S
A
-
4
2

C
o
l
l
i
n
,

H
i
n
t
s
c
h
i
c
h
,

K
l
e
t
t

C
o
n
g
e
n
i
t
a
l

a
n
d

A
c
q
u
i
r
e
d

L
i
d
M
a
l

P
o
s
i
t
i
o
n
s
S
A
-
4
3

I
s
h
i
b
a
s
h
i
,

G
r
o
s
s
n
i
k
l
a
u
s
,
D
i
t
h
m
a
r

R
e
t
i
n
a
l

D
i
s
e
a
s
e
s

a
n
d
D
e
g
e
n
e
r
a
t
i
o
n
s
S
A
-
1
3

K
o
h
l
h
a
a
s
,

K
a
n
p
o
l
a
t
,
N
e
u
h
a
n
n
B
a
s
i
c

R
e
s
e
a
r
c
h
,
U
p
d
.

o
n

T
r
e
a
t
m
.

a
n
d

O
p
t
.

C
o
r
.
S
A
-
1
4

B
i
s
c
h
o
f
f
,

K
e
y
,
B
i
a
l
a
s
i
e
w
i
c
z

C
l
i
n
i
c
a
l

M
a
n
a
g
.
o
f

C
o
n
t
a
c
t

L
e
n
s

C
o
m
p
l
i
c
a
.
S
A
-
1
7

T
s
e
n
g
,

M
e
l
l
e
r

A
m
n
i
o
t
i
c

M
e
m
b
r
a
n
e

T
r
a
n
s
p
l
a
n
t
a
t
i
o
n
S
A
-
1
8

L
i
s
c
h
,

M
u
n
i
e
r

C
o
r
n
e
a
l

D
y
s
t
r
o
p
h
i
e
s
S
A
-
1
9

R
e
i
n
h
a
r
d
,

S
e
i
t
z
,

A
l
R
a
j
h
i

L
a
s
e
r
-
a
s
s
i
s
t
e
d

K
e
r
a
t
o
p
l
a
s
t
y
S
A
-
2
0

K
n
o
p
,

K
n
o
p
,

B
r
o
n

M
e
i
b
o
m
i
a
n

G
l
a
n
d

A
n
a
t
o
m
y
,
P
h
y
s
i
o
l
o
g
y

a
n
d

D
i
s
e
a
s
e
S
A
-
2
1

W
o
r
m
a
l
d
,

K
r
i
e
g
l
s
t
e
i
n
,
R
i
t
c
h

E
v
i
d
e
n
c
e
-
b
a
s
e
d

M
a
n
a
g
e
m
e
n
t

o
f

G
l
a
u
c
o
m
a
S
A
-
2
2

K
u
p
p
e
r
m
a
n
n
,

S
p
a
i
d
e
,
Z
i
e
m
s
s
e
n

P
a
n
e
l
:

C
h
a
l
l
e
n
g
e
s
a
n
d

P
e
r
s
p
.

o
f

I
n
t
r
a
v
i
t
.

D
r
u
g
s

S
A
-
2
3

P
f
e
i
f
f
e
r
,

F
r
i
e
d
m
a
n
,

Z
h
a
o

E
p
i
d
e
m
i
o
l
o
g
i
c
a
l

R
e
s
e
a
r
c
h

i
n
E
y
e

D
i
s
e
a
s
e
S
A
-
2
4

P
f
e
i
f
f
e
r
,

F
r
i
e
d
m
a
n
,

P
e
r
u
l
a
s
a
m
y

N
e
w

C
h
a
l
l
e
n
g
e
s
t
o

V
i
s
i
o
n

2
0
2
0
W
O
C
-
C
-
0
5

K
o
h
n
e
n

W
e
t
L
a
b

R
e
f
r
a
c
t
i
v
e

S
u
r
g
e
r
y

1
W
O
C
-
C
-
0
6

D
u
n
c
k
e
r

W
e
t
l
a
b

R
e
f
r
a
c
t
i
v
e

S
u
r
g
e
r
y

2
W
O
C
-
C
-
0
7

R
i
c
h
a
r
d
,

C
o
r
c
o
s
t
e
g
u
i
,

W
o
n
g

W
e
t
l
a
b
:

E
n
d
o
t
a
m
p
o
n
a
d
e
s

i
n

V
i
t
r
e
o
r
.

W
O
C
-
C
-
0
8

S
t
r
u
c
k
,

S
c
h
r
a
g
e
,
K
i
r
a
l
y

W
e
t
l
a
b

S
u
r
g
i
c
a
l

M
e
a
s
-
u
r
e
m
e
n
t

i
n

t
h
e

E
a
r
l
y

P
h
a
s
e
S
A
-
2
7

B
r
e
t
t
h
a
u
e
r
,

B
e
i
k
o
,

T
a
b
i
n

C
a
t
a
r
a
c
t
/
b
i
o
m
e
t
r
y

1
S
A
-
2
8

S
p
i
e
g
e
l
,

K
r
i
e
g
l
s
t
e
i
n
,

R
e
i
t
s
a
m
e
r

G
l
a
u
c
o
m
a
:

B
a
s
i
c
s

1
M
i
t
g
l
i
e
d
e
r
v
e
r
s
a
m
m
l
u
n
g

d
e
r
S
e
k
t
i
o
n

D
O
G
-
K
o
r
n
e
a
S
A
-
3
1

A
u
n
g
,

C
h
i
s
e
l
i
t
a
,

J
a
n
s
o
n
i
u
s

G
l
a
u
c
o
m
a
:

D
i
a
g
n
o
s
t
i
c
s
S
A
-
3
2

B
i
n
d
e
r
,

F
r
a
m
m
e
,

L
i
p
s
h
i
t
z

R
e
t
i
n
a
:

A
M
D

1
A
O
I

M
e
e
t
i
n
g

a
n
d

L
u
n
c
h
e
o
n

(
A
O
I

O
r
a
t
i
o
n
)
S
A
-
4
4

A
P
S
O
R
P
S

S
y
m
p
o
s
i
u
m
S
A
-
4
7

R
e
p
k
a
,

T
h
o
u
v
e
n
i
n
,

E
h
r
t

A
m
b
l
y
o
p
i
a
:

e
a
r
l
y

d
e
t
e
c
t
i
o
n
a
n
d

s
c
r
e
e
n
i
n
g

p
r
o
g
r
a
m
s
S
A
-
4
8

T
h
u
l
a
s
i
r
a
j
,
G
i
l
b
e
r
t
,
E
t
y
a
'
a
l
e
C
h
a
n
g
i
n
g

R
e
a
l
i
t
i
e
s

i
n

E
y
e

C
a
r
e
S
A
-
4
5

E
n
g
l
e
,

,

N
e
u
g
e
b
a
u
e
r

C
o
n
g
e
n
i
t
a
l

C
r
a
n
i
a
l

D
y
s
i
n
n
e
r
-
v
a
t
i
o
n

D
i
s
o
r
d
e
r
s

(
C
C
D
D
)
S
A
-
4
6

P
e
'
e
r
,

P
r
a
u
s
e
,

G
u
t
h
o
f
f

O
r
b
i
t
a
l
,

A
d
n
e
x
a
l

a
n
d

C
o
n
j
u
n
c
t
i
v
a
l

T
u
m
o
r
s
P
o
s
t
e
r

e
x
h
i
b
i
t
i
o
n

o
f

P
o
s
t
e
r

P
-
S
A
-
0
0
1

t
o

P
-
S
A
-
2
8
2
Interested?
Subscribe FREE
*
to the following products
from Ophthalmology Times Europe
Magazine | Digital Digest | E-news | Web seminars
Ophthalmology Times Europe is a comprehensive publication
covering all of the latest developments within the ophthalmic
industry with a broad focus on cataract, corneal and refractive
surgery, glaucoma and vitreoretinal conditions.
To subscribe for FREE* visit www.oteurope.com/subscribe
*Free to qualifying readers in Europe
Stockholm
08:30 - 10:00 SA-01
Hot Topics in Refractive Surgery
Symposium
Refractive Surgery
Chair:
08:30 IL SA-01-01
Patient Satisfaction With Laser Vision Correction
as Performed by a Large Corporate Provider
Steven C. Schallhorn (San Diego/USA)
08:40 IL SA-01-02
Wavefront Analysis: When Do We Need It?
08:50 IL SA-01-03
Optics and Causes of Rainbow Glare
09:00 IL SA-01-04
Managing the Not Quite Emmetropic Postcorneal
Laser Patient
Julian D. Stevens (London/UK)
09:10 IL SA-01-05
Six-Month Results of All-in-One Femtosecond
Laser Refractive Surgery
Rupal S. Shah (Vadodara/IND)
09:20 IL SA-01-06
Corneal Biomechanics, Refraction, and Corneal
Aberrometry in Keratoconus: An Integrated
Diagnostic Study
09:30 IL SA-01-07
Outcome of Refractive Surgery in Keratoconus
Suspect Eyes
Damin Gatinel, Alain Saad (Paris/F)
09:40 IL SA-01-08
Femtolaser Deep Anterior Keratoplasty with
Baring of Descemet Membrane in Keratoconus
and Post-LASIK Ectasia
Mohamed Alaa El Danasoury (Jeddah/SA)
09:50
Discussion
Stockholm
10:30 - 12:00 SA-02
2010 WOC Femtosecond Laser Review
Symposium
Refractive Surgery
Chairs:
Walter Sekundo (Marburg/D)
10:30 IL SA-02-01
Personal Experience with several fs laser
platforms and review of current status of all fs
lasers for corneal surgery
10:40 IL SA-02-02
Use of FS lasers for cataract surgery
Ramon Naranjo-Tackman (Vadodara/IND)
10:50 IL SA-02-03
FS laser surgery for presbyopia
Mike P. Holzer (Heidelberg/D)
11:00 IL SA-02-04
FLEX Surgical Results
Rupal S. Shah (Vadodara/IND)
11:10 IL SA-02-05
FS Lasers for Corneal Transplantation
Yaron Rabinovitz (Los Angeles/USA)
11:20
Discussion
Stockholm
14:00 - 15:30 SA-03
SOE Symposium: Cell Derived Therapies for Retinal
Degeneration
Symposium
Retina
Chairs:
Marco Zarbin (Roseland/USA)
Robert E. MacLaren (London/UK)
14:00 IL SA-03-01
Cell based therapy for AMD
14:10 IL SA-03-02
Current status of Human RPE transplantation
67
S
a
t
u
r
d
a
y
,

5

J
u
n
e
67
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
WOC
2010
14:20 IL SA-03-03
Rejuvenation of retinal pigment epithelial cells
Kerstin Steindl (Vienna/A)
14:30 IL SA-03-04
Novel aspects of cell-based non viral gene therapy
Gabriele Thumann (Aachen/D)
14:40 IL SA-03-05
Tissue engineering and cellular replacement
strategies of the RPE
Boris V. Stanzel (Bonn/D)
14:50 IL SA-03-06
How close are we in stem cell therapy in retinal
disorder?
Taraprasad P. Das (Hyderabad/IND)
15:00
Discussion
Stockholm
16:00 - 17:30 SA-04
Safety of Refractive Surgery Using New Diagnostic
Technologies
Symposium
Refractive Surgery
Chairs:
Dan Z. Reinstein (London/UK)
Paul-Rolf Preuner (Mainz/D)
16:00 IL SA-04-01
Phakic-IOL sizing and monitoring technology
Carlo F. Lovisolo (Milan/I)
16:15 IL SA-04-02
Keratoconus screening is the back surface of
benefit?
Renato Ambrsio Jr. (Rio de Janeiro/BR)
16:30 IL SA-04-03
Epithelial thickness profiles in sub-surface
keratoconus screening
Timothy C. Archer (London/UK)
16:45 IL SA-04-04
Surface and sub-surface corneal diagnostic
technology in refractive surgery complications
17:00 IL SA-04-05
Everything you ever wanted to know about dry
eye evaluation technology and LASIK
Ilpo Tuisku (Hus/FIN)
17:15
Discussion
Abu Dhabi
08:30 - 10:00 SA-25
Retina: Diagnostics 1
Free Paper
Retina
Chairs:
William F. Mieler (Chicago/USA)
Timothy G. Murray (Miami/USA)
08:30 FP SA-25-01
Pathological Changes of Cerebral and Ocular
Hemodynamics in Optic Nerve Atrophy
Ekaterina Kravchuk, Tatyana Kiseleva
(Moscow/RUS)
08:37 FP SA-25-02
Analysis of indocyanine green angiography in
myopic choroidal neovascularization
Hyoung Jun Koh, Jong Uk Yoon, Yong Min Kim,
Yeo Jue Byun (Seoul/ROK)
08:44 FP SA-25-03
A preliminary study on the value of autofluores-
cence photography in observing inherited fundus
diseases
Kai Ma, Feng Zhang, Ning Pu Liu (Beijing/CN)
08:51 FP SA-25-04
High-speed, high-penetration, swept-source
optical coherence tomography at 1 micrometer wa-
velength band for posterior eye diseases.
Yasushi Ikuno, Yoshiaki Yasuno, Miki Sawa,
Motokazu Tsujikawa, Fumi Gomi (Suita/J)
08:58 FP SA-25-05
Spectral-domain Optical Coherence Tomography
for gas-filled eyes
Makoto Inoue, Kimihiko Sano, Shutaro Taniuchi,
Akito Hirakata (Tokyo/J)
09:05 FP SA-25-06
Analysis of retinal layers in patients with sympto-
matic central serous chorioretinopathy (CSC) by
high resolution spectral domain OCT (SD-OCT)
Mark Saeger, Carsten Klatt, Felix Treumer,
Anne Wissen, Johann Roider (Kiel/D)
09:12 FP SA-25-07
Simultaneous Infrared cSLO and Spectral Domain-
OCT Imaging of RPE Tears
Hans-Martin Helb, Sandeep Saxena, Frank G. Holz,
Carsten H. Meyer (Bonn/D)
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
S
a
t
u
r
d
a
y
,

5

J
u
n
e
68
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
S
a
t
u
r
d
a
y
,

5

J
u
n
e
69
09:19 FP SA-25-08
Macular volume is decreased in Multiple Sclerosis
depending on the disease stage an OCT study
Andrea Hassenstein, Maria-Katharina Wlbert,
Armin Julius Wulff, Benedikt Groe Darrelmann,
Jana Pttgen, Rdiger Schwartz, Sven Schippling
(Hamburg/D)
09:26 FP SA-25-09
Diffuse diabetic macular edema using
Spectral-Domain Optical Coherence Tomography
Avinoam Ophir, Michael R. Martinez,
Paola Mosqueda, Aaron Trevino (Hadera/IL)
09:33 FP SA-25-10
Evaluating retinal and vitreoretinal pathology
with en-face optical coherence tomography
Desislava Koleva-Georgieva, Nelly Sivkova
(Plovdiv/BG)
09:40
Discussion
Abu Dhabi
10:30 - 12:00 SA-26
Refractive Surgery/Refraction 1
Free Paper
Refractive Surgery
Chairs:
10:30 FP SA-26-01
Objective Assessment of Quality of vision and Lens
Stability after Toric Posterior Chamber Phakic IOL
Implantation
Alaa El Danasoury (Jeddah/SA)
10:37 FP SA-26-02
Refractive Outcomes with Toric ICL Implants
Dandapani Ramamurthy (Coimbatore/IND)
10:44 FP SA-26-03
All-In-One Femtosecond Laser (Flex and Smile) for
the correction of myopia and astigmatism
Osama Ibrahim (Alexandria/ET)
10:51 FP SA-26-04
Changes of higher order aberrations after surface
ablation of highly aberrated corneas
Stefan Pieh, Gerald Schmidinger, Christian Skorpik
(Vienna/A)
10:58 SL SA-26-05
Clinical evaluation of the IntraCOR intrastromal
femtosecond laser procedure to correct presbyopia
11:07 FP SA-26-06
Reading performance after implantation of the
AcuFocus Corneal Inlay (ACI) for the surgical
correction of presbyopia a two year follow-up
Alois Dexl, Orang Seyeddain, Wolfgang Riha,
Melchior Hohensinn, Gerhard Nix,
11:14 FP SA-26-07
Our results with Epilasik in Thin Corneas
Chitra Ramamurthy (Coimbatore/IND)
11:21 FP SA-26-08
Thin corneas: how safe in laser refractive surgery?
Hassan Al Arrayed (Manama/BRN)
11:28 FP SA-26-10
Advanced surface ablation at DR. Yap Eye Hospital
Yogyakarta three years experience
Siti Sundari, Suhardjo Suhardjo, Nurfifi Arliani
(Yogyakarta/RI)
11:35
Discussion
Abu Dhabi
14:00 - 15:30 SA-35
Retinal Showcase
Symposium
Retina
Chairs:
Martine J. Jager (Leiden/NL)
Michael H. Foerster (Berlin/D)
14:00 IL SA-35-01
Macrophages and angiogenesis
Rajendra Apte (Rotterdam/NL)
14:10 IL SA-35-02
Angiogenesis in uveal melanoma
Nikolaos E. Bechrakis (Innsbruck/A)
14:20 IL SA-35-03
Macrophages and aging
14:30 IL SA-35-04
Angiogenesis in retinoblastoma
14:40 IL SA-35-05
Von Hippel Lindau disease: why does it develop?
Klaus-Martin Kreusel (Berlin/D)
14:50 IL SA-35-06
Therapy of choroidal and retinal hemangiomas
15:00
Discussion
Abu Dhabi
16:00 - 17:30 SA-36
What's New on Management of Retinal Disease
Symposium
Retina
Chairs:
Donald J. D'Amico (New York/USA)
16:00 IL SA-36-01
Comparison of AMD Treatment Trial: Lucentis
verus Avastin Current Status (CATT)
TBA
16:10 IL SA-36-02
Direct Ophthalmic Artery Delivery of
Chemotherapy for Retinoblastoma 4 Year Results
David H. Abramson (NY/USA)
16:20 IL SA-36-03
Pharmacologic Agents in the Management of
Radition Retinopathy
Carol L. Shields (Philadelphia/USA)
16:30 IL SA-36-04
The Case For and Against Complement in the Pa-
thogenesis of AMD
Anthony P. Adamis (Boston/USA)
16:40 IL SA-36-05
Modulation of the Subretinal Fluid in Retinal
Detachment Patients
Marc A. Veckeneer (Rotterdam/NL)
16:50 IL SA-36-06
New Surgical Treatments for AMD
17:00 IL SA-36-07
Liquid Expansile Vetreous Endotamponades: an
Avenue To Pursue?
17:10
Discussion
Oslo
08:30 - 10:00 SA-09
Ocular Tumors in Childhood Developmental Eye
Diseases
Symposium
Pediatric Ophthalmology, Genetics
Chairs:
Laurence Desjardins (Paris/F)
Eduardo Silva (Coimbra/P)
Dietmar Lohmann (Essen/D)
08:30 IL SA-09-01
Genetic of retinoblastoma
Dietmar Lohmann (Essen/D)
08:40 IL SA-09-02
Treatment of retinoblastoma
Francis Munier (Lausanne/CH)
08:50 IL SA-09-03
Orbital tumors of childhood
Jerry Shields (Philadelphia/USA)
09:00 IL SA-09-04
Medulloepitheloma in childhood
09:10 IL SA-09-05
Conjunctival and lid tumors
Christine Levy (Paris/F)
09:20 IL SA-09-06
Cytogenetic and molecular findings in develop-
mental eye diseases. A complex puzzle
Eduardo Silva (Coimbra/P)
09:30
Discussion
Oslo
10:30 - 12:00 SA-10
Cerebral Visual Impairment
Symposium
Low Vision
Chairs:
Gordon Dutton (Glasgow/UK)
Elisa Fazzi (Brescia/I)
10:30 IL SA-10-01
Cerebral Visual Impairment a Common Cause of
Visual Impairment in Childhood
Gordon Dutton (Glasgow/UK)
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
S
a
t
u
r
d
a
y
,

5

J
u
n
e
70
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
S
a
t
u
r
d
a
y
,

5

J
u
n
e
71
10:45 IL SA-10-02
Visual routes to knowledge and action
Mel Goodale (Ontario/CDN)
11:00 IL SA-10-03
Spectrum of visual disorders with cerebral visual
impairment
Elisa Fazzi (Pavia/I)
11:15 IL SA-10-04
Cerebral Visual Impairment (CVI) Schools need
clear information on clinical findings for assess-
ment of visual processing problems
Lea Hyvrinen (Helsinki/FIN)
11:30 IL SA-10-05
Visual field defects and compensating mechanisms
associated with pre-and perinatal brain damage
Lena Jacobson (Stockholm/S)
11:45
Discussion
Oslo
14:00 - 15:30 SA-11
Trabeculectomy: Problems and Solutions
Symposium
Glaucoma
Chairs:
Stefano Gandolfi (Parma/I)
Francisco Fantes (Miami/USA)
14:00 IL SA-11-01
Patients' selection: which patients, which risks
Stefano Gandolfi (Parma/I)
14:10 IL SA-11-02
Intra-operative complications
Francisco Fantes (Miami/USA)
14:20 IL SA-11-03
Short-term post-operative complications
Carlo E. Traverso (Genova/I)
14:30 IL SA-11-05
Long-term post-operative complications
Roberto Carassa (Milano/I)
14:40 IL SA-11-05
Why and how do blebs fail in the long-term?
14:50 IL SA-11-06
Trabeculectomy: still a worthwhile surgery
15:00
Discussion
Oslo
16:00 - 17:30 SA-12
Graefe Society Symposion
Pressure-independent Factors in Glaucoma
Symposium
Glaucoma
Chairs:
Robert Ritch (New York/USA)
Jost B. Jonas (Mannheim/D)
Josef Flammer (Basel/CH)
16:00 IL SA-12-01
Genetics and epidemiology of normal-tension
glaucoma
16:10 IL SA-12-02
Significance of optic disc hemorrhages
Gustavo de Moraes (New York/USA)
16:20 IL SA-12-03
Peripapillary atrophy and its importance
16:30 IL SA-12-04
Vacular risk factors in normal-tension glaucoma
16:40 IL SA-12-05
Circadian fluctuation of IOP in normal-tension
glaucoma
Yaniv Barkana (Zerifin/IL)
16:50 IL SA-12-06
The role of neuroimaging in normal-tension
glaucoma
Y. L. Dexter Leung (Hong Kong/CN)
17:00 IL SA-12-07
Summary: basic workup of NTG. What to do when
and why
Theodore Krupin (Chicago/USA)
17:10
Discussion
Room Madrid
08:30 - 10:00 SA-13
Basic Research, Update on Treatment and Optical
Correction of Keratoconus
Symposium
Contact Lens and Refraction
Chairs:
Markus Kohlhaas (Dortmund/D)
Ayfer Kanpolat (Ankara/TR)
08:30 IL SA-13-01
Surgical treatment of keratoconus
Markus Kohlhaas (Dortmund/D)
08:45 IL SA-13-02
Causes end etiology of keratoconus
TBA
09:00 IL SA-13-03
Biomechanics and keratoconus problems
and solutions of contact lens
Eberhard Sprl (Dresden/D)
09:15 IL SA-13-04
Fitting for keratoconus
09:30 IL SA-13-05
Keratoconus which examination is the best
Jens Bhren (Frankfurt/D)
09:45
Discussion
Room Madrid
10:30 - 12:00 SA-14
Clinical Management of Contact Lens
Complications
Symposium
Chairs:
James E. Key (Houston/USA)
Alexander A. Bialasiewicz (Doha/QAT)
10:30 IL SA-14-01
The Peter Halberg Lecture: efficacy of disinfecting
solutions against acanthamoeba
James E. Key (Houston/USA)
10:40 IL SA-14-02
Why do complications happen?
Newton Kara-Jos (Sao Paulo/BR)
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
S
a
t
u
r
d
a
y
,

5

J
u
n
e
72
10:50 IL SA-14-03
Complications regarding Contact Lens hygiene,
handling and equipment
Elena Rybakova (Mokau/RUS)
11:00 IL SA-14-04
Contact lens related inflammation recent insights
Christina Grupcheva (Varna/BG)
11:10 IL SA-14-05
Global change of pathogens infectiousness: how
does it affect contact lens wearing?
Alexander A. Bialasiewicz (Doha/QAT)
11:20 IL SA-14-06
Contact lens induced infectious keratitis Review
of recent data
Ren Mly (Saarlouis/D)
11:30 IL SA-14-07
Microsporidia Keratitis in Contact Lens Wearers in
Singapore an Emerging Trend
Cordelia M. L. Chan (Singapore/SGP)
11:40
Discussion
Room Madrid
14:00 - 15:30 SA-42
Congenital and Acquired Lid Mal Positions
Symposium
Oculoplasty, Lacrimal System, Orbit
Chairs:
John Richard O. Collin (London/UK)
14:00 IL SA-42-01
Entropion
14:15 IL SA-42-02
Ectropion
Angelo Tsirbas (Los Angeles/USA)
14:30 IL SA-42-03
Ptosis
Francesco Quaranta-Leoni (Rome/I)
14:45 IL SA-42-04
Retraction
15:00 IL SA-42-05
Coloboma
15:15
Discussion
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
S
a
t
u
r
d
a
y
,

5

J
u
n
e
73
Room Madrid
16:00 - 17:30 SA-43
Retinal Diseases and Degenerations
Symposium
Retina
Chairs:
Tatsuro Ishibashi (Fukuoka/J)
Stefan Dithmar (Heidelberg/D)
16:00 IL SA-43-01
Macular holes
Toshio Hisatomi (Fukuoka/J)
16:15 IL SA-43-02
Age-related macular degeneration
16:30 IL SA-43-03
Retinal Imaging Today: FA, ICG and OCT
16:45 IL SA-43-04
Fundus autofluorescence
17:00 IL SA-43-05
Diabetic retinopathy
Gabriele E. Lang (Ulm/D)
17:15 IL SA-43-06
Lebers optic neuropathy
Cornelia M. Mooy (Dordecht/NL)
17:30
Discussion
Room Sydney
08:30 - 10:00 SA-17
Amniotic Membrane Transplantation
Symposium
External Eye Disease, Cornea
Chairs:
Scheffer C. G. Tseng (Miami/USA)
Daniel Meller (Essen/D)
08:30 IL SA-17-01
Sutureless Amniotic Membrane Transplantation
via ProKera for High-risk Penetrating Keratoplasty
Samuel C. Yiu (Los Angeles/USA)
08:40 IL SA-17-02
Amniotic Membrane Transplantation to
Augment the Success of Conjunctival Autograft
for Pterygium
Viktor L. Perez (Miami/USA)
08:50 IL SA-17-03
Biochemical Purification and Characterization of
HC-HA Complex as the Active Component from
Amniotic Membrane
09:00 IL SA-17-04
Clinical Efficacy of Amniotic Membrane Transplan-
tation for Acute Stevens Johnson Syndrome/Toxic
Epidermal Necrolysis
Darren G. Gregory (Denver/USA)
09:10 IL SA-17-05
Impact of Different Preservation Methods on
Clinical Important Features of Amniotic Membrane
Henning Thomasen (Essen/D)
09:20 IL SA-17-06
Amniotic Membrane Transplantation in Acute
Burns
Henrike Westekemper (Essen)
09:30 IL SA-17-07
Anti-angiogenic Factors in Amniotic Membrane
Mikk Pauklin (Essen/D)
09:40
Discussion
Room Sydney
10:30 - 12:00 SA-18
Corneal Dystrophies
Symposium
Chairs:
Walter Lisch (Hanau/D)
10:30 IL SA-18-01
IC3D classification of corneal dystrophies(CD)
a new guide for the ophthalmologist
10:40 IL SA-18-02
The molecular pathomechanism of CD where we
are staying?
Daniel Schorderet (Sion/CH)
10:50 IL SA-18-03
Gene therapy for diseases of the cornea
Keryn A. Williams (Bredford Park/AUS)
11:00 IL SA-18-04
Indications and results of electrolysis in TGFBI
related CD
Akira Kobayashi (Kanazawa/J)
11:10 IL SA-18-05
Surgical and laser-mediated therapies in CD
Berthold Seitz (Homburg/D)
11:20 IL SA-18-06
Light-, electronmicroscopical and immunohisto-
chemical findings of Franceschetti corneal
dystrophy
Claudia Auw-Hdrich (Freiburg/D)
11:30
Discussion
Room Sydney
14:00 - 15:30 SA-19
Laser-assisted Keratoplasty (Symposium of the
Section Cornea of the German Ophthalmological
Society)
Symposium
Chairs:
Berthold Seitz (Homburg(Saar)/D)
Abdulaziz AlRajhi (Riyadh/SA)
14:00 IL SA-19-01
Basics of Laser Keratoplasty
Achim Langenbucher (Erlangen/D)
14:10 IL SA-19-02
Femtosecond Laser Keratoplasty The Freiburg
Experience
14:20 IL SA-19-03
Femtosecond Laser Keratoplasty The Munich
Experience
14:30 IL SA-19-04
Femtosecond Laser Keratoplasty The Bochum
Experience
H. Burkhard Dick, Astrid Willert (Bochum/D)
14:40 IL SA-19-05
Advantages of Excimer Laser Keratoplasty
14:50
Discussion
Room Sydney
16:00 - 17:30 SA-20
Meibomian Gland Anatomy, Physiology and
Disease
Symposium
Chairs:
Erich Knop (Berlin/D)
Nadja Knop (Hannover/D)
Anthony Bron (Oxford/UK)
16:00 IL SA-20-01
Anatomy and Embryology of the Meibomian gland
16:10 IL SA-20-02
Meibomian gland physiology: factors influencing
ocular surface integrity
16:20 IL SA-20-03
Keratinization of the Meibomian gland as a major
cause for obstructive MGD
Nadja Knop (Hannover/D)
16:30 IL SA-20-04
Regulation of the Meibomian gland in health and
disease
David Sullivan (La Jolla/USA)
16:40 IL SA-20-05
New insight into Meibomian gland function from
gene expression experiments
Frank Schirra (Homburg/D)
16:50 IL SA-20-06
New treatments for Meibomian gland diseases
Stefano Barabino (Genova/I)
17:00
Discussion
Room Hong Kong
08:30 - 10:00 SA-21
Evidence-based Management of Glaucoma
Symposium
Evidence Based Ophthalmology
Chairs:
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
S
a
t
u
r
d
a
y
,

5

J
u
n
e
74
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
S
a
t
u
r
d
a
y
,

5

J
u
n
e
75
08:30 IL SA-21-01
Is there current evidence for effective neuropro-
tection in glaucoma?
Robert N. Weinreb (La Jolla/USA)
08:40 IL SA-21-02
The role of the ocular and systemic circulation in
glaucoma progression
08:50 IL SA-21-03
Tubes versus trabeculectomy
Stephen Gedde (Miami/USA)
09:00 IL SA-21-04
The treatment of acute and chronic angle-closure
09:10 IL SA-21-05
Antimetabolites for glaucoma surgery revisited
Jonathan C. K. Clarke (London/UK)
09:20 IL SA-21-06
Feasibility of a randomised trial of glaucoma
screening
Jennifer Burr (Aberdeen/UK)
09:30 IL SA-21-07
Evidence of selective laser trabeculoplasty
Detlev Spiegel (Augsburg/D)
09:40
Discussion
Room Hong Kong
10:30 - 12:00 SA-22
Panel: Challenges and Perspectives of Intravitreal
Drugs Differences in Biological and Functional
Effects
Panel
Pharmacology, Ocular Drug Delivery
Panel list:
Baruch D. Kuppermann (Irvine/USA)
Richard F. Spaide (New York/USA)
Focke Ziemssen (Tbingen/D)
Peter K. Kaiser (Cleveland)
Combination therapy: what and when to combine?
Fixed regimen vs. adjusted dosing as needed?
Disease parameter: what to consider being rele-
vant?
Risk profile and cardiovascular health: reasonable
care or unjustified hysteria?
Room Hong Kong
14:00 - 15:30 SA-23
Epidemiological Research in Eye Disease
Symposium
Ophthalmic Epidemiology
Chairs:
David Friedman (Baltimore/USA)
Jialiang Zhao (Beijing/CN)
14:00 IL SA-23-01
Epidemiology: Basic Principles to Solve Problems
in Ophthalmology
14:15 IL SA-23-02
Epidemiological research in glaucoma
14:30 IL SA-23-03
Problems in the design of epidemiological studies
14:45 IL SA-23-04
The survey of blindness and visual impairment in
China
15:00
Discussion
Room Hong Kong
16:00 - 17:30 SA-24
New Challenges to Vision 2020: Glaucoma and
Diabetic Retinopathy
Symposium
Vision 2020 Prevention of Blindness
Chairs:
Nam Perulasamy (Madurai/IND)
16:00 IL SA-24-01
How does glaucoma fit into Vision 2020 and how
should it fit in?
TBA
16:15 IL SA-24-02
Is Vision 2020 Ready for Glaucoma?
James E. Standefer (White Bear Lake/USA)
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
76
14:37 SL SA-27-06
New concepts of multifocal IOLs design
Khristo Takhchidi (Moscow/RUS)
14:46 FP SA-27-07
Diffractive add-on IOL as a secondary implant in
pseudophakic eyes: first results
Georg Gerten, Omid Kermani, Karl Schmiedt,
Elham Farvili, Uwe Oberheide (Kln/D)
14:53 FP SA-27-08
The implantation of bifocal prismatic IOL in
patients with age-related macular degeneration
Almazbek Botbaev, A. Eshmambetov (Bishkek/KIS)
15:00 FP SA-27-09
Visual Quality and Ocular Aberrations with
Aspheric Single Piece and Spherical Multi-Piece
IOL; Contralateral comparative study
Ahmed Assaf (Cairo/ET)
15:07 FP SA-27-10
Femtosecond Laser-Assisted Cataract Surgery
(FLACS): A new paradigm for refractive cataract
surgery?
Jonathan H. Talamo (Waltham/USA)
15:14 FP SA-27-11
Optical analysis, reading performance and quality
of life evaluation after implantation of the
Acri.Lisa 366D multifocal intraocular lens
Ana Belen Plaza, David Pablo Piero Llorens,
Ramon Jimenez, Francisco Amparo,
Jose Luis Rodriguez Prats (Alicante/E)
15:21
Discussion
VIP Lounge 1
16:00 - 17:30 SA-28
Glaucoma: Basics 1
Free Paper
Glaucoma
Chairs:
Herbert Reitsamer (Salzburg/A)
16:00 SL SA-28-01
Different aspects on the significance of ocular
blood flow for glaucoma
16:09 FP SA-28-02
Assessment of Intraocular Pressure in response to
isokinetic exercise
Camila Netto, Marcelo Conte, Marinho Scarpi
(Rio de Janeiro/BR, So Paulo/BR)
16:30 IL SA-24-03
The Aravind telemedicine system for detecting
and treating DR
Nam Perulasamy (Madurai/IND)
16:45 IL SA-24-04
Innovations in technology to improve screening
efficiency for DR
Michael Abramoff (Iowa/USA)
17:00 IL SA-24-05
Launching two new DR screening projects in Indo-
nesia and Bangladesh: challenges and successes
17:15
Discussion
VIP Lounge 1
14:00 - 15:30 SA-27
Cataract/Biometry 1
Free Paper
Cataract
Chairs:
Georg Bretthauer (Karlsruhe/D)
George Beiko (St. Catharines/CDN)
Huck Holz (Santa Clara/USA)
14:00 SL SA-27-01
Restoring human accommodation the role of
mechatronics and microtechnology
Georg Bretthauer (Karlsruhe/D)
14:09 FP SA-27-02
Protein Profiling of Human Aqueous Humour
by Mass Spectrometry A Comparative and
Quantitative Study
Marion Funk, Keiryn Bennett, Melanie Planyavsky,
Ceereena Ubaida Mohien, Andreas Pollreisz, Stefan
Sacu, Michael Georgopoulos, Andr Mller, Zlatko
Trajanoski, Jacques Colinge, Giulio Superti-Furga,
14:16 FP SA-27-03
Synchrony dual optic accommodating IOL:
4 year results
Ricardo Alarcon, Victor Bohorquez (Bogota/CO)
14:23 FP SA-27-04
Comparison of vision with accommodating IOLs
versus minimonovison with a standard IOL
14:30 FP SA-27-05
Binovision A New Approach to Presbiopia
Correction with the Calhoun LAL
Sylvia Paulig (Cottbus/D)
S
a
t
u
r
d
a
y
,

J
u
n
e

5
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
77
VIP Lounge 2
08:30 - 10:00 SA-29
Clinical Aspects: Screening, Diagnosing, Treatment
and Medical Workflow, Medical Education
Symposium
Teleophthalmology and Computers
Chairs:
John Olson (Aberdeen/UK)
Frank H. W. Tost (Greifswald/D)
08:30 IL SA-29-01
Worldwide Access to online Education-Atlas of
Ophthalmology
Ludwig Maximilian Heindl (Erlangen/D)
08:45 IL SA-29-02
How computers educate glaucoma patients
Catherina Goltz, Stefan Clemens, Frank H. W. Tost
(Greifswald/D)
09:00 IL SA-29-03
Telemedical glaucoma home monitoring:
blessing or curse?
Clemens Jrgens (Greifswald/D)
09:15 IL SA-29-04
Automated evaluation of the optic nerve head in
respect to glaucoma in colour images
Rdiger Bock (Erlangen/D)
09:30 IL SA-29-05
A regional Tele-ophthalmological Network
evaluating retinal vessels and the optic nerve head
09:45
Discussion
16:16 FP SA-28-03
Corneal Hysteresis and Corneal Resistance Factor
are not associated with occurrence of Disc
Haemorrhage in Patients with Normal Tension
Glaucoma
Nafees B. Baig, Dexter Yu-lung Leung,
Douglas Lam (Hong Kong/HK)
16:23 FP SA-28-04
Immunoproteomics of tears as a diagnostic tool in
glaucoma
Franz Grus, Nils Boehm, Sabine Beck, Markus
Schlich, Ulrike Lossbrandt, Ulrike Lossbrandt,
16:30 FP SA-28-05
Oxidative Stress Markers in Patients with
Primary Open-angle Glaucoma
Asaad Ghanem, Lamiaa Arafa, Ayman El-Baz
(Mansoura/ET)
16:37 FP SA-28-06
Immunization with optic nerve antigens causes
loss of retinal ganglion cells and elevated antibody
reactivity against ocular tissues
Panagiotis Laspas, Stephanie C. Joachim,
Oliver W. Gramlich, Philip F. Gottschling,
Clemens Cuny, Norbert Pfeiffer, Franz H. Grus
(Halandri/GR, Mainz/D)
16:44 FP SA-28-07
Serum endothelin-1 levels in patients with
glaucoma
Daria Nefedova, Yury Astakhov, Irina Birulya,
Margarita Kadinskaya (St. Petersburg/RUS)
16:51 FP SA-28-08
Genomic (epigenetic) DNA methylation in
patients with open-angle glaucoma
Anselm G. M. Jnemann, Bernd Lenz,
Ursula Schltzer-Schrehardt, Robert Rejdak,
Johannes Kornhuber, Friedrich Kruse,
Stefan Bleich (Erlangen/D, Lublin/PL)
16:58 FP SA-28-09
CYP1B1 mutations In South Korean Patients
With Primary Congenital Glaucoma: Genotype
Phenotype Correlations
Wool Suh, Sung Chul Park, Michael S. Kook,
Yong Yeon Kim, Chan Yun Kim, Chang Sik Kim,
Ki Ho Park, Chan Kee Park, Hee Jung Kim, Chang
Seok Ki, Changwon Kee (Seoul/ROK)
17:05 FP SA-28-10
Global Gene Expression and Protein Profiling
of Young and Elderly Retinas Exposed to Elevated
Intraocular Pressures
Molly Walsh (Durham/USA)
17:12
Discussion
S
a
t
u
r
d
a
y
,

5

J
u
n
e
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
VIP Lounge 2
14:00 - 15:30 SA-31
Glaucoma: Diagnostics
Free Paper
Glaucoma
Chairs:
Dorin Chiselita (Iasi/RO)
Nomdo M. Jansonius (Groningen/NL)
14:00 SL SA-31-01
Glaucoma progression
Dorin Chiselita (Iasi/RO)
14:09 SL SA-31-02
On the accuracy of measuring rates of visual field
change in glaucoma
Nomdo Jansonius (Groningen/NL)
14:18 FP SA-31-03
RNFL thickness analysis with fourier domain OCT
compared to time domain OCT
Anna Nowinska, Edward Wylegala, Janiszewska
Dominika, Dariusz Dobrowolski (Katowice/PL)
14:25 FP SA-31-04
Comparison of slitlamp adapted 1310nm OCT
and high-frequency ultrasound in the evaluation
of Schlemms Canal and suture traction after
Canaloplasty
Joshua Torrent Despouy, Anne Bruggemann,
Swaantje Peters, Salvatore Grisanti, Maya Mller
(Lbeck/D)
14:32 FP SA-31-05
A new darkroom provocative test using anterior
segment optical coherence tomography (AS-OCT)
Li Dejiao (Beijing/CN)
14:39 FP SA-31-06
Retrobulber imaging in glaucoma with diffusion
tensor MRI / optic tractography and fMRI:
structural and functional analysis
Kaya N Engin, Blent Yemis ci, Nurten Turan,
Sibel Bayramoglu, Onur zyurt, Esin Karahan,
Cengizhan ztrk (Istanbul/TR)
14:46 FP SA-31-07
Progression of glaucomatous visual field loss in
primary angle closure glaucoma with intraocular
pressure which has decreased to normal range
Noriko Toyokawa, Shinichiro Kuroda, Hideya
Kimura, Atsuko Fukumoto, Makoto Nagata (Nara/J)
14:53 FP SA-31-08
Frequency of the origin of open-angle glaucoma in
patients with hypothyroidism
Pavel Bezdetko, Alla Saveleva, Julia Babak
(Kharkov/UA)
VIP Lounge 2
10:30 - 12:00 SA-30
SEAGIG Symposium: Angle-Closure Glaucoma
Symposium
Glaucoma
Chairs:
Ivan Goldberg (Sydney/AUS)
Prin Rojanapongpun (Bangkok/T)
Seng Kheong Fang (Sydney/AUS)
10:30 IL SA-30-01
Definitions, classifications, epidemiology
Ramanjit Sihota (New Delhi/IND)
10:38 IL SA-30-02
Angle assessment
Paul Chew (Singapore/SGP)
10:46 IL SA-30-03
Mechanisms of angle closure
Prin Rojanapongpun (Bangkok/T)
10:54 IL SA-30-04
Initial Management of PACG
Ki Ho Park (Seoul/ROK)
11:09 IL SA-30-05
Surgical management of PACG
11:24 IL SA-30-06
Management of acute PAC
Paul Healey (Sydney/AUS)
11:32 IL SA-30-07
Secondary ACG
Seng Kheong Fang (Sydney/AUS)
11:40 IL SA-30-08
Newly designed provocative test for detecting
angle closure
Ning-li Wang (Beijing/CN)
11:48
Discussion
S
a
t
u
r
d
a
y
,

5

J
u
n
e
78
WOC
2010
79
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
16:37 FP SA-32-06
Prevalence and Significance of Subretinal
Drusenoid Deposits (Reticular Pseudodrusen) in
Age-Related Macular Degeneration
Sandrine Anne Zweifel, Yutaka Imamura,
Theodore C Spaide, Takamitsu Fujiwara,
Richard F Spaide (New York/USA)
16:44 FP SA-32-07
Anti Oxidant Therapy in Dry Age Related Macular
Degeneration: A Hope for Vision
Swati Tomar (Jaipur/IND)
16:51 FP SA-32-08
LMI Intra Ocular Mirror Telescopic Projector for
AMD
Isaac Lipshitz, Amar Agarwal (Hertzlia/IL)
16:58 FP SA-32-09
Retinal Sensitivity in age related macular degene-
ration using Scanning Laser Ophthalmoscope
imaging stabilized Microperimetry
Kathrin Hartmann, Jae Suk Kim, Helaina Klein,
Sylvia Hsueh, Laura Gomez, Paym Amini,
Lingyun Cheng, Dirk-Uwe Bartsch,
William R. Freeman (San Diego/USA)
17:05 FP SA-32-10
Vitreomacular interface and posterior vitreomacu-
lar adhesion in exsudative age-related macular
degeneration (AMD): A Spectralis-OCT-Study
Mathias Maier, Sarah Pfrommer, Sophie Burzer,
Nikolaus Feucht, Christoph Winkler von
Mohrenfels, Chris Lohmann (Munich/D)
17:12
Discussion
Hall 2
08:30 - 10:00 SA-33
Update on Management of AMD
Symposium
Retina
Chairs:
Gisle Soubrane (Crteil/F)
08:30 IL SA-33-01
Recent clinical trial results on management of
neovascular AMD
08:40 IL SA-33-02
Role of diagnostic tools for assessing
patients response
15:00 FP SA-31-09
Angle closure in Caucasians a pilot, clinic-based
study
Yaniv Barkana, Inbal Dekel (Shoham/IL)
15:07 SL SA-31-10
The diurnal variation of intraocular pressure the
most important symptom for early detection and
follow-up of the glaucomas
Jrg Albert Draeger (Hamburg/D)
15:16
Discussion
VIP Lounge 2
16:00 - 17:30 SA-32
Retina: AMD 1
Free Paper
Retina
Chairs:
Carsten Framme (Bern/CH)
Isaac Lipshitz (Tel Aviv/IL)
16:00 SL SA-32-01
Posterior hyaloid behavior in age-related macular
degeneration
Susanne Binder (Winn/A)
16:09 FP SA-32-02
Interobserver variability for re-treatment indicati-
ons after Ranibizumab upload in neovascular
age-related macular degeneration
Carsten Framme, Georgios Panagakis, Andreas
Walter, Aandrea Gamulescu, Wolfgang Herrmann,
Horst Helbig (Bern/CH, Regensburg/D)
16:16 FP SA-32-03
Intravitreal injection of Bevacizumab for treat-
ment of CNV associated with AMD in Chinese
Lei Gao, Wenjie Liu, Changxia Dong, Huajun Yu
(Yantai/CN)
16:23 FP SA-32-04
Three Major Loci involved in age-related macular
degeneration are also associated with polypoidal
choroidal vasculopathy
Luiz H Lima, Carl Schubert, Daniela Ferrara,
Joanna Merriam, Yutaka Imamura, K. Bailey Freund,
Richard F. Spaide, Lawrence Yannuzzi,
Rando Allikmets (New York/USA)
16:30 FP SA-32-05
Small Hard Macular Drusen and Peripheral Drusen:
Associations with AMD Genotypes in the Inter99
Eye Study
Inger Christine Munch (Glostrup/DK)
S
a
t
u
r
d
a
y
,

5

J
u
n
e
08:50 IL SA-33-03
Combined treatment approaches to wet AMD?
Anat Loewenstein (Tel Aviv/IL)
09:00 IL SA-33-04
Predictors of disease: current treatment guidelines
Paolo Lanzetta (Udine/I)
09:10 IL SA-33-05
Management of pigment epithelial detachments
and PCV in the era of anti-VEGF-therapy
Richard F. Spaide (New York/USA)
09:20 IL SA-33-06
Imaging progression and treatment approaches
for geographic atrophy
09:30
Discussion
Hall 2
10:30 - 12:00 SA-34
Update in Diabetic Retinopathy
Symposium
Retina
Chairs:
Xiaoxin Li (Beijing/CN)
10:30 IL SA-34-01
Information technology in diabetic eye screening
10:40 IL SA-34-02
Inflammatory processes in diabetic retinopathy
Timothy Kern (Cleveland/USA)
10:50 IL SA-34-03
Intravitreal steroids in diabetic macular disease
Albert J. Augustin (Karlsruhe/D)
11:00 IL SA-34-04
Antiangiogenic strategies in diabetic macular and
retinal disease
11:10 IL SA-34-05
The presence and future of laser therapy in
diabetes
11:20 IL SA-34-06
Modern surgery in diabetic disease
David S. H. Wong (Hong Kong/HK)
11:30 IL SA-34-07
Carotid endarterectomy for treatmend of ischemic
diabetic retinopathy
11:40
Discussion
Hall 6
08:30 - 10:00 SA-37
Africa: Can We Succeed in the Greatest Challenge
to Blindness Prevention?
Symposium
Chairs:
K. H. Martin Kollmann (Nairobi/EAK)
Dunera Rahel Ilako (Nairobi/EAK)
Henry Nkumbe (Antananarivo/RM)
08:30 IL SA-37-01
Introduction
a) Why is Africa the "greatest challenge"?
b) What is success in this context?
c) How do we succeed in blindness prevention?
K. H. Martin Kollmann, Henry Nkumbe
(Nairobi/EAK, Antananarivo/RM)
08:40 IL SA-37-02
Co-Ordinated Planning (Global, Regional and
National)
K. H. Martin Kollmann, Kovin Naidoo, Hannah Faal,
Daniel Etya'ale (Nairobi/EAK, Durban/ZA, Accra/GH,
Geneva/CH)
08:50 IL SA-37-03
Advocacy & Resource Mobilisation
Dunera Rahel Ilako, Doulaye Sacko, Adekunle
Olubola Hassan, Amir Bedri, Gullapali N. Rao
(Nairobi/EAK, Lagos/WAN, Addis Abeba/ETH,
Hyderabad/IND)
09:00 IL SA-37-04
Control of Avoidable Blindness: The Evidence
Henry Nkumbe, Wanjiku Mathenge, Susan
Lewallen, Asiwome Seneadza (Antananarivo/RM,
Moshi/EAT)
09:10 IL SA-37-05
Human Resource Development (Incld. Management)
K. H. Martin Kollmann, Kayode, Volker Klauss,
Adekunle Olubola Hassan (Nairobi/EAK, Munich/D,
Lagos/WAN)
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
S
a
t
u
r
d
a
y
,

5

J
u
n
e
80
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
S
a
t
u
r
d
a
y
,

5

J
u
n
e
81
09:20 IL SA-37-06
Infrastructure and Appropriate Technology
Dunera Rahel Ilako, Kolawole Ogundimu,
Ingrid Mason, Adekunle Olubola Hassan, Wanjiku
Mathenge (Nairobi/EAK, Accra/GH, Lagos/WAN)
09:30 IL SA-37-07
Community Participation
Henry Nkumbe, Ngoy Janvier Kilangalanga, Paul
Courtright, Asiwome Seneadza (Antananarivo/RM,
Kinshasa/ZRE, Moshi/EAT)
09:40 IL SA-37-08
Conclusions / Wrap-Up
K. H. Martin Kollmann (Nairobi/EAK)
Hall 6
10:30 - 12:00 SA-38
Panel: Neuro-Ophthalmological Problems
(Handling of NNO, AION, and Benign Tumors;
Neuro-Ophthalmology in Children)
Panel
Neuro-Ophthalmology
Chairs:
Andrew G. Lee (Houston/USA)
Christian Luco (Santiago/RCH)
Panel List:
Emely Karam (Caracas/Y)
Gordon Plant (London/UK)
Caroline Tilikete (Lyon/F)
Thomas R. Hedges (Boston/USA)
Pinar Aydin (Kavaklidere/Ankara/TR)
Carlos Mendoza (Ciudad de la Habana/C)
Hall 6
14:00 - 15:30 SA-15
Panel: Contact Lenses and Children Indications,
Fitting Rules and Benefits
Panel
Chairs:
Albert Franceschetti (Meyrin (Geneva)/CH)
Chong Yew Khoo (Singapore/SGP)
Dorothea Kuhn (Riedlingen/D)
14:00 IL SA-15-01
The Jonathan Kersley Lecture: Children have a
right to contact lenses
Albert Franceschetti (Meyrin/CH)
14:20 IL SA-15-02
Success with RGP-lensfitting in children. First
result of the BVA Juneor Project
Dorothea Kuhn (Riedlingen/D)
14:30 IL SA-15-03
Contact lense in Pediatrics (CLIP) Study in
Singapore
Li Lim (Singapore/SGP)
14:40 IL SA-15-04
RGPs for Children with High Myopia and High
Astigmatism
Jenny Deva (Selangor/MAL)
14:50 IL SA-15-05
Effect of ON-K RGP lenses on the Cornea
Curvatures ans Axial Length of Myopic Children
a cross-over study
Hall 6
16:00 - 17:30 SA-16
Corneal Imaging: New Versus Useful
Symposium
Chairs:
Shigeru Kinoshita (Kyoto/J)
Zoraida Fiol-Silva (Philadelphia/USA)
16:00 IL SA-16-01
IMCLC Special Lecture: Medical Use of Contact
Lens: An Effective Tool for Ocular Surface Surgery
16:10 IL SA-16-02
Diagnostic and Imaging of the Ocular Surface in
Contact Lens
Jacek P. Szaflik (Warsaw/PL)
16:20 IL SA-16-03
HRT 2 Confocal Image In Corneal Epithelium
Christina Jacobi (Erlangen/D)
16:30 IL SA-16-04
Is It Keratoconus or CL Warpage?
Stephen D. Klyce (New Orleans/USA)
16:40 IL SA-16-05
Tear Film Disrupted or Protected By Contact Len-
ses; How To Cope
Marek Habela (Piaseczno/PL)
Hall 7
08:30 - 10:00 SA-40
Genetics and Uveitis
Symposium
Uveitis, Intraocular Inflammation
Chairs:
James T. Rosenbaum (Portland/USA)
Friederike Mackensen (Heidelberg/D)
Ahmet Gul (Istanbul/TR)
08:30 IL SA-40-01
Overview on genome wide scanning
Jrgen Braun (Herne/D)
08:40 IL SA-40-02
HLA-B27 associated Uveitis
Tammy Martin (Portland/USA)
08:50 IL SA-40-03
Blau Syndrome
James T. Rosenbaum (Portland/USA)
09:00 IL SA-40-04
KIR genes and uveitis
Ralph D. Levinson (Los Angeles/USA)
09:10 IL SA-40-05
TINU-Syndrome
09:20 IL SA-40-06
Genetic of Behcets Disease
09:30
Discussion
Hall 7
10:30 - 12:00 SA-41
PAAO Symposium: Retinal and Choroidal Manifes-
tations of Selected Systemic Diseases 2010
Symposium
Retina
Chairs:
Charles P. Wilkinson (San Fransisco/USA)
Jos Roca (Lima/PE)
10:30 IL SA-41-01
Introduction
10:40 IL SA-41-02
AIDS Update
Rubens Belfort, Jr. (So Paulo/BR)
10:50 IL SA-41-03
Phacomatosis
11:00 IL SA-41-04
Retinal and Choroidal Manifestations of SLE
Careen Y. Lowder (Cleveland/USA)
11:10 IL SA-41-05
Diffuse Unilateral Subacute Neuroretinitis (DUSN)
11:20 IL SA-41-06
Intraocular Lymphoma
Lihteh Wu (West Chester/USA)
11:30 IL SA-41-07
Choroidal and Retinal Metastasis
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
S
a
t
u
r
d
a
y
,

5

J
u
n
e
82
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
S
a
t
u
r
d
a
y
,

5

J
u
n
e
83
11:40 IL SA-41-08
Retinal-Choroidal Toxicity of Systemic Drugs
11:50 IL SA-41-09
Final considerations
Charles P. Wilkinson (San Fransisco/USA)
Roof Garden
08:30 - 10:00 SA-05
Advances in Cataract and IOL Technology
Symposium
Cataract
Chairs:
Rupert Menapace (Vienna/A)
William J. Fishkind (Tucson/USA)
Pablo Artal (Murcia/E)
08:30 IL SA-05-01
Aspheres
08:40 IL SA-05-02
Light Adjustable Lens
08:50 IL SA-05-03
Telescope Lenses
Isaac Lipshitz (Tel Aviv/IL)
09:00 IL SA-05-04
MICS: gimmick or progress
09:10 IL SA-05-05
non-US phaco
Peter Rieck (Berlin/D)
09:20 IL SA-05-06
US-phaco: Technical state of the art
William J. Fishkind (Tucson/USA)
09:30
Discussion
Roof Garden
10:30 - 12:00 SA-06
Endophthalmitis
Symposium
Cataract
Chairs:
Terrence O'Brien (Palm Beach/USA)
Peter Barry (Dublin/IRL)
10:30 IL SA-06-01
Why we do not use intracameral cefuroxime at the
end of cataract surgery?
Terrence O'Brien (Palm Beach/USA)
10:50 IL SA-06-02
The clinical implications of the ESCRS Endophthal-
mitis study
Peter Barry (Dublin/IRL)
11:10 IL SA-06-03
Why we do use intracameral cefuroxime at the
end of cataract surgery?
Jean-Franois Korobelnik (Bordeaux/F)
11:30
Discussion
Roof Garden
14:00 - 15:30 SA-07
Phaco Nightmares and Worst Case Scenarios: A
Video-based Symposium
Symposium
Cataract
Various complications can occur in phaco surgery
but the worst case scenarios are dropped lenses
and nuclei. In this course presentation of various
cases will be shown of crazy cases and their
management. The usage of diamond tipped for-
ceps in the removal of dropped IOLs will also be
shown. Difficult cases like subluxated lenses, pos-
terior polar cataracts, colobomas and complicati-
ons will also be shown on videos. Management of
IFIS, Implantation of the glued IOL will also be
taught with endoacapsular rings and capsule re-
tractors.
Chairmen:
Amar Agarwal, Thomas Kohnen
Faculty:
Thomas Kohnen
Amar Agarwal
Athiya Agarwal
Roof Garden
16:00 - 17:30 SA-08
Unmet Needs in Diagnosis of Uveitis
Symposium
Chairs:
Denis Wakefield (Sydney/AUS)
Carlos Pavesio (London/UK)
Stephan Thurau (Munich/D)
16:00 IL SA-08-01
HLA B27 AU what we know and what we dont
know
16:10 IL SA-08-02
Treatment of CME in uveitis other options than
steroids and acetazolamide
16:20 IL SA-08-03
Topical antiinflammatory medication beyond
steroids how to avoid medication-induced
glaucoma and cataract
16:30 IL SA-08-04
Imaging - what would we like to see that
fluorescein and ICG dont show
Carl P. Herbort (Lausanne/CH)
16:40 IL SA-08-05
New perspectives for treatment of human uveitis
from animal models
Gerhild Wildner (Munich/D)
16:50 IL SA-08-06
How to optimize the diagnostic use of intraocular
specimens
Bahram Bodaghi (Paris/F)
17:00 IL SA-08-07
The problem of retinal vasculitis
Elisabetta Miserocchi (Milano/I)
17:10
Discussion
Radio Tower Lounge 1
16:00 - 17:30 SA-44
APSOPRS Symposium: Oculoplastic and Orbital
Surgery
Symposium
Chairs:
XianQun Fan (Shanghai/CN)
Yip Chee Chew (Singapore/SGP)
Ashok Kumar Grover (New Delhi/IND)
16:00 IL SA-44-01
The new concepts of diagnosis and treatment on
orbital diseases
Sun Fengyuan (Tianjin/CN)
16:10 IL SA-44-02
Eyelid anatomy: An update
Hirohiko Kakizaki (Aichi-ken/J)
16:20 IL SA-44-03
Thyroid Myopathy, morbidity and treatment
Seah Lay Leng (Singapore/SGP)
16:30 IL SA-44-04
Rejuvenation of the peri-orbital region
Yip Chee Chew (Singapore/SGP)
16:40 IL SA-44-05
Management of jaw winking ptosis no longer a
problem!
Ashok Kumar Grover (New Delhi/IND)
16:50 IL SA-44-06
Microendoscopy of the lacrimal pathways
Reynaldo M. Javate (Manila/RP)
17:00 IL SA-44-07
Lower lid horizontal laxity correction
Chai Teck Choo (Singapore/SGP)
17:10 IL SA-44-08
Clinical therapy on congenital anophthalmia and
microphthalmia
Xian Qun Fan (Shanghai/CN)
17:20
Discussion
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
S
a
t
u
r
d
a
y
,

5

J
u
n
e
84
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
S
a
t
u
r
d
a
y
,

5

J
u
n
e
85
08:30 - 10:00 SA-45
Congenital Cranial Dysinnervation Disorders
(CCDD)
Symposium
Strabismus
Chairs:
Elizabeth Engle (Boston/USA)
Antje Neugebauer (Cologne/D)
08:30 IL SA-45-01
Genetics in strabismology
08:50 IL SA-45-02
CCDDs the development of a developmental
concept
09:20 IL SA-45-03
Surgical management of CCDDs
David G. Hunter (Boston/USA)
09:40 IL SA-45-04
CCDDs - perspectives
Antje Neugebauer (Cologne/D)
10:30 - 12:00 SA-46
Orbital, Adnexal and Conjunctival Tumors
Symposium
Oncology
Chairs:
Jacob Pe'er (Jerusalem/IL)
Jan Ulrik Prause (Copenhagen/DK)
10:30 IL SA-46-01
Treatment of epithelial and melanocytic
conjunctival tumors
10:40 IL SA-46-02
Epithelial Eyelid Tumors
Mordechai Rosner (Tel-Hashomer/IL)
10:50 IL SA-46-03
Eyelid stromal tumors
Geeta Vemuganti (Hyderabad/IND)
11:00 IL SA-46-04
Systemic association of eyelid and conjunctival
tumors
Arun D. Singh (Cleveland/USA)
11:10 IL SA-46-05
Phantom eye syndrome
Marie Louise Roed Rasmussen (Copenhagen/DK)
11:20 IL SA-46-06
Optic Nerve tumors
Jan Ulrik Prause (Copenhagen/DK)
11:30 IL SA-46-07
Lacrimal gland tumors
Geoffrey Rose (London/UK)
11:40 IL SA-46-08
Fusion oncogenes in lacrimal gland adenoid cystic
carcinoma
Sarah Linea von Holstein (Copenhagen/DK)
11:50 IL SA-46-09
The anophthalmic socket: prevention and treat-
ment of the post enucleation socket syndrome
14:00 - 15:30 SA-47
Amblyopia: Early Detection and Screening
Programs
Symposium
Strabismus
Chairs:
Michael X. Repka (Baltimore/USA)
Dominique Thouvenin (Toulouse/F)
Oliver Ehrt (Munich/D)
14:00 IL SA-47-01
Effectiveness of Screening Preschool Children for
Amblyopia
Wolf A. Lagrze (Freiburg/D)
14:10 IL SA-47-02
Impact of Amblyopia on Quality of Life
Jill Carlton (Sheffield/UK)
14:20 IL SA-47-03
Cost-effectiveness of Screening Programmes for
Amblyopia
Jill Carlton (Sheffield/UK)
14:30 IL SA-47-04
Brckner test: scope and limits
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
S
a
t
u
r
d
a
y
,

5

J
u
n
e
86
14:40 IL SA-47-05
Detection of Refractive Errors, Strabismus and
Cataract with the Plusoptix S04
14:50 IL SA-47-06
Screening Based on Visual Acuity Testing
16:00 - 17:30 SA-48
Changing Realities in Eye Care: What is Needed
Most to Prevent Blindness in Developing Countries
Symposium
Chairs:
R. D. Thulasiraj (Madurai/IND)
Daniel Etya'ale (Genve/CH)
16:00 IL SA-48-01
Tertiary vs. Primary care ophthalmology equal or
unequal emphasis?
Daniel Etya'ale (Genve/CH)
16:15 IL SA-48-02
Are we making any progress in combating cataract
in the developing world? Should we be training
Ophthalmologists or PEC workers and non MD-
Cataract Surgeons?
16:30 IL SA-48-03
Vertical vs. Integrated approach? Satellite eye
clinics in rural areas vs. Integrating eye care into
primary health care. What about urban areas?
Susan Lewallen (Moshi/EAT)
16:45 IL SA-48-04
The challenges of strengthening health systems to
deliver eye care
Hannah Faal (Accra/GH)
17:00 IL SA-48-05
Integrating Ophthalmology and Optometry
Kovin Naidoo (Durban/ZA)
17:15
Discussion
Scientific Program
Sunday, 6 June 2010
WOC
2010
87
S
u
n
d
a
y
,

6

J
u
n
e
S
u
n
d
a
y
,

6

J
u
n
e
S
U
-
4
7

G
r
a
b
n
e
r
,

D
u
n
c
k
e
r
,
G
a
t
i
n
e
l

R
e
f
r
a
c
t
i
v
e
s
u
r
g
e
r
y
/
R
e
f
r
a
c
t
i
o
n

3
E
v
e
n
i
n
g

S
y
m
p
o
s
i
u
m

M
e
r
c
k

E
v
e
n
i
n
g

S
y
m
p
o
s
i
u
m

Z
e
i
s
s
S
E
A
G
I
G

B
o
a
r
d
M
e
e
t
i
n
g
H
i
g
h
l
i
g
h
t
S
y
m
p
o
s
i
u
m
F
r
e
e

P
a
p
e
r
W
O
C

C
o
u
r
s
e
I
n
d
u
s
t
r
y

S
y
m
p
o
s
i
u
m
M
e
e
t
i
n
g
s
I
C
C
H
a
l
l

2
H
a
l
l

3
H
a
l
l

6
H
a
l
l

7
H
a
l
l

8
H
a
l
l

9
H
a
l
l

1
0
R
o
o
f

G
a
r
d
e
n
S
a
l
o
n

1
9
S
a
l
o
n

2
0
S
a
l
o
n

2
2
R
o
o
m

4
4
R
o
o
m

4
5
R
o
o
m

4
6
0
7
1
5
3
0
4
5
0
8
1
5
3
0
4
5
0
9
1
5
3
0
4
5
1
0
1
5
3
0
4
5
1
1
1
5
3
0
4
5
1
2
1
5
3
0
4
5
1
3
1
5
3
0
4
5
1
4
1
5
3
0
4
5
1
5
1
5
3
0
4
5
1
6
1
5
3
0
4
5
1
7
1
5
3
0
4
5
1
8
1
5
3
0
4
5
S
U
-
7
4

K
l
a
u
,

F
i
n
g
e
r

V
i
s
i
o
n

2
0
2
0

P
r
e
v
e
n
t
i
o
n

o
f
B
l
i
n
d
n
e
s
s

1
S
U
-
7
5

B
e
r
t
a
,

S
e
r
e
g
a
r
d
,

S
i
t
n
i
k

C
o
r
n
e
a
/
E
x
t
e
r
n
a
l

D
i
s
e
a
s
e
:
S
u
r
g
i
c
a
l

t
h
e
r
a
p
y

2
I
C
O

C
o
m
m
i
t
t
e
e
:

E
d
u
c
a
t
i
o
n

C
o
m
m
i
t
t
e
e
S
U
-
5
9

R
a
n
d
l
e
m
a
n
,

E
l

D
a
n
a
s
o
u
r
y
,

H
a
f
e
z
i

P
o
s
t
-
L
A
S
I
K

c
o
r
n
e
a
l

e
c
t
a
s
i
a
S
U
-
6
0
M
c
R
a
e
,
C
h
e
n
g
,
M
r
o
c
h
e
n
I
s

a

C
u
s
t
o
m
.

A
b
l
.

P
r
o
f
.

t
h
e

B
e
s
t
f
o
r

S
t
a
n
d
.

R
e
f
r
.

C
o
r
r
e
c
t
i
o
n
s
L
u
n
c
h

S
y
m
p
o
s
i
u
m
A
l
c
o
n
S
U
-
5
8

C
o
l
i
n
,

K
o
l
l
e
r

R
e
h
a
b
i
l
i
t
a
t
i
o
n

i
n

P
r
i
m
a
r
y
K
e
r
a
t
e
c
t
a
s
i
a

S
U
-
5
7

B
u
r
n
i
e
r
,

R
a
o
,

H
o
l
b
a
c
h

U
v
e
i
t
i
s
B
r
e
a
k
f
a
s
t

S
y
m
p
o
s
i
u
m

Z
e
i
s
s
S
U
-
7
3

P
f
e
i
f
f
e
r
,

Z
h
a
o
,

W
o
l
f
r
a
m

E
p
i
d
e
m
i
o
l
o
g
i
c
a
l

S
t
u
d
i
e
s
S
U
-
4
9

G
a
u
d
r
i
c
,

T
r
e
s
e

V
i
t
r
e
o
r
e
t
i
n
a
l

I
n
t
e
r
f
a
c
e

E
p
i
r
e
t
i
n
a
l

M
a
c
u
l
a
r

S
u
r
g
e
r
y
S
U
-
5
0

T
r
e
s
e
,

K
a
m
p
i
k

R
e
t
i
n
a
l
V
a
s
c
u
l
a
r

D
i
s
e
a
s
e
s
:

D
i
a
b
e
t
i
c
R
e
t
i
n
o
p
a
t
h
y

/

V
e
i
n

O
c
c
l
u
.
S
U
-
5
1

K
a
m
p
i
k
,

A
y
l
w
a
r
d

A
M
D
L
u
n
c
h

S
y
m
p
o
s
i
u
m
S
a
n
t
e
n

S
U
-
4
8

A
y
l
w
a
r
d
,

G
a
u
d
r
i
c

R
e
t
i
n
a
l

D
e
t
a
c
h
m
e
n
t

a
n
d

P
V
R
S
U
-
5
3
S
c
h
a
c
h
a
t
,
L
a
n
g
,
S
t
e
f
n
s
-
s
o
n
R
e
v
i
e
w
e
r
s
S
U
-
7
8

P
r
i
c
e
,

C
u
r
s
i
e
f
e
n
,

R
e
i
n
h
a
r
d

P
o
s
t
e
r
i
o
r

L
a
m
e
l
l
a
r
K
e
r
a
t
o
p
l
a
s
t
y
S
U
-
5
3
S
c
h
a
c
h
a
t
,
L
a
n
g
,
S
t
e
f
n
s
-
s
o
n
J
o
u
r
.

P
u
b
l
i
c
.
S
U
-
5
6

N
a
u
m
a
n
n
,

L
a
n
g
,

V
l
c
k
e
r

A
n
a
t
o
m
y
/
p
a
t
h
o
l
o
g
y
S
U
-
5
2

R
e
p
k
a
,
D
e
l

M
o
n
t
e
,
J
a
a
f
a
r

A
A
P
O
S

S
y
m
p
o
s
i
u
m
:

E
m
e
r
g
i
n
g

C
o
n
c
e
p
t
s
S
U
-
3
4

B
e
c
h
r
a
k
i
s
,

K
i
v
e
l
,

H
e
e
g
a
a
r
d

O
n
c
o
l
o
g
y

1
S
U
-
3
5

B
a
r
a
b
i
n
o
,

L
o
h
m
a
n
n
,

D
u
a

C
o
r
n
e
a
/
E
x
t
e
r
n
a
l

D
i
s
e
a
s
e
:
S
u
r
g
i
c
a
l

t
h
e
r
a
p
y

1
S
U
-
3
6

C
o
l
i
n
,

C
o
c
h
e
n
e
r
,

S
l
a
d
e

R
e
f
r
a
c
t
i
v
e

s
u
r
g
e
r
y
/
R
e
f
r
a
c
-
t
i
o
n

2
S
U
-
3
7

H
o
l
o
p
a
i
n
e
n
,

N
m
e
t
h
,
Z
a
g
r
s
k
i

E
x
t
e
r
n
a
l

D
i
s
e
a
s
e
,

D
r
y

E
y
e
W
O
C
-
A
A
D
-
C
-
2
4

M
e
s
s
m
e
r

C
o
r
n
e
a
l

U
l
c
e
r
s

a
n
d

C
o
n
j
u
n
c
-
t
i
v
a
l

S
c
a
r
r
i
n
g
.

W
h
a
t

t
o

d
o
?
W
O
C
-
A
A
D
-
C
-
2
5

S
c
h
i
e
f
e
r

V
i
s
u
a
l

A
g
n
o
s
i
a

a
n
d

o
t
h
e
r

C
e
n
t
r
a
l

V
i
s
u
a
l

I
m
p
a
i
r
m
e
n
t
s
S
U
-
6
1

R
u
d
o
l
p
h
,

Z
e
i
t
z
,

Z
i
n

S
t
r
a
b
i
s
m
u
s
W
O
C
-
A
A
D
-
C
-
2
3

P
l
e
y
e
r

I
m
m
u
n
o
l
o
g
y

o
f

t
h
e

E
y
e
:

I
n
t
r
a
o
c
u
l
a
r

I
n
f
l
a
m
m
a
t
i
o
n
s
S
U
-
6
4

B
e
l
f
o
r
t
,

V
a
s
s
i
l
e
v
a
,

F
i
n
g
e
r

B
e
y
o
n
d

V
e
r
t
i
c
a
l

P
r
o
g
r
a
m
s
:
C
h
a
l
.

a
n
d

S
u
c
c
e
s
s

i
n

B
u
i
l
d
i
n
g
S
U
-
6
5

T
a
y
l
o
r
,

K
l
a
u
,

K
o
c
u
r

V
i
s
i
o
n

2
0
2
0
:

1
0

Y
e
a
r
s

o
n
,

1
0
Y
e
a
r
s

t
o

g
o
S
U
-
6
3

S
u
l
l
i
v
a
n
,

B
r
o
n
,

F
o
u
l
k
s

T
F
O
S

S
y
m
p
.
:

A

R
e
p
o
r
t

f
r
o
m
t
h
e

I
n
t
e
r
n
.

W
o
r
k
s
h
o
p

S
U
-
6
2

M
i
c
h
e
l
s
o
n
,

S
c
h
r
a
g
e
T
e
l
e
o
p
h
t
h
a
l
m
o
l
o
g
y
S
U
-
6
8

S
h
e
t
t
a
,

H
u
n
t
e
r
,

S
e
i
t
z

E
g
y
p
t
i
a
n

G
e
r
m
a
n

S
y
m
p
:

C
o
m
-
b
i
n
e
d

S
u
r
g
e
r
i
e
s

i
n

O
p
h
t
h
a
l
m
.
S
U
-
6
9

T
h
a
n
o
s
,

G
a
t
z
i
o
u
f
a
s
,
S
e
i
t
z

G
r
e
e
k

G
e
r
m
a
n

S
y
m
p
:
F
r
o
m

G
l
a
u
c
o
m
a

t
o

N
e
u
r
o
p
r
.
S
U
-
6
7

P
e
'
e
r
,

C
o
u
p
l
a
n
d
,

V
e
m
u
g
a
n
t
i

I
S
O
O

S
y
m
p
o
s
i
u
m
:
O
c
u
l
a
r

L
y
m
p
h
o
m
a
S
U
-
7
1

E
m
m
e
r
i
c
h
,

J
a
v
a
t
e
,
O
e
s
t
r
e
i
c
h
e
r

N
e
w

D
i
a
g
n
.
a
n
d
T
h
e
r
a
p
.

A
s
p
e
c
t
s

o
f

L
a
c
r
i
.

D
i
s
.
S
U
-
7
0

B
a
r
r
a
q
u
e
r
,

B
a
r
r
a
q
u
e
r
,

B
a
r
r
a
q
u
e
r

H
i
g
h
l
i
g
h
t
s

o
f

A
n
t
e
r
i
o
r

S
e
g
m
e
n
t

S
u
r
g
e
r
y
&

R
e
f
r
a
c
t
i
v
e

S
u
r
g
e
r
y
W
O
C
-
A
A
D
-
C
-
2
7

P
i
t
z

T
h
e

I
n
-
t
e
r
d
i
s
c
i
p
l
.

C
o
n
t
e
x
t

o
f

M
u
l
t
.
S
c
l
e
r
o
s
i
s

a
n
d

M
y
a
s
t
h

G
r
a
v
i
s
W
O
C
-
A
A
D
-
C
-
2
6

S
c
h
a
u
d
i
g

C
o
m
p
l
i
c
.

i
n

P
l
a
s
t
i
c
-
R
e
c
o
n
s
t
r
.
a
n
d

A
e
s
t
h
e
t
i
c

S
u
r
g
e
r
y
W
O
C
-
A
A
D
-
C
-
2
8

K
l
a
u
s
s

O
p
h
t
h
a
l
m
i
c

C
o
n
d
i
t
i
o
n
s

i
n
T
h
i
r
d

W
o
r
l
d

c
o
u
n
t
r
i
e
s

M
e
e
t
i
n
g

B
V
A
-
L
e
i
t
l
i
n
i
e
n
k
o
m
i
s
s
i
o
n
S
i
t
z
u
n
g

d
e
r

S
e
k
t
i
o
n

D
O
G
-
I
n
t
e
r
n
a
t
i
o
n
a
l
e

O
p
h
t
h
a
l
-
m
o
l
o
g
i
e
S
i
t
z
u
n
g

d
e
r

M
a
k
u
l
a
k
o
m
m
i
s
s
i
o
n
S
t
u
d
i
e
n
t
r
e
f
f
e
n

z
u
r
F
A
N
C
Y
-
S
t
u
d
i
e
B
r
e
a
k
f
a
s
t

S
y
m
p
o
-
s
i
u
m

O
c
u
l
u
s

O
p
t
i
k
g
e
r
t
e

G
m
b
H
S
U
-
7
2

L
a
g
r
z
e
,

M
o
j
o
n
,

B
e
s
c
h

S
t
r
a
t
.

i
n

S
u
r
g
i
c
a
l

T
r
e
a
t
m
e
n
t
o
f

E
y
e

D
i
s
e
a
s
e
s

i
n

C
h
i
l
d
h
o
o
d
W
O
C
-
A
A
D
-
C
-
2
9

G
e
r
d
i
n
g

R
e
t
i
n
o
p
.

o
f

P
r
e
m
a
t
u
r
i
t
y

C
l
i
n
i
c
.

D
i
a
g
n
.

a
n
d

T
r
e
a
t
m
e
n
t
S
u
n
d
a
y
,

6

J
u
n
e
E
v
e
n
i
n
g

S
y
m
p
o
s
i
u
m

P
f
i
z
e
r
H
i
g
h
l
i
g
h
t
S
y
m
p
o
s
i
u
m
F
r
e
e

P
a
p
e
r
W
O
C

C
o
u
r
s
e
I
n
d
u
s
t
r
y

S
y
m
p
o
s
i
u
m
M
e
e
t
i
n
g
s
M
e
s
s
e
S
t
o
c
k
h
o
l
m

S
a
o

P
a
u
l
o
A
b
u

D
h
a
b
i

O
s
l
o

H
a
l
l
R
o
o
m

M
a
d
r
i
d
R
o
o
m

S
y
d
n
e
y
R
o
o
m

H
o
n
g

K
o
n
g
R
o
o
m

I
s
t
a
n
b
u
l

V
I
P

L
o
u
n
g
e

1

V
I
P

L
o
u
n
g
e

2

R
a
d
i
o

T
o
w
e
r

L
o
u
n
g
e

1
R
a
d
i
o

T
o
w
e
r
L
o
u
n
g
e

2
H
a
l
l

1
1
0
7
1
5
3
0
4
5
0
8
1
5
3
0
4
5
0
9
1
5
3
0
4
5
1
0
1
5
3
0
4
5
1
1
1
5
3
0
4
5
1
2
1
5
3
0
4
5
1
3
1
5
3
0
4
5
1
4
1
5
3
0
4
5
1
5
1
5
3
0
4
5
1
6
1
5
3
0
4
5
1
7
1
5
3
0
4
5
1
8
1
5
3
0
4
5
B
r
e
a
k
f
a
s
t

S
y
m
p
o
-
s
i
u
m

S
a
n
t
e
n

S
U
-
0
1

Z
a
n
g
w
i
l
l
,
G
a
r
w
a
y
-
H
e
a
t
h
,
H
o
f
f
m
a
n
n

S
U
-
0
2

H
e
i
j
l
,
S
c
h
i
e
f
e
r

F
u
n
c
-
t
i
o
n
a
l

D
i
a
g
n
.
L
u
n
c
h

S
y
m
p
o
s
i
u
m
H
e
i
d
e
l
b
e
r
g

E
n
g
i
n
e
e
r
i
n
g
S
U
-
0
3

P
f
e
i
f
f
e
r
,
A
z
u
a
r
a
-
B
l
a
n
c
o

D
e
c
.

f
o
r

T
r
e
a
t
.

S
U
-
0
4

S
o
m
-
m
e
r
,

W
o
r
m
a
l
d

N
e
w

A
p
p
r
o
a
.
S
U
-
0
5

K
r
i
e
g
l
-
s
t
e
i
n
,

L
a
c
e
y
A
d
h
e
r
e
n
c
e
S
U
-
0
6

K
h
a
w
,
S
h
a
a
r
a
w
y
,
B
a
e
r
v
e
l
d
t

S
U
-
0
7

J
a
k
o
b
-
s
e
n
,

G
r
e
h
n
,
R
a
h
i
C
h
i
l
d
h
.
S
U
-
0
8

F
o
s
t
e
r
,
T
h
a
m

G
l
a
u
-
c
o
m
a

C
a
r
e

L
u
n
c
h

S
y
m
p
o
s
i
u
m
N
o
v
a
r
t
i
s

P
h
a
r
m
a
A
G
S
U
-
2
1

A
O
I

L
e
c
t
u
r
e
S
U
-
0
9

K
o
f
f
l
e
r
,

A
s
b
e
l
l
,

B
e
r
z
a
s

N
e
x
t

G
e
n
e
r
a
t
i
o
n
s

o
f

S
i
l
i
c
o
n
e
H
y
d
r
o
g
e
l

C
o
n
t
a
c
t

L
e
n
s
e
s
S
U
-
1
0

A
l
i
,

A
u
f
f
a
r
t
h

A
A
O
S
y
m
p
o
s
i
u
m
:

E
x
c
e
l
l
e
n
c
e

i
n
C
a
t
a
r
a
c
t

S
u
r
g
e
r
y
S
U
-
1
1

H
a
w
l
i
n
a
,

H
o
l
d
e
r
,

B
a
c
h

S
O
E
/
I
S
C
E
V

S
y
m
p
:

U
s
e

o
f

E
l
e
c
-
t
r
o
p
h
y
s
i
o
l
o
g
i
c
a
l

M
e
t
h
o
d
s

S
U
-
1
2

L
f
f
l
e
r
,

K
l
i
n
t
w
o
r
t
h
,
S
a
o
r
n
i
l

E
y
e
l
i
d
,

O
c
u
l
a
r

A
d
-
n
e
x
a
l

a
n
d

C
o
n
j
u
n
c
t
.

T
u
m
o
r
s
S
U
-
1
3

A
l
i
,

C
l
a
o
u
,

N
e
u
h
a
n
n

C
o
r
r
e
c
t
i
n
g

P
r
e
s
b
y
o
p
i
a

w
i
t
h
I
O
L
s
S
U
-
1
4

M
a
l
y
u
g
i
n
,

B
i
s
s
e
n
-
M
i
y
a
j
i
m
a
,

P
h
a
m

M
a
n
a
g
i
n
g

C
o
m
p
l
e
x

C
a
s
e
s
S
U
-
1
5

N
u
i
j
t
s
,

W
e
r
n
e
r
,

K
o
h
n
e
n

N
e
w

M
o
n
o
f
o
c
a
l

I
O
L

D
e
s
i
g
n
s
S
U
-
1
6

L
u
n
d
s
t
r
m
,

K
o
c
h
,

F
i
n
d
l

E
m
e
r
g
i
n
g

T
e
c
h
n
o
l
o
g
y

i
n
C
a
t
a
r
a
c
t

S
u
r
g
e
r
y
L
u
n
c
h

S
y
m
p
o
s
i
u
m
B
a
y
e
r
S
U
-
1
7

C
e
r
n
k
,

K
r
u
s
e

C
o
r
n
e
a
/
E
x
t
e
r
n
a
l

D
i
s
e
a
s
e
:

B
a
s
i
c
s
S
U
-
1
8

L
u
c
o
,

G
r
f
,

P
l
a
n
t

O
c
u
l
a
r

M
o
t
o
r

P
r
o
b
l
e
m
s
S
U
-
1
9

A
r
m
i
t
a
g
e
,

B
h
r
i
n
g
e
r
,
D
u
q
u
e
s
n
o
y

M
a
t
c
h
i
n
g

i
n

P
e
n
e
t
r
a
t
i
n
g

K
e
r
a
t
o
p
l
a
s
t
y
S
U
-
2
0

W
a
t
s
o
n
,

V
e
r
d
a
g
u
e
r
,
L
i
c
h
t
e
r

A
O
I

S
y
m
p
:

D
e
a
l
i
n
g
w
i
t
h

C
o
m
p
l
i
c
.

o
f

A
n
t
e
r
i
o
r

S
U
-
2
2

K
i
k
k
a
w
a
,

B
a
l
d
e
s
c
h
i
,
E
c
k
s
t
e
i
n

G
r
a
v
e
s
'

D
i
s
e
a
s
e
S
U
-
2
3

G
o
t
t
l
o
b
,

M
o
j
o
n
,

P
i
e
h

P
a
n
e
l
:

C
a
s
e

p
r
e
s
e
n
t
a
t
i
o
n
s
S
U
-
2
4

R
a
o
,

G
a
r
w
e
g
,

P
l
e
y
e
r

I
n
f
e
c
t
i
o
u
s

U
v
e
i
t
i
s
S
U
-
2
5

S
t
o
u
t
,

S
a
h
e
l
,

Z
r
e
n
n
e
r

R
e
c
e
n
t

D
e
v
e
l
o
p
m
e
n
t

i
n

I
n
h
e
r
i
t
e
d

R
e
t
i
n
a
l

D
i
s
e
a
s
e
s
S
U
-
7
7

K
r
u
s
e
,

G
e
l
l

N
e
w

T
e
c
h
n
o
l
o
g
i
e
s

f
o
r

K
e
r
a
t
o
p
l
a
s
t
y
S
U
-
2
7

H
e
i
l
i
g
e
n
h
a
u
s
,

B
o
d
a
g
h
i
,
B
e
c
k
e
r

U
v
e
i
t
i
s
/
i
n
t
r
a
o
c
.

i
n
-
f
l
a
m
.
,

m
i
c
r
o
b
.
/
i
m
m
u
n
o
l
o
g
y

1
S
U
-
2
8

B
e
h
r
e
n
s
-
B
a
u
m
a
n
n
,
D
a
r
t
,

N
m
e
t
h

C
o
r
n
e
a
l

I
n
f
e
c
t
i
o
n
s
S
U
-
2
9

W
i
l
h
e
l
m
,

K
a
s
h
i
i
,

L
e
e

N
e
u
r
o
-
o
p
h
t
h
a
l
m
i
c

E
m
e
r
g
e
n
-
c
i
e
s
S
U
-
3
0

Y
o
g
e
s
a
n
,

L
a
m
m
i
n
e
n
,
P
a
u
l
u
s

P
a
n
e
l
:

F
u
t
u
r
e

A
s
p
e
c
t
s

A
d
v
a
n
c
e
d

I
n
f
.
,

W
a
y
-
f
o
r
w
a
r
d
S
U
-
3
1

N
u
s
s
e
n
b
l
a
t
t
,

F
o
r
r
e
s
t
e
r
,
W
i
l
d
n
e
r

C
u
r
r
e
n
t

O
p
i
n
i
o
n

i
n
I
m
m
u
n
o
l
o
g
y

o
f

U
v
e
i
t
i
s
S
U
-
3
2

H
o
p
k
i
n
s
,

G
u
t
h
o
f
f
,

F
o
s
t
e
r

O
n
c
h
o
c
e
r
c
i
a
s
i
s
:

M
o
v
i
n
g

t
o
e
l
i
m
i
n
a
t
i
o
n
S
U
-
3
3

P
l
e
y
e
r
,

B
o
d
a
g
h
i

E
V
E
R

S
y
m
p
:

T
h
e
r
a
p
y

i
n

n
o
n
-
i
n
f
.

o
c
u
l
a
r

i
n
f
l
a
m
m
a
t
i
o
n
W
O
C
-
C
-
2
1

D
u
n
c
k
e
r

W
e
t
l
a
b
B
a
s
i
c

C
o
u
r
s
e

o
n

P
e
n
e
t
r
a
t
i
n
g
C
o
r
n
e
a
l

G
r
a
f
t
i
n
g

T
e
c
h
n
i
q
u
e
s
W
O
C
-
C
-
2
2

D
u
n
c
k
e
r

W
e
t
l
a
b

f
o
r

t
h
e

A
d
v
a
n
c
e
d
:
L
a
m
e
l
l
a
r

G
r
a
f
t
i
n
g

T
e
c
h
n
i
q
u
e
s
W
O
C
-
C
-
3
6

K
o
c
h
,

B
o
r
n
f
e
l
d
,
K
r
g
e
r

M
o
d
e
r
n

P
a
r
s

p
l
a
n
a
V
i
t
r
e
c
t
o
m
y

D
r
y
L
a
b

(
B
a
s
i
c
s
)
W
O
C
-
C
-
3
7

K
o
c
h
,

K
o
s
s

M
o
d
e
r
n

P
a
r
s

p
l
a
n
a

V
i
t
r
e
c
-
t
o
m
y

D
r
y
L
a
b

(
A
d
v
a
n
c
e
d
)
S
U
-
4
4

P
l
a
n
t
,

W
i
l
h
e
l
m
,

W
i
e

N
e
u
r
o
-
O
p
h
t
h
a
l
m
o
l
o
g
y

1
S
U
-
4
6

F
r
a
n
c
e
s
c
h
e
t
t
i
,

J
o
k
l
,
K
r
o
g
m
a
n
n

J
u
l
i
u
s

H
i
r
s
c
h
b
e
r
g

S
o
c
i
e
t
y
S
U
-
7
6

A
b
b
o
t
t
,

B
e
a
c
o
n
s
f
i
e
l
d
,
L
e
m
m
e
n

I
n
c
o
r
p
.

E
v
i
d
e
n
c
e
-
b
a
s
e
d

C
l
i
n
.

P
r
a
c
t
i
c
e

G
u
i
d
e
l
.
S
U
-
3
8

B
o
r
n
f
e
l
d
,

Z
e
s
c
h
n
i
g
k
,

D
e
s
j
a
r
d
i
n
s

W
o
r
k
s
h
o
p
:

U
v
e
a
l

M
e
l
a
n
o
m
a

G
e
n
e
t
i
c

T
e
s
t
i
n
g
S
U
-
5
5

B
o
b
r
o
v
a
,

G
o
t
t
l
o
b
,
M
i
l
l
e
r

P
e
d
i
a
t
r
i
c

O
p
h
t
h
a
l
m
o
l
-
o
g
y

&

G
e
n
e
t
i
c
s

2
S
U
-
3
9

K
i
n
o
s
h
i
t
a
,

G
u
t
h
o
f
f
,

A
n
d
r
e
w
s

N
a
n
o
t
e
c
h
n
o
l
o
g
y

1
S
U
-
4
0

B
e
l
f
o
r
t
,

J
r
.
,

G
o
l
n
i
k
,
K
a
s
h
i
i

M
i
s
c
e
l
l
a
n
e
o
u
s

1
S
U
-
4
1

G
e
r
i
n
e
c
,

L
o
r
e
n
z
,

Y
e
t
i
k

P
e
d
i
a
t
r
i
c

O
p
h
t
h
a
l
m
o
l
o
g
y

&
G
e
n
e
t
i
c
s

1
S
U
-
4
2

B
e
l
s
h
i
,

M
e
y
e
r
-
R
s
e
n
-
b
e
r
g

O
c
u
l
o
p
l
a
s
t
y
/
o
r
b
i
t
a
/
l
i
d
s
/
l
a
c
r
i
m
a
l

s
y
s
t
e
m

1
S
U
-
4
3

S
i
n
g
h

P
A
A
O

S
y
m
p
:
C
h
a
l
l
e
n
g
i
n
g

C
a
s
e
s

C
l
i
n
i
c
o
-
P
a
t
h
o
l
o
g
i
c

C
o
r
r
e
l
a
t
i
o
n
S
U
-
4
5

R
o
i
d
e
r
,

D
i
c
k
,

K
l
i
n
k

V
i
d
e
o

S
e
s
s
i
o
n

3

a
n
d

P
r
e
s
e
n
-
t
a
t
i
o
n

o
f

V
i
d
e
o

A
w
a
r
d
s
S
U
-
7
9

H
e
l
b
i
g
,

W
a
g
n
e
r

V
i
d
e
o

S
e
s
s
i
o
n

1
:

C
a
t
a
r
a
c
t
S
U
-
8
0

S
c
h
r
a
d
e
r
,

H
o
l
z
e
r

V
i
d
e
o

S
e
s
s
i
o
n

2
:

M
i
s
c
e
l
l
a
n
e
o
u
s

1
S
U
-
8
1

S
t
e
u
h
l

V
i
d
e
o

S
e
s
s
i
o
n

4
;

M
i
s
c
e
l
l
a
n
e
o
u
s

2
P
o
s
t
e
r

e
x
h
i
b
i
t
i
o
n

o
f

P
o
s
t
e
r

P
-
S
U
-
0
0
1

t
o

P
-
S
U
-
2
7
7
Frankfurt/Main
10. 12. Mrz 2011
mit Wet-Labs, Kursveranstaltungen
Programm fr das Pflegepersonal
Frankfurt/Main
10. 12. Mrz 2011
mit Wet-Labs, Kursveranstaltungen
Programm fr das Pflegepersonal
www.dgii.org www.dgii.org
25. Kongress
Deutschsprachigen Gesellschaft
fr Intraokularlinsen-Implantation,
interventionelle und refraktive Chirurgie
Vorankndigung
2011
25. Kongress
Deutschsprachigen Gesellschaft
fr Intraokularlinsen-Implantation,
interventionelle und refraktive Chirurgie
Kongressleitung:
Prof. Dr. med. Michael Amon
Krankenhaus Barmherzige Brder
Abteilung fr Augenheilkunde
Johannes-von-Gott-Platz 1
A1020 Wien
Telefon: (+43) 1 21121 1140
Telefax: (+43) 1 21121 1144
Organisation:
Congress-Organisation Gerling GmbH
Werftstrae 23, D-40549 Dsseldorf
Telefon: (+49) 211 59 22 44
Telefax: (+49) 211 59 35 60
E-Mail: info@congresse.de
Internet: www.congresse.de
PIA Stadt Frankfurt am Main

Foto: Tanja Schfer
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
Stockholm
08:30 - 09:15 SU-01
Present and Future Imaging
Section 1: Structure and Function in Glaucoma Care
Chairs:
Esther M. Hoffmann (Mainz/D)
08:30 IL SU-01-01
What is most useful present imaging (HRT, OCT,
GDx)
08:40 IL SU-01-02
Measuring progressive change with imaging:
which stage, which strategy, which consequences
08:50 IL SU-01-03
Ganglion cell visualization: animals and humans
09:00 IL SU-01-04
Perspectives in retinal imaging: adaptive optics, en
face OCT and full-field doppler
Michel Paques (Paris/F)
09:10
Discussion
Stockholm
09:15 - 10:00 SU-02
Present and Future of Functional Diagnostics
Section 1: Structure and Function in Glaucoma Care
Chairs:
09:15 IL SU-02-01
Useful strategies in present perimetry
09:25 IL SU-02-02
What is weak in present conventional perimetry
and what can we do about it
09:35 IL SU-02-03
Alternatives presently available (Flicker tests [FDT,
Matrix, etc.], electrophysiology)
09:45 IL SU-02-04
What we need the ideal new functional test
09:55
Discussion
Stockholm
10:30 - 11:15 SU-03
Decisions for Treatment and Change in Treatment
Section 2: Present and Future Approaches to Glau-
coma Care
Chairs:
10:30 IL SU-03-01
Risk assessment and risk calculation
Steven L. Mansberger (Portland/USA)
10:40 IL SU-03-02
The impact of risk calculation on physician deci-
sions
10:50 IL SU-03-03
Cost/benefit, Cost effectiveness
11:00 IL SU-03-04
Practice patterns, too much or too little
11:10
Discussion
Stockholm
11:15 - 12:00 SU-04
New Approaches to Gathering Information about
Glaucoma
Section 2: Present and Future Approaches to Glau-
coma Care
Chairs:
11:15 IL SU-04-01
The challenge: conduct large-scale research with
many centers
Don Budenz (Miami/USA)
Sunday, 6 June 2010
S
u
n
d
a
y
,

6

J
u
n
e
91
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
11:25 IL SU-04-02
Insurance database studies: strengths and
weaknesses
11:35 IL SU-04-03
Mining our hard drives (Lessons from Cochrane
approach)
11:45 IL SU-04-04
How to do research cheaper and better
11:55
Discussion
Stockholm
14:00 - 14:45 SU-05
Adherence with Medical Therapy, the Dirty Secret
Section 3: Outlooks to Medical and Surgical
Therapy
Chairs:
14:00 IL SU-05-01
How bad is adherence now?
14:10 IL SU-05-02
Barriers to adherence
14:20 IL SU-05-03
How does physician communication affect
adherence?
14:30 IL SU-05-04
How much would be gained if we increased
adherence?
James C Tsai (New Haven/USA)
14:40
Discussion
Stockholm
14:45 - 15:40 SU-06
Present and Future of Glaucoma Surgery Surgical
Challenges
Section 3: Outlooks to Medical and Surgical
Therapy
Chairs:
14:45 IL SU-06-01
Developments making trabeculectomy safer
14:55 IL SU-06-02
Bleb classification and management of
complications related to blebs
15:05 IL SU-06-03
Non-penetrating glaucoma surgery techniques
has their time come or gone?
15:15 IL SU-06-04
Tubes: When, why, how
15:25 IL SU-06-05
Angle surgery: status report on newer methods
15:35 IL SU-06-06
Standardized reporting on surgical studies
Mark Sherwood (Gainesville/USA)
Stockholm
16:10 - 16:50 SU-07
Childhood Glaucoma Care: the Patient Who Lives
Up to 2100
Section 4: Neglected Areas: Where Can We
Improve
Chairs:
16:10 IL SU-07-01
Present and future surgical techniques: Innovation
at the horizon?
Sunday, 6 June 2010
S
u
n
d
a
y
,

6

J
u
n
e
92
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
16:20 IL SU-07-02
Spontaneous resolution of congenital glaucoma
a natural help for surgery
16:25 IL SU-07-03
Developing vision: Amblyopia is a major challenge
16:35 IL SU-07-04
New aspects of secondary glaucoma after
congenital cataract surgery
16:45
Discussion
Stockholm
16:50 - 17:30 SU-08
Glaucoma Care in Developing Countries
Section 4: Neglected Areas: Where Can We
Improve
Chairs:
16:50 IL SU-08-01
The scope of the problem
16:55 IL SU-08-02
What is done now for OAG in the developing world
17:00 IL SU-08-03
What is done now for ACG in the developing world
What should be done right now: 3 viewpoints
17:05 IL SU-08-04
We should apply the developed country model
17:10 IL SU-08-05
We should use different programs for different
regions
17:15 IL SU-08-06
We should use the center of excellence - pyramid
model
17:20 IL SU-08-07
Where will we make the biggest short-term gains
in reducing impairment
17:25
Discussion
Sao Paulo
08:30 - 10:00 SU-09
Next Generations of Silicone Hydrogel Contact
Lenses
Symposium
Chairs:
Bruce H. Koffler (Lexington/USA)
Cornelius Berzas (Offenbach/D)
08:30 IL SU-09-01
The Oliver Dabezies Lecture; Oliver Dabezies Jr.
M.D.: A True Gentleman
Jane Sparholt (Rnne/DK)
08:40 IL SU-09-02
Is it safe to wear extended and continuous wear
lenses?
Mihly Vgh (Szeged/H)
08:50 IL SU-09-03
Silicone hydrogel multifocal lenses for the
presbyope
Ebru Toker (Istanbul/TR)
09:00 IL SU-09-04
Ophthalmic Drug Delivery by contact lenses
Anuj Chauhan (Florida/USA)
09:10 IL SU-09-05
Silicone hydrogel for ectatic (& irregular) corneas
Ursula Vogt (London/UK)
09:20 IL SU-09-06
Next generations of silicone-Hydrogels
09:30 IL SU-09-07
Treatment and Management of Contact Lens
infectious complications; Pseudonomas infection
and melting and acanthamoeba ceratities
Andrena McElvanney (London/UK)
09:40 IL SU-09-08
Therapeutic uses of Silicone Hydrogels in Ocular
Surface Disease
Antonio Elizondo (San Pedro/MEX)
09:50
Discussion
Sunday, 6 June 2010
S
u
n
d
a
y
,

6

J
u
n
e
93
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
Sao Paulo
10:30 - 12:00 SU-10
AAO Symposium: Excellence in Cataract Surgery:
What We Should Demand in 2010?
Symposium
Cataract
Chairs:
10:30 IL SU-10-01
Excellence in Incision
10:40 IL SU-10-02
Excellence in Outcomes
TBA
10:50 IL SU-10-03
Excellence in Restoring Near Vision Function
TBA
11:00 IL SU-10-04
Excellence in Restoring Visual Optics
11:10 IL SU-10-05
Excellence in Astigmatic Correction during
Cataract Surgery
11:20 IL SU-10-06
Excellence in Phaco Engineering
Michael Colvard (Los Angeles/USA)
11:30
Discussion
Sao Paulo
14:00 - 15:30 SU-11
SOE/ISCEV Symposium: Use of Electrophysiological
Methods in Acquired Retinal and Optic Nerve
Diseases
Symposium
Electrophysiology
Chairs:
Marko Hawlina (Ljubljana/SLO)
Graham E. Holder (London/UK)
14:00 IL SU-11-01
Electrophysiology and imaging in retinal diseases
Ulrich Kellner (Siegburg/D)
14:15 IL SU-11-02
What can we learn from electrophysiology in
AMD patients
Thomas Meigen (Wrzburg/D)
14:30 IL SU-11-03
The differentiation between optic nerve and
macular dysfunction
Marko Hawlina (Ljubljana/SI)
14:45 IL SU-11-04
Electrophysiology in glaucoma
Michael Bach (Freiburg/D
15:00 IL SU-11-05
Electrophysiology in inflammatory and
autoimmune diseases
Graham E. Holder (London/UK)
15:15
Discussion
Sao Paulo
16:00 - 17:30 SU-12
Eyelid, Ocular Adnexal and Conjunctival Tumors
Symposium
Pathology
Chairs:
Gordon Klintworth (Morrisville/USA)
Maria Antonia Saornil (Valladolid/E)
16:00 IL SU-12-01
Eyelid malignancies: conventional and new thera-
peutic modalities
Gonzalo Blanco-Mateos (Valladolid/E)
16:10 IL SU-12-02
Sebaceous carcinoma
Tom Cummings (Durham/USA)
16:20 IL SU-12-03
In vivo confocal microscopy of conjunctival lesions
with histopathologic correlation
Elisabeth M. Messmer (Munich/D)
16:30 IL SU-12-04
Conjunctival intraepithelial neoplasia: risk factors,
prophylaxis and treatment
16:40 IL SU-12-05
New classification of primary acquired melanosis
(PAM)
Sarah E. Coupland (Liverpool/UK)
Sunday, 6 June 2010
S
u
n
d
a
y
,

6

J
u
n
e
94
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
16:50 IL SU-12-06
What is this caruncular tumor?
17:00 IL SU-12-07
Case presentations
17:10
Discussion
Abu Dhabi
08:30 - 10:00 SU-13
Correcting Presbyopia with IOLs
Chairs:
08:30 IL SU-13-01
Monovision
08:40 IL SU-13-02
Multifocal, refractive
08:50 IL SU-13-03
Mulitfocal, diffractive
Jos F. Alfonso (Oviedo/E)
09:00 IL SU-13-04
Accommodating, monooptic
Milind Pande (North Ferriby/UK)
09:10 IL SU-13-05
Accommodating, dualoptic
09:20 IL SU-13-06
Managing astigmatism and residual ametropia
09:30
Discussion
Abu Dhabi
10:30 - 12:00 SU-14
Managing Complex Cases
Chairs:
10:30 IL SU-14-01
Incisional issues
10:40 IL SU-14-02
Dense nuclei
10:50 IL SU-14-04
Small pupils
11:00 IL SU-14-05
Ruptured posterior capsule
11:10 IL SU-14-06
Iris defects (aniridia, coloboma, traumatic)
11:20 IL SU-14-07
Dislocated IOLs
TBA
11:30
Discussion
Abu Dhabi
14:00 - 15:30 SU-15
New Monofocal IOL Designs
Chairs:
Thomas Kohnen (Frankfurt/D)
14:00 IL SU-15-01
Aspheric
14:10 IL SU-15-02
Toric overview
Sunday, 6 June 2010
S
u
n
d
a
y
,

6

J
u
n
e
95
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
14:20 IL SU-15-03
Surgical pearls for toric IOLs
David Spalton (London/UK)
14:30 IL SU-15-04
Extreme cases
14:40 IL SU-15-05
Light-adjustable
Fritz Hengerer (Bochum/D)
14:50 IL SU-15-06
New IOL biomaterials
15:00
Discussion
Abu Dhabi
16:00 - 17:30 SU-16
Emerging Technology in Cataract Surgery
Chairs:
16:00 IL SU-16-01
Advances in techniques for patient assessment
16:10 IL SU-16-02
IOL calculations, technology? formulas Haigis,
IOL calculations after refractive surgery DDK
Jaime Aramberri Agesta (Vitoria-Gasteiz/E)
16:20 IL SU-16-03
Phaco technology
Barry S. Seibel (Los Angeles/USA)
16:30 IL SU-16-04
Prevention of PCO
16:40 IL SU-16-05
Prevention of endophthalmitis
16:50 IL SU-16-06
Small-incision ECCE" to "Modern Manual Cataract
TBA
17:00
Discussion
Oslo
08:30 - 10:00 SU-17
Cornea/External Disease: Basics
Free Paper
Cornea, External Disease
Chairs:
Rupert Strau (Linz/A)
08:30 FP SU-17-01
Donor corneal tissue characteristics and graft
survival
Tatyana Hergeldzhieva-Fileva, Petja Ivanova
Vassileva, Nickolai Surchev, Yordanka Kirilova
(Sofia/BG)
08:37 FP SU-17-02
The effect of human and rabbit serum on the
recovery of the wounded corneal surface in the
Ex vivo Eye Irritation test
B. Kranz-Opgen-Rhein, Norbert Schrage,
M. Frentz (Aachen/D, Kln/D)
08:44 FP SU-17-03
Immunocytochemical analysis after treatment
with osmoprotective lubricant in patients with
dysfunctional tear syndrome
Rossen M. Hazarbassanov (Sao Paulo/BR)
08:51 FP SU-17-04
Osmoprotectants can protect corneal epithelial
cells from death after exposure to hyper-osmolar
solutions
Mark Willcox, Qian Garrett, Sharon Shih,
Joseph Vehige, Peter Simmons (Sydney/AUS,
Irvine/USA)
08:58 FP SU-17-05
Keratoconus experimentally induced in mice using
collagenase
Mahsa Hadipour Jahromy,
Farhad Adhami-moghadam, Simin Fazelipour,
Shahrzad Khakpour, Mohammadsadegh Younesian
(Tehran/IR)
09:05 FP SU-17-06
Differentiation of human bone mesenchymal
stem cells into keratocytes in vitro
Dong Shi, Yuji Tanaka, Akira Kubota, Kohji Nishida
(Sendai/J)
09:12 FP SU-17-07
Atomic Force Microscopy of the corneal ultrastruc-
ture before and after corneal crosslinking
Rupert Strau, David Diesenberger, Martin
Dirisamer, Manfred Dichtl, Andreas Wedrich,
Kurt Schilcher, Siegfried G. Priglinger (Linz/A)
Sunday, 6 June 2010
S
u
n
d
a
y
,

6

J
u
n
e
96
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
09:19 FP SU-17-08
Monitoring osmotic stress within a new in vitro
dry eye model
Felix Spler, Markus Frentz, Heinrich Kurz,
Norbert Schrage (Aachen/D, Kln/D)
09:26 FP SU-17-09
Bone Marrow-Derived Endothelial Progenitor Cells:
a Promising Therapeutic Alternative for Corneal
Endothelial Dysfunction
Chunyi Shao, Yao Fu, Wenjuan Lu, Xianqun Fan
(Shanghai/CN)
09:33 FP SU-17-10
Expression of Tim-3 in high risk murine model of
corneal graft rejection
Wei Kun Hu, Nan Xiang, Rong Liu, Jing Yuan
(Wuhan/CN)
09:40 SL SU-17-11
Tomographic normal values for elevation and
pachymetry in a hyperopic population
Michael W. Belin, Michael Cortese (Marana/USA,
Albany/USA)
09:49
Discussion
Oslo
10:30 - 12:00 SU-18
Ocular Motor Problems
Symposium
Neuro-Ophthalmology
Chairs:
10:30 IL SU-18-01
Localizing value of nystagmus
10:40 IL SU-18-02
Cryptic Ocular motor Palsies
Emely Karam (Caracas/Y)
10:50 IL SU-18-03
Congenital and acquired paretic strabismus
11:00 IL SU-18-04
Differential diagnosis of diplopia
11:10 IL SU-18-05
Localising value of disorders of saccades
Caroline Tilikete (Lyon/F)
11:20 IL SU-18-06
Paroxysmal diplopia
11:30
Discussion
Oslo
14:00 - 15:30 SU-19
Matching in Penetrating Keratoplasty
Symposium
Chairs:
John Armitage (Bristol/UK)
Daniel Bhringer (Freiburg/D)
Ren J. Duquesnoy (Pittsburgh/USA)
14:00 IL SU-19-01
HLA matching in keratoplasty: The Bristol
experience
14:15 IL SU-19-02
HLA matching in keratoplasty: The Freiburg
experience
Daniel Bhringer (Freiburg/)
14:30 IL SU-19-03
HLA matching at the epitope level: a new ap-
proach to select transplant donors
Ren J. Duquesnoy (Pittsburgh/USA)
14:45 IL SU-19-04
Minor transplantation antigens
Eric Spierings (Utrecht/NL)
15:00 IL SU-19-05
Pathophysiology of corneal graft rejection
John V. Forrester (Aberdeen/UK)
15:15
Discussion
Sunday, 6 June 2010
S
u
n
d
a
y
,

6

J
u
n
e
97
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
Oslo
16:00 - 17:30 SU-20
AOI Symposium: Dealing with Complications of
Anterior Segment Surgery
Symposium
Cataract
Chairs:
Peter G. Watson (Cambridge/UK)
Juan Verdaguer (Santiago/RCH)
16:00 IL SU-20-01
Dealing with infections after LASIK
Richard L. Abbott (San Francisco/USA)
16:10 IL SU-20-02
Management of post-Lasik corneal ectasia
16:20 IL SU-20-03
Dealing with zonular dialysis during phacoemulsi-
fication
Marie-Jos Tassignon (Antwerb/B)
16:30 IL SU-20-04
Dealing with non filtering, flat or encapsulated
blebs
16:40 IL SU-20-05
Intraocular lens implantation in the absence of
capsular support
Enrique Malbrn (Buenos Aires/RA)
16:50 IL SU-20-06
Dealing with early-onset endophthalmitis after
cataract surgery
Pran Nath Nagpal (Ahmedabad/IND)
17:00 IL SU-20-07
Late-onset endophthalmitis after cataract surgery
17:10 IL SU-20-08
Cystoid macular edema in early pseudophakia
Kenasaku Miyake (Nagoya/J)
17:20 IL SU-20-09
Management of suprachoroidal hemorrhage after
anterior segment surgery
Oslo
17:30 - 18:15 SU-21
Academia Ophthalmologica Internationalis
Lecture
Highlights
Chairs:
17:30 IL SU-21-01
Introduction
17:35 IL SU-21-02
Galileo's Blindness
Peter G. Watson (Cambridge/UK)
Room Madrid
08:30 - 10:00 SU-22
Graves' Disease
Symposium
Strabismus
Chairs:
Don O. Kikkawa (La Jolla/USA)
Lelio Baldeschi (Amsterdam/NL)
Anja K. Eckstein (Essen/D)
08:30 IL SU-22-01
Pathogenesis of GO
Marian Ludgate (Cardiff/UK)
08:40 IL SU-22-02
Symptoms and assessment of GO
Alison J. Dickenson (New Castle/UK)
08:50 IL SU-22-03
EUGOGO Management Plan of GO
Anja K. Eckstein (Essen/D)
09:00 IL SU-22-04
Orbital surgery
Lelio Baldeschi (Amsterdam/NL)
09:10 IL SU-22-05
Eye muscle surgery
Joachim Esser (Essen/D)
09:20 IL SU-22-06
Lid surgery
Don O. Kikkawa (La Jolla/USA)
09:30
Discussion
Sunday, 6 June 2010
S
u
n
d
a
y
,

6

J
u
n
e
98
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
Room Madrid
10:30 - 12:00 SU-23
Panel: Case Presentations
Symposium
Strabismus
Chairs:
Daniel Mojon (St. Gallen/CH)
Christina Pieh (Freiburg/D)
10:30 IL SU-23-01
Elevation of one eye during tooth brushing
10:40 IL SU-23-02
Complications of botulinum toxin injection in an
infant: remaining mydriasis
Claude Speeg-Schatz (Strasbourg/F)
10:50 IL SU-23-03
Vertical angle "kappa"
11:00 IL SU-23-04
Unilateral exophthalmos surprise, surprise
Andrea Langmann (Graz/A)
11:10 IL SU-23-05
"I dont like to ride my bike anymore!"
Bettina K. Wabbels (Bonn/D)
11:20 IL SU-23-06
"I wish I hadnt done this!"
Heimo Steffen (Wrzburg/D)
11:30 IL SU-23-07
Synergistic adduction in a 5-year-old girl
Christina Pieh (Freiburg/D)
11:40
Discussion
Room Madrid
14:00 - 15:30 SU-24
Infectious Uveitis
Symposium
Chairs:
Narsing A. Rao (Los Angeles/USA)
Justus G. Garweg (Bern/CH)
14:00 IL SU-24-01
Pathophysiology and Diagnostics for Toxo-
plasmosis
Michael E. Grigg (Bethesda/USA)
14:10 IL SU-24-02
Challenges in the Diagnosis and Management of
Ocular Toxoplasmosis
14:20 IL SU-24-03
Pathophysiology and Diagnostics for Lymes
Disease
Volker Fingerle (Oberschleiheim/D)
14:30 IL SU-24-04
Ocular Lymes Disease
14:40 IL SU-24-05
Pathophysiology and Diagnostics for Tuberculosis
Daniel Vtor Vasconcelos Santos (Belo Horizonte/
BR)
14:50 IL SU-24-06
Ocular Tuberculosis
15:00
Discussion
Room Madrid
16:00 - 17:30 SU-25
Recent Development in Inherited Retinal Diseases
Symposium
Retina, Vitreous
Chairs:
Tim Stout (Portland/USA)
Jos-Alain Sahel (Paris/F)
16:00 IL SU-25-01
Gene Replacement Therapy for Inherited Retinal
Disease
James W. B. Bainbridge (London/UK)
16:10 IL SU-25-02
Stem Cell Therapy
Peter J. Francis (Portland/USA)
16:20 IL SU-25-03
The Future of High-Throughput Ophthalmic DNA
Diagnostics
Bernhard H. F. Weber (Regensburg/D)
Sunday, 6 June 2010
S
u
n
d
a
y
,

6

J
u
n
e
99
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
16:30 IL SU-25-04
Rod derived Cone Viability
16:40 IL SU-25-05
Control of VEGF Gene Expression
16:50 IL SU-25-06
Outer retina a role for channels and connections
in degenerative diseases
Mathias Seeliger (Tbingen/D)
17:00
Discussion
Room Sydney
08:30 - 10:00 SU-77
New Technologies for Keratoplasty
Symposium
New Technology, Bioengineering
Chairs:
08:30 IL SU-77-01
A New Collagen Implant to Treat Corneal Defects
Bjrn Bachmann (Erlangen/D)
08:40 IL SU-77-02
New Developments in DALK
Donald T. H. Tan (Singapore/SGP)
08:50 IL SU-77-03
Mushroom Keratoplasty for High, Irregular
Astigmatism After Penetrating Keratoplasty
Gabriel van Rij (Rotterdam/NL)
09:00 IL SU-77-04
Long-term Results of DSAEK in 1000 Eyes
Francis W. Price (Indianapolis/USA)
09:10 IL SU-77-05
Visual Rehabilitation after DASEK and DMEK
09:20 IL SU-77-06
DELK, DASEK, DMEK, the Thinner the Better
Gerrit R. J. Melles (Rotterdam/NL)
09:30 IL SU-77-07
Future Options for Endothelial Transplantation
09:40
Discussion
Room Sydney
10:30 - 12:00 SU-27
Uveitis/Intraocular Inflammation,
Microbiology/Immunology 1
Symposium
Chairs:
Matthias D. Becker (Zurich/CH)
10:30 FP SU-27-01
Rationale and Study Design of a Phase III Clinical
Trial Evaluating IL-17A Inhibition with AIN457 in
Patients with Posterior Segment Uveitis Secondary
to Behets Disease
Yonca Akova (Ankara/TR)
10:37 FP SU-27-02
Experience with Adalimumab for the treatment
of non-infectious uveitis
Bianca Dobner, Regina Max, Matthias D. Becker,
Carsten Heinz, Talin Barisani-Asenbauer,
Arnd Heiligenhaus, Friederike Mackensen
(Heidelberg/D, Vienna/A, Zurich/CH, Mnster/D)
10:44 FP SU-27-03
An Open-Label Trial to Assess the Efficacy of
AIN457, a Monoclonal Antibody Against IL-17A, in
Noninfectious Uveitis
C. Stephen Foster, Rosa Kim, C. Michael Samson,
Naomi Falk, David Chu, David Callahan,
Quan Dong Nguyen, Thaddeus P. Dryja
(Cambridge/USA)
10:51 FP SU-27-04
Safety Profile of LX211 (Luveniq/voclosporin
oral capsule) in Sight-Threatening Noninfectious
Uveitis as reported in the LUMINATE Studies
Christoph Deuter, on behalf of the LUMINATE
Study Group (Tbingen/D)
10:58 FP SU-27-06
Uveitis refractive to cyclosporine A improves with
additional everolimus: a pilot study
11:05 FP SU-27-07
Acute retinal necrosis a national survey in
Germany
Sibylle Winterhalter, Antonia M Joussen,
Uwe Pleyer, Arnd Heiligenhaus, Friederike
Mackensen, Manfred Zierhut, Anna-Karina Maier,
Thomas Ness (Berlin/D, Mnster/D, Heidelberg/D,
Freiburg/D, Tbingen/D)
Sunday, 6 June 2010
S
u
n
d
a
y
,

6

J
u
n
e
100
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
11:12 FP SU-27-08
Twenty five gauge pars plana vitrectomy for vitre-
ous opacities secondary to ocular toxoplasmosis
Claudio Garcia, Tiago Arantes, Fabio Barreto,
Cristina Muccioli (Sao Paulo/BR)
11:19 FP SU-27-09
Long-term follow-up of patients with Behcets
disease: Apropos one case
Mirsad Ibisevic (Sarajevo/BIH)
11:26 FP SU-27-10
Severe cases of occlusive retinal vasculitis
Anne Wissen, Mark Saeger, Johann Roider,
Bernhard Nlle (Kiel/D)
11:33
Discussion
Room Sydney
14:00 - 15:30 SU-28
Corneal Infections
Symposium
Chairs:
Wolfgang Behrens-Baumann (Magdeburg/D)
John K. G. Dart (London/UK)
Janos Nmeth (Budapest/H)
14:00 IL SU-28-01
Problem solving for progressive microbial keratitis
14:15 IL SU-28-02
Current aspects of keratomycosis
14:30 IL SU-28-03
The Challenge of Acanthamoeba Keratitis
Elmer Tu (Chicago/USA)
14:45 IL SU-28-04
Mycobacterial keratitis
Prashant Garg (Hyderabad/IND)
15:00 IL SU-28-05
Herpetic keratitis
Lies Remeijer (Rotterdam/NL)
15:15
Discussion
Room Sydney
16:00 - 17:30 SU-29
Neuro-Ophthalmic Emergencies
Symposium
Neuro-Ophthalmology
Chairs:
Satoshi Kashii (Osaka/J)
16:00 IL SU-29-02
Acute eye pain
16:15 IL SU-29-03
Perilous pupils
16:30 IL SU-29-04
Traumatic Optic Neuropathy: Is there an evidence
based recommendation for management?
16:45 IL SU-29-05
Giant cell Arteriitis
Aki Kawasaki (Lausanne/CH)
17:00 IL SU-29-06
Abnormal eye movements that should not be
missed
Francois Borruat (Lausanne/CH)
17:15
Discussion
Room Hong Kong
08:30 - 10:00 SU-30
Panel: Future Aspects Advanced Information,
Way-forward
Symposium
Chairs:
Kanagasingam Yogesan (Nedlands/AUS)
Heikki Lamminen (Tampere/FIN)
Dietrich Paulus (Koblenz/D)
08:30 IL SU-30-01
Round table discussion
Kanagasingam Yogesan (Nedlands/AUS)
08:50 IL SU-30-02
Current status and way forward
Sajeesh Kumar (Pittsburgh/USA)
Sunday, 6 June 2010
S
u
n
d
a
y
,

6

J
u
n
e
101
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
09:10 IL SU-30-03
Heikki Lamminen (Tampere/FIN)
09:30 IL SU-30-04
Dietrich Paulus, Kanagasingam Yogesan,
Heikki Lamminen (Koblenz/D, Nedlands/AUS,
Pittsburgh/USA, Tampere/FIN)
Room Hong Kong
10:30 - 12:00 SU-31
Current Opinion in Immunology of Uveitis
Symposium
Immunology, Molecular Biology, Microbiology
Chairs:
Robert Nussenblatt (Bethesda/USA)
10:30 IL SU-31-01
Recent developments of experimental uveitis in
mice
Rachel R. Caspi (Bethesda/USA)
10:40 IL SU-31-02
Recent developments of experimental uveitis in
rats
10:50 IL SU-31-03
Intraocular immune response in human uveitis
S. John Curnow (Birmingham/UK)
11:00 IL SU-31-04
Leukocyte migration in uveitis
Isabel J. Crane (Aberdeen/UK)
11:10 IL SU-31-05
How is uveitis initiated?
11:20 IL SU-31-06
"Immunologicals" as therapy for uveitis
11:30
Discussion
Room Hong Kong
14:00 - 15:30 SU-32
Onchocerciasis: Moving to Elimination
Symposium
Prevention of Blindness
Chairs:
Adrian Dennis Hopkins (Decatur/USA)
Allen Foster (London/UK)
14:00 IL SU-32-01
Onchocerciasis Eye pathology and current under-
standing
Tony Ukety (Geneva/CH)
14:10 IL SU-32-02
Elimination of Onchocerciasis in the Americas on
course for 2012
Mauricio Sauerbrey (San Salvador/ES)
14:20 IL SU-32-03
A paradigm shift from Control to Elimination in
Africa
Adenike Abiose (Ibadan/WAN)
14:30 IL SU-32-04
Community Directed Interventions; Onchocerciasis
control leads the way in Public Health
Uche Amazigo (Ouagadougou/HV)
14:40 IL SU-32-05
Current research: What do we need to know to
eliminate the disease?
Frank Richards (Atlanta/USA)
14:50 IL SU-32-06
Neglected Tropical Diseases and Onchocerciasis:
can widening the vision lose focus?
15:00
Discussion
Room Hong Kong
16:00 - 17:30 SU-33
EVER Symposium: Therapy in Noninfectious Ocular
Inflammation: Recent Developements
Symposium
Chairs:
Sunday, 6 June 2010
S
u
n
d
a
y
,

6

J
u
n
e
102
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
16:00 IL SU-33-01
Principles and new targets in immunemodulation
TBA
16:15 IL SU-33-02
Biologicals: Beyond anti-TNF treatment
Marc D. de Smet (Antwerpen/B)
16:30 IL SU-33-03
Immunosuppression in children (JIA)
16:45 IL SU-33-04
Corticosteroids: old agents new options
17:00 IL SU-33-05
Optimised monitoring of inflammation suppres-
sive therapy (IST)
Carl P. Herbort (Lausanne/CH)
17:15
Discussion
VIP Lounge 1
08:30 - 10:00 SU-44
Neuro-Ophthalmology 1
Free Paper
Neuro-Ophthalmology
Chairs:
Shihui Wei (Beijing/CN)
08:30 SL SU-44-01
Relaticity analysis of rhinogenous ocular
manifestations
08:39 FP SU-44-02
Neuroprotective effect on retinal ganglion cells
by transpupillary laser irradiation of the optic
nerve head
Libin Jiang (Beijing/CN)
08:46 FP SU-44-03
Clinical analysis of 52 cases with ophthalmologic
signs in vertebral-basilar insufficiency
08:53 FP SU-44-04
Are we neglecting visual neglect?
Shu Jeng Ting, Alex Pollock, Fergus Doubal,
Gordon Dutton, Shu Wei Ting, Bal Dhillon,
Thompson Michelle (Glasgow/UK)
Sunday, 6 June 2010
S
u
n
d
a
y
,

6

J
u
n
e
103
09:00 FP SU-44-05
Saccade dynamics in peripheral vs central fourth
nerve palsies
Tao Fu, Alan Blakeman, Manokaraananthan
Chandrakumar, Herbert Goltz, Agnes M. F. Wong
(Beijing/CN)
09:07 FP SU-44-06
Restoration of vision: non-invasive current
stimulation enhances brain synchronization
after optic nerve damage a retrospective,
observational study with 446 patients
Anton Fedorov, Sandra Jobke, Alexandra N.
Chibisova, Julia M. Chibisova, Carolin Gall,
Bernhard Sabel (Magdeburg/D, St. Petersburg/RUS)
09:14 FP SU-44-07
Neuroplasticity in acute optic neuritis: an
Functional magnetic resonance imaging (fMRI)
study
Anoop Kishore Gupta, Senthil kumaran,
Rohit Saxena, Vimla Menon, Pradeep Sharma,
Pradeep Sharma (Dehli/IND)
09:21 FP SU-44-08
Restoration of vision: Non-invasive current
stimulation for the treatment of visual field
defects in optic neuropathy as single-center
prospective trial
Bernhard A. Sabel, Anton B. Fedorov, Christoph
Herrmann, Carolin Gall (Magdeburg/D)
09:28 FP SU-44-09
Automated morphometry of the visual pathway in
primary open-angle glaucoma
Aditya Hernowo, Christine Boucard,
Nomdo Jansonius, Johanna Hooymans,
Frans Cornelissen (Groningen/NL)
09:35 FP SU-44-10
Dissemination of glioblastoma multiforme
masquerading multiple sclerosis
Nikolai Holak, Heinrich Holak, S. Pfeifenbring,
S. Baumgarten (Salzgitter/D)
09:42
Discussion
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
VIP Lounge 1
14:00 - 15:30 SU-46
Julius Hirschberg Society: Symposion Contribution
to Hundred and Fifty Years of Ophthalmology
Symposium
International Ophthalmology
Chairs:
Danny Hirsch-Kauffmann Jokl (New York/USA)
Frank Krogmann (Thngersheim/D)
14:00 IL SU-46-01
An ophthalmologist's trip to India
Gregor Wollensak (Halle/D)
14:10 IL SU-46-02
Swiss contribution to International
Ophthalmology
Balder P. Gloor (Zurich/CH)
14:20 IL SU-46-03
The first female medical students
14:30 IL SU-46-04
Albrecht von Graefe- previously unrecognized
contributions to modern Ophthalmology
Danny Hirsch-Kauffmann Jokl (New York/USA)
14:40 IL SU-46-05
Vienna and its significance in worldwide
ophthalmology
Frank Krogmann (Thngersheim/D)
14:50 IL SU-46-06
Glaucoma und migraine a historical review
Carl Erb (Berlin/D)
15:00 IL SU-46-07
Ludwik Zamenhof One of the most famous
ophthalmologists in the worlds Culture
Andrzej Grzybowski (Poznan/PL)
15:10
Discussion
VIP Lounge 1
16:00 - 17:30 SU-76
Incorporating Evidence-based Clinical Practice
Guidelines into the Care of our Patients
Symposium
Evidence-based Ophthalmology
Chairs:
Michle Beaconsfield (London/UK)
16:00 IL SU-76-01
Incorporating evidence based clinical practice
guidelines into patient care
16:15 IL SU-76-02
Guideline development in the absence of evidence
16:30 IL SU-76-04
Evidence Based Clinical Guidelines in Strabismus
Emilio Carlo Campos (Bologna/I)
16:45 IL SU-76-05
Diabetic Retinopathy: an international problem
with national clinical practice guidelines
17:00 IL SU-76-06
Promoting and Implementing Clinical Practice
Guidelines in Developing Countries: What We have
learned from the China Experience
17:15
Discussion
Sunday, 6 June 2010
S
u
n
d
a
y
,

6

J
u
n
e
104
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
VIP Lounge 2
08:30 - 12:00 SU-39
Workshop: Uveal Melanoma Genetic Testing
Workshop
Oncology
Session 1: Uveal Melanoma Prognostic Testing
Chairs:
08:30 IL SU-39-01
Introduction
08:45 IL SU-39-02
Prognosis Assessment by Genome Wide Profiling
in Uveal Melanoma
Jerome Couturier (Paris/F)
09:00 IL SU-39-03
MSA and MLPA for Genetic Testing of Uveal
Melanoma
Michael Zeschnigk (Essen/D)
09:15 IL SU-39-04
Follow-Up Study of 347 Patients with Uveal
Melanoma Tested by Microsatellite Analysis
Stefanie Thomas (Essen/D)
09:30 IL SU-39-05
Genetic Changes and Expression Profiling in Uveal
Melanoma: Markers of Patient Survival
Hanneke Mensink (Rotterdam/NL)
09:45 IL SU-39-06
High PTP4A3 Phosphatase Expression Correlates
with Uveal Melanoma Metastasis
Simon Saule (Paris/F)
Session 2: Taking Biopsy
Chairs:
Michael Zeschnigk (Essen/D)
10:30 IL SU-39-07
Serum Markers
10:45 IL SU-39-08
To Biopsy or Not to Biopsy
Stefan Seregard (Stockholm/S)
11:00 IL SU-39-09
Clinical Application of Genetic Studies on
Choroidal Melanoma
Bertil D. Damato (Liverpool/UK)
11:15 IL SU-39-10
Techniques for Harvesting Fresh Tumor Tissue for
Genetic Studies
11:30 IL SU-39-11
Fine Needle Aspiration Biopsy for Genetic Testing
of Uveal Melanoma in 500 Cases
VIP Lounge 2
14:00 - 15:30 SU-55
Pediatric Ophthalmology & Genetics 2
Free Paper
Chairs:
Nadija F. Bobrova (Odessa/UA)
Marilyn Miller (Chicago/USA)
14:00 SL SU-55-01
Pediatrics Ophthalmology New Approaches
Nadiya Bobrova (Odessa/UA)
14:09 FP SU-55-02
Incidence of retinopathy of prematurity in Bahrain,
2002-2008
Ebtisam K. Al Alawi, Mohamed Shaker Omran
(Isa Town/BRN)
14:16 FP SU-55-03
Effect of Two Months Oral CDP-Choline on Visual
Function in Amblyopic Patients: Long-Term Results
Emilio Carlo Campos, Michela Fresina (Bologna/I)
14:23 FP SU-55-04
Infants implantation surgery specific features
Nadiya Bobrova, Oleksii Zhekov,
Anna Dembovetskaya (Odessa/UA)
14:30 FP SU-55-05
Systemic Exposure and Safety of Latanoprost
0.005% in Infants with Glaucoma
Susan Raber, Tomoko Maeda-Chubachi,
Rachel Courtney, Brad Simons, Sharon Freedman,
Barbara Wirostko (San Diego/USA)
14:37 FP SU-55-06
Demyelinating optic neuritis in Asian children:
clinical features and risk of multiple sclerosis
Yoon Jeon Kim, Joo Hyun Choi, Hyun Taek Lim
(Seoul/ROK)
14:44 FP SU-55-07
OCT charecteristics of the macula and optic disc in
high myopic children
Michal Szuminski, Alina Bakunowicz-Lazarczyk
(Bialystok/PL)
Sunday, 6 June 2010
S
u
n
d
a
y
,

6

J
u
n
e
105
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
14:51 FP SU-55-08
Earlier visual rehabilitation in pediatric cataracts
Role of cataract surgery with primary posterior
capsulotomy with anterior vitrectomy primary IOL
implantation
Seema Deshmukh, Vikas Mahatme (Nagpur/IND)
14:58 FP SU-55-09
Prevention of oxygen induced retinopathy by high
doses of vitamin A in the newborn rat
Xanthi Couroucli, Yan-hong Wei, Weiwu Jiang,
Bhagavatula Moorthy (Houston/USA)
15:05 FP SU-55-10
Neonatal Dacryostenosis as a Risk Factor for
Anisometropia
Brian Mohney, Joshua Piotrowski (Rochester/USA)
15:12
Discussion
VIP Lounge 2
16:00 - 17:30 SU-38
New technology, Bioengineering,
Nanotechnology 1
Free Paper
Chairs:
Russell Andrews (Los Gatos/USA)
16:00 FP SU-38-01
Image Quality of a Novel Navigated Retina Laser
(NAVILAS)
Aljoscha Neubauer, Marcus Kernt, Christos
Haritoglou, Michael Ulbig, Anselm Kampik,
Igor Kozak, Stephen Oster, Katrin Hartmann,
Jae Suk Kim, William R Freeman (Munich/D,
San Diego/USA, La Jolla/USA)
16:07 FP SU-38-02
Benefit of NAVILAS Retina Navigation in Chal-
lenging Retinal Pathologies
Alexandra Hoeh, Thomas Ach, Mira Ruppenstein,
Giovanni Staurenghi, Stefan Dithmar
(Heidelberg/D, Milano/I)
16:14 FP SU-38-03
Different ways to treat Presbiopia, including the
new PresbV (Vejarano Method)
L. Felipe Vejarano (Popayn/CO)
16:21 FP SU-38-04
Assessing the functionality and biocompatibility
of a wireless contact lens sensor for 24 hour-
intraocular pressure monitoring in volunteers:
preliminary results.
Stefan De Smedt, Sylvain Roy, Andr Mermoud,
Joseph Geinoz, Philippe Seira, Jeanette Lindell,
Corinne Schnyder (Lausanne/CH)
16:28 FP SU-38-05
Pupillometer-Based Objective Chromatic Perimetry
Preliminary Evaluation
Ygal Rotenstreich, Andrew Kolker, Shlomo
Melamed, Michael Belkin, Alon Skaat (Kfar Bilu/IL,
Tel Hashomer/IL)
16:35 FP SU-38-06
Gene Therapy to Modulate Apoptosis and Prevent
Loss of Corneal Endothelial Cells
Thomas Fuchsluger, Ula Jurkunas, Andrius
Kazlauskas, Reza Dana (Essen/D, Boston/USA)
16:42 FP SU-38-07
Photography of meibomian glands with scanning
laser ophthalmoscope
Takashi Sone, Kazufumi Kaneda, Atsushi Hirota,
Hiroshi Nakamoto, Ryotaro Toda, Kaori Ideguchi,
Yoshiaki Kiuchi (Hiroshima/J, Yamaguchi/J)
16:49 FP SU-38-08
Surgical Media Centre, a scientific tool in Phaco
training programme
Navneet Toshniwal (Solapur/IND)
16:56 FP SU-38-09
A new computer assisted technique to correct the
post-enucleation socket syndrome
Martin Rcker, Harald Essig, Isabella Rcker, Horst
Kokemueller, Frank Tavassol, Nils-Claudius Gellrich
(Hannover/D)
17:03 FP SU-38-10
Reconstruction of conjunctival epithelium by
trans-differentiated human amniotic epithelial
cells
Jian Chen (Guangzhou/CN)
17:10
Discussion
Sunday, 6 June 2010
S
u
n
d
a
y
,

6

J
u
n
e
106
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
Hall 2
08:30 - 10:00 SU-57
Uveitis
Symposium
Pathology
Chairs:
Miguel Noel Burnier (Montreal/CDN)
Leonard M. Holbach (Erlangen/D)
08:30 IL SU-57-01
Role of pathology in diagnosis and management
of uveitis
Rubens Belfort Neto (So Paulo/BR)
08:40 IL SU-57-02
Role of vitreous biopsy specimen in intraocular
inflammation
08:50 IL SU-57-03
Role of extraocular tissue biopsy in uveitis
Kalpana Babu (Bangalore/IND)
09:00 IL SU-57-04
Retina and choroidal biopsy in the diagnosis
of recalcitrant uveitis
09:10 IL SU-57-05
Role of aqueous humor microscopic examination
in uveitis
Hiroshi Goto (Shinjuku-ku/J)
09:20 IL SU-57-06
Iris biopsy in management of uveitis
Anita S. Yee Chan (Los Angeles/USA)
09:30
Discussion
Hall 2
10:30 - 12:00 SU-58
Rehabilitation in Primary Keratectasia
(Keratoconus, Pellucid Marginal Degeneration)
Symposium
Refractive Surgery
Chairs:
Tobias Koller (Dietikon/CH)
10:30 IL SU-58-01
Differentiation and Diagnostics in Different Forms
of Keratectasia
10:45 IL SU-58-02
Intrastromal Rings
Jonathan H. Talamo (Waltham/USA)
11:00 IL SU-58-03
Corneal Crosslinking (CLX)
Paolo Vinciguerra (Milano/I)
11:15 IL SU-58-04
Lamellar Keratoplasty
11:30 IL SU-58-05
Decision Tree for Management of Keratectasia
11:45
Discussion
Hall 2
14:00 - 15:30 SU-59
Post-LASIK Corneal Ectasia: Understanding and
Treating
Symposium
Refractive Surgery
Chairs:
Farhad Hafezi (Fribourg/CH)
14:00 IL SU-59-01
Ectasia: Biomechanics
14:10 IL SU-59-02
Ectasia: Diagnosis & Screening
14:20 IL SU-59-03
Advanced topographic/diagnostic indices
14:30 IL SU-59-04
Ectasia treatment: CXL: CXL in iatrogenic keratec-
tasia: long-term results
Farhad Hafezi (Fribourg/CH)
14:40 IL SU-59-05
Ectasia treatment: ICRS
Sunday, 6 June 2010
S
u
n
d
a
y
,

6

J
u
n
e
107
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
14:50 IL SU-59-06
Ectasia Treatment: Corneal Transplantation:
Intralase Enabled DALK with Big Bubble "iDALK" is
the best for advanced ectasia; 1 year results
15:00
Discussion
Hall 2
16:00 - 17:30 SU-60
Is a Customized Ablation Profile the Best for
Standard Refractive Correction?
Symposium
Refractive Surgery
Chairs:
Scott McRae (Rochester/USA)
Arthur C. Cheng (Hong Kong/CN)
16:00 IL SU-60-01
Clinical advantages and limitations of wavefront
sensing
16:10 IL SU-60-02
Optical aberrations and vision, which aberrations
matter?
16:20 IL SU-60-03
Clinical outcomes with "standard/wavefront
optimized" refractive treatments
Karl G. Stonecipher (Greensboro/USA)
16:30 IL SU-60-04
Topography based treatments indications and
limitations
16:40 IL SU-60-05
Clinical outcomes wavefront guided treatments
with different platforms
Stephen G. Slade (Houston/USA)
16:50 IL SU-60-06
Ray tracing, the missing link between wavefront
and topography guided treatment
17:00
Discussion
08:30 - 10:00 SU-40
Miscellaneous 1
Free Paper
Miscellaneous
Chairs:
Rubens Belfort (So Paulo/BR)
Karl Golnik (Cincinatti/USA)
08:30 FP SU-40-02
New trainees in ophthalmology their
experiences and perspectives from the UK
Nishant Kumar, Robert Cheeseman (London/UK)
08:37 FP SU-40-03
The Training of Para-ophthalmic Personnel
A Caribbean Experience
Marilyn Watkins (Bridgetown/BDS)
08:44 FP SU-40-04
Aspects of Educational Inclusion in Brazilian public
schools: Students Experience with Special Need
Colleagues
M. Cristina de O. Regina (Campinas/BR)
08:51 FP SU-40-05
Perioperative Anaesthetic Management in
Ophthalmologic Surgery Current changes in
guidelines and clinical practice
Jan-Peer Rogmann, Michael Goerig, Alwin E. Goetz
(Hamburg/D)
08:58 FP SU-40-06
Study the functional statement of the visual
analyzer in patients with chronic vertebral-basilar
insufficiency
Ramazanova Lyia (Moscow/RUS)
09:05 F SU-40-07
First Demonstration of Fermentation and
Putrefaction by Ambient Bacteria (Theodor
Schwann 1837)
Dieter Schmidt (Freiburg/D)
09:12
Discussion
Sunday, 6 June 2010
S
u
n
d
a
y
,

6

J
u
n
e
108
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
10:30 - 12:00 SU-41
Free Paper
Chairs:
Huseyin Yetik (Istanbul/TR)
10:30 SL SU-41-01
Retinopathy of prematurity (ROP): What we know
and what we should know about?
Huseyin Yetik (Istanbul/TR)
10:39 FP SU-41-02
Computer quantitative assessment of retinal
vessel measures in predicting the outcome of
retinopathy of prematurity
Wai Ching Lam, Crystal Cheung, Ziad Nasser,
Nasrin Tehrani (Toronto/CDN)
10:46 FP SU-41-03
Predictive Value of Pre-plus Disease in Retinopathy
of Prematurity
David Wallace, Sharon Freedman, Mary Elizabeth
Hartnett, Graham Quinn (Durham/USA)
10:53 FP SU-41-04
Mutational Screening of the RB1 gene in Chinese
Patients with Retinoblastoma
Bin Li (Beijing/CN)
11:00 FP SU-41-07
Tumor necrosis factor alpha blockers in the
therapy of uveitis in childhood
L. A. Katargina, Ekaterina Denisova, A. V. Starikova,
N. V. Lubimova (Moscow/RUS)
11:07 FP SU-41-08
To know the awareness amongst the children &
their parents regarding the conditions causing
childhood blindness between age-group 0-18
years.
Vikas Mahatme (Nagpur/IND)
11:14 FP SU-41-09
Results of late onset amblyopia therapy in excen-
tric fixation
Gabriele Gusek-Schneider (Erlangen/D)
11:21 FP SU-41-10
When good is not good enough visual acuity,
refractive error and visual quality in school
children
Alicja Krawczyk, Jacek P. Szaflik,
Urszula Malinowska, Jerzy Szaflik (Warsaw/PL)
11:28 FP SU-41-11
Photoleukocoria Study: Encouraging the
Early Detection of Retinoblastoma and Childhood
Blindness
Ashwin Mallipatna, Helen Dimaras,
Cynthia VandenHoven, Lindsay Hampejskov,
Maria Pezzente, Brenda Gallie (Bangalore/IND,
Toronto/CDN)
11:35
Discussion
14:00 - 15:30 SU-42
Oculoplasty/Orbita/Lids/Lacrimal System 1
Free Paper
Oculoplasty, Orbita, Lids
Chairs:
Amarildo Belshi (Tirana/AL)
Luigi Colangelo (Chieti/I)
Hans-Werner Meyer-Rsenberg (Hagen/D)
14:00 SL SU-42-01
Palpebral Reconstructive Surgery
Amarildo Belshi (Tirana/AL)
14:09 FP SU-42-02
Combined Endoscopic and Transconjunctival
Approach to the Orbital Apex
Gonzalo Blanco-Mateos, Jaime Santos-Prez,
Eduardo J. Duarte Silva, Marta Alonso Mesonero
(Valladolid/E)
14:16 FP SU-42-03
Divided nevus of the eyelids a 10 year experience
with 73 Chinese cases
Renbing Jia (Shanghai/CN)
14:23 FP SU-42-04
Eye'dentifying correctable impaired visual
acuity and visual field loss in patients undergoing
elective lower limb arthroplasty surgery
Jaswant Sandhu, Kwok Yin Chan, Philip Roberts
(Wolverhampton/UK)
14:30 FP SU-42-05
Eyelid Malposition in Patients with Isolated
Congenital and Childhood Acquired Facial Palsy
Adel Alsuhaibani, Yasser Elfakey, Robert Goldberg
(Riyadh/SA)
14:37 FP SU-42-06
Dual delivery of VEGF and BMP2 enhances
angiogenesis and bone regeneration in critical-size
orbital wall defects
Caiwen Xiao, Xianqun Fan (Shanghai/CN)
Sunday, 6 June 2010
S
u
n
d
a
y
,

6

J
u
n
e
109
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
S
u
n
d
a
y
,

6

J
u
n
e
110 110
Sunday, 6 June 2010
WOC
2010
16:40 IL SU-43-06
Choroidal MCT
David Pelayes (Buenos Aires/RA)
16:48 IL SU-43-07
BDUMP
Ernest Rand Simpson (Toronto/CDN)
16:56 IL SU-43-08
Ciliary body mass
17:04 IL SU-43-09
Cytogenetic analysis of choroidal melanoma after
radiotherapy
Werner Wackernagel (Graz/A)
17:12
Discussion
08:30 - 10:00 SU-79
Video Session 1: Cataract
Free Paper
Chairs:
Horst Helbig (Regensburg/D)
Peter Wagner (Ulm/D)
08:30 VF SU-79-01
Automated Foot-controlled Lens Insertion
John Smiles (Canberra/AUS)
08:40 VF SU-79-02
Complicated IOL insertions: just when you thought
your surgery went smoothly...
Naira Pereyra-Munoz, Jaun Manuel Paulin-Huerta,
Jaime Zapata, Eduardo Chavez-Mondragon
(Mexico City/MEX)
08:50 VF SU-79-03
Implantation technique for the Toric Artiflex
Camille Budo (Sint-Truiden/B)
09:00 VF SU-79-04
In-Situ Phaco a newer concept is a preferred
choice in difficult situations
Navneet Toshniwal (Solapur/IND)
09:10 VF SU-79-05
Rock 'n Roll phacoemulsification
Detlef Uthoff (Kiel/D)
14:44 FP SU-42-07
Evaluation of an Integrated Orbital Tissue
Expander in Congenital Anophthalmos: Report of
Preliminary Clinical Experience
David Tse, Mohammad Hafez, Marcia Orozco,
Len Pinchuk (Miami/USA)
14:51 FP SU-42-08
Endonasal dacryocystorhinostomy in children less
than 2 years of age
Angelo Tsirbas (Bondi Junction/AUS)
14:58 FP SU-42-09
Nitrogen-containing bisphosphonates: an
attractive alternative to surgery in periobital
fibrous dysplasia
R. J. W. de Keizer (Leiden/NL)
15:05 FP SU-42-10
Palpebral lipogranuloma caused by transcanalicu-
lar ointment injection after laser canaliculoplasty
Xianqun Fan, Yefei Wang, Xiaoping Bi
(Shanghai/CN)
15:12
Discussion
16:00 - 17:30 SU-43
PAAO Symposium: Challenging Cases Clinico-
Pathologic Correlation
Symposium
Pathology
Chairs:
16:00 IL SU-43-01
Angiogenesis in Uveal Melnoma
16:08 IL SU-43-02
Choroidal mass
16:16 IL SU-43-03
Choroidal Osteoma
16:24 IL SU-43-04
Corneal tumor
16:32 IL SU-43-05
The course of a metastasizing conjunctival
melanom followed over a period of 15 years
Peter Karl Lommatzsch (Leipzig/D)
Sunday, 6 June 2010
WOC
2010
14:00 - 15:30 SU-45
Video Session 3: Presentation of Video Awards
Free Paper
Chairs:
14:00 VF SU-45-01
Blind Date: Reencountering Ophthalmology
Excellance
Victor Cvintal, Jose Ricardo C. L. Rehder,
Paulo C. Sampaio (Sao Paulo/BR)
14:10 VF SU-45-02
Adjuvant use of a novel releasable suture
Technique in 20-G Trocar vitrectomy for prevention
of imcompetent wound closure
Byung Ro Lee, Yumi Song, Young Hee Yoon
(Seoul/ROK)
14:20 VF SU-45-03
Ipsilateral autologous rotating lamellar
keratoplasty with femtosecondlaser
Hans-Jrgen Buchwald, Sebastian Kupferschmid,
Gerhard K. Lang (Ulm/D)
14:30 VF SU-45-04
Microincisional surgery of subluxed lenses with
the modified capsular tension ring
14:40 VF SU-45-05
Pediatric Cataract Surprises
Tanja M. Rabsilber, Mike P. Holzer, Maria J. Sanchez,
Dragana Vucic, Gerd U. Auffarth
(Heidelberg/D, Knjazevac/SRB)
14:50 VF SU-45-06
Treatment of complex ocular trauma with 25/23
gauge systems
Cesare Forlini, Paolo Rossini (Ravenna/I)
15:00 VF SU-45-07
Glued IOL Reloaded
15:10
Video Award of the DOG,
donated by Carl Zeiss Meditec AG (Munich/D)
09:20 VF SU-79-06
The MultiKeratome for Cataract Surgery Curved
with Multiple Points Engineered to Seal Better
and to Minimize the Induced Astigmatism
Tom Schossau, Matthew Giegengack,
Shree K. Kurup, Gerald W. Zaidman (Scarsdale/USA)
09:30 VF SU-79-07
Cataract surgery 30 years after excision of
a melanotic iris tumor
Peter Wagner, Ingo Conzelmann, Gerhard K. Lang
(Ulm/D)
10:30 - 12:00 SU-80
Video Session 2: Miscellaneous 1
Free Paper
Chairs:
Wolfgang F. Schrader (Nrnberg/D)
10:30 VF SU-80-01
Outcome of hole and chop technique phacoemul-
cification on hard cataracts
Keembiyage Dayawansa (Kandy/CL)
10:40 VF SU-80-02
Orientation of toric IOL (TIOL) The evolution
from Screen Transparencies (STACY) to
standardized limbal and axis tracking (Z-ALIGN)
Detlev Breyer (Dsseldorf/D)
10:50 VF SU-80-03
Corneoplastique: ART of Vision Surgery
Arun Gulani (Jacksonville/USA)
11:00 VF SU-80-04
Microendoscopic lacrimal duct surgery
Stefan Clemens, Frank Tost, Martin Kstner
(Greifswald/D)
11:10 VF SU-80-05
CO2 Laser Surgery for Ophthalmology
Nobuyuki Miyata, Eiichi Okada (Yokohama/J)
11:20 VF SU-80-06
Overcoming pediatric challenges
Manish Mahendra (Kanpur/IND)
11:30 VF SU-80-07
Hynrid Technique using conventional illuminated
Infusion Cannula in any Gauge Trocar Vitrectomy
Byung Ro Lee, Yumi Song, Yong Woon Shin
(Seoul/ROK)
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
S
u
n
d
a
y
,

6

J
u
n
e
111
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
16:00 - 17:30 SU-81
Video Session 4: Miscellaneous 2
Free Paper
Chairs:
Hans-Jrgen Buchwald (Ulm/D)
Klaus-Peter Steuhl (Essen/D)
16:00 VF SU-81-01
Parachute Keratoplasty
Wesley Herman, Oren N. Fass (Dallas/USA)
16:10 VF SU-81-02
Ahmed Glaucoma Valve-Prime,Implant and
Reprime
Dipanjan Pal, Alokesh Ganguly (Kolkata/IND)
16:20 VF SU-81-03
Superficial Lateral Canthopexy to Correct Lateral
Canthal Tendon Disinsertion
Erin Shriver, David Tse (Palm Beach Gardens/USA,
Miami/USA)
16:30 VF SU-81-04
Surgical approach in acute retinal necrosis
Ilian Shandurkov, Petja Vassileva, Tatyana
Hergeldzhieva, Daniela Paskaleva (Sofia/BG)
16:40 VF SU-81-05
Diagnostic image-guide for indentification of early
acute retinal necrosis
Byung Ro Lee, Yong Woon Shin (Seoul/ROK)
16:50 VF SU-81-06
Half day for eye screening cures blindness in
many
Rekha Khandelwal, Shashank Bidaye, D. Kose,
Mohana Majumdar, Shivani Bidaye (Nagpur/IND)
17:00 VF SU-81-07
Jesus and the Eye: New Testament Miracles of
Vision
Ahmad Mansour, Ahmad Nasri, Rami Santini,
Majd Akar (Beirut/RL)
Hall 3
08:30 - 10:00 SU-48
Retinal Detachment and PVR
Chairs:
08:30 IL SU-48-01
Surgical instrumentation for RD and PVR repair
(20, 23, 25 g etc.)
08:40 IL SU-48-02
Which new drugs can treat PVR?
Louisa Wickham (London/UK)
08:50 IL SU-48-03
Is there still place for scleral buckling in primary
surgery for RD?
09:00 IL SU-48-04
Management after failure of primary RD-repair
Periklis Brazitikos (Athens/GR)
09:10 IL SU-48-05
Prevention of RD: are there cases in which it is
worthwhile
Fred Hendrikse (Maastricht/NL)
09:20 IL SU-48-06
Management of second eye in vitreoretinal
dystrophies
09:30 IL SU-48-07
Trauma and vitreoretinal surgery timing and
management
Masahito Ohji (Otsu/J)
09:40 IL SU-48-08
Intraocular tamponade whats new
David Wong (Pok Fu Lam/HK)
09:50 IL SU-48-09
TBA
Sunday, 6 June 2010
S
u
n
d
a
y
,

6

J
u
n
e
112
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
Hall 3
10:30 - 12:00 SU-49
Vitreoretinal Interface Epiretinal Macular
Surgery
Chairs:
10:30 IL SU-49-01
Pathology of the vitreoretinal interface:
Implications for surgery
10:40 IL SU-49-02
Microplasmin to treat vitreomacular traction:
results of a phase III clinical trial (MIVI-006)
Matthew S. Benz (Houston/USA)
10:50 IL SU-49-03
Progress in epiretinal surgery: vital stains
Christos Haritoglou (Munich)
11:00 IL SU-49-04
Macular hole surgery: is face -down positioning
still necessary?
D. Alistair H. Laidlaw (London/UK)
11:10 IL SU-49-05
Macular hole surgery: is ILM peeling always
useful?
Ramin Tadayoni (Paris/F)
11:20 IL SU-49-06
ERM and VMTS surgery: cases which fail
11:30 IL SU-49-07
Vitreoretinal interface in AMD
11:40 IL SU-49-08
Vitreoretinal Interface in children therapeutic
implications
11:50 IL SU-49-09
TBA
Hall 3
14:00 - 15:30 SU-50
Retinal Vascular Diseases: Diabetic Retinopathy /
Vein Occlusions
Chairs:
14:00 IL SU-50-01
Retinal oximetry in diabetic retinopathy and
retinal vein occlusions
14:10 IL SU-50-02
Steroids vs laser in DME
14:20 IL SU-50-03
Anti VEGFs vs Steroids in DME
Julia A. Haller (Philadelphia/USA)
14:30 IL SU-50-04
Slow release steroids in DME
14:40 IL SU-50-05
Combination of pharmacology and VR surgery in
DR
14:50 IL SU-50-06
Does early intravitreal drug therapy change the
course of BRVO and CVRO
15:00 IL SU-50-07
Is surgery useful in BRVO and CRVO
15:10 IL SU-50-08
TBA
15:20 IL SU-50-09
TBA
Sunday, 6 June 2010
S
u
n
d
a
y
,

6

J
u
n
e
113
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
Hall 3
16:00 - 17:30 SU-51
AMD
Chairs:
16:00 IL SU-51-01
When to stop anti VEGF therapy?
Adnan Tufail (London/UK)
16:10 IL SU-51-02
Update on Clinical Trials of Intravitreal Drugs for
Neovascular AMD
16:20 IL SU-51-03
Geographic atrophy: Imaging Metrics and Progres-
sion Determinants
16:30 IL SU-51-04
Future drugs for treatment of dry AMD
Salvatore Grisanti (Lbeck/D)
16:40 IL SU-51-05
Genetics and prevention of AMD
Hendrik Peter Nicolas Scholl (Bonn/D)
16:50 IL SU-51-06
Is there a place for surgery in AMD?
17:00 IL SU-51-07
Cell therapy for AMD
TBA
17:10 IL SU-51-08
How to prevent endophthalmitis in intravitreal
therapy?
Thierry C. Verstraeten (Pittsburgh/USA)
17:20 IL SU-51-09
TBA
Hall 6
08:30 - 10:00 SU-52
AAPOS Symposium: Emerging Concepts in
Amblyopia and Strabismus 2010:
Recognizing Gunter K. von Noorden, MD
Symposium
Strabismus
Chairs:
Monte A. Del Monte (Ann Arbor/USA)
Mohamad Jaafar (Washington/USA)
08:30 IL SU-52-01
Treatment of bilateral superior oblique palsy
Derek Sprunger (Indianapolis/USA)
08:40 IL SU-52-02
Brown Syndrome: When and How to Intervene
Mohamad Jaafar (Washington/USA)
08:50 IL SU-52-03
The Goal of Treatment in "Organic Amblyopia"
Robert LaRoche (Halifax/CDN)
09:00 IL SU-52-04
Lessons Learned in Strabismus Diagnosis from
Telemedicine
Eugene Helvestone (Indianapolis/USA)
09:10 IL SU-52-05
Atropine Treatment for Severe Amblyopia
09:20 IL SU-52-06
TBD
Jan-Tjeerd de Faber (Rotterdam/NL)
09:30 IL SU-52-07
Strabismus in patients with posterior fossa tumors
Jane C. Edmond (Houston/USA)
09:40
Discussion
Sunday, 6 June 2010
S
u
n
d
a
y
,

6

J
u
n
e
114
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
Hall 6
10:30 - 11:15 SU-53
Journal Publications, As a Mean to Evaluate
Scientists: He/She Publishes in Good Journals
Symposium
World Forum of Journal Editors
Chairs:
10:30 IL SU-53-01
Journal independent evaluation of scientists
and faculties by citation counts
Holger Schwechheimer (Bielefeld/D)
10:40 IL SU-53-02
The Better Way to Evaluate Researchers
10:50 IL SU-53-03
Is there a future to Non-English scientific journals?
11:00
Discussion
Hall 6
11:15 - 12:00 SU-54
Reviewers, Contents Language
Symposium
Chairs:
11:15 IL SU-54-01
How to find suitable reviewers
Martijn J. Schuemie (Rotterdam/NL)
11:25 IL SU-54-02
Is the presentation of a theory sufficient to justify
publication?
11:35 IL SU-54-03
Current situation and prospects of Chinese
ophthalmological journals internationalization
Xiu-Wen Hu (Xian/CN)
11:45
Discussion
Hall 6
14:00 - 15:30 SU-78
Posterior Lamellar Keratoplasty
Symposium
Chairs:
Claus Cursiefen (Erlangen/D)
14:00 IL SU-78 -01
Long-term results of DSEK/DSAEK in over
1300 cases: endothelial cell counts, incidence of
rejection, visual acuity, glaucoma
14:10 IL SU-78 -02
DSAEK in Asian Eyes: The Singapore Perspective
14:20 IL SU-78 -03
Femtosecond laser-assisted DSAEK
Philip Maier (Freiburg/D)
14:30 IL SU-78 -04
Is DMEK the preferred method of PLK?
How can corneal surgeons begin doing this?
14:40 IL SU-78 -05
Advances in EK techniques
Massimo Busin (Forli/I)
14:50 IL SU-78 -06
Results of his hybrid DSEK/DMEK technique
Pavel Studeny (Sokolov/CZ)
15:00 IL SU-78 -07
The German DMEK Experience
15:10 IL SU-78 -08
Scuba Technique for DMEK: Results and Pearls
Art Giebel (Chehalis/USA)
15:20 IL SU-78 -09
Cultivated Endothelial Cell Transplantation:
The Future?
Sunday, 6 June 2010
S
u
n
d
a
y
,

6

J
u
n
e
115
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
Hall 6
16:00 - 17:30 SU-56
Anatomy/Pathology
Free Paper
Anatomy/Pathology
Chairs:
Gottfried O. H. Naumann (Erlangen/D)
Hans Eberhard Vlcker (Heidelberg/D)
16:00 FP SU-56-01
Diagnosis and differential diagnosis of orbital
spindle cell tumours
Yongping Li (Guangzhou/CN)
16:07 FP SU-56-02
Applied anatomy of endoscopic transnasal
lacrimal duct reconstruction with grafting of
autogenous tissue
Hai Tao (Beijing/CN)
16:14 FP SU-56-03
Analysis of p53 mutations and the expression of
p53 and p21WAF1/CIP1 protein in sebaceous carci-
noma of the eyelid
Kunihiro Kiyosaki, Chisato Nakada, Masamoto
Imaizumi, Masatsugu Moriyama, Toshiaki Kubota
(Yufu/J)
16:21 FP SU-56-04
Alterations of the cornea and retina in a mouse
model of Niemann-Pick disease type C1
Marine Hovakimyan, Oliver Stachs, Mariya Reichard,
Arndt Rolfs, Jan Lukas, Moriz Frech, Rudolf Guthoff,
Martin Witt, Andreas Wree (Rostock/D)
16:28 FP SU-56-05
Clinical and pathologic studies on nanophthalmos
complicated with uveal effusion
Jing Tao, Naiqing Weng, Ningli Wang, Bowen Zhao,
Qian Liu (Beijing/CN)
16:35 SL SU-56-06
Value of ocular pathology in clinical practice
16:44 FP SU-56-07
Introduction
Gottfried Naumann (Erlangen/D)
16:49 FP SU-56-08
Ophthalmic Pathology Award
Ursula Schltzer-Schrehardt (Erlangen/D)
Hall 7
08:30 - 10:00 SU-34
Oncology 1
Free Paper
Oncology
Chairs:
Nikolaos E. Bechrakis (Innsbruck /A)
08:30 SL SU-34-01
Ophthalmic Oncology and Pathology
08:39 SL SU-34-02
Hemodynamic modifications of the choroid and
the retina in ocular oncology
Leonidas Zografos, A. Schalenbourg, L. Chamot
(Lausanne/CH)
08:48 FP SU-34-03
The role of transpupillary thermotherapy in
treatment of residual and recurrent choroidal
melanomas
Svetlana V. Saakyan, Vladimir V. Valsky,
Ekaterina A. Semenova (Moscow/RUS)
08:55 FP SU-34-04
SD OCT and Auto-Fluorescence Features of
Indeterminate Choroidal Melanocytic Lesions
Arun Singh, Rubens Belfort, Kaori Sayanagi,
Peter Kaiser (Cleveland/USA, So Paulo/BR)
09:02 FP SU-34-05
Changing concepts regarding management of or-
bital extension of uveal melanoma
Jerry Shields, Carol Shields, Ralph C. Eagle
(Philadelphia/USA)
09:09 FP SU-34-06
Receiver Operating Characteristic (ROC) Curve for
the Marker Melanoma inhibitory activity (MIA)
in Patients with Metastatic Uveal Melanoma
Annemarie Klingenstein, Ingrid Haritoglou,
Markus Schaumberger, Martin Nentwich,
Hein Rdiger, Ulrich Christoph Schaller (Munich/D)
09:16 FP SU-34-07
Choroidal Melanocytic Clusters: A Distinct Clinical
Entity?
James J. Augsburger, Zelia M. Corra,
Camila C. Simes (Cincinnati/USA)
09:23 FP SU-34-08
Imaging of anterior segment tumours
Lubna Razzaq, Marina Marinkovic, G. Luyten,
J. C. Bleeker, R. J. W. de Keizer (Leiden/NL)
Sunday, 6 June 2010
S
u
n
d
a
y
,

6

J
u
n
e
116
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
09:30 FP SU-34-09
Metastasis of iris, ciliary body, and choroidal
melanoma in 8033 patients
Carol Shields, Minoru Furuta, Archana Thangappan,
Saya Nagori, Rishita Nutheti, Arman Mashayekhi,
09:37 FP SU-34-10
Role of episcleral brachytherapy as adjuvant
therapy in conjunctival tumors
Alejandro Portero-Benito, Carmen Valverde-Collar,
Ester Carreo, Maria Antonia Saornil,
Ciro Garcia-Alvarez, Jesus M. Frutos, Patricia Diez-
Andino, Francisco J Lopez-Lara (Valladolid/E)
09:44 FP SU-34-11
Clinical profile of epithelial conjunctival tumors at
an ocular oncology unit
Ester Carreo, Alejandro Portero-Benito, Fernando
Snchez-Mannarelli, Mara Antonia Saornil, Mara
Fe Muoz, Ciro Garca-lvarez (Valladolid/E)
09:51
Discussion
Hall 7
10:30 - 12:00 SU-35
Cornea/External Disease: Surgical therapy 1
Free Paper
Chairs:
Stefano Barabino (Genova/I)
Chris Patrick Lohmann (Munich/D)
10:30 FP SU-35-01
Crosslinking and Topography-guided Surface
Ablation for Keratoconus-121 Eyes
Tassos Georgiou, Pavlos Greveniotis, Soula Michael,
Panayiotis Neophytou (Nicosia/CY)
10:37 FP SU-35-02
Effect of an irregular anterior surface on a lamellar
femtosecond laser cut
Robert Fintelmann, Michele Bloomer, Bennie Jeng
(San Francisco/USA)
10:44 FP SU-35-03
Cross-Linking for Progressive Keratoconus in
Pediatrics
Aldo Caporossi, Cosimo Mazzotta, Stefano Baiocchi,
Rosario Denaro (Siena/I)
10:51 FP SU-35-04
Keratoprosthesis. 40-year experience of study and
application in the Filatov Institute (analysis of
1000 operations)
Stanislav Iakymenko (Odessa/UA)
10:58 FP SU-35-05
Descemets Membrane Endothelial Keratoplasty
(DMEK): safety and outcomes
Aruna Dharmasena (Manchster/UK)
11:05 FP SU-35-06
New method of destructive corneal diseases treat-
ment by using cellular technology
Daria Danilova, Ekaterina Chentsova,
Irina Saburina, Irina Maklakova (Moscow/RUS)
11:12 FP SU-35-07
Corneal aberrometric and refractive performance
of 2 intrastromal corneal ring segment models in
early and moderate ectatic disease
David Pablo Piero Llorens, Jorge Ali (Alicante/E)
11:19 FP SU-35-08
Corneal Intrastromal Implantation Surgery (CISIS)
vs. Keratoplasty for the treatment of Keratokonus
Albert Daxer (Ybbs/A)
11:26 FP SU-35-09
Effectiveness of Triple Procedure in Severe Bacter-
ial Keratitis
Shamurad Amansakhatov, Maya Zhutdieva
(Seyidi/TUR)
11:33 FP SU-35-10
Cultured oral epithelium in treatment of limbal
stem cell deficiency in aniridia
Dariusz Dobrowolski, Edward Wylegala (Sos-
nowiec/PL, Katowice/PL)
11:40 FP SU-35-11
Quadruple-procedure for Correction of Congenital
Aniridia with Cataract and Corneal Scarring
Alexey Dashevsky, Konstantin Kotliar (Munich/D)
11:47
Discussion
Hall 7
14:00 - 15:30 SU-36
Free Paper
Refractive Surgery
Chairs:
Batrice Cochener (Brest/F)
14:00 SL SU-36-01
Keys for Successful phakic IOLs implantation
Batrice Cochener, Pierre Marie Josselin,
Mathieu Lamard (Brest/F)
Sunday, 6 June 2010
S
u
n
d
a
y
,

6

J
u
n
e
117
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
14:09 FP SU-36-02
Corneal stromal ablation by femtosecond UV
pulses: in vivo study
Egle Danieliene, Romualdas Danielius,
Egle Gabryte, Osvaldas Ruksenas,
Agne Vaiceliunaite, Mikas Vengris (Vilnius/LT)
14:16 FP SU-36-03
Results of All-in-One Femtosecond Laser Surgery
for correction of myopia and myopic astigmatism
Rupal Shah (Vadodara/IND)
14:23 FP SU-36-04
The functional results of the Sub-Bowmen
Femto-keratomileusis (SBFK) & Tissue Saving
Ablation (TSA)
Alexander Doga, Galina Kachalina,
Nataliya Maychuk (Moscow/RUS)
14:30 FP SU-36-05
Comparison of postoperative pain, reepithelializa-
tion speed and early visual and refractive out-
comes between PRK with mechanical epithelial
removal and integrated transepithelial custom
ablation in treatment of low to moderate myopia
Xiangjun Chen (Oslo/N)
14:37 FP SU-36-06
Tunnel Keratoplasty with Different Intracorneal
Implants in Myopia and Myopic Astigmatism
Correction, 20-Year-Old Experience
Yuriy Shusterov (Karaganda/KZ)
14:44 FP SU-36-07
Theoretical relationship between surgical
parameters and refractive correction of
conductive keratoplasty
Xiaobing Wang (Beijing/CN)
14:51 FP SU-36-08
Use of an Image-Guided Femtosecond Laser
in Cataract Surgery with Accommodating or
Multi-Focal IOL
Stephen Slade (Houston/USA)
14:58 FP SU-36-09
Position-depending pseudo-accommodation of
retropupillary fixed iris claw lenses
Kilian Schpfer, Alexandra Berger,
Bernhard M. Stoffelns, Walter Sekundo (Mainz/D,
Marburg/D)
15:05 FP SU-36-10
Effects of Pterygium on Ocular Aberrations
Siamak Zarei-Ghanavati, Mohammad Zare,
Mohammad-Reza Ansari-Astaneh,
Alireza Baradaran-Rafiee, Bahram Einolahi
(Mashhad/IR)
15:12
Discussion
Hall 7
16:00 - 17:30 SU-37
External Disease, Dry Eye
Free Paper
Chairs:
Juha M. Holopainen (Helsinki/FIN)
Zbigniew Zagrski (Lublin/PL)
16:00 SL SU-37-01
Molecular pathogenesis of dry eye
Juha Holopainen (Helsinki/FIN)
16:09 SL SU-37-02
New diagnostic methods in dry eye
16:18 FP SU-37-03
Results of phase 1 tolerability study of LX214
(0.2% Voclosporin topical solution) in healthy
volunteers and subjects with Keratoconjunctivitis
Sicca (KCS)
Thomas Reinhard, Daniel Bhringer, Sid Weiss,
Eddy Anglade (Freiburg/D, Jersey City/USA)
16:25 FP SU-37-04
Biomarkers for Dry Eye Tested in Two Patient
Populations
Roger Beuerman, Choi Mun Chan, Lei Zhou,
Louis Tong, Michael Stern, Xiaor Li, Shao Zhao (Sin-
gapore/SGP)
16:32 FP SU-37-05
Assessment of Dry Eye Treatment Effectiveness
Using the TearLab Osmolarity System
Timothy Albert, Marco Nardi, Chiara Posarelli,
Umberto Benelli (Pisa/I)
16:39 FP SU-37-06
Immune Response in Conjunctival Epithelium of
Dry Eye Patients
Stefano Barabino (San Remo/I)
16:46 FP SU-37-07
Permanent punctal occlusion for severe dry eye
syndrome a new approach
Chedly Bouzouaya, Peter Raus (Tunis/TN, Mol/B)
16:53 FP SU-37-08
Liposomes spray versus non preserved tears
substitutes in patients with meibomian gland
dysfunction
Maria Elena Langman, Nathalie Amouroux-Gicquel,
Jean-Jacques Gicquel (Poitiers/F)
Sunday, 6 June 2010
S
u
n
d
a
y
,

6

J
u
n
e
118
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
17:00 FP SU-37-09
Role of Ultrasound Bio-Microscopy (UBM) in the
diagnosis of subconjunctival cysticercosis
Bipasha Mukherjee (Chennai/IND)
17:07
Discussion
Hall 8
10:30 - 12:00 SU-61
Strabismus
Free Paper
Strabismus
Chairs:
Oliver Zeitz (Berlin/D)
10:30 FP SU-61-01
Multifocal VEP, Bifoveal Fusion and Stereopsis in
Children with Esotropia
Wei Zhang (Tianjin/CN)
10:37 FP SU-61-02
Comparisons of cryo therapy and laser therapy
with simple follow-up in globe perforation
meanwhile strabismus surgery in an animal model
Abbas Bagheri (Teheran/IR)
10:44 FP SU-61-03
CFEOM Congenital fibrosis of the extraocular
muscles. Clinical phenotypes and molecular
mechanisms.
Gnther Rudolph, Alfons Meindl, Michael
Nentwich, Heide Hellebrand (Munich/D)
10:51 FP SU-61-04
Analysis of patients with congenital fibrosis of
the extraocular muscles: clinical, tomographic and
genetic findings.
Naira Pereyra-Munoz, Claudia Murillo-Correa,
Sanjuanita Flores-Limas, Juan Carlos Zenteno Ruiz
(Mexico City/MEX)
10:58 FP SU-61-05
Ultrarapid School Vision Screening Using the
Brckner test
Mihir Kothari (Mumbai/IND)
11:05 FP SU-61-06
Inverse occlusion a therapy option bei eccentric
fixation 20 years follow-up
Samad Abri, E. Windischbauer, E. Kramar, T. K. Keindl,
B. Neudorfer, Siegfried Priglinger (Salzburg/A,
Linz/A)
11:12 FP SU-61-07
Superior Oblique Palsy A Review of 817 Cases
Ze Wang (Nanjing/CN)
11:19 FP SU-61-08
Treatment of potentially amblyopia inducing early
childhood eyelid hemangioma with systemic
propanolol
Rike Michels, Kathrin Schaeffer, Veit Sturm, Marcel
Menke, Klara Landau, Clemens Schiestl (Zurich/CH)
11:26 FP SU-61-09
Diplopia after orbital floor fracture: Look for the
causative muscle away from the floor in some
cases
Akmal Rizk (Cairo/ET)
11:33 FP SU-61-10
Triamcinolone acetonide loaded PLGA nanoparti-
cles pharmacokinetics characterization and
application in actue extraocular muscle injury
Hong Yan, Lihua Sun (Xi'an/CN)
11:40
Discussion
Hall 9
08:30 - 10:00 SU-62
Teleophthalmology
Free Paper
Teleophthalmology
Chairs:
Norbert Franz Schrage (Cologne/D)
08:30 FP SU-62-01
Automated Estimation of Image-Level Vessel
Tortuosity in Retinal Images
Alfredo Ruggeri, Giovanni Ughi, Enrico Grisan,
Tunde Peto (Padua/I, London/UK)
08:37 FP SU-62-02
Telemedicine diabetic retinopathy assessment in
the US: Impediments to wide-scale adoption
Ingrid E. Zimmer-Galler, Ran Zeimer (Frederick/USA)
08:44 FP SU-62-03
Tele-ophthalmology as a screening tool for
Diabetic retinopathy in a rural population
Rodney John Morris, Narendran Venkatapathy
(Coimbatore/IND, Tamilnadu/IND)
Sunday, 6 June 2010
S
u
n
d
a
y
,

6

J
u
n
e
119
120
Sunday, 6 June 2010
10:50 IL SU-63-03
Definition and Classification of MGD
Gary Foulks (Louisville/USA)
11:00 IL SU-63-04
Epidemiology of, and Associated Risk Factors for,
MGD
David Sullivan (Boston/USA)
11:10 IL SU-63-05
Evaluation, Diagnosis and Grading of Severity of
MGD
11:20 IL SU-63-06
Design and Conduct of Clinical Trials
Kerstin Wickstrom (Uppsala/S)
11:30 IL SU-63-07
Management and Therapy of MGD
Gerd Geerling (Wrzburg/D)
11:40
Discussion
Hall 9
14:00 - 15:30 SU-64
Beyond Vertical Programs: Challenges and Success
in Building in Comprehensive Eye Care Within a
Health Care System
Symposium
Chairs:
Petja Ivanova Vassileva (Sofia/BG)
Robert P. Finger (Bonn/D)
14:00 IL SU-64-01
Eye care services in the Republic of Kosovo
Gazmend Kaaniku (Prishtina/KS)
14:10 IL SU-64-02
WetLab educational system for ophthalmic
microsurgery the Russian experience
14:20 IL SU-64-03
Providing comprehensive eye care within
underfinanced health care system
Tatyana G. Hergeldzhieva-Fileva (Sofia/BG)
14:30 IL SU-64-04
TBA
Paulo Henrique Morales (So Paulo/BR)
14:40 IL SU-64-05
The Cuban Eye Care Program as innovative public
model of health system
Marcelino Rio Torres (Ciudad Habana/C)
08:51 FP SU-62-04
Automated Image Analysis and Disease
Stratification in RISANet: a Web-Based Telemedi-
cine Network in the Southern United States
Thomas Karnowski, Kenneth Tobin, Luca Giancardo,
Yaqin Li, Seema Garg, Michael Abramoff,
Matthew Tennant, Karen Fox, Edward Chaum
(Oak Ridge/USA)
08:58 FP SU-62-07
Comparing the accuracy of a RETCAM Trained
Technician versus a Pediatric Ophthalmologist-in-
training in diagnosing Retinopathy of Prematurity
(ROP) using wide-field digital imaging
Mayuri Bhargava, Anand Vinekar, Ravindra Battu,
P. Devika, Bhujang Shetty, Siva Kumar
(Bangalore/IND)
09:05 SL SU-62-08
First clinical application of the ACTO online visual
evaluation
Norbert Schrage, B. Seeliger, F. Simsonsen (Kln/D)
09:14 FP SU-62-09
Telemedicine in ophthalmic practice our
experience with Cyber-Sight
Nikolay Surchev, Petja Vassileva, Tatyana
Hergeldzhieva-Fileva, Yordanka Kirilova,
Ilian Shandurkov (Sofia/BG)
09:21
Discussion
Hall 9
10:30 - 12:00 SU-63
Tear Film & Ocular Surface Society Symposium:
A Report from the International Workshop on
Meibomian Gland Dysfunction
Symposium
Chairs:
David Sullivan (Boston/USA)
10:30 IL SU-63-01
Anatomy, Physiology and Pathophysiology of the
Meibomian Gland
10:40 IL SU-63-02
Tear Film Lipids, and Lipid-Protein Interactions, in
Health and Disease
Friedrich Paulsen (Halle/D)
WOC
2010
S
u
n
d
a
y
,

6

J
u
n
e
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
Sunday, 6 June 2010
Hall 10
10:30 - 12:00 SU-67
ISOO Symposium: Ocular Lymphoma
Symposium
Oncology
Chairs:
10:30 IL SU-67-01
Overview on ocular adnexal lymphoma
Lene Dissing Sjo (Copenhagen/DK)
10:40 IL SU-67-02
Update on ocular adnexal MALT lymphoma
Estelle Chanudet (Cambridge/UK)
10:50 IL SU-67-03
Unusual Ocular Andexal Lymphomas
11:00 IL SU-67-04
TNM staging of ocular adnexal lymphoma
11:10 IL SU-67-05
Treatment of ocular adnexal lymphoma
Bita Esmaeli (Houston/USA)
11:20 IL SU-67-06
Overview of intraocular lymphoma
Justine R. Smith (Portland/USA)
11:30 IL SU-67-07
Clinical presentations of intraocular lymphoma
Nathalie Cassoux (Paris/F)
11:40 IL SU-67-08
Treatment of vitreoretinal lymphoma with
methotrexate
11:50 IL SU-67-09
Treatment of Vitreoretinal lymphoma with
rituximab
Jose S. Pulido (Rochester/USA)
14:50 IL SU-64-06
Comprehensive eye care at the Sankara Eye
Foundation
R. V. Ramani (Coimbatore/IND)
15:00 IL SU-64-07
Vision 2020 in Latin America
Rainaldo Duerksen (Asuncin/PY)
15:10
Discussion
Hall 9
16:00 - 17:30 SU-65
Vision 2020: 10 Years on, 10 Years to go
Symposium
Chairs:
Hugh R. Taylor (Carlton/AUS)
Ivo Kocur (Geneva/CH)
16:00 IL SU-65-01
Why VISION 2020 was Initiated
Allen Foster (London/UK)
16:10 IL SU-65-02
How VISION 2020 Developed
Gullapali N. Rao (Hyderabad/IND)
16:20 IL SU-65-03
VISION 2020 in Africa the Challenge in
Developing Countries
Daniel Etya'ale (Geneva/CH)
16:30 IL SU-65-04
VISION 2020 in Latin America the Challenge in
Mid Level Countries
16:40 IL SU-65-05
VISION 2020 in Australia the Challenge in
Developed Countries
16:50 IL SU-65-06
The Role of Advocacy and Political Leadership
17:00 IL SU-65-07
Lessons Learnt and the Way Forward
Ivo Kocur (Geneva/CH)
17:10
Discussion
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
S
u
n
d
a
y
,

6

J
u
n
e
121
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
Hall 10
14:00 - 15:30 SU-68
Egyptian German Symposium: Combined Surgeries
in Ophthalmology
Symposium
Chairs:
Sherif Shetta (Cairo/ET)
Mostafa Hunter (Bonn/D)
14:00 IL SU-68-01
International Public Private Partnership in Eye
Healthcare, a Success Story between Egypt and
Germany
Mostafa Hunter (Bonn/D)
14:10 IL SU-68-02
Sustainable Relationships between Egyptian
and German Pediatric and Rehabilitative
Ophthalmology
Barbara Ksmann-Kellner (Homburg/D)
14:20 IL SU-68-03
Combined Scleral Buckling and Pars Plana
Vitrectomy in the Management of Primary Retinal
Detachment
14:30 IL SU-68-04
Temporary Keratoprosthesis in the Management
of Posterior Segment Problems in Eyes with
Opaque Corneas
Hassan Mortada (Cairo/ET)
14:40 IL SU-68-05
Combined Procedures in Diabetic Vitrectomy
Mahmoud Soliman (Cairo/ET)
14:50 IL SU-68-06
Simultaneous Glaucoma and Cataract Surgery
Christian-Paul Jonescu-Cuypers (Homburg/D)
15:00 IL SU-68-07
Combined Corneal Transplantation and Cataract
Surgery (The Triple Procedure)
15:10
Discussion
Hall 10
16:00 - 17:30 SU-69
Greek German Symposium: From
to Neuroprotection a Long Journey in Under-
standing Glaucoma
Symposium
Glaucoma
Chairs:
Solon Thanos (Mnster/D)
Zisis Gatzioufas (Homburg/D)
16:00 IL SU-69-01
Congenital glaucoma today
Nikolaos Kozeis (Thessaloniki/GR)
16:10 IL SU-69-02
The spectrum of pediatric glaucoma beyond
buphthalmia
16:20 IL SU-69-03
Sclerotrabeculectomy for better IOP control
Vassilios Kozobolis (Alexandroupoli/GR)
16:30 IL SU-69-04
Glaucoma management before and after kerato-
plasty
Christian-Paul Jonescu-Cuypers (Homburg/D)
16:40 IL SU-69-05
Present and future role of fixed combinations in
glaucoma therapy
Anastasios Konstas (Thessaloniki/GR)
16:50 IL SU-69-06
Neuroprotection in glaucoma: reality soon or
dream?
Solon Thanos (Mnster/D)
17:00
Discussion
Sunday, 6 June 2010
S
u
n
d
a
y
,

6

J
u
n
e
122
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
Roof Garden
10:30 - 12:30 SU-70
Highlights of Anterior Segment Surgery &
Refractive Surgery
Symposium
Cataract, Refractive Surgery
Chairs:
Joaquin Barraquer (Barcelona/E)
Rafael Barraquer (Barcelona/E)
Maria-Elena Barraquer (Barcelona/E)
This 120-minutes multi-authored Symposium is
divided in five different sections: 1. Cataract Sur-
gery; 2. Corneal Surgery; 3. Refractive Surgery
(Cornea and Lens); 4. Surgical Management of
Glaucoma; and 5. Management of Ocular Injuries.
Each section comprises several rapid fire contribu-
tions of different members of the team from
Barcelona, illustrated with didactic material and
challenging casuistics. Cataract surgery is reviewed
from the suction cup procedure for intracapsular
extraction, called Phacoerysis, invented in 1917, in-
clusion of intraocular anterior chamber lenses to
correct aphakia (1954) and enzymatic zonulolysis to
overcome zonular resistence prior to the extraction
(1958), to modern techniques such as sonophaco
and injectable lenses with due consideration to
management of certain complications, such as
secondary cataract and intraoperative small pupil.
In the Section on Corneal Surgery the techniques
of anterior and posterior lamellar procedures are
presented. The topics discussed in the Section on
Refractive surgery (Cornea and Lens) include mold-
ing of the cornea (crosslinking), photokeratomileu-
sis for astigmatismus, tectonic and refractive large
diameter penetrating keratoplasties, clear lens
extraction and multifocal IOL. In Glaucoma Surgery,
besides advances in goniotomy and iridotomy, the
procedure of non-perforating deep sclerecotomy
with intrascleral T-Flux implantation is highlighted.
The Section of Management of Ocular Injuries in-
cludes modern approach of severe physical (explo-
sion) and chemical trauma.
Cataract Surgery
10:30 IL SU-70-01
Introduction
10:31 IL SU-70-02
Phacoeresis of Professor Ignacio Barraquer
10:33 IL SU-70-03
Enzymatic Zonulolysis
10:37 IL SU-70-04
Strampellis anterior chamber IOL
10:38 IL SU-70-05
Sonophaco & injectable lenses
10:42 IL SU-70-06
YAG Laser capsulotomy for secondary cataract
Isabel Canut (Barcelona/E)
10:43 IL SU-70-07
Management of intraoperative small pupil
10:49
Discussion
Corneal Surgery
10:58 IL SU-70-08
Lamellar anterior keratoplasty
11:03 IL SU-70-09
Lamellar posterior keratoplasty
J. P. Alvarez de Toledo (Barcelona/E)
11:08
Discussion
Refractive Surgery
11:13 IL SU-70-10
Molding of the cornea from intracorneal segments
to collagen crosslinking
11:22 IL SU-70-11
Photokeratomileusis in astigmatismus induced by
keratoplasty
J. P. Alvarez de Toledo (Barcelona/E)
11:25 IL SU-70-12
Large diameter penetrating keratoplasties
(Tectonic and refractive)
Joaquin Barraquer, Merc Ux (Barcelona/E)
11:37 IL SU-70-13
Clear lens extraction and multifocal IOL
11:42
Discussion
Sunday, 6 June 2010
S
u
n
d
a
y
,

6

J
u
n
e
123
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
Surgical Management of Glaucoma
11:47 IL SU-70-14
Goniotomy
Ignacio Garca-Barbern, Joaquin Barraquer
(Barcelona/E)
11:49 IL SU-70-15
Peripheral Iridotomy
Muhsen Samaan (Barcelona/E)
11:50 IL SU-70-16
Non-perforating deep sclerectomy with
intrascleral implantation of T-Flux
Isabel Canut, Joaquin Barraquer (Barcelona/E)
11:55
Discussion
Management of Ocular Injuries
12:00 IL SU-70-17
Bomb explosion affecting both eyes
Joaquin Barraquer, Merc Ux (Barcelona/E)
12:14 IL SU-70-18
Alkali burn with extensive ocular surface
alterations
Juan P. Alvarez de Toledo, M de la Paz (Barcelona/E)
12:21 IL SU-70-19
Keratoprosthesis
Joaquin Barraquer, Jos Temprano (Barcelona/E)
12:25
Discussion
Roof Garden
14:00 - 15:30 SU-71
New Diagnostic and Therapeutic Aspects of
Lacrimal Diseases
Symposium
Chairs:
Karl-Heinz Emmerich (Darmstadt/D)
James Oestreicher (Toronto/CDN)
14:00 IL SU-71-01
Clinical and Imaging Evaluation of the Tearing
Patient
James Oestreicher (Toronto/CDN)
14:10 IL SU-71-02
Congenital Lacrimal Disorders
Franz Josef Steinkogler (Vienna/A)
14:20 IL SU-71-03
Management of Lacrimal Trauma
Hunter K. L. Yuen (Kowloon/HK)
14:30 IL SU-71-04
Current Techniques in DCR
Yannis Ntountas (GR)
14:40 IL SU-71-05
Microendoscopy of the Lacrimal Outflow System
Efficacy of Endoscopic Lacrimal Duct Recanaliza-
tion using Microendoscope
14:50 IL SU-71-06
Influence of Microendoscopic Techniques to
Lacrimal Surgery
15:00
Discussion
Roof Garden
16:00 - 17:30 SU-72
Strategies in Surgical Treatment of Eye Diseases in
Childhood
Symposium
Chairs:
Herbert Jgle (Regensburg/D)
16:00 IL SU-72-01
Minimally invasive strabismus surgery
16:15 IL SU-72-02
Advances in the treatment of pediatric glaucoma
16:30 IL SU-72-03
Current management of pediatric cataract
16:45 IL SU-72-04
Current management of capillary hemangioma
Herbert Jgle (Regensburg/D)
17:00 IL SU-72-05
Anti VEGF for ROP
17:15
Discussion
Sunday, 6 June 2010
S
u
n
d
a
y
,

6

J
u
n
e
124
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
Room 44
08:30 - 10:00 SU-73
Epidemiological Studies
Free Paper
Epidemiological Studies
Chairs:
Christian Wolfram (Mainz/D)
08:30 FP SU-73-01
Adenoviral Eye Infections at the Main Tertiary
Eye Center in Kuwait
Maya Pandova (Kuwait/KWT)
08:37 FP SU-73-02
Retinopathy in Persons without Diabetes:
The Handan Eye Study
Fenghua Wang (Beijing/CN)
08:44 FP SU-73-03
Alcohol Consumption and the Long-term
Incidence of Cataract and Cataract Surgery The
Blue Mountains Eye Study
Gowri Kanthan, Paul Mitchell, George Burlutsky,
Jie Jin Wang (Strathfield/AUS)
08:51 FP SU-73-04
Choroidal nevi prevalence in a Portuguese
population series of 80.000 patients
Esmeralda Costa, Lus Miguel Cristvo,
Rui Proena (Coimbra/P)
08:58 FP SU-73-05
Longitudinal study of visual acuity changes in
cone and cone-rod dystrophies
Elena Prokofyeva, Eric Trger, Robert Wilke,
09:05 FP SU-73-06
The 5 year incidence of visual impairment in
adult Chinese. The Beijing Eye Study
Qisheng You, Liang Xu, Jost B. Jonas (Beijing/CN,
Mannheim/D)
09:12 FP SU-73-07
Improving the detection and early management of
blindness in childhood: findings from the British
Childhood Vision Impairment Study
Phillippa Cumberland, Catherine Peckham,
09:19 FP SU-73-08
Blindness in the state of Northrhine now and in
2030
Robert P. Finger, Rolf Fimmers, Hendrik P. N. Scholl,
09:26 FP SU-73-09
Rapid Assessment of Avoidable Blindness in Tribal
Areas of Andhra Pradesh State in India
Srinivasa Pallerla (Hyderabad/IND)
09:33
Discussion
Room 44
10:30 - 12:00 SU-74
Vision 2020 Prevention of Blindness 1
Free Paper
Chairs:
10:30 FP SU-74-01
Trachoma in Brazil a nationwide school survey
Maria de Fatima Lopes, Karen Brock, Helen Freitas,
Norma Helen Medina, Expedito Luna,
Ligia Caligaris, Maria Regina Alves, Ins Koizumi,
Neusa Bernardes (Brasilia/BR, Nova Lima/BR,
So Paulo/BR, Palmas Tocantins/BR)
10:37 FP SU-74-02
Using Digital Cameras to Elicit Red-Reflexes for the
Detection of Childhood Blindness
Alefia Merchant, Brenda Gallie, Helen Dimaras,
Maria Pezzente, Robert Downie, Cynthia Vanden-
Hoven, Lindsay Hampejskov, K. Vasudha,
Kaushik Hegde, Nasrin Najm-Tehrani, Pradeep
Banandur, Ashwin Mallipatna (Bangalore/IND,
Toronto/CDN)
10:44 FP SU-74-03
Reaching rural Africans with eye care services:
Findings from primary eye care approaches in
Rwanda
Andreas Mueller, Janvier Murenzi, Wanjiku
Mathenge, Joseph Munana, Paul Courtright
(South Melbourne/AUS, Gisenyi/RWA, Nairobi/EAK,
Kigali/RWA, Moshi/EAT)
10:51 FP SU-74-04
Utilisation of Eye Care Services in a Rural Adult
Population of South-Western Nigeria
Bolutife Olusanya, A. O. Ashaye, B. G. K. Ajayi,
E. Owoaje (Ibadan/WAN)
10:58 FP SU-74-05
Factors Affecting Uptake of Cataract Surgical
Services at University College Hospital Ibadan,
Nigeria by Patients Screened in Outreach Camps
Charles Bekibele, G. V. S. Murthy (Ibadan/WAN)
Sunday, 6 June 2010
S
u
n
d
a
y
,

6

J
u
n
e
125
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
11:05 FP SU-74-06
Profile of Patients with Retinopathy of Prematu-
rity at a Pediatric Low Vision Service in Brazil
Galton Carvalho Vasconcelos, Cristina Helena
Toledo de Paula, Clovis Correa de Carvalho,
Jose Herculano De Carvalho, Luciene Chaves
Fernandes (Belo Horizonte/BR)
11:12 FP SU-74-07
Analysis of Correlation Factors Concerning Early
Visual Acuity of High Volume Cataract Surgery in
China
Kai Wang, Yong Zhen Bao, Xian Ru Hou, Xiao Xin Li
(Beijing/CN)
11:19 FP SU-74-08
Eye Care Development as a Tool for Stimulating
General Health Care Development
Kolawole Ogundimu, Suleiman Buhari (Accra/GH)
11:26 FP SU-74-09
Expression and Biological Activity Identification of
Human Pigment Epithelium-derived Factor
Yi Dai, Wenjing Shi, Yuxiong Wang, Chao Chen,
Min Yu (Shanghai/CN)
11:33 FP SU-74-10
Ophthalmologic short-term operations in the
Black Continent Namibia and Mali: What makes
sense?
Andreas Knster, Thomas Schwarz
(Traben-Trarbach/D)
11:40
Discussion
Room 44
14:00 - 15:30 SU-75
Cornea/External Disease: Surgical Therapy 2
Free Paper
Chairs:
Andrs Berta (Debrecen/H)
14:00 FP SU-75-01
Phototherapeutic keratectomy in the treatment
of corneal dystrophies and degenerations own
results
Ewa Mrukwa-Kominek (Katowice/PL)
14:07 FP SU-75-02
DMEK-S surgery in patients with posterior
polymorphous corneal dystrophy
Katerina Liehneova, Deli Sivekova, Andrej Farkas,
Michal Hyndrak, Pavel Studeny (Prague/CZ)
14:14 FP SU-75-03
Combining treatments to control advanced
keratoconic aberropia
Sergio Kandelman (Rio de Janeiro/BR)
14:21 FP SU-75-04
Post-DALK corneal endothelial assessment by
confocal microscopy and manual morphometry
Sven Jonuscheit, Michael J. Doughty,
Kanna Ramaesh (Glasgow/UK)
14:28 FP SU-75-05
Anterior lamellar keratectomy using the Gebauer
mikrokeratom
Toam Katz, Gisbert Richard, Stephan Linke
(Hamburg/D)
14:35 SL SU-75-06
Proteolytic enzymes in corneal wound healing
Andras Berta (Debrecen/H)
14:44 FP SU-75-07
Pre Cut Tissue: Organ culture preservation of OCT
guided femtosecond laser lamellar dissected
corneas
Lutz Blomberg, Konstantinos Zinelis, Frank Will,
Holger Lubatschowski, Rolf Winter (Hannover/D)
14:51 SL SU-75-08
Combined surgical treatment of severe corneal
ulcers and perforations
15:00 FP SU-75-09
Corneal patch grafts as a primary treatment for
corneal perforations
Robin Rios (Guayaquil/EC)
15:07 FP SU-75-10
Epidermal Growth Factor Variations in Culture
Ready Amniotic Membranes
Jean-Jacques Gicquel, A. Brodie, A. Hopkinson,
I. Mohammed, H. Suleman, E. Lazutina, D. K. James,
Harminder S. Dua (Poitiers/F, Nottingham/UK)
15:14
Discussion
Sunday, 6 June 2010
S
u
n
d
a
y
,

6

J
u
n
e
126
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
Room 44
16:00 - 17:30 SU-47
Free Paper
Refractive Surgery
Chairs:
16:00 FP SU-47-01
The evaluation of the magnitude of cyclotorsion
using the Advanced Control Eyetracking (ACE)
technology in the Technolas Excimer Workstation
217P
Eon-hee Bae, Keon-uk Park, Jong-ook Kim,
Chul-min Woo (Daegu/ROK)
16:07 FP SU-47-02
Comparison of hyperopic lasik using Femto laser
and mechanical microkeratome
Maja Bohac, Nikica Gabric, Iva Dekaris (Zagreb/HR)
16:14 FP SU-47-03
LASIK for moderate and high myopia. A compari-
son of eyes operated using a Moria M2 micro-
keratome and a Visumax femto-second laser
Jesper Hjortdal, Anders Ivarsen, Sven Asp,
Mikkel Lyngholm (Aarhus/DK)
16:21 FP SU-47-04
Influence of wavefront aberrations on visual
performance after conventional LASIK and wave-
front-guided LASIK with iris-registration
Jing Zhang, Yue-hua Zhou, Rui Li, Lei Tian
(Beijing/CN)
16:28 FP SU-47-05
Optical performance of multifocal lenses with
combined capsular tension ring implantation
Tobias Neuhann (Munich/D)
16:35 FP SU-47-06
Comparison of different types of multifocal
intraocular lenses after clear lens extraction
Nikica Gabric, Iva Dekaris, Maja Bohac, Ante Barisic
(Zagreb/HR)
16:42 FP SU-47-07
ICL vault assessment in patients with high myopia
Khristo Takhchidi (Moscow/RUS)
16:49 FP SU-47-08
Correction of Presbyopia in Hyperopic and Myopic
Patients with Biaspheric Multifocal Ablation
Mounir Khalifa, Tarek A. Wahab (Alexandria/ET)
16:56 FP SU-47-09
Binocular interaction in visual evoked responses:
a presbyopic treatment study
Kimiya Shimizu, Misae Ito (Sagamihara/J)
17:03 FP SU-47-10
Results of Conventional, OATz, and OPDCAT LASIK
for the treatment of high astigmatism with the
cross cylinder technique.
Tamer Gamaly (Muscat/MAO)
17:10
Discussion
Sunday, 6 June 2010
S
u
n
d
a
y
,

6

J
u
n
e
127
INVITATION
Scientific Programme
Chair: Gabriele Lang (Germany)

12.30 Epidemiology & current evidence for treatment of diabetic macular edema
patients in the Phase II RESOLVE study
Gabriele Lang (Germany)
12:40 Improving vision in patients with visual impairment due to diabetic
macular edema in the Phase III RESTORE study
Paul Mitchell (Australia)
13:05 Further clinical trial evidence of treating patients with diabetic macular edema
Neil M Bressler (USA)
13:30 Close
Novartis-sponsored symposium at the 32nd World Ophthalmology Congress (WOC),
Berlin, Germany, 59 June 2010
Improving vision for patients with DME:
Compelling New Evidence
Abu Dhabi Room, International Congress Centrum
6 June 2010, 12:3013:30
M
o
n
d
a
y
,

7

J
u
n
e
Scientific Program
Monday, 7 June 2010
WOC
2010
129
M
o
n
d
a
y
,

7

J
u
n
e
E
V
I
C
R
.
n
e
t

M
e
e
t
i
n
g
E
V
I

S
t
e
e
r
i
n
g

C
o
m
m
i
t
t
e
e
B
r
e
a
k
f
a
s
t

S
y
m
p
o
-
s
i
u
m

O
D
-
O
S
E
v
e
n
i
n
g

S
y
m
p
o
s
i
u
m

S
a
n
t
e
n

G
e
n
e
r
a
l

A
s
s
e
m
b
l
y

o
f

t
h
e
D
O
G
H
i
g
h
l
i
g
h
t
S
y
m
p
o
s
i
u
m
F
r
e
e

P
a
p
e
r
W
O
C

C
o
u
r
s
e
I
n
d
u
s
t
r
y

S
y
m
p
o
s
i
u
m
M
e
e
t
i
n
g
s
I
C
C
H
a
l
l

3
H
a
l
l

4
/
5
H
a
l
l

6
H
a
l
l

7
H
a
l
l

8
H
a
l
l

9
H
a
l
l

1
0
I
C
C

L
o
u
n
g
e
R
o
o
f

G
a
r
d
e
n
S
a
l
o
n

1
1
/
1
2
S
a
l
o
n

1
9
S
a
l
o
n

2
0
S
a
l
o
n

2
1
S
a
l
o
n

2
2
R
o
o
m

3
7
0
7
1
5
3
0
4
5
0
8
1
5
3
0
4
5
0
9
1
5
3
0
4
5
1
0
1
5
3
0
4
5
1
1
1
5
3
0
4
5
1
2
1
5
3
0
4
5
1
3
1
5
3
0
4
5
1
4
1
5
3
0
4
5
1
5
1
5
3
0
4
5
1
6
1
5
3
0
4
5
1
7
1
5
3
0
4
5
1
8
1
5
3
0
4
5
M
O
-
3
7

K
o
c
h
,

R
o
s
e
n
,

N
e
u
h
a
n
n
C
o
r
n
e
a
l

A
p
p
r
o
a
c
h
e
s

f
o
r

A
d
d
r
e
s
s
i
n
g

P
r
e
s
b
y
o
p
i
a
M
O
-
3
8

G
r
a
b
n
e
r
,

R
a
n
d
l
e
m
a
n
,
K
n
o
r
z

C
o
r
n
e
a
l

L
a
s
e
r

R
e
f
r
a
c
-
t
i
v
e

S
u
r
g
e
r
y
M
O
-
3
9

A
l
i
,

D
u
p
p
s
,

S
e
i
l
e
r

C
o
r
n
e
a
l

P
h
y
s
i
o
l
o
g
y

a
n
d

B
i
o
-
m
e
c
h
a
n
i
c
s
M
O
-
4
0

C
o
l
i
n
,

Z
a
l
d
i
v
a
r
,
K
o
h
n
e
n

M
a
n
a
g
i
n
g

H
i
g
h

R
e
f
r
a
c
t
i
v
e

E
r
r
o
r
s
M
O
-
4
1

G
o
l
n
i
k
,

A
y
d
i
n
,

S
t
e
u
h
l

W
o
r
l
d
w
i
d
e

P
r
o
g
r
a
m

o
f
T
e
a
c
h
i
n
g

D
i
r
e
c
t
o
r
s

o
f

O
p
h
t
h
.
M
O
-
4
2

L
e
e
,

H
a
w
l
i
n
a
,

G
a
b
e
l

T
h
e

N
e
w

F
r
o
n
t
i
e
r

o
f

C
h
a
n
g
-
i
n
g

P
a
r
a
m
e
t
e
r
s

o
f

R
e
s
i
d
e
n
c
y
M
O
-
4
3

T
s
o
,

E
d
w
a
r
d
,

L
f
f
l
e
r

I
n
n
o
v
a
t
i
v
e

T
e
c
h
n
o
l
o
g
i
e
s

f
o
r
T
e
a
c
h
i
n
g

O
p
h
t
h
a
l
m
o
l
o
g
y
M
O
-
4
4

M
a
y
o
r
g
a

A
r
g
a
a
r
a
z
,
T
s
o
,

L
f
f
l
e
r
E
m
e
r
g
i
n
g

T
e
c
h
n
.
f
o
r

O
p
h
t
h
.
T
e
a
c
h
i
n
g
a
n
d
L
e
a
r
n
.
M
O
-
4
9

H
e
i
l
i
g
e
n
h
a
u
s
,

K
i
n
o
s
h
i
t
a

C
i
c
a
t
r
i
z
i
n
g

C
o
n
j
u
n
c
t
i
v
i
t
i
s
M
O
-
5
0

B
e
l
f
o
r
t
,

J
r
.
,

L
o
e
w
e
n
-
s
t
e
i
n
,

N
e

I
n
t
r
a
-
O
c
u
l
a
r

T
h
e
r
a
p
y
M
O
-
5
1

C
o
n
g
d
o
n
,

E
h
r
t
,

G
i
l
b
e
r
t

C
o
m
b
a
t
i
n
g

C
h
i
l
d
h
o
o
d

B
l
i
n
d
-
n
e
s
s
M
O
-
5
2

L
e
e
,

K
e
e
f
f
e

T
h
e

E
c
o
-
n
o
m
i
c
s

o
f

B
l
i
n
d
n
e
s
s
:

W
h
a
t
D
o
e
s

L
o
s
t

V
i
s
i
o
n

C
o
s
t
M
O
-
5
4

M
i
g
d
a
l
,

G
o
i

F
o
n
c
i
l
-
l
a
s
,

T
h
y
g
e
s
e
n

E
G
S

S
y
m
p
:
G
l
a
u
c
o
m
a

M
a
n
a
g
e
m
e
n
t
M
O
-
5
5

H
a
w
l
i
n
a
,

A
c
l
i
m
a
n
d
o
s
,
T
a
s
s
i
g
n
o
n
E
B
O

S
y
m
p

F
r
o
m
N
a
t
.

t
o
w
a
r
d
s

E
u
r
o
p
.

t
r
a
i
n
i
n
g

M
O
-
5
6

C
o
n
s
t
a
b
l
e
,

L
a
i
,

L
i

A
P
A
O

S
y
m
p
:

A
g
e
-
r
e
l
a
t
e
d
M
a
c
u
l
a
r

D
e
g
e
n
e
r
a
t
i
o
n

M
O
-
5
8

V
a
l
d
e
z
,

T
u
u
l
o
n
e
n
,

J
a
n
,
O
b
e
r
a
c
h
e
r
-
V
e
l
t
e
n

O
r
g
a
n
i
s
a
t
i
o
n
a
l

A
s
p
e
c
t
s
M
O
-
5
9

A
s
t
l
e
,

B
i
s
c
h
o
f
f

J
C
A
H
P
O

S
y
m
p
o
s
i
u
m
:

T
e
a
c
h
-
i
n
g

a
l
l
i
e
d

H
e
a
l
t
h

P
e
r
s
o
n
n
e
l
M
O
-
6
0

S
c
h
l
t
z
e
r
-
S
c
h
r
e
h
a
r
d
t
,
I
r
k
e
c
,

H
o
l
l
L
i
n
d
b
e
r
g

S
o
c
i
e
t
y
S
y
m
p
:

E
x
f
o
l
i
a
t
i
o
n

S
y
n
d
r
o
m
e
M
O
-
6
3

G
r
a
g
o
u
d
a
s
M
a
c
u
l
a

S
o
c
i
e
t
y

S
y
m
p
:

N
o
n
-
s
u
r
g
i
c
a
l

T
r
e
a
t
m
e
n
t
M
O
-
6
4

T
a
n
,

G
e
e
r
l
i
n
g
,

A
l
R
a
j
h
i

P
t
e
r
y
g
i
u
m

S
u
r
g
e
r
y
M
O
-
6
5

T
s
a
i
,

B
a
r
t
o
n
,

T
h
i
e
m
e

A
A
O

S
y
m
p
:

G
l
a
u
c
o
m
a

i
m
-
p
l
a
n
t
s
:

n
o
w

a
n
d

t
h
e

f
u
t
u
r
e
M
O
-
6
6

M
o
j
o
n
,

A
l
i

M
i
n
i
m
a
l
l
y

I
n
v
a
s
i
v
e

O
p
h
-
t
h
a
l
m
i
c

S
u
r
g
e
r
y
M
O
-
6
7

M
e
y
e
r
,

S
o
u
b
r
a
n
e
,
W
o
l
f
e
n
s
b
e
r
g
e
r

R
e
t
i
n
a
:

V
a
s
c
u
l
a
r

D
i
s
e
a
s
e

1
M
O
-
8
2

P
e
r
r
o
s
,

H
i
n
t
s
c
h
i
c
h
,
D
i
c
k
i
n
s
o
n
,

L
u
d
g
a
t
e

E
U
G
O
G
O

S
y
m
p
o
s
i
u
m
M
O
-
4
5

H
o
l
z
,

C
u
n
h
a
-
V
a
z
,
C
h
a
k
r
a
v
a
r
t
h
y

E
d
i
t
o
r
i
a
l

M
a
n
a
g
e
m
e
n
t
M
O
-
4
6

N
u
s
s
e
n
b
l
a
t
t
,

F
o
r
r
e
s
t
e
r
,
Z
i
e
r
h
u
t

I
U
S
G

S
y
m
p
:

U
p
d
a
t
e
o
f

n
e
w

D
e
v
e
l
o
p
m
e
n
t
s
M
O
-
4
7

R
i
t
c
h
,

Z
a
r
b
i
n

N
a
n
o
t
e
c
h
n
o
l
o
g
y
L
u
n
c
h

S
y
m
p
o
s
i
u
m
Z
e
i
s
s
M
O
-
6
9

S
p
r
u
n
g
e
r
,

M
a
r
t
i
n
,

d
e
F
a
b
e
r
,

S
c
h
i
a
v
i

I
S
A

S
y
m
p
:

C
l
i
n
i
-
c
a
l

C
h
a
l
l
e
n
g
e
s

i
n

S
t
r
a
b
i
s
m
u
s
M
O
-
7
0
T
a
r
y
a
m
,
S
h
e
t
t
a
,
K
i
r
c
h
h
o
f

M
E
A
C
O

S
y
m
p
:

M
a
n
a
g
e
m
e
n
t
o
f

R
e
t
i
n
a

a
n
d

M
a
c
u
l
a
r
M
O
-
7
1

W
i
g
g
s
,

H
u
n
t
e
r

A
R
V
O

S
y
m
p
o
s
i
u
m
:

G
e
n
e
t
i
c
s
o
f

E
y
e

D
i
s
e
a
s
e
I
C
O

F
e
l
l
o
w
s
h
i
p
s

A
l
u
m
n
i

R
e
c
e
p
t
i
o
n
M
O
-
8
1

L
u
c
o

D
i
s
a
s
t
e
r

R
e
s
p
o
n
s
e
:

O
p
h
t
h
a
l
m
o
l
o
g
y
s

O
r
g
a
n
i
z
a
t
i
o
n
a
l

R
o
l
e
T
r
e
f
f
e
n

d
e
r

W
o
c
h
e

d
e
s

S
e
h
e
n
s
T
r
e
f
f
e
n

d
e
r

V
i
s
i
o
n

2
0
2
0

I
n
i
t
i
a
t
i
v
g
r
u
p
p
e
M
i
t
g
l
i
e
d
e
r
v
e
r
s
a
m
m
l
u
n
g

d
e
r
S
e
k
t
i
o
n

D
O
G
-
U
v
e
i
t
i
s
H
e
r
a
u
s
g
e
b
e
r
s
i
t
z
u
n
g

D
e
r

O
p
h
t
h
a
l
m
o
l
o
g
e

2
0
1
0
K
o
m
m
i
s
s
i
o
n
s
s
i
t
z
u
n
g

R
e
f
r
a
k
t
i
v
e

C
h
i
r
u
r
g
i
e
E
B
O

E
x
e
c
u
t
i
v
e

B
o
a
r
d
U
v
e
i
t
i
s

A
w
a
r
d
2
0
1
0
E
V
I

G
e
n
e
r
a
l

A
s
s
e
m
b
l
y
M
O
-
5
3

K
h
a
w
,

M
i
c
h
e
l
s
o
n

A
R
V
O

S
y
m
p
:

T
r
a
n
s
l
.

R
e
s
e
a
r
c
h

D
e
v
e
l
o
p
.

I
n
n
o
v
.

N
e
w

T
r
e
a
t
m
.
M
O
-
5
7

d
e

F
r
e
i
t
a
s
,

A
b
b
o
t
t

P
A
A
O

S
y
m
p
:

A

c
l
o
s
e

l
o
o
k

i
n
t
o
t
h
e

f
u
t
u
r
e
M
O
-
2
6

P
a
h
o
r
,

T
a
k
h
c
h
i
d
i
,

L
a
n
z
l

M
i
s
c
e
l
l
a
n
e
o
u
s

2
M
O
-
4
8

K
o
r
w
i
t
z
,

S
c
h
a
c
h
a
t
,
K
i
r
c
h
h
o
f

G
o
o
g
l
e
'
s

A
p
p
r
o
a
c
h
,
O
p
e
n

A
c
c
e
s
s

P
u
b
l
i
s
h
i
n
g
M
O
-
7
2

W
u
,

A
u
g
u
s
t
i
n

A
A
O

S
y
m
p
o
s
i
u
m
:

R
e
t
i
n
a
l
P
h
a
r
m
a
c
o
t
h
e
r
a
p
y
M
o
n
d
a
y
,

7

J
u
n
e
H
i
g
h
l
i
g
h
t
S
y
m
p
o
s
i
u
m
F
r
e
e

P
a
p
e
r
W
O
C

C
o
u
r
s
e
I
n
d
u
s
t
r
y

S
y
m
p
o
s
i
u
m
M
e
e
t
i
n
g
s
R
o
o
m

4
2
R
o
o
m

4
3
R
o
o
m

4
4
R
o
o
m

4
5
M
e
s
s
e
S
t
o
c
k
h
o
l
m

S
a
o

P
a
u
l
o
A
b
u

D
h
a
b
i

O
s
l
o

H
a
l
l

R
o
o
m

M
a
d
r
i
d
R
o
o
m

S
y
d
n
e
y
R
o
o
m

H
o
n
g

K
o
n
g
R
o
o
m

I
s
t
a
n
b
u
l

V
I
P

L
o
u
n
g
e

1

V
I
P

L
o
u
n
g
e

2

R
a
d
i
o

T
o
w
e
r

L
o
u
n
g
e

1
R
a
d
i
o

T
o
w
e
r
L
o
u
n
g
e

2
H
a
l
l

1
1
0
7
1
5
3
0
4
5
0
8
1
5
3
0
4
5
0
9
1
5
3
0
4
5
1
0
1
5
3
0
4
5
1
1
1
5
3
0
4
5
1
2
1
5
3
0
4
5
1
3
1
5
3
0
4
5
1
4
1
5
3
0
4
5
1
5
1
5
3
0
4
5
1
6
1
5
3
0
4
5
1
7
1
5
3
0
4
5
1
8
1
5
3
0
4
5
W
O
C
-
C
-
3
8

M
a
r
k

U
p
d
a
t
e

o
n

T
o
n
o
m
e
t
r
y
W
O
C
-
C
-
3
9

D
a
x
e
r
,

M
a
h
m
o
o
d

A

F
l
e
x
i
b
l
e

R
i
n
g

i
n

a

C
o
r
n
e
a
l
P
o
c
k
e
t

f
o
r

t
h
e

T
r
e
a
t
m
e
n
t

W
O
C
-
C
-
4
0

B
a
r
r
a
q
u
e
r
,

B
a
r
r
a
-
q
u
e
r
,

N
a
d
a
l

M
o
d
e
r
n

S
u
r
g
.
o
f
t
h
e

P
o
s
t
e
r
i
o
r

S
e
g
m
.

o
f

t
h
e

E
y
e
W
O
C
-
C
-
4
1

W
o
n
g
,
S
u
l
l
i
v
a
n
,
B
a
r
t
z
-
S
c
h
m
i
d
t

C
o
m
p
l
i
c
a
t
i
o
n
s
i
n

V
i
t
r
e
o
r
e
t
i
n
a
l

S
u
r
g
e
r
y
M
O
-
7
3

A
h
m
e
d
,

G
e
r
i
n
e
c
,

P
i
l
l
u
n
a
t

G
l
a
u
c
o
m
a
:

B
a
s
i
c
s

2
M
O
-
7
4

G
a
r
w
e
g
,

G
u
l
,

B
i
s
w
a
s

U
v
e
i
t
i
s
/
i
n
t
r
a
o
.

i
n
f
l
a
m
m
a
t
i
o
n
,
m
i
c
r
o
b
.
/
i
m
m
u
n
o
l
o
g
y

2
M
O
-
7
5

B
a
r
t
z
-
S
c
h
m
i
d
t
,

S
a
h
e
l
,
S
c
h
m
i
d
t
-
E
r
f
u
r
t
h
R
e
t
i
n
a
:

M
i
s
c
e
l
l
a
n
e
o
u
s

1
M
O
-
7
6

C
h
a
n
,
D
e
c
a
u
d
i
n
,
Z
i
e
r
h
u
t

U
v
e
i
t
i
s
/
i
n
t
r
a
o
.

i
n
f
l
a
m
m
a
t
i
o
n
,
m
i
c
r
o
b
i
o
l
.
/
i
m
m
u
n
o
l
o
g
y

3
C
E
V
G

I
n
t
e
r
n
a
t
i
o
n
a
l

A
d
v
i
s
o
r
y

G
r
o
u
p
M
O
-
7
7

B
o
r
n
f
e
l
d
,

G
a
l
l
i
e
,

R
o
m
a
n
o
w
s
k
a
-
D
i
x
o
n

O
n
c
o
l
o
g
y

2
M
O
-
7
8

D
r
n
o
v
s
e
k
-
O
l
u
p
,

E
m
m
e
r
i
c
h
,

T
s
e

O
c
u
l
o
p
l
.
/
o
r
b
i
t
a
/
l
i
d
s
/
l
a
c
r
i
m
a
l

s
y
s
t
e
m

2
M
O
-
7
9

v
a
n

R
i
j
,
X
i
a
o
,
Z
a
r
b
i
n

N
e
w

t
e
c
h
n
o
l
o
g
y
,

B
i
o
e
n
g
i
n
e
e
r
-
i
n
g
,

N
a
n
o
t
e
c
h
n
o
l
o
g
y

2
I
C
O

A
d
v
i
s
o
r
y

G
r
o
u
p

o
n

S
u
b
-
S
a
h
a
r
a
n
A
f
r
i
c
a
B
r
e
a
k
f
a
s
t

S
y
m
p
o
-
s
i
u
m

S
a
n
t
e
n
M
O
-
0
1

N
g
u
y
e
n
,

O
g
u
r
a
,
J
o
u
s
s
e
n

R
e
t
i
n
a

a
n
d

A
n
g
i
o
g
e
n
e
s
i
s
M
O
-
0
2

L
e
y
s
,

L
a
n
g
,

G
r
e
g
o
r

R
e
t
i
n
a
l

C
a
s
e
s

w
i
t
h

D
i
s
c
u
s
-
s
i
o
n
M
O
-
0
3

B
e
l
f
o
r
t
,

G
r
a
h
a
m
,
D
i
t
h
m
a
r

R
e
t
i
n
a
l

a
n
d
C
h
o
r
o
i
d
a
l

M
a
n
i
f
e
s
t
a
t
i
o
n
s
L
u
n
c
h

S
y
m
p
o
s
i
u
m
S
a
n
t
e
n
M
O
-
6
1

R
i
c
h
a
r
d
,

C
u
n
h
a
-
V
a
z
,
D
r
e
x
l
e
r

E
u
r
e
t
i
n
a

S
y
m
p
o
s
i
u
m
B
r
e
a
k
f
a
s
t

S
y
m
p
o
-
s
i
u
m

P
f
i
z
e
r
M
O
-
0
4

Z
i
n
,

V
i
n
e
k
a
r
,

L
o
r
e
n
z

U
p
d
a
t
e

o
n

R
e
t
i
n
o
p
a
t
h
y

o
f
P
r
e
m
a
t
u
r
i
t
y
M
O
-
0
5

L
o
r
e
n
z
,

T
a
s
s
i
g
n
o
n
,
N
i
s
c
h
a
l
S
u
r
g
i
c
a
l

C
h
a
l
l
e
n
g
e
s

i
n
P
a
e
d
i
a
t
r
i
c

A
n
t
e
r
i
o
r

S
e
g
m
.

D
i
s
.
M
O
-
0
6

G
o
t
t
l
o
b
,

Z
e
i
t
z
,

L
o
r
e
n
z

U
p
d
a
t
e

o
n

I
n
f
a
n
t
i
l
e

N
y
s
t
a
g
-
m
u
s
M
O
-
0
7

L
o
r
e
n
z
,

G
i
l
b
e
r
t
,

T
a
y
l
o
r

E
P
O
S

S
y
m
p
:

V
i
s
i
o
n

2
0
2
0

i
n
p
a
e
d
i
a
t
r
i
c

o
p
h
t
h
a
l
m
o
l
o
g
y
M
O
-
0
8

G
r
e
h
n
,

Q
u
i
g
l
e
y
,

T
h
a
m

G
l
a
u
c
o
m
a

R
e
s
e
a
r
c
h

S
o
c
i
e
t
y
S
y
m
p
o
s
i
u
m
M
O
-
0
9

z
k
a
n
,

L
e
e
,

S
c
h
i
a
v
i

E
S
A

S
y
m
p
o
s
i
u
m
:

H
o
t

T
o
p
i
c
s
i
n

S
t
r
a
b
i
s
m
u
s

a
n
d

A
m
b
l
y
o
p
i
a
M
O
-
1
0

v
a
n

R
e
n
s
,

R
u
b
i
n
I
S
L
R
R

S
y
m
p
:

V
i
s
i
o
n

o
n

L
o
w
V
i
s
i
o
n

R
e
s
e
a
r
c
h
M
O
-
1
1

K
a
m
p
i
k
,

B
e
a
c
o
n
s
f
i
e
l
d

F
E
O
p
h

S
y
m
p
o
s
i
u
m
:

U
v
e
i
t
i
s
B
r
e
a
k
f
a
s
t

S
y
m
p
o
-
s
i
u
m

H
o
y
a

S
u
r
g
i
c
a
l
O
p
t
i
c
s

G
m
b
H
M
O
-
1
2

K
r
u
p
i
n
,

H
o
m
m
e
r
,
J
n
e
m
a
n
n

M
e
d
i
c
a
l

a
n
d

L
a
s
e
r
T
r
e
.

o
f

O
p
e
n
-
A
n
g
l
e

G
l
a
u
c
o
m
a
M
O
-
1
3

L
i
e
b
m
a
n
n
,

C
o
h
n
,

H
o
f
f
-
m
a
n
n

P
a
n
e
l
:

P
r
e
d
i
c
t
i
n
g

a
n
d
D
e
t
e
r
m
.

R
a
t
e
s

o
f

G
l
a
u
c
.

P
r
o
.
M
O
-
1
4

H
e
i
j
l
,

G
a
r
w
a
y
-
H
e
a
t
h
,
S
c
h
i
e
f
e
r

P
e
r
i
m
e
t
r
y
:

N
o
w

a
n
d

F
u
t
u
r
e
M
O
-
1
5

S
u
a
r
e
z
,

O
s
s
m
a
-
G
o
m
e
z
,
A
l
i
,

A
l
f
o
n
s
o

A
L
A
C
C
S
A
-
R

S
y
m
p
o
s
i
u
m
B
r
e
a
k
f
a
s
t

S
y
m
p
o
-
s
i
u
m

A
l
l
e
r
g
a
n
O
p
h
t
h
a
l
m
o
l
o
g
y
M
O
-
1
6

A
u
g
u
s
t
i
n
,

R
i
z
z
o
,
M
i
e
l
e
r

V
i
t
r
e
o
-
R
e
t
i
n
a
l

C
o
n
s
i
d
-
e
r
a
t
i
o
n
s

i
n

C
a
t
a
r
a
c
t

S
u
r
g
e
r
y
M
O
-
1
7

D
u
a
,

K
r
u
s
e
,

P
e
l
l
e
g
r
i
n
i

O
c
u
l
a
r

S
u
r
f
a
c
e

R
e
c
o
n
s
t
r
u
c
-
t
i
o
n
M
O
-
1
8

C
o
u
p
l
a
n
d
,

H
o
l
b
a
c
h
,
S
e
r
e
g
a
r
d

T
u
m
o
r
s

o
f

t
h
e

O
c
u
l
a
r

S
u
r
f
a
c
e
M
O
-
1
9

R
o
s
e
n
,

D
i
c
k

A
s
t
i
g
m
a
t
i
s
m

M
a
n
a
g
e
m
e
n
t

i
n
C
a
t
a
r
a
c
t

S
u
r
g
e
r
y
W
O
C
-
C
-
3
0

H
a
t
t
e
n
b
a
c
h

S
u
t
u
r
e
l
e
s
s

=

H
a
p
p
i
n
e
s
s
?

W
O
C
-
C
-
3
1

B
u
r
k
,

C
h
a
u
h
a
n
,
B
u
r
g
o
y
n
e

H
R
T

a
n
d

S
p
e
c
t
r
a
l
O
C
T

i
n

G
l
a
u
c
o
m
a
W
O
C
-
C
-
3
2

L
a
n
g

L
a
s
e
r

T
r
e
a
t
m
e
n
t

o
f

R
e
t
i
n
a
l
D
i
s
e
a
s
e
s
W
O
C
-
C
-
3
3

R
i
e
d
e
l

B
l
e
p
h
a
r
o
p
l
a
s
t
y

o
f

t
h
e

U
p
p
e
r
a
n
d

L
o
w
e
r

E
y
e

L
i
d
s
M
O
-
2
0

T
a
s
s
i
g
n
o
n
,

v
a
n

R
i
j

S
O
E

S
y
m
p
o
s
i
u
m
:

S
l
i
p
s
,

T
r
i
c
k
s
a
n
d

F
a
l
l
M
O
-
2
1

L
i
e
s
e
g
a
n
g
,

V
e
r
j
a
n
s
,
H
e
i
l
i
g
e
n
h
a
u
s

D
N
A

V
i
r
u
s
e
s

a
n
d

t
h
e

E
y
e
M
O
-
2
2

A
r
a
i
e
,

G
r
u
s
,

M
e
d
e
i
r
o
s

A
O
G
S

S
y
m
p
o
s
i
u
m
:

N
o
r
m
a
l
-
t
e
n
s
i
o
n

G
l
a
u
c
o
m
a
M
O
-
2
3

C
o
l
e
n
b
r
a
n
d
e
r
,
R
o
h
r
s
c
h
n
e
i
d
e
r
,

v
a
n

R
e
n
s

P
a
n
e
l
:

V
i
s
i
o
n

R
e
h
a
b
i
l
i
t
a
t
i
o
n
W
O
C
-
C
-
3
4

P
f
e
i
f
f
e
r

W
e
t
l
a
b

G
l
a
u
c
o
m
a

S
u
r
g
e
r
y
f
o
r

B
e
g
i
n
n
e
r
s
W
O
C
-
C
-
3
5

P
f
e
i
f
f
e
r

W
e
t
l
a
b

G
l
a
u
c
o
m
a

S
u
r
g
e
r
y
f
o
r

t
h
e

A
d
v
a
n
c
e
d
M
O
-
2
4

F
o
e
r
s
t
e
r
,

I
m
s
h
e
n
e
t
-
s
k
a
y
a
,

O
h
n
o
-
M
a
t
s
u
i

R
e
t
i
n
a
:

S
u
r
g
i
c
a
l

t
h
e
r
a
p
y

1
M
O
-
3
2

B
e
l
f
o
r
t
,

L
o
e
w
e
n
s
t
e
i
n
R
e
t
i
n
a
:

M
e
d
i
c
a
l

t
h
e
r
a
p
y

1
M
O
-
2
5

L
a
g
a
n
o
v
s
k
a
,

M
a
n
d
i
c
,
S
t
a
r
k

C
a
t
a
r
a
c
t
/
b
i
o
m
e
t
r
y

2
M
O
-
6
2

T
r
i
m
m
e
l
,

K
i
b
a
t
a
,
B
u
e
h
l
e
r
N
G
O
/
P
r
i
v
a
t
e

S
e
c
t
o
r
P
a
r
t
n
e
r
s
h
i
p
s
:

W
I
N
/
W
I
N
M
O
-
2
7

K
i
r
c
h
h
o
f
,

W
a
l
t
e
r
,
S
c
h
o
l
l

R
e
t
i
n
a
:

D
i
a
g
n
o
s
t
i
c
s

2
M
O
-
2
8

S
c
h
r
a
d
e
r
,

S
i
v
k
o
v
a

T
r
a
u
m
a
M
O
-
2
9

D
'
A
m
i
c
o
,

W
o
l
f
e
n
s
-
b
e
r
g
e
r
,

W
i
e
d
e
m
a
n
n

C
l
u
b

J
u
l
e
s

G
o
n
i
n

S
y
m
p
o
s
i
u
m
M
O
-
3
0

B
i
r
n
b
a
u
m
,

W
y
l
e
g
a
l
a
,
A
l
R
a
j
h
i

S
u
r
g
i
c
a
l

T
h
e
r
a
p
y

o
f
K
e
r
a
t
o
c
o
n
u
s
M
O
-
3
1

B
a
r
t
o
n
,

S
t
e
i
n
,

+
F
l
a
m
-
m
e
r

G
l
a
u
c
o
m
a
:

S
u
r
g
i
c
a
l

t
h
e
r
a
p
y

1
M
O
-
6
8

H
o
l
z
,

R
a
d
e
c
k
a
,
S
u
l
z
b
a
c
h
e
r

R
e
t
i
n
a
:

A
M
D

2
M
O
-
3
3

G
r
o
s
s
n
i
k
l
a
u
s
,

B
u
r
n
i
e
r
,
A
u
w
-
H
d
r
i
c
h

I
n
t
r
a
o
c
u
l
a
r

T
u
m
o
r
s
M
O
-
3
4

R
o
s
e
,

G
u
t
h
o
f
f
,

K
a
t
o
w
i
t
z
N
e
w

D
i
a
g
n
.

a
n
d

T
h
e
r
a
p
e
u
t
i
c
A
s
p
e
c
t
s

o
f

O
r
b
i
t
a
l

D
i
s
e
a
s
e
s
M
O
-
3
5

D
a
r
t
,

S
e
i
t
z
,

S
p
i
e
r
i
n
g
s

C
o
r
n
e
a
/
E
x
t
e
r
n
a
l

D
i
s
e
a
s
e
:

D
i
-
a
g
n
o
s
t
i
c
s
M
O
-
3
6

S
z
u
r
m
a
n
,

R
o
i
d
e
r
,
S
p
i
t
z
e
r

O
c
u
l
a
r

P
h
a
r
m
a
c
o
l
o
g
y
E
u
r
o
p
e
a
n
V
i
s
i
o
n
A
w
a
r
d

P
o
s
t
e
r

e
x
h
i
b
i
t
i
o
n

o
f

P
o
s
t
e
r

P
-
M
O
-
0
0
1

t
o

P
-
M
O
-
2
9
8
117th Congress
of the French Society of Ophthalmology
7 - 10 May 2011
Paris
www.sfo.asso.fr
W
e
l
c
o
m
e

t
o

P
a
r
i
s
Of cial languages: French - English
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
Stockholm
08:30 - 10:00 MO-01
Retina and Angiogenesis
Symposium
Retina
Chairs:
Quan Dong Nguyen (Baltimore/USA)
Yuichiro Ogura (Nagoya/J)
Antonia M. Joussen (Berlin/D)
08:30 IL MO-01-01
The role of cathepsin L from bone marrow-derived
cells in retinal angiogenesis
Kyoko Ohno-Matsui (Tokyo/J)
08:40 IL MO-01-02
How to promote regeneration of functional capil-
laries in the ischemic retina
Akiyoshi Uemura (Kobe/J)
08:50 IL MO-01-03
Modulation of Retinal Angiogenesis by Retinal
Ganglion Cells: Implications for Proliferative
Retinopathies
Mike Sapieha (Montreal(CDN)
09:00 IL MO-01-04
Can VEGF Blockade Result in Regression of
Choroidal Neovascularization?
Diana Do (Baltimore/USA)
09:10 IL MO-01-05
Advanced glycation endproducts in vascular
disease
Alan Stitt (Belfast/UK)
09:20 IL MO-01-06
Inflammation in Angiogenesis
09:30
Discussion
Stockholm
10:30 - 12:00 MO-02
Retinal Cases with Discussion
Symposium
Retina
Chairs:
Anita Leys (Leuven/B)
10:30 IL MO-02-01
Radiation retinopathy: what to do?
10:40 IL MO-02-02
Light chain deposition disease
Anita Leys (Leuven/B)
10:50 IL MO-02-03
A man with recurrent macular hermorrhage
Timothy Lai (Hong Kong/CN)
11:00 IL MO-02-04
Mystery case
11:10 IL MO-02-05
Brain melanoma: How did it get there?
11:20 IL MO-02-06
Mystery Case
11:30 IL MO-02-07
Mystery Case
Andries Stulting (Bloemfontein/ZA)
11:40 IL MO-02-08
Mysterious macular disease
11:50 IL MO-02-09
Mystery case
Stockholm
14:00 - 15:30 MO-03
Retinal and Choroidal Manifestations of Systemic
Diseases
Symposium
Retina
Chairs:
Elisabeth Graham (London/UK)
14:00 IL MO-03-01
Metabolic diseases: Diabetes
14:10 IL MO-03-02
Metabolic diseases: non diabetic diseases
Elisabeth Graham (London/UK)
Monday, 7 June 2010
M
o
n
d
a
y
,

7

J
u
n
e
133
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
14:20 IL MO-03-03
Retinochoroiditis
14:30 IL MO-03-04
Vasculitis
14:40 IL MO-03-05
Neurological diseases
Alfredo Sadun (Los Angeles/USA)
14:50 IL MO-03-06
Oncological entities
15:00
Discussion
Stockholm
16:00 - 17:30 MO-61
Euretina Symposium: Retinal Imaging with Optical
Coherence Tomography / Future of Imaging
Symposium
Retina
Chairs:
Jos Cunha-Vaz (Coimbra/P)
Wolfgang Drexler (Cardiff/UK)
16:00 IL MO-61-01
OCT in Macula Pathologies
16:10 IL MO-61-02
Multimodal Macula Mapping
16:20 IL MO-61-03
Cellular Resolution Retinal Imaging and
Optophysiology
Wolfgang Drexler (Cardiff/UK)
16:30 IL MO-61-04
Polarization Sensitive Retinal OCT
Christoph Hitzenberger (Vienna/A)
16:40 IL MO-61-05
Ultrahigh speed retinal OCT
James G. Fujimoto (Cambridge/USA)
16:50 IL MO-61-06
Retinal OCT at 1060nm
Yoshiaki Yasuno (Ibaraki/J)
17:00
Discussion
Stockholm
17:45 - 18:15 MO-83
European Vision Award 2010 Lecture
see also p. 18
Sao Paulo
08:30 - 10:00 MO-04
Update on Retinopathy of Prematurity: New
Approaches for Research, Diagnosis and Treatment
Chairs:
08:30 IL MO-04-01
New research areas in ROP diagnosis and
management
Ann Hellstrom (Gothenburg/S)
08:40 IL MO-04-02
Organizing national screening programs for ROP
08:50 IL MO-04-03
ROP Screening in Vietnam
Nguyen Xuan Tinh (Hanoi/VN)
09:00 IL MO-04-04
Telemedicine as an option for screening: The ex-
perts view on WFDI in ROP
09:10 IL MO-04-05
Telemedicine in ROP: The Indian Experience
09:20 IL MO-04-06
WFDI in ROP: Opportunity for automated image
analysis
09:30 IL MO-04-07
Anti-VEGF and ROP
Helen A. Mintz-Hittner (Houston/USA)
09:40
Discussion
Monday, 7 June 2010
M
o
n
d
a
y
,

7

J
u
n
e
134
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
Sao Paulo
10:30 - 12:00 MO-05
Surgical Challenges in Pediatric Anterior
Segment Diseases
Chairs:
10:30 IL MO-05-01
Best choice surgery in pediatric cataract
10:450 IL MO-05-02
Alternatives to penetrating keratoplasty in
pediatric corneal disease
11:00 IL MO-05-03
Pediatric Corneal Transplantation: Experiences
from a large tertiary referral center in India.
Pravin V. Krishna (Hyderabad/IND)
11:15 IL MO-05-04
The choice and effectiveness of surgery in different
clinical forms of congenital glaucoma
11:30 IL MO-05-05
Pediatric perforating injuries of the globe: timing
of surgical steps
11:45
Discussion
Sao Paulo
14:00 - 15:30 MO-06
Update on Infantile Nystagmus: Clinics, Genetics,
and Treatment
Chairs:
14:00 IL MO-06-01
Modern work-up in infantile nystagmus
14:15 IL MO-06-02
Genetics of X-linked idiopathic nystagmus
14:30 IL MO-06-03
Genetics of cone dysfunction disorders
Susanne Kohl (Tbingen/D)
14:45 IL MO-06-04
Genetic and clinical hetereogeneity of congenital
forms of night blindness
15:00 IL MO-06-05
Medical and surgical treatment options
Anil Kumar (Leicester/UK)
15:15 IL MO-06-06
Gene therapy provides cure for achromatopsia
Sao Paulo
16:00 - 17:30 MO-07
EPOS Symposium: Vision 2020 in Pediatric
Ophthalmology. Dreams and Realities in
Eliminating Avoidable Childhood Blindness
Chairs:
16:00 IL MO-07-01
VISION 2020 and children: achievements and
challenges
16:15 IL MO-07-02
Pediatric cataract: can we improve on what we
have achieved?
Michael OKeefe (Dublin/IRL)
16:30 IL MO-07-03
Pediatric glaucoma. Holes, tubes and more.
16:45 IL MO-07-04
Pediatric infectious eye diseases: Prevention and
treatment
17:00 IL MO-07-05
Predictions of genotype and phenotype in
pediatric hereditary diseases: present
achievements and future challenges
Josseline Kaplan (Paris/F)
17:15 IL MO-07-06
Retinal dystrophies: hopes for cure
Monday, 7 June 2010
M
o
n
d
a
y
,

7

J
u
n
e
135
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
Abu Dhabi
08:30 - 10:00 MO-08
Glaucoma Research Society Symposium:
The Impact of Glaucoma on Real Life
Symposium
Glaucoma
Chairs:
08:30 IL MO-08-01
Functional impairment in glaucoma
Pradeep Ramulu (Baltimore/USA)
08:40 IL MO-08-02
Psychology of glaucoma and blindness
Robert Dolgoff (Berkeley/USA)
08:50 IL MO-08-03
Assessing Quality of Life in Glaucoma Patients
09:00 IL MO-08-04
Patient Presentation Living with Glaucoma
Joseph Cohen (New York/USA)
09:10 IL MO-08-05
Patient Presentation Living with Glaucoma
Jeffrey Kassel (USA)
09:20 IL MO-08-06
Patient presentation living with glaucoma
Maria Gorby (Waterford/USA)
09:30 IL MO-08-07
How to start a glaucoma support group
Beverly Lindsell (Crows Nest/AUS)
09:40
Discussion
Abu Dhabi
10:30 - 12:00 MO-09
ESA Symposium: Hot Topics in Strabismus and
Amblyopia
Symposium
Strabismus
Chairs:
Seyhan B. zkan (Aydin/TR)
John P. Lee (London/UK)
Costantino Schiavi (Bologna/I)
10:30 IL MO-09-01
Accommodation and strabismus
Emilio Carlo Campos (Bologna/I)
10:40 IL MO-09-02
Amblyopia beyond acuity
John Sloper (London/UK)
10:50 IL MO-09-03
How do the extraocular muscles function do we
know all?
11:00 IL MO-09-04
Surgical strategies for incomitance
11:10 IL MO-09-05
Lateral rectus orbital wall fixation where and
how to use?
Seyhan B. zkan (Aydin/TR)
11:20 IL MO-09-06
Botulinum toxin versus surgery in treatment of
infantile esotropia
Rosario Gomez de Liano (Madrid/E)
12:30
Discussion
Abu Dhabi
14:00 - 15:30 MO-10
ISLRR Symposium: Vision on Low Vision Research
Symposium
Low Vision
Chairs:
Ger van Rens (Amsterdam/NL)
Gary S. Rubin (London/UK)
Veera Ramani (Coimbatore/IND)
14:00 IL MO-10-01
Rehabilitation and quality of life
Ruth M. A. van Nispen (Amsterdam/NL)
14:10 IL MO-10-02
Effects of CCTV training
Marloes C. Burggraaff (Amsterdam/NL)
14:20 IL MO-10-03
CCTV and vision related quality of life
14:30 IL MO-10-04
Low vision related research in the UK
Gary S. Rubin (London/UK)
Monday, 7 June 2010
M
o
n
d
a
y
,

7

J
u
n
e
136
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
14:40 IL MO-10-05
Development and use of the preferred retinal
locus
Michael D. Crossland (London/UK)
14:50 IL MO-10-06
DAI, outcome of a pilot study
Janna Bruijning (Amsterdam /NL)
15:00
Discussion
Abu Dhabi
16:00 - 17:30 MO-11
FEOph Symposium: Uveitis
Symposium
Chairs:
16:00 IL MO-11-01
HLA A29 and B27: Hypotheses and Links to Disease
Mechanism in Uveitis
Dominique Monnet (Paris/F)
16:10 IL MO-11-02
Th17 in the Pathogenesis of Uveitis
Rafael Grajewski (Gnheim/D)
16:20 IL MO-11-03
Aqueous Humor Neutrophil Gelatinase-associated
Lipocalin Levels in Patients with Acute Anterior
Uveitis
David Salom (Valencia/E)
16:30 IL MO-11-04
Aqueous Humor Analysis for the Differential
Diagnosis of Uveitis
16:40 IL MO-11-05
Occurence and Long-term Surgical Outcome in Sec-
ondary Glaucoma in Juvenile Idiopathic Arthritis-
associated Uveitis
Carsten Heinz (Mnster/D)
16:50 IL MO-11-06
Intraocular Lens Implantation in Juvenile
Idiopathic Arthritis-associated Uveitis
17:00 IL MO-11-07
Birdshot Chorioretinopathy: A Model for the
Long-term Follow-up of Patients with Posterior
Uveitis
Antoine Brezin (Paris/F)
17:10 IL MO-11-08
Differential Diagnosis of Anterior Uveitis
Philip I. Murray (Birmingham/UK)
17:20 IL MO-11-09
Adalimumab Therapy for Refractory Uveitis
A Multicenter Study
Manuel Daz-Llopis (Valencia/E)
Oslo
08:30 - 10:00 MO-12
Medical and Laser Treatment of Open-Angle
Glaucoma
Symposium
Glaucoma
Chairs:
Anton Bernhard Hommer (Vienna/A)
Anselm G. M. Jnemann (Erlangen/D)
08:30 IL MO-12-01
Who needs treatment, who needs observation only
08:40 IL MO-12-02
Medication is the first step in glaucoma treatment
08:50 IL MO-12-03
The different methods of Laser trabeculoplasty
09:00 IL MO-12-04
Don't forget iridoplasty in your therapeutic consid-
erations
Christoph Faschinger (Graz/A)
09:10 IL MO-12-05
Pressure independent treatment
09:20 IL MO-12-06
Combination therapy
Anastasios Konstas (Thessaloniki/GR)
09:30
Discussion
Monday, 7 June 2010
M
o
n
d
a
y
,

7

J
u
n
e
137
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
Oslo
10:30 - 12:00 MO-13
Panel: Predicting and Determining Rates of
Glaucoma Progression
Panel
Glaucoma
Chairs:
Jeffrey M. Liebmann (New York/USA)
Howard C. Cohn (Paris/F)
10:30 IL MO-13-01
Optic disc and Nerve fiber layer features that
predict future progression
Christopher A. Girkin (Birmingham/USA)
10:40 IL MO-13-02
Detection of retinal nerve fiber layer progression
Sek Tien Hoh (Singapore/SGP)
10:50 IL MO-13-03
Detection of optic disc progression
Remo Susanna, Jr (So Paulo/BR)
11:00 IL MO-13-04
Detection of visual field progression
Boel Bengtsson (Malm/S)
11:10 IL MO-13-05
Optic disc hemorrhage: Progression endpoint or
predictor?
Gustavo de Moraes (New York/USA)
11:20 IL MO-13-06
What constitutes clinically significant structural
progression?
Robert Fechtner (Newark/USA)
11:30 IL MO-13-07
What constitutes clinically significant functional
progression?
11:40 IL MO-13-08
Using structure and funciton information in
clinical practice
11:50
Discussion
Oslo
14:00 - 15:30 MO-14
Perimetry: Now and Future
Symposium
Glaucoma
Chairs:
14:00 IL MO-14-01
Do new psychophysical tests have any advantages
of SAP?
John G. Flanagan (Toronto/CDN)
14:10 IL MO-14-02
Visual field progression in glaucoma - definition
and assessment
Boel Bengtsson (Malm/S)
14:20 IL MO-14-03
The importance of signal-to-noise ratio in
measuring progression
Paul Artes (Halifax/CDN)
14:30 IL MO-14-04
The relation of visual field loss to quality of life
and disability
David P. Crabb (London/UK)
14:40 IL MO-14-05
STAT3 and retinal ganglion cell protection
Samuel Shao-Min Zhang (New Haven/USA)
14:50 IL MO-14-06
What can structure add to function in identifying
early glaucoma and progresssion?
15:00 IL MO-14-07
Visual field assessment in advanced glaucoma
15:10
Discussion
Monday, 7 June 2010
M
o
n
d
a
y
,

7

J
u
n
e
138
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
Oslo
16:00 - 17:30 MO-15
ALACCSA-R Symposium: Presbyopia Correcting
IOLS: The Best Option
Symposium
Cataract
Chairs:
Enrique Suarez (Caracas/Y)
16:00 IL MO-15-01
A New concept in Multifocal IOLs: The M Plus
Oculentis
16:10 IL MO-15-02
Presbyopia correction with Pseudoaccommodative
IOL
Enrique Suarez (Caracas/Y)
16:20 IL MO-15-03
Lens based reversal of presbyopia
16:30 IL MO-15-04
Comparative study of quality of vision with OKAS
in Multifocal IOLs vs Accommodative IOLs
Carlos Palomino (Madrid/E)
16:40 IL MO-15-05
TEK-CLEAR Clinical Results
Jose M. Vargas (Valencia/Y)
16:50 IL MO-15-06
Restor and Lasik
Angel Pineda Fernandez (Caracas/Y)
17:00 IL MO-15-07
Results with New Difractives Multifocal IOLs:
Restor +3 vs Tecnis
Luis Izquierdo (Lima/PE)
17:10 IL MO-15-08
Monocular Restor
Juan Manuel Paulin Huerta (Mexico City/MEX)
17:20 IL MO-15-09
Cataract Surgery: Challenging cases
Jorge Villar Kuri (Mexico City/MEX)
Room Madrid
08:30 - 10:00 MO-16
Vitreo-Retinal Considerations in Cataract Surgery
Symposium
Cataract
Chairs:
Stanislao Rizzo (Pisa/I)
08:30 IL MO-16-01
Bifocal lenses and the vitreoretinal surgeon
Stanislao Rizzo (Pisa/I)
08:40 IL MO-16-02
DR and CE: How to prepare the eye with diabetic
retinopathy for CE
08:50 IL MO-16-03
AMD and CE: Progression/prevention
09:00 IL MO-16-04
Pucker and phaco: combined or sequential
09:10 IL MO-16-05
CME after CE
09:20 IL MO-16-06
RD in high myopes after phaco
Irmingard Neuhann (Tbingen/D)
09:30
Discussion
Room Madrid
10:30 - 12:00 MO-17
Ocular Surface Reconstruction
Symposium
Chairs:
Harminder S. Dua (Nottingham/UK)
Graziella Pellegrini (Modena/I)
10:30 IL MO-17-01
Oral mucosa cells for ocular surface reconstruction
Monday, 7 June 2010
M
o
n
d
a
y
,

7

J
u
n
e
139
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
10:40 IL MO-17-02
Decision making for ocular surface reconstruction
Bjrn Bachmann (Erlangen/D)
10:50 IL MO-17-03
The role of amniotic membrane in ocular surface
reconstruction
Harminder S. Dua (Nottingham/UK)
11:00 IL MO-17-04
Principles and perspectives of cell based ocular
surface reconstruction
11:10 IL MO-17-05
Ex vivo expanded limbal stem cells for ocular
surface reconstruction
Paolo Rama (Venice/I)
11:20 IL MO-17-06
Bridging anterior and posterior ocular surfaces
Iqbal Ahmad (New Haven/USA)
11:30
Discussion
Room Madrid
14:00 - 15:30 MO-18
Tumors of the Ocular Surface
Symposium
Chairs:
14:00 IL MO-18-01
Epidemiology of conjunctival melanoma
14:10 IL MO-18-02
Management of conjunctival melanoma
14:20 IL MO-18-03
Management of conjunctival carcinoma
14:30 IL MO-18-04
Why I prefer 5-FU for topical chemotherapy
Edoardo Midena (Padova/I)
14:40 IL MO-18-05
Why I prefer mitomycin for topical chemotherapy
14:50 IL MO-18-06
Ocular surface reconstruction
15:00
Discussion
Room Madrid
16:00 - 17:30 MO-19
Astigmatism Management in Cataract Surgery
Symposium
Cataract
Chairs:
16:00 IL MO-19-01
Current options of astigmatism correction in
cataract surgery: a critical overview
16:20 IL MO-19-02
On-axis versus temporal clear corneal incisions
Which to choose?
Edmund Borasio (London/UK)
16:40 IL MO-19-03
Toric IOLs: a wide variety of options
17:00 IL MO-19-04
Changes in astigmatism after congenital cataract
surgery and IOL implantation
Abraham Spierer (Tel-Hashomer/IL)
17:20
Discussion
Room Hong Kong
08:30 - 10:00 MO-20
SOE Symposium: Slips, Tricks and Falls in Cataract
Surgery
Symposium
Cataract
Chairs:
08:30 IL MO-20-01
Basic phacoemulsification
David Allen (Newcastle on Tyne/UK)
Monday, 7 June 2010
M
o
n
d
a
y
,

7

J
u
n
e
140
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
08:50 IL MO-20-02
IOL calculation after refractive surgery
Wolfgang Haigis (Wrzburg/D)
09:10 IL MO-20-03
Basic phacoemulsification
Khiun F. Tjia (Zwolle/NL)
09:30 IL MO-20-04
Calibration, sizing and centration of the anterior
capsulorhexis
09:50
Discussion
Room Hong Kong
10:30 - 12:00 MO-21
DNA Viruses and the Eye
Symposium
Chairs:
Thomas J. Liesegang (Jacksonville/USA)
G. M. G. M. Verjans (Rotterdam/NL)
10:30 IL MO-21-01
CMV retinitis, clinical
Gary N. Holland (Los Angeles/USA)
10:40 IL MO-21-02
Adenoviruses of the Cornea; Virology and
Treatment
Eric G. Romanowski (Pittsburgh/USA)
10:50 IL MO-21-03
Fundamentals of herpetic keratitis
G. M. G. M. Verjans (Rotterdam/NL)
11:00 IL MO-21-04
Diagnosis and treatment of herpetic keratitis,
acyclivir resistance
Lies Remeijer (Rotterdam/NL)
11:10 IL MO-21-05
Herpes zoster Ophthalmicus and Complications
11:20 IL MO-21-06
Herpes Zoster: Epidemiology, risk factors and pre-
vention through vaccination
Thomas J. Liesegang (Jacksonville/USA)
11:30
Discussion
Room Hong Kong
14:00 - 15:30 MO-22
AOGS Symposium: Normal-tension Glaucoma
Symposium
Glaucoma
Chairs:
Makoto Araie (Tokyo/J)
Franz H. Grus (Mainz/D)
Felipe A. Medeiros (La Jolla/USA)
14:00 IL MO-22-01
Ocular blood flow in normal tension glaucoma
Leopold Schmetterer (Vienna/A)
14:10 IL MO-22-02
Managing Glaucoma in Patients with
Keratoprostheses
14:20 IL MO-22-03
Genetic aspect of normal tension glaucoma
Kenji Kashiwagi (Yamanashi/J)
14:30 IL MO-22-04
Central corneal thickness in NTG: Measurement
error or risk factor?
Michael Kook (Seoul/ROK)
14:40 IL MO-22-05
Autoimmune phenomena in glaucoma
14:50 IL MO-22-06
IOP dynamics in NTG: Water loading and postural
change
15:00 IL MO-22-07
Treatment of normal-tension glaucoma IOP
Jian Ge (Guangzhou/CN)
15:10 IL MO-22-08
Treatment of normal tension glaucoma Non IOP
Catherine Liu (Taipei/TJ)
15:20
Discussion
Monday, 7 June 2010
M
o
n
d
a
y
,

7

J
u
n
e
141
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
Room Hong Kong
16:00 - 17:30 MO-23
Panel: Vision Rehabilitation Demands and Chal-
lenges in the 21st Century
Panel
Low Vision
Chairs:
August Colenbrander (Novato/USA)
Klaus Rohrschneider (Heidelberg/D)
16:00 IL MO-23-01
Comprehensive Vision Rehabilitation
August Colenbrander (Novato/USA)
16:10 IL MO-23-02
Rehabilitation Guidelines for General Ophthalmol-
ogists; Development and Follow-up
16:20 IL MO-23-03
Comprehensive Low Vision Rehabilitation in Ger-
many Now and in the Future
Klaus Rohrschneider (Heidelberg/D)
16:30 IL MO-23-04
Low Vision Rehabilitation Model at the L V Prasad
Eye Institute, India
Vijaya Kumari Gothwal (Hyderabad/IND)
16:40 IL MO-23-05
Bridging gaps in Low Vision Care in the Philippines
Sheila Santos-Jimenez (Quezon City/RP)
16:50 IL MO-23-06
Successes in the Development Low Vision Services
in Latin America
Rosario Espinoza (Lima/PE)
17:00 IL MO-23-07
Expanding Low Vision benefits in Turkey
Kardircan Keskinbora (Tekirdag/TR)
17:10 IL MO-23-08
Multidisciplinary Rehabilitation and Resident
Education
Mary Lou Jackson (Boston/USA)
17:20
Discussion
VIP Lounge 1
10:30 - 12:00 MO-24
Retina: Surgical Therapy 1
Free Paper
Retina
Chairs:
Tatsiana Imshenetskaya (Minsk/BY)
Kyoko Ohno-Matsui (Tokyo/J)
10:30 FP MO-24-01
Pars-plana vitrectomy alone versus vitrectomy
with scleral buckling for primary rhegmatogenous
pseudophakic retinal detachment
Khalifa Al Sawidi (Triploi/LAR)
10:37 FP MO-24-02
The clinical outcomes of short-term heavy silicon
oil (Densiron-68) intraocular tamponade.
Li-bo Ma, Tie-hong Chen, Zhi Zhng, Jian-dong
Zhang, Ju Wen (Shenyang/CN)
10:44 FP MO-24-03
Surgical outcomes in vitrectomy for myopic
foveoschisis
Michael Engelbert, D. Kar, S. Chang (New York/USA)
10:51 SL MO-24-04
Rhegmatogenous retinal detachment: philosophy
of surgical delicacy
Tatsiana Imshenetskaya, Volha Yarmak (Minsk/BY)
10:58 FP MO-24-05
Postoperative results of vitrectomy with ICG
assisted ILM-peeling from idiopathic macular
holes stage 4 and with baseline visual acuity 0,2
Mete Gk, Harun Akgl, Michael Freisthler,
Theodora Gkika, Norbert Bornfeld (Essen/D)
11:05 FP MO-24-06
Staining properties, anatomical and functional
outcome in Brilliant Blue G Chromovitrectomy
Paul Bernhard Henrich (Basel/CH)
11:12 FP MO-24-07
Surgical Management of Coats disease presen-
tation of a modified technique
Sabine Aisenbrey, Daniela Suesskind, K. Ulrich
Bartz-Schmidt (Tbingen/D)
11:19 FP MO-24-08
Randomized Trial of Transpupillary Thermotherapy
Versus Sham Treatment for Central Serous
Chorioretinopathy (TTT4CSC): Long-term results
Harvey Uy (Makati City/RP)
Monday, 7 June 2010
M
o
n
d
a
y
,

7

J
u
n
e
142
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
11:26 FP MO-24-09
Combined Cataract Extraction, PCIOL, Pars Plana
Vitrectomy, Retisert Implant, and Pars Plana Tube
in Chronic Advanced Non-Infectious Uveitis with
Cataract and Glaucoma. The CPR-PT Procedure
Tamer Mahmoud (Troy/USA)
11:33 FP MO-24-10
"Re-flow" surgical strategy with one pars plana
port for the treatment of epiretinal disesases:
sutdy of the endothelial cells loss
Cesare Forlini, Paolo Rossini, Matteo Forlini
(Ravenna/I)
11:40
Discussion
VIP Lounge 1
16:00 - 17:30 MO-32
Retina: Medical Therapy 1
Free Paper
Retina
Chairs:
16:00 FP MO-32-01
Benefits of Early Treatment with Dexamethasone
Intravitreal Implant in Patients with Macular
Edema due to BRVO or CRVO over 12 Months
Rubens Belfort, Jeffrey Heier, Julia A. Haller,
Mark S. Blumenkranz, Francesco Bandello,
Anat Loewentstein, Young-Hee Yoon, Jenny Jiao,
Xiao-Yan Li, Scott M. Whitcup (Sao Paulo/BR,
Stanford/USA, Milano/I, Philadelphia/USA,
Tel Aviv/IL, Boston/USA, Irvine/USA, Seoul/ROK)
16:07 FP MO-32-02
12-month Evaluation of Dexamethasone
Intravitreal Implant in Patients with Macular
Edema due to Branch Retinal Vein Occlusion
Anat Loewenstein, Julia A. Haller, Mark S. Blu-
menkranz, Francesco Bandello, Rubens Belfort, Jr.,
Mark Gillies, Jeffrey Heier, Young-Hee Yoon,
Jenny Jiao, Xiao-Yan (Joanne) Li, Scott M. Whitcup
(Tel-Aviv/IL, Stanford/USA, Milano/I, Sao Paulo/BR,
Vienna/A, Philadelphia/USA, Sydney/AUS,
Boston/USA, Seoul/ROK, Irvine/USA)
16:14 FP MO-32-03
Prospective Study of Intravitreal Ranibizumab as a
Treatment for Decreased Visual Acuity Secondary
to Central Retinal Vein Occlusion
Richard Spaide, Louis Chang, James Klancnik,
Lawrence Yannuzzi, John Sorenson, Jason Slakter
(New York/USA)
16:21 FP MO-32-04
Verteporfin photodynamic therapy in combination
with ranibizumab or alone versus ranibizumab
monotherapy for symptomatic macular polypoidal
choroidal vasculopathy (PCV): Anatomical out-
comes of the EVEREST study
Tock Han Lim, on behalf of the EVEREST study
group (Singapore/SGP)
16:28 FP MO-32-05
Peribulbar Triamcinolone for Diabetic Macular
Edema: Efficacy and Effects on Glycemic Control
Jelliti Bechir, Attia Sonia, Kahloun Rym,
Ammari Wafa, Messaoud Riadh, Moncef Khairallah
(Monastir/TN)
16:35 FP MO-32-06
A randomized clinical trial to compare the efficacy
and safety of isolated or combined intravitreal
injection of Triamcinolone Acetonide and
Bevacizumab for diabetic macular edema
Hermelino Oliveira Neto, Rafael Ernane Andrade,
Cristina Muccioli, Antonio Marcelo Casella,
Mario Junqueira Nobrega, Michel Eid Farah,
Rubens Belfort (Feira de Santana-Bahia/BR)
16:42 FP MO-32-07
Comparison of intravitreally applied Bevacizumab
and Triamcinolone on diabetic macular edema
Sonja G. Prager, Katharina Kriechbaum,
Georgios Mylonas, Georg Rainer, Ursula Schmidt-
Erfurth (Vienna/A)
16:49 FP MO-32-08
Does the Prevention of Dark adaptation affect the
course of Diabetic Macular Oedema?
Sobha Sivaprasad, Sreedhar Jyothi, Geoffrey Arden
(London/UK)
16:56 FP MO-32-09
Syringes, needles, and techniques for intravitreal
injections in retinal pharmacotherapy
Eduardo Rodrigues, Octaviano Magalhaes,
Eduardo Dib, Fernando M. Penha, Carsten H. Meyer,
Quan D. Nguyen, Mauricio Maia, Michel Eid Farah
(Florianopolis/BR, So Paulo/BR, Bonn/D,
Baltimore/USA)
17:03 FP MO-32-10
Intravitreal Growth Factors in AMD, DME and RVO
Michael Koss, Marcel Pfister, Florian Rothweiler,
Jindrich Cinatl, Martin Michaelis, Frank Koch
(Frankfurt/D)
17:10
Discussion
Monday, 7 June 2010
M
o
n
d
a
y
,

7

J
u
n
e
143
Monday, 7 June 2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
WOC
2010
M
o
n
d
a
y
,

7

J
u
n
e
144
09:41 FP MO-25-10
B Guided Versus Contact A-mode Biometry for
Accurate Measurement of Axial Length and I.O.L
Power Calculation in Siliconized Eyes
Mervat H Shalaby, Khaled G. Abu El Einen,
Hoda Elshiwy Elshiwy (Cairo/ET)
09:48
Discussion
VIP Lounge 2
10:30 - 12:00 MO-62
NGO/Private Sector Partnerships: WIN/WIN or
Conflicting Agendas?
Symposium
Chairs:
Johannes Trimmel (Vienna/A)
Amos Kibata (Uheal/EAK)
10:30 IL MO-62-01
Introduction to the Session
10:35 IL MO-62-02
Introduction to the Speakers
10:40 IL MO-62-03
Corporate Social Responsibility-an opportunity for
NGO/Private Sector partnerships
Roy Acosta (Fort Worth/USA)
10:50 IL MO-62-04
How Do You Bridge Competing Interests?
Joanna Conlon (London/UK)
11:00 IL MO-62-05
How Private Ophthalmologist Engage with NGO
the Kikuyu Eye Unit Model
11:10 IL MO-62-06
How NGOs Participate in Developing Ophthalmic
Markets
John M. Barrows (Kensington/USA)
11:20 IL MO-62-07
Key Successes and Never Dos in NGO/Private
Sector Partnerships
Peter Ackland (London/UK)
11:30 IL MO-62-08
Question / Answer Session
VIP Lounge 2
08:30 - 10:00 MO-25
Cataract/Biometry 2
Free paper
Cataract
Chairs:
Zdravko Mandic (Zagreb/HR)
Walter Stark (Baltimore/USA)
08:30 SL MO-25-01
Surgical technique for suture fixation of an acrylic
intraocular lens in the absence of capsule support
Walter Stark (Baltimore/USA)
08:39 FP MO-25-02
Correction of medium-to-high myopia and
myopic astigmatism with AcrySof Cachet phakic
intraocular lens and limbal relaxing incisions
Thomas Kohnen, Oliver Klaproth (Frankfurt/D)
08:46 SL MO-25-03
Treatment of lens dislocation
08:55 FP MO-25-04
Comparative study of corneal endothelial
protection characteristics between dispersive and
adaptive OVDs
Randall Olson (Salt Lake City/USA)
09:02 FP MO-25-05
Vitrectomy and Retropupillar Artisan IOLs in the
Management of Aphakia and Luxated Cataract
with Insufficient Zonular Support
Justus G. Garweg, Markus Halberstadt (Bern/CH)
09:09 SL MO-25-06
Contemporary aproach to the combined glaucoma
and cataract procedure
Zdravko Mandic (Zagreb/HR)
09:18 FP MO-25-07
Comparison of torsional mode and conventional
ultrasound mode phacoemulisification for cataract
surgery
Jing Ji, Min Luo, Xianqun Fan, Yilei Pan, Jianfeng Lu
(Shanghai/CN)
09:25 SL MO-25-08
Coaxial MICS an important step in phacoemulsi-
fication development
Wojciech Omulecki (L
dz/PL)
09:34 FP MO-25-09
outcome of hole and chop technique phaco on
hard cataracts
Keembiyage Dayawansa (Kandy/CL)
145
Monday, 7 June 2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
WOC
2010
M
o
n
d
a
y
,

7

J
u
n
e
14:42 FP MO-27-07
Comparison of microperimetry and conventional
computer perimetry in patients with macular hole
Alexander Shpak, Galina Kachalina, Elena Pedanova
(Moscow/RUS)
14:49 FP MO-27-08
Optical coherence tomography findings in shaken
adult syndrome
Volha Yarmak, Tatsiana Imshenetskaya, Galina
Vashkevich, Vladimir Rubis (Zaslavl/BY, Minsk/BY)
14:56 FP MO-27-09
Maculopathy After Long-Term Chloroquine
Treatment A Microperimetry and MF-ERG-Study
Christina Springer, Petra Weimer, Dorothea
Thiemeyer, Regina Max, Klaus Rohrschneider,
Friederike Mackensen (Zurich/CH, Heidelberg/D)
15:03 FP MO-27-10
Visual prognosis of Purtschers-retinopathy-like
central retinal artery occlusion
Hiroyuki Iijima (Yamanashi/J)
15:10
Discussion
VIP Lounge 2
16:00 - 17:30 MO-28
Trauma
Free Paper
Trauma
Chairs:
16:00 FP MO-28-01
The influence of alcohol abuse on the etiology and
severity of open globe injuries
Florian Rfer, Andrea Peters, Alexa Klettner,
Felix Treumer, Johann Roider (Kiel/D)
16:07 SL MO-28-02
War and Eye Trauma in West Darfur (Sudan)
Mohamed Siddig (Elafuon/SUD)
16:16 FP MO-28-03
Intraocular metal foreign body: personal
experience
16:23 FP MO-28-04
Is There Ocular Primary Blast Injury?
Richard Blanch, Robert A. H. Scott, David R. J. Snead
(Birmingham/UK)
VIP Lounge 2
14:00 - 15:30 MO-27
Free Paper
Retina
Chairs:
Peter Walter (Aachen/D)
Hendrik P. N. Scholl (Baltimore/USA)
14:00 FP MO-27-01
Detection of Drusen using Polarization-sensitive
Optical Coherence Tomography
Ferdinand Georg Schlanitz, Bernhard Baumann,
Christian Ahlers, Sabine Schriefl, Tobias Spalek,
Isabelle Golbaz, Michael Pircher, Erich Gtzinger,
Christoph Hitzenberger, Ursula Schmidt-Erfurth
(Vienna/A)
14:07 FP MO-27-02
Automated detection and quantification of hard
exudates in diabetic macular edema using polar-
ization sensitive optical coherence tomography
Jan Lammer, Matthias Bolz, Bernhard Baumann,
Michael Pircher, Barbara Wetzel, Christoph
Hitzenberger, Ursula Schmidt-Erfurth (Vienna/A)
14:14 FP MO-27-03
Retinal Cellular Imaging using a New Clinical Ultra
High Resolution Confocal Microscope with Ultra
High Speed Spectral Domain OCT
Richard Rosen, Patricia Garcia, Gennady Landa,
Mark Hathaway, John Rogers, Rishard Weitz,
Thomas Muldoon, Ronald Gentile, Alfonso Ponce,
Joseph Walsh (New York/USA)
14:21 FP MO-27-04
Spectral domain OCT in central serous
chorioretinopathy description of retinal changes
Veronique Valet, Mathias Maier, Chris Patrick
Lohmann (Munich/D)
14:28 FP MO-27-05
Spectral OCT observations of non full thickness
defects of the fovea
Janusz Michalewski, Zofia Michalewska,
Dominik Odrobina, Slawomir Cisiecki,
Krzysztof Dziegielewski, Zbigniew Pikulski,
Jerzy Nawrocki (L
dz/PL)
14:35 FP MO-27-06
Structure-Function Correlation of the Human
Central Retina
Hendrik P. N. Scholl, Peter Charbel Issa, Eric Trger,
Robert P. Finger, Frank G. Holz, Robert Wilke
(Baltimore/USA, Bonn/D)
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
16:30 FP MO-28-05
A comparitive study of visual outcome, ocular
survival and complications of open globe injuries
in age groups of <18 yr and >18 year old individuals
Lavanya Rao, Krishna Rao, Manali Hazarika,
Sulatha Bhandary (Manipal/IND)
16:37 FP MO-28-06
Location of the canalicular laceration and the
clinical outcome after surgical repair
Shi Wodong (Shanghai/CN)
16:44 FP MO-28-07
Phakoanaphylactic Endophthalmitis 67 years after
trauma
Fabian Hhn, Alireza Mirshahi, Lars-Olof
Hattenbach (Mannheim/D, Ludwigshafen/D,
Mainz/D)
16:51 FP MO-28-08
Multi-local exposure within the Ex Vivo Eye
Irritation Test (EVEIT)
Norbert Schrage, M. Frentz, F. Spler (Kln/D)
16:58 FP MO-28-09
Long-term results after endonasal microsurgical
decompression of the optic nerve
Hartmut Mbius, Lothar Bauer, Hans-Jrgen
Welkoborsky, Burkhard Wiechens (Hannover/D)
17:05 FP MO-28-10
Vitreous metastasis in cutaneous malignant
melanoma
Isabella Rcker, Fariba Mohammadi Rad,
Christine Frster, Ludwig Wilkens, Burkhard
Wiechens (Hannover/D)
17:12 SL MO-28-11
Post-traumatic eyelid repair
Brigita Drnovsek-Olup (Ljubljana/SI)
17:21
Discussion
08:30 - 10:00 MO-29
Club Jules Gonin Symposium: Surgical
Management of Macular Diseases
Symposium
Retina
Chairs:
08:30 IL MO-29-01
Anti-VEGF therapy and surgery for PDR
08:40 IL MO-29-02
Anti-VEGF therapy and surgery for ROP
08:50 IL MO-29-03
Intraoperative use of Plasmin for vitreoretinal
surgery
09:00 IL MO-29-04
Perioperative use of steroids and lasers in
vitreoretinal surgery
Mark S. Blumenkranz (Stanford/USA)
09:10 IL MO-29-05
Pharmacological adjuvants in retinal detachment
surgery
09:20 IL MO-29-06
Role of t-PA in vitreoretinal surgery
09:30 IL MO-29-07
State of the Art management of endophthalmitis
09:40
Discussion
10:30 - 12:00 MO-30
Surgical Therapy of Keratoconus
Symposium
Chairs:
Florian Birnbaum (Freiburg/D)
Edward Wylegala (Katowice/PL)
10:30 IL MO-30-01
Crosslinking treatment to stopp keratoconus
progression
Philip Maier (Freiburg)
10:40 IL MO-30-02
Excimer laser assisted penetrating keratoplasty in
advanced keratoconus
10:50 IL MO-30-03
Deep anterior lamellar keratoplaty vs. penetrating
keratoplasty in advanced keratoconus
Monday, 7 June 2010
M
o
n
d
a
y
,

7

J
u
n
e
146
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
11:00 IL MO-30-04
Femtosecondlaser assisted penetrating
keratoplasty in keratoconus
11:10 IL MO-30-05
Intracorneal ring segments in keratoconus patients
Efekan Coskunseven (Istanbul/TR))
11:20 IL MO-30-06
Treatment of keratoconus recurrence
TBA
11:30
Discussion
14:00 - 15:30 MO-31
Glaucoma: Surgical Therapy 1
Free Paper
Glaucoma
Chairs:
14:00 FP MO-31-01
Investigation of the Efficacy of Selective Laser
Trabeculoplasty (=SLT) particularly its health-
economic Aspects. Presentation of 12 Month
Postoperative Results
Juergen Reese, Mark Tomalla (Duisburg/D)
14:07 FP MO-31-02
Selective Laser Trabeculoplasty (SLT) in Patients
with inadequate Reduction of Intraocular Pressure
under maximum tolerated Drug Therapy.Results
12-month postoperative
Cornelia Hirn, Sandrine Zweifel, Annette Hediger,
Marc Tteberg-Harms, Jens Funk (Zurich/CH)
14:14 FP MO-31-03
Comparision of Trabeculectomy With and Without
Amniotic Membrane A Pilot Study
14:21 FP MO-31-04
The outcome of combined endoscopic cyclophoto-
coagulation and phacoemulsification in treatment
of medically controlled primary open angle glau-
coma patients
Hon Seng Wong , Ropilah Abdul Rahman
(Kuala Lumpur/MAL)
14:28 FP MO-31-05
How does viscocanaloplasty work? In vivo anterior
segment ultrasound to explain the mechanism.
Jan Olivier, Robert Stegmann (Pretoria/ZA)
14:35 FP MO-31-06
Conventinal Trabeculectomy versus ExPress
Shunt(R) Filtering surgery both with 5-FU: a
prospective clinical ramdomized trial
Gangolf Sauder (Stuttgart/D)
14:42 FP MO-31-07
Does the size of the subconjunctival preparation
influence the outcome of trabeculectomy with
mitomycin C?
Joanna Wasielica-Poslednik, Daniel Herzog,
Esther Hoffmann, Shakhsanam Aliyeva,
14:49 FP MO-31-08
Outcome of Repeat Trabeculectomies
Carpi Olali, Alan Rotchord, Anthony J. King
(Boston/UK)
14:56 FP MO-31-10
Vitrectomy does not influence the incidence of
ocular hypertension or open-angle glaucoma
a 5-year follow-up
Alice Yu, Wolfgang Brummeisl, Anselm Kampik,
Ulrich Welge-Len (Munich/D, Erlangen/D)
15:03 FP MO-31-11
Optimizing the detection of visual field change
using automated pointwise linear regression
analysis: the truncated trend-event based
approach
Gustavo V. De Moraes, C. Tello, Robert Ritch, J. M.
Liebmann (New York/USA)
15:10
Discussion
16:00 - 17:30 MO-68
Retina: AMD 2
Free Paper
Retina
Chairs:
Liga Radecka (Riga/LV)
Florian Sulzbacher (Vienna/A)
16:00 SL MO-68-01
ARMD and Cataract Surgery
Liga Radecka (Riga/LV)
16:09 FP MO-68-02
Safety profiles of diabetic versus non-diabetic
AMD patients in randomized controlled clinical
studies with ranibizumab
Frank G. Holz, Gabriela Burian, Andreas Weichsel-
berger, Yehia Hashad (Bonn/D, Basel/D)
Monday, 7 June 2010
M
o
n
d
a
y
,

7

J
u
n
e
147
Monday, 7 June 2010
WOC
2010
148
M
o
n
d
a
y
,

7

J
u
n
e
17:05 FP MO-68-10
One-Years Treatment Result of Chinese with
Neovascular Age-related Macular Degeneration
with Intra-vitreal Ranibizumab in Clinical Setting
Thomas Tai Ka Fat (Hong Kong/HK)
17:12
Discussion
08:30 - 10:00 MO-33
Intraocular Tumors
Symposium
Pathology
Chairs:
08:30 IL MO-33-01
Melanoma
08:40 IL MO-33-02
Ciliary body tumors
08:50 IL MO-33-03
Primary intraocular lymphoma
09:00 IL MO-33-04
Retinoblastoma
Ralph C. Eagle (Philadelphia /USA)
09:10 IL MO-33-05
Mimickers of intraocular tumors
09:20 IL MO-33-06
Metastatic intraocular tumors
Rubens Belfort Neto (So Paulo/BR)
09:30 IL MO-33-07
Mystery intraocular tumors
09:40
Discussion
16:16 FP MO-68-03
SDOCT-morphology and the corresponding
retinal function in neovascular age-related
macular degeneration (nAMD)
Florian Sulzbacher, Christopher Kiss, Marion Munk,
Stefan Eisenkoelbl, Stefan Sacu, Ursula Schmidt-
Erfurth (Vienna/A)
16:23 FP MO-68-04
Safety and efficacy of OZURDEX (Dexametha-
sone Intravitreal Implant) as adjunctive therapy
to Lucentis in patients with Choroidal Neovascu-
larization (CNV) secondary to Age-Related Macular
Degeneration (AMD)
Baruch Kuppermann, Michael Singer,
Dov Weinberger, Anat Loewenstein, Ching-chi Liu,
Jean Lou, Xiao-Yan (Joanne) Li, Scott M. Whitcup
(Irvine/USA, Tel-Aviv/IL)
16:30 FP MO-68-05
Targeting the alternative pathway of complement
in AMD with a factor D selective antibody
Menno van Lookeren Campagne, Kenneth J.
Katschke, Ping Wu, Christian Wiesmann,
Robert F. Kelley, Kelly Loyet, Laura DeForge,
Philip E. Hass, Peter Haughney, Lisa A. Damico
(San Francisco/USA)
16:37 FP MO-68-06
Microperimetry as a method for monitoring
macular function in patients with dry age-related
macular degeneration
Yuri Astakhov, Alla Lisochkina, Pavel Nechiporenko
(Saint-Petersburg/RUS)
16:44 FP MO-68-07
Activity Loss Predicts Cognitive Decline in
Age-Related Macular Degeneration (AMD)
William Tasman, Barry Rovner, Robin Castin
(Wyndmoor/USA, Philadelphia/USA)
16:51 FP MO-68-08
Senile Local Eye Amyloidosis Risk Factor for
Age-related Macular Degeneration
Victor Ermilov (Volgograd/RUS)
16:58 FP MO-68-09
A prospective study on different methods of treat-
ment for choroidal neovascularization. The efficacy
of verteporfin photodynamic therapy (PDT),
intravitreal bevacizumab and transpupillary
thermo therapy (TTT) in patients with neovascular
AMD
Michal Nowak, Piotr Jurowski, Roman Gos,
Miroslaw Pastuszka, Andrzej Kapica, Janusz
Smigielski (L
dz/PL)
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
Monday, 7 June 2010
WOC
2010
14:00 - 15:30 MO-35
Cornea/External Disease: Diagnostics
Free Paper
Chairs:
Eric Spierings (Utrecht/NL)
14:00 FP MO-35-01
Multicenter Study of the Herpes Simplex Virus
Immunochromatography Kit for the Diagnosis of
Herpetic Epithelilal Keratitis
Yoshitsugu Inoue, Yoshikazu Shimomura,
Masahiko Fukuda, HSV kit study group (Yonago/J,
Osaka-Sayama/J)
14:07 FP MO-35-02
Impact of voriconazole in fungal keratitis in East-
ern India
Suman Saha, Jayangshu Sengupta,
Debdulal Banerjee, Archana Khetan (Kolkata/IND)
14:14 FP MO-35-03
Intraocular pressure survey in patients who
underwent lamellar keratoplasty
Janiszewska Dominika, Edward Wylegala,
Anna Nowinska, Dariusz Dobrowolski
(Katowice/PL)
14:21 FP MO-35-04
Distribution of antigen presenting cells in human
corneas with different pathologic entities
correlation of confocal in vivo microscopy and
immunofluorescence histochemistry
Marc Mackert, Nicole Kranebitter, Elisabeth
Messmer, Martin Grterich, Daniel Kook,
Armin Wolf, Anselm Kampik, Eveline Irschick,
Wolfgang Mayer (Munich/D)
14:28 FP MO-35-05
Confocal microscopic evaluation of corneal
changes after riboflavin-UVA corneal collagen
cross-linking for keratoconus
Laurence Lim, Roger Beuerman, Li Lim, Donald Tan
(Singapore/SGP)
14:35 FP MO-35-06
Repeatability of corneal wavefront measurements
with the Orbscan IIz topographer in normal and
keratoconus eyes
Yasemin Tanyildizi (Frankfurt/D)
14:42 FP MO-35-07
Detection of subclinical keratconus using conven-
tional and corneal wavefront-based metrics
Jens Bhren, Daniel Kook, Thomas Kohnen
(Frankfurt/D)
10:30 - 12:00 MO-34
New Diagnostic and Therapeutic Aspects of Orbital
Diseases
Symposium
Chairs:
James A. Katowitz (Philadelphia/USA)
10:30 IL MO-34-01
Ab-externo lateral wall decompression for thyroid
eye disease
10:40 IL MO-34-03
The significance of Orbit Imaging particulary
with regard to differential diagnosis and therapy
planing of orbital diseases
Volker Hingst (Rostock/D)
10:50 IL MO-34-04
Compressive neuropathy in thyroid eye disease
diagnostic features and therapeutic strategies
Nicole Fichter (Olten/CH)
11:00 IL MO-34-05
Orbital space occupying lesions decision
orientated strategies
11:10 IL MO-34-06
Innovative uses for dermis fat grafting in orbital
reconstruction
James A. Katowitz (Philadelphia/USA)
11:20 IL MO-34-07
Angiodysplasia of the Orbit or Complications
of Orbital Surgery How to Avoid
Serge Morax (Neuilly-sur-Seine/F)
11:30
Discussion
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
149
M
o
n
d
a
y
,

7

J
u
n
e
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
14:49 FP MO-35-08
Peculiarities of corneal changes of patients with
diabetes mellitus depending on the compensation
of diabetes
Olesya Zavoloka, Pavlo Bezditko,
Maryna Shchadnykh, Darya Zubkova (Kharkiv/UA)
14:56 FP MO-35-09
Clinical and ultrasound biomicroscopy (UBM) fea-
tures predictive of growth in iris melanocytic lesions
Gian Paolo Giuliari, Hatem Krema, E. Rand Simpson,
Charles J. Pavlin (Toronto/CDN)
15:03 SL MO-35-10
Experience of corneal collagen cross-linking with
riboflavin and ultraviolet-A light for progressive
keratoconus: one year follow-up in Pakistani
population
Wajid Khan (Rawalpindi/PK)
15:10
Discussion
16:00 - 17:30 MO-36
Ocular Pharmacology: Preclinical Safety and
Efficacy Testing
Symposium
Chairs:
Peter Szurman (Tbingen/D)
Martin S. Spitzer (Tbingen/D)
16:00 IL MO-36-01
Preclinical drug evaluation more than a simple
biocompatibility testing?
16:10 IL MO-36-02
Ocular cell culture the cheap and easy way to
test preclinical safety and efficacy
Martin S. Spitzer (Tbingen/D)
16:20 IL MO-36-03
VEGF Inhibitor efficacy can cell culture experi-
ments tell us which of them is the best?
16:30 IL MO-36-04
Penetration and distribution of VEGF-Inhibitors
after intravitreal injection
Swaantje Peters (Lbeck/D)
16:40 IL MO-36-05
Superfused isolated bovine retina testing intrav-
itreal drugs in-vivo without sacrificing animals
Matthias Lke (Lbeck/D)
16:50 IL MO-36-06
In-vivo veritas animal models for ocular drug
testing
Peter Heiduschka (Tbingen/D)
17:00 IL MO-36-07
Optic nerve crush testing Evaluation of neuro-
protective drugs
Frank Schttauf (Tbingen/D)
17:10
Discussion
Hall 3
08:30 - 10:00 MO-37
Corneal Approaches for Addressing Presbyopia
Chairs:
08:30 IL MO-37-01
Corneal Techniques (Monovision)
08:45 IL MO-37-02
Corneal Pseudoaccommodation
09:00 IL MO-37-03
Presby-Lasik
09:15 IL MO-37-04
Intracorneal Lenses
09:30 IL MO-37-05
Small Aperture Devices
09:45
Discussion
Monday, 7 June 2010
M
o
n
d
a
y
,

7

J
u
n
e
150
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
Hall 3
10:30 - 12:00 MO-38
Corneal Laser Refractive Surgery
Chairs:
10:30 IL MO-38-01
Femtosecond Laser Technology
10:40 IL MO-38-02
Excimer Laser Technology
10:50 IL MO-38-03
Femtosecond Laser: More Than a Flap Maker
Holger Lubatschowski (Hannover/D)
11:00 IL MO-38-04
Eye-tracking
11:10 IL MO-38-05
LASIK Techniques and Complications
11:20 IL MO-38-06
Surface Techniques and Complications
11:30 IL MO-38-07
Ectasia
11:40
Discussion
Hall 3
14:00 - 15:30 MO-39
Corneal Physiology and Biomechanics
Chairs:
14:00 IL MO-39-01
Biomechanics
14:10 IL MO-39-02
Accommodation and presbyopia
Adrian Glasser (Houston/USA)
14:20 IL MO-39-03
Normal wavefront error as function of age, pupil
size and anatomy
14:30 IL MO-39-04
Retinal image quality in refractive surgery
14:40 IL MO-39-05
Laser tissue interaction
14:50 IL MO-39-06
New advances in corneal imaging
Mitchell P. Weikert (Houston/USA)
15:00
Discussion
Hall 3
16:00 - 17:30 MO-40
Managing High Refractive Errors
Chairs:
16:00 IL MO-40-01
Phakic IOLs vs Corneal Refractive Surgery
16:10 IL MO-40-02
Angle-supported
16:20 IL MO-40-03
Iris-fixated
16:30 IL MO-40-04
Sulcus-fixated
16:40 IL MO-40-05
Phakic IOLs: Complications
Monday, 7 June 2010
M
o
n
d
a
y
,

7

J
u
n
e
151
Monday, 7 June 2010
WOC
2010
Hall 4/5
16:00 - 17:30 MO-64
Pterygium Surgery
Symposium
Chairs:
16:00 IL MO-64-01
Epidemiology and Etiology
16:16 IL MO-64-02
Current Understanding of Pterygium Pathogenesis
Nick Di Girolamo (Sydney/AUS)
16:32 IL MO-64-03
Mind the Gap Surgical Pearls for Primary and
Recurrent Pterygia
16:48 IL MO-64-04
EBM Review of Surgical Trials in Pterygia
Cordelia M. L. Chan (Singapore/SGP)
17:04 IL MO-64-05
Anti-angiogenic Treatment Modalities
17:14 IL MO-64-06
Management of Complications of Pterygium
Surgery
Hall 6
08:30 - 10:00 MO-49
Cicatrizing Conjunctivitis
Symposium
Chairs:
08:30 IL MO-49-01
Stevens Johnson syndrome and toxic epidermal
necrolysis; management in the acute phase with
immunosuppression, steroids, and AMT
08:40 IL MO-49-02
Pathogenesis, autoantigens, diagnostics of mucous
membrane pemphigoid
Detlef Zillikens (Lbeck/D)
16:50 IL MO-40-06
Refractive Lens Exchange
Antonio A. P. Marinho (Porto/P)
17:00 IL MO-40-07
IOL Selection for Refractive Lens Exchange
Roberto Bellucci (Verona/I)
17:10
Discussion
Hall 4/5
14:00 - 15:30 MO-63
Macula Society Symposium: Nonsurgical
Treatment of Macular Diseases
Symposium
Retina
Chairs:
Evangelos S. Gragoudas (Boston/USA)
14:00 IL MO-63-01
New developments in pharmacotherapy for AMD
Anthony P. Adamis (Chicago/USA)
14:10 IL MO-63-02
Treatment of diabetic macular dedma
Lloyd Paul Aiello (Boston/USA)
14:20 IL MO-63-03
Management of macula edema in branch an
central retinal vein occlusion
Thomas Friberg (Pittsburgh/USA)
14:30 IL MO-63-04
Management of dry AMD
Ivana Kim (Boston/USA)
14:40 IL MO-63-05
Treatment of geographic atrophy
Michael L. Klein (Portland/USA)
14:50 IL MO-63-06
Treatment of macular telangiectasia type 2
Joan Miller (Boston/USA)
15:00
Discussion
152
M
o
n
d
a
y
,

7

J
u
n
e
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
Monday, 7 June 2010
WOC
2010
11:30 IL MO-50-07
Intraocular antibiotic therapy
Denise Freitas (Sao Paulo/BR)
11:40
Discussion
Hall 6
14:00 - 15:30 MO-51
Combating Childhood Blindness: Strategies of
Prevention, Detection and Treatment
Symposium
Chairs:
Nathan G. Congdon (Baltimore/USA)
14:00 IL MO-51-01
Combating Childhood Blindness: Overview of the
avoidable causes of blindness in children
14:10 IL MO-51-02
Prevention: Strategies for preventing retinopathy
of prematurity
Luz Gordillo (Lima/PE)
14:20 IL MO-51-03
Early detection: Neonatal screening: experiences
from Brazil
14:30 IL MO-51-04
Early detection: Key informant method for
identifying blind children
Mohammad Muhit (Dhaka/BD)
14:40 IL MO-51-05
Treatment: Optimising the outcome of cataract
surgery in children clinical aspects
14:50 IL MO-51-06
Treatment: Optimising the outcome of cataract
surgery in children non-clinical aspects
Paul Courtright (Moshi/EAT)
15:00 IL MO-51-07
Treatment: Lessons learnt from school eye health
program programmes
15:10
Discussion
08:50 IL MO-49-03
Immunosuppression and immunoglobulins in
cicatrizing conjunctivitis
09:00 IL MO-49-04
Stem cell deficiency and fornix reconstruction in
cicatrizing conjunctivitis
09:10 IL MO-49-05
Clinic and management of other cicatrizing
conjunctivitis
Thanh Hoang-Xuan (Paris/F)
09:20 IL MO-49-06
Mucous membrane pemphigoid: making the
diagnosis
09:30
Discussion
Hall 6
10:30 - 12:00 MO-50
Intra-Ocular Therapy
Symposium
Chairs:
Thomas Ness (Freiburg/D)
10:30 IL MO-50-01
Intraocular implants
10:40 IL MO-50-02
Vitrectomy in uveitis
10:50 IL MO-50-03
Bevacizumab and Rainbizumab in uveitis
Ahmad Mansour (Beirut/RL)
11:00 IL MO-50-04
Glaucoma devices in uveitis
Thomas Ness (Freiburg/D)
11:10 IL MO-50-05
Antiviral therapy
Careen Y. Lowder (Cleveland/USA)
11:20 IL MO-50-06
Cataract surgery in uveitis
Soon Phaik Chee (Singapore/SGP)
153
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
M
o
n
d
a
y
,

7

J
u
n
e
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
Hall 6
16:00 - 17:30 MO-52
The Economics of Blindness: What Does Lost Vision
Cost, How Much Can Prevention Save?
Symposium
Chairs:
Paul Lee (Durham/USA)
Jill Keeffe (Melbourne/AUS)
16:00 IL MO-52-01
The need for good epidemiological data on causes,
prevalence and incidence of vision impairment for
on vision impairment analyses
Paul Lee (Durham/USA)
16:15 IL MO-52-02
Is there a role for public health in promoting visual
screening? Cost-effectiveness results from the
United States
David B. Rein (Atlanta/USA)
16:30 IL MO-52-03
Modeling changes in mean deviation in glaucoma
Bringing together the results of the CIGTS, OHTS,
and AGIS studies using decision analytic methods
Steven M. Kymes (St. Louis/USA)
16:45 IL MO-52-04
Willingness to pay for cataract surgery in rural
China
17:00 IL MO-52-05
What are the sources of data that we use to
establish costs?
17:15
Discussion
Hall 7
06:45 - 08:15
World Ophthalmic Education Colloquium
Breakfast
Attendance upon invitation only
Hall 7
08:30 - 10:00 MO-53
ARVO Symposium: Translational Research
Developing Innovative New Treatments for
Glaucoma
Symposium
Glaucoma
Chairs:
08:30 IL MO-53-01
Tissue bioengineering
Dong Feng Chen (Boston/USA)
08:40 IL MO-53-02
Neuroprotection of retinal ganglion cells
Henry Klassen (Irvine/USA)
08:50 IL MO-53-03
Gene therapy for glaucoma
Keith Martin (Cambridge/UK)
09:00 IL MO-53-04
CNS implications of glaucoma damage and
potential therapies
Neeru Gupta (Toronto/CDN)
09:10 IL MO-53-05
Nanostrategies to restore neurons in glaucoma
Rutledge G. Ellis-Behnke (Cambridge/USA)
09:20 IL MO-53-06
New methods of preventing scarring
09:30 IL MO-53-07
Identifying pressure response genes in the
trabecular meshwork
Terete Borras (Chapel Hill/USA)
09:40
Discussion
Monday, 7 June 2010
M
o
n
d
a
y
,

7

J
u
n
e
154
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
Hall 7
10:30 - 12:00 MO-54
EGS Symposium: Glaucoma Management: Hot
Topics from the new EGS Guidelines
Symposium
Glaucoma
Chairs:
Clive Migdal (London/UK)
Francisco Javier Goi Foncillas (Barcelona/E)
John Thygesen (Copenhagen/DK)
10:30 IL MO-54-01
Progression is the key; where are we going with
perimetry
Francisco Javier Goi Foncillas (Barcelona/E)
10:50 IL MO-54-02
Target IOP where are we now?
John Thygesen (Copenhagen/DK)
11:10 IL MO-54-03
The combined approach to glaucoma medications
11:30 IL MO-54-04
The cutting edge glaucoma incisional surgery
11:50
Discussion
Hall 7
14:00 - 15:30 MO-55
EBO Symposium: From National towards European
Training in Ophthalmology
Symposium
Chairs:
Wagih Aclimandos (London/UK)
14:00 IL MO-55-01
European Board of Ophthalmology-what and why
Peter J. Ringens (Amsterdam/NL)
14:10 IL MO-55-02
European Board of Ophthalmology diploma
examination (EBOD)
Catherine Creuzot-Garcher (Dijon/F)
14:20 IL MO-55-03
European CME accreditation
Gordana Sunaric-Megevand (Genve/CH)
14:30 IL MO-55-04
European accreditation of training centers
Wagih Aclimandos (London/UK)
14:40 IL MO-55-05
ENET unifying European subspecialty Societies
14:50 IL MO-55-06
"Concordia pro visu": education meets research
15:00 IL MO-55-07
Harmonisation of training accross Europe
15:10
Discussion
Hall 7
16:00 - 17:30 MO-56
APAO Symposium: Age-related Macular
Degeneration and Polypoidal Choroidal
Vasculopathy in Asia-Pacific Region
Symposium
Retina
Chairs:
Ian Constable (Nedlands/AUS)
16:00 IL MO-56-01
Epidemiology of AMD and PCV in the Asia-Pacific
region
Tien Ying Wong (Singapore/SGP)
16:10 IL MO-56-02
Molecular genetics of Asian AMD and PCV
Chi-Pui Pang (Hong Kong/CN)
16:20 IL MO-56-03
Comparison of angiographic features in
neovascular AMD and PCV
Adrian Koh (Singapore/SGP)
16:30 IL MO-56-04
Optical coherence tomography imaging in AMD
and PCV
Won-Ki Lee (Seoul/ROK)
16:40 IL MO-56-05
Pharmacotherapy for neovascular AMD
Taraprasad P. Das (Hyderabad/IND)
16:50 IL MO-56-06
Role of Photodynamic therapy and Transpupillary
thermal therapy in PCV
Monday, 7 June 2010
M
o
n
d
a
y
,

7

J
u
n
e
155
Monday, 7 June 2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
WOC
2010
Hall 8
10:30 - 12:00 MO-58
Organisational Aspects: Training, Policy, Economics,
Legal, Regulations, Interoperability
Symposium
Chairs:
Anja Tuulonen (Oulu/FIN)
Jiri Jan (Brno/CZ)
Isabel Oberacher-Velten (Regensburg/D)
10:30 IL MO-58-01
Screening for retinopathy of prematurity
a telemedicine project in Bavaria
Isabel Oberacher-Velten (Regensburg/D)
10:45 IL MO-58-02
The experiences of the EyeMo (mobile eye unit) in
Northern Finland: process, quality end economics
Anja Tuulonen (Oulu/FIN)
11:00 IL MO-58-03
Signal analysis in functional OCT
Leopold Schmetterer (Vienna/A)
11:15 IL MO-58-04
Correcting Motion Artifacts of OCT Volume Scans
by using a Novel Software Registration Method
Markus Meier (Erlangen/D)
11:30
Discussion
17:00 IL MO-56-07
Long-term outcome of monotherapy with
verteporfin photodynamic therapy for PCV
Mitsuko Yuzawa (Tokyo/J)
17:10 IL MO-56-08
Anti-VEGF and combination therapy for PCV
17:20 IL MO-56-09
Prevention of AMD and PCV
Hall 8
08:30 - 10:00 MO-57
PAAO Symposium: A Close Look Into the Future:
Pearls on New Cornea and External Diseases
Techniques and Strategies of Treatment
Symposium
Chairs:
Denise de Freitas (So Paulo/BR)
08:30 IL MO-57-01
Update in the treatment of Acanthamoeba
keratitis
Denise de Freitas (So Paulo/BR)
08:40 IL MO-57-02
New approaches for the treatment and kerato-
conus and keratectasia. What is the best choice?
Joaquim Neto Murta (Lisboa/P)
08:50 IL MO-57-03
Platelet rich plasm in the treatment of ocular
surface disease and corneal ulcers
09:00 IL MO-57-04
Molecular biology technique for keratitis diagnosis
Mauro Nishi (So Paulo/BR)
09:10 IL MO-57-05
Current Developments and strategies on lamelar
corneal transplants
Luis Isquierdo Jr. (Lima/PE)
09:20 IL MO-57-06
Corneal cross-linking combined with topography-
guided laser treatment
Mirko R. Jankov (Belgrado/SRB)
09:30
Discussion
156
M
o
n
d
a
y
,

7

J
u
n
e
Monday, 7 June 2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
WOC
2010
Hall 8
16:00 - 17:30 MO-60
Lindberg Society Symposium: Exfoliation
Syndrome From Molecules to Manifestations
Symposium
Miscellaneous
Chairs:
Murat Irkec (Istanbul/TR)
Gbor Holl (Budapest/H)
16:00 IL MO-60-01
The LOXL1 gene function and implications
Fridbert Jonasson (Reykjavik/IS)
16:10 IL MO-60-02
Molecular pathophysiology of XFS closer to a
solution?
16:20 IL MO-60-03
Exfoliative glaucoma an open window to
neurodegeneration and neuroprotection
16:30 IL MO-60-04
Systemic associations and vascular dysfunction
Murat Irkec (Istanbul/TR)
16:40 IL MO-60-05
Ocular manifestations of XFS beyond glaucoma
Gbor Holl (Budapest/H)
16:50 IL MO-60-06
Exfoliative glaucoma clinical features and cur-
rent treatment
Anastasios G. P. Konstas (Thessaloniki/GR)
17:00 IL MO-60-07
Asymmetry in manifestation still an enigma
17:10 IL MO-60-08
Cataract extraction in XFS: Management and
prevention of complications
17:20
Discussion
Hall 8
14:00 - 15:30 MO-59
JCAHPO Symposium: Teaching Allied Health
Personnel
Symposium
Chairs:
William F. Astle (Calgary/CDN)
14:00 IL MO-59-01
Introduction & IJCAHPO Overview
Teaching vs. training
Training & Certification
William H. Ehlers (Farmington/USA)
14:10 IL MO-59-02
Accreditation & International Standards for
Education Programs
Peter Donshik (Bloomfield/USA)
14:25 IL MO-59-03
International Core Curriculum ICO & IJCAHPO
A teaching model for training the eye care team
Foundation of knowledge & principles
Resources: ICO, IJCAHPO, ATPO, CSOMP, COTP,
Others
14:40 IL MO-59-04
Implementing the ICO Curriculum in Africa
A teaching model for training the eye care tea
Boateng Wiafe (Kasoa/GH)
14:55 IL MO-59-05
Teaching Methods Best Practices
Synchronous
Asynchronous
Clinical Experiential learning
14:10 IL MO-59-06
Retinoscopy Action Learning Presentation
Provide attendees an interactive learning
experience on retinoscopy
Attendees will receive a course syllabus,
checklist, training resources
Course will demonstrate use of resources:
online, simulation
William H. Ehlers, William F. Astle
(Farmington/USA, Calgary/CDN)
15:25 IL MO-59-07
Conclusion & Discussion
M
o
n
d
a
y
,

7

J
u
n
e
157
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
Hall 9
08:30 - 10:00 MO-41
Worldwide Program of Teaching Directors of
Ophthalmic Residency Programs
Symposium
World Ophthalmic Educational Colloquium
Chairs:
Klaus-Peter Steuhl (Essen/D)
08:30 IL MO-41-01
Introduction
08:40 IL MO-41-02
Principles of Performance Assessment
Eduardo Mayorga Argaaraz (Buenos Aires/RA)
08:50 IL MO-41-03
ICO International Basic Science and Clinical
Sciences Assessments for Ophthalmologists
09:00 IL MO-41-04
Resident Assessment: Objective Structured Clinical
Examination (OSCE)
09:10 IL MO-41-05
The 360 Degree Evaluation
Gabriela Palis (Buenos Aires/RA)
09:20 IL MO-41-06
Can Professionalism and Communication Skills be
Taught and Assessed?
09:30 IL MO-41-07
Videos/Vignettes for Teaching Professionalism
09:40
Discussion
Hall 9
10:30 - 12:00 MO-42
The New Frontier of Changing Parameters of
Residency Education
Symposium
Chairs:
Veit-Peter Gabel (Regensburg/D)
10:30 IL MO-42-01
Introduction
10:40 IL MO-42-02
Harmonisation of Residency Education in Europe
10:50 IL MO-42-03
Generational Learning: Teaching When the Times
Are Changing
11:00 IL MO-42-04
New Models for Ophthalmic Educational
Assessments: Dreyfus, Ericsson, and Schon
11:10 IL MO-42-05
Teaching Learning: Changing Parameters in
Resident Education
11:20 IL MO-42-06
Curriculum: More Than Just Words: Paradigm Shift
in the Structured Learning Plan for Residents
11:30 IL MO-42-07
Competency vs. Striving for Excellence in Surgical
Teaching, Specifically Cataracts
Susan Ksiazek (Chicago/USA)
11:40 IL MO-42-08
Selecting the Next Generation of Ophthalmologists
Susan H. Day (San Francisco/USA)
11:50
Discussion
Monday, 7 June 2010
M
o
n
d
a
y
,

7

J
u
n
e
158
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
Hall 9
14:00 - 15:30 MO-43
Innovative Technologies for Teaching
Ophthalmology
Symposium
Chairs:
Mark O. M. Tso (Baltimore/USA)
Deepak P. Edward (Akron/USA)
14:00 IL MO-43-01
We are in the Age of Innovative Technologies
14:10 IL MO-43-02
A Spectrum of Innovative Technologies for
Teaching Ophthalmology
Hans-Martin Helb (Bonn/D)
14:20 IL MO-43-03
Simulators In Ophthalmic Surgery: Are we there
yet?
14:30 IL MO-43-04
Animations in Teaching Ophthalmology
14:40 IL MO-43-05
Teaching Refraction through Animation
Technology
14:50 IL MO-43-06
3D Teaching Systems in Ophthalmology: Retina &
Optic Nerve
Wico W. Lai (Hong Kong/CN)
15:00 IL MO-43-07
How to teach Ophthalmic Pathology using
Innovative Technologies
15:10 IL MO-43-08
The Neuro-Ophthalmology Virtual Education
Library: NOVEL
Susan Ksiazek (Chicago/USA)
15:20 IL MO-43-09
Conclusions
Hall 9
16:00 - 17:30 MO-44
Emerging Technologies for Ophthalmic Teaching
and Learning: Internet Tools for Teaching
Teaching Without Classrooms
Symposium
Chairs:
16:00 IL MO-44-01
Introduction
Eduardo Mayorga Argaaraz, Mark O. M. Tso
(Buenos Aires/RA, Baltimore/USA)
16:10 IL MO-44-02
Coping With Lack of Knowledge: An Online Tool to
Diagnose Conditions You Never Knew Existed
16:20 IL MO-44-03
Interactive Teaching and Audience Response
Systems
16:30 IL MO-44-04
Concept Mapping Software for Enhancing
Teaching and Learning Selection and Application
16:40 IL MO-44-05
Synchronous E-learning Considerations for
Selecting the Right Software
16:50 IL MO-44-06
Using the Web 2.0 Tool Box for Ophthalmology
Teaching and Learning
Helena Filipi (Lisbon/P)
17:00 IL MO-44-07
Training Ophthalmic Technicians in the 21
st
Century
17:10 IL MO-44-08
Simulation in Ophthalmic Surgical Training
Colin A. McCannel (Los Angeles/USA)
17:20
Discussion
Monday, 7 June 2010
M
o
n
d
a
y
,

7

J
u
n
e
159
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
Hall 10
08:30 - 10:00 MO-65
AAO Symposium: Glaucoma Implants: Now and
the Future
Symposium
Glaucoma
Chairs:
James C Tsai (New Haven/USA)
Hagen Thieme (Mainz/D)
08:30 IL MO-65-01
Tube vs Trabeculectomy and other studies
08:40 IL MO-65-02
Flow dynamics of aqueous shunts. What do they
do?
Sheng Lim (London/UK)
08:50 IL MO-65-03
Surface modification of shunts. Does it matter?
09:00 IL MO-65-04
Size matters, but small is better
Marlene Moster (Bala Cynwyd/USA)
09:10 IL MO-65-05
Not yet shunting to the suprachoroidal space
Walter Konen (Cologne/D)
09:20 IL MO-65-06
Implanting the Baerveldt Shunt without ligation
09:30 IL MO-65-07
Ahmed Implantation Technique
James C. Tsai (New Haven/USA)
09:40 IL MO-65-08
Conclusion and Future of aqeous shunts
09:50
Discussion
Hall 10
10:30 - 12:00 MO-66
Minimally Invasive Ophthalmic Surgery
Symposium
Miscellaneous
Chairs:
10:30 IL MO-66-01
Introduction to the session: Minimally invasive,
the present and future of ophthalmic surgery
Daniel Mojon, Jorge L. Ali (St. Gallen/CH,
Alicante/E)
10:40 IL MO-66-02
Minimally invasive vitreoretinal surgery
10:50 IL MO-66-03
Minimally invasive strabismus surgery
11:00 IL MO-66-04
Minimally invasive refractive surgery
11:10 IL MO-66-05
Minimally invasive corneal surgery
Roger Steinert (Orange/USA)
11:20 IL MO-66-06
Minimally invasive cataract surgery
11:30 IL MO-66-07
Minimally invasive glaucoma surgery
Julian Garci-Feijo (Madrid/E)
11:40 IL MO-66-08
Minimally invasive ocular surface surgery
11:50 IL MO-66-09
Mimimally invasive tumor treatment
Monday, 7 June 2010
M
o
n
d
a
y
,

7

J
u
n
e
160
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
Hall 10
14:00 - 15:30 MO-67
Retina: Vascular Disease 1
Free Paper
Retina
Chairs:
Carsten H. Meyer (Bonn/D)
14:00 SL MO-67-01
Macular teleanciectasis
Ute Wolf-Schnurrbusch (Bern/CH)
14:09 FP MO-67-02
Pharmacokinetics and pharmacodynamics of
the sustained-release dexamethasone intravitreal
implant
Devin Welty, Joan-En Chang Lin, Mayssa Attar,
Andrew Acheampong, Michael Robinson,
Scott M. Whitcup (Irvine/USA)
14:16 FP MO-67-03
Retinal Vascular Events After Anti-Vascular
Endothelial Growth Factors
Ahmad Mansour, Therese von Hanno, Peter Kofoed,
Shree Kurup, Michel Shami, Eric Chen, Jad Akesby,
Sabine Aisenbrey, Focke Ziemssen, Alay Banker,
Wael Soliman, Zei-Lun Huang, Ozgur Artunay,
Hamid Hosseini, Sami Uwaydat, Padmamalini
Mahendradas, Leon Bynoe (Beirut/RL)
14:23 FP MO-67-04
Spatial distribution of intraocular oxygen in
advanced diabetic retinopathy
Clemens Lange, Panagiotis Stavrakas,
Julian da Silva, Ulrich Luhmann, Zdenek Gregor,
James Bainbridge (London/UK)
14:30 FP MO-67-05
Prevalence of retinopathy in patients with type 2
diabetes Preliminary report from BNDC trial,
BIRDEM, Bangladesh
M. K. Goswami (Dhaka/BD)
14:37 FP MO-67-06
Efficacy outcomes of the CRUISE study of
intravitreal ranibizumab in patients with macular
edema secondary to central retinal vein occlusion
Leonard Feiner, Roman G. Rubio, Namrata Saroj,
Zhengrong Li, Amy Chen Rundle, Sarah Gray,
Wendy Yee Murahashi (Kenilworth/USA, San Fran-
cisco/USA)
14:44 FP MO-67-07
Intravitreal ranibizumab for the treatment of
significant macular edema secondary to acute
branch retinal vein occlusion
Stefan Sacu, Gerlinde Matt, Wolf Bhl,
Roman Dunavlgyi, Erna Schranz, Christian Prnte,
14:51 FP MO-67-08
A case of retinal regeneration in Norrie's disease
Yun-Sik Yang, Seong-Min Hong, Ji-Yun Yang,
Eun-Heui Jin (Icksan/ROK)
14:58 FP MO-67-09
Incidence of damage to the crystalline lens and
retina during intravitreal injections
Carsten H. Meyer, Stefan Michels,
Hans-Martin Helb, Stefan Mennel, Jrg C. Schmidt,
Annette Hager, Eduardo B. Rodrigues (Bonn/D,
Duisburg/D, Marburg/D, Zurich/CH, Hamburg/D)
15:05 FP MO-67-10
Amalric Sign and CRAO-A Review
Sribhargava Natesh, Mayuri Bhargava,
Naresh Kumar Yadav, Rohit Shetty, Bhajung Shetty
(Bangalore/IND)
15:12
Discussion
Hall 10
16:00 - 17:30 MO-82
EUGOGO Symposium
Symposium
Strabismus
Chairs:
Petros Perros (Newcastle upon Tyne/UK)
Alison Dickinson (Newcastle upon Tyne/UK)
Marian Ludgate (Cardiff/UK)
16:00 IL MO-82-01
From Science to Clinical Management to Politics:
Amsterdam Declaration
Petros Perros (Newcastle upon Tyne/UK)
16:20 IL MO-82-02
Evidence Based Medical Management of Thyroid
Dysfunction and Orbitopathy
Mario G. Salvi (Milan/I)
16:40 IL MO-82-03
EUGOGO Consensus Statement and Surgical
Management
Lelio Baldeschi, Susanne Pitz, Anja K. Eckstein
(Amsterdam/NL, Mainz/D, Essen/D)
17:00
Discussion
Monday, 7 June 2010
M
o
n
d
a
y
,

7

J
u
n
e
161
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
Salon 21
10:30 - 12:00 MO-26
Miscellaneous 2
Free Paper
Miscellaneous
Chairs:
Duica Pahor (Maribor/SI)
Khristo P. Takhchidi (Moscow/RUS)
Ines M. Lanzl (Munich/D)
10:30 SL MO-26-01
Impact of U.S. Economic Stimulus Funding on
Vision Research
James Jorkasky (Rockville/USA)
10:39 SL MO-26-02
Ocular findings in Hemodialysis Patients
Duica Pahor (Maribor/SI)
10:48 SL MO-26-03
Ocular involvement in lysosomal storage diseases
Ines Lanzl (Munich/D)
10:57 SL MO-26-04
Modern ocular biomechanics as an effective tool
for evaluation of advanced directions in clinical
and experimental research
Konstantin Kotliar, Elena Iomdina, Ivan Koshitz,
Svetlana Bauer, Ines Lanzl (Munich/D)
11:06 SL MO-26-05
Five millions surgeries in the S. Fyodorov Eye
Microsurgery Federal State Institution
Khristo Takhchidi, Alexander Doga (Moscow/RUS)
11:15 FP MO-26-06
Medically Unexplained Visual Loss (MUVL) in
Singapore
Leonard Yuen, Lisa Ong, Maria Goh, Tan Zhen Kiat,
James Cullen (Singapore/SGP)
11:22
Discussion
Roof Garden
08:30 - 10:00 MO-69
ISA Symposium: Clinical Challenges in Strabismus
Symposium
Strabismus
Chairs:
Derek Sprunger (Indianapolis/USA)
Frank Martin (Sydney/AUS)
08:30 IL MO-69-01
Surgery for Duane Syndrome
Frank Martin (Sydney/AUS)
08:40 IL MO-69-02
Surgery for Dissociated Strabismus
Anthony Murray (Cape Town/ZA)
08:50 IL MO-69-03
1) Congenital ET; Surgery vs toxin
2) Choice of Surgery for Nystagmus
09:00 IL MO-69-04
1) Strabismus Surgery in High Myopia
2) Acute Ocular Trauma; Strabismus Concerns
09:10 IL MO-69-05
Surgery for Superior Oblique Palsy
Miho Sato (Hamamatsu/J)
09:20 IL MO-69-06
Topical Anesthesia in Strabismus Surgery
Sonal Farzavandi (Singapore/SGP)
09:30
Discussion
Roof Garden
10:30 - 12:00 MO-70
MEACO Symposium: Management of Macular and
Retinal Vascular Diseases
Symposium
Retina
Chairs:
Manal Omran Taryam (Dubai/UAE)
10:30 IL MO-70-01
Introduction to Diabetic Macular edema
Hassan A. Dhibi (Riyadh/SA)
10:45 IL MO-70-02
24 Hours Pre operative Intravitreal Bevacizumab
for Repair of Retinal Detachment in Eyes with
Active Proliferative Diabetic Retinopathy
Massan Mortada (Cairo/ET)
11:00 IL MO-70-03
Staining epiretinal membranes
11:15 IL MO-70-04
Vitrectomy for traction maculopathy
Monday, 7 June 2010
M
o
n
d
a
y
,

7

J
u
n
e
162
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
11:30 IL MO-70-05
Vitrectomy: intraoperative complications and how
to deal with them
11:45
Discussion
Roof Garden
14:00 - 15:30 MO-71
ARVO Symposium: Genetics of Eye Disease:
Current Clinical Perspective
Symposium
Genetics
Chairs:
Janey L. Wiggs (Boston/USA)
14:00 IL MO-71-01
Ocular Genetics NEI Perspective
Introduction and Overview
14:04 IL MO-71-02
Ocular Genetics: NEI Perspective
Paul Sieving (Bethesda/USA)
14:16 IL MO-71-03
Genetics of Strabismus
14:28 IL MO-71-04
Genetics of Leber's Congenital Amaurosis
Elise Heon (Toronto/CDN)
14:40 IL MO-71-05
Glaucoma Genetics
David Mackey (East Melbourne/AUS)
14:52 IL MO-71-06
AMD Genes and Risk Factors
Eric Souied (Crteil/F)
15:04 IL MO-71-07
Pharmacogenomics and Approaches to
Personalized Medicine
Louis R. Pasquale (Boston/USA)
15:16
Open discussion and concluding remarks
Roof Garden
16:00 - 17:30 MO-72
AAO Symposium: Retinal Pharmacotherapy
Symposium
Retina
Chairs:
Lihteh Wu (San Jose/CR)
16:00 IL MO-72-01
Anti-VEGF in Central Retinal Vein Occlusions
16:10 IL MO-72-02
Update Regarding Extended Drug Delivery to the
Posterior Segment
16:20 IL MO-72-03
Primary Intravitreal Bevacizumab for Diffuse
Diabetic Macular Edema: The Pan-American
Collaborative Retina Study Group Results
16:30 IL MO-72-04
Intravitreal Bevacizumab for Choroidal Neovascu-
larization secondary to multifocal choroiditis
16:40 IL MO-72-05
Suprachoroidal Drug Delivery via Catheter
16:50 IL MO-72-06
The Ability of In-Office Genetic Testing for
Exudative Macular Degeneratione to Predict
Response to Anti-VEGF Therapy
Tarek S. Hassan (Royal Oak/USA)
17:00 IL MO-72-07
A State of the Art in Antiangiogenic Therapy
Evidence and Conclusions
17:10 IL MO-72-08
Macrophages and AMD Rationale for Treatment
or Epiphenomenon
17:20
Discussion
Monday, 7 June 2010
M
o
n
d
a
y
,

7

J
u
n
e
163
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
ICC Lounge
08:30 - 10:00 MO-45
Editorial Management
Symposium
Chairs:
08:30 IL MO-45-01
Ethical dilemmas in scientific publications:
pitfalls and solutions for editors
Diana Epstein (Glasgow/UK)
08:40 IL MO-45-02
Self-citations
Wolfgang Glnzel (Leuven/B)
08:50 IL MO-45-03
Meeting abstracts, tabloids and peer-reviewed
articles duplicate publications?
09:00 IL MO-45-04
Affiliations of journals with scientific societies
pros and cons
09:10 IL MO-45-05
Editorship the publishers' perspective
Esther Wieland (Heidelberg/D)
09:20 IL MO-45-06
Role of the editorial board expectations and
limitations
09:30
Discussion
ICC Lounge
10:30 - 12:00 MO-46
IUSG Symposium: Update on New Treatment
Against Uveitis
Symposium
Chairs:
10:30 IL MO-46-01
Daclizumab
10:45 IL MO-46-02
Voclosporin
11:00 IL MO-46-03
Ozurdex
Marc D. de Smet (Amsterdam/NL)
11:15 IL MO-46-04
Interferon alpha
Christoph M. E. Deuter (Tbingen/D)
11:30 IL MO-46-05
Anti-TNF-alpha blocking Antibodies
Emmett T. Cunnigham (San Francisco/USA)
11:45
Discussion
ICC Lounge
14:00 - 15:30 MO-47
Nanotechnology
Symposium
Chairs:
14:00 IL MO-47-01
Building contact lenses with integrated radios and
biosensors
Babak Amir Parviz (Seattle/USA)
14:10 IL MO-47-02
Intravitreal cell-encoated drug therapy for
neuroprotection and anti-angiogenesis
14:20 IL MO-47-03
Nanotechnology-mediated targeted nonviral gene
therapy approaches to treat corneal diseases
Rajiv R. Mohan (Columbia/USA)
14:30 IL MO-47-04
Functionalized nanoparticles for targeted drug
and gene delivery
Uday B. Kompella (Aurora/USA)
14:40 IL MO-47-05
Using nanotechnology to control ocular
inflammation
14:50 IL MO-47-06
Therapeutic potential of stem cells for retinal
regeneration
Ting Xie (Kansas City/USA)
Monday, 7 June 2010
M
o
n
d
a
y
,

7

J
u
n
e
164
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
15:00 IL MO-47-07
Eye-Opening Retinal Prostheses: Nanotechnology
and the Neural-Electrical Interface
Russell Andrews (Los Gatos/USA)
15:10 IL MO-47-08
Nanotheragnostics in normal-tension glaucoma
Sung Chul Park (Seoul/ROK)
15:20 IL MO-47-09
Keynote Speech: Nanomedicine where is it
headed?
Carlo Montemagno (Cincinnati/USA)
ICC Lounge
16:00 - 17:30 MO-48
Google's Approach, Open Access Publishing
Symposium
Chairs:
Ulrich Korwitz (Cologne/D)
Harald Mller (Heidelberg/D)
16:00 IL MO-48-01
Goals of Google
Stefan Keuchel (Hamburg/D)
16:10 IL MO-48-02
Googles digital books: Contra
Jessica Snger (Munich/D)
16:20 IL MO-48-03
Digital books: Pro
Harald Mller (Heidelberg/D)
16:30 IL MO-48-04
Open access publishing in Medicine
Ulrich Korwitz (Cologne/D)
16:40 IL MO-48-05
Open Access to Research Data
Anita Eppelin (Cologne/D)
16:50 IL MO-48-06
A film repository
17:00
Discussion
Salon 11/12
14:00 - 15:30 MO-81
Disaster Response: Ophthalmologys
Organizational Role
Symposium
Chairs:
14:00 IL MO-81-01
Collaboration with Host National Society
Mildred M. G. Olivier (Hoffman Estates/USA)
14:10 IL MO-81-02
Relationships with NGOs and Governmental
Organizations
Michael W. Brennan (Burlington/USA)
14:20 IL MO-81-03
Haiti Experience; Immediate Response
Natalio Izquierdo (San Juan/PR)
14:30 IL MO-81-04
Concepcion Experience
14:40 IL MO-81-05
Tsunami Experience
S. Natarajan (Mumbai/IND)
14:50 IL MO-81-06
Strategies for Donor Solicitation
Stephanie J. Marioneaux (Chesapeake/USA)
15:00 IL MO-81-07
Volunteer Realities
Philip R. Rizzuto (Providence/USA)
15:10 IL MO-81-08
Assistance to War Displaced Physicians
15:20 IL MO-81-09
Global Ophthalmology in Disaster Relief Efforts
Monday, 7 June 2010
M
o
n
d
a
y
,

7

J
u
n
e
165
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
Room 42
08:30 - 10:00 MO-73
Glaucoma: Basics 2
Free Paper
Glaucoma
Chairs:
Lutz E. Pillunat (Dresden/D)
08:30 SL MO-73-01
The new possibilities for exploiting of the
genotype-phenotype correlation in primary
congenital glaucoma
08:39 FP MO-73-02
Atherogenic risk factors and Primary Open Angle
Glaucoma
Lus Abego Pinto, Joana Ferreira, Ana Amaral,
Paula Leito, Isabel Domingues, Joo Lisboa
(Belas/P)
08:46 FP MO-73-03
Cerebrospinal fluid dynamics and subarachnoid
space diameter in normal-tension glaucoma
Hanspeter Killer, Gregor Jaggi, Neil Miller,
Josef Flammer, Angel Mironow, Luca Remonda
(Aarau/CH)
08:53 FP MO-73-04
The photoreceptor layer appears intact in ad-
vanced glaucomatous optic neuropathy: a spectral
domain OCT study
Imran Masood, Trushar Patel, Simon Longstaff (UK)
09:00 FP MO-73-05
Elevated intraocular pressure reduces aquaporin-9
expression in rat optic nerve head and retina.
Makoto Nakamura, Maiko Naka, Akiyasu Kanamori,
Akira Negi (Kobe/J)
09:07 FP MO-73-06
Comparison of Glaucomatous Optic Neuropathy
and Blindness in Symptomatic and Asymptomatic
Primary Angle Closure Glaucoma in Central India.
Rekha Khandelwal, Shivani Bidaye, Suresh Ughade,
Ketaki Shah (Nagpur/IND)
09:14 FP MO-73-07
Increased Expression of Cellular Senescence in
Cultured Trabecular Meshwork Cells by TGF-beta
Ulrich Welge-Len (Erlangen/D)
09:21 FP MO-73-08
Does Intraocular Pressure (IOP) Reduction Affect
Intracranial Pressure (ICP)? An animal Model
Morteza Mehdizadeh (Shiraz/IR)
09:28 FP MO-73-09
Immune-mediated injury and the retinal ganglion
cell survival
Ping Huang, Yan-Jiao Huo, Hong Li,
Samuel Shao-Min Zhang, Chun Zhang (Beijing/CN)
09:35 FP MO-73-10
Analysis of IgM autoantibody patterns as
marker for acute phase immunoreactions in
pseudoexfoliation glaucoma
Katrin Lorenz, Marcus Schlich, Nils Bhm,
Christina Kramann, Norbert Pfeiffer, Franz Grus
(Mainz/D)
09:42
Discussion
Room 42
10:30 - 12:00 MO-74
Free Paper
Chairs:
Jyotirmay Biswas (Chennai/IND)
10:30 FP MO-74-01
Anti-Inflammatory Effects of Topical Application of
Curcuma Longa Extract in Experimental Uveitis
Puneet Agarwal, Renu Agarwal, S. K. Gupta,
Sushma Srivastava, Rohit Saxena, S. S. Agrawal
(Kuala Lumpur/MAL, New Delhi/IND)
10:37 FP MO-74-02
Mesenchymal Stem Cells Ameliorate Experimental
Autoimmune Uveitis by Modulation of the Th1-
dependent Immune Response
Xiaomin Zhang, Xinjun Ren, Shaozhen Zhao,
Xiaorong Li (Tianjin/CN)
10:44 FP MO-74-03
Intravitreal Adalimumab for Uveitis-Related
Macular Edema
Anna Praidou, Sofia Androudi, Evangelia Tsironi,
Christos Kalogeropoulos, Athina Theodoridou,
Periklis Brazitikos (Thessaloniki/GR)
10:51 FP MO-74-04
Risk factors for the development of macular
edema in non-infectious uveitis
Martin Rsel, Anne Ruttig, Claudia Schumacher,
Carsten Heinz, Arnd Heiligenhaus (Mnster/D)
Monday, 7 June 2010
M
o
n
d
a
y
,

7

J
u
n
e
166
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
10:58 FP MO-74-05
Young age as risk factor for complicated course
and visual outcomes in intermediate uveitis in
children.
Viera Kalinina Ayuso, Hermine ten Cate,
Patricia van den Does, Aniki Rothova,
Joke de Boer (Utrecht/NL)
11:05 FP MO-74-06
Cataract Formation in Patients Treated with
LX211 (Luveniq/voclosporin oral capsules) with
Non-Infectious Uveitis
11:12 FP MO-74-07
Elevated laser flare values correlate with
complicated course of anterior uveitis in patients
with juvenile idiopathic arthritis
Christoph Tappeiner, Carsten Heinz, Martin Roesel,
Arnd Heiligenhaus (Bern/CH, Mnster/D)
11:19 FP MO-74-08
The Many Faces of Ocular Tuberculosis and Short
Course Oral Isoniazid Trial: a UKMMC Experience
Siew Yuen Goh, Wan Haslina Wah, Hon Seng Wong,
Othmaliza Othman, Muhaya Mohamed (Kuala
Lumpur/MAL)
11:26 FP MO-74-09
The expression of VEGF of OCM-1 cell line of
human choroidal melanoma and OCM-1 cell line
tumor implanted in nude mice
Haiyan Liu (Shanghai/CN)
11:33 FP MO-74-10
Role of Quantiferon TB GOLD test in serpiginous
like choroiditis
Jyotirmay Biswas, Swapnesh D. Sawant,
S. Sudharshan, R. Gayathri, Lily K. Therese,
H. N. Madhavan (Chennai/IND)
11:40
Discussion
Room 42
14:00 - 15:30 MO-75
Retina: Miscellaneous 1
Free Paper
Retina
Chairs:
14:00 SL MO-75-01
How can we manage uveal melanoma in 2010
14:09 FP MO-75-02
Lanreotide Autogel for persistent diabetic
macular edema: a prospective study of effective-
ness and quality of life
Maria C. Hernaez-Ortega, Enrique Soto-Pedre,
Jose A. Pinies (Castro-Urdiales/E)
14:16 FP MO-75-03
NAVILAS: A New Paradigm in Retina Education
Michael Ober, Michael Ulbig, Aljoscha Neubauer,
Anselm Kampik (Southfield/USA, Munich/D)
14:23 FP MO-75-04
Natural history of visual acuity changes in sham-
treated patients in a randomized, controlled trial
of Dexamethasone intravitreal implant in patients
with Macular Edema (ME) due to branch or central
Retinal Vein Occlusion (RVO)
Mark Gillies, Julia A. Haller, Mark S. Blumenkranz,
Francesco Bandello, Rubens Belfort, Jeffrey Heier,
Anat Loewentstein, Young-Hee Yoon, Jenny Jiao,
Xiao-Yan (Joanne) Li, Scott M. Whitcup
(Sydney/AUS, Philadelphia/USA, Milano/I,
So Paulo/BR, Stanford/USA, Tel Aviv/IL,
Boston/USA, Seoul/ROK, Irvine/USA)
14:30 FP MO-75-05
Effect of dexamethasone intravitreal implant
on patient-reported visual functioning for the
treatment of macular edema following retinal
vein occlusion
Jonathan W. Kowalski, Anne Rentz, Dennis Revicki,
Francesco Bandello, Mark Gillies, Young-Hee Yoon,
Charlie Liu, Scott M. Whitcup (Irvine/USA,
Cologne/D, Bethesda/USA, Milano/I, Sydney/AUS,
Seoul/ROK)
14:37 FP MO-75-06
Kenalog-40 Induces Inflammatory Cytokines and
Other Proteins in Eyes after Intravitreal Injection
and In Human Macrophages: Biomarkers of Sterile
Endophthalmitis
Jeffrey L. Edelman, Maria Castro-Paiz, Quan Dong
Nguyen, Diana Do, Michael Robinson (Irvine/USA)
14:44 FP MO-75-07
Effectiveness of dexamethasone intravitreal
implant in an animal model of chronic retinal
neovascularization.
James Burke, Yong Li, Ton Lin, Corine Ghosn,
Scott M. Whitcup, Larry Wheeler, Abhiram Vilupuru,
Susan Tsai, Alexandra Almazan (Irvine/USA)
14:51 FP MO-75-08
Influence of anti-VEGF treatment on retinal vessel
diameters
Christos Chryssafis, S. Asteriades, Paraschos Tranos,
A. Vakalis, Aljoscha Neubauer (Thessaloniki/GR,
Munich/D)
Monday, 7 June 2010
M
o
n
d
a
y
,

7

J
u
n
e
167
Monday, 7 June 2010
WOC
2010
16:28 FP MO-76-05
LX211 (Luveniq/voclosporin oral capsules) as
in Clinically Quiescent Sight-Threatening Non-
Infectious Uveitis: Results of the LX211-02 Study of
the LUMINATE Clinical Program
Manfred Zierhut, on behalf of the LUMINATE Study
Group (Tbingen/D)
16:35 FP MO-76-06
Visual acuity and quality of life in patients treated
with LX211 (Luveniq/Voclosporin Oral Capsules) in
an active uveitis affecting the posterior segments
Talin Barisani-Asenbauer (Vienna/A)
16:42 FP MO-76-07
Prevalence of hepatitis B & C in patients scheduled
for cataract surgery A Hospital Based Study
Shahid Shaikh (Karachi/PK)
16:49 FP MO-76-08
Serologic Strain-typing of Toxoplasma Gondii
Associated with Ocular Toxoplasmosis in the
United States.
Partho Kalyani, Chloe Gottlieb, Patrick Coady,
Amy Liu, Michael Zegans, Fei Yu, H. Nida Sen,
Robert Nussenblatt, Gary Holland, Michael Grigg
(Los Angeles/USA, Bethesda/USA)
16:56 FP MO-76-09
Clinical profile of CMV-associated anterior uveitis
in immunocompetent patients
Martina Angi, Flore Rozenberg, Phuc LeHoang,
Bahram Bodaghi (Roma/I, Paris/F)
17:03 FP MO-76-10
Ocular disease awareness and pattern of ocular
manifestation in patients with biopsy proven lung
sarcoidosis
Maria Pefkianaki, Sofia Androudi, Vasileios Sourlas,
Epameinondas Zakynthinos, Maria Kotoula,
Konstantinos Gourgoulianis, Zoe Daniil,
Evangelia Tsironi (Larissa/GR)
17:10
Discussion
14:58 FP MO-75-09
R213W mutation in the XLRS1 gene causes
severe retinoschisis with vitreous hemorrhage in
a Chinese family
Jun Xu, Hong Gu, Ningpu Liu (Beijing/CN)
15:05 FP MO-75-10
Punctate inner choroidopathy: A case report
with improvement after combined intraocular
anti-VEGF and photodynamic therapy
Sebastian Wei, Michael Meyer, Konstantinos
Zinelis, Rolf Winter (Hannover/D)
15:12
Discussion
Room 42
16:00 - 17:30 MO-76
Free Paper
Chairs:
Chi Chao Chan (Bethesda/USA)
Didier Decaudin (Paris/F)
16:00 FP MO-76-01
Improvement of uveitis with everolimus is
associated with Treg cells
Maren Hennig, Susanne Wasmuth, Dirk Bauer,
Martin Busch, Beatrix Zureck-Imhoff, Solon Thanos,
16:07 FP MO-76-02
Evaluation of OCT as a Measure of Response
to LX211 (Luveniq/Voclosporin Oral Capsules)
Therapy in Active Non-Infectious Uveitis
16:14 FP MO-76-03
LX211 (Luveniq/voclosporin oral capsules) for
Active Sight-Threatening Non-Infectious Uveitis
Involving the Posterior Segment: Results of the
LX211-01 Study of the LUMINATE Program
Friederike Mackensen, for the LUMINATE
investigators (Heidelberg/D)
16:21 FP MO-76-04
The Multicenter Uveitis Steroid Treatment (MUST)
Trial: Design and Baseline Characteristics
John H. Kempen, Michael M. Altaweel,
Janet T. Holbroook, Douglas A. Jabs,
Elizabeth A. Sugar (Philadelphia/USA)
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
M
o
n
d
a
y
,

7

J
u
n
e
168
Monday, 7 June 2010
WOC
2010
11:21 FP MO-77-08
Clinical and pathologic characteristics of iris
melanomas: results of a multicenter international
study
Samira Khan, Paul Finger, Per Sandkull,
Stefan Seregard, Daniel Gologorsky, Amy Schefler,
Sander Dubovy, Timothy Murray, Tero Kivela,
Sebastian Eskelin, Robert Raut, Christine Corriveau
(New York/USA, Stockholm/S, Miami/USA,
Helsinki/FIN, Montreal/CDN)
11:28 FP MO-77-09
Conjunctival tumor in Hispanic population.
Clinical serie in 100 patients from Chile
Maria Manquez (Santiago/RCH)
11:35 FP MO-77-10
Primary orbital malignant melanoma in Chinese
Xiaolin Xu (Beijing/CN)
11:42
Discussion
Room 44
14:00 - 15:30 MO-78
Oculoplasty/Orbita/Lids/Lacrimal System 2
Free Paper
Oculoplasty, Orbita, Lids
Chairs:
Brigita Drnovek-Olup (Ljubljana/SI)
David Tse (Miami/USA)
14:00 SL MO-78-01
The use of Titanium T-Plate as platform for globe
alignment in severe paralytic strabismus
David Tse, Erin Shriver, Kenneth Krantz, Jeffrey Tse,
Hilda Capo, Craig McKeown (Miami/USA)
14:09 FP MO-78-02
Composite (hydroxyapatite-silicon) integrated
orbital implants experience with 80 cases
Arkadiusz Pogrzebielski, Anna Michalik-Wjcik,
Anna Markiewicz, Boena Romanowska-Dixon
(Krakw/PL)
14:16 FP MO-78-03
Clinical impact of virtual models for computer-
assisted planning and surgery in orbital recon-
struction
Nils-Claudius Gellrich, Martin Rcker, Harald Essig,
Horst Kokemller, Frank Tavassol, Andr Eckardt,
Alexander Schramm (Hannover/D)
14:23 FP MO-78-04
Functional evaluation of patients with globe
dislocations
Yaroslav Grusha (Moscow/RUS)
Room 44
10:30 - 12:00 MO-77
Oncology 2
Free Paper
Chairs:
Brenda L. Gallie (Toronto/CDN)
Boena Romanowska-Dixon (Krakow/PL)
10:30 SL MO-77-01
TTT in intraocular tumors
Boena Romanowska-Dixon (Krakow/PL)
10:39 FP MO-77-02
Vascular changes in uveal melanoma after
radiotherapy
Anush Amiryan (Moscow/RUS)
10:46 FP MO-77-03
Long-term follow-up on patients treated with
photodynamic therapy for amelanotic choroidal
melanoma
Irene Barbazetto, Thomas Lee, Reza Iranmanesh,
James Klancnick, Brian Maar, David H. Abramson
(New York/USA)
10:53 FP MO-77-04
Comparison of different treatment modalities in
therapy of juxtapapillary uveal melanomas
Michael Freisthler, Harun Akgl, Theodora Gkika,
Dirk Flhs, Wolfgang Sauerwein, Norbert Bornfeld
(Essen/D)
11:00 FP MO-77-05
Integrative Analysis of Differentially Expressed
Genes from Choroidal Melanoma Fine Needle
Biopsies
Tara McCannel, Barry L. Burgess, Nagesh P. Rao, Stan
F. Nelson, Bradley R. Straatsma (Los Angeles/USA)
11:07 FP MO-77-06
Reinterpreting the evidence: Is better survival of
patients with smaller uveal melanomas evidence
of a treatment benefit?
Zelia Correa, James J. Augsburger, Camila Simoes
(Cincinnati/USA)
11:14 FP MO-77-07
Optical Coherence Tomography in 18 Cases of
Subfoveolar Choroidal Osteoma. Evidence for
Photoreceptor Atrophy over the Decalcified
Portion of the Tumor
Benjamin Perez, Carol Shields, Jerry Shields
(Mexico City/MEX, Philadelphia/USA)
169
M
o
n
d
a
y
,

7

J
u
n
e
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
14:30 FP MO-78-05
Levator Excision with Fascia Lata Sling Surgery in
Jaw Winking Ptosis by a Modified Technique
Ashok Grover (New Delhi/IND)
14:37 FP MO-78-06
Treatment of lagophthalmos with hyaluronic acid
gel injection
Elena Agafonova, Yaroslav Grusha,
Dilyara Ismailova, Yulia Ivanchenko (Moscow/RUS)
14:44 FP MO-78-07
Morphologic analysis of interpalpebral adhesions
in different lateral tarsorraphy techniques
Yulia Ivanchenko, Yaroslav Grucha,
Anatoly Fyodorov (Moscow/RUS)
14:51 FP MO-78-08
Exposure Keratopathy Associated with Thyroid Eye
Disease
Dilyara Ismailova, Yaroslav Grusha, Arkady Kasparov
(Moscow/RUS)
14:58 FP MO-78-09
The Mini Tarsal Strip Lateral Canthopexy
Indications, Technique and Complications in 634
Cases
James Oestreicher, Kia Tarassoly (Toronto/CDN)
15:05 FP MO-78-10
Transcanalicular Laser-DCR with 5 mm Ballon-
Dilatation
Karl-Heinz Emmerich, Ralf Ungerechts,Hans-
Werner Meyer-Rsenberg (Darmstadt/D, Hagen/D)
15:12
Discussion
Room 44
16:00 - 17:30 MO-79
New Technology, Bioengineering,
Nanotechnology 2
Free Paper
Chairs:
Caiwen Xiao (Shanghai/CN)
16:00 FP MO-79-01
Laser-actived gold-nanoparticles as a potential
new treatment modality for exsudative age-
related macular-degeneration
Ina Hahn, Florian Levold, Claudine Strack,
Jrgen Groll, Heidrun Keul, Gereon Httmann,
Florian Rudnitzki, Elmar Endl, Nicole Eter (Bonn/D)
16:07 FP MO-79-02
EUREQUO a multinational project for improving
outcomes in cataract and refractive surgery
16:14 FP MO-79-03
The MultiKeratome for cataract surgery curved
with multiple points engineered to seal better
and to minimize the induced astigmatism
Tom Schossau, Matthew Giegengack,
Gerald W. Zaidman, Shree K. Kurup (Scarsdale/USA)
16:21 FP MO-79-04
OCT-Camera assisted intraoperative anterior and
posterior segment surgery First results of the
new intraoperative OCT (iOCT)
Maya Mller, Philipp Steven, Eva Lankenau,
Marc Krug, Emrah Acidereli, Stephan Oelckers,
Reginald Birngruber, Salvatore Grisanti, Gereon
Httmann (Lbeck/D)
16:28 FP MO-79-05
Multimodal imaging of corneal cross-linking
effects
Oliver Stachs, Marine Hovakimyan,
Rudolf F Guthoff, Gereon Httmann,
Alexander Krger, Philipp Steven (Rostock/D,
Lbeck/D)
16:35 FP MO-79-06
Evaluation of cortical activation patterns and
white matter tracts in cases of amblyopia using
fMRI
Rohit Saxena, Shikha Gupta, Senthil Kumaran,
Vimla Menon, Pradeep Sharma (New Delhi/IND)
16:42 FP MO-79-07
Simulation of the accommodation demand to
estimate the power consumption of the artificial
accommodation system
Jrg Nagel, Ulrich Gengenbach, Helmut Guth,
Gerog Bretthauer, Rudolf Guthoff (Eggenstein-
Leopoldshafen/D, Karlsruhe/D, Rostock/D)
16:49 FP MO-79-08
Optimized sensor concept for the Artificial
Accommodation System
Liane Rheinschmitt, Fabian Ritter, Jrg Andr Nagel,
Ulrich Gengenbach, Georg Bretthauer,
Rudolf F. Guthoff (Eggenstein-Leopoldshafen/D,
Karlsruhe/D, Rostock/D)
16:56 SL MO-79-09
Reconstruction of orbital wall defects with
tissue-engineered bone enhanced by human bone
morphogenetic protein 2 in a canine model
17:05
Discussion
Monday, 7 June 2010
M
o
n
d
a
y
,

7

J
u
n
e
170
Scientific Program
T
u
e
s
d
a
y
,

8

J
u
n
e
WOC
2010
171
T
u
e
s
d
a
y
,

8

J
u
n
e
T
U
-
5
8

S
t
r
e
i
f
f

L
e
c
t
u
r
e
H
i
g
h
l
i
g
h
t
S
y
m
p
o
s
i
u
m
F
r
e
e

P
a
p
e
r
W
O
C

C
o
u
r
s
e
I
n
d
u
s
t
r
y

S
y
m
p
o
s
i
u
m
M
e
e
t
i
n
g
s
I
C
C
H
a
l
l

3
H
a
l
l

4
/
5
H
a
l
l

6
H
a
l
l

7
H
a
l
l

8
H
a
l
l

9
H
a
l
l

1
0
I
C
C

L
o
u
n
g
e
R
o
o
f

G
a
r
d
e
n
S
a
l
o
n

1
1
/
1
2
S
a
l
o
n

1
9
S
a
l
o
n

2
0
R
o
o
m

4
2
R
o
o
m

4
3
R
o
o
m

4
4
0
7
1
5
3
0
4
5
0
8
1
5
3
0
4
5
0
9
1
5
3
0
4
5
1
0
1
5
3
0
4
5
1
1
1
5
3
0
4
5
1
2
1
5
3
0
4
5
1
3
1
5
3
0
4
5
1
4
1
5
3
0
4
5
1
5
1
5
3
0
4
5
1
6
1
5
3
0
4
5
1
7
1
5
3
0
4
5
1
8
1
5
3
0
4
5
T
U
-
4
5

D
'
A
m
i
c
o
,

L
i
g
g
e
t
t
,
B
i
n
d
e
r

R
e
t
i
n
a

S
o
c
i
e
t
y

S
y
m
p
:
A
d
v
a
n
c
e
s

i
n

I
n
s
t
r
u
m
e
n
t
a
t
i
o
n
T
U
-
4
6

A
g
a
r
w
a
l
,

L
a
n
g
,

L
a
n
g
,
R
y
a
n
,

S
p
i
v
e
y

O
p
h
t
h
a
l
m
i
c

P
r
e
m
i
e
r

L
e
a
g
u
e

(
O
P
L
)
T
U
-
4
7

K
u
p
p
e
r
m
a
n
n
,

M
u
r
r
a
y
,
P
l
e
y
e
r

U
v
e
i
t
i
s

a

G
l
o
b
a
l

C
h
a
l
l
e
n
g
e
T
U
-
4
8

G
a
r
c
a

A
r
u
m
,
P
o
u
r
n
a
r
a
s
,

B
i
n
d
e
r

C
u
r
r
e
n
t
T
r
e
a
t
m
e
n
t

O
p
t
i
o
n
s
T
U
-
4
9

B
a
u
d
o
u
i
n
,

M
e
s
s
m
e
r
,
Z
a
g
r
s
k
i

I
a
t
r
o
g
e
n
i
c

D
i
s
e
a
s
e
s
o
f

O
c
u
l
a
r

S
u
r
f
a
c
e
T
U
-
5
0

B
a
r
i
s
a
n
i
-
A
s
e
n
b
a
u
e
r
,
B
o
d
a
g
h
i
,

H
e
i
l
i
g
e
n
h
a
u
s

I
O
I
S

S
y
m
p
:

P
e
d
i
a
t
r
i
c

U
v
e
i
t
i
s
T
U
-
4
1

C
o
c
h
e
n
e
r
,

B
e
a
c
o
n
s
f
i
e
l
d
,
G
a
r
c
a
-
D
e
l
p
e
c
h
,

G
a
l
l
e
n
g
a
,
K
a
m
p
i
k

F
E
O
p
h

S
y
m
p
.
T
U
-
5
6

H
u
b
b
a
r
d
,

A
b
r
a
m
o
f
f
,
H
o
r
n
e
g
g
e
r
T
e
c
h
n
i
c
a
l

A
s
p
e
c
t
s
:
T
e
l
e
c
o
m
m
u
n
i
c
a
t
i
o
n
,

C
o
m
p
u
t
.
T
U
-
5
7

G
i
l
b
e
r
t
,

K
l
a
u

B
r
a
i
n
d
r
a
i
n
:

C
h
a
l
l
e
n
g
e
s

a
n
d
S
o
l
u
t
i
o
n
s
T
U
-
5
9

H
e
l
v
e
s
t
o
n
e
,

P
a
r
i
s
,

G
r
f

T
h
e
r
a
p
y

o
f

A
c
q
u
i
r
e
d

S
t
r
a
b
i
s
-
m
u
s
T
U
-
6
0

B
o
d
a
g
h
i
,

C
h
e
e
,

H
e
i
n
z

V
i
r
a
l

U
v
e
i
t
i
s
T
U
-
6
1

V
e
r
g
s
,

Z
a
l
d
i
v
a
r
,
K
o
h
n
e
n

P
a
n
e
l
:

P
h
a
k
i
c

I
O
L
s
T
U
-
6
2

S
e
i
l
e
r

T
h
e

F
e
m
t
o
s
e
c
o
n
d

F
a
c
e
-
o
f
f
T
U
-
6
3

J
o
r
d
a
n
,

C
a
p
r
i
o
l
i
,
T
h
i
e
m
e

G
l
a
u
c
o
m
a
:

S
u
r
g
i
c
a
l

t
h
e
r
a
p
y

2
T
U
-
6
4

J
a
n
k
o
v
,

S
e
i
l
e
r

T
h
e
r
a
p
e
u
t
i
c

C
u
s
t
o
m
i
z
e
d

A
b
l
a
t
i
o
n
T
U
-
6
5

A
y
d
i
n
,

L
i
g
h
t
m
a
n
,

G
l
o
o
r
A

N
e
w

A
p
p
r
o
a
c
h

t
o

T
e
a
c
h
i
n
g
O
p
h
t
h
a
l
m
o
l
o
g
y
T
U
-
6
6

A
s
t
l
e
,

F
i
e
l
d
e
r
,

A
n
d
e
r
-
s
o
n

T
h
e

T
r
a
i
n
i
n
g

o
f

P
a
r
a
-
o
p
h
-
t
h
a
l
m
i
c

P
e
r
s
o
n
n
e
l
T
U
-
6
7

V
e
r
d
a
g
u
e
r
,

S
t
r
a
a
t
s
m
a
,
Z
a
g
r
s
k
i

I
m
p
r
o
v
i
n
g

C
o
n
t
i
n
u
-
i
n
g

E
d
u
c
a
t
i
o
n

W
o
r
l
d
w
i
d
e
T
U
-
6
8

O
l
s
o
n
,

T
a
s
s
i
g
n
o
n
,

N
a
u
m
a
n
n

S
e
t
t
i
n
g

U
p

N
e
w
P
a
r
a
m
.

f
o
r

T
e
a
c
h
i
n
g

O
p
h
t
h
.
T
U
-
6
9

W
i
l
k
i
n
s
o
n
,

A
y
l
w
a
r
d
,
E
t
e
r

C
u
r
r
e
n
t

C
o
n
c
e
p
t
s

i
n
R
e
t
i
n
a
l

D
e
t
a
c
h
m
e
n
t

S
u
r
g
e
r
y
T
U
-
7
0

K
l
i
n
t
w
o
r
t
h
,

M
e
s
s
m
e
r
,
H
e
e
g
a
a
r
d

I
S
O
P

S
y
m
p
:

O
p
h
-
t
h
a
l
m
i
c

P
a
t
h
o
l
o
g
y

U
p
d
a
t
e
T
U
-
7
1

C
o
s
c
a
s

I
O
A
T

S
y
m
p
o
-
s
i
u
m
:

T
e
n

Y
e
a
r
s

t
o

G
o

t
o
t
h
e

G
l
o
b
a
l

E
l
i
m
i
n
a
t
i
o
n
T
U
-
7
2

M
d
i
s

G
e
r
m
a
n
,

P
o
l
i
s
h
,
D
a
n
i
s
h

a
n
d

H
u
n
g
a
r
i
a
n

S
y
m
-
p
o
s
i
u
m

o
n

K
e
r
a
t
o
c
o
n
u
s
W
O
C
-
C
-
6
1

C
o
s
c
a
s

S
D
-
O
C
T

a
n
d

A
M
D

T
r
e
a
t
m
e
n
t
a
n
d

F
o
l
l
o
w

U
p
T
U
-
7
3

O
h
n
o
,

C
h
e
e
,

M
c
C
l
u
s
k
e
y

A
P
I
I
S
G

S
y
m
p
o
s
i
u
m
:

U
v
e
i
t
i
s
W
h
i
c
h

O
n
e

S
h
o
u
l
d

N
o
t

M
i
s
s
T
U
-
7
4

V
a
r
g
a
s
,

T
s
e
n
g
,

C
a
r
r
i
a
z
o
,
A
l
f
o
n
s
o

A
L
A
C
C
S
A
-
R

S
y
m
p
:
C
o
r
n
e
a

a
n
d

O
c
u
l
a
r

S
u
r
f
a
c
e
T
U
-
5
2

W
o
l
f
r
a
m
,

W
e
s
t
,

Z
h
a
o
C
u
r
r
e
n
t

E
p
i
d
e
m
i
o
l
o
g
i
c
a
l

E
y
e
S
t
u
d
i
e
s
T
U
-
5
3

C
h
a
n
,

C
o
u
p
l
a
n
d
,
D
e
u
t
e
r

I
n
t
r
a
o
c
u
l
a
r

l
y
m
p
h
o
m
a
T
U
-
5
4

B
l
u
m
e
n
k
r
a
n
z

O
c
u
l
a
r

P
h
a
r
m
a
c
o
l
o
g
y

f
o
r
P
o
s
t
e
r
i
o
r

S
e
g
m
e
n
t

D
i
s
e
a
s
e
s
T
U
-
7
5

N
i
s
h
i
,

H
a
e
f
l
i
g
e
r
,

G
o
e
s

M
u
l
t
i
f
o
c
a
l

a
n
d

A
c
c
o
m
m
o
d
a
t
-
i
n
g

I
O
L
s
T
U
-
7
6

G
e
l
l
,

T
a
s
s
i
g
n
o
n
,
Z
e
t
t
e
r
s
t
r
m

E
S
C
R
S

S
y
m
p
o
-
s
i
u
m
:

N
e
w

I
O
L

C
o
n
c
e
p
t
s
T
U
-
7
7

J
n
e
m
a
n
n
,

R
e
j
d
a
k

R
e
g
e
n
e
r
a
t
i
o
n

a
n
d

r
e
p
a
i
r

i
n
r
e
t
i
n
a
l

d
e
g
e
n
e
r
a
t
i
o
n
W
O
C
-
C
-
6
3

G
a
r
c
i
a
-
M
a
r
c
o
s

F
e
m
t
o
s
e
c
o
n
d

(
F
S
)

C
o
u
r
s
e

i
n
O
p
h
t
h
a
l
m
o
l
o
g
y
T
U
-
8
3

Z
i
e
r
h
u
t

I
U
S
G

W
o
r
k
s
h
o
p
:

D
i
a
g
n
o
s
t
i
c

C
r
i
t
e
r
i
a

o
f

V
i
r
u
s
-
i
n
d
u
c
e
d

A
n
t
e
r
i
o
r

U
v
e
i
t
i
s
M
e
e
t
i
n
g

d
e
r

I
n
t
e
r
n
a
t
i
o
n
a
l

A
g
e
n
c
y

f
o
r

t
h
e

P
r
e
v
e
n
t
i
o
n

o
f

B
l
i
n
d
n
e
s
s
W
O
C
-
C
-
4
7

W
y
l
e
g
a
l
a
,

B
a
u
d
o
u
i
n
,

G
u
t
h
o
f
f

C
o
r
n
e
a
l

I
m
a
g
i
n
g
W
O
C
-
C
-
4
6

F
e
i
n
b
a
u
m
,

P
a
t
e
l
,
M
r
u
k
w
a
-
K
o
m
i
n
e
k

A
c
h
i
e
v
i
n
g

E
x
c
e
l
l
e
n
c
e
W
O
C
-
C
-
4
8

H
a
t
t
e
n
b
a
c
h

C
u
r
r
e
n
t

C
o
n
c
e
p
t
s

i
n

t
h
e
M
a
n
a
g
.

o
f

R
e
t
.

V
e
s
s
e
l

O
c
c
l
u
.
T
U
-
7
9

M
u
r
u
b
e

d
e
l

C
a
s
t
i
l
l
o
,
U
g
u
r
b
a
s
,

G
e
e
r
l
i
n
g

D
r
y

E
y
e
:
L
a
t
e
s
t

A
d
v
.

i
n

S
u
r
f
o
c
.

D
r
y
n
e
s
s
W
O
C
-
C
-
5
0

V
i
e
s
t
e
n
z
,

K
u
h
n

M
a
n
a
g
e
m
e
n
t

o
f

t
h
e

r
u
p
t
u
r
e
d

G
l
o
b
e
W
O
C
-
C
-
4
9

H
o
e
r
a
u
f

C
u
r
r
e
n
t

M
a
n
a
g
e
m
e
n
t

o
f

D
i
a
b
e
t
i
c

M
a
c
u
l
a
r

E
d
e
m
a
W
O
C
-
C
-
5
1

L
a
n
g

C
h
a
l
l
e
n
g
i
n
g

C
a
s
e
s

i
n

A
n
t
e
-
r
i
o
r

S
e
g
m
e
n
t

S
u
r
g
e
r
y
W
O
C
-
C
-
5
2

M
e
y
e
r
-
R
s
e
n
b
e
r
g

B
l
e
p
h
a
r
o
p
l
a
s
t
y

I
I
T
U
-
8
1

A
r
m
i
t
a
g
e
,

B
i
r
n
b
a
u
m
,
G
o
t
t
s
c
h

C
o
r
n
e
a
/
E
x
t
e
r
n
a
l

D
i
s
-
e
a
s
e
:

M
i
s
c
.
,

S
u
r
g
i
c
a
l

t
h
e
r
a
p
y

3
T
U
-
8
0

H
o
l
l
a
d
a
y
,

R
e
i
n
s
t
e
i
n
,
M
c
D
o
n
n
e
l
l

R
e
f
r
a
c
t
i
v
e

s
u
r
g
e
r
y
/
R
e
f
r
a
c
t
i
o
n

4
W
O
C
-
C
-
5
4

S
c
h
e
u
e
r
l
e

T
h
e
o
p
t
i
c

d
i
s
c

f
u
n
d
u
s
c
.
,

p
e
r
i
m
e
-
t
r
y
,

l
a
s
e
r

s
c
a
n
n
i
n
g

o
p
h
t
h
a
l
m
.
T
U
-
8
2

H
a
i
g
i
s
,

P
h
a
m
,

M
a
l
y
u
g
i
n

C
a
t
a
r
a
c
t
/
b
i
o
m
e
t
r
y

4
T
U
-
5
5

L
o
r
e
n
z
,

M
a
u
m
e
n
e
e
L
e
b
e
r

C
o
n
g
e
n
i
t
a
l

A
m
a
u
r
o
s
i
s
T
U
-
7
8

V
i
n
c
i
g
u
e
r
r
a
,

K
e
z
i
r
i
a
n
,
E
p
s
t
e
i
n

B
e
s
t

E
x
c
i
m
e
r

L
a
s
e
r
T
u
e
s
d
a
y
,

8

J
u
n
e
H
i
g
h
l
i
g
h
t
S
y
m
p
o
s
i
u
m
F
r
e
e

P
a
p
e
r
W
O
C

C
o
u
r
s
e
I
n
d
u
s
t
r
y

S
y
m
p
o
s
i
u
m
M
e
e
t
i
n
g
s
M
e
s
s
e
S
t
o
c
k
h
o
l
m

S
a
o

P
a
u
l
o
A
b
u

D
h
a
b
i

O
s
l
o

H
a
l
l

R
o
o
m

M
a
d
r
i
d
R
o
o
m

S
y
d
n
e
y
R
o
o
m

H
o
n
g

K
o
n
g
R
o
o
m

I
s
t
a
n
b
u
l

V
I
P

L
o
u
n
g
e

1

V
I
P

L
o
u
n
g
e

2

R
a
d
i
o

T
o
w
e
r

L
o
u
n
g
e

1
R
a
d
i
o

T
o
w
e
r
L
o
u
n
g
e

2
H
a
l
l

1
1
0
7
1
5
3
0
4
5
0
8
1
5
3
0
4
5
0
9
1
5
3
0
4
5
1
0
1
5
3
0
4
5
1
1
1
5
3
0
4
5
1
2
1
5
3
0
4
5
1
3
1
5
3
0
4
5
1
4
1
5
3
0
4
5
1
5
1
5
3
0
4
5
1
6
1
5
3
0
4
5
1
7
1
5
3
0
4
5
1
8
1
5
3
0
4
5
T
U
-
0
1

L
u
c
k
e
,

D
u
c
o
u
r
n
a
u
E
V
R
S

S
y
m
p
:

I
n
n
o
v
.

T
e
c
h
-
n
i
q
u
e
s

i
n

V
i
t
r
e
o
r
.

S
u
r
g
e
r
y
T
U
-
0
2

V
a
s
s
i
l
e
v
a
,

N
m
e
t
h
,
K
a
s
k
a
l
o
g
l
u

S
E
E
O
S
/
B
S
O
S
S
y
m
p
:

C
o
u
n
t
r
i
e
s

i
n

T
r
a
n
s
i
t
i
o
n
T
U
-
0
3

H
a
e
f
l
i
g
e
r
,

K
i
r
c
h
h
o
f
,
S
c
h
a
r
r
e
r

D
O
C

S
y
m
p
o
s
i
u
m
:
O
c
u
l
a
r

S
u
r
g
e
r
y

T
U
-
0
4

O
b
s
t
b
a
u
m
,

T
e
t
z

C
o
m
b
i
n
a
t
i
o
n
s

C
a
t
a
r
a
c
t

a
n
d
O
t
h
e
r

S
u
r
g
e
r
i
e
s
T
U
-
8
4
G
o
i
n
g

B
l
i
n
d
T
U
-
0
6

A
d
e
n
i
s
,

M
e
y
e
r
-
R
s
e
n
-
b
e
r
g
,

S
e
i
f
f

O
p
h
t
h
a
l
m
.

C
h
a
l
-
l
e
n
g
e
s

i
n

A
e
s
t
h
e
t
i
c

S
u
r
g
e
r
y
T
U
-
0
7

L
o
r
e
n
z
P
e
d
i
a
t
r
i
c

C
a
t
a
r
a
c
t

S
u
r
g
e
r
y
T
U
-
0
8

L
a
n
d
a
u
,

S
c
h
i
e
f
e
r
,
A
y
d
i
n

U
n
e
x
p
l
a
i
n
e
d

V
i
s
u
a
l

L
o
s
s
T
U
-
0
9

B
o
r
n
f
e
l
d
,

L
e
m
m
e
n

V
i
t
r
e
o
r
e
t
i
n
a
l
e
s

U
p
d
a
t
e

d
e
r
R
e
t
i
n
o
l
o
g
i
s
c
h
e
n

G
e
s
e
l
l
s
c
h
a
f
t
T
U
-
1
0

O
l
s
e
n
,

H
o
l
l
a
d
a
y
,

H
a
i
g
i
s

G
e
t
t
i
n
g

t
h
e

P
o
w
e
r

R
i
g
h
t
:

I
O
L
P
o
w
e
r

C
a
l
c
u
l
a
t
i
o
n
s
T
U
-
1
1

W
o
l
f
,

L
a
n
g
,

d
e

L
a
e
y

N
e
t
z
h
a
u
t
-
F
a
l
l
k
o
n
f
e
r
e
n
z
T
U
-
1
2

S
e
i
t
z

C
o
n
s
i
l
i
u
m

d
i
a
g
n
o
s
t
i
c
u
m
T
U
-
1
3

A
h
m
e
d
,

S
h
a
a
r
a
w
y
,

E
r
b

S
u
r
g
i
c
a
l

V
i
d
e
o
s

a
n
d

P
a
n
e
l
D
i
s
c
u
s
s
i
o
n
T
U
-
1
4

N
g
u
y
e
n
,

F
l
e
t
c
h
e
r
,

O
n
d
i
-
v
e
e
r
a
n

I
n
t
e
r
v
e
n
t
i
o
n
s

i
n

A
M
D

B
e
y
o
n
d

I
n
t
r
a
v
.

I
n
j
e
c
t
i
o
n
s
T
U
-
1
5

G
u
p
t
a
,

C
o
r
d
e
i
r
o
,

V
o
r
w
-
e
r
k

N
e
u
r
a
l

B
a
s
e
d

T
a
r
g
e
t
i
n
g

i
n
G
l
a
u
c
o
m
a
T
U
-
1
6

O
r
g
l
,

G
r
a
m
e
r
,

H
a
r
r
i
s

O
c
u
l
a
r

B
l
o
o
d

F
l
o
w

C
l
i
n
i
c
a
l
R
e
l
e
v
a
n
c
e

f
o
r

G
l
a
u
c
o
m
a
T
U
-
1
7

N
u
s
s
e
n
b
l
a
t
t
,

C
u
r
n
o
w
,
T
h
u
r
a
u
P
r
o
t
e
o
m
i
c
s

a
n
d

G
e
n
o
m
i
c
s

i
n

U
v
e
i
t
i
s
T
U
-
1
8

H
a
s
s
a
n
,

K
a
i
s
e
r
,

H
u
-
m
a
y
u
n

A
S
R
S

S
y
m
p
:

T
h
e

F
u
-
t
u
r
e

o
f

S
u
r
g
.

a
n
d

M
e
d
.

R
e
t
i
n
a
T
U
-
1
9

C
e
r
n
k
,

M
a
i
e
r

E
y
e
B
a
n
k
i
n
g
:

O
p
t
i
m
i
z
i
n
g

T
e
c
h
-
n
i
q
u
e
s

a
n
d

Q
u
a
l
i
t
y

C
o
n
t
r
o
l
T
U
-
2
0

L
a
r
k
i
n
,

P
l
e
y
e
r
,

S
a
w
a
t
z
k
i

I
m
m
u
n
o
l
o
g
y

o
f

K
e
r
a
t
o
p
l
a
s
t
y
T
U
-
2
1

F
o
r
s
o
t
t
,

E
h
l
e
r
s
,

D
u
n
c
k
e
r
R
G
P

L
e
n
s
e
s
:

N
o
n

S
u
r
g
i
c
a
l
T
r
e
a
t
m
.

o
f

R
e
f
r
a
.

E
r
r
o
r
s
T
U
-
2
2

S
h
i
e
l
d
s
,

D
a
m
a
t
o
,

B
o
r
n
f
e
l
d

P
a
n
e
l
:

U
v
e
a
l

T
u
m
o
r
s
T
U
-
2
3

B
h
i
s
i
t
k
u
l
,

A
y
l
w
a
r
d
,
H
e
i
m
a
n
n

E
v
i
d
e
n
c
e
-
b
a
s
e
d
M
a
n
a
g
e
m
.

o
f

R
e
t
i
n
a
l

D
i
s
e
a
s
e
T
U
-
2
4

P
r
a
j
n
a
,

N
e
u
h
a
n
n

M
o
d
e
r
n

M
a
n
u
a
l

C
a
t
a
r
a
c
t
S
u
r
g
e
r
y
T
U
-
2
5

A
r
t
e
a
g
a
,

K
a
m
m
a
n
n
,
Z
e
t
t
e
r
s
t
r
m

C
a
t
a
r
a
c
t
/
b
i
o
m
e
t
r
y

3
T
U
-
2
6

G
o
l
d
s
t
e
i
n
,

M
l
y
,

T
o
s
t
T
h
e
r
a
p
.

C
o
n
t
a
c
t

L
e
n
s
e
s
:

B
a
n
d
.
L
e
n
s
e
s

a
n
d

D
r
u
g

R
e
l
e
a
s
e
T
U
-
2
7

S
c
h
r
a
g
e
,

L
a
n
g
e
r
,

G
i
n
i

H
o
t

T
o
p
i
c
s

i
n

O
c
u
l
a
r

T
r
a
u
m
a
-
t
o
l
o
g
T
U
-
2
8

K
u
h
n
,

S
c
h
r
a
d
e
r
,

S
u
l
l
i
v
a
n

G
l
o
b
e

R
e
c
o
n
s
t
r
u
c
-
t
i
o
n

a
f
t
e
r

S
e
v
e
r
e

E
y
e

I
n
j
u
r
y
W
O
C
-
C
-
4
2

T
h
i
e
m
e

W
e
t
l
a
b

G
l
a
u
c
o
m
a

D
r
a
i
n

I
m
p
l
a
n
t
s
W
O
C
-
C
-
4
3

A
u
f
f
a
r
t
h
,

D
i
c
k

W
e
t
l
a
b

P
h
a
c
o

C
o
u
r
s
e

f
o
r

B
e
g
i
n
n
e
r
s
W
O
C
-
C
-
4
4

A
u
f
f
a
r
t
h

W
e
t
l
a
b

P
h
a
c
o

C
o
u
r
s
e

f
o
r

t
h
e
A
d
v
a
n
c
e
d
W
O
C
-
C
-
4
5

A
u
f
f
a
r
t
h
,

D
i
c
k

W
e
t
l
a
b

B
i
a
x
i
a
l

a
n
d

M
i
c
r
o
-
c
o
a
x
i
a
l

P
h
a
c
o
e
m
u
l
s
i
f
i
c
a
t
i
o
n
T
U
-
2
9

H
a
t
t
e
n
b
a
c
h
,

C
o
s
c
a
s
,
S
t
o
u
t

R
e
t
i
n
a
:

V
a
s
c
u
l
a
r

D
i
s
e
a
s
e

2
T
U
-
3
0

B
a
e
r
v
e
l
d
t
,

W
o
r
m
a
l
d
,
Y
o
u
n
g

G
l
a
u
c
o
m
a
:

M
e
d
i
c
a
l

t
h
e
r
a
p
y
T
U
-
3
1

B
a
u
d
o
u
i
n
,

R
e
i
n
h
a
r
d
C
o
r
n
e
a
/
E
x
t
e
r
n
a
l

D
i
s
e
a
s
e
:
M
e
d
i
c
a
l

t
h
e
r
a
p
y
T
U
-
3
2

H
e
l
b
i
g
,

P
a
s
y
e
c
h
n
i
k
o
v
a
,
R
i
c
h
a
r
d

R
e
t
i
n
a
:

S
u
r
g
i
c
a
l

t
h
e
r
a
p
y

3
T
U
-
3
3

J
o
u
s
s
e
n
,

T
h
e
e
l
e
n

R
e
t
i
n
a
:

D
i
a
g
n
o
s
t
i
c
s

3
T
U
-
3
4

L
e
m
m
e
n
,

P
o
u
r
n
a
r
a
s
R
e
t
i
n
a
:

S
u
r
g
i
c
a
l

t
h
e
r
a
p
y

2
T
U
-
3
5

F
i
n
g
e
r
,

M
i
t
c
h
e
l
l
,

B
a
n
d
e
l
l
o

R
e
t
i
n
a
:

M
e
d
i
c
a
l

t
h
e
r
a
p
y

2
T
U
-
3
6

L
i
,

M
a
c
L
a
r
e
n
,

W
i
e
d
e
m
a
n
n

R
e
t
i
n
a
:

B
a
s
i
c
s
T
U
-
3
7

T
h
u
m
a
n
n
,

K
a
i
s
e
r
,
P
a
u
l
e
i
k
h
o
f
f

R
e
t
i
n
a
:

A
M
D

3
T
U
-
3
8

P
l
e
y
e
r

E
V
E
R

S
y
m
p
o
s
i
u
m
:

H
o
w

t
o
g
e
t

y
o
u
r

w
o
r
k

p
u
b
l
i
s
h
e
d
?
T
U
-
3
9

A
l
i
,

S
e
i
l
e
r
I
S
R
S
/
A
A
O

S
y
m
p
o
s
i
u
m
:

C
u
t
t
i
n
g

E
d
g
e

P
r
o
g
r
e
s
s
T
U
-
4
0

F
i
n
g
e
r
,

S
e
r
e
g
a
r
d
,

K
i
v
e
l
A
J
C
C
/
U
I
C
C

S
y
m
p
:

T
N
M

b
a
s
e
d
C
l
a
s
s
i
f
.

S
y
s
t
.

f
o
r

O
n
c
.

O
n
c
o
l
o
g
y
T
U
-
4
2

K
a
m
p
i
k
,

B
e
d
r
i
,

Q
u
r
e
s
h
i
S
u
s
t
a
i
n
a
b
l
e

E
y
e

H
e
a
l
t
h

P
r
o
g
r
a
m
s
T
U
-
4
3

S
u
s
a
n
n
a
,

J
r
,

S
i
n
g
h
,
H
e
a
l
e
y

W
G
A

S
y
m
p
:

M
a
n
a
g
-
i
n
g

A
d
v
a
n
c
e
d

G
l
a
u
c
o
m
a
T
U
-
4
4

C
u
n
h
a
-
V
a
z
,

S
a
h
e
l
,
P
f
e
i
f
f
e
r

N
e
t
w
o
r
k
i
n
g

f
o
r

C
l
i
n
i
-
c
a
l

T
r
i
a
l

R
e
s
e
a
r
c
h

i
n

E
u
r
o
p
e
P
o
s
t
e
r

e
x
h
i
b
i
t
i
o
n

o
f

P
o
s
t
e
r

P
-
T
U
-
0
0
1

t
o

P
-
T
U
-
2
6
5
S I X T
R E N T
A C A R
Y K L S
Looking sharp means
facing Sixt!
(Sixt the official car rental partner
of the World Ophthalmology Congress)
Reservations and information:
From Europe: +49(0)180/5 25 25 25
(0,14 per min. from the German landlines,
prices from mobile phones max. 0,42 per min)
From North America: 1-888-SIXTCAR
From South America: 0800-772 SIXT (from Brazil; toll free)
From Australia: 3 9824 2273
or www.sixt.com
WOC
2010
Stockholm
10:30 - 12:00 TU-02
SEEOS/BSOS Symposium: Countries in Transition
Challenges and Achievements in Eye Care
Symposium
Chairs:
Mahmut Kaskaloglu (Izmir/TR)
10:30 IL TU-02-01
Challenges of Diabetic Rethinopathy treatment in
Serbia today
Slobodanka Latinovic (Novi Sad/SRB)
10:40 IL TU-02-02
Mini-invasive vitrectomy: expanded indications in
complex cases
Cesare Forlini (Ravenna/I)
10:50 IL TU-02-03
The current state of ophthalmology in Turkey
Mahmut Kaskaloglu (Izmir/TR)
11:00 IL TU-02-04
Clear lens extraction 6 years follow-up
Nikica Gabric (Zagreb/HR)
11:10 IL TU-02-05
East meets West, South meets North harmonisa-
tion of ophthalmology training in Europe
11:20 IL TU-02-06
Prevention of blindness and visual rehabilitation
11:30 IL TU-02-07
Russian experience in quality ophthalmic care
Elena Khristovna Takhchidi (Moscow/RUS)
11:40 IL TU-02-08
Cross-borders Education and Blindness Prevention
11:50
Discussion
Stockholm
08:30 - 10:00 TU-01
EVRS Symposium: Innovative Techniques in
Vitreoretinal Surgery
Symposium
Retina
Chairs:
Klaus Lucke (Bremen/D)
Didier Ducournau (Nantes/F)
08:30 IL TU-01-01
Membrane Peeling without Vitrectomy
Fabio Patelli (Milan/I)
08:40 IL TU-01-02
Brilliant blue vs. ICG in macular hole surgery
08:50 IL TU-01-03
ILM Peeling in Macular Edema
Didier Ducournau (Nantes/F)
09:00 IL TU-01-04
A New Theory of Lamellar Macular Hole
Jerzy Nawrocki (Lodz/PL)
09:10 IL TU-01-05
Posterior Hyaloid Peeling in Myopic Foveoschisis
09:20 IL TU-01-06
ILM Peeling in diabetic Retinopathy
Giampaolo Gini (Prato/I)
09:30 IL TU-01-07
PVR Prophylaxis in Trauma
Ferenc Kuhn (Birmingham/USA)
09:40 IL TU-01-08
cPPV and PVD Induction Back to the Future?
Frank Koch (Frankfurt/D)
09:50
Discussion
175
T
u
e
s
d
a
y
,

8

J
u
n
e
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
T
u
e
s
d
a
y
,

8

J
u
n
e
176
WOC
2010
Stockholm
14:00 - 15:30 TU-03
DOC Symposium: Ocular Surgery Progress and
Perspective
Symposium
Ocular Surgery
Chairs:
Eduard A. Haefliger (Binningen/CH)
Armin Scharrer (Frth/D)
14:00 IL TU-03-01
Part I: Defining the"State of the art": Glaucoma
Surgery what makes a gold standard?
14:10 IL TU-03-02
After-cataract prevention: Evaluating the standard
and defining the gold standard
14:20 IL TU-03-03
Avastin in wet AMD: State of the art or good
enough for the savings?
14:30 IL TU-03-04
Surgical correction of Presbyopia: What can we do
and what should we not do?
14:40 IL TU-03-05
Part II: Assuring the quality: Guidelines for refrac-
tive surgery in Germany: 15 years of experience
with the KRC
14:50 IL TU-03-06
Providing highest quality LASIK the LASIK
TUEV certification and quality label
15:00 IL TU-03-07
Tailoring indication to surgery to patients
satisfaction
15:10 IL TU-03-08
Outcome of quality assessment and benchmarking
in external cataract surgery: Rationale for using a
survey versus a prospective follow-up design
Burkhard Awe, Ursula Hahn, Stefanie Schmickler
(Wilhelmshaven/D, Dsseldorf/D, Ahaus/D)
15:20
Discussion
Stockholm
16:00 - 17:30 TU-04
Combinations Cataract and Other Surgeries
Symposium
Cataract
Chairs:
Stephen A. Obstbaum (New York/USA)
16:00 IL TU-04-01
Cataract and Glaucoma Surgery
Stephen A. Obstbaum (New York/USA)
16:20 IL TU-04-02
Cataract and Canaloplasty
16:40 IL TU-04-03
Cataract Surgery and Keratoplasty
Marc Muraine (Rouen/F)
17:00 IL TU-04-04
Combined Trabeculectomy and Cataract
Extraction Versus Trabeculectomy Alone in Primary
Angle-closure Glaucoma
Hin Yeung Tsai (Taichung/TJ)
Stockholm
18:00 - 20:00 TU-84
Going Blind
Symposium
There are too many people with vision loss who
could benefit from much earlier diagnosis and
intervention and dramatically increased awareness
of what's possible in vision rehabilitation. I would
ask that physicians don't wait until we've lost
much of our vision before they talk to us about
vision rehabilitation, including the services and
resources that can help us live most effectively and
plan positively for the future.
Please refer us to these specialists and don't ever
tell patients that there is nothing more that can
be done! There are always new skills to learn. Enor-
mous progress has come through the power of
strong advocates. We have many disability role
models who broke the rules and made stunning
progress! We need to do the same to increase
public awareness of sight loss!
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
T
u
e
s
d
a
y
,

8

J
u
n
e
177
WOC
2010
Sao Paulo
10:30 - 12:00 TU-06
Ophthalmological Challenges in Aesthetic Surgery
Symposium
Oculoplasty
Chairs:
Jean-Paul Adenis (Limoges/F)
Stuart Seiff (San Francisco/USA)
10:30 IL TU-06-01
Brow lift
10:45 IL TU-06-02
Lower lid blepharoplasty and midface lift
11:00 IL TU-06-03
Laser blepharoplasty
11:15 IL TU-06-04
Minimal invasive surgery in aesthetic
Raymond Douglas (Ann Arbor/USA)
11:30 IL TU-06-05
Aesthetic oculofacial rejuvenation in Asians
11:45
Discussion
Sao Paulo
14:00 - 15:30 TU-07
Pediatric Cataract Surgery
Symposium
Cataract
Chairs:
14:00 IL TU-07-01
Sutureless pars plana anterior vitrectomy and
capsulotomy for significant PCO in young children
TBA
14:10 IL TU-07-02
Sutured IOL's
Edward G. Buckley (Durham/USA)
14:20 IL TU-07-03
Congenital Idiopathic Microcoria in an infant,
IOL implantation in children with uveitis
Scott R. Lambert (Atlanta/USA)
14:30 IL TU-07-04
Combined Procedure for Treatment of Aphakia and
Glaucoma after Infantile Cataract Surgery
David A. Plager (Indianapolis/USA)
14:40 IL TU-07-05
Secondary infantile cataract associated with
presumed intrauterine infection
Birgit Lorenz (Giessen)
14:50 IL TU-07-06
Anterior and Posterior Capsulorexis in Children
Charlotta Zetterstrm (Oslo/N)
15:00
Discussion
Sao Paulo
16:00 - 17:30 TU-08
Unexplained Visual Loss
Symposium
Neuro-Ophthalmology
Chairs:
16:00 IL TU-08-01
Optical pitfalls
Oliver Job (Lucerne/CH)
16:10 IL TU-08-02
Seven easy steps to managing unexplained visual
loss
16:20 IL TU-08-03
Easily Missed Retinal Disorders
Murat Karacorlu (Istanbul/TR)
16:30 IL TU-08-04
The How and the Why of non-organic visual loss
16:40 IL TU-08-05
Panel discussion / Case demonstration
Klara Landau, Ulrich Schiefer, Pinar Aydin, Gordon
Plant, Andrew G. Lee, Oliver Job, Murat Karacorlu
(Zurich/CH, Tbingen, Ankara/TR, London/UK,
Houston/USA, Lucerne/CH, Istanbul/TR)
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
T
u
e
s
d
a
y
,

8

J
u
n
e
178
WOC
2010
Abu Dhabi
08:30 - 10:00 TU-09
Vitreoretinal update Retinological Society
(Session in German)
Symposium
Retina
Chairs:
08:30 IL TU-09-01
Strategien zur Versorgung kombinierter Verletzun-
gen von Vorder- und Hinterabschnitt aus der Sicht
des Vorderabschnitts-Chirurgen
08:45 IL TU-09-02
Strategien zur Versorgung kombinierter Verletzun-
gen von Vorder- und Hinterabschnitt aus der Sicht
des Hinterabschnitts-Chirurgen
09:00 IL TU-09-03
Wehrmedizinische Aspekte der Versorgung ein-
satzbedingter schwerer Augenverletzungen
Hermann O. C. Gmbel (Ulm/D)
09:15 IL TU-09-04
Makuladem bei diabetischer Retinopathie und
bei retinalen Venenverschlssen: Gewebsdestruk-
tive oder medikamentse Therapie?
09:40 IL TU-09-05
Netzhautkomplikationen bei refraktiver Chirurgie
Albrecht Lommatzsch, Daniel Pauleikhoff (Mn-
ster/D)
Abu Dhabi
10:30 - 12:00 TU-10
Getting the Power Right: IOL Power Calculations
Symposium
Cataract
Chairs:
Thomas Olsen (Aarhus/DK)
10:30 IL TU-10-01
Intraocular lens power calculations following
keratorefractive surgery
10:45 IL TU-10-02
IOL calculation using paraxial matrix optics
11:00 IL TU-10-03
Intraocular lens calculation in extreme ametropia
Michel Puech (Paris/F)
11:15 IL TU-10-04
Comparing ultrasound biometry with partial
coherence interferometry for intraocular lens
power calculations
Thomas Olsen (Aarhus/DK)
11:30
Discussion
Abu Dhabi
14:00 - 15:30 TU-11
Retina Case Presentations with Focus on
Fluorescein Angiography and Optical Coherence
Tomography
(Session in German)
Symposium
Retina
Chairs:
Jean-Jacques de Laey (Gent/B)
In this interactive conference interesting fluores-
cein angiographic and OCT findings are discussed.
Short case presentations will be given including
anamnesis and the important findings. Especially
rare and dubious cases shall be discussed.
Abu Dhabi
16:00 - 17:30 TU-12
Consilium diagnosticum
(Session in German)
Symposium
Chairs:
Hans Hoerauf (Gttingen)
Panel:
Hans Hoerauf (Gttingen/D)
Jan E. E. Keunen (Nijmegen/NL)
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
T
u
e
s
d
a
y
,

8

J
u
n
e
179
WOC
2010
In dem Symposium werden ungewhnliche
Krankheitsbilder vorgestellt. Ein internationales
Panel und das Auditorium werden um diagnos -
tischen und therapeutischen Rat gebeten.
Oslo
08:30 - 10:00 TU-13
Surgical Videos and Panel Discussion
Symposium
Glaucoma
Chairs:
Carl Erb (Berlin/D)
08:30 IL TU-13-01
Canaloplasty
Norbert Korber (Cologne/D)
08:40 IL TU-13-02
Glaukos iStent
08:50 IL TU-13-03
ExPress
Leon W. Herndon (Durham/USA)
09:00 IL TU-13-04
SOLX Gold shunt
Shlomo Melamed (Tel Hashomer/IL)
09:10 IL TU-13-05
Trabectome
Steven D. Vold (Rogers/USA)
09:20 IL TU-13-06
Ahmed Glaucoma valve
09:30 IL TU-13-07
Baerveldt glaucoma implant
09:40 IL TU-13-08
Endocyclophotocoagulation
TBA
09:50
Discussion
Oslo
10:30 - 12:00 TU-14
Interventions in AMD Beyond Intravitreal
Injections
Symposium
Retina
Chairs:
Nhung Xuan Nguyen (Tbingen/D)
Daniel Fletcher (San Francisco/USA)
Veera Ramani Ondiveeran (Selangor Darul
Ehsan/MAL)
10:30 IL TU-14-01
Effectiveness of magnifying low vision aids in
Nhung Xuan Nguyen (Tbingen/D)
10:40 IL TU-14-02
Practical Ways to Help Patients Become Aware of
Macular Scotomas and Minimize Their Impact on
Reading
Daniel Fletcher (San Francisco/USA)
10:50 IL TU-14-03
Changing trends in Management of AMD-
Malaysian Perspective
Veera Ramani Ondiveeran (Selangor Darul
Ehsan/MAL)
11:00 IL TU-14-04
Quality of life and age-related macular
degeneration: Does Anti-VEGF treatment in day to
day settings impact vision-related QoL in AMD?
11:10 IL TU-14-05
Can diet reduce the genetic risk of AMD?
Carolin Klaver (Rotterdam/NL)
11:20 IL TU-14-06
Italian Smith-Kettlewell Read Test to assess
reading difficulties in AMD
Gianfrancesco Villani (Verona/I)
11:30
Discussion
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
T
u
e
s
d
a
y
,

8

J
u
n
e
180
WOC
2010
Oslo
14:00 - 15:30 TU-15
Neural Based Targeting in Glaucoma
Symposium
Glaucoma
Chairs:
14:00 IL TU-15-01
Mitochondrial targets in glaucoma
Neville N. Osborne (Oxford/UK)
14:10 IL TU-15-02
Targeting RGCs and dendrites in glaucoma
14:20 IL TU-15-03
Targeting the brain in glaucoma
14:30 IL TU-15-04
Emerging stem cell therapies for glaucoma
14:40 IL TU-15-05
Regenerative approaches for glaucoma
Michael J. Young (Boston/USA)
14:50 IL TU-15-06
Nano-strategies to protect neurons in glaucoma
15:00
Discussion
Oslo
16:00 - 17:30 TU-16
Ocular Blood Flow Clinical Relevance for
Glaucoma
Symposium
Glaucoma
Chairs:
Selim Orgl (Basel/CH)
Eugen Gramer (Wrzburg/D)
Alon Harris (Indianapolis/USA)
16:00 IL TU-16-01
Population based studies: perfusion pressure and
blood flow in glaucoma
Alon Harris (Indianapolis/USA)
16:10 IL TU-16-02
Measurements of ocular blood flow
Ingrida Janulevciene (Kaunas/LT)
16:20 IL TU-16-03
The ischemic optic nerve in glaucoma
16:30 IL TU-16-04
Genetic markers for ischemia in glaucoma
Louis R. Pasquale (Boston/USA)
16:40 IL TU-16-05
Circadian blood pressure and perfusion pressure in
the glaucoma patient
Vital P. Costa (So Paulo/BR)
16:50 IL TU-16-06
Systemic medications and ocular blood flow in the
glaucoma patient
17:00
Discussion
Room Madrid
08:30 - 10:00 TU-17
Proteomics and Genomics in Uveitis
Symposium
Chairs:
S. John Curnow (Birmingham/UK)
08:30 IL TU-17-01
Genomics
Tammy Martin (Portland/USA)
08:45 IL TU-17-02
Profiling of the human retinal endothelial cell;
implications for the pathogenesis of uveitis
09:00 IL TU-17-03
Gene expression profiles in patients with
noninfectious uveitis
09:15 IL TU-17-04
Gene expression of pathogenic T cells in EAU
09:30 IL TU-17-05
Proteomics in equine uveitis
Cornelia A. Deeg (Munich/D)
09:45
Discussion
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
T
u
e
s
d
a
y
,

8

J
u
n
e
181
WOC
2010
Room Madrid
10:30 - 12:00 TU-18
ASRS Symposium: The Future of Surgical and
Medical Retina: Where Do We Go Next?
Symposium
Retina
Chairs:
Peter K. Kaiser (Cleveland/USA)
Mark Humayun (Los Angeles/USA)
10:30 IL TU-18-01
Evolving techniques of vitreous removal:
Pharmacologic and Portable Vitrectomy
10:40 IL TU-18-02
The Future of Pharmacologic Treatment of Age-
Related Macular Degeneration
10:50 IL TU-18-03
The Retinal Prosthesis: Epiretinal Approach
11:00 IL TU-18-04
Neuroprotection for Retinal Disease
11:10 IL TU-18-05
Next-generation Vitrectomy Devices: Essential
Features
Carl C. Awh (Nashville/USA)
11:20 IL TU-18-06
Genetic testing for AMD Is the Future here?
David Chow (Reston/CDN)
11:30 IL TU-18-07
Automation: Augmented Reality & Robotics
Steven Schwartz (Los Angeles/USA)
11:40 IL TU-18-08
Physical Determinants of Ocular Trauma
Suber Huang (Shaker/USA)
11:50 IL TU-18-09
The Future of Vitrectomy Systems
Philip Ferrone (Riverhead/USA)
Room Madrid
14:00 - 15:30 TU-19
Eye Banking: Optimizing Techniques and Quality
Control
Symposium
Chairs:
14:00 IL TU-19-01
Notification and evaluation of SAR and SEE UK
model
14:10 IL TU-19-02
Serious adverse reactions and events in the USA
Patricia Dahl (Healdsburg/USA)
14:20 IL TU-19-03
Quality control in eye banking, European versus
USA model
Diego Ponzin (Venice/I)
14:30 IL TU-19-04
Clinical follow-up registration and eye banking:
the Australian Graft registry
Keryn A. Williams (Bredford Park/AUS)
14:40 IL TU-19-05
Clinical follow-up registration and eye banking in
Europe
Daniel Bhringer (Freiburg/D)
14:50 IL TU-19-06
Implementation of the European Tissue Guidelines
in different member states
Vincent Borderie (Paris/F)
15:00 IL TU-19-07
Eu Directories and international allocation of
corneal grafts
Arlinke G. Bokhorst (Leiden/NL)
15:10 IL TU-19-08
Serum-free medium for orgen culture
Katrin Engelmann (Chemnitz/D)
15:20 IL TU-19-09
Precut tissue for lamellar keratoplasty
Sonja Ute Heinzelmann (Freiburg/D)
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
T
u
e
s
d
a
y
,

8

J
u
n
e
182
WOC
2010
Room Madrid
16:00 - 17:30 TU-20
Immunology of Keratoplasty
Symposium
Chairs:
Daniel Frank P. Larkin (London/UK)
Birgit Sawatzki (Berlin/D)
16:00 IL TU-20-01
HLA class II
TBA
16:15 IL TU-20-02
Immunology of corneal graft rejection:
current understanding
Daniel Frank P. Larkin (London/UK)
16:30 IL TU-20-03
Future approaches on immunmodulation
16:45 IL TU-20-04
Tolerance induction: insights from the
immunologists perspective
Birgit Sawatzki (Berlin/D)
17:00 IL TU-20-05
Immunpharmacology: Update on clinical
and experimental data
17:15
Discussion
Room Sydney
08:30 - 10:00 TU-21
RGP Lenses: Non Surgical Treatment of Refractive
Errors and Ectatic Corneas
Symposium
Chairs:
Lance Forsott
08:30 IL TU-21-01
Toric Contact Lenses/Correction of astigmatism
with contact lenses
Ayfer Kanpolat (Ankara/TR)
08:40 IL TU-21-02
Contact Lens fitting after Keratoplasty
mur Uakhan Gndz (Ankara/TR)
08:50 IL TU-21-03
The use of semi-scleral contact lenses
Orestes Miraglia (Belo Horizonte/BR)
09:00 IL TU-21-04
Contact lenses and ectasias
Cesar Lipener (Sao Paulo/BR)
09:10 IL TU-21-05
Thin corneas and refractive surgery
Julieta Goncalves (Porto Alegre/BR)
09:20 IL TU-21-06
Anterior corneal "microfolds" in orthokeratology
Sami El Hage (Houston/USA)
09:30 IL TU-21-07
Clinical record of toric RGP lenses prescribed in the
advanced astigmatic eyes
Kajita Masayoshi (Fukushima/J)
Room Sydney
10:30 - 12:00 TU-22
Panel: Uveal Tumors
Panel
Oncology
Chairs:
Panellist:
Minoru Furuta (Fukushima/J)
Michael Giblin (Sydney/AUS)
Maria E. Manquez (Santiago/RCH)
Leonidas Zografos (Lausanne/CH)
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
T
u
e
s
d
a
y
,

8

J
u
n
e
183
WOC
2010
Room Sydney
14:00 - 15:30 TU-23
Evidence-based Management of Retinal Diseases
Symposium
Evidence Based Ophthalmology
Chairs:
Robert B. Bhisitkul (San Francisco/USA)
14:00 IL TU-23-01
EBM in retinal practice
14:10 IL TU-23-02
Prophylaxis of retinal detachment
14:20 IL TU-23-03
Initial treatment of rhegmatogenous retinal
detachment
14:30 IL TU-23-04
Clinical trial results in the medical and surgical
management of diabetic retinopathy
Rajendra Apte (Saint Louis/USA)
14:40 IL TU-23-05
Update on retinal venous occlusive disease
14:50 IL TU-23-06
Evidence based comparisons of variable and
monthly anti-VEGF therapy in AMD
Robert B. Bhisitkul (San Francisco/USA)
15:00
Discussion
Room Sydney
16:00 - 17:30 TU-24
Modern Manual Cataract Surgery
Symposium
Cataract
Chairs:
Srinivas Kamalakara Rao (Chennai/IND)
N. Venkatesh Prajna (Madurai/IND)
16:00 IL TU-24-01
Key issues in manual cataract surgical techniques
16:10 IL TU-24-02
Manual small incision cataract surgery (M-SICS):
my technique and results
16:20 IL TU-24-03
Sutureless large incision manual cataract extrac-
tion (SLIMCE): technique and results
16:30 IL TU-24-04
M-SICS: the fishhook technique and tips for
avoiding complications
Albrecht Hennig (Kathmandu Lahan/NEP)
16:40 IL TU-24-05
Comparing outcomes of SLIMCE with
phacoemulsification
Yingpeng Liu (Shantou/CN)
TU-24-06
The Need for and the Approach to teaching
manual cataract surgery
17:00 IL TU-24-07
The approach adopted by Project Vision in
training doctors to perform manual cataract
surgery
17:10
Discussion
WOC
2010
09:19 FP TU-25-08
Alkylphosphocholines for Intraocular Lens Coating
Kirsten Eibl, Raffael Liegl, Marcus Kernt,
Katja Obholzer, Armin Wolf, Ricarda Schumann,
Christos Haritoglou, Anselm Kampik (Munich/D)
09:26 SL TU-25-09
Contact lenses in children: indications and
complications
Susanne Marx-Gross (Mainz/D)
09:35 SL TU-25-10
12-Month Results after Implantation of a New
Accommodative IOL that Works with one focus
9:42
Discussion
Room Hong Kong
10:30 - 12:00 TU-26
Therapeutic Contact Lenses: Bandage Lenses and
Drug Release
Symposium
Chairs:
Michael H. Goldstein (Boston/USA)
10:30 IL TU-26-01
The Hikaro Hamano Lecture: Pathophysiologic
changes of ocular surface by contact lens wear
Mitsuro Sawa (Tokyo/J)
10:50 IL TU-26-02
General Principles and Current Indications in
Medical Contactology
Peter Donshik (Bloomfield/USA)
11:00 IL TU-26-03
When not to use Bandage Lenses
11:10 IL TU-26-04
Scleral Lenses for Ocular Surface Diseases
Deborah S. Jacobs (Needham/USA)
11:20 IL TU-26-05
The vicious circle story: dry-eye surface contact
lenses
Gurdal Canan (Ankara/TR)
11:30 IL TU-26-06
Extensions of Indications of bandage lenses
Room Hong Kong
08:30 - 10:00 TU-25
Cataract/Biometry 3
Free Paper
Cataract
Chairs:
Arturo Perez Arteaga (Tlalnepantla/MEX)
Jochen Kammann (Davos/CH)
08:30 FP TU-25-01
Application of the ESCRS recommendations on
antibiotics for postoperative endophthalmitis
prophylaxis following cataract surgery in the UK
Salman Waqar, Salem Murjaneh, Maan Kasmiya,
Julia Elizabeth Hale, Anthony Quinn (Exeter/UK)
08:37 FP TU-25-02
Comparison of various torsional handpieces in
MCCS Comparison of Mini-Flared 30 Kelman and
Mini-Flared 45 Kelman and Reverse Mini-Flared
30 Kelman attending torsional phaco cases
Choun-ki Joo, Kim Eun-kyoung (Seoul/ROK)
08:44 FP TU-25-03
How to seal clear cornea incisions after cataract
surgery: the role of a liquid ocular bendage
Matteo Piovella (Monza/I)
08:51 FP TU-25-04
Postoperative Refractive Error by Using A-scan in
Cataract Surgery After Vitrectomy
Seok Joon Kong, Seungbum Kang, Sung Kun Chung
(Seoul/ROK)
08:58 FP TU-25-05
Complications of couching and visual outcome
after IOL implantation A study of 60 patients in
Sudan Darfur
Mohamed Siddig (Elafuon/SUD)
09:05 FP TU-25-06
The use of the Eyesi surgical simulator in training
phacoemulsification for medical students in King
Faisal University, Saudi Arabia
Mohamed Morsy (Hufuf/SA)
09:12 FP TU-25-07
Prospective multicenter masked bilateral con-
trolled randomized trial of YAG laser photolysis:
the laser capsule opacity prevention (LCOP) study
George Waring, Wolfram Wehner, Burkhard Dick,
Siegfried Priglinger, Jorge Ali, Pavel Stodulka,
Reinhardt Thyzel, Rudolf Walker (Atlanta/USA,
Nrnberg/D, Linz/A, Alicante/E)
184
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
T
u
e
s
d
a
y
,

8

J
u
n
e
WOC
2010
Room Hong Kong
16:00 - 17:30 TU-28
Globe Reconstruction after Severe Eye Injury
Symposium
Eye Trauma and Emergencies
Chairs:
Paul Sullivan (London/UK)
16:00 IL TU-28-01
A. Combined topical anesthesia and sedation for
open-globe injuries in selected patients
B. Partial vitrectomy in the management of open-
globe injuries
Francesco Boscia (Bari/I)
16:10 IL TU-28-02
Choosing Wisely: How Does Initial Management of
Open Globe Injuries Affect Ultimate Outcome?
Vytautas Al Pakalnis (Columbia/USA)
16:20 IL TU-28-03
Ocular trauma in outdoor sports
Ron Adelman (New Haven/USA)
16:30 IL TU-28-04
Outcomes of surgery for posterior segment
intraocular foreign bodies a retrospective review
of 17 years of clinical experience.
16:40 IL TU-28-05
Primary silicone oil tamponade in the manage-
ment of severe intraocular foreign body injuries:
an 8-year follow-up
16:50 IL TU-28-06
Results of early vitrectomy in severe open globe
injuries
17:00 IL TU-28-07
Combined anterior and posterior segment injuries
in children
Petra Meier (Leipzig/D)
17:10 IL TU-28-08
Pearls and pitfalls in the treatment of severe ocu-
lar trauma
17:20
Discussion
11:40 IL TU-26-07
Use of therapeutic contact lenses for drug release:
current status
11:50 IL TU-26-08
Therapeutic uses of tinted lenses
Zoraida Fiol-Silva (Philadelphia/USA)
Room Hong Kong
14:00 - 15:30 TU-27
Hot Topics in Ocular Traumatology
Symposium
Chairs:
Paul D. Langer (Newark/USA)
14:00 IL TU-27-01
Management of Incompletely Repaired Orbital
Fractures
Paul D. Langer (Newark/USA)
14:10 IL TU-27-02
Management of occult and non-occult
orbitocranial penetrating injuries
Roger Turbin (Newark/USA)
14:20 IL TU-27-03
Secondary repair of anterior-posterior trauma of
the globe
Andreas Kay Cordes (Cologne/D)
14:30 IL TU-27-04
Chemical trauma
14:50 IL TU-27-05
Rational approach to open globe injuries
15:00 IL TU-27-06
Round Table: Concensus Paper on treatment of
chemical injuries
Paul D. Langer, Roger Turbin, Andreas Kay Cordes,
Norbert Franz Schrage, Giampaolo Gini, Harold
Merle, Christopher A. Paterson (Newark/USA,
Cologne/D, Prato/I, Fort de France/F)
185
T
u
e
s
d
a
y
,

8

J
u
n
e
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
WOC
2010
09:21 FP TU-29-08
Ranibizumab for Branch Retinal Vein Occlusion
Associated Macular Edema Study (R.A.B.A.M.E.S.)
a prospective randomized multicenter trial
Lars-Olof Hattenbach, Nicolas Feltgen,
Amelie Pielen, Lutz Hansen, Katrin Lorenz,
Norbert Pfeiffer, Hans Hoerauf, Caroline Jnemann,
Fabian Hhn, Thomas Kreutzer, Siegfried G.
Priglinger Jr., Alireza Mirshahi (Ludwigshafen/D,
Gttingen/D, Freiburg/D, Mainz/D, Mannheim/D,
Munich/D, Linz/A)
09:28 FP TU-29-09
Efficacy Outcomes of the BRAVO Study of Intravit-
real Ranibizumab in Patients with Macular Edema
Secondary to Branch Retinal Vein Occlusion
Quan Dong Nguyen, Sarah Gray, Wendy Yee
Murahashi, Namrata Saroj, Amy Chen Rundle,
Roman G. Rubio (Baltimore/USA, San
Francisco/USA)
09:35 SL TU-29-10
How fast does the Avastin concentration fall
away in the eye? Measurements of the pharmaco-
kinetics of Bevacizumab in the human eyes
Carsten H. Meyer, Tim Krohne, Frank G. Holz
(Bonn/D)
09:42
Discussion
VIP Lounge 1
10:30 - 12:00 TU-30
Glaucoma: Medical Therapy
Free Paper
Glaucoma
Chairs:
Michael J. Young (Boston/USA)
10:30 FP TU-30-01
Control of intraocular pressure and intraocular
pressure hluctuation with fixed combination
BrimonidineTimolol versus Brimonidine or
Timolol monotherapy
George L. Spaeth, Joseph Caprioli, Paula Bernstein,
Rhett M. Schiffman (Philadelphia/USA)
10:37 FP TU-30-02
A Randomized, Controlled Comparison of
Conjunctival Hyperemia in Patients Treated
with Bimatoprost 0.01% or Vehicle Who Were
Previously Controlled on Latanoprost
E. Randy Craven, Anup K. Khatana,
Thomas K. Mundorf, Ching-chi Liu,
Amy L. Batoosingh (Parker/USA)
VIP Lounge 1
08:30 - 10:00 TU-29
Retina: Vascular Disease 2
Free Paper
Retina
Chairs:
Lars-Olof Hattenbach (Ludwigshafen/D)
Gabriel J. Coscas (Crteil/F)
08:30 SL TU-29-01
CMV Retinitis Managed at the Primary Care
Level in a Resource-Poor Setting by Non-Ophthal-
mologists: A description of an NGO program in
Myanmar
Heiden David (San Francisco/USA)
08:39 FP TU-29-02
The Association of Serum Apolipoproteins and C
Reactive Protein with the Severity of Diabetic
Retinopathy
Muhammad Bayu Sasongko, Tien Yin Wong,
Ryo Kawasaki, Jonathan Shaw, Alicia Jenkins,
Jie Jin Wang (Melbourne/AUS)
08:46 FP TU-29-03
Cost-effeciveness of automated algorithms
versus manual grading for the detection of
referable diabetic retinopathy
Graham Scotland, Paul McNamee, Alan D Fleming,
Keith Goatman, Sam Philip, Gordon J. Prescott,
Peter F. Sharp, Graeme J. Williams, William Wykes,
Graeme P. Leese, John A. Olson (Aberdeen/UK)
08:53 FP TU-29-04
Intravitreal anti-VEGF therapy in diabetic macular
edema
Stanislav Rodin, Veronika Aslanova (Odessa/UA)
09:00 FP TU-29-05
Monotherapy for diffuse diabetic macular edema:
Photocoagulation or Bevacizumab
Vladimir Poposki, D. Vilaplana, D. Poposka,
I. Alarcn I., O. Marnez-Giralt, M. Castilla
(Barcelona/E)
09:07 FP TU-29-06
Intravitreal anti-VEGF therapy for retinal macroa-
neurysms with macular exsudation
Magdalena Tnz, Stephan Michels, Rike Michels,
Lukas Pfenninger (Zurich/CH)
09:14 FP TU-29-07
Intraocular concentrations of growth factors and
cytokines in diabetic macular edema and macular
edema due to retinal vein occlusion
Heeyoon Cho, Byung Ro Lee (Guri-city/ROK)
186
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
T
u
e
s
d
a
y
,

8

J
u
n
e
WOC
2010
11:33 FP TU-30-10
Role of Herbal Drugs in the Management of
Glaucoma An Experimental Study
Suresh Gupta, Renu Agarwal, Sushma Srivastava,
Rohit Saxena (New Delhi/IND, Kuala Lumpur/MAL)
11:40
Discussion
VIP Lounge 1
14:00 - 15:30 TU-31
Cornea/External Disease: Medical therapy
Free Paper
Chairs:
Christophe Baudouin (Paris/F)
14:00 FP TU-31-01
Visual rehabilitation after Descemet Membrane
Endothelial Keratoplasty (DMEK) Results of the
first 100 cases
Konstantinos Droutsas, Lisanne Ham, Isabel
Dapena, Kyros Moutsouris, Jaqueline van der Wees,
14:07 FP TU-31-02
Optimization of the Refractive Results of Corneal
Collagen Crosslinking (CXL).
Andriy Kovalov, Oksana Averyanova (Kiev/UA)
14:14 FP TU-31-03
Collagen Crosslinking for Bullouse Keratopathy:
1,5 Year Follow-Up
Guzel Bikbova, Mukharram Bikbov (Ufa/RUS)
14:21 FP TU-31-04
Effect of topical application of terbinafine on
fungal keratitis
Qingfeng Liang, Xiu-ying Jin (Beijing/CN)
14:28 FP TU-31-05
The effect of subconjunctival bevacizumab for
corneal neovascularization
Berraho Amina, Adil Megzari (Rabat/MA)
14:35 FP TU-31-06
Low-Concentration Bevacizumab Topical Solution
in Treatment of Corneal Neovascularization
Jacek P. Szaflik, Urszula Kolodziejska,
Anna Kaminska, Justyna Izdebska, Jerzy Szaflik
(Warszawa/PL)
10:44 FP TU-30-03
Randomized, Investigator-Masked Study
Comparing the Efficacy and Tolerability of
Bimatoprost and Latanoprost in Patients After
Initial Latanoprost Treatment
Ehsan Sadri, Ronald Frenkel, Joseph Caprioli,
Jason Bacharach, Ching-chi Liu, Amy L. Batoosingh
(Newport Beach/USA)
10:51 FP TU-30-04
Intraocular pressure-lowering efficacy of
brinzolamide compared with placebo when added
to travoprost/timolol fixed combination as adjunc-
tive therapy in primary open-angle glaucoma or
ocular hypertensive patients
Ivan Goldberg, Jonathan Crowston,
Barbara Cvenkel, Mark C. Jasek, Jeanette A. Stewart,
William C. Stewart (Sydney/AUS)
10:58 FP TU-30-05
Twelve-month, Randomized, Controlled Trial of the
Efficacy and Safety of Bimatoprost 0.01%, 0.0125%,
and 0.03% in Patients With Glaucoma or Ocular
Hypertension
Michael Tepedino, L. Jay Katz, John S. Cohen,
Amy L. Batoosingh, Carlos Felix, Vincent Shu,
Rhett M. Schiffman (High Point/USA, Irvine/USA)
11:05 FP TU-30-06
The effects of Combigan versus Cosopt on ocular
perfusion pressure and blood flow in patients with
open angle glaucoma
Yochai Shoshani, Brent Siesky, Rita Ehrlich,
Louis Cantor, Darrell WuDunn, Chi Wah Yung,
Lynne McCranor, John Abrams, Julia Williams,
David Hollander, Alon Harris (Indianapolis/USA)
11:12 FP TU-30-07
Aqueous humor VEGF levels before and after in-
travitreal bevacizumab in eyes with neovascular
glaucoma: a two-dose comparative study
Yuzuru Sasamoto, Yusuke Oshima,
Taku Wakabayashi, Atsuya Miki, Kenji Matsushita,
Motohiro Kamei (Suita/J)
11:19 FP TU-30-08
Trabeculectomy with Mitomycin-C versus
trabeculectomy with 5-Fluorouracil for the treat-
ment of childhood glaucoma
Osama Badeeb (Jeddah/SA)
11:26 FP TU-30-09
The success rate of trabeculectomy bleb needling
augmented with 5-Fluorouracil
Kaveh Vahdani, Adam Paget Booth,
Aristeidis Konstantinidis (Plymouth/UK)
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
T
u
e
s
d
a
y
,

8

J
u
n
e
187
WOC
2010
16:16 FP TU-32-03
Histology of fibrovascular membranes of
proliferative diabetic rerinopathy after the
intravitreal injection of bevacizumab
Toshiaki Kubota, Hirofumi Morita, Norihiko Tou,
Norikazu Nitta, Kenichi Kimoto, Akihiko Tawara,
Hitoshi Satoh, Shohei Shimajiri (Yufu-shi/J)
16:23 FP TU-32-04
Vitreous surgery combined with Brilliant blue-G
dye assisted ILM peel for traumatic macular holes
Atul Kumar, Varun Gogia (New Dehli/IND)
16:30 FP TU-32-05
Heavy Silicone Oil versus Standard Silicone Oil in
as vitreous tamponade in Inferior PVR (HSO
Study): Interim Analysis of 94 consecutive patients
Antonia M. Joussen, Christina Ocklenburg,
Norbert Schrage, Bernd Kirchhof, Ralf-Dieter
Hilgers (Berlin/D, Kln/D, Aachen/D)
16:37 FP TU-32-06
Transcleral Posterior Chamber Paracentesis for
Posterior Chamber Gas Entrapment with Anterior
Chamber Angle Collapse Following Intravitreal
C3F8 Injection in a Phakic Eye
Yi-Ting Hsieh (Xindian/TJ)
16:44 FP TU-32-07
High-resolution Fourier-domain Optical Coherence
Tomography Findings in Eyes with Surgically
Closed Macular Hole: Correlation between Visual
Acuity Outcome and Inner Macular Volume
Susanna Park (Sacramento/USA)
16:51 FP TU-32-08
Vitreoretinal complications of regressed
Takao Endo (Suita/J)
16:58 FP TU-32-09
Safety testing of indocyanine green with different
surgical light sources and the protective effect of
optical filters
Jost Hillenkamp, Sofia Dydykina, Alexa Klettner,
Felix Treumer, Rudolf Vasold, Wolfgang Bumler,
17:05 SL TU-32-10
New technologies in the treatment of pathology
of eye fundus
Andrii R. Korol (Odessa/UA)
17:14
Discussion
14:42 FP TU-31-07
Topical Bevacizumab eye drops for corneal
neovascularisation preliminary results
Pavel Studeny, Deli Sivekova, Magdalena Vokrojova,
Andrej Farkas, Magdalena Netukova, Pavel
Kuchynka (Prague/CZ)
14:49 FP TU-31-08
An Ocular Surface Prosthesis for Visual Rehabilita-
tion of Corneal Ectasia
Deborah S. Jacobs, James Bradley, Inna Baran,
Fateme Alipour, Perry Rosenthal (Needham/USA)
14:56 FP TU-31-09
Fixed, dilated pupil, iris atrophy, cataract, and
secondary glaucoma in Acanthamoeba keratitis
Denise Freitas, Elcio Sato, Luiz Antonio Vieira,
Patricia Contarini, Fabio Ramos, Annette Foronda
(Sao Paulo/BR)
15:03 FP TU-31-10
Oral pilocarpine for the treatment of dry eye
symptoms in patients with aqueous-deficient and
evaporative dry eye
Tatsuro Miyamoto, Hiroshi Eguchi (Tokushima/J)
15:10
Discussion
VIP Lounge 1
16:00 - 17:30 TU-32
Free Paper
Retina
Chairs:
16:00 SL TU-32-01
12-month evaluation of Dexamethasone
intravitreal implant in patients with macular
edema due to central retinal vein occlusion
Francesco Bandello, Julia A. Haller, Mark S.
Blumenkranz, Rubens Belfort, Mark Gillies,
Jeffrey Heier, Anat Loewentstein, Young-Hee Yoon,
Jenny Jiao, Xiao-Yan Li, Scott M. Whitcup (Milano/I,
So Paulo/BR, Sydney/AUS, Philadelphia/USA,
Stanford/USA, Tel Aviv/IL, Boston/USA, Irvine/USA,
Seoul/ROK)
16:09 FP TU-32-02
Intravitreal triamcinolone acetonide and
intravitreal bevacizumab (Avastin) in diffuse
diabetic macular edema (A comparative study).
Rasheed El-Lakkany, Maha Shahin (Mansoura/ET)
188
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
T
u
e
s
d
a
y
,

8

J
u
n
e
WOC
2010
VIP Lounge 2
08:30 - 10:00 TU-33
Free Paper
Retina
Chairs:
Thomas Theelen (Nijmegen/NL)
08:30 FP TU-33-02
Functional impairment of pigment epithelial
detachments determined by microperimetry
Carolin Milojcic, Christoph Clemens, Nicole Eter,
08:37 FP TU-33-03
Quantitative computerized colour vision testing in
diabetic retinopathy a possible screening tool?
Rashid Alsaeidi, Christos Haritoglou,
Thomas Kreutzer, Gnther Rudolph, Michael Ulbig,
Aljoscha Neubauer, Anselm Kampik (Munich/D)
08:44 FP TU-33-04
Clinical Applications of Ultrasound in the
Evaluation of Posterior Hyaloid Detachment
Peter Stalmans (Leuven/B)
08:51 FP TU-33-05
Fluorescein Angiography Changes after Intravitreal
Injection of Bevacizumab (Avastin)
Maha Shahin (Mansoura/ET)
08:58 FP TU-33-06
Does internal longitudinal microstructure of
retinal arteries and veins change with age in
medically healthy persons?
Konstantin Kotliar, Ali Kharoubi, Arno Schmidt-
Trucksss, Martin Halle, Ines Lanzl (Munich/D)
09:05 FP TU-33-07
Fundus autofluorescence at two different
wavelengths in patients with dry age-related
Pavel Nechiporenko, Alla Lisochkina, Yuri Astakhov
09:12 FP TU-33-08
Fundus autofluorescence of congenital and
acquired loss of macular pigment
Thomas Theelen, Tos T. J. M. Berendschot, Johannes
R. M. Cruysberg, B. Jeroen Klevering, Carel B. Hoyng
(Nijmegen/NL)
09:19 FP TU-33-09
The Relevance of Near-Infrared Autofluorescence
in the Evaluation of Chorioretinal Diseases: 4 years
experience
Ulrich Kellner, Simone Kellner, Silke Weinitz, Elena
Torres Suarez, Azadeh Golshahi (Bonn/D, Sieg-
burg/D, Cologne/D)
09:26 FP TU-33-10
Changes in macular morphology after macular
hole closure visualized with Spectral Optical
Coherence Tomography
Zofia Michalewska, Janusz Michalewski, Jerzy
Nawrocki (Lodz/PL)
09:33
Discussion
VIP Lounge 2
10:30 - 12:00 TU-34
Free Paper
Retina
Chairs:
10:30 SL TU-34-01
Macular surgery: The ILM story
10:39 FP TU-34-02
Complications in 208 consecutive cases of laser
vitreolysis for symptomatic vitreous opacities
Scott Geller (Fort Myers/USA)
10:46 FP TU-34-03
Vitreoretinal surgery, choice of endotamponade in
Proliferative Diabetic Retinopathy
Tatjana Josifova (Basel/CH)
10:53 FP TU-34-04
The Heavy Tamponade Densiron-68 For
Persistent Macular Holes
Alexandra Lappas, Albert Caramoy,
Andreas M. H. Foerster, Bernd Kirchhof (Kln/D)
11:00 FP TU-34-06
Partial liquefaction of the vitreous gel and
vitreo-retinal separation by intraocular injection
of heparin
Willi Halfter, Wingard Jeremy, Eller Andrew
(Pittsburgh/USA)
189
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
T
u
e
s
d
a
y
,

8

J
u
n
e
VIP Lounge 2
14:00 - 15:30 TU-35
Retina: Medical Therapy 2
Free Paper
Retina
Chairs:
Paul T. Finger (New York City/USA)
14:00 FP TU-35-01
Evaluation of the re-treatment criteria effective-
ness in the RESOLVE study
Francesco Bandello, Yehia Hashad, Gabriela Burian,
Andreas Weichselberger (Milano/I, Basel/CH)
14:07 FP TU-35-02
Intravitreal Lucentis (ranibizumab) for radiation
maculopathy: A pilot study
Paul Finger, Kimberly Chin (New York/USA)
14:14 FP TU-35-03
Intravitreal Bevacizumab (Avastin) treatment Trial
in Macula Oedema of Retinal Venous Occlusive
Diseases
Muthusamy Malaravan, Dushyantha Wariyapola
(Dehiwala/CL)
14:21 FP TU-35-05
Alteration of the foveal avascular zone after intra-
vitreal anti-VEGF application in patients with branch
retinal vein occlusion or diabetic macular disease
Nikolaus Feucht, Mathias Maier, Konstantin Kotliar,
Sarah Pfrommer, Ines Lanzl, Chris Patrick Lohmann
(Munich/D)
14:28 FP TU-35-07
Randomized clinical trial comparing grid laser,
intravitreal triamcinolone, and combined
triamcinolone and sequential grid laser for
diabetic macular edema: one-year outcomes
Shaheeda Mohamed, Carmen K. M. Chan,
Dennis S. C. Lam (Hong Kong/HK)
14:35 FP TU-35-08
Monthly Ranibizumab for non-proliferative
macular telangiectasia type 2 (RAMA trial):
A one-year prospective study
Peter Charbel Issa, Robert P. Finger, Kathrin Kruse,
Snke Baumller, Hendrik P. N. Scholl, Frank G. Holz
(Oxford/UK, Bonn/D)
11:07 FP TU-34-07
LED technology for intraoperative vitreoretinal
illumination
Stefan Dithmar, Alexandra Eva Hoeh,
Mira Ruppenstein, Roman Amberger, Thomas Ach
(Heidelberg/D)
11:14 FP TU-34-08
Direct Artery Massage for Central Retinal Artery
Occlusion: The Experimental and Clinical Research
Lili Zhao, Ningli Wang, Ning Lu (Beijing/CN)
11:21 FP TU-34-09
The transchoroidal implantation of subretinal ac-
tive visual prostheses in blind RP patients: Surgical
results in the first 12 patients. Potential and safety
of this new complex surgical procedure allowing
reproducible usable visual percepts.
Helmut Sachs, Karl Ulrich Bartz-Schmidt,
Florian Gekeler, Dorothea Besch, Uschi Brunner,
Barbara Wilhelm, Robert Wilke, Walter Wrobel,
Veit-Peter Gabel, Eberhart Zrenner (Tbingen/D)
11:28 FP TU-34-10
Macular EpiRetinal brachytherapy in treated
age-related macular degeneration patients
(MERITAGE): interim results
Tim Jackson, Pravin Dugel, Robert Petrarca, Jeff Nau
(London/UK, Phoenix/USA, Freemont/USA)
11:35 FP TU-34-11
Clinical treatment accuracy in diabetic macular
edema using navigated laser photocoagulator
NAVILAS: A multicentered clinical trial.
Igor Kozak, Stephen Oster, Marco Cortes,
Kathrin Hartmann, Jae Suk Kim, Aljosha Neubauer,
Anselm Kampik, William Freeman (La Jolla/USA)
11:42
Discussion
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
WOC
2010
190
T
u
e
s
d
a
y
,

8

J
u
n
e
191
16:21 FP TU-36-04
Apoptosis Rate and Mitochondria Respiration
Function of Photoreceptor Cells of Rats Exposed by
Toluene
Syntia Nusanti (Jakarta/RI)
16:28 FP TU-36-05
Astrocyte hypoxic response is essential for
pathological but not developmental angiogenesis
of the retina
Tim U. Krohne, Alexander Weidemann,
Edith Aguilar, Toshihide Kurihara, Norihiko Takeda,
Michael I. Dorrell, M. Celeste Simon,
Volker H. Haase, Randall S. Johnson,
Martin Friedlander (La Jolla/USA)
16:35 FP TU-36-06
Time-related expression of glial fibrillary acidic
protein in a non-intraocular-pressure related
glaucoma model
Vanessa D. Stahl, Stephanie C. Joachim,
Oliver W. Gramlich, Laspas Panos, Norbert Pfeiffer,
16:42 FP TU-36-07
Effects of growth factors bFGF, IGF-1 and VEGF165
on permeability and tight-junctions in microvascu-
lar retinal endothelial cells
Heidrun Deissler, Gabriele E. Lang (Ulm/D)
16:49 FP TU-36-08
VEGF and PEDF secretions over time following
various laser irradiations on an RPE organ culture
Yoko Miura, Felix Treumer, Alexa Klettner,
Jost Hillenkamp, Ralf Brinkmann, Reginald
Birngruber, Johann Roider (Lbeck/D, Kiel/D)
16:56 FP TU-36-09
The influence of high glucose concentrations and
elastin derived peptides on metalloproteinases
(MMP-1, 2 and 9) and their inhibitors (TIMP-1, 2, 3,
4) expression in human retinal pigment cells.
Mariola Dorecka, Tomasz Francuz,
Wojciech Garczorz, Wanda Romaniuk, Jan Gminski
(Bedzin/PL)
17:03
Discussion
14:42 FP TU-35-09
Efficacy and safety of intravitreal triamcinolone at
the end of phacoemulsification surgery in patients
with significant diabetic macular edema
Enrique Rodriguez de la Rua, David Galarreta,
Maria Isabel Lopez Galvez, Belen Carrasco,
Lucia Manzanas, Cristina Perez Fernandez,
Nestor Cortes Mora, Maria Teresa Sanchez Sanchez
(Valladolid/E)
14:49 FP TU-35-10
The Change of Vision Related Quality of Life
After Panretinal Photocoagulation in Patients with
Angela Nurini Agni, Muhd Zafran Muhd Zafran
bin Shamsudin (Yogyakarta/RI)
14:56 FP TU-35-11
Double-Masked, Sham-Controlled, Randomized
Study of Dexamethasone Intravitreal Implant for
the Treatment of Uveitis
Sue Lightman, Rubens Belfort, Careen Lowder,
Steven Foster, Michael Robinson, Rhett M. Schiff-
man, Xiao-Yan Li, Harry Cui, Scott M. Whitcup (Lon-
don/UK, So Paulo/BR, Cleveland/USA, Irvine/USA)
15:03
Discussion
VIP Lounge 2
16:00 - 17:30 TU-36
Retina: Basics
Free Paper
Retina
Chairs:
16:00 FP TU-36-01
Vascular endothelial growth factor (VEGF)
clearance in rabbit eyes with posterior vitreous
detachment induction
Wei-Chi Wu (Kweishan/TJ)
16:07 FP TU-36-02
Specific expression of Erythrocyte tropomodulin in
the retina of E-Tmod+/lacZ and E-Tmod-/- mice
Lin Xie (ChongQing/CN)
16:14 FP TU-36-03
Microglia invasion in retina during retinal
ganglion cell loss in animals with experimental
autoimmune glaucoma
Oliver Gramlich, Stephanie C. Joachim,
Vanessa D. Stahl, Clemens Cuny, Philip F.
Gottschling, Norbert Pfeiffer, Franz H. Grus
(Mainz/D)
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
WOC
2010
T
u
e
s
d
a
y
,

8

J
u
n
e
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
08:30 - 10:00 TU-37
Retina: AMD 3
Free Paper
Retina
Chairs:
Gabriele Thumann (Aachen/D)
08:30 FP TU-37-01
Efficacy and safety of verteporfin PDT in combina-
tion with ranibizumab compared to ranibizumab
monotherapy in AMD: 12-month outcome of the
DENALI study
Peter Kaiser, on behalf of the DENALI study group
(Cleveland/USA)
08:37 FP TU-37-02
Design and Rationale for the Phase 3 Study: VEGF
Trap-Eye Investigation of Efficacy and Safety in
Wet AMD (VIEW 2)
Yuichiro Ogura, the VIEW 2 investigators (Nagoya/J)
08:44 FP TU-37-03
What determines the functional outcome of AMD
treated with Lucentis?
Heinrich Gerding, Melanie Timmermann,
Lars Hefner, Juliane Riese, Vlassios Loukopoulos
(Olten/CH)
08:51 FP TU-37-04
Levels of aqueous humour trace elements in
Robert Rejdak, Bernhard Michalke, Anwar Chaudhri,
Piotr Stopa, Ursula Schltzer-Schrehardt,
Friedrich Kruse, Eberhart Zrenner, Anselm G. M.
Jnemann (Lublin/PL, Erlangen/D, TbingenD)
08:58 FP TU-37-05
Automatic Segmentation of Subretinal Fluid in
Patients with Choroidal Neovascularization
using Polarization-Sensitive Optical Coherence
Tomography
Christopher Schtze, Christian Ahlers,
Bernhard Baumann, Michael Pircher, Erich
Gtzinger, Ren Donner, Joachim Ofner,
Christoph Hitzenberger, Ursula Schmidt-Erfurth
(Vienna/A)
09:05 FP TU-37-06
Targeting Complement Factor 5 in combination
with Vascular Endothelial Growth Factor (VEGF)
Inhibition for Neovascular Age Related Macular
Degeneration (AMD) a Phase 1 Study
David S. Boyer (Los Angeles/USA)
09:12 FP TU-37-07
Development of a gene therapy based on
transfection of pigment epithelial cells with PEDF
Gabriele Thumann, Olga Kazanskaya, Peter Walter,
Sandra Johnen (Aachen/D)
09:19 FP TU-37-08
Analysis of drusen SD-OCT (Spectral Domain
Optical Coherence Tomography) characteristics
and correspondent FAF (fundus autofluorescence)
changes in dry AMD patients.
Gennady Landa, Richard Rosen, John Pilavas,
Patricia Garcia, Jeanne Rosenthal, Alfonso Ponce,
Thomas Muldoon, Joseph Walsh (New York/USA)
09:26 FP TU-37-09
Characteristics of Fixation in Patients with
Geographic Atrophy recorded with the MP-1
Microperimeter
Julia-Sophie Kroisamer, Ramzi G. Sayegh,
Christian Simader, Ulla Scheschy, Christopher Kiss,
Christian Prnte, Ursula Schmidt-Erfurth
(Vienna/A)
09:33
Discussion
10:30 - 12:00 TU-38
EVER Symposium: How to Get Your Work
Published?
Symposium
Miscellaneous
Chairs:
10:30 IL TU-38-01
Characteristics of a good paper
10:50 IL TU-38-02
Ethical concerns in sientific publications
11:10 IL TU-38-03
The challenge to be a reviewer (view of the Editor
and beyond ..)
11:30
Discussion
T
u
e
s
d
a
y
,

8

J
u
n
e
192
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
14:00 - 15:30 TU-39
ISRS/AAO Symposium: Cutting Edge Progress
All What the Practical Refractive Surgeon needs to
Know
Symposium
Refractive Surgery
Chairs:
14:00 IL TU-39-01
Cutting Edge in Surface Ablation
Gustavo Tamayo (Bogota/CO)
14:10 IL TU-39-02
Cutting Edge in Femtolasers
14:20 IL TU-39-03
Application of Retinal Stem Cells in Treating
Retinal Degenerative Diseases
Ting Xie (Kansas City/USA)
14:30 IL TU-39-04
Cutting Edge in Phakic IOLs
14:40 IL TU-39-05
Cutting Edge in Cataract Surgery
14:50 IL TU-39-06
Cutting Edge in Corneal Surgery
15:00 IL TU-39-07
Femto Laser Refractive Cataract Surgery
15:10
Discussion
16:00 - 17:30 TU-40
AJCC/UICC Symposium: TNM based Classification
System for Oncular Oncology
Symposium
Oncology
Chairs:
16:00 IL TU-40-01
Do You Speak Ocular Tumor? How using the 7
th
editon AJCC-UICC Eye Cancer Staging System will
Can Save Lives
16:08 IL TU-40-02
The 7th edition AJCC-UICC Staging System for
Ocular Adnexal Lymphoma: Use to Predict
Systemic Lymphoma
16:16 IL TU-40-03
How to use the 7th edition AJCC Staging of
Melanoma of the Conjunctiva and Cornea to
predict Local Control and Metastasis
16:24 IL TU-40-04
Internet-based, High resolution Cases Illustrating
How to Use 7th edition AJCC Cancer Staging
16:37 IL TU-40-05
7
th
Edition AJCC-UICC Staging Used to Predict
Outcomes for Patients with Adenoid Cystic
Carcinoma of the Lacrimal Gland: A Multicenter
Collaborative Study
Bita Esmaeli (Houston/USA)
16:40 IL TU-40-06
Application of the AJCC 7
th
Edition Carcinoma of
the Eyelid staging system: A Medical Center
pathology based, 15 year review
Colby Fernelius (Tacoma/USA)
16:48 IL TU-40-07
Incorporating the 7
th
Edition AJCC-UICC Staging
of Ocular Squamous Carcinoma into your Clinical
Practice
T
u
e
s
d
a
y
,

8

J
u
n
e
193
14:00 - 15:30 TU-43
WGA Symposium: Managing Advanced Glaucoma
Symposium
Glaucoma
Chairs:
Remo Susanna, Jr (So Paulo/BR)
Paul Healey (Sydney/AUS)
14:00 IL TU-43-01
Who gets advanced glaucoma and why?
Jamie Craig (Adelaide/AUS)
14:10 IL TU-43-02
Predicting advanced glaucoma
14:20 IL TU-43-03
Achieving Target pressures in advanced
glaucoma when to operate
14:30 IL TU-43-04
Surgical options for advanced pediatric glaucoma
Anil Kumar Mandal (Hyderabad/IND)
14:40 IL TU-43-05
Novel surgical options in advanced disease
Fabian Lerner (Buenos Aires/RA)
14:50 IL TU-43-06
Management of Advanced NTG
15:00 IL TU-43-07
Now the pressure is low, what then?
15:10 IL TU-43-08
Maximizing quality of life in advanced glaucoma
George L. Spaeth (Philadelphia/USA)
15:20
Discussion
16:56 IL TU-40-08
7
th
Edition AJCC-UICC Staging Predict Survival of
Patients with Iris, Ciliary body and Choroidal
melanoma
Emma Kujala (Helsinki/FIN)
17:04 IL TU-40-09
Retinoblastoma Care, Implementation of the 7
th
edition AJCC-UICC Staging System for E-Cancer
Care in Canada, Kenya and India
Ashwin Mallipatna (Bangalore/IND)
17:12 IL TU-40-10
7
th
edition AJCC-UICC Staging Software for Uveal
Melanoma
Ernest Rand Simpson (Toronto/CDN)
17:20
Discussion
10:30 - 12:00 TU-42
Sustainable Eye Health Programs: Where Does the
Government Fit In?
Symposium
Chairs:
Amir Bedri (Addis Adaba/ETH)
Mohammed Babar Qureshi (Peshawar/PK)
10:30 IL TU-42-01
Can programs be sustainable without
Government participation
Adekunle Olubola Hassan (Lagos/WAN)
10:45 IL TU-42-02
High Impact, large scale NGO sector models of eye
care delivery
11:00 IL TU-42-03
Comprehensive eye care programs, A model within
the Government structures
Mohammed Daud Khan (Peshawar/PK)
11:15 IL TU-42-04
An NGO having tried both approaches
(Government and NGO sector)
Mohammed Babar Qureshi (Peshawar/PK)
11:30
Discussion
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
WOC
2010
194
T
u
e
s
d
a
y
,

8

J
u
n
e
195
Hall 3
08:30 - 10:00 TU-45
Retina Society Symposium: Advances in
Instrumentation and Adjuvant Pharmacology in
Vitreoretinal Surgery
Symposium
Retina
Chairs:
Peter Liggett (New Haven/USA)
08:30 IL TU-45-01
Anti-VEGF Agents and Vitreoretinal Surgery
for Proliferative Diabetic Retinopathy: Are There
Surgical and Outcome Benefits?
08:40 IL TU-45-02
Triamcinolone in Epiretinal Membrane Surgery:
Surgical Visualization and Pharmacological Actions
08:50 IL TU-45-03
Advances in Posterior Segment Drug Delivery
Eugene de Juan, Jr. (San Fransisco/USA)
09:00 IL TU-45-04
Portable Vitrectomy with Plasmic Enzyme
Assistance: An Evolving Approach
09:10 IL TU-45-05
Advances in Instrumentation of Vitreoretinal
Surgery
09:20 IL TU-45-06
Combined MIVS 23 Gauge Vitrectomy and Pha-
coemulsification in the Management of Complex
Macular Pathology
09:30 IL TU-45-07
Endoscopic Visualization for Complex Vitreoretinal
Pathology
Christopher D. Riemann (Cincinnati/USA)
09:40 IL TU-45-08
Current Status of Heavy Tamponade Liquids
Eric R. Holz (Houston/USA)
09:50 IL TU-45-09
Beyond 25 Gauge: Pros and Cons of 27 Gauge
Macular Pucker Surgery
Fabio Patelli (Milan/I)
16:00 - 17:30 TU-44
Networking for Clinical Trial Research in Europe
Symposium
Miscellaneous
Chairs:
16:00 IL TU-44-01
EVI.CRnet. the European Network for Clinical
Research
16:10 IL TU-44-02
Perspectives for Investigator-Driven Clinical Trials
in Retinal Disease
16:20 IL TU-44-03
in Glaucoma
16:30 IL TU-44-04
in Ocular Surface and Inflammation
Ilse Claerhout (Gent/B)
16:40 IL TU-44-05
Perspectives for an European Reading Centre
Network
Tunde Peto (London/UK)
16:50 IL TU-44-06
in Cornea, Cataract and Refractive Surgery
17:00
Discussion
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
WOC
2010
T
u
e
s
d
a
y
,

8

J
u
n
e
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
T
u
e
s
d
a
y
,

8

J
u
n
e
196
WOC
2010
Hall 3
10:30 - 12:00 TU-46
Ophthalmic Premier League (OPL)
Symposium
Cataract
This is a session called the Ophthalmic Premier
League (OPL) to be conducted in the WOC 2010 in
Berlin. This is similar to the European league
games but with a difference as the OPL is con-
nected to ophthalmology. There will be 4 teams
with 4 captains, and each will have a total of 4
members in the team. Each team member will be
given 4 minutes to show his or her most challeng-
ing cataract / complication cataract case using
videos. In the video the speaker will need to show
how he or she managed this case. There will be a
good discussion on each case for the remaining
time. There will be an ARS (Automatic response
system) if available for audience to enjoy and vote
which is the best team. All the speakers will have
to be top class with excellent videos.
Moderator:
Chairmen and Judges:
Stephen J. Ryan (Los Angeles/USA)
Bruce E. Spivey (San Francisco/USA)
The Surgeless Sultans
Keiki R. Mehta (Mumbai/IND) Captain
Thomas F. Neuhann (Munich/D) Vice Captain
John Hovanesian (Laguna Hills/USA)
The Chopping Conquerors
Uday Devgan (Los Angeles/USA) Captain
Gabor Scharioth (Recklinghausen/D) Vice Captain
Athiya Agarwal (Bangalore/IND)
Brian Little (London/UK)
The Diffractive DareDevils
Mohan Rajan (Chennai/IND) Captain
Mahipal S. Sachdev (New Delhi/IND) Vice Captain
The Bursting Buccaneers
Roger Steinert (Orange/USA) Captain
Joseph Colin (Bordeaux/F) Vice Captain
Hall 3
14:00 - 15:30 TU-47
Uveitis a Global Challenge
Symposium
Retina
Chairs:
14:00 IL TU-47-01
New insights: Clinical manifestations and progno-
sis of herpetic posterior uveitis
Aniki Rothova (Utrecht/NL)
14:10 IL TU-47-02
How "typical" is "typical"? Atypical presentations
of ocular toxoplasmosis
Miles R. Stanford (London/UK)
14:20 IL TU-47-03
Ocular sarcoidosis definite, probable, possible
Manabu Mochizuki (Tokyo/J)
14:30 IL TU-47-04
Birdshot chorioretinopathy recent insights
Ralph D. Levinson (Los Angeles/USA)
14:40 IL TU-47-05
Eales' disease: a forgotten disorder?
14:50 IL TU-47-06
Surgical treatment of posterior segment
complications of uveitis in China
Wu Liu (Beijing/CN)
15:00
Discussion
Hall 3
16:00 - 17:30 TU-48
Current Treatment Options for Retinal Vascular
Disease
Symposium
Retina
Chairs:
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
T
u
e
s
d
a
y
,

8

J
u
n
e
197
WOC
2010
16:00 IL TU-48-01
The results of the EAGLE-Study for central artery
occlusion of the retina
Hansjrgen T. Agostini (Freiburg/D)
16:15 IL TU-48-02
Treatment of branch retinal vein occlusion in the
antiangiogenic era
Marta S. Figueroa (Madrid/E)
16:30 IL TU-48-03
Anti-VEGF treatment options in retinal vein
occlusion
16:45 IL TU-48-04
Results of the ROVO-Study
17:00 IL TU-48-05
The management of retinal artery occlusion
17:15
Discussion
Hall 4/5
08:30 - 10:00 TU-49
Iatrogenic Diseases of Ocular Surface
Symposium
Chairs:
08:30 IL TU-49-01
Introduction
08:35 IL TU-49-02
Ocular surface toxicity: iatrogenic and factitious
disease
08:45 IL TU-49-03
The ocular surface of glaucoma patients treayted
over the long-term
08:55 IL TU-49-04
Ocular surface disease and systemic medications
Catherine Creuzot-Garcher (Dijon/F)
09:05 IL TU-49-05
Ocular surgery resulting in ocular surface disease
09:15 IL TU-49-06
Acute iatrogenic damage to the anterior segment:
case reports
Rimvydas Asoklis (Vilnius/LT)
09:25
Discussion
Hall 4/5
10:30 - 12:00 TU-50
IOIS Symposium: Pediatric Uveitis in Memoriam
David Benezra
Symposium
Chairs:
10:30 IL TU-50-01
JIA and Uveitis
Paula Pivetti, Massimo Accorinti (Rom/I)
10:40 IL TU-50-02
Outcome measures on uveitis in juvenile
idiopathic arthritis: proposed guidelines from the
international interdisciplinary working group for
uveitis in childhood
10:50 IL TU-50-03
Congenital Toxoplasmosis
11:00 IL TU-50-04
Imaging in Pediatric Uveitis
11:10 IL TU-50-05
Results of an European Multicenter Survey on
juvenile Uveitis
11:20 IL TU-50-06
QoL and Coping Mechanisms in Pediatric Uveitis
11:30
Discussion
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
T
u
e
s
d
a
y
,

8

J
u
n
e
198
WOC
2010
Hall 4/5
14:00 - 15:30 TU-41
FEOph Symposium: Cutting Edge in
Ophthalmology
Symposium
Miscellaneous
Chairs:
Salvador Garca-Delpech (Valencia/E)
Pier Enrico Gallenga (Chieti/I)
14:00 IL TU-41-01
News in Presbyopic Surgery: Corneal Compensa-
tion of Presbyopia
14:06 IL TU-41-02
News in Enzymatic Vitreolisys: Microplasmin
14:12 IL TU-41-03
News in Enzymatic Vitreolisys: Autologous Plasmin
Patricia Udaondo (Valencia/E)
14:18 IL TU-41-04
News in Presbyopic Surgery: New Multifocal IOLs
14:24 IL TU-41-05
News Treating Corneal Neovascularization: Results
from Germany
14:30 IL TU-41-06
News Treating Corneal Neovascularization: Results
from Spain
Salvador Garca-Delpech (Valencia/E)
14:36 IL TU-41-07
News Treating Retinal Diseases: Some New Ideas
14:42 IL TU-41-08
News Treating Retinal Diseases: Choroidal
Melanomas
14:48 IL TU-41-09
Ocular Surface News: New concepts, New Drugs,
New approaches
D. Juan Murube del Castillo (Madrid/E)
14:54 IL TU-41-10
News in Glaucoma: Minimally Invasive Repair of
Post-trabeculectomy Hypotony
15:00 IL TU-41-11
News in Glaucoma: New Surgical Devices
David Salom (Valencia/E)
15:06 IL TU-41-12
News in Oculoplastics: Non Surgical Treatment of
Basal Cell Carcinoma
15:12 IL TU-41-13
News in Oculoplastics: Orbit
15:18
Discussion
Hall 6
08:30 - 10:00 TU-56
Technical Aspects: Telecommunication, Computer-
aided Diagnosis Systems, Image Processing and
Analysis, Process Flow, Electronic Patient Charts
Symposium
Chairs:
Larry D. Hubbard (Madison/USA)
Joachim Hornegger (Erlangen/D)
08:30 IL TU-56-01
Vessel structure segmentation via matched
filtering and neural fibre layer detection using
texture analysis
Jiri Jan (Brno/CZ)
08:40 IL TU-56-02
Computer-aided Diagnosis of Diabetic Retinopathy
08:50 IL TU-56-03
Improving DR Algorithms Through Online
Competition
Gwnol Quellec (Brest/F)
09:00 IL TU-56-04
Quantification of Diabetic Retinopathy Lesions,
Methodological Problems and Clinical Significance
Toke Bek (rhus/DK)
09:10 IL TU-56-05
A large-scale Verification of Automated Grading
for Diabetic Retinopathy using Arbitration by Sen-
ior Ophthalmologists
Alan D. Fleming (Aberdeen/UK)
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
09:20 IL TU-56-06
Automated Detection of New Vessels on the Optic
Disc Using Retinal Photography
Keith Goatman (Aberdeen/UK)
09:30
Discussion
Hall 6
10:30 - 12:00 TU-57
Braindrain: Challenges and Solutions
Symposium
Vision 2020 Preventation of Blindness
Chairs:
Suzanne Gilbert (Berkeley/USA)
10:30 IL TU-57-01
Training of Medical Personnel and the
Predicament of Brain Drain
Hans Werner Mundt (Berlin/D)
10:40 IL TU-57-02
Challenges and Solutions from India
10:50 IL TU-57-03
Conditions that keep African Ophthalmologists
in Africa/ Prevent Brain Drain
11:00 IL TU-57-04
Recent Findings on Task-Shifting to optimize
ophthalmologists service delivery
Khumbo Kalua (Blantyre/MW)
11:10 IL TU-57-05
Plenty of Ophthalmologists; How about Equity?
11:20 IL TU-57-06
Management & IT Strategies to Enhance Ophthal-
mologist Effectiveness and Satisfaction
11:30 IL TU-57-07
Contribution of Paramedical team members
11:40
Discussion
Hall 6
12:15 - 12:45 TU-58
Streiff Lecture
Chairs:
Global Blindness Control What Can We Possibly
Achieve by 2020?
Hall 6
14:00 - 15:30 TU-59
Therapy of Acquired Strabismus
Symposium
Strabismus
Chairs:
Vincent Paris (Lige/B)
14:00 IL TU-59-01
N.III palsy
Saxena Rohit (New Delhi/IND)
14:10 IL TU-59-02
N.IV palsy
14:20 IL TU-59-03
Trauma
14:30 IL TU-59-04
High myopia
Tsuranu Yokoyama (Osaka/J)
14:40 IL TU-59-05
Botulinum
Rosario Gomez de Liano (Madrid/E)
14:50 IL TU-59-06
Prism therapy
Jan Roelof Polling (Rotterdam/NL)
15:00
Discussion
T
u
e
s
d
a
y
,

8

J
u
n
e
199
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
Hall 6
16:00 - 17:30 TU-60
Viral Uveitis
Symposium
Chairs:
16:00 IL TU-60-01
Diagnostic and therapeutic challenges in herpetic
anterior uveitis
Emmet T. Cunnigham (Hillsborough/USA)
16:10 IL TU-60-02
Acute retinal necrosis syndrome
16:20 IL TU-60-03
CMV and anterior uveitis
16:30 IL TU-60-04
HIV associated uveitis in the era of HAART
Gary N. Holland (Los Angeles/USA)
16:40 IL TU-60-05
Emerging viruses and West Nile Virus
Moncef Khairallah (Monastir/TN)
16:50 IL TU-60-06
HTLV1, EBV and HHV6 associated uveitis
17:00 IL TU-60-07
Parvovirus and other non herpetic viruses
17:10
Discussion
Hall 7
08:30 - 10:00 TU-61
Panel: Phakic IOLs
Panel
Refractive Surgery
Chairs:
Carlos Vergs (Barcelona/E)
08:30 IL TU-61-01
Angle-supported PIOL
08:40 IL TU-61-02
Iris-fixated PIOL
08:50 IL TU-61-03
CL/PRL
09:00 IL TU-61-04
Complications of PIOL
Carlos Vergs (Barcelona/E)
09:10 IL TU-61-05
Discussion usefulness of PIOL in the spectrum of
refractive options
Thomas Kohnen, Roberto Zaldivar, Carlos Vergs,
Gernot I. W. Duncker (Frankfurt//D, Houston/USA,
Buenos Aires/RA, Barcelona/E, Halle/D)
Hall 7
10:30 - 12:00 TU-62
The Femtosecond Face-off
Symposium
Refractive Surgery
Chairs:
10:30 IL TU-62-01
Introduction:
i. Physics of femtosecond mechanism of action
ii. Descriptions of the 4 major lasers
iii. Highlights of major physics differences
between lasers
T
u
e
s
d
a
y
,

8

J
u
n
e
200
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
T
u
e
s
d
a
y
,

8

J
u
n
e
201
WOC
2010
10:40 IL TU-62-02
Intralase
10:50 IL TU-62-03
Femtec
11:00 IL TU-62-03
Visumax
11:10 IL TU-62-05
Ziemer
11:20
Discussion
Hall 7
14:00 - 15:30 TU-63
Free Paper
Glaucoma
Chairs:
Jens F. Jordan (Freiburg/D)
Joseph Caprioli (Los Angeles/USA)
14:00 FP TU-63-01
Using Ex-press Implant in a Patient with
Congenital Glaucoma
Dida Kazakova (Sofia/BG)
14:07 FP TU-63-02
Successful tube-extender implantation to
control congenital glaucoma awaiting penetrating
keratoplasty surgery
Carolina Palls (Barcelonas/E)
14:14 FP TU-63-03
Trypane blue test after incisional glaucoma
surgery
Gabor Scharioth (Recklinghausen/D)
14:21 FP TU-63-04
Trabeculectomy Using Biodegradable Collagen
Matrix Implant in Chronic Primary Glaucoma
Patients: A Preliminary Study
Astrianda Suryono (Jakarta/RI)
14:28 FP TU-63-05
Trabeculectomy and retrobulbar hemodynamics in
glaucoma
Andreas Remky, Marion Kaup, Anke Weber,
Niklas Plange (Regensburg/D)
14:35 FP TU-63-06
The Trabectome clinical feasibility and first
results.
Jens Jordan, Matthias Neuburger, Thomas Reinhard
(Freiburg/D)
14:42 FP TU-63-07
Therapeutic Effect of a Combined Laser Technique
for Plateau Iris Glaucoma 18 months follow-up
Poopalaratnam Sriharanathan (Colombo/CL)
14:49 FP TU-63-08
Long-term results after Selective Laser Trabeculo-
plasty (=SLT) in various forms of glaucoma.
Presentation of 12-year postoperative results
Peter Kaulen (Berlin/D)
14:56 FP TU-63-09
Our methods of surgical treatment of refractory
postburn glaucoma
Petro Kostenko, S. Iakymenko (Odessa/UA)
15:03 FP TU-63-10
Combined phacoemulsification and non-
penetrating glaucoma surgery (NPGS) with
goniosynechiolysis ab interno
Alireza Mirshahi, Gabor Scharioth (Mainz/D,
Recklinghausen/D)
15:10
Discussion
Hall 7
16:00 - 17:30 TU-64
Therapeutic Customized Ablation
Symposium
Refractive Surgery
Chairs:
Mirko R. Jankov (Belgrade/SRB)
16:00 IL TU-64-01
Technological requirements for therapeutic
customized treatments
Paulo Schor (Sao Paulo/BR)
16:15 IL TU-64-02
Wavefront vs topography guided treatments.
Which one is better?
16:30 IL TU-64-03
Surface ablation vs LASIK. Which one makes more
sense?
Arthur C. Cheng (Hong Kong/CN)
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
T
u
e
s
d
a
y
,

8

J
u
n
e
202
WOC
2010
16:45 IL TU-64-04
Dealing with previous failures of refractive
surgery: small optical zones, decentrations, etc.
17:00 IL TU-64-05
How to treat corneal scars, PKP etc.
Arthur Cummings (Dublin/IRL)
17:15 IL TU-64-06
Laser ablation and corneal collagen cross-linking.
Can we make it?
Aleksandr Stojanovic (Troms/N)
Hall 8
08:30 - 10:00 TU-65
A New Approach to Teaching Ophthalmology to
Medical Students: Strengths and Improvement for
the New ICO Medical Student Handbook
Symposium
Chairs:
Susan Lightman (London/UK)
Balder P. Gloor (Zurich/CH)
08:30 IL TU-65-01
Teaching: A Skill or a Talent?
08:40 IL TU-65-02
Teaching the Basic Knowledge
08:50 IL TU-65-03
Teaching Clinical Skills
Simon Taylor (London/UK)
09:00 IL TU-65-04
Teaching Emergency Ophthalmology to Medical
Students
Richard Andrews (London/UK)
09:10 IL TU-65-05
Using a Virtual Eye Clinic
Peter McCluskey (Sydney/AUS)
09:20 IL TU-65-06
Using the ICO Undergraduate Booklet
Jasmin Singh (London/UK)
09:30 IL TU-65-07
Designing an E-learning Module in Ophthalmology
Lavnish Joshi (London/UK)
09:40
Discussion
Hall 8
10:30 - 12:00 TU-66
The Training of Para-ophthalmic Personnel with
the Improved ICO Curriculum: Review of New
Experiences
Symposium
Chairs:
Lynn D. Anderson (Saint Paul/USA)
10:30 IL TU-66-01
Introduction
10:40 IL TU-66-02
ICO Curriculum for Ophthalmic Assistants: A Teach-
ing Model for Training the Eye Care Team
10:50 IL TU-66-03
Visual Fields Education for Ophthalmic Nurses
Lene Martin (Stockholm/S)
11:00 IL TU-66-04
Teaching Optometrists in China
Lu Fan (Wenzhou/CN)
11:10 IL TU-66-05
Implementing the ICO Curriculum in Africa
Boateng Wiafe (Kasoa/GH)
11:20 IL TU-66-06
Implementing the ICO Curriculum in Barbados
Sonja Johnston, Marilyn Watkins (Arima/TT,
Bridgetown/BDS)
11:30 IL TU-66-07
Development of an Accredited Training Program
with Certification of Graduates
Emad Abboud (Riyadh/SA)
11:40
Discussion
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
T
u
e
s
d
a
y
,

8

J
u
n
e
203
WOC
2010
Hall 8
14:00 - 15:30 TU-67
Improving Continuing Education Worldwide with
ICO Programs
Symposium
Chairs:
Bradley R. Straatsma (Los Angeles/USA)
14:00 IL TU-67-01
Introduction
14:10 IL TU-67-02
Principles of Continuing Professional Development
Bradley R. Straatsma (Los Angeles/USA)
14:20 IL TU-67-03
The Role of ICO Guidelines for Planning CME
Programs
14:30 IL TU-67-04
Continuing Medical Education in Germany
Friedrich Flohr (Hamburg/D)
14:40 IL TU-67-05
ICO Programs for Continuing Medical Education in
14:50 IL TU-67-06
My Experience as an ICO Visiting Professor in
Tanzania
15:00 IL TU-67-07
My Experience as an ICO Professor in Algeria
15:10
Discussion
Hall 8
16:00 - 17:30 TU-68
Setting Up New Parameters for Teaching
Ophthalmic Subspecialties in Developing and
Developed Countries
Symposium
Chairs:
Randall J. Olson (Salt Lake City/USA)
Gottfried O. H. Naumann (Erlangen/D)
16:00 IL TU-68-01
Strategies to Develop Ophthalmic Subspecialty
Education Worldwide
16:10 IL TU-68-02
Organization of Teaching Programs of Glaucoma
for the Worldwide Ophthalmic Community
16:20 IL TU-68-03
Establishing Training Programs of Pediatric
Ophthalmology Across the Continents
16:30 IL TU-68-04
Teaching Oculoplastic Surgery in Developed and
16:40 IL TU-68-05
How The Fellowship Compliance Committee of the
Association of University Professors of Ophthal-
mology (USA) came to be a Voluntary Compliance
Process in the USA
Alfredo Sadun (Los Angeles/USA)
16:50 IL TU-68-06
Our Experience with the Compliance Process of
the Fellowship Compliance Committee in the USA
17:00 IL TU-68-07
The Education of Cataract and Research in China
vs. Sweden
Per Soderberg, MD
17:10 IL TU-68-08
Training of Cataract Surgeons Across the
Continents
Randall J. Olson, MD
17:20
Discussion
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
T
u
e
s
d
a
y
,

8

J
u
n
e
204
WOC
2010
Hall 9
10:30 - 12:00 TU-69
Current Concepts in Retinal Detachment Surgery
Symposium
Retina
Chairs:
Charles P. Wilkinson (Baltimore/USA)
Nicole Eter (Bonn/D)
10:30 IL TU-69-01
Interventions for preventing retinal detachment
10:40 IL TU-69-02
Pneumatic retinopexy: the first choice?
10:50 IL TU-69-03
Buckle surgery in times of vitrectomy
11:00 IL TU-69-04
Transconjunctival vitrectomy for retinal
detachment surgery: How small shall we get?
11:10 IL TU-69-05
What have we learned from the SPR Study?
11:20 IL TU-69-06
Update on how to deal with PVR
11:30
Discussion
Hall 9
14:00 - 15:30 TU-70
ISOP Symposium: Ophthalmic Pathology Update
Symposium
Pathology
Chairs:
14:00 IL TU-70-01
Recent advances in corneal dystrophies
14:10 IL TU-70-02
Histopathology of crosslinking for keratoconus
14:20 IL TU-70-03
Pathology of LASIK/DSEK
14:30 IL TU-70-04
Lacrimal drainage system pathology
14:40 IL TU-70-05
Lacrimal gland tumors
J. Oscar Croxatto (Buenos Aires/RA)
14:50 IL TU-70-06
Optic nerve glioma
15:00 IL TU-70-07
Orbital tumors
15:10
Discussion
Hall 9
16:00 - 17:30 TU-71
IOAT Symposium: Ten Years to Go to the Global
Elimination of Blinding Trachoma
Symposium
Cornea
Chairs:
16:00 IL TU-71-01
Opening of the Meeting
16:05 IL TU-71-02
Priorities for the global trachoma elimination
and its certification
Silvio P. Mariotti, Ivo Kocur (Geneva/CH)
16:20 IL TU-71-03
Challenges in the elimination of pockets of
trachoma and implications on certification
16:35 IL TU-71-04
Challenges that will be faced by ITI for the
trachoma elimination
Danny Haddad (Decatur/USA)
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
T
u
e
s
d
a
y
,

8

J
u
n
e
205
WOC
2010
16:50 IL TU-71-05
Challenges in trachoma elimination in low-income
countries
Amza Abdou (Niamey/RN)
17:05 IL TU-71-06
Epidemiological dynamics of trachoma in the
perspective of a global trachoma elimination
Thomas M. Lietman (San Francisco/USA)
17:20
Discussion
Hall 10
08:30 - 10:00 TU-72
German, Polish, Danish and Hungarian Symposium
on Keratoconus
Symposium
Cornea
Chairs:
Lszl Mdis (Debrecen/H)
08:30 IL TU-72-01
New imaging techniques
Jacek P. Szaflik (Warsaw/PL)
08:45 IL TU-72-02
Collegene cross-linking and biomechanics
Jesper Hjortdahl (Aarhus/DK)
09:00 IL TU-72-03
Lasers and keratoconus
Zoltn Zsolt Nagy (Budapest/H)
09:15 IL TU-72-04
Surgical treatment
09:30 IL TU-72-05
Acute keratoconus
Lszl Mdis (Debrecen/H)
09:45
Discussion
Hall 10
14:00 - 15:30 TU-73
APIISG Symposium: Uveitis Which One Should Not
Miss
Symposium
Chairs:
14:00 IL TU-73-01
Tuberculosis
14:10 IL TU-73-02
Toxoplasmosis
Khalid F. Tabbara (Riyadh/SA)
14:20 IL TU-73-03
CMV Uveitis
14:30 IL TU-73-04
Acute Retinal Necrosis
Hiroshi Goto (Shinjuku-ku/J)
14:40 IL TU-73-05
Behcet's Disease
14:50 IL TU-73-06
VKH Disease
Peizeng Yang (Chongqing/CN)
15:00 IL TU-73-07
Sclerouveitis
15:10 IL TU-73-08
Sarcoidosis
Annabelle A. Okada (Tokyo/J)
15:20
Discussion
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
WOC
2010
Roof Garden
08:30 - 10:00 TU-75
Multifocal and Accommodating IOLs
Symposium
Cataract
Chairs:
Okihiro Nishi (Osaka/J)
Frank J. Goes (Antwerp/B)
08:30 IL TU-75-01
Lens Refilling: How Close to Nature Can We Get
08:40 IL TU-75-02
NuLens
08:50 IL TU-75-03
Prediction of satisfaction ("happy patient project")
09:00 IL TU-75-04
Mix and match options
Frank J. Goes (Antwerp/B)
09:10 IL TU-75-05
Bifocal lenses
Paul H. Ernest (Jackson/USA)
09:20 IL TU-75-06
Shift IOL: They don't work
09:30 IL TU-75-07
Shift IOL: They do work
09:40
Discussion
Roof Garden
10:30 - 12:00 TU-76
ESCRS Symposium: New IOL Concepts in Cataract
and Refractive Surgery
Symposium
Cataract
Chairs:
Hall 10
16:00 - 17:30 TU-74
ALACCSA-R Symposium: Cornea and Ocular
Surface: What's new?
Symposium
Cornea
Chairs:
Cesar Carriazo (Barranquilla/CO)
16:00 IL TU-74-01
Fibrin glue for pterigium surgery
Luis Izquierdo (Lima/PE)
16:10 IL TU-74-02
Clinical significance of lid margin pathologies in
ocular surface reconstruction
16:20 IL TU-74-03
Dohlman Kpro personal Experience
16:30 IL TU-74-04
Have we Over-Diagnosed Limbal Stem Cell
Deficiency?
16:40 IL TU-74-05
Controlling Advanced Keratoconic Aberropia
Sergio Kandelman (Rio de Janeiro/BR)
16:50 IL TU-74-06
Management of infectious keratitis with AM
17:00 IL TU-74-07
Pterigium: Surgical Management
Alonso Otto Solorzano (Cuernavaea/MEX)
206
T
u
e
s
d
a
y
,

8

J
u
n
e
207
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
WOC
2010
14:08 IL TU-77-02
Inner retina: Chronic degeneration in glaucoma-
tous optic neuropathy Diagnostics for the
minimal functional and morphological damage
14:16 IL TU-77-03
tous optic neuropathy New neuroprotective
strategies in glaucoma
Pawel Grieb (Warsaw/PL)
14:24 IL TU-77-04
Inner retina: Acute degeneration in retinal
ischemia/trauma Characterization of acute
neurodegeneration in different animal models
Frank Schttauf (Tbingen/D)
14:32 IL TU-77-05
Inner retina: Acute degeneration in retinal
ischemia/trauma The role of new drugs and
alimentation in acute degeneration
Tomasz Z
arnowski (Lublin/PL)
14:40 IL TU-77-06
Outer retina: Acute retinal degeneration in retinal
detachment Toxicity of vital dyes
Sebastian Thaler (Tbingen/D)
14:48 IL TU-77-07
Outer retina: Chronic retinal degeneration
Evolution of vitreoretinal surgery the smaller the
better?
14:56 IL TU-77-08
Intrectomy clinical and preclinical results
Michael Janusz Koss (Frankfurt/D)
15:04 IL TU-77-09
detachment Biomarkers for neurodegeneration
TBA
15:12 IL TU-77-10
detachment Does retina regenerate- Spectral
OCT data
Jerzy Nawrocki (Lodz/PL)
15:20 IL TU-77-11
Mechanisms of photoreceptor degeneration and
visual repair
10:30 IL TU-76-01
Best haptic design?
10:40 IL TU-76-02
Latest advances in the iris-claw style IOL
10:50 IL TU-76-03
Clinical outcomes and functional visual
performance in new designs of multifocal IOLs:
the Lentis Mplus
11:00 IL TU-76-04
New trifocal diffractive IOL for a better intermedi-
ate and qualitative vision
11:10 IL TU-76-05
Presbyopia treatment using second generation ac-
commodative and multifocal IOL
11:20 IL TU-76-06
Lens refilling: how far we are
Ioannis G. Pallikaris (Voutes, Heraklion/GR)
11:30 IL TU-76-07
Novel implants for aniridia
Daniel Epstein (Bern/CH)
11:40 IL TU-76-08
Implants for Ectopia Lentis
Charlotta Zelterstrm (Oslo/N)
11:50 IL TU-76-08
Artificial capsule
11:50
Discussion
Roof Garden
14:00 - 15:30 TU-77
Regeneration and Repair in Retinal Degeneration:
Mechanisms and Approaches (RRR Symposium)
Symposium
Retina
Chairs:
Robert Rejdak (Lublin/PL)
14:00 IL TU-77-01
tous optic neuropathy New aspects of retinal
ganglion cell loss mechanisms
Robert Rejdak (Lublin/PL)
T
u
e
s
d
a
y
,

8

J
u
n
e
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
T
u
e
s
d
a
y
,

8

J
u
n
e
208
WOC
2010
Roof Garden
16:00 - 17:30 TU-78
Best Excimer Laser
Symposium
Refractive Surgery
Chairs:
Guy M. Kezirian (Scottsdale/USA)
16:00 IL TU-78-01
Introduction
16:05 IL TU-78-02
Survey of current excimer platforms
16:15 IL TU-78-03
Diverging approaches in excimer laser vision cor-
rection aberrometry, topography or other modal-
ities?
Charles P. Lin (Boston/USA)
16:25 IL TU-78-04
Criteria for safety and efficacy in excimer
laser surgery
Guy M. Kezirian (Scottsdale/USA)
16:35 IL TU-78-05
All excimers are not created equal
Christoph Binder (Schramberg/D)
16:45 IL TU-78-06
Improvement potential and limits of excimer laser
treatments
16:55 IL TU-78-07
Laser correction of astigmatism: what does work
and what does not?
Peter McDonnell (Baltimore/USA)
17:05 IL TU-78-08
Session highlights
17:15
Discussion
ICC Lounge
08:30 - 10:00 TU-52
Current Epidemiological Eye Studies
Symposium
Ophthalmic Epidemiology
Chairs:
Christian Wolfram (Mainz/D)
Sheila West (Baltimore/USA)
08:30 IL TU-52-01
Results of the Latino eye study
Rohit Varma (Los Angeles/USA)
08:45 IL TU-52-02
The prevalence and impact on quality of life of
uncorrected refractive error in a Latino population
09:00 IL TU-52-03
Neglected Areas of Research in Developing
Countries
09:15 IL TU-52-04
Early detection of primary open angle closure
glaucoma
09:30
Discussion
ICC Lounge
10:30 - 12:00 TU-53
Intraocular Lymphoma
Symposium
Chairs:
10:30 IL TU-53-01
Classification and molecular biology of intraocular
lymphomas
10:40 IL TU-53-02
Epidemiology and racial differences in intraocular
lymphomas
Jose S. Pulido (Rochester/USA)
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
10:50 IL TU-53-03
Signs and symptoms of intraocular lymphomas
11:00 IL TU-53-04
Diagnosis of intraocular lymphomas
11:10 IL TU-53-05
Overview of treatment of intraocular lymphoma
Didier Decaudin (Paris/F)
11:20 IL TU-53-06
Experience of intraocular lymphoma with
methotrexate
11:30
Discussion
ICC Lounge
14:00 - 15:30 TU-54
Ocular Pharmacology for Posterior Segment
Diseases
Symposium
Chairs:
14:00 IL TU-54-01
Effect of ocular steroids on retinal wound healing
following laser photocoagulation
Daniel Palanker (Stanford/USA)
14:10 IL TU-54-02
Non-viral methods of ocular cell transfection:
extended drug delivery to the posterior pole
TBA
14:20 IL TU-54-03
Radiation targeting and dose verification for
Darius Moshfeghi (Stanford/USA)
14:30 IL TU-54-04
Use of Lentivirus vectors for treatment of
choroidal neovascularization by modified gene
therapy
Yusuke Murakami, Y. Ikeda, Tatsuro Ishibashi
(Fukuoka/J)
14:40 IL TU-54-05
Treatment of retinal venous occlusive disease with
extended delivery formulation of dexamethasone
14:50 IL TU-54-06
Treatment of choroidal neovascularization with
modified gene therapy employing AAV and soluble
FLT receptor
Ian Constable (Nedlands/AUS)
15:00
Discussion
ICC Lounge
16:00 - 17:30 TU-55
Leber Congenital Amaurosis: Classification and
Treatment of Childhood Onset Severe Retinal
Dystrophies
Symposium
Chairs:
Irene H. Maumenee (Baltimore/USA)
16:00 IL TU-55-01
Leber congenital amaurosis in Puerto Rico: natural
history of LCA1, LCA6 and LCA8 and search for new
genes
Irene H. Maumenee (Baltimore/USA)
16:15 IL TU-55-03
Laboratory Diagnosis of LCA
Govindasamy Kumaramanickavel (Bangalore/IND)
16:30 IL TU-55-04
The phenotypic spectrum of RPE65 mutations
16:45 IL TU-55-05
Safety aspects of gene therapy
17:00 IL TU-55-06
The challenge of quantifiying morphology and
function in LCA to monitor the effect of gene
therapy
Frederick W. Fitzke (London/UK)
17:15
Discussion
T
u
e
s
d
a
y
,

8

J
u
n
e
209
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
WOC
2010
210
Room 44
08:30 - 10:00 TU-80
Free Paper
Refractive Surgery
Chairs:
Peter McDonnell (Baltimore/USA)
08:30 FP TU-80-01
Predicting Visual Quality Post-Laser Vision
Correction
Jack Holladay (Bellaire/USA)
08:37 FP TU-80-02
FLEx refractive corrections for hyperopia Latest
results of the clinical trials
Marcus Blum, Kathleen Kunert,
Urs Vossmerbaeumer, Walter Sekundo (Erfurt/D,
Marburg/D)
08:44 FP TU-80-03
Clinical Results of Aspheric Wavefront-guided
LASIK
Suphi Taneri, Saskia Oehler (Mnster/D)
08:51 FP TU-80-04
Corneal Vertex Versus Entrance Pupil Centration
for hyperopic Corneal Ablations
Timothy Archer, Dan Reinstein, Marine Gobbe
(London/UK)
08:58 FP TU-80-05
Long-term follow-up of PRK for myopia.
A comparative study between excimer lasers
Waldir Neira, Timo Tervo, Juha Holopainen
(Helsinki/FIN)
09:05 FP TU-80-06
Corneal modulation with excimer laser for simul-
taneous correction of Presbyopia & Ammetropia:
Preliminary results after 3 months.
Detlef Uthoff, Daniel Hepper, Markus Poelzl,
Detlef Holland (Kiel/D)
09:12 FP TU-80-07
Clinical measure of the quality of vision using a
novel technique based on Moir pattern interfer-
ometry in patients treated with presbyLASIK and
an accommodative IOL: A preliminary study.
Sudi Patel, Jorge Ali (Edinburgh/UK, Alicante/E)
09:19 FP TU-80-08
Ray tracing analysis of corneas operated with a
PresbyLASIK technique (PresbyMax)
Luis Moreno, Jorge Ali, Esperanza Sala
(Alicante/ES)
Room 42
16:00 - 17:30 TU-79
Dry Eye: Latest Advances in Surfocular Dryness
Symposium
Chairs:
Suat H. Ugurbas (Zonguldak/TR)
16:00 IL TU-79-01
Modern concept of Dry Eye
16:10 IL TU-79-02
Diagnostic Tests to Select the Treatment: Part I
Jos M. Bentez del Castillo Snchez (Madrid/E)
16:20 IL TU-79-03
Diagnostic Tests to Select the Treatment: Part II
Jesus Merayo-Lloves (Madrid/E)
16:30 IL TU-79-04
Psychological and environmental treatment
Gysbert van Setten (Danderyd/S)
16:40 IL TU-79-05
Medical treatment: Etiologic, pathogenic and
tear-stimulant
Suat H. Ugurbas (Zonguldak/TR)
16:50 IL TU-79-06
Medical treatment: Substitutive: artificial tears
Luigi Bauchiero (Torino/I)
17:00 IL TU-79-07
Medical Treatment, Autologous Serum, CyA,
Antiinflamm
Ashley Behrens (Baltimore/USA)
17:10 IL TU-79-08
Surgical treatment of Mild and Medium Dry Eye
Peter P. M. Raus (Mol/B)
17:20 IL TU-79-09
Surgical Treatment of Severe Dry Eye
T
u
e
s
d
a
y
,

8

J
u
n
e
211
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
WOC
2010
T
u
e
s
d
a
y
,

8

J
u
n
e
11:00 FP TU-81-05
Comparison of Simultaneous and Sequential
procedures in Combination Treatments for Kerato-
conus using Intrastromal Corneal Ring segments
with Collagen Cross-Linking
Juan Grandin (Mendoza/RA)
11:07 FP TU-81-06
Two-year results of corneal collagen cross-linking
using riboflavin and ultraviolet-A light for
progressive keratoconus.
Mashhoor Alfayez (Jeddah/SA)
11:14 FP TU-81-07
Amniotic membrane transplantation on the ocular
surface: A meta-analysis
Hanif Suleman, E. Lazutina, J. J. Gicquel, A. M. Yeung,
I. Mohammed, N. L. Tint, P. Desai , Harminder S. Dua
(Nottingham/UK)
11:21 FP TU-81-08
Surgical methods of treatment of post-burn
persistent corneal ulceration
Oleksiy Buznyk, Stanislav Iakymenko,
Sergiy Shchypun (Odessa/UA)
11:28 FP TU-81-09
Riboflavin-UVA induced cross-linking treatment
for keratoconus and LASIK keratectasia an Asian
perspective
Li Lim, Hla Myint Htoon, Donald Tan,
Lennard Yuen (Singapore/SGP)
11:35 FP TU-81-10
Ophthalmologic tissue donation Changes and
effects from German Tissue Law on example of
Mitteldeutsche Corneabank Halle Update 2010
Diana Wille (Hannover/D)
11:42
Discussion
Room 44
16:00 - 17:30 TU-82
Cataract/Biometry 4
Free Paper
Cataract
Chairs:
16:00 SL TU-82-01
Application of closing-capsular injection of
viscous and arc capsulectomy in small-incision
with non-phaco extra-capsular cataract extraction
for hyper-mature cataract
Baolinghuang Huang (Wuhu/CN)
09:26 FP TU-80-09
Surgical correction of presbyopia with INTRACOR
Cati Albou-Ganem, D. A. Lebuisson, Jean-Jacques
Saragoussi, Raphael Amar (Paris/F)
09:33 FP TU-80-10
Quality of vision after presbyopic LASIK: contrast
sensitivity and stereo acuity
Dan Reinstein, Timothy Archer, Marine Gobbe
(London/UK)
09:40 FP TU-80-11
Surgical correction of presbyopia with the
AcuFocus Corneal Inlay a two year follow-up
Melchior Hohensinn (Salzburg/A)
09:47
Discussion
Room 44
10:30 - 12:00 TU-81
Cornea/External Disease: Miscellaneous, Surgical
Therapy 3
Free Paper
Chairs:
John D. Gottsch (Baltimore/USA)
10:30 SL TU-81-01
What we have learned abouts Fuchs corneal
dystrophy in the 100 years since Ernst Fuchs' initial
description
John D. Gottsch (Baltimore/USA)
10:39 FP TU-81-02
The opacity patterns of Lisch corneal dystrophy
Susanne Butros, Gerhard K. Lang, Gabriele E. Lang,
Juan Alvarez de Toledo, Ulrich Teimann,
Jens M. Rohrbach, Walter Lisch (Ulm/D,
Barcelona/E, Tbingen/D, Hanau/D, Dortmund/D)
10:46 FP TU-81-03
High-risk corneal transplantation what's new?
Iva Dekaris, Nikica Gabric, Natasa Draca,
Ante Barisic, Maja Pauk, Marija Anticic (Zagreb/HR)
10:53 FP TU-81-04
Deep Anterior Lamellar Keratoplasty with Big
Bubble Technique, assisted by Femtosecond laser,
to treat keratoconus
Adriana Lotfi (Mendoza/RA)
Salon 19
08:30 - 18:00 TU-83
IUSG Workshop: Diagnostic Criteria of Virus-
induced Anterior Uveitis
Symposium
Uveitis
Chairs:
Jolanda de Groot (Utrecht/NL)
Philip Murray (Birmingham/UK)
Program
09:00 11:00
Virology and the Eye
1. Viruses and their clinical eye manifestations
Jolanda de Groot-Mijnes
2. Herpesviruses and the immune system
Maaike Ressing
3. Pathology of virus-induced anterior uveitis
Kalpana Babu
11:15 13:15
AC-tap for VIAU
1. Techniques and pitfalls of AC tap analysis
Jolanda de Groot-Mijnes
2. Antibody determination from the AC tap:
Pro and Contra
Justus Garweg
3. PCR determination from AC tap: Pro and Contra
Colin Fink
Literature Research:
4. Use of AC tap for detection of HSV: Colin Fink,
Janet Davis
5. Use of AC tap for detection of VZV: Jolanda de
Groot-Mijnes, Phil Murray
6. Use of AC tap for detection of Rubella virus:
Jolanda de Groot-Mijnes, Aniki Rothova
7. Use of AC tap for detection of CMV: Justus
Garweg
14:00 16:00
HSV
16:15 17:15
Rubella
In case of interest please contact Phil Murray:
p.i.murray@bham.ac.uk
The second part of the workshop will take place on
Wednesday, 9 June 8:30 to 18:00
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
WOC
2010
16:09 FP TU-82-02
Kinostat reduces the clinical onset and
development of cataracts in diabetic dogs
implications for humans?
Peter Kador, Milton Wyman, Terah Webb,
Dineli Bras, Kerry Ketring (Omaha/USA, Powell/USA,
Worthington/USA, Cincinnati/USA)
16:16 FP TU-82-03
Calculation of zero power lenses with current IOL
power formulas
Wolfgang Haigis, Jose R. Villada (Wrzburg/D,
Albacete/E)
16:23 FP TU-82-04
IOL calculation in very long eyes
Paul-Rolf Preuner, Peter Hoffmann, Jochen Wahl
(Mainz/D)
16:30 FP TU-82-05
Optimizing Torsional Phaco with OZil IP
David Allen (Newcastle on Tyne/UK)
16:37 FP TU-82-06
Laser cataract surgery: nucleus liquefaction using
the LenSx intraocular femtosecond laser
16:44 FP TU-82-07
Optical and clinical outcomes with the LENTIS
Mplus LS-312 MF intraocular lens
Ana Belen Plaza, Jorge Ali, Luis Moreno,
Antonio Fimia, Mercedes Lagua, Roque Madrigal
(Alicante/E)
16:51 FP TU-82-08
22Gauge Bi-Axial Technology for Lens Extraction
without Ultrasonic Power for Soft Nucleus
Arturo Prez-Arteaga (Tlalnepantla/MEX)
16:58 FP TU-82-09
Optimized Diffractive Multifocal Intraocular Lens
Centration Using A New Surgery Guidance System
Omid Kermani, Uwe Oberheide (Kln/D)
17:05 FP TU-82-10
Assessment of cyclotorsion errors in marker based
toric IOL implantation
Rudy Nuijts, Nienke Visser (Maastricht/NL)
17:12 FP TU-82-11
Phacoemulsification in Subluxed Lenses with the
Modified Capsular Tension Ring
17:19
Discussion
212
T
u
e
s
d
a
y
,

8

J
u
n
e
W
e
d
n
e
s
d
a
y
,

9

J
u
n
e
Scientific Program
WOC
2010
213
W
e
d
n
e
s
d
a
y
,

9

J
u
n
e
H
i
g
h
l
i
g
h
t
S
y
m
p
o
s
i
u
m
F
r
e
e

P
a
p
e
r
W
O
C

C
o
u
r
s
e
I
n
d
u
s
t
r
y

S
y
m
p
o
s
i
u
m
M
e
e
t
i
n
g
s
I
C
C
H
a
l
l

3
H
a
l
l

4
/
5
H
a
l
l

6
H
a
l
l

7
H
a
l
l

8
H
a
l
l

9
H
a
l
l

1
0
I
C
C

L
o
u
n
g
e
R
o
o
f

G
a
r
d
e
n
S
a
l
o
n

1
1
/
1
2
S
a
l
o
n

1
9
S
a
l
o
n

2
1
R
o
o
m

4
2
R
o
o
m

4
3
R
o
o
m

4
4
0
7
1
5
3
0
4
5
0
8
1
5
3
0
4
5
0
9
1
5
3
0
4
5
1
0
1
5
3
0
4
5
1
1
1
5
3
0
4
5
1
2
1
5
3
0
4
5
1
3
1
5
3
0
4
5
1
4
1
5
3
0
4
5
1
5
1
5
3
0
4
5
1
6
1
5
3
0
4
5
1
7
1
5
3
0
4
5
1
8
1
5
3
0
4
5
W
E
-
0
9

H
o
l
m
s
t
r
m
,

T
r
e
s
e
,
T
h
u
r
a
u

R
e
t
i
n
o
p
a
t
h
y

o
f

P
r
e
m
a
t
u
r
i
t
y

U
v
e
i
t
i
s
W
E
-
1
0

K
o
h
n
e
n
G
e
r
m
a
n

S
o
c
i
e
t
y

o
f

I
n
t
r
a
-
o
c
u
l
a
r

L
e
n
s

I
m
p
l
a
n
t
a
t
i
o
n
W
E
-
1
1

C
o
s
c
a
s
,

K
a
m
p
i
k

E
A
O
S
y
m
p
:

I
m
p
a
c
t

o
f

r
e
c
e
n
t

d
e
v
e
l
.

o
n

c
l
i
n
i
c
a
l

p
r
a
c
t
i
c
e
W
E
-
3
1

A
w
a
r
d

C
e
r
e
m
o
n
y

a
n
d

H
a
n
d
o
v
e
r

o
f

D
O
G

P
r
e
s
i
d
e
n
c
y

W
E
-
1
2

C
o
l
l
i
n
,

G
u
t
h
o
f
f
,

K
r
e
i
n
e
r
P
a
n
e
l
:

I
m
p
l
a
n
t

M
a
t
e
r
i
a
l
s

a
n
d
T
i
s
s
u
e

I
n
t
e
r
a
c
t
i
o
n
W
E
-
1
3

W
e
i
n
r
e
b
,

K
o
n
s
t
a
s
,
P
f
e
i
f
f
e
r

G
l
a
u
c
o
m
a

R
h
y
t
h
m
s
W
E
-
1
4

Z
r
e
n
n
e
r
,

M
a
c
L
a
r
e
n

R
e
s
t
o
r
i
n
g

S
i
g
h
t

b
y

I
m
p
l
.

a
n
d
T
i
s
s
u
e

E
n
g
i
n
.

o
f

t
h
e

R
e
t
i
n
a
W
E
-
1
7

A
g
a
r
w
a
l
,

K
o
c
h

W
h
a
t

W
i
l
l

Y
o
u

D
o
?
W
E
-
1
8

S
c
h
a
r
i
o
t
h
,

A
l
i

M
i
c
r
o
i
n
c
i
s
i
o
n

C
a
t
a
r
a
c
t

S
u
r
g
e
r
y
W
E
-
1
9

R
a
o
,

S
t
e
g
m
a
n
n
,
M
e
s
t
e
r

T
h
e

M
a
l
p
o
s
i
t
i
o
n
e
d
I
O
L

a
n
d

I
O
L

I
m
p
l
a
n
t
.

i
n

E
y
e
s

W
E
-
2
0

Z
r
e
n
n
e
r
,

M
o
j
o
n
,
H
e
d
g
e
s

A
s
s
e
s
s
i
n
g

S
t
r
u
c
t
.

a
n
d
F
u
n
c
t
.

i
n

N
e
u
r
o
-
O
p
h
t
h
a
l
m
.
W
E
-
2
1

S
c
h
a
e
f
e
r
,

S
e
i
t
z

W
a
v
e
f
r
o
n
t

a
n
d

A
b
e
r
r
a
t
i
o
n
.
W
E
-
2
2

F
o
u
l
k
s
,

H
o
l
z
c
h
u
h
,
K
a
e
r
c
h
e
r
U
p
d
a
t
e

o
n

S
a
f
e
t
y
a
n
d

E
f
f
i
c
a
c
y

o
f

C
o
n
t
.

L
e
n
s

S
o
l
.
W
E
-
2
3

K
i
v
e
l
,

H
u
n
g
e
r
f
o
r
d
,
D
e
s
j
a
r
d
i
n
s

O
O
G

S
y
m
p
:

C
o
m
-
p
l
i
c
.

o
f

O
c
u
l
a
r

I
r
r
a
d
i
a
t
i
o
n
W
E
-
2
4

G
a
l
l
i
e
,

D
e
s
j
a
r
d
i
n
s
,
B
e
c
h
r
a
k
i
s
T
u
m
o
r
s

o
f

t
h
e
R
e
t
i
n
a

a
n
d

R
e
t
.

P
i
g
m
.

E
p
i
t
h
.
W
E
-
2
5

S
p
a
h
n
,

G
a
r
m
s
,

R
a
o
T
h
e

N
e
w

R
e
a
l
i
t
i
e
s

o
f

N
o
n
-
G
o
v
e
r
n
m
e
n
t
a
l

D
e
v
e
l
o
p
m
e
n
t
W
E
-
2
6

K
u
h
n
,

S
c
h
r
a
d
e
r

M
a
n
a
g
e
m
e
n
t

o
f

t
h
e

R
u
p
-
t
u
r
e
d

E
y
e
W
E
-
2
7

K
u
h
n
,

S
c
h
r
a
d
e
r
,
P
e
l
a
y
e
s

I
S
O
T

S
y
m
p
:

O
c
u
l
a
r
t
r
a
u
m
a
t
o
l
o
g
y
:

T
h
e

B
a
s
i
c
s
W
E
-
2
8

K
u
h
n
,

B
a
r
a
k
,

M
o
r
t
a
d
a
M
i
n
i
s
y
m
p
o
s
i
u
m
:

O
c
u
l
a
r
t
r
a
u
m
a
W
O
C
-
C
-
5
6

W
o
l
f
f

R
e
f
r
a
c
t
i
v
e

L
e
n
s

S
u
r
g
e
r
y
W
E
-
2
9

A
r
e
v
a
l
o
,

R
o
c
a
,

W
u

S
P
R
V

S
y
m
p
o
s
i
u
m
:

U
p
d
a
t
e

o
n

P
e
d
i
a
t
r
i
c

R
e
t
i
n
a
W
E
-
3
0

M
u
r
r
a
y
,

S
m
i
t
h
,

B
i
s
w
a
s
P
a
n
e
l

D
i
s
c
u
s
s
i
o
n

T
h
e

T
e
a
c
h
-
i
n
g

o
f

U
v
e
i
t
i
s

W
E
-
1
6

A
l
R
a
j
h
i
,

E
l
-
M
a
g
h
r
a
b
y
,
S
p
i
v
e
y

V
i
s
i
o
n

2
0
2
0

P
r
e
v
e
n
-
t
i
o
n

o
f

B
l
i
n
d
n
e
s
s

2
W
E
-
1
5

S
c
h
r
a
e
r
m
e
y
e
r
,

B
e
h
a
r
,
F
a
r
r
a
r

O
c
u
l
a
r

D
r
u
g

D
e
l
i
v
e
r
y
t
o

t
h
e

P
o
s
t
e
r
i
o
r

S
e
g
m
e
n
t
W
O
C
-
C
-
6
2

K
r
e
i
s
s
i
g
,

A
y
l
w
a
r
d
,
L
i
n
c
o
f
f

P
r
e
s
e
n
t

O
p
t
i
o
n
s

i
n
t
h
e

M
a
n
a
g
e
m
e
n
t

W
E
-
4
2

Z
i
e
r
h
u
t

I
U
S
G

W
o
r
k
s
h
o
p
:

D
i
a
g
n
o
s
t
i
c

C
r
i
t
e
r
i
a

o
f

V
i
r
u
s
-
i
n
d
u
c
e
d

A
n
t
e
r
i
o
r

U
v
e
i
t
i
s
S
i
t
z
u
n
g

K
l
i
n
i
s
c
h
e

M
o
n
a
t
s
b
l
t
t
e
r

f
r

A
u
g
e
n
h
e
i
l
k
u
n
d
e
W
O
C
-
C
-
5
7

K
a
i
s
e
r
,

W
o
l
f
,

H
o
e
r
a
u
f

L
a
s
e
r

i
n

R
e
t
i
n
a
l

D
i
s
e
a
s
e
s

D
o
s

a
n
d

D
o
n
t
s
W
O
C
-
C
-
5
8

N
a
r
e
n
d
r
a
n
,

A
z
a
d
,
D
o
g
r
a

C
u
r
r
e
n
t

T
r
e
n
d
s

i
n
M
a
n
a
g
e
m
.

o
f

R
e
t
i
n
o
p
a
t
h
y
W
E
-
3
8

A
z
a
d
,

M
i
t
c
h
e
l
l
,

K
a
i
s
e
r

B
r
e
a
k
i
n
g

N
e
w
s

i
n

R
e
t
i
n
a
W
O
C
-
C
-
5
9

C
a
r
v
a
l
h
o

V
a
s
c
o
n
-
c
e
l
o
s
,

K
e
e
f
f
e

I
n
t
r
o
d
u
c
i
n
g

P
e
d
i
a
t
r
i
c

L
o
w

V
i
s
i
o
n

W
E
-
3
9

B
u
r
g
o
y
n
e
,

S
e
k
h
a
r
,
H
o
r
n
y
k
e
w
y
c
z

G
l
a
u
c
o
m
a
:

S
u
r
g
i
c
a
l

t
h
e
r
a
p
y

3
W
O
C
-
C
-
6
0

G
i
b
l
i
n
,

K
i
v
e
l
,

F
o
e
r
s
t
e
r
D
i
a
g
n
o
s
i
n
g

M
e
l
a
n
o
-
c
y
t
i
c

T
u
m
o
u
r
s

o
f

t
h
e

U
v
e
a
W
E
-
4
0

M
i
t
c
h
e
l
l
,

P
i
t
z

E
p
i
d
e
m
i
o
l
o
g
y
W
E
-
4
1

A
r
n
o
l
d
,

Z
r
e
n
n
e
r

N
e
u
r
o
-
O
p
h
t
h
a
l
m
o
l
o
g
y

2
W
e
d
n
e
s
d
a
y
,

9

J
u
n
e
W
E
-
0
1

K
n
o
r
z
,

A
l
i

M
a
n
a
g
e
-
m
e
n
t

o
f

C
o
m
p
l
i
c
a
t
i
o
n
s

i
n
L
A
S
I
K

a
n
d

S
u
r
f
a
c
e

A
b
l
a
t
i
o
n
W
E
-
0
2

M
c
D
o
n
a
l
d
,

M
a
r
s
h
a
l
l
,
D
i
c
k

W
h
y

D
o

W
e

S
t
i
l
l

P
e
r
-
f
o
r
m

S
u
r
f
a
c
e

A
b
l
a
t
i
o
n
s
?
W
E
-
0
3

W
i
l
s
o
n
,

S
e
i
t
z

T
h
e

R
e
f
r
a
c
t
i
v
e

C
o
r
n
e
a
:

S
c
i
e
n
c
e

P
r
o
g
r
e
s
s

H
i
g
h
l
i
g
h
t
S
y
m
p
o
s
i
u
m
F
r
e
e

P
a
p
e
r
W
O
C

C
o
u
r
s
e
I
n
d
u
s
t
r
y

S
y
m
p
o
s
i
u
m
M
e
e
t
i
n
g
s
M
e
s
s
e
S
t
o
c
k
h
o
l
m

S
a
o

P
a
u
l
o
O
s
l
o

H
a
l
l

R
a
d
i
o

T
o
w
e
r

L
o
u
n
g
e

1
R
a
d
i
o

T
o
w
e
r
L
o
u
n
g
e

2
0
7
1
5
3
0
4
5
0
8
1
5
3
0
4
5
0
9
1
5
3
0
4
5
1
0
1
5
3
0
4
5
1
1
1
5
3
0
4
5
1
2
1
5
3
0
4
5
1
3
1
5
3
0
4
5
1
4
1
5
3
0
4
5
1
5
1
5
3
0
4
5
1
6
1
5
3
0
4
5
1
7
1
5
3
0
4
5
1
8
1
5
3
0
4
5
W
O
C
-
C
-
5
5

A
g
o
s
t
i
n
i
,

F
e
l
t
g
e
n

M
a
n
a
g
e
m
e
n
t

o
f

V
a
s
c
u
l
a
r

O
c
u
l
a
r

E
m
e
r
g
e
n
c
i
e
s
W
E
-
3
5

H
e
i
m
a
n
n
,

M
o
o
r
e

R
e
t
i
n
a
:

M
i
s
c
e
l
l
a
n
e
o
u
s

2
W
E
-
0
4

T
r
a
u
z
e
t
t
e
l
,

S
u
b
r
a
m
a
n
-
i
a
n
,

G
a
n
d
h
i

H
e
m
i
a
n
o
p
i
a
:
F
e
a
t
u
r
e
s

a
n
d

I
n
t
e
r
v
e
n
t
i
o
n
s
W
E
-
0
5

M
e
l
l
e
r
,

T
s
a
i
,

W
y
l
e
g
a
l
a

M
a
n
a
g
e
m
e
n
t

o
f

L
i
m
b
a
l

S
t
e
m
C
e
l
l

D
e
f
i
c
i
e
n
c
y
W
E
-
0
7

P
i
l
l
u
n
a
t
,

F
e
c
h
t
n
e
r
,
Z
e
y
e
n

A
s
s
e
s
s
m
e
n
t

o
f

t
h
e
O
p
t
i
c

N
e
r
v
e

H
e
a
d
W
E
-
0
8

C
h
o
n
g
,

W
e
d
r
i
c
h
,
K
i
r
c
h
h
o
f

S
u
b
m
a
c
u
l
a
r

H
e
m
o
r
r
h
a
g
e

M
a
n
a
g
e
m
e
n
t
W
E
-
3
3

B
e
a
c
o
n
s
f
i
e
l
d
,

C
o
l
l
i
n
,
H
i
n
t
s
c
h
i
c
h
E
S
O
P
R
S

S
y
m
p
:
M
a
n
a
g
.

o
f

P
e
r
i
o
c
.

T
u
m
o
u
r
s
W
E
-
3
4

E
t
e
r
,

S
i
n
g
e
r

R
e
t
i
n
a
:

A
M
D

4
W
E
-
3
6

F
r
h
l
i
c
h
,

C
o
n
g
d
o
n
,
N
a
i
d
o
o

R
e
f
r
.

E
r
r
o
r

f
r
o
m
S
c
h
o
o
l

A
g
e

t
h
r
.

P
r
e
s
b
y
o
p
i
a
W
E
-
3
7

A
z
a
d
,

D
e
s
j
a
r
d
i
n
s
,

K
a
r
a
c
o
r
l
u
P
e
d
i
a
t
r
i
c

O
p
h
t
h
a
l
-
m
o
l
o
g
y

&

G
e
n
e
t
i
c
s

3
APAO Central Secretariat:
Tel: (852) 2762 3040 Fax: (852) 2715 9490
Email: secretariat@apaophth.org
Host Secretariat:
Tel: (86) 10 8515 8141 Fax: (86) 10 6512 3754
Email: apao2010@cma.org.cn
www.apao2010beijing.org www.apao2010beijing.org
September 16-20, 2010
China National Convention Center
Beijing, China
September 16-20, 2010
China National Convention Center
Beijing, China
held in conjunction with

The 15
th
Congress of the Chinese Ophthalmological Society

The 15
th
Congress of the Chinese Ophthalmological Society
*
Over 500 international top-notch speakers
*
Over 8000 delegates (4000 international,
4000 from China)
Scientifc Program Committee Scientifc Program Committee
Chair: Dennis Lam
Co-Chairs: Xiaoxin Li / Charles McGhee
Senior Secretary: Clement Tham
18 Miscellaneous Dennis Lam / Xiaoxin Li / Charles McGhee / Clement Tham
Secretary
(from APAO Central)
International
Coordinator
Asia
Coordinator
Pacific Rim
Coordinator
Host
Coordinator
Stanley Chang Chi Chun Lai Andrew Chang Zhizhong Ma 17 Retina (Surgical) Zdenek Gregor Vincent Lee
Alexander Brucker Taraprasad Das Diane Sharp Xiaoxin Li 16 Retina (Medical) Ian Constable
Michael Knorz Kazuo Tsubota Michael Lawless Jia Qu 15 Refractive Surgery Ronald Krueger Vishal Jhanji
Akira Murakami Garry Brian Youxin Chen 14 Prevention of Blindness R Pararajasegaram Dennis Lam
Marilyn Miller May May Choo Craig Donaldson Kanxing Zhao 13 Pediatric Ophthalmology & Strabismus Frank Martin Dorothy Fan
Michael Grant Yoon-Duck Kim Tim Sullivan Xianqun Fan 12 Orbits and Oculoplastics David Tse Hunter Yuen
Paul Foster Hidetoshi Yamashita Paul Mitchell Jialiang Zhao 11 Ophthalmic Epidemiology Tien Wong Nathan Congdon
Peter McCluskey Mingwei Zhao 10 Ophthalmic Education Mark Tso Nancy Yuen
Tero Kivel Santosh Honavar Sehu Weng Wei Wang 9 Ocular Pathology & Tumors Jerry Shields David Liu
David Hwang Srinivas Rao Kathy McClellan Xuguang Sun 8 Ocular Microbiology and Ocular Infectious Diseases Terrence OBrien Ben Lam
Neeru Gupta Tin Aung Dipika Patel Ningli Wang 7 Ocular Imaging Charles McGhee Christopher Leung
Andy Lee Navin Jayakumar Helen Danesh-Meyer Shihui Wei 6 Neuro-ophthalmology Neil Miller Carmen Chan
Terete Borras Susumu Ishida Mark Gillies Zhengqin Yin 5 Laboratory Eye Research Vincent Raymond Calvin Pang
Susan Lightman Shigeaki Ohno Sam Lertsumitkul Peizeng Yang 4 Intraocular Inflammation, Uveitis & Scleritis Narsing Rao Timothy Lai
Jost Jonas Makoto Araie Paul Healey Jian Ge 3 Glaucoma Robert Ritch Clement Tham
Ke Yao
2 Cornea and External Eye Disease Shigeru Kinoshita Alvin Young Michael Belin Donald Tan Gerard Sutton Lixin Xie
Philip Lam Richard Packard Abhay Vasavada Tim Roberts
Subspecialty Convener
1 Cataract David Chang
Timothy Lai
Gondhowiardjo Tjahjono Eduardo Mayorga Argaaraz
Mohamed Babar Qureshi
Advance Registration Deadline: Aug 31, 2010 Advance Registration Deadline: Aug 31, 2010
www.apao2010beijing.org www.apao2010beijing.org

SSeppte te embbe er 16
CChin in na Na Na attio ioon nal Co Co on
he he eld ld iin cco onjuunc nc ct tio io on wwi itth
TTh he 155
nj

6- 6-2 -2 20, 0, 2010
nv nve ve ennt tio io on Ce Ce ennte teer
5
tth
Co Coonnggre reesss oof tthe he 5

CChhin ine neesse OOppht htthhaalm lm

mo moolo looggic iccaal So Sooccie ieety ty

Be Be eij ijinnng, g, CChin in na
AAdv dva vannce ce Re Reeggis issttra raa

ttio ioon De Deeaadlinnnee: AAug ug 3

31, 220010

Scientifc Program Scientifc Program SSc cie eent nt tif ifc Pro ro ogra ram
y t l a i c e p s b u S
Ad Advvvancce ce Re Reegis isttrra
ww ww .appao ao2 o201 ww w

m Committee m Committee m Co Co ommit itt tte te ee
) l a r t n e C O A P A m o r f (
y r a t e r c e S
r e n e v n o C
tttiooon DDeeaddlineee: Au Aug 3
0bbeij ijing.org rg

r o t a n i d r o o C
l a n o i t a n r e t n I
a i s A
o C
a P
31, 20010

r o t a n i d r o o
im R c i f i c a
t s o H

Tel: (852) 2762 3040 Fax: (852) 2715 9490

.apao201 .apao201 www www
Tel: (852) 2762 3040 Fax: (852) 2715 9490
APAO Central Secretariat:
www .appao ao2 o20 201 www

0beijing.org 0beijing.org
Email: apao2010@cma.org.cn
Tel: (86) 10 8515 8141 Fax: (86) 10 6512 3754
Host Secretariat:
0bbeij ijinng.oorg rg

Tel: (86) 10 8515 8141 Fax: (86) 10 6512 3754

WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
Stockholm
08:30 - 10:00 WE-01
Management of Complications in LASIK and
Surface Ablation
Symposium
Refractive Surgery
Chairs:
08:30 IL WE-01-01
Ocular surface syndrome-dry eye
Steven E. Wilson (Cleveland/USA)
08:40 IL WE-01-02
Incidence of complications in a chain of high-
volume surgical centers
Jan Venter (London/UK)
08:50 IL WE-01-03
Impact of complications in quality of life
Konrad Pesudovs (Adelaide/AUS)
09:00 IL WE-01-04
Prevention of ectasia a grading system is
necessary
R. Doyle Stulting (Atlanta/USA)
09:10 IL WE-01-05
Management of Keratectasia
09:20 IL WE-01-06
When and how should we use mitomcin C?
09:30
Discussion
Stockholm
10:30 - 12:00 WE-02
Why Do We Still Perform Surface Ablations?
Symposium
Refractive Surgery
Chairs:
John Marshall (London/UK)
10:30 IL WE-02-01
The Pros and Cons of Surface Ablation in 2010
W
e
d
n
e
s
d
a
y
,

9

J
u
n
e
217
10:40 IL WE-02-02
Patient Selection for Surface Ablation
Thomas Claringbold (Clare/USA)
10:50 IL WE-02-03
Pain Control for Surface Ablation
Aleksander Stojanovic (Troms/N)
11:00 IL WE-02-04
Epi-LASIK in 2010
Ioannis G. Pallikaris (Voutes, Heraklion/GR)
11:10 IL WE-02-06
Surface Ablation to Enhance Premium
(Presbyopia-correcting) IOLs
11:20 IL WE-02-07
Recent Advances in Surface Ablation Research
11:30
Discussion
Stockholm
13:00 - 14:30 WE-03
The Refractive Cornea: Science Progress for the
Corneal Refractive Surgeon
Symposium
Refractive Surgery
Chairs:
13:00 IL WE-03-01
Advances in corneal biomechanics
13:10 IL WE-03-02
New insights into cytokine control of myofibrob-
last development, persistence and death in the de-
velopment and disappearance of haze after PRK
13:20 IL WE-03-03
Customized ablation wavefront-guided or
wavefront-optimized?
13:30 IL WE-03-04
Optical changes of the cornea after refractive
surgery impact on IOL power calculation
Achim Langenbucher (Homburg/D)
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
WOC
2010
Sao Paulo
10:30 - 12:00 WE-05
Management of Limbal Stem Cell Deficiency
Symposium
Chairs:
Ray Jui-Fang Tsai (Taipei/TJ)
10:30 IL WE-05-01
Novel Ex Vivo Expansion based on Preservation of
Limbal Stem Cells and their Native Niche Cells
10:40 IL WE-05-02
Biologic view of ex vivo expansion for Limbal stem
cells
Graziella Pellegrini (Venezia/I)
10:50 IL WE-05-03
Clinical application of ex vivo expansion of limbal
stem cells and the mechanism for success
Ray Jui-Fang Tsai (Taipei/CN)
11:00 IL WE-05-04
Ex vivo expansion of autologous mucosal epithe-
lial stem cells for limbal stem cell deficiency
Tsutomu Inatomi (Kyoto/J)
11:10 IL WE-05-05
Reconstruction of ocular surface using living
related limbal grafts in children
11:20 IL WE-05-06
Keratinocytes for limbal stem cell replacement -
insights into corneal epithelial differentiation
11:30 IL WE-05-07
Midterm Results of Cultivated Autologous and Al-
logeneic Limbal Epithelial Transplantation in Lim-
bal Stem Cell Deficiency
11:40
Discussion
13:40 IL WE-03-05
Efficacy of the combination of UV-Riboflavin
crosslinking and PRK
13:50 IL WE-03-06
The US trials on UV-Riboflavin crosslinking
Stephen D. Klyce (Port Washington/USA)
14:00 IL WE-03-07
Current limits of corneal laser surgery
14:10
Discussion
Sao Paulo
08:30 - 10:00 WE-04
Hemianopia: Features and Interventions
Symposium
Low Vision
Chairs:
Susanne Trauzettel-Klosinski (Tbingen/D)
Prem Subramanian (Baltimore/USA)
Rashmin Gandhi (Chennai/IND)
08:30 IL WE-04-01
Training in Hemianopia
Susanne Trauzettel-Klosinski (Tbingen/D)
08:40 IL WE-04-02
Development of a Neuro hemifield test
Prem Subramanian (Baltimore/USA)
08:50 IL WE-04-03
Bitemporal Hemianopia Neuro Ophthalmic
Features and Investigation
Rashmin Gandhi (Chennai/IND)
09:00 IL WE-04-04
Epidemiology of Homonymous Hemianopia
Sachin Kedar (Jackson/USA)
09:10 IL WE-04-05
Hemianopia in neurosurgical practice: causes,
features, outcomes
Natalia Serova (Moscow/RUS)
09:20 IL WE-04-06
The Roadmap of the Visual Pathway- Have you
ever seen *i*?
09:30
Discussion
218
W
e
d
n
e
s
d
a
y
,

9

J
u
n
e
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
WOC
2010
Oslo
08:30 - 10:00 WE-07
Assessment of the Optic Nerve Head and Lamina
Cribrosa
Symposium
Glaucoma
Chairs:
Thierry Zeyen (Leuven/B)
08:30 IL WE-07-01
Ophthalmoscopic evaluation of the optic disk
08:40 IL WE-07-02
The role of optic disc stereophotographs
Thierry Zeyen (Leuven/B)
08:50 IL WE-07-03
Digitized optic disc imaging for glaucoma
diagnosis
Joseph Caprioli (Los Angeles/USA)
09:00 IL WE-07-04
Digitized optic disc imaging for glaucoma
progresssion
09:10 IL WE-07-05
Correlation between structure and function
09:20 IL WE-07-06
Biomechanics of the lamina cribrosa
Eberhard Sprl (Dresden/D)
09:30 IL WE-07-07
In vivo biochemechanics of the optic disc
Claude Burgoyne (Portland/USA)
09:40 IL WE-07-08
Optic nerve blood flow in glaucoma
09:50
Discussion
W
e
d
n
e
s
d
a
y
,

9

J
u
n
e
219
Oslo
10:30 - 12:00 WE-08
Submacular Hemorrhage Management
Symposium
Retina
Chairs:
Lawrence P. Chong (Los Angeles/USA)
Andreas Wedrich (Graz/A)
10:30 IL WE-08-01
Natural History of macular subretinal hemorrhage
in age-related macular degeneration
10:40 IL WE-08-02
23g Vitrectomy with r-TPA and Gas for submacular
hemorrhage
Anton Haas (Graz/A)
10:50 IL WE-08-03
Intravitreal Bevacizumab for neovascular
age-related macular degeneration with large
submacular hemorrhage
11:00 IL WE-08-04
Effects of intravitreal gas with or without tissue
plasminogen activator on submacular haemor-
rhage in age-related macular degeneration
Chang-Hao Yang (Taipei/TJ)
11:10 IL WE-08-05
Pigmentepithelium Transplantation in massive
submacular hemorrhage
11:20 IL WE-08-06
Displacement of Submacular Hemorrhage
by injection of Tissue Plasminogen Activator and
expansile gas
Wilson Heriot (Templestowe Lower/AUS)
11:30
Discussion
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
10:30 - 12:00 WE-33
ESOPRS Symposium: Management of Periocular
Tumours
Symposium
Chairs:
10:30 IL WE-33-01
Diagnosis and differential diagnosis
Marco Puccioni (Florence/I)
10:40 IL WE-33-02
Aetiology
Tim Sullivan (Bernardsville/USA)
10:50 IL WE-33-03
Surgical therapy (tumour clearance, local
and distant)
11:00 IL WE-33-04
Principles of eyelid reconstruction
Mehmet Unal (Ankara/TR)
11:10 IL WE-33-05
Alternative (non-surgical) therapies
11:20 IL WE-33-06
Treatment of local and distant recurrences
11:30
Discussion
13:00 - 14:30 WE-34
Retina: AMD 4
Free Paper
Retina
Chairs:
Michael Singer (San Antonio/USA)
13:00 SL WE-34-01
Update on the molecular genetics of age related
Andrew Lotery (Southampton/UK)
13:09 FP WE-34-02
HORIZON Extension Trial of Ranibizumab (LUCEN-
TIS) for Neovascular Age-related Macular
Degeneration (AMD): Two-year Safety and Efficacy
Results
Michael Singer, Pamela Wong, Lisa Tuomi
(San Antonio/USA)
13:16 FP WE-34-03
Can intravitreal ranibizumab injection in AMD
cause blindness?
Mohamed El-Ashry, Gerasimos Lascaratos,
Archana Vani, Anna-Marie Ambrecht, Baljean
Dhillon (Edinburgh/UK)
13:23 FP WE-34-04
Bonn Ophthalmology Online Network (BOON):
first results of a pilot study
Nicole Eter, Carolin Milojcic, Hans-Martin Helb
(Bonn/D)
13:30 FP WE-34-05
Intravitreal Ranibizumab Versus Bevacizumab In
CNVM Due to ARMD A Prospective Study
Partha Biswas, Subhrangshu Sengupta, Subhankar
Home, Ajoy Paul, Ruby Choudhary (Kolkata/IND)
13:37 FP WE-34-06
Comparison of combined treatment of intravitreal
bevacizumab or intravitreal recombinant tissue
plasminogen activator with expansile gas for
large subretinal fovea involving haemorraghes
secondary to age related neovascular macular
degeneration
Wolfgang Mayer, Imad Hakim, Christos Haritoglou,
Arnd Gandorfer, Michael Ulbig, Anselm Kampik,
Armin Wolf (Mnchen/D)
13:44 FP WE-34-07
Using aspheric monofocal intraocular lenses as
intraocular low vision devise for eyes with macular
damage
Cosme Ildefonso Naval, Analyn T. Suntay, Carmela
Q. Olivares (San Juan/RP)
13:51 FP WE-34-08
Optical coherence tomography and autofluore-
scence findings in areas with geographic atrophy
due to age-related macular degeneration
Steffen Schmitz Valckenberg, Monika Fleckenstein,
Arno P. Gbel, Thomas Hohman, Frank G. Holz
(Bonn/D)
13:58 FP WE-34-09
Influence of antocianozidi on ocular blood flow in
patients with non-exudative age-related macula
degeneration
Tatyana Kiseleva, Ekaterina Kravchuk, Sergey Vlasov
(Moscow/RUS)
W
e
d
n
e
s
d
a
y
,

9

J
u
n
e
220
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
14:05 FP WE-34-10
Fundus Autofluorescence Abnormalities and
Local Macular Pigment Density
Simon Rothenbuehler, Ute Wolf-Schnurrbusch,
14:12
Discussion
08:30 - 10:00 WE-35
Retina: Miscellaneous 2
Free Paper
Retina
Chairs:
Anthony T. Moore (London/UK)
08:30 FP WE-35-01
Retinoblastoma in sub-Saharan African:
Challenges and prospects
Dupe Ademola-Popoola, Foluso Owoeye,
Sunday Abuh (Ilorin/WAN)
08:37 FP WE-35-02
The results of risk-adapted therapy in patiens with
unilateral retinoblastoma
Tatiana Ushakova, Igor Dolgopolov, Olga
Gopovtzova, Alentina Pavlovskaya, Irina Matveeva,
Igor Glekov, Vladimir Polyakov, Geordge Mentkevich
(Moscow/RUS)
08:44 SL WE-35-03
Inherited macular disease
Anthony T. Moore (London/UK)
08:53 FP WE-35-04
Normative comparison of generic- and vision-
targeted health-related quality of life (HRQL) out-
comes in patients with vision loss due to macular
edema following retinal vein occlusion
Anne Rentz, Jonathan W. Kowalski, Dennis Revicki,
Anat Loewentstein, Scott M. Whitcup (Kln/D,
Irvine/USA, Tel Aviv/IL)
09:00 FP WE-35-05
Clinical Effect of Valproic Acid in Patients with RP
and ARMD
Shalesh Kaushal (Worcester/USA)
09:07 FP WE-35-06
The regeneration of adult retinal ganglion cells
through improper targets
Sarah Pfrommer, Solon Thanos (Mnchen/D)
09:14 FP WE-35-07
Which Vessel Segments are Suited for Measure-
ments with the Retinal Vessel Analyzer?
Christoph Wirtz (Bochum/D)
09:21 FP WE-35-08
Natural Evolution from Macular Retinoschisis to
Full-thickness Macular Hole in Highly Myopic Eyes
Chuan-bin Sun, Zhe Liu, Ke Yao (Hangzhou/CN)
09:28 FP WE-35-09
Prophylaxis of Retinal Detachment: To do, not to
do, to observe
Bojimir Petrovski (Sofia/BG)
09:35 FP WE-35-10
Momolayer RPE transplantation for treatment of
hemorrhagic ARMD An expanding procedure of
RPE-Bruchs membrane complex transplantation
Changguan Wang, Yuntao Hu, Hongliang Dou,
Xuefeng Feng (Beijing/CN)
09:42
Discussion
10:30 - 12:00 WE-36
Refractive Error from School Age through
Presbyopia: Combating the World's Leading Cause
of Visual Disability
Symposium
Chairs:
Stephan J. Frhlich (Nrnberg/D)
10:30 IL WE-36-01
Population density and myopia risk among
Chinese children
10:40 IL WE-36-02
The ICEE Approach to Vision Centres
Brien A. Holden (Sydney/AUS)
10:50 IL WE-36-03
New evidence for the impact of environment on
refractive error in Children
11:00 IL WE-36-04
The accuracy of self-refraction among Chinese
secondary school children
He Mingguang (Guangzhou/CN)
W
e
d
n
e
s
d
a
y
,

9

J
u
n
e
221
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
11:10 IL WE-36-05
The potential role of adjustable-power spectacles
in refractive correction programs
Graeme E. Mackenzie (Oxford/UK)
11:20 IL WE-36-06
Human resources in refractive error programs:
training, motivation, retention
11:30 IL WE-36-07
Refractive error in Germany
Stephan J. Frhlich (Nrnberg/D)
11:40
Discussion
13:00 - 14:30 WE-37
Free Paper
Chairs:
Rajvardhan Azad (New Delhi/IND)
Murat Karacorlu (Istanbul/TR)
13:00 FP WE-37-01
Phakic(iris-Fixated) IOLs for anisomyopic
amblyopia in children: pilot study
Mustafa Ibrahim (Dammam/SA)
13:07 FP WE-37-02
An Independent Long Term Outcome Study of
Bilateral Pseudophakia in Children
Malcolm Ing (Honolulu/USA)
13:14 FP WE-37-03
Breaking down barriers in communicating
complex Retinoblastoma information: can pictures
be the solution?
Hannah Chiu, Helen Dimaras, Rob Downie,
Brenda Gallie (Richmond Hill/CDN)
13:21 FP WE-37-04
International Intraocular Retinoblastoma
Classification and histopathology classification
Junyang Zhao (Beijing/CN)
13:28 FP WE-37-05
Visual function in children with hypoxic-ischemic
encephalopathy
Dorota Pojda-Wilczek (Katowice/PL)
13:35 FP WE-37-06
First experiences in the treatment of ROP with
VEGF-inhibitors
Synke Meltendorf, Thoralf Wecke, Simone Tuchen,
Sven Walter, Arne Viestenz, Wolfgang Behrens-
Baumann (Magdeburg/D)
13:42 FP WE-37-07
Visual perceptual and neurocognition deficits in
visually impaired children do we overlook the
obvious?
Barbara Ksmann-Kellner, Christine Basel,
13:49 SL WE-37-09
Batten Disease one disease but many diagnoses
Frank Stehr (Hamburg/D)
13:58
Discussion
Hall 3
08:30 - 10:00 WE-09
Retinopathy of Prematurity Uveitis
Symposium
Chairs:
Gerd Holmstrm (Uppsala/S)
08:30 IL WE-09-01
ROP in premature and extremely premature
infants
Gerd Holmstrm (Uppsala/S)
08:45 IL WE-09-02
Role of digital imaging in ROP
Anna Ells (Calgary/CDN)
09:00 IL WE-09-03
Indications and options for treatment
09:15 IL WE-09-04
Uveitis in childhood Therapy
09:30 IL WE-09-05
Uveitis in childhood Indication for surgery
09:45
Discussion
W
e
d
n
e
s
d
a
y
,

9

J
u
n
e
222
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
Hall 3
10:30 - 12:00 WE-10
Update Deutschsprachige Gesellschaft fr
Intraokularlinsen-Implantation, interventionelle
und refraktive Chirurgie
German Society of Intraocular Lens Implantation,
Interventional and Refractive Surgery
(Session in German)
Symposium
Cataract
Chairs:
10:30 IL WE-10-01
State of the Art Standard IOL
10:40 IL WE-10-02
Premium IOL berblick
10:50 IL WE-10-03
Nachbehandlung nach refraktivchirurgischen
Eingriffen
11:00 IL WE-10-04
Qualittsmanagent in der refraktiven und
Kataraktchirurgie
Ekkehard Fabian (Rosenheim/D)
11:10 IL WE-10-05
Trabekulektomie vs Kanaloplastik
Maya Mller (Lbeck/D)
11:20 IL WE-10-06
Neue Injektorsysteme
Jrn Kuchenbecker (Berlin/D)
11:30 IL WE-10-07
Intraokulare Medikamenteneinbringung
11:40 IL WE-10-08
OCT-Diagnostik am vorderen Augenabschnitt
Christopher Wirbelauer (Frankfurt(Oder)/D)
Hall 3
13:00 - 14:30 WE-11
EAO Symposium: Impact of Recent Developments
on Clinical Practice
Symposium
Miscellaneous
Chairs:
13:00 IL WE-11-01
Surgical Retina
13:10 IL WE-11-02
Medical Retina
13:20 IL WE-11-03
Glaucoma
13:30 IL WE-11-04
Cornea
13:40 IL WE-11-05
Cataract Surgery
13:50 IL WE-11-06
Neuroophthalmology
14:00 IL WE-11-07
Ocular Surface
14:10 IL WE-11-08
Rare Diseases
14:20
Discussion
W
e
d
n
e
s
d
a
y
,

9

J
u
n
e
223
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
Hall 4/5
08:30 - 10:00 WE-12
Panel: Implant Materials and Tissue Interaction in
Ophthalmic Plastic and Reconstructive Surgery
Panel
Chairs:
Christine F. Kreiner (Hennigsdorf/D)
08:30 IL WE-12-01
Osmoexpansion of orbital structures a 10 years
experience
08:40 IL WE-12-02
Applied features of different orbital implants
Michail Kataev (Moscow/RUS)
08:50 IL WE-12-03
Implant exposure and its management
09:00 IL WE-12-04
Minimal invasive application of osmoexpanders
and its local tissue reaction
Michael P. Schittkowski (Gttingen/D)
09:10 IL WE-12-05
Tissue reactions in filler therapy
Christine F. Kreiner (Hennigsdorf/D)
09:20 IL WE-12-06
Frontalis sling materials
09:30 IL WE-12-07
Biomaterials as medpore in orbital floor fractures
Luigi Colangelo (Chieti/I)
09:40 IL WE-12-08
Jones Tubes for lacrimal canalicular obstructions
Daniel Weil (Buenos Aires/RA)
09:50
Discussion
Hall 4/5
10:30 - 12:00 WE-13
Glaucoma Rhythms
Symposium
Glaucoma
Chairs:
Anastasios G. P. Konstas (Thessaloniki/GR)
10:30 IL WE-13-01
Circadian rhythms in human health and disease
10:40 IL WE-13-02
What have we learned about IOP from the sleep
laboratory?
Jonathan Liu (Omaha/USA)
10:50 IL WE-13-03
Aqueous humor rhythms
Arthur J. Sit (Rochester/USA)
11:00 IL WE-13-04
Should the one-eye therapeutic trial be
abandoned?
Anthony Realini (Morgantown/USA)
11:10 IL WE-13-05
Are blood pressure and perfusion pressure risk
factors for glaucoma?
Selim Orgl (Basel/CH)
11:20 IL WE-13-06
Continuous monitoring of IOP with a contact lens
Matteo Leonardi (Lausanne/CH)
11:30 IL WE-13-07
Continuous monitoring of IOP with an implantable
device
Samir A. Melki (Brookline/USA)
11:40 IL WE-13-08
Implications for glaucoma management
11:50
Discussion
W
e
d
n
e
s
d
a
y
,

9

J
u
n
e
224
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
Hall 4/5
13:00 - 14:30 WE-14
Restoring Sight by Implants and Tissue
Engineering of the Retina
Symposium
Chairs:
13:00 IL WE-14-01
Retinal prostesis
13:10 IL WE-14-02
Seeing with subretinal electronic implants
13:20 IL WE-14-03
Trans-corneal electrical stimulation to rescue the
death of retinal neurons
Takashi Fujikado (Osaka/J)
13:30 IL WE-14-04
How mechanisms of retinal disease will guide
forthcomming gene therapy approaches
13:40 IL WE-14-05
Retinitis pigmentosa and iPS cells
Masayo Takahashi (Kobe/J)
13:50 IL WE-14-06
Seoul Artificial Retina Project
Hum Chung (Seoul/ROK)
14:00
Discussion
Hall 6
08:30 - 10:00 WE-17
What Will You Do?
Symposium
Cataract
Chairs:
Hans-Reinhard Koch (Bonn/D)
This Symposium will teach important pearls and
management strategies when a clinician is faced
with a difficult clinical scenario.
This will be highlighted with the help of surgical
videos. Each speaker will share an interesting
clinical case which will be discussed with other
faculties and the audiance.
Chairs:
08:30 IL WE-17-01
Management of zonulopathy in Marfan's
Tim Roberts (Chatswood/AUS)
08:40 IL WE-17-02
Video
Suhas Haldipurkar (Panvel/IND)
08:50 IL WE-17-03
To keep or not to keep the capsular bag
09:00 IL WE-17-04
Video
Biro Zsolt (Pcs/H)
09:10 IL WE-17-05
Video
Hadi Prakoso (Jakarta/RI)
09:20 IL WE-17-06
Video
09:30
Discussion
W
e
d
n
e
s
d
a
y
,

9

J
u
n
e
225
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
Hall 6
10:30 - 12:00 WE-18
Microincision Cataract Surgery: Mastering the
Phakonit / Mics Technique
Symposium
Cataract
This symposium will highlight different aspects of
Micro Incision Cataract surgery. It would include
Micro phakonit biaxial and coaxial Micro Inicion
surgery. The experts will also teach applications of
different techniques in difficult as well as routine
cataract cases.
Chairs:
Gabor B. Scharioth (Recklinghausen/D)
10:30 IL WE-18-01
Ideal tips and power modulation for MICS
Takayuki Akahoshi (Tokyo/J)
10:40 IL WE-18-02
A Low Fluidics Strategy for Micro-coaxial Torsional
Phaco for Dense Cataracts
Khiun F. Tjia (Zwolle/NL)
10:50 IL WE-18-03
Microphakonit: 700 micron cataract surgery in
tough cases
11:00 IL WE-18-04
Step by Step: Surgical Advantages of 700 micron
Technology during Lens Extraction
Arturo Perez Arteaga (Tlalnepantla/MEX)
11:10 IL WE-18-05
Is it possible to Manage any Cataract Case with
Biaxial technique?
L. Felipe Vejarano (Popayn/CO)
11:20 IL WE-18-06
MICS with the Infiniti Vision System
11:30
Discussion
Hall 6
13:00 - 14:30 WE-19
The Malpositioned IOL and IOL Implantation in
Eyes with Deficient Capsules
Symposium
Cataract
Chairs:
Ulrich Mester (Sulzbach/D)
13:00 IL WE-19-01
Secondary IOL implantation in eyes with partial or
complete capsular support
13:10 IL WE-19-02
Iris fixation of IOLs in aphakic eyes
TBA
13:20 IL WE-19-03
Anterior chamber IOL placement in aphakic eyes
what to do and what not to do
TBA
13:30 IL WE-19-04
Scleral fixation of the IOL into the sulcus
techniques and pearls
13:40 IL WE-19-05
Comparison of AC and scleral fixated IOLs
TBA
13:50 IL WE-19-06
Dealing with the malpositioned IOL
TBA
14:00 IL WE-19-07
Influence on optical quality on malpositioned IOL
Ulrich Mester (Sulzbach/D)
14:10 IL
Techniques in retrieving and fixing a posterior
dislocated IOL
Vincent Y. W. Lee (Hong Kong/CN)
14:20
Discussion
W
e
d
n
e
s
d
a
y
,

9

J
u
n
e
226
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
Hall 7
08:30 - 10:00 WE-20
Assessing Structure and Function in Neuro-
Ophthalmology
Symposium
Neuro-Ophthalmology
Chairs:
08:30 IL WE-20-01
Using OCT for Neuro-ophthalmic disorders
Carlos Mendoza (Ciudad de la Habana/C)
08:40 IL WE-20-02
Using OCT and ERG to Distinguish Retinopathy
from Optic Neuropathy
08:50 IL WE-20-03
What can a comparison of multifocal ERG and OCT
results tell us about the locus/nature of visual de-
fects?
TBA
09:00 IL WE-20-04
Visual hallucinations: who, what, when, why?
Francois Borruat (Lausanne/CH)
09:10 IL WE-20-05
Chromatic pupillometry in patients with outer
photoreceptor disease: correlation with ERG and
visual field
Aki Kawasaki (Lausanne/CH)
09:20 IL WE-20-06
Objective visual assessment along the visual
pathway: optophysiology and electrophysiology
09:30
Discussion
Hall 7
10:30 - 12:00 WE-21
Wavefront and Aberration. How to Optimize
"Quality of Vision" in Contactology
Symposium
Chairs:
Tanja Schaefer (Curitiba/P)
10:30 IL WE-21-01
Newton Kara Jos Lecture; Keratoconus. Contact
lenses and cross-linking
Cleusa Coral-Ghanem (Joinville/BR)
10:40 IL WE-21-02
The corneal aberrometry and contact lens
Tanja Schaefer (Curitiba/P)
10:50 IL WE-21-03
Wavefront in Presbyopia and Contact Lenses
Nilo Holzchuh (So Paulo/BR)
11:00 IL WE-21-04
Wavefront. What equipment?
Paulo Ricardo (Goiania/BR)
11:10 IL WE-21-05
Corneal Topography and Abberometer
Measurement in RGP Lens Wear
Naoyuki Maeda (Osaka/J)
11:20 IL WE-21-06
Thirty Years of Follow Up and the New Possibilities
Using the Wavefront
Ari de Souza Pena (Niteroi/BR)
11:30
Discussion
Hall 7
13:00 - 14:30 WE-22
Update on Safety and Efficacy of Contact Lens
Solutions
Symposium
Chairs:
Nilo Holzchuh (So Paulo/BR)
Thomas Kaercher (Heidelberg/D)
13:00 IL WE-22-01
Solution compatibility with silicone lenses
Ebru Toker (Istanbul/TR)
W
e
d
n
e
s
d
a
y
,

9

J
u
n
e
227
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
WOC
2010
09:00 IL WE-23-05
How to prevent the complications of proton beam
irradiation of the ocular surface
09:10 IL WE-23-06
Retinal complications of brachytherapy and proton
beam irradiation: dosage and irradiation field
09:20 IL WE-23-07
The treatment of persisting serous retinal
detachment due to irradiation
09:30 IL WE-23-08
Radiation optic neuropathy: if prevention fails
Raffaele Parrozzani (Padova/I)
09:40 IL WE-23-09
Thoughts on Management of Radiation Macular
Edema
09:50
Discussion
Hall 8
10:30 - 12:00 WE-24
Tumors of the Retina and Retinal Pigment
Epithelium
Symposium
Oncology
Chairs:
Nikolaos E. Bechrakis (Innsbruck /A)
10:30 IL WE-24-01
Genetics and diagnosis of retinoblastoma
10:40 IL WE-24-02
Retinoblastoma in developing countries
Vikas Khetan (Tamil Nadu/IND)
10:50 IL WE-24-03
Optimizing radiotherapy of retinoblastoma
11:00 IL WE-24-04
Systemic chemotherapeutic protocols in
retinoblastoma
John Hungerford (London/UK)
13:10 IL WE-22-02
Contact lens disinfection compliance in Brazil
Paulo Ricardo (Goiania/BR)
13:20 IL WE-22-03
Update on contact lense disinfection systems in
USA
13:30 IL WE-22-04
Contact lens disinfection system performance in
Japan
Rioji Yanai (Yamaguthi/J)
13:40 IL WE-22-05
Role of osmolarity in contact wear and care
Michael A. Lemp (Lake Wales/USA)
13:50 IL WE-22-06
Corneal infections related to Contact Lenses
Yoshikazu Shimonura (Osakasayama-shi/J)
14:00 IL WE-22-07
Influence of Cosmetics and Cleansing Products for
the Eyes on Soft Contact Lenses
Junko Tsukiyama (Wakayama/J)
14:10
Discussion
Hall 8
08:30 - 10:00 WE-23
OOG Symposium: Complications of Ocular
Irradiation: Prevention and Treatment
Symposium
Oncology
Chairs:
John Hungerford (London/UK)
08:30 IL WE-23-01
Pathology of radiation induced ocular
complications
08:40 IL WE-23-02
Complications of direct ocular irradiation:
the clinical scenario
08:50 IL WE-23-04
The eye as an indirect target of orbital and
periorbital irradiation
Edoardo Midena (Padova/I)
228
W
e
d
n
e
s
d
a
y
,

9

J
u
n
e
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
WOC
2010
14:00 IL WE-25-07
Elevating the priority of Eye Care within WHO
Ala Alwan (Geneve/CH)
14:10
Discussion
Hall 9
08:30 - 10:00 WE-26
Management of the Ruptured Eye
Symposium
Chairs:
08:30 IL WE-26-01
Video
08:40 IL WE-26-02
Video
08:50 IL WE-26-03
Video
09:00 IL WE-26-04
Video: Combined pars plana vitrectomy and artifi-
cial iris diaphragm implant after globe rupture
Tommaso Rossi (Rome/I)
09:10 IL WE-26-05
Video: Ab interno' intravitreal suturing of a large
traumatic scleral perforation at the posterior pole
Jrg Christian Schmidt (Duisburg/D)
09:20 IL WE-26-06
Panel discussion on cases presented by the
moderators
11:10 IL WE-24-05
Intraarteral chemotherapy in retinoblatoma: Pro
David H. Abramson (New York/USA)
11:20 IL WE-24-06
Intraarteral chemotherapy in retinoblatoma:
Contra
11:30 IL WE-24-07
RPE and ciliary epithelium tumors
11:40 IL WE-24-08
Retinal vascular tumors
11:50
Discussion
Hall 8
13:00 - 14:30 WE-25
The New Realities of Non-Governmental
Development in 2010 and Beyond
Symposium
World Forum of Prevention of Blindness
Chairs:
Kathy Spahn (New York/USA)
Christian Garms (Bensheim/D)
13:00 IL WE-25-01
Introduction, and Fundraising in the New Decade
Kathy Spahn (New York/USA)
13:10 IL WE-25-02
The Need to Reach Beyond the Eye Care World and
Partner with Other Initiatives
13:20 IL WE-25-03
Partnering with Disability Initiatives
13:30 IL WE-25-04
Partnering with Infectious Disease Initiatives
Danny Haddad (Decatur/USA)
13:40 IL WE-25-05
Partnering with Chronic Disease Initiatives
13:50 IL WE-25-06
Partnering with Poverty Alleviation Initiatives and
the MDGs
W
e
d
n
e
s
d
a
y
,

9

J
u
n
e
229
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
Hall 9
10:30 - 12:00 WE-27
ISOT Symposium: Ocular Traumatology: The Basics
Symposium
Trauma
Chairs:
10:30 IL WE-27-01
Counseling and Diagnostics
10:40 IL WE-27-02
How to exercise for trauma surgery on the animal
eye
Siegfried Priglinger (Linz/A)
10:50 IL WE-27-03
Primary anterior segment surgery
Frank Wilhelm (Schwerin/D)
11:00 IL WE-27-04
Prevention and treatment of posttraumatic
endophthalmitis
11:10 IL WE-27-05
Primary and secondary posterior segment surgery
11:20 IL WE-27-06
Pole to pole surgery
11:30 IL WE-27-07
Ocular tension variations in trauma injuries
11:40
Discussion
Hall 9
13:00 - 14:30 WE-28
Minisymposium: Ocular Trauma Caused by War
and Terrorist Attacks
Symposium
Chairs:
Adiel Barak (Tel-Aviv/IL)
13:00 IL WE-28-01
Ophthalmic combat injuries in the German sector
of Northern Afghanistan 2003-2009, Management
and outcome
13:10 IL WE-28-02
Management of war and terror related eye injuries
on the British mainland and in her theatres of war
Robert A. Scott (Birmingham/UK)
13:20 IL WE-28-03
Treating concept for mass casualties in Russia
Ernest V. Boiko (Sankt Petersburg/RUS)
13:30 IL WE-28-04
Experience from Terror attacks in India
S. Natarajan (Mumbai/IND)
13:40 IL WE-28-05
Experience from war and terror related eye injuries
in Egypt
13:50 IL WE-28-06
Management of eye injuries after terror attacks in
Israel
Adiel Barak (Tel-Aviv/IL)
14:00 IL WE-28-07
Terror related open-globe injuries in turkey
Gngr Sobaci (Ankara/TR)
14:10 IL WE-28-08
Conclusion
W
e
d
n
e
s
d
a
y
,

9

J
u
n
e
230
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
Hall 10
10:30 - 12:00 WE-29
SPRV Symposium: Update on Pediatric Retina
Symposium
Retina
Chairs:
Jos Roca (Lima/PE)
10:30 IL WE-29-01
Vitreo-Retinal Surgery in Children with Uveitis
10:40 IL WE-29-02
Coats Disease
Jos Roca (Lima/PE)
10:50 IL WE-29-03
Familial exudative vitreoretinopathy
11:00 IL WE-29-04
Small-gauge Vitrectomy for Pediatric Retinal
Detachment
Andres Kychenthal (Vitacura/RCH)
11:10 IL WE-29-05
Stage 5 retinopathy of prematurity: then and now
11:20 IL WE-29-06
Anti-angiogenics in ROP
Hugo Quiroz-Mercado (Mexico City/MEX)
11:30 IL WE-29-07
Plasmin enzyme-assisted vitreoretinal surgery in
congenital X-linked retinoschisis
Kimbely A. Drenser (Royal Oak/USA)
11:40 IL WE-29-08
Choroidal Neovascularization in Children
Audina Berrocal (Miami/USA)
11:50
Discussion
Hall 10
13:00 - 14:30 WE-30
Panel Discussion The Teaching of Uveitis at
Residency Level and Fellowships
Panel
Chairs:
Ronald E. Smith (Los Angeles/USA)
13:00 IL WE-30-01
Education in Brasil
Cristina Mucchioli (Brooklyn/USA)
13:15 IL WE-30-02
Education in Japan
13:30 IL WE-30-03
Education in India
13:45 IL WE-30-04
Education in USA
Ronald E. Smith (Los Angeles/USA)
14:00 IL WE-30-05
Education in UK
14:15 IL WE-30-06
Education in Germany
Roof Garden
11:30 - 13:00 WE-31
Awards and Fundings
(list of the awards available at page 18)
Bestowal of the Honorary Membership of the
DOG to Prof. Petja Ivanova Vassileva, Bulgaria
Handover of DOG Presidency to
Prof. Thomas Reinhard, Freiburg
Photo Shooting Award Winners
W
e
d
n
e
s
d
a
y
,

9

J
u
n
e
231
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
WOC
2010
13:00 FP WE-16-01
Diabetic Eye Disease in the Pacific: a problem de-
manding attention now
Konstanze Fischer-Harder, Garry Brian,
Jaqueline Ramke, Louise Maher, Biu Sikivou,
John Szetu (Suva/FJI)
13:07 FP WE-16-02
Cataract surgical outcomes during micro surgical
training in China
Guan Chunhong , Richard LeMesurier,
Andreas Mueller (South Melbourne/AUS,
Nanchang City/CN)
13:14 FP WE-16-03
AGENT (Afro-German-Eye-Net) Program for
Continuous Medical Education of Ophthalmolo-
gists in Africa
Martin M. Nentwich, Michaela Wilke, Katrin Winter,
Ulrich C. Schaller, Anselm Kampik, Volker Klauss
(Munich/D)
13:21 FP WE-16-04
Rapid assessment of avoidable blindness in the
Occupied Palestinian Territories (East Jerusalem,
West Bank and Gaza) a population-based survey.
Far Chiang, Hannah Kuper, Robert Lindfield,
Tiarnan Keenan, Na'el Seyam, Denise Magauran,
Nasrallah Khalilia, Habes Batta, Ziad Abdeen,
Nicholas Sargent (London/UK, Northolt/UK)
13:28 FP WE-16-06
Developing international research capacity for
VISION 2020.
Robert Lindfield, Shaheen Shah, Clare Gilbert
(London/UK)
13:35 FP WE-16-07
Ongoing Community Eye Health Status of the
People Affected with Leprosy in some of the SARC
Countries
Swapan K. Samanta (Tamluk/IND)
13:42 FP WE-16-08
Prevalence of low vision amongst students
attending all the Schools for the blind in Oyo
State, Nigeria, and the need for visual aids.
Adedamola Mosuro (Lagos/WAN)
13:49 FP WE-16-09
Ophthalmic subspecialization in Ibadan, West
Africa
Tunji Oluleye, Benedictus Ajayi, Adeyinka Ashaye,
Ronke Baiyeroju, Ayotunde Ajaiyeoba, Charles
Bekibele, Oluyemi Fasina, Bolutife Olusanya,
Bade Ogundipe, Olufunmi Ogun, Sola Olawoye,
Olutoke Ayorinde (Ibadan/WAN)
13:56
Discussion
ICC Lounge
08:30 - 10:00 WE-15
Ocular Drug Delivery to the Posterior Segment
Symposium
Chairs:
Ulrich Schraermeyer (Tbingen/D)
Francine Behar (Paris/F)
Jane Farrar (Dublin/IRL)
08:30 IL WE-15-01
Transport of intravitreally injected proteins
through the retina
Ulrich Schraermeyer (Tbingen/D)
08:40 IL WE-15-02
Non-viral ocular gene therapy
Francine Behar (Paris/F)
08:50 IL WE-15-03
Aspects of ocular gene therapy work with siRNA
Jane Farrar (Dublin/IRL)
09:00 IL WE-15-04
Transporter and receptor targeted drug delivery to
the retina
Ashim K. Mitra (Kansas City/USA)
09:10 IL WE-15-05
Drug delivery platforms, drug sensors
09:20 IL WE-15-06
Drug Transporters in Corneal Epithelium and
Retinal Pigment Epithelial Cells: Potential Role in
Drug Delivery
Arto Urtti (Helsink/FIN)
09:30
Discussion
ICC Lounge
13:00 - 14:30 WE-16
Vision 2020 Prevention of Blindness 2
Free Paper
Chairs:
Akef El-Maghraby (Jeddah/SA)
Bruce E. Spivey (San Francisco/USA)
232
W
e
d
n
e
s
d
a
y
,

9

J
u
n
e
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
WOC
2010
Room 43
10:30 - 12:00 WE-39
Free Paper
Glaucoma
Chairs:
Karin Hornykewycz (Dresden/D)
10:30 FP WE-39-01
Drainage of the anterior and vitreous chamber
with Ahmed glaucoma valve in uncontrolled
pediatric and adult glaucoma
Roman Troyanovsky, Oleg Sinyavsky, Svetlana
Solonina, Julia Antipova, Alexandr Golovin
(St-Petersburg/RUS)
10:37 FP WE-39-02
Canaloplasty as alternative to goniotrepanation
and deep sclerectomy clinical experience
Maren Klemm, Claudia Rebel, Johannes Steinberg,
Mario Matthaei (Hamburg/D)
10:44 FP WE-39-03
Tabeculectomy without suturing the conjuntiva
Josef Weindler (Esslingen/D)
10:51 FP WE-39-04
Longtime Efficiency of Combined Cataract-Surgery
and Excimer-Laser-Trabeculotomy in Glaucoma
Surgery 12 month results
Marc Tteberg-Harms, Peter Paul Ciechanowski,
Cornelia Hirn, Jens Funk (Zurich/CH)
10:58 FP WE-39-05
Effect of Selective-Laser-Trabeculoplasty (SLT) on
ocular hemodynamics in glaucoma
Karin Hornykewycz, Eberhard Spoerl,
Richard Stodtmeister, Lutz E. Pillunat (Dresden/D)
11:05 FP WE-39-06
Clinical study on Ahmed glaucoma valve implanta-
tion for 12 eyes with glaucoma after vitrectomy
Hong-Ping Cui, Xin-Rui Gao, Qian Li, Xin Liao,
Fang Wang (Shanghai/CN)
11:12 FP WE-39-07
One-site versus two-site fornix based
phacotrabeculectomy in patients with cataract
and pseudoexfoliative glaucoma
Zdravko Mandic, Mia Zoric Geber, Katia Novak Laus,
Ivanka Petric Vickovic (Zagreb/HR)
Room 42
13:00 - 14:30 WE-38
Breaking News in Retina
Symposium
Retina, Vitreous
Chairs:
13:00 IL WE-38-01
VEGF Trap-Eye for Diabetic Macular Edema:
The DA VINCI Study
13:15 IL WE-38-02
Efficacy and safety of intravitreal ranibizumab as
adjunctive therapy to laser photocoagulation
or as monotherapy in diabetic macular edema:
12-month results from the RESTORE study
13:30 IL WE-38-03
The phase 1 results of KH902 a improved version
of VEGF Trap
13:45 IL WE-38-04
Epimacular Brachytheryp in the treatment of
exsudative age-related macular degneration
Pravin Dugel (Phoenix/USA)
14:00 IL WE-38-05
Pfizer A5751013 Trial, A Phase 2/3 Randomized,
Controlled, Double-Masked, Multi-Center,
Comparative Trial, in Parallel Groups, Compares
the Safety and Efficacy of Intravitreous Injections
of 0.3 mg Pegaptanib Sodium (Macugen),
Given as Often as Every 6 Weeks for 2 years, to
Sham Injections, in Subjects with Diabetic
Macular Edema (DME).
14:15 IL WE-38-06
Pascal Laser in DME Pain vs. Performance
W
e
d
n
e
s
d
a
y
,

9

J
u
n
e
233
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
11:19 FP WE-39-08
Posterior chamber aspiration as an adjuvant of
intravitreal bevacizumab for the treatment of
decompensated neovascular glaucoma
Walter Noske, Hermann Burau (Brandenburg/D)
11:26 FP WE-39-09
Safety and efficacy of topical bevacizumab in the
early bleb failure after trabeculectomy
Tomasz Zarnowski, Justyna Klos-Rola,
Maria Tulidowicz-Bielak, Anselm Jnemann
(Lublin/PL, Erlangen/D)
11:33 FP WE-39-10
The result of management in primary angle
closure glaucoma for Indonesians eyes
Ikke Wiyogo (Jakarta/RI)
11:40
Discussion
Room 44
08:30 - 10:00 WE-40
Epidemiology
Free Paper
Epidemiology
Chairs:
08:30 FP WE-40-01
Ocular manifestations of Fabrys disease: an
update from the Fabry Outcome Survey with focus
on longitudinal and pediatric data
Susanne Pitz, Andrea Sodi, Pauline Wilson,
Roberto Ebner, Roberto Ebner,
Gere Sunder-Plassmann (Mainz/D)
08:37 FP WE-40-02
Regional Differences in Rates of Exfoliation
Syndrome Throughout the United States
Joshua D. Stein, Nidhi Talwar, Julia E. Richards,
Denise S. Kim, David M. Reed, Bin Nan,
Jae Hee Kang, Janey L. Wiggs, Louis Pasquale
(Ann Arbor/USA)
08:44 FP WE-40-03
Agricultural pesticide use and childhood orbital
malignant tumor
Jayanta Das (Guwahati/IND)
08:51 FP WE-40-04
Prevalence and risk factors of undercorrected
refractive errors among Singaporean Malay adults:
the Singapore Malay Eye Study
Mohamad Rosman, Tien Yin Wong, Wan Ting Tay,
Louis Tong, Seang Mei Saw (Singapore/SGP)
08:58 FP WE-40-05
High Coverage with Azithromycin and effect
on Trachoma and C. trachomatis infection in
mesoendemic villages in Tanzania
09:05 FP WE-40-06
Retinal Detachment after Phaco Cataract
Extraction with posterior capsular defekt
Ulrich Giers (Detmold/D)
09:12 FP WE-40-07
Identifying the content for a novel vision-related
quality of life questionnaire for visually impaired
children and young people
Valerie Tadic, Sarah Keeley, Gillian Lewando-Hundt,
Jugnoo Rahi (London/UK, Coventry/UK)
09:19 FP WE-40-08
The Incidence of Neonatal Endophthalmitis in the
United States May Be Declining
Andrew Moshfeghi, Resmi Charalel,
Tina Hernandez-Boussard, John Morton,
Darius Moshfeghi (Palm Beach Gardens/USA)
09:26 FP WE-40-09
Australian National Survey of Diabetic
Retinopathy Management by General
Practitioners and Optometrists
Daniel Ting, Joshua Yuen, Antony Clark,
Jonathan Ng, Nigel Morlet, Hugh Taylor,
David Preen (Perth/AUS)
09:33 FP WE-40-10
Complicated diabetic retinopathy among Egyptian
patients
Khaled G. Abu El Einen, Hany Hamed El Defrawy
El Defrawy, hany elmekawey, Yasser Sayed Saif Saif,
Mahmoud Gamal Elboraey Elboraey, Hoda Ibrahim
Rizk Rizk (Giza/ET)
09:40
Discussion
W
e
d
n
e
s
d
a
y
,

9

J
u
n
e
234
WOC
2010
S
c
i
e
n
t
i
f
i
c

P
r
o
g
r
a
m

S
c
h
e
d
u
l
e
Room 44
10:30 - 12:00 WE-41
Neuro-Ophthalmology 2
Free Paper
Neuro-Ophthalmology
Chairs:
Anthony C. Arnold (Los Angeles/USA)
10:30 FP WE-41-01
Juvenile pilocytic astrocytomas do not undergo
spontaneous malignant transformation
Cameron F. Parsa (Baltimore/USA)
10:37 FP WE-41-02
Charles Bonnet syndrome in a Low Vision depart-
ment
Heike Elflein, Susanne Pitz (Mainz/D)
10:44 SL WE-41-03
Restoration of vision: restoration hot spots in
hemianopia after stroke are influenced by local
topographic interactions
Bernhard A. Sabel, Iris Mueller, Markus Preuss,
Fred Wolf, Tobias Guenther (Magdeburg/D)
10:53 FP WE-41-04
Clinical analysis of empty sella syndrome with
visual disturbance
LI Juanjuan (Kunming/CN)
11:00 FP WE-41-05
Pulfrich Pendulum Phenomenon in Patients with a
Demyelinating Optic Neuropathy
Joana Ferreira, Lus Abego Pinto, Duarte Amado,
Joo Paulo Cunha (Lisboa/P)
11:07 FP WE-41-06
Clinical features of acute & subacute optic neuri-
tis/ perineuritis in Hong Kong Chinese patients
Ching Yan Noel Chan (Hongkong/HK)
11:14 FP WE-41-07
Proportion and Characteristics of Dyschromatopsia
Among Glue Sniffers
Emil Sjahreza, Muhammad Sidik (Jakarta/RI)
11:21 FP WE-41-08
Spectrum of neuro-ophthalmic diseases and
challenges encountered in an indigenous black
population in West-Africa: A tertiary hospital-
based review.
Olufunmilola A. Ogun, Benedictus Ajayi, Charles
Bekibele, Ayotunde Ajaiyeoba (Northampton/UK,
Ibadan/WAN)
11:28 FP WE-41-09
Sildenafil Citrate Therapy for Pulmonary Arterial
Hypertension: Ocular Safety Assessment
Barbara Wirostko, Charles Tressler, Lie-Ju Hwang,
Gary Burgess, Alan M. Laties (New York/USA)
11:35
Discussion
Salon 19
08:30 - 18:00 WE-42
IUSG Workshop: Diagnostic Criteria of Virus-
Induced Anterior Uveitis
Symposium
Uveitis
Chairs:
Jolanda de Groot (Utrecht/NL)
Philip Murray (Birmingham/UK)
09:00 10:30
CMV
10:45 12:15
VZV
13:30 18:00
Planning of the Validation Study for all 3 Viruses
In case of interest please contact Phil Murray:
p.i.murray@bham.ac.uk
The first part of the workshop will take place on
Tuesday, 8 June 8:30 to 18:00.
W
e
d
n
e
s
d
a
y
,

9

J
u
n
e
235
Secretariat
c/o Congress Corporation
Kohsai-kaikan Bldg., 5-1 Kojimachi, Chiyoda-ku, Tokyo 102-8481, Japan
Phone: +81-3-5216-5551 Fax: +81-3-5216-5552 E-mail: woc2014tokyo@congre.co.jp
President
Tetsuro Oshika, M.D.
Professor and Chairman, Department of Ophthalmology
Institute of Clinical Medicine, University of Tsukuba
WOC2014
Tokyo
XXXIV International Congress of Ophthalmology
World Ophthalmology Congress 2014 Tokyo
Venue: Tokyo International Forum / Imperial Hotel Tokyo
April 2 6, 2014
www.woc2014.org
Courses an Wetlabs
WOC
2010
237
23
rd
INTERNATIONAL CONGRESS OF
GERMAN OPHTHALMIC SURGEONS

October 21
st
24
th
, 2010
Congress Center Hamburg
FREE PAPER SESSION*
SCIENTIFIC POSTERS/ePOSTERS*
SURGICAL FILMS*
23
rd
International Congress of German Ophthalmic Surgeons, Congress Center Hamburg, October 21
st
- 24
th
, 2010
Name
Street
Country/Zip Code/City
Phone Fax
E-Mail
Please send me: < a Preliminary Program

MCN Medizinische Congress-
organisation Nrnberg AG
Neuwieder Str. 9
90411 NRNBERG
GERMANY
Organizer / Registration: MCN Medizinische Congressorganisation Nrnberg AG
Neuwieder Str. 9, 90411 Nrnberg, Germany
Phone: ++49/911/3931639, FAX: ++49/911/3931620, E-Mail: doc@mcnag.info
VIDEO LIVE SURGERY
OCTOBER 21
ST
AND 22
ND
, 2010
MAIN TOPICS
(Simultaneous translation
English - German)
Honorary Lectures
Cataract surgery
DOC ISRS / AAO Symposium
Glaucoma surgery
Vitreoretinal surgery
Corneal surgery
Orbita, lacrimal and lid surgery
Forum Eye surgery in the developing
countries
*
D
E
A
D
L
IN
E June 15
th
, 2010
www.doc2010.de
S
a
t
u
r
d
a
y
,

5

J
u
n
e
C
o
u
r
s
e
s

a
n
d

W
e
t
l
a
b
s
239
WOC
2010
Sao Paulo
08:30 - 10:00 WOC-AAD-C-01
Differential Diagnosis of Macular Diseases
Chair:
Speakers:
Arnd Gandorfer (Munich/D), Gabriele E. Lang
(Ulm/D), Peter Walter (Aachen/D)
Course fees: 50 c / 75 c
Assessment and diagnosis of macular diseases ac-
cording to clinical, angiographic, and OCT-findings
with practical guidelines for patient work-up and
management.
The exact diagnosis of macular diseases is impor-
tant for decisions concerning treatment and prog-
nosis. The differential diagnosis of macular
diseases however, is difficult. The most common
clinical findings, characteristica angiographic fea-
tures, and OCT-findings of macular dystrophies
and different macular degenerations will be pre-
sented. Besides the classical macular dystrophies
and age-related macular degeneration, which can
display a highly variable image, more rare macular
diseases will also be addressed. The course will end
with an interactive macula quiz of particularly in-
teresting cases.
08:30
Age-related Macular Degeneration
08:50
Macular Dystrophies
Peter Walter (Aachen/D)
09:10
Different Macular Diseases
09:30
Interactive Macula Quiz
All speaker
09:50
Discussion
Sao Paulo
10:30 - 12:00 WOC-AAD-C-02
Glaucoma without High Pressure Normal-
Tension Glaucoma
Chair:
Thomas S. Dietlein (Dsseldorf/D)
Speakers:
Thomas S. Dietlein (Dsseldorf/D), Detlev Spiegel
(Augsburg/D)
Optimisation of the diagnostics and treatment of
normal pressure glaucoma.
In this course the important pathomechanisms,
which cause damage in normal-tension glaucoma
will be explained so that the practising ophthal-
mologist can take the necessary diagnostic steps
and start the necessary treatment. An extensive
medical history as well as a well-directed examina-
tion on the slit-lamp already displays the most
vital information. Which additional information is
necessary and when it is necessary, as well as
where such examinations take place, will be
covered.
When, how intensely, and in which ways intraocu-
lar pressure should be lowered, and which addi-
tional treatment options exist will also be
explained. Particularly the significance of vasoac-
tive substances will be discussed. Examples of clini-
cal cases will be presented and discussed.
Sao Paulo
14:00 - 15:30 WOC-AAD-C-03
Chair:
Speakers:
Anselm Kampik (Munich/D), Klaus-Dieter Lemmen
(Dsseldorf/D), Michael W. Ulbig (Munich/D)
Teaching standardised treatment options accord-
ing to ETDRS criteria
A presentation pathogenesis and stage classifica-
tion of diabetic maculopathy with a diagnosis for
laser treatment with different laser wavelengths,
followed by a discussion of the effects of risk fac-
tors like pregnancy and high blood pressure, and
the assessment of intensified diabetes
management with insulin pump or pancreas
transplant, as well as a critical discussion of medic-
inal treatment.
S
a
t
u
r
d
a
y
,

5

J
u
n
e
C
o
u
r
s
e
s

a
n
d

W
e
t
l
a
b
s
240
WOC
2010
Sao Paulo
16:00 - 17:30 WOC-AAD-C-04
Optic Disc Elevation Differential Diagnosis and
Work Up
Chair:
Jan Schroeter (Berlin/D)
Speakers:
Klaus Rther (Berlin/D), Jan Schroeter (Berlin/D)
Swelling of the optic disc can have different causes.
Besides an elevated intracranial pressure optic disc
drusen, inflammatory and ischemic processes have
to be thought of. Hyperopia and a reduced disc size
or tilted disc can also be causative. The morpholog-
ical appearance of the optic nerve is mostly not
specific for the underlying causes, so functional
testing and often cerebral imaging is necessary.
The course will give an overview of different
pathologies leading to a swelling of the optic disc.
Strategies to obtain the correct diagnoses and the
necessity and order of different examinations (e.g.
CT, MRI, lumbar puncture) will be discussed.
The most common diseases leading to a swelling
of the optic disc will be presented in detail includ-
ing ischemic anterior optic neuropathy, both the
arteritic and non arteritic form, neuritis nervi
optici, optic disc drusen, chronic and acute
papilledema, compressive optic neuropathy,
tumors of the optic nerve.
The course is intended for ophthalmologist
interested in neuroophthalmology and the
differential diagnoses of optic disc swelling.
Room Istanbul
08:30 - 10:00 WOC-C-05
WetLab Refractive Surgery 1
Chair:
Speakers:
Ekkehard Fabian (Rosenheim/D), Jrgen Kamp-
meier (Ulm/D), Thomas Kohnen (Frankfurt/D),
Carlo Lackerbauer (Munich/D), Walter Sekundo
(Marburg(D)
The surgical techniques (LASIK, PRK, LASEK,
Epi-LASIK, phaco IOLs, Intacs, AK+ LRI) will be
demonstrated in the KRC-Wet-Labs and the partici-
pants will be able to practise them on pig eyes.
Room Istanbul
10:30 - 12:00 WOC-C-06
Wetlab Refractive Surgery 2
Chair:
Speakers:
Gernot I. W. Duncker (Halle/D), Bettina Jendritza
(Mannheim/D), Markus Kohlhaas (Dortmund/D),
Christopher Wirbelauer (Frankfurt/D)
The surgical techniques (LASIK, PRK, LASEK,
Epi-LASIK, phaco IOLs, Intacs, AK+ LRI) will be
demonstrated in the KRC-Wet-Labs and the partici-
pants will be able to practise them on pig eyes.
The emphasis is on the practical exercises in
refractive techniques.
Room Istanbul
2010, 14:00 - 15:30 WOC-C-07
Wetlab: Endotamponades in Vitreoretinal Surgery
An Introduction to Beginners
Chair:
Gisbert Richard (Hamburg/D), Borja Corcostegui
(Barcelona/E), David S. H. Wong (Hong Kong/HK)
Speakers:
Borja Corcostegui (Barcelona/E), Gisbert Richard
(Hamburg/D), Lars Wagenfeld (Hamburg/D), David
S. H. Wong (Hong Kong/HK)
The subject of this course is the handling of differ-
ent endotamponades (gases, oils, and heavy liq-
uids). The focus lies on practical Wet-Lab exercises
on pig eyes. This course is aimed at colleagues who
are familiar with the basics of vitrectomy, yet have
little or no practical experience in the use of endo-
tamponades.
Gasendotamponades
Heavy fluides
Borja Corcostegui (Barcelona/E)
Siliconoil
Lars Wagenfeld (Hamburg/D)
Heavy Siliconoil
S
a
t
u
r
d
a
y
,

5

J
u
n
e
C
o
u
r
s
e
s

a
n
d

W
e
t
l
a
b
s
241
WOC
2010
Room Istanbul
16:00 - 17:30 WOC-C-08
Wetlab Surgical Measurement in the Early Phase
of Chemical and Thermal Eye Burns
Chairs:
Hans Gert Struck (Halle/D), Laszlo Kiraly (Halle/D),
Speakers:
Norbert Franz Schrage (Cologne/D), Hans Gert
Struck (Halle/D)
Aim:
Studying the management of surgical complica-
tions with regards to early therapy following
medium and severe chemical and thermal burns.
Ophthalmologists should reach a high standard of
quality in these fundamental techniques.
Content:
There will be exercises in the mechanical cleansing
and rinsing of pig eyes with lime corrosion, fol-
lowed by training in the surgical techniques of
peridotomy, peridectomy, necrosis excision, Tenon-
plastic, amnioplasty, and keratoplasty according to
Putschkowskaja. These fundamental techniques of
surgical treatment will be practised on isolated
rabbit eyes and orbitae. Diagnosis and implemen-
tation of these surgical techniques in new scientifi-
cally founded concepts of early and follow-up
therapy of ocular chemical and thermal burns will
be discussed. This will be based on the longstand-
ing clinical and research experience of the Halle
and Aachen teaching hospitals.
Physiopathology of eye burns, Modulation of
the biological reaction by antiinflammatory and
surgical therapy
Hans Gert Struck (Halle/D)
Mechanism and prognostic evaluation of corro-
sives, Prognostic value of eye burns classification
Strategies in therapy
Hans Gert Struck, Norbert Franz Schrage
(Halle/D, Cologne/D)
Salon 11/12
08:30 - 10:00 WOC-AAD-C-09
Corneal Degeneration / Dystrophy
Chair:
Hans Eberhard Vlcker (Heidelberg/D)
Speakers:
Gerhard K. Lang (Ulm/D), Hans Eberhard Vlcker
(Heidelberg/D)
Clinical diagnosis and differential diagnosis of
corneal dystrophies and corneal degenerations,
taking into account histopathological findings as
well as genetic and treatment related aspects
Corneal degenerations can be a symptom of the
generic ageing process or appear in combination
with specific conditions. In particular these corneal
transformations, including the marginal ulcer, their
morphology and treatment will be covered.
As opposed to the degenerative transformations,
which take place without any genetic predisposi-
tion and increasingly apply to old age, the term
'corneal dystrophy' includes hereditary, symmetric,
and bilateral conditions, which occur both in iso-
lated form as well as in combination with other
systemic conditions. The epithelial, stromal, and
endothelial dystrophies will be presented with
particular attention paid to the clinical differential
diagnosis, which takes genetic, morphological, and
treatment aspects into account.
Hall 9
10:30 - 12:00 WOC-C-10
Evidence-Based Ophthalmology How to Get It
and How to Use It
Chairs:
Richard Wormald (London/UK), Gianni Virgili
(Florence/I)
Speakers:
Jennifer Burr (Aberdeen/UK), David Friedman
(Baltimore/USA), Iris Gordon (London/UK),
Gianni Virgili (Florence/I), Richard Wormald
(London/UK)
10:30
EBM and EBO Introduction
WOC
2010
S
a
t
u
r
d
a
y
,

5

J
u
n
e
Hall 9
16:00 - 17:30 WOC-C-12
Advanced Biaxial Microphaco and Coaxial Phaco /
Microphaco Techniques in Challenging (White and
Suprahard) Cataracts: A Video Course
Chair:
Arup Chakrabarti (Trivandrum/IND)
Speakers:
Amar Agarwal (Chennai/IND), Jorge L. Ali
(Alicante/E), Arup Chakrabarti (Trivandrum/IND),
Sri Ganesh (Bangalore/IND), Boris Malyugin
(Moscow/RUS), Som Prasad (Wirral/UK)
Description:
Biaxial micro incision cataract surgery, as well
as coaxial microphacoemulsification are fast
becoming increasingly popular techniques to deal
with cataracts. These techniques have been found
to be effective in standard cataract situations.
However, the application of these techniques can
also be extended to deal with difficult situations
including white and suprahard cataracts. This
video based course will present a rationale
approach for biaxial microphacoemulsification and
coaxial phaco /microphaco in challenging white
and suprahard cataracts. Fluid dynamics, instru-
mentation, basic surgical techniques, simple and
practical hints to overcome difficulties will be
discussed.
Objective:
Attendees will be able to perform standard phaco
as well as biaxial / coaxial microphacoemulsifica-
tion for challenging cataracts.
16:00
Introduction and Problems to Anticipate in a White
and Suprahard Cataract
16:05
Review of Dyes to Stain the Anterior Capsule, the
Staining Techniques and Capsulorhexis in White
and Suprahard Cataracts
16:15
Coaxial Phaco in White and Suprahard Cataracts
16:25
C-MICS with the Newer Machines
TBA
10:40
How to get EBO - Searching, Filtering, Synthesizing
and Disseminating
Richard Wormald, Iris Gordon (London/UK)
11:00
How to Use it - in clinic and operating theatre
11:10
How to Use it - Policy and Guidelines
Jennifer Burr (Aberdeen/UK)
11:20
Diagnostic test accuracy reviews
Gianni Virgili (Florence/I)
11:30
Discussion
Hall 9
14:00 - 15:30 WOC-AAD-C-11
Crosslinking of the Cornea: When, How and Why?
Chair:
Speakers:
Claus Cursiefen (Erlangen/D), Gerd Geerling
(Wrzburg/D)
Crosslinking of the cornea is a new emerging tech-
nique for surgical treatment of keratoconus. Aim of
this course to outline the current indications for
corneal crosslinking in patients with keratoconus
and beyond, to explain the surgical treatment itself
and postoperative care of patients and fincally to
discuss complications and their prevention and
management. The participant should be confident
afterwards to deal with patients having undergone
crosslinking of the cornea.
242
C
o
u
r
s
e
s

a
n
d

W
e
t
l
a
b
s
WOC
2010
243
S
a
t
u
r
d
a
y
,

5

J
u
n
e
Hall 10
10:30 - 12:00 WOC-C-14
Management of Complex Glaucoma
Chairs:
Gerd Geerling (Wrzburg/D), Franz Grehn
(Wrzburg/D), Maya Mller (Lbeck/D)
Speakers:
Gerd Geerling (Wrzburg/D), Franz Grehn
(Wrzburg/D), Thomas Klink (Wrzburg/D),
Maya Mller (Lbeck/D), Manfred Zierhut
(Tbingen/D)
This course presents the management of complex
glaucoma situations such as congenital glaucoma
and the combination of glaucoma and lens, cornea,
and retina mutations. The secondary glaucoma in
uveitis will be addressed separately. Alongside
conservative therapy, indications for surgery, the
question of single or double procedure surgery, as
well as further features of surgical procedures and
aftercare, will be dealt with.
10:30
Congenital Glaucoma
10:40
Uveitis and Glaucoma
10:50
Cataract and Glaucoma
11:00
Retinal disease and Glaucoma
11:10
Keratoplasty and Glaucoma
16:35
C-MICS/B-MICS with the Newer Machines
(Signature) for White and Suprahard Cataracts
Sri Ganesh (Bangalore/IND)
16:45
B-MICS / C-MICS with the Newer Machines
(Stellaris) in White and Suprahard Cataracts
16:55
Biaxial Microphaco and Microphaconit-700 micron
Cataract Surgery in White and Suprahard Cataracts
17:05
Learning Pearls, Pitfalls and Complications in
Biaxial Microphacoemulsification and Coaxial
Microphaco in White and Suprahard Cataracts
Som Prasad (Wirral/UK)
17:15
Newer Micro-incision IOLs for Bi-Axial/Co-Axial
Microphaco
Hall 10
08:30 - 10:00 WOC-C-13
The Aging Lid Functional Effects and their
Treatment
Chair:
Speakers:
Karl-Heinz Emmerich (Darmstadt/D),
Gabriele M. Emmerich (Darmstadt/D),
Hans-Werner Meyer-Rsenberg (Hagen/D),
Uwe Peter Press (Trier/D)
Age-related changes of the lid have numerous
functional and aesthetic consequences. A series of
lid changes can thus lead to malpositioning of
the lid with a variety of implications for vision and
wettability of the eye as well as the lacrimal
glands.
Causes, implications and the demonstration of
therapeutic surgical measures are the core and
focus of this course. The psychosomatic aspects
will also be outlined and discussed.
C
o
u
r
s
e
s

a
n
d

W
e
t
l
a
b
s
S
a
t
u
r
d
a
y
,

5

J
u
n
e
C
o
u
r
s
e
s

a
n
d

W
e
t
l
a
b
s
244
WOC
2010
Hall 10
14:00 - 15:30 WOC-C-15
Modern OCT imaging: Clinical Value and
Perspectives
Chair:
Speakers:
Matthias Bolz (Vienna/A), Jay S. Duker
(Boston/USA), Christopher Kiss (Vienna/A),
Christian Prnte (Binningen/CH),
Srinivas R. Sadda (Los Angeles/USA),
The course OCT Present and Future offers a
compact state-of-the-art and comprehensive
update regarding options and relevance of modern
OCT-technology over a vast spectrum of retinal
pathologies and expert insights.OCT is a milestone
in ophthalmologic diagnostics with the opportu-
nity of a non-invasive, high-resolution representa-
tion of all retinal compartments e.g. vitreoretinal
interface, intraretinal layers and subretinal space.
Already, conventional OCT provides important and
clinically relevant information about the condition
of the central retina for diagnosis and therapeutic
indication. Applications of OCT are all the frequent
and severe retinal diseases such as age-related
macular degeneration (AMD), diabetic retinal
disease (DRP) and vascular pathologies. With the
evolution of the high-resolution technology the
value of OCT has increased significantly, since a
precise imaging of all details and, based on raster-
scanning, a complete three-dimensional represen-
tation at all locations became available.
Accordingly, modern OCT offers a realistic and
quantified analysis of diseases of the central retina.
Hence, OCT has become one of the most impor-
tant parameters in the anti-angiogenetic therapy
with high relevance for indication, prognosis and
long-term management. For the understanding of
pathogenesis OCT provides essential novel insights
e.g. in diabetic retinopathy.
14:00
Overview on state-of-the-art technology
Jay S. Duker (Boston/USA)
14:10
OCT in AMD
14:20
OCT in diabetic macular disease
Matthias Bolz (Vienna/A)
14:30
OCT in retinal vascular disease
Christopher Kiss (Vienna/A)
14:40
OCT in macular surgery
Christian Prnte (Binningen/CH)
14:50
Perspectives and developments
Srinivas R. Sadda (Los Angeles/USA)
Hall 10
16:00 - 17:30 WOC-AAD-C-16
KRC Advanced Course for the Refractive Surgery
Chair:
Speakers:
Michael C. Knorz (Mannheim/D), Thomas Kohnen
(Frankfurt/D), Thomas F. Neuhann (Munich/D)
Presenting the current developments in refractive
surgery
This course will present the state of affairs in the
development of the refractive surgical method.
Alongside this the discussion among participants
is a key element of this course. We are happy to
discuss cases brought forward by participants.
Room 44
08:30 - 10:00 WOC-AAD-C-17
Episcleritis and Scleritis
Chair:
Speakers:
Uwe Pleyer (Berlin/D), Manfred Zierhut (Tbin-
gen/D)
Differentiation between the different sclera condi-
tions and their differential diagnoses. Choice of an
effective treatment.
Following a brief outline of the basics and the
pathophysiology of sclera conditions, the current
classification of the different forms shall be evalu-
ated. Furthermore, the diagnostically and differen-
tially recommended examination techniques will
S
a
t
u
r
d
a
y
,

5

J
u
n
e
C
o
u
r
s
e
s

a
n
d

W
e
t
l
a
b
s
245
WOC
2010
be introduced. Lastly, locally and systemically
applied medication (antiphlogistics, immunosup-
pressants, biologica) as well as surgical options
will be discussed. Participants are encouraged to
introduce their own problem patients.
Room 44
10:30 - 12:00 WOC-AAD-C-18
Diagnosis and Treatment of Peripheral Retinal
Degeneration
Chair:
Speakers:
Bernd Kirchhof (Cologne/D), Peter Wiedemann
(Leipzig/D)
Classification and prognostic significance of the
manifold manifestations of peripheral retinal
degenerations with regards to the risk of amotio.
We shall define retinas periphery and its anatomi-
cal characteristics. We differentiate between
peripheral retinal degeneration following primarily
trophic- and primarily traction-dependant dyspla-
sia. We distinguish between peripheral retinal
degenerations according to their significance for
the development of amotio. Aside from morpho-
logical criteria, epidemiologial data is consulted to
justify the diagnosis of prophylactic retinopexy.
Room 44
14:00 - 15:30 WOC-AAD-C-19
Diagnosis and Treatment of Keratomycoses
Chair:
Speakers:
How do I recognise a keratomycosis? How do I test
my presumptive diagnosis? Treatment optimisa-
tion in fungal keratitis
The characteristics of keratomycosis will be shown
on example cases. Medical history, risk factors, and
fungal occurrence will be discussed and advice on
securing the diagnosis. Eventually antimycotics,
their dosage, use and sensible application will be
covered with regards to the different fungal
strains.
Room 44
16:00 - 17:30 WOC-AAD-C-20
Glaucoma Surgery Follow-up Care
Chair:
Speakers:
Franz Grehn (Wrzburg/D), Thomas Klink
(Wrzburg/D), Jochen Wahl (Mainz/D)
Optimising postoperative care with the aim of
maximising the long-term success of glaucoma
surgeries.
Identification and treatment of postoperative
complications
Characteristic signs of postoperative scarring
using standardised assessment of filtering bleb
evaluation
DD postoperative hypotony
DD postoperative increase in intraocular
pressure
5-FU use in postoperative care
Needling of the filtering bleb
Possible revision surgeries
This course is aimed at ophthalmologists in hospi-
tals and medical practices in particular because
in the future most postoperative care will be done
in outpatient departments or ophthalmic prac-
tices.
S
u
n
d
a
y
,

6

J
u
n
e
C
o
u
r
s
e
s

a
n
d

W
e
t
l
a
b
s
246
WOC
2010
Room Istanbul
08:30 - 10:00 WOC-C-21
Wetlab Basic Course on Penetrating Corneal
Grafting Techniques
Chair:
Speakers:
Gernot I. W. Duncker (Halle/D), Bernhard Nlle
(Kiel/D), Berthold Seitz (Homburg/D),
Frank Wilhelm (Schwerin/D)
The different surgical steps of penetrating kerato-
plasty on the pig eye and regular corneoskleral
buttons will be presented and practised in this
basic course. Different trephine systems will be
used. Tips and tricks regarding the surgical proce-
dure will be given, and the suture technique will
be practised extensively.
This focus of this course lies on the practical
applications.
Room Istanbul
10:30 - 12:00 WOC-C-22
Wetlab for the Advanced: Lamellar Grafting
Techniques
Chair:
Speakers:
Gernot I. W. Duncker (Halle/D), Jrg. H. Krumeich
(Bochum/D), Friedrich E. Kruse (Erlangen/D),
This advanced course introduces the new tech-
niques of lamellar keratoplasty, which will be
practised and simulated on the pigs eye. The
characteristics of this surgical procedure as well as
tips for handling the individual methods will be
given, while there is an emphasis on their practical
application in order to familiarise the participants
with the new equipment.
Hall 8
08:30 - 10:00 WOC-AAD-C-23
Immunology of the Eye: Intraocular Inflammations
Chair:
Speakers:
Uwe Pleyer (Berlin/D), Stephan Thurau (Munich/D)
The aim of this course is to present the current
state of knowledge with regards to immuno-
dependant eye conditions and to offer rational
decision-making advice with regards to diagnosis
and treatment.
Intraocular inflammations are the subject focus.
Upon briefly addressing pathophysiological basics,
current aspects of diagnosis and treatment will be
discussed on clinical examples. Among others, the
following topics shall be covered:
Diagnostic strategies for uveitis:
When should (or shouldn't) one start diagnostics?
Which types of patients indicate invasive diagnos-
tics (e.g. ppV).
Aspects of interdisciplinary cooperation, signifi-
cance of the DRGs for diagnostics and treatment.
Conservative treatment: Indications and imple-
mentation.
Systemic treatment - when? How? Monitoring and
unwanted effects. Options and limits of new
kinds of therapy (e.g. biologica?) (CME-Therapy).
Surgical therapy: Indications and implementation
(cataract/glaucoma).
Is pseudophakia generally something to aim for?
Characteristics of childhood perioperative care in
intraocular surgeries Indications for ppV.
Additionally participants are encouraged to intro-
duce their own problem patients.
Room Istanbul
14:00 - 15:30 WOC-C-36
Modern Pars Plana Vitrectomy DryLab (Basics)
Chairs:
Frank Koch (Frankfurt/D), Norbert Bornfeld
(Essen/D), Helge Krger (Frankfurt/D)
Speakers:
Norbert Bornfeld (Essen/D), Lars-Olof Hattenbach
(Ludwigshafen/D), Frank Koch (Frankfurt/D),
Helge Krger (Frankfurt/D), Klaus Lucke
(Bremen/D), Stephan Nikolic (Hannover/D),
Pankaj Singh (Frankfurt/D), Clemens Wagner
(Mannheim/D)
Sunday, 6 June 2010
S
u
n
d
a
y
,

6

J
u
n
e
C
o
u
r
s
e
s

a
n
d

W
e
t
l
a
b
s
247
WOC
2010
The Virtual Reality Pars plana Vitrectomy DryLab
was developed in order to realise evidence-based
ophthalmosurgical training. The strategies that
ensure reliability and success of retina and vitreous
surgery as well as fundamental principles of
intraocular surgical interventions in the vitreous
body will be trained and tested within the VR-
magic-Vitrectomy simulator.
Experienced colleagues will guide you through
targeting strategies, methods of vitreous excision
in different retina/vitreous affections, vitreous
membrane detachment, as well as the intravitreal
application of medication. The simulator will cap-
ture a performance profile and your achievements
will be evaluated.
14:00
EYESi technology, part 1
Clemens Wagner (Mannheim/D)
14:10
Abstract-to-real transfer
14:20
EYESi Diagnosis and treatment
Pankaj Singh (Frankfurt/D)
14:30
Complication management
14:40
EYESi-Expertise
Stephan Nikolic (Hannover/D)
14:50
VR in Aviation + Ophthalmology
Room Istanbul
16:00 - 17:30 WOC-C-37
Modern Pars Plana Vitrectomy DryLab (Advanced)
Chairs:
Frank Koch (Frankfurt/D), Michael Janusz Koss
(Frankfurt/D)
Speakers:
Hermann O. C. Gmbel (Ulm/D), Hans Hoerauf
(Gttingen/D), Frank Koch (Frankfurt/D), Michael
Janusz Koss (Frankfurt/D), Klaus Lucke (Bremen/D),
Maya Mller (Lbeck/D), Markus Schill
(Mannheim/D)
The Virtual Reality Pars plana Vitrectomy DryLab
was developed in order to realise evidence-based
ophthalmosurgical training. The strategies that
ensure reliability and success of retina and vitreous
surgery as well as fundamental principles of
intraocular surgical interventions in the vitreous
body will be trained and tested within the VR-
magic-Vitrectomy simulator.
Experienced colleagues will guide you through
targeting strategies, methods of vitreous excision
in different retina/vitreous affections, vitreous
membrane detachment, as well as the intravitreal
application of medication. The simulator will cap-
ture a performance profile and your achievements
will be evaluated.
16:00
EYESi technology, part 2
Markus Schill (Mannheim/D)
16:10
Deliberate Practice
16:20
Limitations of VR-Training
16:30
Guidelines based on expertise
16:40
EYESi-Expertise
16:50
VR in Aviation + Ophthalmology
Hall 8
14:00 - 15:30 WOC-AAD-C-24
Corneal Ulcers and Conjunctival Scarring.
What to Do?
Chair:
Speakers:
Arnd Heiligenhaus (Mnster/D), Elisabeth M.
Messmer (Munich/D)
Instructions on diagnosis and treatment of
problematic disease patterns
The correct diagnosis and treatment of the differ-
ent types of corneal ulcers portrays quite a chal-
lenge to the ophthalmologist. The differential
diagnosis of conjunctival scarring, particularly in
early stages, can also be problematic.
Sunday, 6 June 2010
S
u
n
d
a
y
,

6

J
u
n
e
C
o
u
r
s
e
s

a
n
d

W
e
t
l
a
b
s
248
WOC
2010
1
st
part of the course:
Systematic outline of the clinic, the diagnostic
approach, as well as the treatment in pathogene-
dependant, trophic and immunological corneal
ulcers.
2
nd
part of the course:
Etiology, clinic, diagnosis and differential diagnosis
as well as conservative and operative treatment
options in conjunctival scarring.
Hall 8
16:00 - 17:30 WOC-AAD-C-25
Visual Agnosia and Other Central Visual
Impairments
Chair:
Speakers:
Visual agnosias disturb the visual recognition of
e.g. objects (or related features), faces, places, paths
or letters. They are caused by lesions of higher vi-
sual centers located in the parieto-temporal and
occipito-temporal cortical visual areas or their as-
sociated subcortical connections. Given the well-
vascularized tissue of the poststriate visual cortex,
damage to vision in these regions is comparatively
uncommon (found in approximately 2% of cases of
posterior brain disease) and is often transient,
managing to recover within a few weeks following
onset.
Agnosias are primarily a neurological entitiy. How-
ever, in case of visual agnosias the patient experi-
ences disturbances in vision and will therefore
primarily contact his eye doctor. A general ophthal-
mologist might be somewhat puzzled by the obvi-
ous discrepancy between normal morphological
findings and peculiar visual symptoms. Quite often
patients are threatened by this kind of visual dis-
turbances and do not spontaneously report on
their specific problems as they assign these as pre-
cursors of progressive mental derangement. Ade-
quate explanation of the cause for the visual
symptoms and information about the realistic
chances of spontaneous recovery in visual function
are important elements of medical counselling.
Where possible, the patients closests relatives
should be included in theses discussion as the too
need to understand the specific problems of the
patient.
The aim of this course is to make the ophthalmo-
logical colleagues sensitive for typical signs and
symptoms of visual agnosias. Appropriate diagnos-
tic and therapeutic care of such patients requires a
multidisciplinary approach, including participation
by neurologists, neuroradiologists, neuropsycholo-
gists and neuro-ophthalmologists.
Adequate explanation of the cause for the visual
symptoms and information about the realistic
chances of spontaneous recovery in visual function
are important elements of medical counselling.
Where possible, the patients closest relatives
should be included in these discussions as they too
need to understand their specific problems.
Salon 19
08:30 - 10:00 WOC-AAD-C-26
Complications in Plastic-Reconstructive and
Aesthetic Surgery of the Lids and the Periorbital
Region
Chair:
Ulrich Schaudig (Hamburg/D)
Speakers:
Gerd Geerling (Wrzburg/D), Uwe Peter Press
(Trier/D), Ulrich Schaudig (Hamburg/D)
Recognising and treating typical and crucial com-
plications postoperatively and long-term following
surgical procedures on the lids and the periorbital
region
This new theoretical course aims to provide an
overview over possible complications according to
the systematic of lid-surgical procedures. What are
the causes of typical complications and how can
they be prevented as early as in the preoperative
planning stage by choosing the appropriate surgi-
cal approach? Which side-effects can occur that
are not considered to be complications? On the
other hand, what is considered an actual complica-
tion and how do I approach these patients? What
are the indications for a surgical follow-up proce-
dure? The management of complex developments
and possible treatment will be addressed accord-
ing to case studies.
Salon 19
10:30 - 12:00 WOC-AAD-C-27
The Interdisciplinary Context of Multiple Sclerosis
and Myasthenia Gravis
Chair:
Speakers:
Martin Eicke (Idar-Obenstein/D), Susanne Pitz
(Mainz/D)
Sunday, 6 June 2010
S
u
n
d
a
y
,

6

J
u
n
e
C
o
u
r
s
e
s

a
n
d

W
e
t
l
a
b
s
249
WOC
2010
The presentation of current diagnostic and treat-
ment strategies in multiple sclerosis and myasthe-
nia gravis.
Patients suffering from multiple sclerosis (MS) and
myasthenia gravis are often treated interdiscipli-
nary: While the ophthalmologist often makes the
first diagnosis, the neurologist generally initiates
treatment. This often leads to differing diagnostic
and treatment strategies in both areas of expertise.
Does every patient with acute neuritis nervi optici
(NNO) for example require neurological examina-
tion? Are MRIs (with or without contrast dye), clini-
cal neurophysiology or lumbar punctures always
absolutely necessary? How important is the intra-
venous steroid treatment in acute NNOs and other
acute MS-episodes?
What are the indicators for episode prevention
with Interferon-? Which diagnostic strategy is
most appropriate in response to suspected
myasthenia? Is the Tensilon test absolutely
necessary? How important are clinical neurophysi-
ology and the identification of autoantibodies
for acetylcholine receptors? Is a CT of the thorax
generally imperative? Which surgical treatments
are currently possible?
In this course we would like to evaluate current
concepts regarding both conditions and give
rational decision-making advice on typical ques-
tion. This course is aimed at professional as well as
trainee colleagues.
Salon 19
14:00 - 15:30 WOC-AAD-C-28
Ophthalmic Conditions in Third World countries /
Ophthalmic Travel Medicine
Chair:
Speakers:
Volker Klauss (Munich/D),
Markus Schulze Schwering (Ahlen/D)
Motivation and further training for participants in
the field of ophthalmic conditions in the tropics.
Due to the rise in global travel of tourists and busi-
nesspeople as well as an increase in international
migration, these days Germany is faced with more
and more cases of ophthalmic conditions that are
typically associated with tropical and subtropical
regions.
Fortunately German ophthalmologists display
increasing interest in short-term and long-term
work in third world countries, within the world-
wide Vision 2020 programme, 'The Right To Sight'.
This course is intended to prepare German oph-
thalmologists for imported conditions as well as
broaden their knowledge of epidemiology, pathol-
ogy, and the diagnostics of such conditions and to
thus provide some all-round preparation for work-
ing abroad. Tips will be given on advising travelling
patients on the risks associated with the individual
regions as well as on the concrete risks for patients
suffering from chronical ophthalmic conditions.
The following conditions are considered the most
crucial imported eye conditions: Trachoma,
onchocerciasis, loiasis, leprosy, acute hemorrhaging
conjunctivitis (Apollo), dengue fever, leishmaniasis,
paratisoses like echinococcosis.
Contacts for national and international organisa-
tions for international developmental cooperation
(International none Governemental Organizations)
will be mentioned briefly.
Salon 19
16:00 - 17:30 WOC-AAD-C-29
Retinopathy of Prematurity Clinical Diagnosis
and Treatment
Chair:
Heinrich Gerding (Olten/CH)
Speakers:
Arnd Gandorfer (Munich/D), Heinrich Gerding
(Olten/CH)
Optimisation of the ophthalmologic provisioning
of premature infants
The course is intended to train participants for
providing optimized clinical care for premature
children. The programme covers the necessary
knowledge on etiology, pathophysiology and
classification of retinopathy of prematurity.
Current international guidelines for performing
screening examinations of premature babies will
be presented and compared. Adequate examina-
tion techniques of premature children and docu-
mentation of clinical findings will be presented as
well as current and future treatment approaches
including laser photocoagulation, cryotherapy, anti-
VEGF injections, cerclage and vitrectomy.
Sunday, 6 June 2010
M
o
n
d
a
y
,

7

J
u
n
e
C
o
u
r
s
e
s

a
n
d

W
e
t
l
a
b
s
250
WOC
2010
Room Sydney
08:30 - 10:00 WOC-C-30
Sutureless = Happiness? Pearls and Pitfalls in
Transconjunctival Vitreoretinal Surgery
Chair:
Speakers:
Carl-Friedrich Arndt (Reims/F), Stefan Dithmar
(Heidelberg/D), Nicolas Feltgen (Gttingen/D),
Lars-Olof Hattenbach (Ludwigshafen/D), Maya
Mller (Lbeck/D), Siegfried Priglinger (Linz/A)
In sutureless vitreoretinal surgery, one must often
deal with specific problems usually not encoun-
tered with conventional vitrectomy systems. This
course will be highlighted by interactive case dis-
cussions as well as experienced faculty providing
pitfalls and pearls of various sutureless transcon-
junctival vitrectomy systems. Focus will be on spe-
cific technical issues, typical or unsuspected
difficulties, innovative treatment approaches, com-
bined microincision cataract surgery, and compli-
cating patient variables. Participants are
encouraged to be a part of the discussion by pro-
viding opinions on different treatment avenues.
Room Sydney
10:30 - 12:00 WOC-C-31
HRT and Spectral OCT in Glaucoma
Chairs:
Reinhard O. W. Burk (Bielefeld/D), Claude Burgoyne
(Portland/USA), Balwantray C. Chauhan
(Halifax/CDN)
Speakers:
Claude Burgoyne (Portland/USA),
Reinhard O. W. Burk (Bielefeld/D),
Balwantray C. Chauhan (Halifax/CDN),
Kester Nahen (Smithfield/USA)
This course discusses and explains HRT glaucoma
diagnostics. Structural parameters like papilla size,
neuroretinal rim area, excavation can be captured.
Macro-papillae with large excavation areas and
depth values must possess at least the neuroreti-
nal rim parameters of normal papillae. Discrimi-
nant functions, which can estimate the probability
of the existence of glaucomatous visual field de-
fects, will be assessed (FSM, RB). One option of
analysis without interactive examination is the
glaucoma probability score (GPS). The validity of
the HRT findings as the gold standard of three di-
mensional papilla analysis is supported by the data
of high resolution optical coherence tomography
(spectral OCT): localised reflectivity loss through
nerve fiber bundle loss, which are detected by HRT,
correlate with the thinning of the nerve fiber layer
in high resolution spectral OCTs.
10:30
The HRT in glaucoma research
10:45
The development of the Spectral OCT
Kester Nahen (Heidelberg/D)
11:00
Spectral OCT for the Evaluation of the lamina
cribrosa
11:15
Clinical use of HRT and Spectral OCT in Glaucoma
Reinhard O. W. Burk (Bielefeld/D)
Room Sydney
14:00 - 15:30 WOC-C-32
Laser Treatment of Retinal Diseases
Chair:
Speakers:
Francesco Bandello (Milano/I), Hans Hoerauf
(Gttingen/D), Gabriele E. Lang (Ulm/D)
Laser photocoagulation is still the gold standard in
the treatment of several retinal diseases. Diabetic
retinopathy and retinal vein occlusions are dis-
cussed in detail concerning diagnostic procedures,
staging, indication and techniques of laser treat-
ment. Other diseases like retinal holes, Coats
disease, macroaneurysm, optic pits with serous
detachment of the retina, central serous chori-
oretinopathy and peripheral hemorrhagic exuda-
tive chorioretinopathy are presented. The most
common mistakes in laser treatment are also
discussed. Finally the combination of laser and
pharmacological treatment of retinal diseases are
described.
14:00
Laser Treatment of Diabetic Retinopathy, Vein Oc-
clusions and Other Diseases
Monday, 7 June 2010
M
o
n
d
a
y
,

7

J
u
n
e
C
o
u
r
s
e
s

a
n
d

W
e
t
l
a
b
s
251
WOC
2010
14:40
Combination of Laser with Pharmacological Treat-
ment
15:05
Common Mistakes in Laser Treatment
Room Sydney
16:00 - 17:30 WOC-C-33
Blepharoplasty of the Upper and Lower Eye Lids:
Innovative Concepts for Excellent Surgical Results
Chair:
Klaus G. Riedel (Munich/D)
Speakers:
Blepharoplasty for the correction of upper and
lower dermatochalasis is, with increasing tenden-
cies, the most popular form of cosmetic surgery.
The success rate with regards to aesthetics and
function, depends on the preoperatve analysis of
diagnostic findings, individual choice of inscision,
and an atraumatic surgical technique. Independ-
ent from the chosen equipment, scalpel, high
frequency needle or laser, modern blepharoplasty
is comprised of more than the mere removal of
excess skin. All types of tissue in the eyelids may
need to be tackled: skin, muscle, lid band, orbital
septum, and orbital fat compartments. The crucial
part is what remains on the lid, rather than what is
removed. The correct position oft the scin crease
determines the method of surgical lid closure.
Individual characteristics have to remain to achieve
excellent surgical results.
Room Istanbul
14:00 - 15:30 WOC-C-34
Wetlab Glaucoma Surgery for Beginners
Chair:
Speakers:
Walter Konen (Cologne/D), Norbert Pfeiffer
(Mainz/D), Lutz E. Pillunat (Dresden/D),
Manfred Tetz (Berlin/D), Hagen Thieme (Mainz/D),
Jochen Wahl (Mainz/D)
Despite all the advances of medication-based glau-
coma treatment, surgical intervention remains
inevitable for many glaucoma patients. This course
teaches the fundamentals of preparation tech-
nique, in particular of penetrating methods.
The non-penetrating methods, however, shall be
addressed as well.
The flap preparation in trabeculectomy, iridectomy
as well as trabeculotomy will be practised on the
pig's eye, after a brief theoretical introduction.
Furthermore deep flap preparation during deep
sclerectomy shall be demonstrated.
This course is aimed at beginners in glaucoma sur-
gery as well as offering the opportunity to revise
and expand upon previously gained knowledge on
the subject.
Room Istanbul
16:00 - 17:30 WOC-C-35
Wetlab Glaucoma Surgery for the Advanced
Chair:
Speakers:
Walter Konen (Cologne/D), Norbert Pfeiffer
(Mainz/D), Lutz E. Pillunat (Dresden/D),
Manfred Tetz (Berlin/D), Hagen Thieme (Mainz/D),
Jochen Wahl (Mainz/D)
This course is aimed at the more experienced glau-
coma surgeon. It expands upon the basics taught
in the beginners' course. Non-penetrating methods
like sclerectomy and viscocanalostomy will be
demonstrated and practised. Additionally the
handling of implants like the Ahmed Valve and
Molteno Implants will be demonstrated.
Monday, 7 June 2010
M
o
n
d
a
y
,

7

J
u
n
e
C
o
u
r
s
e
s

a
n
d

W
e
t
l
a
b
s
252
WOC
2010
Room 43
08:30 - 10:00 WOC-C-38
Update on Tonometry
Chair:
Harry Mark (North Haven/USA)
Speakers:
Synopsis:
Year after year patents are issued for new tonome-
ters, each claiming to be more accurate and com-
fortable, though none measures true intra-ocular
pressure. This course will present the latest
tonometers and the evidence concerning the
physical parameters of the eye that influence all
tonometric reading. Clinical examples of their
application in myopia, normal-tension glaucoma,
and ocular hypertension will illustrate their utility.
Objective:
At the end of this course attendees will be able to
apply tonometric information more confidently
and reliably in the diagnosis and management of
glaucoma, and decide when to obtain ancillary
data, such as corneal thickness. The course will also
help attendees choose a tonometer.
Introduction
a. Many U.S. patent applications for new
tonometers annually.
b. Brief history. Helmholtzs first tonometer.
c. Need for standard quantification
Geometry and physics
a. Size and shape. 1. Acrophthalmos.
2. Brachophthalmos.
b. Envelope. 1. Cornea 2. Sclera. 3. Optic foramen.
c. Contents. 1. Aqueous. 2. Vitreous.
d. Pressure from within (IOP).
e. Pressure from without the tonometers
f. Imbert-Fick law: the elusive mmHg
Necessity of ancillary data
a. Central corneal thickness
b. Corneal curvature
c. Ocular volume (axial length, A and B scans)
d. Elasticity (scleral thickness)
e. Corneal hysteresis
f. Terminology and reimbursement
Clinical application
a. Glaucoma suspect, risk factors.
b. Normal/low-tension glaucoma
c. Ocular hypertension
d. Gender differences
e. Myopia and glaucoma
Conclusion
a. Nomograms
b. Flow-chart
c. Which tonometer is best.
d. The future
Room 43
10:30 - 12:00 WOC-C-39
A Flexible Ring in a Corneal Pocket for the
Treatment of Keratoconus and Myopia
Chairs:
Albert Daxer (Linz/A), Haifa Mahmood
(Manama/BRN)
Speakers:
Albert Daxer (Linz/A), Millicent Grim (Dubai/UAE),
Haifa Mahmood (Manama/BRN), Ali Rahji
(Riyadh/SA), Pavel Studeny (Sokolov/CZ)
Objectives:
Attendees will understand corneal intrastromal
implantations surgery (CISIS) using a flexible,
continous ring implant placed within a closed
corneal pocket for the btreatment of keratoconus
and myopia.
Description:
The course will review clinically important aspects
of CISIS including surgical techniques, inclusion
criteria, and nomograms, complications and side
effects, case studies and statistical data. The surgi-
cal techniques are demonstrated via educational
videos.
Room 43
14:00 - 15:30 WOC-C-40
Modern Surgery of the Posterior Segment of the
Eye
Chairs:
Joaquin Barraquer (Barcelona/E), Rafael Barraquer
(Barcelona/E), Jeroni Nadal (Barcelona/E)
Speakers:
Joaquin Barraquer (Barcelona/E), Rafael Barraquer
(Barcelona/E), Javier Elizalde (Barcelona/E),
Jeroni Nadal (Barcelona/E)
In this 90 minutes multi-authored Course the
following topics are discussed:
Monday, 7 June 2010
M
o
n
d
a
y
,

7

J
u
n
e
C
o
u
r
s
e
s

a
n
d

W
e
t
l
a
b
s
253
WOC
2010
1)
Surgical management of proliferating vitreo-
retinopathy with special emphasis on different
techniques of peeling of the epiretinal and
retroretinal membranes, the use of biological
colorants and intraocular tamponnades.
2)
Presentation of an update of modern surgical tech-
niques in macular surgery, different options, use
of biologic colorants and indications for peeling of
the internal limiting membrane.
3)
Biopsy techniques for cytogenic studies of uveal
melanoma, especially cytogenic phenotyping, an
universally accepted procedure in ocular oncology
to evaluate the risk of metastatic desease in uveal
melanoma. Different approaches for microsurgical
procedures to achieve the obtention of adequate
tumor samples are described in detail.
4)
Conservative resection of uveal melanoma is re-
viewed on the basis of personal experience with
different techniques of local conservative resection
as a valid option in the management of selected
cases of uveal melanoma.
5)
Finally: Ligature of afferent vessel for retinal hae-
mangioma, a new surgical technique for manage-
ment of yuxtapapillar capillar haemangioma is
described. Ligature of the afferent artery to the
tumor has been performed and proved to be effec-
tive to reduce the volume of the haemangioma
and exudative activity at the level of the posterior
pole. Images from the different authors personal
casuistics will be shown to illustrate the presenta-
tions.
Ligature of afferent vessel for retinal hemangioma
Conservative resection of uveal melanoma
Biopsy techniques for cytogenic study of uveal
Melanoma
Javier Elizalde (Barcelona/E)
Macular Surgery
Joaquin Barraquer, Jeroni Nadal (Barcelona/E)
Surgical management of proliferating vitreo-
retinopathy
Room 43
16:00 - 17:30 WOC-C-41
Complications in Vitreoretinal Surgery
Chairs:
David S. H. Wong (Hong Kong/HK), Paul Sullivan
(London/UK), Karl Ulrich Bartz-Schmidt
(Tbingen/D)
Speakers:
George William Aylward (London/UK), Keith Barton
(London/UK), Karl Ulrich Bartz-Schmidt
(Tbingen/D), Rubens Belfort, Jr. (So Paulo/BR),
Carlos Pavesio (London/UK), Paul Sullivan
(London/UK), Charles P. Wilkinson (Baltimore/USA),
Per operative Complications of scleral buckling
surgery
Retinal Trauma from vitreoretinal surgery
Inflammation and Infection after vitreoretinal
surgery
Glaucoma after vitreoretinal surgery
Complications of tamponade agents
Complications of vitrectomy for diabetic
retinopathy
Monday, 7 June 2010
T
u
e
s
d
a
y
,

8

J
u
n
e
C
o
u
r
s
e
s

a
n
d

W
e
t
l
a
b
s
254
WOC
2010
Hall 10
10:30 - 12:00 WOC-C-61
SD-OCT and AMD Treatment and Follow Up
Chair:
Speakers:
Gabriel J. Coscas (Crteil/F), Srinivas R. Sadda
(Los Angeles/USA), Gisle Soubrane (Crteil/F),
Giovanni Staurenghi (Milano/I), Sebastian Wolf
(Bern/CH)
10:30
Principles of SD-OCT and advantages in AMD
Florence Coscas (Crteil/F)
10:45
Differences of the SD-OCTs
11:00
SD-OCT characteristics of choroidal neovasculariza-
tion (Before, during and after treatment)
Giovanni Staurenghi (Milano/I)
11:15
SD-OCT analysis of Outer retinal layers changes
(hyper-reflective dots: prognostic value during
management of exudative AMD)
11:30
Polypoidal Vascular choroidopathy and AMD
11:45
Morphology and structure of retinal pigment ep-
ithelium detachments in AMD (Before, during and
after treatment)
Bruno Lumbroso (Roma/I)
Salon 11/12
14:00 - 15:30 WOC-C-63
Femtosecond (FS) Course in Ophthalmology
Chair:
M. Garcia-Marcos (Malaga/E)
Speakers:
Federico A. Aliste (Sevilla/E), M. Garcia-Marcos
(Torre del Mar/E), Rafael Rubio (Malaga/E),
Jose V. Rodriguez (Las Palmas/E), Alberto Villarrubia
(Crdoba/E)
14:00
Indications and advantajes with FS
Federico Alonso Aliste (Sevilla/E)
14:10
Lasik with FS
Rafael Rubio (Malaga/E)
14:20
Intracorneal rings with FS
Jose Vicente Rodriguez (Las Palmas/E)
14:30
Arcuates with FS
M. Garcia-Marcos (Malaga/E)
14:40
Keratoplasty with FS
Alberto Villarrubia (Crdoba/E)
Room Istanbul
08:30 - 10:00 WOC-C-42
Wetlab Glaucoma Drain Implants
Chair:
Speakers:
Thomas S. Dietlein (Dsseldorf/D), Hagen Thieme
(Mainz/D), Christian K. Vorwerk (Magdeburg/D)
This course is aimed at experienced glaucoma sur-
geons. Glaucoma implants are gaining more and
more acceptance as part of the repertoire of the
glaucoma surgeon. This course shall introduce the
most important models (Molteno, Ahmed Valve,
and Baerveldt Implant) as well as convey skills for
safe implantation. Furthermore, alongside the
episcleral models, chamber angle models will be
addressed and their practical application shall be
practised.
T
u
e
s
d
a
y
,

8

J
u
n
e
C
o
u
r
s
e
s

a
n
d

W
e
t
l
a
b
s
255
WOC
2010
Room Istanbul
10:30 - 12:00 WOC-C-43
Wetlab Phaco Course for Beginners
Chairs:
Gerd U. Auffarth (Heidelberg/D), H. Burkhard Dick
(Bochum/D)
Speakers:
(Bochum/D), Thomas S. Dietlein (Dsseldorf/D),
Hagen Thieme (Mainz/D), Christian K. Vorwerk
(Magdeburg/D)
This course will outline the individual stages of
phacoemulsification surgery in a step-by-step
approach. In order to avoid and adjust complicated
surgical procedures, individual viewpoints and
approaches of the best respective methods will be
presented.
The incision types and architecture as well as their
relevance, dependant on the individual circum-
stances, will be addressed. Possible measures to
deepen the anterior chamber, widen the pupil, cap-
sulorhexis techniques, hydrodissection and hy-
drodelineation will be introduced.
The different techniques of nucleusprocessing (e.g.
Divide and Conquer, chop-techniques) will be
addressed regarding the respective situations.
There will be an introduction of the common in-
traocular lenses and their implant characteristics
as well as the rules of conduct in complicated
surgery progressions. Some advice will be given as
to how to avoid decentration of the lens, lens de-
fects and cataracta secundaria.
Room Istanbul
14:00 - 15:30 WOC-C-44
Wetlab Phaco Course for the Advanced
Chair:
Speakers:
(Bochum/D), Helmut Hh (Neubrandenburg/D),
Gangolf Sauder (Stuttgart/D)
The generic problems of advanced surgeons will be
presented in theory and practice. After an introduc-
tion of the individual preferred techniques of the
course administrators the course will move on to
outline the appropriate techniques for complex cir-
cumstances like narrow pupils, synechiae, hard
lenses, mature and hypermature lenses, previous
operations, and loose zonulae. The ideal procedure
will be demonstrated both theoretically as well as
by means of video clip examples. Avoidance and
management of generic complications like tear of
anterior capsule, capsular rupture, vitreous prolaps,
zonular tear-off, loss of nucleus, IOL luxation,
corneal burn, iris defects, and expulsive bleeding
will be discussed and practised. This course is
aimed at advanced phaco-surgeons.
Room Istanbul
16:00 - 17:30 WOC-C-45
Wetlab Biaxial and Microcoaxial Phacoemulsifica-
tion
Chairs:
(Bochum/D)
Speakers:
(Bochum/D), Ekkehard Fabian (Rosenheim/D),
Helmut Hh (Neubrandenburg/D), Gangolf Sauder
(Stuttgart/D)
This course shall provide user information for biax-
ial as well as microcoaxial phacoemulsification
technique, various phacoemulsification equipment
and techniques, instruments, and appropriate
micro-incision-intraocular lenses. Following an in-
troduction to the underlying technologies and rele-
vant instruments, the diagnosis, aims, and limits of
biaxial and microcoaxial phacoemulsification will
be discussed. After reviewing the advantages and
disadvantages of the different procedures, we will
explain in detail the practical implementations of
bi- and microcoaxial phacoemulsification including
the necessary instruments, implant techniques and
clinical findings of respective foldable lenses. Intra-
and postoperative complications as well as their
prevention and management will be addressed.
T
u
e
s
d
a
y
,

8

J
u
n
e
C
o
u
r
s
e
s

a
n
d

W
e
t
l
a
b
s
256
WOC
2010
Room 42
08:30 - 10:00 WOC-C-46
Achieving Excellence: Teamwork in Cataract and
Refractive Surgery
Chairs:
Claes Feinbaum (Lund/S), Sudhir Patel (Alicante/E),
Speakers:
Claes Feinbaum (Lund/S), Ewa Mrukwa-Kominek
(Katowice/PL), Sudhir Patel (Alicante/E)
08:30
Introduction Key topics and chief aims of the
course
Sudhir Patel (Alicante/E)
08:35
Modern Cataract Surgery: Review of most popular
techniques today & top tips to avoid complications
08:45
Modern Refractive Surgery: Review of most popular
techniques today & top tips to avoid complications
08:55
The Why, What and Which of Pre-operative Assess-
ment in Cataract Surgery: Referral criteria, patient
education to avoid complications, essentials of clin-
ical assessment, grading key clinical markers
Claes Feinbaum (Lund/S)
09:05
The Why, What and Which of Pre-operative Assess-
ment in Refractive Surgery Surgery: Referral criteria,
patient education to avoid complications, essen-
tials of clinical assessment, grading key clinical
markers
Claes Feinbaum (Lund/S)
09:15
Essentials for Success after cataract surgery:
Patient education = Patient satisfaction
09:30
Essentials for Success after refractive surgery:
Patient education = Patient satisfaction
09:45
Wind up: Interactive question & answer session
Claes Feinbaum, Sudhir Patel (Lund/S, Alicante/E)
Room 42
10:30 - 12:00 WOC-C-47
Corneal Imaging
Chairs:
Rudolf F. Guthoff (Rostock/D), Edward Wylegala
(Katowice/PL), Christophe Baudouin (Paris/F)
Speakers:
J. Oscar Croxatto (Buenos Aires/RA),
Rudolf F. Guthoff (Rostock/D), Pedram Hamrah
(Boston/USA), Bartlomiej J. Kaluzny (Bydgoszcz/PL),
Antoine Labb (Paris/F), Edward Wylegala
(Katowice/PL), Christophe Baudouin (Paris/F)
10:30
Corneal innervation new insights with confocal
in-vivo microscopy
10:40
Application of confocal microscopy in infectious
keratopathies
Antoine Labb (Paris/F)
10:50
Comparison of confocal and histopathological
images
J. Oscar Croxatto (Buenos Aires/RA)
11:00
Spectral vs time- domain OCT applying in different
Descemet membrane corneal pathology
11:10
Swept source OCT for quantitative assessment of
the cornea
Bartlomiej J. Kaluzny (Bydgoszcz/PL)
11:20
In Vivo Imaging and Quantification of Corneal
Inflammation
Pedram Hamrah (Boston/USA)
Room 42
14:00 - 15:30 WOC-C-48
Current Concepts in the Management of Retinal
Vessel Occlusion
Chair:
T
u
e
s
d
a
y
,

8

J
u
n
e
C
o
u
r
s
e
s

a
n
d

W
e
t
l
a
b
s
257
WOC
2010
Speakers:
Stefan Dithmar (Heidelberg/D), Nicolas Feltgen
(Gttingen/D), Lars-Olof Hattenbach
(Ludwigshafen/D), Siegfried G. Priglinger Jr. (Linz/A)
Over the past years, various novel treatment strate-
gies have expanded our options in the manage-
ment of retinal vessel occlusion. However, there is
still no consensus among ophthalmologists about
the optimal approach.
This course provides an overview of the histo-
pathologic and clinical features of retinal vein and
retinal artery occlusion. Current concepts such as
the intravitreal administration of anti-VEGF (vascu-
lar endothelial growth factor) drugs, surgical tech-
niques including the cannulation of retinal vessels,
or the use of thrombolytic or anticoagulant agents
are reviewed to determine whether these treat-
ments are likely to improve major clinical out-
comes. Case presentations will serve as an open
forum for an interactive group discussion with re-
gards to complicated clinical scenarios and treat-
ment decisions.
Room 43
08:30 - 10:00 WOC-C-49
Current Management of Diabetic Macular Edema
Chair:
Speakers:
Nicole Eter (Bonn/D), Nicolas Feltgen
(Gttingen/D), Hans Hoerauf (Gttingen/D),
Johann Roider (Kiel/D), Georg Spital (Mnster/D)
The diabetic macular edema are one of the most
crucial challenges of clinical everyday life and is
bound to gain even more significance in the future,
due to the continuous rise cases of diabetis mellitus.
While vitrectomy and the introduction of the in-
travitreal injection of Triamcinolon and Anti-VEFG
medication significantly broadened the therapeu-
tic spectrum, straight-forward recommendations
are still lacking. Laser treatment is still considered
the standard treatment for focal as well as diffuse
forms. The lecturers shall present the different
therapeutic approaches in detail, evaluate their
significance according to current research and
discuss diagnoses and determination in case
studies with the participants.
Room 43
10:30 - 12:00 WOC-C-50
Management of the Ruptured Globe
Chairs:
Arne Viestenz (Magdeburg/D), Ferenc Kuhn
(Birmingham/USA)
Speakers:
Gregorio Gabela (Quito/EC), Ferenc Kuhn
(Birmingham/USA), David Pelayes
(Buenos Aires/RA), Wolfgang F. Schrader
(Nrnberg/D), Arne Viestenz (Magdeburg/D)
Globe ruptures have a very unfortunate prognosis.
A prominent hyposphagma or monocle hematoma
often masks the sheltered globe rupture. Quick
surgical dressing is crucial alongside the assurance
of the diagnosis, as there is a threat of posttrau-
matic endophthalmitis and expulsive bleeding.
In the first part this course will present guidance
in diagnostic decision making and techniques of
primary wound treatment as well as avoidable
pitfalls. There will be a discussion of surgery videos
of limbus-parallel ruptures, ruptures behind the
straight eye muscle, and atypical ruptures.
Recommendations regarding the prevention of
posttraumatic endophthalmitis will be provided.
The second part will address the controversies of
primary vitrectomy (proactive regime) and pre-
emptively indenting surgery, as well as the ideal
time for surgical intervention, and the manage-
ment of secondary complications.
10:30
Surgery of traumatic macular hole
10:40
Timing of surgery in ruptured globes
10:50
Primary wound repair
Gregorio Gabela (Quito/EC)
11:00
Management of secondary complications after
globe rupture
Arne Viestenz (Magdeburg/D)
11:10
Retinal surgery after globe rupture
T
u
e
s
d
a
y
,

8

J
u
n
e
C
o
u
r
s
e
s

a
n
d

W
e
t
l
a
b
s
258
WOC
2010
Room 43
14:00 - 15:30 WOC-C-51
Challenging Cases in Anterior Segment Surgery
Chair:
Speakers:
Jochen Kammann (Davos/CH),
Gerhard K. Lang (Ulm/D), Duy-Thoai Pham
(Berlin/D), Peter Wagner (Ulm/D)
Challenges in anterior segment surgery can be
both extractive and refractive! Even with the most
modern phaco techniques there are occasionally
still complicated anterior segment situations,
which demand the modification of the standard
techniques and the preoperative planning of oper-
ative strategies.
Topics:
Luxatio (ICCE, VKL) or Subluxatio lentis
(slow-motion phaco, stabilisation of the
capsular bag), dense cataracts (catarocks)
Explantation/recentration and sutural fixation
of IOLs
Cataract surgery in combination with silicon
oil drainage or perforating keratoplasty
Iris hooks, capsular tension ring, iris diaphragm,
aniridia lens
Watch the signs: Pupillary-snap Sign, Spider-
web Sign, Argentina-flag Sign, Bounce Sign,
Misled Fluid Sign
Iris sutures in traumatic mydriasis (iris sphincter
suture), iridodyalisis (refixation sutures)
Anterior vitrectomy technique and optic-
capture techniques
Cataract surgery combined with pars plana
vitrectomy
Cyclodialysis occlusion
Course, video sequences, and interactive discussion
Room 43
16:00 - 17:30 WOC-C-52
Blepharoplasty II Complication, Analysis,
Management, and Prevention Strategies
Chair:
Speakers:
In the Federal Republic of Germany an estimated
10,000 blepharoplasties are done each year by
doctors of various fields. Hence both surgically as
well as conservatively active ophthalmologists will
be faced with the issues arising from less ideal
blepharoplasties. In case studies, this course will
present the possible complications, followed by an
analysis of the respective causes as well as possible
management suggestions where they would be
applicable. Prevention strategies that can ensure
successful blepharoplasty will be discussed.
Room 44
14:00 - 15:30 WOC-C-54
The Optic Disc Funduscopy, Perimetry, Laser
Scanning Ophthalmoscopy
Chair:
Alexander Friedrich Scheuerle (Heidelberg/D)
Speakers:
Andreas G. Bhm (Radebeul/D),
Alexander Friedrich Scheuerle (Heidelberg/D),
Eckart Schmidt (Radebeul/D)
This interactive workshop illustrates different
pathologies of the optic disc and their specific
diagnostic profile with a focus on glacoma.
W
e
d
n
e
s
d
a
y
,

9

J
u
n
e
C
o
u
r
s
e
s

a
n
d

W
e
t
l
a
b
s
259
WOC
2010
Oslo
13:00 - 14:30 WOC-C-55
Management of Vascular Ocular Emergencies
Chair:
Nicolas Feltgen (Gttingen/D),
Speakers:
Hansjrgen T. Agostini (Freiburg/D),
Nicolas Feltgen (Gttingen/D), Andreas Hetzel
(Freiburg/D), Wolf A. Lagrze (Freiburg/D)
The goal of this course is to discuss the most fre-
quent vascular emergencies of the eye and visual
pathways with regard to symptoms, diagnosis and
state of the art therapies from both an ophthalmo-
logical and a neurological point of view. Starting
with insights as to how patients perceive vascular
malfunction, the presentation will cover transitory
ischemia of the retina, occlusion of retinal veins
and arteries, anterior ischemic neuropathy,
apoplexy of the central visual system, and oculo-
motor emergencies. This systematic course will
include interactive elements and will focus on the
interdisciplinary management of these patients.
13:00
Introduction
13:10
More than just seeing worse Symptoms
Andreas Hetzel, Wolf A. Lagrze (Freiburg/D)
13:20
Retinal vein occlusions
Nicolas Feltgen (Gttingen/D)
13:30
Retinal artery occlusions
13:40
AION, Tersons Syndrome, Motility disorders
13:50
Central ischemia of the visual system
Andreas Hetzel (Freiburg/D)
Hall 10
08:30 - 10:00 WOC-C-56
Refractive Lens Surgery
Chair:
Josef Wolff (Heppenheim/D)
Speakers:
Stephan Kohnen (Aachen/D), Thomas Kohnen
(Frankfurt/D), Anja Liekfeld (Potsdam/D),
Walter Sekundo (Marburg/D), Josef Wolff
(Heppenheim/D)
Within the scope of refractive surgery more and
more surgical procedures of the lens are being
developed. This involves modern intraocular lenses,
which are implanted either underneath the natural
lens (phaco IOL) or following its extraction (RLA),
depending on the respective diagnosis. Particular
attention will be paid to diagnosis-specific and
individual feasibilities in high myopia, hyperopia,
astigmatism, and presbyopia, or their possible
combinations. The individual procedures and lens
types will be presented and evaluated and particu-
larly
phaco IOLs
multifocal lenses
toric IOLs.
will be covered.
Refractive lens surgery is also increasingly used in
cataract surgery. The respective options that arise
from the choice of modern IOLs will also be
evaluated in combination with cornea procedures.
In particular this will cover:
multifocal lenses
toric IOLs
Astigmatism correction by choice of incision
and additional cornea procedures
WOC
2010
W
e
d
n
e
s
d
a
y
,

9

J
u
n
e
Room 42
10:30 - 12:00 WOC-C-58
Current Trends in Management of Retinopathy of
Prematurity
Chairs:
Venkatapathy Narendran (Coimbatore/IND),
Rajvardhan Azad (New Delhi/IND), Mangat Dogra
(Chandigarh/IND)
Speakers:
Rajvardhan Azad (New Delhi/IND), Mangat Dogra
(Chandigarh/IND), Venkatapathy Narendran
(Coimbatore/IND), Kalpana Narendran
(Coimbatore/IND), Parag K. Shah (Coimbatore/IND)
10:30
Introduction
Venkatapathy Narendran (Coimbatore/IND)
10:35
Pathogenesis and Classification
Parag K. Shah (Coimbatore/IND)
10:45
Risk factors & Screening
Venkatapathy Narendran (Coimbatore/IND)
10:55
Laser in ROP: Indications & Technique
Mangat Dogra (Chandigarh/IND)
11:05
Surgical management of ROP
11:15
Rehabilitaion of ROP
Kalpana Narendran (Coimbatore/IND)
Room 42
08:30 - 10:00 WOC-C-57
Laser in Retinal Diseases Dos and Donts
Chairs:
Hans Hoerauf (Gttingen/D), Sebastian Wolf
(Bern/CH), Peter K. Kaiser (Cleveland/USA)
Speakers:
Diana Do (Baltimore/USA), Peter K. Kaiser
(Cleveland/USA), Darius Moshfeghi (Stanford/USA),
Johann Roider (Kiel/D), Gisle Soubrane (Crteil/F),
DRCR.net laser results
Pattern scan laser technology
Darius Moshfeghi (Stanford/USA)
PDT-Combination therapy for AMD
Laser photocoagulation in choroidal neovascular-
ization: is there still an indication?
SRT, temperature controlled laser, sublethal laser
effectes, scanning laser systems
Combination therapy for DME
260
C
o
u
r
s
e
s

a
n
d

W
e
t
l
a
b
s
WOC
2010
261
W
e
d
n
e
s
d
a
y
,

9

J
u
n
e
Room 43
13:00 - 14:30 WOC-C-60
Diagnosing Melanocytic Tumours of the Uvea:
New Techniques and Guidelines for Referral
Chairs:
Michael Giblin (Sydney/AUS), Tero Kivel
(Helsinki/FIN), Michael H. Foerster (Berlin/D)
Speakers:
James Augsburger (Cincinnati/USA),
Norbert Bornfeld (Essen/D), Michael H. Foerster
(Berlin/D), Michael Giblin (Sydney/AUS),
Tero Kivel (Helsinki/FIN), Carol L. Shields
(Philadelphia/USA)
13:00
The frequency and prognosis of melanocytic
tumours of the uvea relative to size
James Augsburger (Cincinnati/USA)
13:10
How large are small uveal melanomas when they
first metastasise?
13:20
How to recognise a small melanocytic lesion which
may grow, and when to refer?
13:30
Optical coherence tomography and autofluo-res-
cence in assessing melanocytic tumours
13:40
When, why and how to biopsy a small melanocytic
tumour?
13:50
A small melanocytic tumour which needs treat-
ment: radiotherapy or thermotherapy?
Michael Giblin (Sydney /AUS)
Room 43
08:30 - 10:00 WOC-C-59
Introducing Pediatric Low Vision in
Ophthalmology Practice
Chairs:
Galton Carvalho Vasconcelos (Belo Horizonte/BR),
Speakers:
Galton Carvalho Vasconcelos (Belo Horizonte/BR),
Lucienne Chaves Fernandes (Belo Horizonte/BR),
Jill Keeffe (Melbourne/AUS), Linda Lawrence
(Salina/USA)
Synopsis: This course will focus on the basic con-
cepts of low vision in children, especially in infancy.
It will review definitions in low vision, early identi-
fication and assessment, the need of a multidisci-
plinary team and aspects of the inclusion of
children with low vision. Two important themes
are going to be reviewed: retinopathy of prematu-
rity and congenital glaucoma. Discussion and
questions will be encouraged at the end. The
course is directed to general ophthalmologists and
pediatric ophthalmologists.
By the end of the course, attendees will be able to
learn (1) basic concepts of pediatric of low vision, (2)
early and effective strategies to assess the principal
causes of low vision in children at an office setting,
(3) the benefits of early intervention in pediatric low
vision, (4) the importance of continuous multidisci-
plinary communication among different specialists.
08:30
Early Identification and assessment
Linda Lawrence (Charleston/USA)
08:50
Multidisciplinary team
Galton Carvalho Vasconcelos (Belo Horizonte/BR)
09:00
Inclusion
09:10
Retinopathy of Prematurity
09:20
Congenital Glaucoma
Lucienne Chaves Fernandes (Belo Horizonte/BR)
09:30
Discussion
Linda Lawrence, Galton Carvalho Vasconcelos,
Jill Keeffe, Lucienne Chaves Fernandes (Charleston/
USA, Belo Horizonte/BR, Melbourne/AUS)
C
o
u
r
s
e
s

a
n
d

W
e
t
l
a
b
s
W
e
d
n
e
s
d
a
y
,

9

J
u
n
e
C
o
u
r
s
e
s

a
n
d

W
e
t
l
a
b
s
262
WOC
2010
Salon 11/12
10:30 - 12:00 WOC-C-62
Present Options in the Management of Primary
Rhegmatogenous Retinal Detachment: Teaching
Course with International Faculty
Chairs:
Ingrid Kreissig (Mannheim/D),
George William Aylward (London/UK),
Harvey Lincoff (New York/USA)
Speakers:
George William Aylward (London/GB), Thorsten
Bker (Dortmund/D), Ingrid Kreissig (Mannheim),
Harvey Lincoff (New York/USA), William F. Mieler
(Chicago/USA), Shuichi Yamamoto (Sakura/J)
10:30
1. Diagnostics: 1.1. The 4 Rules to find the primary
break
Ingrid Kreissig (Mannheim/D)
10:40
1.2. Lattice degeneration and breaks in the fellow
eye: What to do or not to do?
George William Aylward (London/GB)
10:50
2. Minimal E.O. Surgery (Segm. Sponge(S),
Nondrainage): Indications, complications, longterm
results
Thorsten Bker (Dortmund/D)
11:00
3. Pneumatic Retinopexy: Indications, complica-
tions, longterm results
11:10
4. Cerclage With Drainage: A look at cerclage after
50 years
Harvey Lincoff (New York/USA)
11:20
5. Primary Vitrectomy: Rationale, indications, com-
plications, longterm results
Shuichi Yamamoto (Sakura /J)
11:30
6. Reoperation: The 4 Rules to find the undetected
break
Ingrid Kreissig (Mannheim/D)
11:40
7. Comparison of Present Techniques for Repair of
Primary Retinal Detachment: Morbidity, results,
socio-economic issues
Thorsten Bker (Dortmund/D)
Posters
WOC
2010
263
Vorsprung durch Wissen
1. Mehr Know-how
Monat fr Monat neueste
wissenschaftliche Erkenntnisse
fr Diagnostik und Therapie
2. Mehr Fortbildung
Mit CME-Beitrgen Wissen
aurischen und Punkte
sammeln
3. Mehr Benet
Beitrge komfortabel und
schnell online recherchieren
Name, Vorname
Strae, Hausnummer
PLZ, Ort
Datum, Unterschrift
0
5
0
0
2
1
www.DerOphthalm
ologe.de
Ja, ich mchte die nchsten 3 Ausgaben der
Zeitschrift Der Ophthalmologe kostenlos testen.
Sollte ich von der Zeitschrift nicht berzeugt sein, teile ich Ihnen dies innerhalb von 14 Tagen nach
Erhalt des 3. Heftes mit. Wenn ich die Zeitschrift weiterlesen mchte, brauche ich nichts zu tun
und erhalte die Zeitschrift zum Preis von 327,- EUR inkl. 7% MwSt. (12 Hefte jhrl.) in 2010 fr min-
destens 1 Jahr (als rztin/Arzt in Aus- und Weiterbildung, Student/in 196,20 EUR inkl. 7% MwSt.
Nachweis anbei) zzgl. Versandkosten (Inland 26,- EUR/Ausland 68,- EUR). Das Abonnement kann
ich bis 2 Monate vor Ende des Bezugszeitraumes kndigen. (Preisnderungen und Irrtmer vorbehalten)
Jetzt
3 Ausgaben
gratis testen!
Faxantwort: 0 62 21-3 45-42 29
Oder einsenden an: Springer Customer Service Center GmbH
Haberstrae 7 D-69126 Heidelberg
E-Mail: Leserservice@springer.com Tel.: 06221-345-4303
Ja, bitte senden Sie mir aktuelle Angebote und Newsletter gerne auch per E-Mail:
E-Mail
Ich bin ttig in Klinik Praxis
Springer-Verlag GmbH, Tiergartenstrae 17, 69121 Heidelberg
Zweigniederlassung der Springer-Verlag GmbH, Heidelberger Platz 3, 14197 Berlin Amtsgericht Berlin-Charlottenburg, HRB 91881 B
Geschftsfhrer: Derk Haank, Martin Mos, Peter Hendriks Springer ist Teil der Fachverlagsgruppe Springer Science + Business Media
P-SA-008
Benefits of using ASPHERIC implants in Cataract
surgery
Mohamed Attitich (Rabat/MA)
P-SA-009
Bi-axial Prechoping with two 25 G cannulas at the
iris plane.
Arturo Prez-Arteaga (Tlalnepantla/MEX)
P-SA-010
Comparison of biometric measurements with
ultrasound and a new laser interference biometer
in cataract eyes
Mike P. Holzer, Charlotte Jepsen, Tanja M. Rabsilber,
P-SA-011
Complication rate and risk factors for intraoperative
complications in resident-performed phacoemulsifi-
cation surgery
Wolfgang Herrmann, Andrea briszi, Horst Helbig
(Regensburg/D)
P-SA-012
Correlation between risk factors and intraoperative
complications in phacoemulsification surgery
performed by trainees
Anna Praidou, Evgenia Kanonidou, Matheos
Antoniadis, Aggeliki Doudou, Sofia Androudi,
P-SA-013
Does implantation of a Capsular Tension Ring in
context with phacoemulsification influence the
refractive outcome in highly myopic eyes?
Andrea Schild, Andre Rosentreter, Martin Hellmich,
Thomas Dietlein (Cologne/D, Duesseldorf/D)
P-SA-014
Ectopia Lentis a vitreo-retinal surgical approach
Seddiqu Salahim (Sana'a/ADN)
P-SA-015
Effectiveness of Cataract Surgery with
Phacoemulsification for Nanophthalmos
Kaori Suzuki, Yukihiko Suzuki, Asaka Kudou,
Mitsuru Nakazawa (Hirosaki/J)
P-SA-024
Manual Small Incision Cataract Surgery (Manual
SICS) a friend in need is a friend indeed
Bhaskar Bhattacharyya (Kolkata/IND)
P-SA-025
MRSA Endophthalmitis A Wake-up Call for the
Ophthalmologist
Gerald Schultz (Indio/USA)
P-SA-026
Multicenter and site-specific results on behaviour
and performance of the Tecnis 1-Piece IOL
Christopher Wirbelauer, Duy-Thoai Pham
(Frankfurt(Oder)/D, Berlin/D)
Saturday, 5 June 2010 15:30 to 17:00
Posters
Poster exhibition of Poster P-SA-001 to P-SA-282.
All poster authors will attend their posters from
15:30 to 17:00 hrs.
Moderation Poster sessions on Saturday
Chairs:
Gerd Geerling (Wuerzburg)
Duica Pahor (Maribor)
Co-Chairs:
Christoph M. E. Deuter (Tbingen)
H. Burkhard Dick (Bochum)
Michael Diestelhorst (Cologne)
Stephan Eckert (Ulm)
Lars-Olof Hattenbach (Ludwigshafen)
Mathias Seeliger (Tbingen)
Alexander Reis (Triesen)
Heimo Steffen (Wuerzburg)
Cataract/Biometry 1 P01
P-SA-001
Accuracy of IOLMaster in axial length measurement
in silicone oil-filled eyes
Jing Sun, Situo Liang (Shanghai/CN)
P-SA-002
Accuracy of the IOL calculation formula SRK/T
vs. Haigis for the Acri.Smart 46LC (now CT Asphina
409M)
Ruediger Schmid, Holger Luedtke (Ulm/D)
P-SA-003
Application of Femtosecond Laser in Cataract
Surgery for the Creation of Multi-planar Self-
Sealing Corneal Incisions
Roger Steinert, Enrique Baragan (Irvine/USA)
P-SA-004
Application of Tokyo University Egogram in cases
with multifocal IOL
Hiroko Bissen-Miyajima, Shinichi Oki,
Mami Yoshino, Izumi Kamei (Tokyo/J)
P-SA-005
Argentina's Flag- phaco in an intumescent mature
cataract (managing a run-out rhexis)
P-SA-006
Astigmatism correction after cataract surgery,
toric IOL vs conventional IOL + opposite clear
corneal incisions
Daniel Nahra (Barcelona/E)
P-SA-007
Axial length measurement in eyes with macular
edema: A-scan ultrasound versus IOLMaster.
Jing Sun, Situo Liang (Shanghai/CN)
S
a
t
u
r
d
a
y
,

5

J
u
n
e
P
o
s
t
e
r
s
265
WOC
2010
P-SA-027
Office based cataract surgery Architectural and
Technical choices for an independence of
hospitalisation structure Three Years of an
innovative concept in France Efficiency, Quality and
costs.
Franois Blondeau (Chateau d'Olonne/F)
P-SA-028
Optimizing Fluidics using both Venturi and Peri-
staltic Pumps during Phacoemulsification Surgery
Uday Devgan (Los Angeles/USA)
P-SA-029
Postoperative Ptosis following cataract surgery
Yanin Suwan (Songkhla/T)
P-SA-030
Reliable Presbyopia surgery with a toric bifocal
MICS IOL (BIOL) 2 years and 70 eyes
Detlev Breyer (Duesseldorf/D)
P-SA-031
Results of a prospective study to evaluate the
quality of vision with two aberration-free aspheric
intraocular lenses (with and without blue light-
filter) vs. a conventional spherical IOL
Michael Wolter-Roessler, Michael Kchle (Lauf/D,
Erlangen/D)
P-SA-032
Safety and efficacy of phacoemulsification in
various types of post uveitic cataracts
P-SA-033
Stenotrophomonas maltophilia endophthalmitis
after cataract extraction.
Marcelino Rio Torres, Meisy Ramos Lopz,
Juan Ral Hernndez Silva (Habana/C)
P-SA-034
Surgically induced astigmatism (SIA) after coaxial
micro incision cataract surgery (MICS) through
2.2mm incision in comparison to small incision
cataract surgery (SICS) through 3.0mm incision
Bernhard Steinhuber, Lilly Speicher, Wolfgang
Philipp (Innsbruck/A)
P-SA-035
Technique for Centration of the Tecnis Aspheric
Multi-focal Lens Implant in the Visual Axis of
Cataract Surgery Patients
Uday Devgan (Los Angeles/USA)
P-SA-036
The meaning of galactose metabolism for
congenital cataract a 12-year analysis
Christoph Raum, Gabriele Gusek-Schneider,
Saturday, 5 June 2010 15:30 to 17:00
S
a
t
u
r
d
a
y
,

5

J
u
n
e
P
o
s
t
e
r
s
266
WOC
2010
P-SA-037
The power definition of multifocal IOL using IOL
Master and A-scan biometry
Mami Yoshino, Hiroko Bissen-Miyajima,
Kunihiko Nakamura, Shinichi Oki (Tokyo/J)
P-SA-038
Tilt and decentration of five kinds of aspheric IOLs
in vivo from Scheimpflug imaging
Xiaojie Xing, Xin Tang, Hui Song (Tianjin/CN)
P-SA-039
Toric IOL Versus Adjustable Incision for Treatment
of Mild to Moderate Astigmatism in Phacoemulsifi-
cation
Khaled Kotb Ali (Cairo/ET)
P-SA-040
Visual performance of +3.0D aspheric AcrySof
ReSTOR Apodized Diffractive IOL: A Prospective
Comparative Trial
Fang Tian, Hong Zhang (Tianjin/CN)
Cornea/Eye Bank: Surgical Therapy P02
P-SA-041
A technique to salvage big-bubble deep lamellar
keratoplasty after inadvertent full-thickness
trephination
Siamak Zarei-Ghanavati, Mehran Zarei-Ghanavati
(Mashhad/IR)
P-SA-042
Autologic Perforating Keratoplasy
Khakima Karim-Zade, Safarali Mirsoev,
Alexander Enikeev (Dushanbe/TAD)
P-SA-043
Better visual outcomes using a microkeratome for
endothelial donor lamella preparation during
DSAEK compared with the preparation using a
femtosecond laser
Jan Markus Vetter, Melissa Faust, Walter Sekundo
(Mainz/D)
P-SA-044
Central and peripheral corneal iron deposits after
the AcuFocus Intracorneal Inlay (ACI 7000)
implantation
Gerhard Nix, Orang Seyeddain, Wolfgang Riha,
Melchior Hohensinn, Gnther Grabner, Alois Dexl,
Elisabeth Messmer (Salzburg/A, Mnchen/D)
P-SA-045
Clinical confirmation of DMEK possibility after
previous DSEK surgery
Rosa Gundorova, Oganes Oganesyan,
Mary Smetanina, Daria Danilova (Moscow/RUS)
P-SA-046
Clinical evaluation of highly aberrated eyes: the
importance of the patient self perception.
Juliane Paranhos (Goiania/BR)
P-SA-047
Clinical Evaluation of non-Descemets Stripping
Automated Endothelial Keratoplasty (nDSAEK)
Toshinori masaki, Akira Kobayashi, Hideaki
Yokogawa, Kazuhisa Sugiyama (Kanazawa/J)
P-SA-048
Clinical outcomes after DMEK-S surgery combined
with cataract extraction
Deli Sivekova, Magdalena Vokrojova, Katerina
Liehneova, Magdalena Netukova, Pavel Studeny
(Prague/CZ)
P-SA-049
Clinical outcomes in patients 2 years after DMEK-S
surgery
Pavel Studeny, Deli Sivekova, Katerina Liehneova,
Magdalena Vokrojova, Michal Hyndrak (Prague/CZ)
P-SA-050
Comparative study of steam cautery and subabla-
tive Er:YAG laser therapy in microbial keratitis
Juergen Kampmeier, Peter Wagner, Simone Stop-
per, Eva Koler, Gerhard K. Lang, Detlef Russ (Ulm/D)
P-SA-051
Comparison of corneal inflammation after flap
creation using a mechanical microkeratome and
a 200 kHz femtosecond laser an in vitro organ
culture study
Wolfgang Mayer, Armin Wolf, Martin Grterich,
Carlo Lackerbauer, Anselm Kampik, Daniel Kook
(Munich/D)
P-SA-052
Comparison of Pterygium Recurrence rate after
pterygium resection and conjunctival autograft
with additive phototherapeutic keratectomy
Julia Promesberger, Sharmila Kohli, Matthias
Schmidt, Constantin E. Uhlig (Mnster/D)
P-SA-053
Complications after penetrating and lamellar
keratoplasty at pations with outcomes of herpetic
keratitis
Tetyana Gaydamaka, Galyna Drozhyna,
Sergiy Grechko (Odessa/UA)
P-SA-054
Conjunctival covering of autologus stem cells in the
treatment of the herpetic neurotrophic keratopathy
Eygene Ilyina, Pavel Bezditko (Kharkov/UA)
P-SA-055
Corneal Intrastromal Implantation Surgery (CISIS)
for Keratoconus
Albert Daxer (Ybbs/A)
P-SA-056
Deep Anterior Lamellar Keratoplasty for Pellucid
Marginal Corneal Degeneration
Abdullah Al-Turbaq (Riyadh/SA)
P-SA-057
Deep Anterior Lamellar Keratoplasty for Treatment
of Herpetic Corneal Scars
Banu Torun Acar, Suphi Acar (Istanbul/TR)
P-SA-058
Descemets Stripping Automated Endothelial
Keratoplasty (DSAEK) for Congenital Hereditary
Endothelial Dystrophy (CHED)
Ali Alrajhi (Riyadh/SA)
P-SA-059
Disturbance of tight junction proteins in gelatinous
drop-like dystrophy
Enken Gundlach, Claudia Auw-Hdrich, Constantin
Uhlig, Thomas Reinhard (Freiburg/D)
P-SA-060
DSAEK with Carriazo-Pendular-Mikrokeratome and
a newly designed Artificial Anterior Chamber first
clinical results
Jan Darius Unterlauft, Katharina Weller, Johann
Schmiedl, Gunda Kann, Kasper Berit, Gerd Geerling
(Wuerzburg/D)
P-SA-061
DSAEK, Preparation of the donor tissue with the
Carriazo-pendular-microkeratome and an artificial
anterior chamber.
Gregor Schaaf, Arash Amjadi, Norbert Schrage
(Hrth/D, Cologne/D)
P-SA-062
Evaluation of Three Lamellar Keratoplasty
Techniques in Keratoconic Eyes: Results One Year
After Surgery.
Luigi Mosca (Rom/I)
P-SA-063
Evolution of astigmatism in keratoconic eyes
implanted with intracorneal ring segments
David Pablo Piero Llorens, Jorge Ali (Alicante/E)
P-SA-064
Factors influencing the consent for cornea donation
requested via telephone interview
Martin Hermel, Andre Steinfeld, Sabine Salla,
Nicole Hamsley, Peter Walter, Stefanie Stiel
(Aachen/D)
P-SA-065
Histopathologic changes after deep anterior
lamellar keratoplasty (DALK) using the big-bubble
technique
Joachim Braun, Carmen Rummelt, Ursula
Schltzer-Schrehardt, Friedrich Kruse,
P-SA-066
Impact of histopathological findings for the
treatment strategy of Schnyder corneal dystrophy
(SCD)
Tobias Hager, Andrea Hasenfus, Berthold Seitz
(Homburg/D)
Saturday, 5 June 2010 15:30 to 17:00
S
a
t
u
r
d
a
y
,

5

J
u
n
e
P
o
s
t
e
r
s
267
WOC
2010
Saturday, 5 June 2010 15:30 to 17:00
P-SA-077
Regeneration of subepithelial nerve plexus and its
correlation with corneal sensation after fs-LASIK:
a 6 month follow-up study
Andrey Zhivov, Oliver Stachs, Philipp Martius,
Marcus Blum, Wilfried Bissmann, Rudolf F. Guthoff
(Rostock/D, Erfurt/D)
P-SA-078
Remote results of deep lamellar keratoplasty (DLK)
at keratoconus III-IV stage.
Nadiya Bobrova, Elena V. Ivanovskaya, G. Droggina,
Tetyana B. Gaydamaka, Borys M. Kogan
(Odessa/UA)
P-SA-079
Results of penetrating keratoplasty in keratoconus
Omar Beltaief, Khalil Errais (Tunis/TN)
P-SA-080
Rethinking Keratoconus with Bioptics
Susan Senft, Dalel Tartak, Maria Tartak
(Kailua-Kona/USA)
P-SA-081
Salzmann s nodular degeneration on a corneal
graft twenty-one years after penetrating
keratoplasty
Arnulf G. Schnaidt, Zisis Gatzioufas, Andreas C.
Schrder, Ursula Lw, Susanne C. Goebels,
Frank Schirra, Berthold Seitz (Homburg/D)
P-SA-082
Superficial keratectomy, PTK and MMC as
combined treatment option for Salzmanns Nodular
Degeneration
Stephan Linke, Toam Katz, Gisbert Richard, R. Baile,
Riad Khaireddin (Hamburg/D)
P-SA-083
Surgical treatment for suppurative corneal ulcers
P-SA-084
Traumatic Wound Dehiscence after Deep Anterior
Lamellar Keratoplasty
Siamak Zarei-Ghanavati, Mehran Zarei-Ghanavati
(Mashhad/IR)
P-SA-085
Treating hydrops keratoconus by epikeratoplasty
with corneocompression
Mukharram Bikbov, Guzel Bikbova (Ufa/RUS)
P-SA-086
Visual perception changes and optical stability after
ICRS implantation: Comparison between 4 months
and 1 year after surgery.
Juliane Paranhos, Paulo Schor (Goiania/BR,
So Paulo/BR)
P-SA-067
In vivo confocal microscopy of AcuFocus corneal
inlays
Wolfgang Riha, Orang Seyeddain, Melchior
Hohensinn, Gerhard Nix, Gnther Grabner,
Elisabeth Messmer (Innsbruck/A, Munich/D)
P-SA-068
Interface reflectivity measured by Pentacam and
visual outcome following Descemet stripping
automated endothelial keratoplasty (DSAEK)
Sonja Ute Heinzelmann, Daniel Bhringer,
Philip Maier, Thomas Reinhard (Freiburg/D)
P-SA-069
lamellar corneal tattooing for better cosmetical
appearance in corneal scars
Syska Widyawati, Johan Hutauruk (Jakarta/RI)
P-SA-070
Long-term outcome of penetrating keratoplasty
combined with simultaneous vitrectomy without
temporary keratoprosthesis
Amelie Pielen, Bernd Junker, Daniel Bhringer,
Hansjrgen T. Agostini, Thomas Reinhard
(Freiburg/D)
P-SA-071
Morphological and Functional Correlations in
Riboflavin UV A Corneal Collagen Cross-Linking for
Keratoconus
Cosimo Mazzotta, Stefano Baiocchi,
Rosario Denaro, Aldo Caporossi (Siena/I)
P-SA-072
Nd:YAG laser supported superficial keratectomy for
deep band keratopathy
Heinrich Holak, Katja Schielke, Malgorzata
Jaworska, Nikolai Holak, Heinrich Holak
(Salzgitter/D)
P-SA-073
Outcomes after Type 1 Boston Keratoprosthesis and
Glaucoma Tube Shunt
Jessica Wong, Thasarat Vajaranant, Jacob Wilensky,
Jose de la Cruz (Chicago/USA)
P-SA-074
Pneumodescematopexy using 6 % C3F8
Sheshadri Mahajan (Nasik/IND)
P-SA-075
Poor corneal wettability, its influence on surface
ablations outcomes.
Claes Feinbaum (Landskrona/S)
P-SA-076
Recent tendencies in indications for penetrating
keratoplasty in Bulgaria
Nikolay Surchev, Yordanka Kirilova, Tatyana
Hergeldzhieva-Fileva, Petja Vassileva (Sofia/BG)
S
a
t
u
r
d
a
y
,

5

J
u
n
e
P
o
s
t
e
r
s
268
WOC
2010
Saturday, 5 June 2010 15:30 to 17:00
P-SA-096
RDH5 Mutation Analysis in a Series of Israeli
Patients Affected by Fundus Albipunctatus:
Detection of Novel Mutations.
Eran Pras, S. Ravech, D. Sharon, E. Banin,
Y. Rotenstreich, I. Avni, A. Abu (Qiryat Ono/IL)
P-SA-097
Single Nucleotide Polymorphisms in Promoter
Region of Matrix Metalloproteinase 1, 2, and 3 in
Japanese with High Myopia
Hisako Hayashi, Hideo Nakanishi, Ryo Yamada,
Kenji Yamashiro, Isao Nakata, Noriaki Shimada,
Kyoto Ohno, Manabu Mochizuki, Mineo Ozaki,
Shin Yoshitake, Shoji Kuriyama, Masaaki Saito,
Tomohiro Iida, Nagahisa Yoshimura (Kyoto/J)
P-SA-098
TGFBI gene mutations caused a corneal dystrophy
in Ukranian families
Galyna Drozhyna, Natalia Pasiechnikova, Vladimir
Pampucha, Ljudmila Livchits, Tetyana Gaydamaka,
Valerij Vit (Odessa/UA)
P-SA-099
The 972G>C polymorphism of the hMYH gene in
AMD
Jerzy Szaflik, Ewelina Synowiec, Urszula
Kolodziejska, Jacek P. Szaflik, Janusz Blasiak
(Warszawa/PL)
Glaucoma P04
P-SA-100
One-Year Incidence of Dry Eye with Latanoprost
(LAT) or Travoprost-Z (TRAV-Z) in Patients With
Open-Angle Glaucoma (OAG) and Ocular Hyper-
tension (OH)
Sameer Kotak, Gail Schwartz, Joel Fain,
Jack Mardekian (New York/USA)
P-SA-101
23-gauge pars plana Vitrectomy for the Manage-
ment of Malignant Glaucoma after Ex-PRESS Mini
Glaucoma Shunt
Mounira J. Dridi, Mathias Maier, Jens Huber,
Chris Patrick Lohmann, Aharon Wegner (Munich/D)
P-SA-102
Ability of the Flashlight Test to Discriminate Be-
tween Eyes with Open and Narrow Angles
Carolina Pelegrini Barbosa, Bruno Landgren, Aline
Katia Siqueira Sousa, Tiago S. Prata, Augusto
Paranhos (So Paulo/BR)
P-SA-103
Analysis of light-dark change of iris and anterior
chamber angle in the non-glaucoma subjects with
or without exfoliation syndrome
Takanori Mizoguchi (Nagasaki/J)
Genetics P03
P-SA-087
A Novel Stop Codon Mutation in Rhodopsin Gene
in Two Indonesian Families with Autosomal
Recessive Retinitis Pigmentosa
Arief Kartasasmita, Akira Murakami, Keiko Fujiki,
Takuro Fujimaki, Iwan Sovani, Erwin Iskandar
(Bandung/RI, Tokyo/J)
P-SA-088
ABCA4 and ROM1: Implications for modification
of the PRPH2-associated macular dystrophy
phenotype
Charlotte Poloschek, Michael Bach, Wolf Lagrze,
Esther Glaus, Johannes Lemke, Wolfgang Berger,
John Neidhardt (Freiburg/D)
P-SA-089
Clinical and Genetic Investigation of Isolated
Microspherophakia in a Consanguineous Tunisian
Family
Ouechtati Farah, Ben Yahia Salim, Nouira Sonia,
Chakroun Sonia, Abdelhak Sonia,
Moncef Khairallah (Monastir/TN)
P-SA-090
Detection of polymorphism in cdon 72 of gene
p53 in glaucoma patients and its socio-economic
correlation
Rodrigo Egidio, Francisco Rodrigues, Euler Franco,
Katia Verolli (Goiania/BR)
P-SA-091
Exclusion of known chromosomal loci in a family
with dominant optic atrophy: Evidence for novel
genetic background?
Monika Oldak, Jacek P. Szaflik, Aneta Federowicz,
Ewa Langwinska-Wosko, Kamil Szulborski, Joanna
Kosi ska, Rafal Ploski, Jerzy Szaflik (Warsaw/PL)
P-SA-092
Mutation screening of CHX10 and RAX genes in
Chinese nanophthalmos
Jing Tao, Ningli Wang, Naiqing Weng, Bowen Zhao,
Qian Liu (Beijing/CN)
P-SA-093
Patient and Control Recruitments for Genetic Inves-
tigation of Macular Diseases
David Liu, Scarlet Chan, Dennis Lam, Calvin Pang
(Hong Kong/HK)
P-SA-094
Polymorphism in codon of gene p53 in glaucoma
patients and its correlation with systemic diseases
Francisco Rodrigues, Rodrigo Egidio, Euler Franco,
Katia Verolli (Goiania/BR)
P-SA-095
Positional Cloning of Disease Gene in A Chinese
XLRP Pedigree
Qingsong Yang, Ningli Wang, Hongyan Jia, Kai Ma,
Liqin Gao (Beijing/CN)
S
a
t
u
r
d
a
y
,

5

J
u
n
e
P
o
s
t
e
r
s
269
WOC
2010
Saturday, 5 June 2010 15:30 to 17:00
P-SA-112
Comparison of Dynamic Contour Tonometry vs.
Goldmann Applanation Tonometry and Biometry
of the Anterior Segment pre and post Cataract
Surgery
Mitja Alexander Heinrich, Achim Langenbucher,
Wolfgang Behrens-Baumann, Arne Viestenz
(Magdeburg/D, Homburg/D)
P-SA-113
Comparison of functional and morphological
diagnostics in glaucoma patients and healthy
subjects
Matthias Klamann, Anja Grnert, Anna-Karina B.
Maier, Florian M. A. Heuen, Sibylle Winterhalter,
Antonia M. Joussen, Klaudia K. Huber (Berlin/D)
P-SA-114
Comparison of Scanning Laser Polarimetry and
Optical Coherence Tomography to Detect the
Retinal Nerve Fiber Layer Thickness in Primary Angle
Closure Glaucoma
Mei-Ju Chen, Ching-Yu Chen, Catherine Jui-Ling
Liu, Ching-Kuang Chou, Shui-Mei Lee (Taipei/TJ)
P-SA-115
Comparison of the effect of Latanoprost and
Tafluprost on 24-hour intraocular pressure in
Normal-tension Glaucoma
Noriko Yasuda, Kenji Nakamoto (Tokyo/J)
P-SA-117
Correlation between central corneal thickness
and retinal nerve fiber layer thickness in primary
open-angle glaucoma patients
Lachaya Orapiriyakul, Boonchai Wangsupadilok
(Hatyai Songkhla/T)
P-SA-118
Correlation Between Bleb Trabeculectomy Morphol-
ogy with Intraocular Pressure in Primary Glaucoma
Dian Estu, Edi Supiandi, Widya Artini,
Joedo P (Jakarta/RI)
P-SA-119
Could smoking be regarded as an additional risk
factor in elder women with primary open angle
glaucoma?
Vicente Zanon-Moreno, Jose Javier Garcia-Medina,
Maria A. Moreno-Nadal, Pedro Sanz-Solana, Maria
D. Pinazo-Duran (Valencia/E)
P-SA-120
Effect of anti-glaucoma therapy on 24-hour IOP for
primary glaucoma patients with open angle and
angle closure
Shoichi Sawaguchi, Hiroshi Sakai, Yoshikuni
Arakaki, Ichiko Medoruma, Eriko Tomoyose
(Nishihara/J)
P-SA-104
Arcuate scotoma suggests optic disc may be
sinking in glaucoma
Syed Hasnain (Porterville/USA)
P-SA-105
Assessment of the ISNT Rule by Peripapillary Retinal
Nerve Fiber Thickness in Primary Open Angle and
Angle-Closure Glaucoma
Tsung-Yu Ho, Ching-Yu Cheng, Catherine Jui-Ling
Liu, Pei-Jung Lee, Yu-Chieh Ko, Shui-Mei Lee
(Taipei/TJ)
P-SA-106
Associations of FOS Curve, False-Positive and
False-Negative Responses with the Performance of
Fully Automated Kinetic Perimetry (Program K) in
Virtual Patients
Shigeki Hashimoto, Chota Matsumoto, Sachiko
Okuyama, Sonoko Takada, Eiko Arimura,
Fumi Tanabe, Jens Paetzold, Ulrich Schiefer,
Yoshikazu Shimomura (Osaka-Sayama/J,
Tbingen/D)
P-SA-107
Bleb-related Infection after Filtering Surgery
Shinya Komori, Nobumichi Takahashi, Nobuhide
Hori, Akira Sawada, Kiyofumi Mochizuki, Tetsuya
Yamamoto (Gifu/J)
P-SA-108
Clinical features of hypoperfusion retinopathy
complicating neovascular glaucoma
P-SA-109
Clinical usefulness of CLOCK CHART for
detection of visual field abnormalities in patients
with glaucoma and macula diseases
Mariko Shoji, Chota Matsumoto, Sachiko
Okuyama, Sonoko Takada, Eiko Arimura,
Shigeki Hashimoto, Fumi Tanabe,
Yoshikazu Shimomura (Osaka Sayama/J)
P-SA-110
Color Doppler imaging correlations with
quantitative analysis of the optic disc in primary
open angle glaucoma.
Corina Tudor (Sibiu/RO)
P-SA-111
Comparing the effect of POAG serum on the
protein profiles of neuroretinal cells and human
trabecular meshwork cells
Katharina Bell, Gail Seigel, Lars Choritz, Norbert
Pfeiffer, Franz Grus (Mainz/D)
S
a
t
u
r
d
a
y
,

5

J
u
n
e
P
o
s
t
e
r
s
270
WOC
2010
Saturday, 5 June 2010 15:30 to 17:00
P-SA-129
Inter-Eye Symmetry of Corneal Biomechanical
Properties in Glaucomatous Eyes
Anthony Realini, Robert Weinreb
(Morgantown/USA, La Jolla/USA)
P-SA-130
New options for glaucoma therapy
Tomislav Ivandic, Boris Ivandic (Munich/D)
P-SA-131
Postural changes of intraocular pressure affect the
inter-eye difference both in visual field damage and
retinal nerve fiber layer thickness reduction in the
same patients with primary open-angle glaucoma.
Junji Mizokami, Kumiko Ishikawa, Maiko Naka,
Koji Hirai, Yuko Yamada, Makoto Nakamura,
Akira Negi (Hyogo/J)
P-SA-132
Quality of life (QOL) among patients with primary
open angle glaucoma (POAG)
Iman Fahmy, Manal H. Abu El Ela (Giza/ET)
P-SA-133
Reliability of ICare tonometer in different measure-
ment situations
Gombos Katalin, Kalman Reka, Zsarnoti Katalin
(Budapest/H)
P-SA-134
Risk Factors for Progression to Advanced Glaucoma
in Ghana
Andrew Francis, Michael Gyasi, Li Deng,
Haiyan Gong (Boston/USA)
P-SA-135
Role of functional single nucleotide polymorphisms
of MMP-1, MMP-2 and MMP-9 in open angle
glaucomas
Georg Mossbck, Martin Weger,
Christoph Faschinger, Christina Zimmermann,
Yosuf El-Shabrawi (Graz/A)
P-SA-136
Seasonal Isolates from Bacteria in Bleb Surface
of Eyes Trabeculectomized with Adjunctive
Mitomycin C
Nobumichi Takahashi, Shinya Komori, Toshihiko
Katada, Akira Sawada, Kiyofumi Mochizuki,
Tetsuya Yamamoto (Gifu/J)
P-SA-137
Selective Laser Trabeculoplasty: Hypotensive
Efficacy, Anterior Chamber Inflammation and
Postoperative Pain
Paolo Frezzotti, Ilaria Motolese, Sabrina Peruzzi,
Vincenzo Mittica, Pietro Mittica, Mario Fruschelli,
Eduardo Motolese (Siena/I)
P-SA-121
Effect of soft contact lens fitting on the non-
contact tonometry readings and corneal behavior
during tonometry observed by high speed camera
Yoshiaki Kiuchi, Joji Takenaka, Makoto Kaneko,
Kenji Yamada, Takumi Gosho (Hiroshima/J)
P-SA-122
Efficacy of Rho-kinase inhibition in reducing glial
reactivity and promoting retinal ganglion cell (RGC)
survival in vitro
Aysegl Tura, Karl-Ulrich Bartz-Schmidt, Sigrid
Henke-Fahle (Lbeck/D, Tbingen/D)
P-SA-123
Evaluation of peripheral anterior chamber depth
of fellow eyes of acute angle closure by Scanning
Peripheral Anterior Chmaber Depth Analyzer
Yoshikuni Arakaki, Ichiko Medoruma,
Michiko Yonahara, Eriko Tomoyose,
Yuko Nakamura, Hiroshi Sakai, Shoichi Sawaguchi
(Nishihara/J)
P-SA-124
Exudative retinal detachment in a child with
Sturge-Weber syndrome three years after
trabeculotomy for congenital glaucoma
Isabel Oberacher-Velten, Tina Dietrich,
Roman Regler, Horst Helbig (Regensburg/D)
P-SA-125
Glaucoma monitoring quality and its role in the
disease progression.
Oksana Vitovska (Kiev/UA)
P-SA-126
Glaucoma Short-term Progression Detected by
Retinal Thinning Assessed by Using Spectral-
Domain Optical Coherence Tomography
Satoshi Mori, Masanori Hangai, Noriko Nakano,
Masayuki Nukada, Hideo Nakanishi, Yuriko Kotera,
Hanako Ikeda, Hajime Nakamura, Nonaka Atsushi,
Nagahisa Yoshimura (Kyoto/J)
P-SA-127
How to Preserve Conjunctiva During Glaucoma
Surgery?
Jorge Topete-Jimenez (Guadalajara/MEX)
P-SA-128
In vitro evaluation of apoptic effects of single and
combined use of alpha tocopherol and current
antifibrotics, in human tenons fibroblast and
endothelium cells
Kaya N. Engin, Blent Yemi ci, Serap Erdem Kuruca,
Ugur Serbes, Gl zcan Arcan, Kadriye Akgn Dar,
Ebru Grel, Selim Kocabora, Beyza etin, Sabriye
Karadenizli (Istanbul/TR)
S
a
t
u
r
d
a
y
,

5

J
u
n
e
P
o
s
t
e
r
s
271
WOC
2010
Saturday, 5 June 2010 15:30 to 17:00
S
a
t
u
r
d
a
y
,

5

J
u
n
e
P
o
s
t
e
r
s
272
WOC
2010
P-SA-147
Color stimulator for electrophysiological investiga-
tions in the human eye
Dietmar Link, Sascha Klee, Bernd Ulrich Seifert,
Jens Haueisen (Ilmenau/D)
P-SA-148
Color-vision disturbances in patients with occlusive
arterial disease with or without coronary heart
disease
Carl Erb, Eva-Maria Fischer, Stefanie Lichtenberg
(Berlin/D)
P-SA-149
Comparison of visual field indices of flimmer
perimetry (Pulsar) with standard achromatic
perimetry (Octopus 311) in patients with cyclic
citrullinated peptide positive rheumatoid arthritis
(CCP-RA) in comparison to controls.
Katja Gbel, Carl Erb (Berlin/D)
P-SA-150
Contrast sensitivity, ocular higher-order aberration,
and corneal surface light scattering after instillation
of timolol maleate gel-forming solution and
brinzolamide ophthalmic suspension
Takahiro Hiraoka, Masakazu Daito, Fumiki
Okamoto, Takahiro Kiuchi, Tetsuro Oshika
(Tsukuba/J)
P-SA-151
Functional and hemodynamic parameters in
glaucoma patients with increased intraocular
pressure.
Elena Ponomareva, Armine Kazaryan,
Ludmila Martinova (Moscow/RUS)
P-SA-152
Functional estimates of inner retinal output and
corresponding measures of nerve fibre layer
thickness in healthy eyes
Ieva Sliesoraityte, Bogomil Voykov, Eric Trger,
Anne Kurtenbach, Eberhart Zrenner (Tbingen/D)
P-SA-153
Occult Macular Dystrophy case report
Dorota Pojda-Wilczek, Wanda Romaniuk
(Katowice/P)
P-SA-154
Optimization of electrode position in recording
multifocal visually evoked potential in Japanese
individuals
Kumiko Ishikawa, Junji Mizokami, Maiko Naka,
Koji Hirai, Yuko Yamada, Makoto Nakamura,
Akira Negi (Kobe/J)
P-SA-138
The different changes of anterior segment after
cataract surgery in normal eyes and eyes with
filtered primary angle closured glaucoma
Li Mei, Xing Liu, Dandan Wang, Ye Yang,
Yangfa Zeng, Jingjing Huang (Guangzhou/CN)
P-SA-139
The Impact of Glaucoma Stage on the Ocular
Biomechanics
Michael Haustein, Savvakis Hadjiraftis,
Lutz E. Pillunat, Eberhard Spoerl (Dresden/D)
P-SA-140
The Magnitude and Determinants of Intentional
and Non-Intentional Adherence to Glaucoma
Medication in Individuals with Glaucoma
Xue Ling Chong, Tin Aung, Gwyneth Rees,
Wan Ling Wong, Ecosse Lamoureux
(Singapore/SGP)
P-SA-141
The Prevalence of primary open-angle Glaucoma in
a Moroccan population: 1182 cases
Nawal Jennane, Tarik El Alloussi, Youssef Zekraoui,
Adil Megzari, Amina Berraho (Rabat/MA)
P-SA-142
Trabeculectomy with Amniotic Membrane
Transplantation in Refractory Glaucoma
Asaad Ghanem, Ihab Nafie, Hatem El-Awady,
Salah Mady (Mansoura/ET)
P-SA-143
Variability of serum oxidative stress indicators
according to biochemical datae and clinical
parameters of glaucoma
Kaya N. Engin, Blent Yemisci, Ulviye Yigit,
Ahmet Agahan, Cihan Cos kun (Istanbul/TR)
Physiological Optics/Psychophysics/ P05
Electrophysiology
P-SA-144
A New ERG Paradigm to Evoke S-cone Potentials
Andreas Schatz, Andre Messias, Robert Wilke,
P-SA-145
Application of a fundus-controlled color stimulator
for selective cone excitation
Sascha Klee, Dietmar Link, Patrick Bessler,
Jens Haueisen (Ilmenau/D)
P-SA-146
Blue-blocking filters are of minor effect on
retinal function as assessed with the multifocal
electroretinogram
Wolfgang Behrens-Baumann, Michael Hoffmann,
F. Spors, Achim Langenbucher , Sven Walter,
J. Reupsch, Arne Viestenz (Magdeburg/D,
Homburg/D)
Saturday, 5 June 2010 15:30 to 17:00
S
a
t
u
r
d
a
y
,

5

J
u
n
e
P
o
s
t
e
r
s
273
WOC
2010
P-SA-164
Comparison of Spectral-Domain Optical Coherence
Tomography and Fundus Autofluorescence in
Patients with Geographic Atrophy
Ramzi Gilbert Sayegh, Christian Simader, Ulrike
Scheschy, Alessio Montuoro, Christopher Kiss,
Stefan Sacu, David Kreil, Christian Prnte, Ursula
Schmidt-Erfurth (Vienna/A)
P-SA-165
Correlation between Visual Acuity and Spectral
Domain Optical Coherence Tomography Features
in Patients with Neovascular Age-related Macular
Degeneration
Sandra Liakopoulos, Tina Ristau, Pearse A. Keane,
Jared Updike, Alexander C. Walsh, Alicia Engin,
Steffen Hillebrand, Bernd Kirchhof, SriniVas R.
Sadda (Cologne/D, Los Angeles/USA)
P-SA-166
Detection of Esterified Cholesterol in Murine
Bruchs Membrane Wholemounts with a Novel
Cholesterol Dye
Marie Christine Dettbarn, Martin Rudolf,
Johannes Knobloch, Salvatore Grisanti (Lbeck/D)
P-SA-167
Development of a Novel Method to Detect Single
Nucleotide Polymorphism of Age-related Macu-
lopathy Susceptibility 2 (ARMS2) Gene for Clinical
Laboratories
Kenji Yamashiro, Norimoto Gotoh, Hideo
Nakanishi, Hisako Hayashi, Isao Nakata,
Akitaka Tsujikawa, Atsushi Otani, Hiroshi Tamura,
Sotaro Ooto, Nagahisa Yoshimura (Kyoto/J)
P-SA-168
Differential Role of TNF-alpha Receptors in the
development of choroidal neovascularization
Irina Semkova, Monika Jasielska, Xuan Shi, Kristina
Schmidt, Dimitrios Karagiannis, Jerzy Mackiewicz,
Norbert Kociok, Antonia M. Joussen
(Duesseldorf/D, Berlin/D)
P-SA-169
Do intravitreal ranibizumab injections for wet
age-related macular degeneration affect the vitreo-
macular interface?
Sreekanth Sreekantam (Birmingham/UK)
P-SA-170
Early effects of triamcinolone acetonide on matrix
metalloproteinases and endostatin in human
choroidal neovascularization
Olcay Tatar, Kei Shinoda, Edwin Kaiserling,
Gabor B. Scharioth, Grazia Pertile, Klaus Lucke,
Claus Eckardt, Tillmann Eckert, Silvia Bopp,
Bernd Kirchhof, Efdal Yoeruek, Salvatore Grisanti,
Karl Ulrich Bartz-Schmidt (Tbingen/D, Bremen/D,
Recklinghausen/D, Cologne/D, Lbeck/D, Tokyo/J)
P-SA-155
Phosphene Thresholds Elicited by Transcorneal
Electrical Stimulation in Healthy Subjects and
Patients with Retinal Diseases
Lubka Naycheva, Andreas Schatz, Tobias Rck,
Gabriel Willmann, Karl Ulrich Bartz-Schmidt,
Eberhart Zrenner, Florian Gekeler (Tbingen/D)
P-SA-156
Relationship between reading performance and
quality of a life in patients whith presbyopia
Maryna Shchadnykh, Olesya Zavoloka, Pavel
Bezditko, Darya Zubkova (Kharkiv/UA)
P-SA-157
The impact of individual Zernike coefficients on
retinal image quality a simulation study
Jens Bhren, Thomas Kohnen (Frankfurt/D)
Retina: AMD P06
P-SA-158
A computer-based documentation and data
management system of clinically relevant parame-
ters during repeated anti-VEGF injections
Carsten H. Meyer, Hans-Martin Helb, Frank G. Holz
(Bonn/D)
P-SA-159
Age-Related Macular Degeneration in Patients with
Nahoko Ogata, Tadanobu Yoshikawa, Tsuyoshi
Otsuji, Masato Matsuoka, Kayako Matsuyama,
Kanji Takahashi (Moriguchi/J)
P-SA-160
Changes of Ocular Hemodynamics in Patients
with Pathologicaltortuousity of the Internal Carotid
Artery
Sergey Avetisov, Tatyana Kiseleva, Sergey Vlasov,
Alexandr Gavrilenko, Andrey Kuklin,
Arsen Abramyan, Irina Omarganova (Moscow/RUS)
P-SA-161
Characterization of a spontanously immortalized
cell line derived from neovascular CNV membranes
(CNV-RPE)
Maria Magdalena Guichard, Christoph Ehlken,
Gottfried Martin, Hansjrgen Agostini (Freiburg/D)
P-SA-162
Clinical experiences with loading doses of anti-
VEGF Lucentis in the treatment of exsudative AMD
Markus Motschmann, A. Krappe, H.-W. Schlote,
T. Brosius, D. Kersten (Haldensleben/D)
P-SA-163
Comparison of intravitreal bevacizumab alone ver-
sus combined with photodynamic therapy for small
CNV lesions of age-related macular degeneration
Mihoko Suzuki, Fumi Gomi, Miki Sawa, Motokazu
Tsujikawa (Suita/J)
Saturday, 5 June 2010 15:30 to 17:00
P-SA-180
Inner Segment-Outer Segment Junctional Layer
Integrity and Corresponding Retinal Sensitivity
in Dry and Wet forms of Age-Related Macular
Degeneration
Gennady Landa, Richard Rosen, Emily Su,
Patricia Garcia, William Seiple, Alfonso Ponce,
Jeanne Rosenthal, Ronald Gentile, Thomas
Muldoon, Joseph Walsh (New York/USA)
P-SA-181
Intravitreal Bevacizumab (Avastin) Treatment for
Neovascular Age-related Macular Degeneration:
Twelve-Month Results
Andrius Cimbalas, Ausra Liveikiene, Rasa
Sirtautiene, Kristina Kuoliene, Rimvydas Asoklis
(Vilnius/LT)
P-SA-182
Intravitreal injection of tyrosine kinase inhibitor
PTK787 reduces the size of laser-induced
chorioretinal neovascularisation in a mouse model
Anne Wiermann, Birthe Meyer-Rsenberg,
Sebastian Bigdon, Gisbert Richard, Oliver Zeitz,
Michelle Berna (Munich/D, Hamburg/D)
P-SA-183
Intravitreal ranibizumab therapy for exudative
age-related macular degeneration (AMD) affects
the retinal autoimmunity.
Agnieszka Kubicka-Trza ska, Izabella Karska-Basta,
Krzysztof Morawski, Boz ena Romanowska-Dixon
(Krakw/PL)
P-SA-184
Late Outgrowth Endothelial Progenitor Cells in
Patients with neovascular AMD and effect of
Lucentis treatment
Michelle Berna-Thill, Rebecca Grierson, Frank
Kunst, Nina Krger, Birthe Meyer-Rsenberg,
Anne Wiermann, Marc Jean Berna, Gisbert Richard
(Hamburg/D)
P-SA-185
Mecamylamine reduces the size of laser induced
CNV in a mouse model and inhibits VEGFR-2
phosphorylation in vitro
Birthe Meyer-Rsenberg, Anne Wiermann,
Sebastian Bigdon, Nina Krger, Frank Kunst,
Rebecca Grierson, Christos Skevas, Gisbert Richard,
Marc J. Berna, Oliver Zeitz, Michelle Thill
(Hamburg/D)
P-SA-186
Morphological and functional response of the
retinal pigment epithelium (RPE) after selective
retina therapy (SRT) in cultivated porcine RPE-
choroid explants
Felix Treumer, Yoko Miura, Johannes Baltz, Alexa
Klettner, Ralf Brinkmann, Reginald Birngruber,
Johann Roider, Jost Hillenkamp (Kiel/D)
P-SA-171
Effect of Atorvastatin and Aspirin on the threshold
retinal sensitivity in patients with nonexudative
Maryna Karliychuk (Chernivtsi/UA)
P-SA-172
Evaluation of Safety for Bilateral Same-day
Intravitreal Injections of Anti-Vascular Endothelial
Growth Factor Therapy
Luiz H. Lima (New York/USA)
P-SA-173
Filtering blue light reduces light-induced oxidative
stress, senescence, and accumulation of extracellu-
lar matrix oroteins in human RPE cells
Marcus Kernt, Raffael Liegl, Katja Obholzer,
Renate Scheler, Axel Walch, Aljoscha Neubauer,
Kirsten Eibl, Armin Wolf, Michael Ulbig,
Arndt Gandorfer, Anselm Kampik (Munich/D)
P-SA-174
Fixation site and scotoma size in patients with
retinal pigment epithelium tears after Ranibizumab
treatment
Katja Christina Schielke, Tomas Ilginis (Aalborg/DK)
P-SA-175
Focal Macular Electroretinograms after
Photodynamic Therapy Combined with Intravitreal
Bevacizumab
Kohei Ishikawa, Shinsuke Ozawa, Yasuki Ito,
Mineo Kondo, Hiroko Terasaki (Nagoya/J)
P-SA-176
Geographic Atrophy in AMD: Junctional Zone
Classified by High-resolution Spectral Domain OCT
Imaging
Monika Fleckenstein, Steffen Schmitz-Valckenberg,
Christian K. Brinkmann, Robert P. Finger,
Peter Charbel Issa, Frank G. Holz (Bonn/D)
P-SA-177
High resolution in vivo and in vitro imaging of
human RPE cells using structured illumination
microscopy
Thomas Ach, Gerrit Best, Mira Ruppenstein,
Christoph Cremer, Stefan Dithmar (Heidelberg/D)
P-SA-178
Induction of the Angiopoietin/Tie System by
oxidative Stress and Light
Armin Wolf, Marcus Kernt, Wolfgang Mayer,
Anselm Kampik, Claudia Priglinger-Alge (Munich/D)
P-SA-179
Influence of vitreous on anti-VEGF therapy in
patients with CNV secondary to AMD in the excite
study
Ulrike Sponer (Vienna/A)
S
a
t
u
r
d
a
y
,

5

J
u
n
e
P
o
s
t
e
r
s
274
WOC
2010
Saturday, 5 June 2010 15:30 to 17:00
P-SA-196
Quantification of the therapeutic response of
intraretinal, subretinal and subpigmentepithelial
compartments in exudative AMD during
antiangiogenic therapy
Isabelle Golbaz, Christian Ahlers, Christopher
Schtze, Sabine Schriefl, Ferdinand Schlanitz,
Christian Simader, Christian Prnte,
Ursula Schmidt-Erfurth (Vienna/A, Binningen/CH)
P-SA-197
Screening for patient eligibility using fundus auto-
fluorescence in a randomized interventional clinical
trial for geographic atrophy secondary to age-
related macular degeneration
Christian Karl Brinkmann, Steffen Schmitz-
Valckenberg, Monika Fleckenstein, Nina Stratmann,
Florian Alten, Glenn J. Jaffe, Thomas C. Hohman,
P-SA-198
SDOCT and angiography related prognostic factors
for visual acuity outcome after Ranibizumab in
patients with neovascular AMD
Tina Ristau, Dzenita Smailhodzic, Steffen
Hillebrand, Jared Updike, Alexander C. Walsh,
Bernd Kirchhof, SriniVas R. Sadda, Sandra
Liakopoulos (Cologne/D, Los Angeles/USA)
P-SA-199
Serum Uric Acid Levels and its Association With
Age-Related Macular Degeneration (ARMD)
Siddharth Subramani, Sim Ee Khor, Bethel Indira
Livingstone, Utkarsh V. Kulkarni (Aberdeen/UK)
P-SA-200
Short-term progression of neovascular AMD
Marion Munk, Christopher Kiss, Florian Sulzbacher,
Stefan Eisenkoelbl, Wolfgang Huf, Ursula Schmidt-
Erfurth (Vienna/A)
P-SA-201
Short-term Intraocular Pressure Changes
Immediately After Intravitreal Injections of
Bevacizumab for Neovascular Age-related Macular
Degeneration
Guoge Han, Junyi Wang, Changzheng Chen,
Yiqiao Xing, An Huai Yang (Wuhan/CN)
P-SA-202
Sorafenib Reduces Expression of VEGF-Receptor 1/2
and Prevents Human Retinal Pigment Epithelium
Cells from Light-Induced Over-Expression of VEGF
Marcus Kernt, Raffael Liegl, Christoph Hirneiss,
Aljoscha Neubauer, Claudia Alge-Priglinger,
Kirsten Eibl, Carl-Arnold Lackerbauer, Michael
Ulbig, Anselm Kampik, Armin Wolf (Munich/D)
P-SA-187
Morphometry of Cell Phenomena in Histological
Sections of Geographic Atrophy due to Age-related
Macular Degeneration
Joshua Torrent Despouy, Anna Wagner, Salvatore
Grisanti, Susan Vogt, Russell Read, Christine Curcio,
Martin Rudolf (Lbeck/D)
P-SA-188
Natural course of pigment epithelium detachment
(PED) during induction treatment with Anti-VEGF
therapy for neovascular age-related macular
degeneration
Johann Rping, Nicole Eter, Christos Haritoglou,
Anselm Kampik, Armin Wolf (Munich/D)
P-SA-189
New insights of the underestimated impairment of
quality of life in age-related macular degeneration
a review of the literature
Birthe Meyer-Rsenberg, Gisbert Richard
(Hamburg/D)
P-SA-190
Non-responders to ranibizumab in the treatment of
neovascular age-related macular degeneration
Christina Kramann, Katrin Lorenz, Isabella Zwiener,
Bernhard Stoffelns, Norbert Pfeiffer (Mainz/D)
P-SA-191
One year results of prospective, multi-center study
of photodynamic therapy for polypoidal choroidal
vasculopathy
Tomohiro Iida, Ophthalmic PDT study group
(Fukushima/J)
P-SA-192
Oxidative DNA damage in patients with age-related
Orhan Ates, Osman Ceylan, Hamit Alp, Sedat Azizi,
Bekir Ondas (Erzurum/TR)
P-SA-193
Peripheral Exudative Hemorrhagic Chorioretino -
pathy
Guido Krzinger, Gabriele E. Lang (Ulm/D)
P-SA-194
Peripheral Fundus Autofluorescence is increased in
AMD
Tamer Wasfy, Carolin Fischer, Johann Rping,
Armin Wolf, Michael Ulbig, Anselm Kampik,
Marcus Kernt (Munich/D)
P-SA-195
Pigment epithelial detachments in AMD evaluated
by spectral domain OCT, near-infrared reflectance,
fluorescein and indocyanine green angiography
Christoph Clemens, Carolin Milojcic, Frank G. Holz,
S
a
t
u
r
d
a
y
,

5

J
u
n
e
P
o
s
t
e
r
s
275
WOC
2010
Saturday, 5 June 2010 15:30 to 17:00
S
a
t
u
r
d
a
y
,

5

J
u
n
e
P
o
s
t
e
r
s
276
WOC
2010
P-SA-211
Twelve-month Safety and Visual Acuity Outcome
of a Pilot Study Exploring Ranibizumab Combined
with Proton Beam Irradiation as Treatment for
Exudative Age-Related Macular Degeneration
Susanna Park, Inder Daftari, Theodore Phillips,
Lawrence Morse (Sacramento/USA)
P-SA-212
Verteporfin photodynamic therapy in combination
with anti-VEGF ranibizumab therapy in AMD
patients: Second year outcomes in the MONT
BLANC study
Paolo Lanzetta, on behalf of the MONT BLANC
study group (Udine/I)
P-SA-213
Vision related quality of life after intravitreal
injection of Anti-VEGF is "better" really "better"?
Daniela Claessens, Bernd Kirchhof (Cologne/D)
P-SA-214
Visual Acuity and Fixation Correlation in Age-
related Macular Degeneration
Albert Caramoy, Sabine Schrder, Jonathan
Foerster, Sascha Fauser, Bernd Kirchhof (Cologne/D)
Strabismus P07
P-SA-215
A case of superior oblique palsy caused by endo-
scopic paranasal sinus surgery
Takashi Negishi, Akiko Hikoya, Yoko Tsuchiya,
Mayu Sawada, Yoshihiro Hotta, Miho Sato
(Hamamatsu/J)
P-SA-216
Alerted Functional Connectivity of Primary Visual
Cortex in Adult Comitant Strabismus using resting-
functional MRI
Xiaohe Yan, Xiaoming Lin, Yuan Zhou, Lijuan Xu,
Tianzi Jiang, Yingming Chen, Shaojie Song
(Munich/D)
P-SA-217
Characteristics and Outcomes of Inferior Rectus
Recession under Topical Anesthesia in Thyroid
Myopathy using Absorbable versus Non-Absorbable
Sutures.
Ingrid Franco, Sonal Farzavandi, Seah Lay Leng,
Choo Chai Teck, Chee Soon Phaik (Singapore/SGP)
P-SA-218
Clinical study of the binocular visual function in
strabismus patients between before and after
strabismus surgery
Fang Zhang (Wenzhou/CN)
P-SA-219
Clinical usefulness and the accuracy of Distance
Krimsky method for the distance deviation
measurement
Kwang Sic Joo, Nam Ju Moon (Seoul/ROK)
P-SA-203
The analysis of the NEI-VFQ-25 as an Evaluation
Tool for the Quality of Life of Russian Patients with
Age-Related Macular Degeneration.
Alla Lisochkina, Yury Astakhov, Nina Vanchakova,
Pavel Nechiporenko, Tatyana Kuznetsova
P-SA-204
The assessment of matrix metalloproteinases 3
gene 5A/6A (-1171) polymorphism in age-related
Rasa Liutkeviciene, Giedre Sinkunaite, Sandrita
Simonyte, Abdonas Tamosiunas, Dalia Zaliuniene,
Vytautas Jasinskas, Olivija Gustiene,
Vaida Mizariene, Diana Zaliaduonyte-Peksiene,
Vaiva Lesauskaite (Kaunas/LT)
P-SA-205
The Effect of Oxidative Stress on Components of
the Endothelial Glycocalyx
Armin Wolf, Marcus Kernt, Mathias Jacob, Kirsten
Eibl, Anselm Kampik, Claudia Alge-Priglinger
(Munich/D)
P-SA-206
The influence of vitreomacular adhesion on efficacy
of treatment of neovascular age-related macular
degeneration with intravitreal bevacizumab
injections
Mojca Urbancic, Polona Jaki Mekjavic, Aleksandra
Kraut, Mojca Globocnik Petrovic (Ljubljana/SI)
P-SA-207
The Influence of Vitreomacular Interaction on the
Development of Exudative Age-Related Macular
Degeneration: 4-Year-Results of a Longitudinal
Study
Sebastian Waldstein, Ulrike Sponer, Christian
Simader, Stefan Sacu, Ursula Schmidt-Erfurth (Vi-
enna/A)
P-SA-208
The macular mapping test as tool for vision
assessment and monitoring of anti-VEGF therapy in
patients with NV-AMD
Nikolaus Feucht, Werner Eisenbarth, Christian
Enders, Manfred MacKeben, Mathias Maier
(Munich/D)
P-SA-209
The progression rate of wet age-related
macular degeneration after inicial treatment with
bevacizumab
Liga Radecka, Guna Laganovska (Riga/LV)
P-SA-210
The structural changes in the central retina in
patients with age-related macular degeneration.
Ganna Kruglova, Pavel Bezdetko (Kharkov/UA)
Saturday, 5 June 2010 15:30 to 17:00
S
a
t
u
r
d
a
y
,

5

J
u
n
e
P
o
s
t
e
r
s
277
WOC
2010
P-SA-231
Transposition of the Inferior Oblique under Inferior
Rectus Insertion for Treating Patients with Double
Elevator Palsy
Lejin Wang, Juan Bu, Jing Li, Yanlei Jia, Mei Sun
(Beijing/CN)
Uveitis/Intraocular Inflammation, P08
Microbiology/Immunology
P-SA-232
A culture independent metagenomic analysis of
contact lens storage case
Hiroshi Eguchi, Tomomi Kuwahara, Tatsuro
Miyamoto (Tokushima/J)
P-SA-233
Advantages of 55 degree lens in compare with
30 degree lens in Wide-Angle Imaging in HRA2-
Spectral OCT and Angiograph in 10 uveitis patients
Undine Simmet, Mathias Maier, Chris Patrick
Lohmann, Nikolaus Feucht (Munich/D)
P-SA-234
Anti Tumor Necrosis Factor Monoclonal Antibodies
(Infliximab) in Treatment of Behcets Disease
Maja Zivkovic (Nis/SRB)
P-SA-235
Antiendotoxin immunity in patients with HLA-B27
associated endogenous anterior uveitis
Ganna Kopayenko, Gennadiy Zhaboedov,
Nanuli Ivanova (Simferopol/UA)
P-SA-236
Causes of visual loss in Uveitis in the 21st century.
Paul Muambi B. Kabasele, S. R. Taylor, J. Singh,
C. Hooper, Susan Lightman (London/UK)
P-SA-237
Changes in the Eyes in Patients with Juvenile
Rheumatoid Arthritis
Marko Zlatanovic (Nis/SRB)
P-SA-239
CMV-Retinitis: A review of treatment procedures
between 1996 and 2009
Claudia Metz, Eva Biewald, Bernhard Jurklies,
P-SA-240
Common sense to prevent endophthalmitis
Albert Galand (Neupr/B)
P-SA-241
Commparison of three methods of imaging the
central retina in chronic uveitis patients: Stratus
OCT, Spectralis OCT and HRT retina modul
Eva Jakob, Alexander Scheuerle, Stephan Schulz,
P-SA-220
Congenital - infantile esotropia vs. refractive errors
Branko Stankov, Milorad Ljutica, Radovan Stojkovic,
Darko Bubalo, Vinko Regoda (Beograd/SRB)
P-SA-221
Disruption of white matter tract integrity in adult
comitant strabismus: A diffusion tensor imaging
study.
Xiaohe Yan, Xiaoming Lin, Qifeng Wang,
Tianzi Jiang, Yingming Chen (Munich/D)
P-SA-222
Influence of Intermuscular Septum on Eye
Movement
Fumiko Kishimoto, Hiroshi Ohtsuki (Ibara/J)
P-SA-223
Intended Undercorrection in Surgical Management
on Adult Intermittent Exotropia
Apatsa Lekskul, Apatsa Lekskul (Bangkok/T)
P-SA-224
Interocular suppression and visual acuity
development during occlusion therapy of
amblyopic patients aged between 5 and 16 years
Stephan Kmmerling, Iris Bachert, Julia Kracht,
Marc Lchtenberg, Maria Fronius (Frankfurt/D)
P-SA-225
Intracystic 70% isopropyl alcohol injection for post
operative conjunctival inclusion cysts.
Mihir Kothari (Mumbai/IND)
P-SA-226
Mechanisms of binocular fusion in patients with
superior oblique paresis
Kristina Irsch, David Guyton, Murilo Roggia,
Pittaya Phamonvaechavan, Howard Ying
(Baltimore/USA)
P-SA-228
Stereoacuity before and after neutral zone shifting
in congenital nystagmus with vertical compensatory
head posture
Wei Zhang (Tianjin/CN)
P-SA-229
Strabismus in pathologic myopes
Manabu Mochizuki, Kyoko Ohno-Matsui, Akiko
Tanaka, Yuko Shibata, Muka Moriyama, Kengo
Hayashi, Takashi Tokoro, Makiko Yamashita, Noriaki
Shimada (Tokyo/J)
P-SA-230
The role of inferior oblique myectomy in improving
ocular nystagmus
Momen Moustafa (Cairo/ET)
Saturday, 5 June 2010 15:30 to 17:00
P-SA-251
Inflammatory cytokine responses to tuberculin and
retinal autoantigens in vitro from a patient with
Bacillus Calmette-Gurin-induced uveitis
Aylin Garip, Maria Diedrichs-Mhring, Cornelia
Deeg, Stephan Thurau, Gerhild Wildner (Munich/D)
P-SA-252
Interleukin-18 gene polymorphisms in Chinese
patients with Vogt Koyanagi Harada disease
Timothy Lai, Pancy Tam, Chenghong Lan,
Sylvia Chiang, Carmen Chan, Chi-Pui Pang,
Dennis Lam (Kowloon/HK)
P-SA-253
Intravitreal rituximab for primary intraocular
lymphoma
Ermioni Panidou, Rainer Guthoff, M. Griebel
(Wuerzburg/D)
P-SA-254
Long-term results of therapy with mycophenolate
mofetil in non-infectious uveitis
Deshka Doycheva, Christoph Deuter, Nicole
Stuebiger, Manfred Zierhut (Tbingen/D)
P-SA-255
Monitoring uveitis patients with the digital 200-
widefield-angiography system Optomapfa
Eva Jakob, Bianca Dobner, Christian Kahlert,
P-SA-256
Necrotizing sarcoid granulomatosis: oular
manifestation in three children
Claudia Schumacher, Anne Lohr, Martin Roesel,
Norbert Wagner, Arnd Heiligenhaus (Mnster/D)
P-SA-257
Nuclear factor- B inhibitor, dehydroxy methyl
epoxyquinomicin, ameliorates experimental
autoimmune uveoreitnitis in mice
Daiju Iwata (Sapporo/J)
P-SA-258
Ocular cysticercosis a pediatric clinical report
Gil Calvo-Santos, Joel Ferreira,
Jos Guilherme-Monteiro, Jos Salgado-Borges
(So Mamede de Infesta/P)
P-SA-259
One and a half blind eye in a tuberculosis patient:
a case review
Rona A. Nasaruddin, Wan Haslina Wah,
Ropilah Abdul Rahman, Ropilah Abdul Rahman
(Kuala Lumpur/MAL)
P-SA-260
Outcome of phacoemulsification for uveitic cataract
in Vogt-Koyanagi Harada (VKH) disease
Victoria Wong, Rose Chan, Carmen Chan,
Timothy Lai (Kowloon/HK)
P-SA-242
Depigmentation of peripapillary crescent in Vogt-
Koyanagi-Harada disease
Yumiko Yamaguchi, Tomohiro Otani, Shoji Kishi
(Maebashi/J)
P-SA-243
Elevated levels of heparin binding epidermal
growth factor-like growth factor in aqueous humor
of patients with acute anterior uveitis
Salvador Garcia-Delpech, Stephanie Rohrweck,
David Salom, Patricia Udaondo, Maria Jesus
Lopez-Prats, Manuel Diaz-Llopis (Valencia/E)
P-SA-244
Endogenous Candida Endophthalmitis: Outcomes
from Early Vitrectomy
Lavnish Joshi, Ahmed Sallam, Aldrin Khan,
Peter McCluskey, William A Lynn, Kiran Manku,
Sue Lightman (London/UK)
P-SA-245
Endophthalmitis Caused by Pseudomonas
aeruginosa in Taiwan
Kuan-Jen Chen, Ming-Hui Sun (Taoyuan/TJ)
P-SA-246
Episcleral osseous lesion
Melanie Jger, Birgit Lorenz (Giessen/D)
P-SA-247
Expression of toll like receptors in Behets
disease with refractory uveitis following infliximab
treatment
Takeshi Kezuka, Masaru Takeuchi, Naoyuki
Yamakawa, Yoko Okunuki, Yoshihiko Usui,
Jun-ichi Sakai, Hiroshi Goto (Tokyo/J)
P-SA-248
Favourable outcome after cataract surgery with
IOL implantation in selected JIA associated uveitis
patients
Rafael Grajewski, Beatrix Zurek-Imhoff,
Martin Roesel, Carsten Heinz, Arnd Heiligenhaus
(Cologne/D, Mnster/D)
P-SA-249
Fuchs Heterochromic Uveitis: a Review of 27 Cases
Jenzeri Salah, Jelliti Bechir, Attia Sonia, Haj Taher
Olfa, Zouid Sonia, Moncef Khairallah (Monastir/TN)
P-SA-250
Indocyanine Green Angiography in Acute Vogt
Koyanagi Harada Disease: Signs at Presentation and
their Evolution under Treatment
Kahloun Rym, Hasnaoui Wafa, Gargouri Salma,
Zaouali Sonia, Ben Yahia Salim, Moncef Khairallah
(Monastir/TN)
S
a
t
u
r
d
a
y
,

5

J
u
n
e
P
o
s
t
e
r
s
278
WOC
2010
Saturday, 5 June 2010 15:30 to 17:00
P-SA-271
Spectral Domain Optical Coherence Tomography
(SD-OCT) and time domain (TD) in Toxoplasmic
Retinochoroiditis
Bruno Diniz, Mariann Midori Yabiku, Carlos
Alexandre Garcia Filho, Rafael Ernane Andrade,
Rubens Belfort Jr (So Paulo/BR)
P-SA-272
Spectrum of Ocular Tuberculosis in Selayang
Hospital
Hanizasurana Hashim, Shelina Oli Mohamed,
Roslin Azni Aziz, Tara Mary George, Nor Fariza
Ngah (Kuala Lumpur/MAL)
P-SA-273
Spontaneous fungal endophthalmitis in healthy
man
Keembiyage Dayawansa, Jayantha Edirisooriya
(Kandy/CL)
P-SA-274
Subthreshold Micropulse Diode Laser Treatment for
Uveitic Macular Edema
Bruno Diniz, Carolina Pelegrini Barbosa,
Daniel Lavinsky, Tiago Arantes, Rubens Belfort Jr.
(So Paulo/BR)
P-SA-275
Successful Treatment of Acute Annular Outer
Retinopathy with Combination of Oral Ciclosporin
A and Prednisolone
Nor' Ain Mohd Rawi, Othmaliza Othman, Wan
Haslina Wan Abdul Halim, Che Muhaya Mohamad
(Kuala Lumpur/MAL)
P-SA-276
Susceptibility trends of Staphylococcus epidermidis
and Staphylococcus aureus ocular isolates A four
year study.
Evgenia Kanonidou, Christina Kanonidou,
Anna Praidou, Vasilios Konidaris, Paraskevi Zotta,
Irini Chatziralli, Nikolas Ziakas (Thessaloniki/GR)
P-SA-277
Sympathetic ophthalmia following pars plana
vitrectomy
Regine Augsten, Bernhard Thei, Jens Dawczynski,
Ulrich Voigt, Ekkehart Knigsdrffer (Jena/D)
P-SA-278
The Immunohistological Comparison of Vitreous
Body Injection in both Autologous and Homolo-
gous Forms with Hyalgan in Rabbits Knee Jionts
Mahnaz Mosallaei, Negar Azarpira, Morsal Mehriar
(Shiraz/IR)
P-SA-279
The Value of Real-time PCR in Cytomegalovirus-
associated anterior segment inflammation
Michiko Kandori, Keiko Yakura, Naoki Komatsu,
Chizu Touge, Yoshifumi Ikeda, Dai Miyazaki,
Yoshitsugu Inoue (Yonago/J)
P-SA-261
Patient with previously undiagnosed Autoimmune
Hypophysistis (AH) presenting with bilateral
recurrent cystoid macular oedema (CMO)
secondary to Intermediate uveitis
Venkat Kotamarthi, Muhammad Amjad,
Arun Sachdev (Manchester/UK)
P-SA-262
Preoperative treatment of posttraumatic
endophthalmitis
Dauletbekov Daniyar, Daniyar Dauletbekov
(Almaty/KZ)
P-SA-263
Primary intraocular lymphoma, a diagnostic
challenge. Case report
Claudia Zorn, Alexander Erben, Eva Glaser, Mathias
Maier, Chris Patrick Lohmann, Elen Bschlepp,
Uwe Pleyer, Korinna Jhrens (Munich/D)
P-SA-264
Prognostic factors and Outcomes in Endogenous
Klebsiella pneumoniae Endophthalmitis
Marcus Ang, Aliza Jap, Soon-Phaik Chee
(Singapore/SGP)
P-SA-265
Rat-to-human transmission of cowpox infection
with membraneous conjunctivitis
Silke Brx, H. Kramp, H. Teutloff, M. Knorr,
F. Hessler (Kalkar/D)
P-SA-266
Reemergence of ocular syphilis two atypical cases
of ocular syphilis
Diamar Pardo-Lpez, Ana Marina Suelves-Cogollos,
Stephanie Rorhweck, Ruth Lpez-Lizcano, Salvador
Garca-Delpech, Manuel Daz-Llopis (Valencia/E)
P-SA-267
Retinal Pigment Epithelium Layer Changes in Vogt-
Koyanagi-Harada Disease Using Scanning Laser
Ophthalmoscopy Indirect Viewing
Satoshi Ishiko, Reiko Kinouchi, Eiichi Sato,
Yuji Kato, Akitoshi Yoshida (Asahikawa/J)
P-SA-268
Rituximab in the treatment of refractory ophthalmic
Wegeners Granulomatosis
Simon Taylor, Lavnish Joshi, Alan Salama, Charles
Pusey, Sue Lightman (London/UK)
P-SA-269
Scleritis necrotizing: A case Report about a patient
with Wegener granulomatosis
Graciela Graneros (San Miguel de Tucuman/RA)
P-SA-270
Serous Retinal Detachment Secondary to Acute
Toxoplasmic Retinochoroiditis.
Gargouri Selma, Zaouali Sonia, Ammari Wafa,
Jelliti Bechir, Messaoud Riadh, Moncef Khairallah
(Monastir/TN)
S
a
t
u
r
d
a
y
,

5

J
u
n
e
P
o
s
t
e
r
s
279
WOC
2010
Sunday, 6 June 2010 15:30 - 17:00 Saturday, 5 June 2010 15:30 to 17:00
P-SA-280
Transeptal Triamcinolone Injection In The Manage-
ment of Non-Infectious Uveitis
Harvey Uy (Makati City/RP)
P-SA-281
Visual loss in Behets disease.
Jasmin Singh, Simon Taylor, Miles Stanford, Susan
Lightman (London/UK)
P-SA-282
Vogt-Koyanagi-Harada disease simulating acute
posterior multifocal placoid pigment epitheliopathy
Noriko Nishikawa, Reiko Kinouchi, Satoshi Ishiko,
Akitoshi Yoshida (Asahikawa/J)
S
a
t
u
r
d
a
y
,

5

J
u
n
e
P
o
s
t
e
r
s
280
WOC
2010
Poster exhibition of Poster P-SU-001 to P-SU-277.
15.30 to 17.00 hrs.
Moderation Poster sessions on Sunday
Chairs:
Alexander A. Bialasiewicz (Doha)
Antonia M. Joussen (Berlin)
Co-Chairs:
Oliver Ehrt (Munich)
Anselm G. M. Jnemann (Erlangen)
Franz H. Grus (Mainz)
Carsten H. Meyer (Bonn)
Susanne Pitz (Mainz)
Susanne Butros (Ulm)
Philip Maier (Freiburg)
Jrgen Kampmeier (Ulm)
Claus Cursiefen (Erlangen)
Anatomy/Pathology P09
P-SU-001
Adenoid cystic carcinoma of the inferior medial
eyelid.
Anima Buehler (Freiburg/D)
P-SU-002
Aspects regarding the arterial vascularization of the
optic nerve
Carmen Bolintineanu, Sorin Bolintineanu,
Alina Sisu, Izabella Sargan, Loredana Stana,
Luminioara Rosu (Timisoara/RO)
P-SU-003
Biometrics: Anatomy of the human eye
Hector Barajas (Mexico City/MEX)
P-SU-004
Central Corneal Thickness, Lamina Cribrosa and
Peripapillary Scleral Histomorphometry in Chinese
Eyes
Ruojin Ren (Beijing/CN)
P-SU-005
Computed tomographic diagnosis in the tumoral
pathology of orbits
Carmen Bolintineanu, Sorin Bolintineanu,
Monica Vaida, Elena Pop, Corina Matu,
Iulia Ciobanu (Timisoara/RO)
P-SU-006
Lens artifacts in human fetal eyes
Martina C. Herwig, Annette M. Mller,
Frank G. Holz, Karin U. Loeffler (Bonn/D)
P-SU-007
Mixed lid tumour with an anusual high fraction of
lipomatous tissue
Sylvia Stadler, Claudia Auw-Hdrich (Freiburg/D)
Sunday, 6 June 2010 15:30 - 17:00
P
o
s
t
e
r
s
281
WOC
2010
S
u
n
d
a
y
,

6

J
u
n
e
P-SU-018
The Redwing-D Knowledgebase: Comprehensive
Patent Informatics for Ocular Drugs and Diagnostics
from 1970 Onward
Hermann Mucke, Eva Mucke, Peter M. Mucke (Vi-
enna/A)
Conjunctiva/Contact Lenses P11
P-SU-020
A novel usage of pterygium tissue as an autologous
graft in treating necrotising scleritis
Othmaliza Othman, Norshamsiah Md Din,
Howe Sen Kok (Kuala Lumpur/MAL)
P-SU-021
Contact lens dry eye: new therapeutic approach.
Lorenzo Mannucci (Padova/I)
P-SU-022
Decreased bioavilability of thioredoxin may
contribute to oxidative stress in the lens of diabetes
Marjorie Lou (Lincoln/USA)
P-SU-023
Development and antigen-related modulation of
conjunctiva-associated lymphoid tissue (CALT)
Sebastian Siebelmann, Uta Gehlsen, Salvatore
Grisanti, Maya Mueller, Philipp Steven (Lbeck/D)
P-SU-024
Doxycycline Effect in the Cytokine Profile and in
the Pro/Anti-apoptotic proteins in pterygia derived
cells
Miguel Angel Vazquez Membrillo, Araceli Rojas-
Diaz, Ximena Mira-Lorenzo, Atzin Robles-
Contreras, Iliana Pealoza-Roman, Ellery Lopez-Star,
Teresa Valdez-Gonzalez, Francisco Martinez-Castro,
Maria del Carmen Jimenez-Martinez, Victor Manuel
Bautista De Lucio (Edo Mex/MEX)
P-SU-025
Effect of Pterygium Surgery on Corneal Topography
Banu Torun Acar, Suphi Acar (Istanbul/TR)
P-SU-026
Effects of chemical disinfection contact lens care
solutions on Acathamoeaba castellani
Jacek P. Szaflik, Lidia Chomicz, Gabriela Oledzka,
Jerzy Szaflik (Warszawa/PL)
P-SU-027
Extensive Conjunctival Lymphangioma. A case
report.
Markus van Son, Magdalena Sara Tnz, Stephan
Michels, Bernhard Schuknecht, Stephan Estermann
(Zurich/CH)
P-SU-028
Fitting contact lenses in childhood
Beata Kettesy, Annamria Nagy, Andrs Berta
(Debrecen/H)
P-SU-008
The eye: Atlas of anatomical history
Hector Barajas (Mexico City/MEX)
P-SU-009
The spectrum of histopathological diagnoses in
non-infectious orbital inflammation.
Hazlita Isa, L. T. Tan, S. R. J. Taylor, P. J. Luthert,
Biochemistry/Pharmacology P10
P-SU-010
An Analysis of Corneal Anesthesia Data from
Patents Reveals Information Not Represented in the
Peer Review Literature
Hermann Mucke, Eva Mucke, Peter M. Mucke (Vi-
enna/A)
P-SU-011
Biochemical analysis of indocyanine green and
infracyanine green solutions: pH, anions, osmo-
larity, precipitation and decomposition products
Eduardo Rodrigues, Fernando Marcondes Penha,
Elaine de Paula Fiod Costa, Mauricio Maia, Carsten
H. Meyer, Michel Eid Farah (Florianopolis/BR,
Bonn/D)
P-SU-012
Detection of CXCR4 and CXCR7 at the ocular
surface and in the lacrimal apparatus
Julia Dieckow, Ute Schulze, Friedrich Paulsen
(Halle/D)
P-SU-013
Different Effects of PDGF and TGF-beta on
fibroblast contractility and cell morphology
Tobias Meyer-ter-Vehn (Wuerzburg/D)
P-SU-014
Glucocorticoid-induced changes of Na+,
K+-ATPase in lens: effect by a glucocorticoid
receptor antagonist
Guoli Xie, Hong Yan (Xi'an/CN)
P-SU-015
Increased Oxidative DNA damage and Lipid
Peroxidation in Cultured Orbital Fibroblasts from
Patients with Graves Ophthalmopathy
Chieh-Chih Tsai, Hui-Chuan Kau, Shu-Ching Kao,
Shu-Mei Lee (Taipei/TJ)
P-SU-016
Metabonomics in ophthalmology
Anna Midelfart (Trondheim/N)
P-SU-017
The Effects of Prostaglandin Analogues on
intracellular Ca2+ concentrations in EP-Receptor-
Deficient Mice Ciliary Arteries
Sanae Abe (Akita/J)
Sunday, 6 June 2010 15:30 - 17:00
Cornea/Eye Bank: Basics P12
P-SU-037
Anisotropic Swelling Behavior of the Cornea
Toyoaki Matsuura, Masahiko Annaka, Futoshi
Taketani, Eiichi Yukawa, Tokuko Hara, Yoshiaki Hara
(Kashihara /J)
P-SU-038
Cell morphology and pluripotency marker
expression in limbal epithelial stem cells cultured in
different media
Henning Thomasen, Emre Trkeli, Mikk Pauklin,
Klaus-Peter Steuhl, Daniel Meller (Essen/D)
P-SU-039
Confocal Microscopy in Chronic and Delayed
Mustard Gas Keratopathy
Siamak Zarei-Ghanavati, Mohammad-Reza
Jafarinasab, Mojgan Rezaei-Kanavi, Farid Karimian,
Mohammad-Reza Soroush, Mohammad-Ali Javadi
(Mashhad/IR)
P-SU-040
Effects of Selenium on Endothelial cells of mid-term
stored corneas in the rabbit
Chen Qu (Shanghai/CN)
P-SU-041
Evaluation of a medium with human AB-serum for
xenofree cornea preservation
Burkhard von Jagow, Christian Ohrloff, Halvard
Bnig (Frankfurt/D)
P-SU-042
Expression of stem cell markers in conjunctival
intraepithelial neoplasias
Anne Pester, Mikk Pauklin, Henning Thomasen,
Friedrich Otterbach, Kurt Werner Schmid,
Klaus-Peter Steuhl, Daniel Meller (Essen/D)
P-SU-043
Expression of the RAGE-receptor system and its
ligands in Fuchs endothelial corneal dystrophy
Hans Sebastian Walter, Stephan Hoffmann, D.
Hasenfus, Berthold Seitz (Karlsruhe/D, Homburg/D)
P-SU-044
Preliminary study of mesenchymal stem cells
derived from murine corneal stroma
Xiu-Jun Song, Jian-Min Lu (Shijiazhuang/CN)
P-SU-045
Regulatory T cells as therapeutic option following
keratoplasty in baby rats
Johannes Schwartzkopff, Christian Jarsch, Laura
Bredow, Yvonne Kern, Daniel Bhringer, Thomas
Reinhard (Freiburg/D)
P-SU-046
The Role of TNF-Rp-55 and TNF-Rp-75 on the
Angiogenesis and Lymphangiogenesis in Corneal
Neovascularization
Johannes Gonnermann (Duesseldorf/D)
P-SU-029
High risk of pseudomonas infection in contact lens
induced keratitis in Eastern India
Suman Saha, Jayangshu Sengupta, Archana Khetan
(Kolkata/IND)
P-SU-030
Impression Cytology in SLK: A Diagnostic Guideline
Nibaran Gangopadhyay, Jayangshu Sengupta,
Archana Khetan, Suman Saha, Merle Fernandes
(Kolkata/IND)
P-SU-031
Intravital multidimensional two-photon microscopy
reveals rapid cellular dynamics in conjunctiva-
associated lymphoid tissue
Philipp Steven, Uta Gehlsen, Sebastian Siebelmann,
Norbert Koop, Regina Orzekowsky-Schroeder,
Salvatore Grisanti, Gereon Httmann (Lbeck /D)
P-SU-032
Isolation, Characterization and Functional Activity
of Adult and Fetal Human Conjunctival Epithelial
Progenitors
Nick Di Girolamo, Jeanie Chui, Sarah Davies,
P-SU-033
Myopia Control and the Future of Ortho-k
Ken Kopp (Mesa/USA)
P-SU-034
Non invasive multi-dimensional two-photon
microscopy enables optical characterization of key
players in ocular surface inflammation
Uta Gehlsen, Gereon Huettmann, Regina
Orzekowsky-Schroeder, Norbert Koop,
Sebastian Siebelmann, Philipp Steven (Lbeck/D)
P-SU-035
Patterns of contact lenses wearing among students
and attitudes towards a future refractive surgery.
Evgenia Kanonidou, Anna Praidou, Christina
Kanonidou, Paraskevi Zotta, Vasilio s Konidaris,
Irini Chatziralli, Nikolas Ziakas (Thessaloniki/GR)
P-SU-036
Topical cyclosporine A 0.05% in the treatment of
severe vernal keratoconjunctivitis in Vietnamese
patients.
Tho Nguyen (Ho Chi Minh/VN)
S
u
n
d
a
y
,

6

J
u
n
e
P
o
s
t
e
r
s
282
WOC
2010
Sunday, 6 June 2010 15:30 - 17:00
P-SU-057
Ophthalmia Neonatorum: The true extent of the
disease?
Jaswant Sandhu, Kwok Yin Chan, Stephanie Hardy
(Wolverhampton/UK)
P-SU-058
Personal costs in retinal diseases a cost of illness
study
Gabriele Porz, Hendrik P. N. Scholl, Frank G. Holz,
Robert P. Finger (Brohl-Ltzing/D, Bonn/D)
P-SU-059
Population-based study of microaneurysm number
and distribution in the macula of Chinese type 2
diabetics with early diabetic retinopathy
William Tao-Hsin Tung, Jorn-Hon Liu, Ch-Ming Liu
(Taipei/TJ)
P-SU-060
Prevalence and risk factors for myopia in college
students in Shanghai.
Jing Sun, Xianqun Fan, Jibo Zhou (Shanghai/CN)
P-SU-061
Prevalence of anisometropia among 18 year old
students in Poland
Ewa Majdanik, Damian Czepita (Szczecin/P)
P-SU-062
Prevalence of cataract blindness and visual
impairment in Russian city.
Sergey Branchevskiy, Khristo Takhchidi, Igor Malov
(Samara/RUS, Moscow/RUS)
P-SU-063
Prevalence of Demodex folliculorum and Demodex
brevis on eyelashes in a Polish population
Andrzej Grobelny, Damian Czepita (Szczecin/P)
P-SU-064
Prevalence of diabetes and diabetic retinopathy in
Nigeria: results from the Nigeria National Blindness
and Visual Impairment Survey
Fatima Kyari, Selvaraj Sivasubramaniam, Tunde
Peto, Clare Gilbert, The Nigeria National Blindness
and Visual Impairment Study Group (London/UK)
P-SU-065
The impact of visual impairment and eye diseases
on quality of life in Taiwanese patients utilizing eye
care services
Jen-Chieh Lin, Mei-Shu Lai (Taipei/TJ)
P-SU-066
The prevalence and causes of visual impairment in
Sichuan Province: findings from the China Second
National Sample Survey on Disability
Min Wei, Sophia Pathai, Ying Chuan Fan (New
York/USA)
Epidemiological Studies P13
P-SU-047
Associations Between Dietary Factors and Intra-
ocular Pressure
Laurence Lim, Seang Mei Saw (Singapore/SGP)
P-SU-048
Common causes of visual handicap and blindness
in the registered blind people from the region of
Eastern Herzegovina
Ceklic Lala, Slobodanka Latinovic (Sarajevo/BIH,
Novi Sad/SRB)
P-SU-049
Early detection and treatment of eye diseases in
children in Poland
Beata Chrzanowska, Alina Bakunowicz-Lazarczyk
(Bialystok/PL)
P-SU-050
Epidemiology of ocular casualty among the
Egyptian population: a five year retrospective study
Hany Elmekawey, Abueleinen K. G. Khaled,
Abdelmaboud M. Mohamed, Khafagy A. Amr
(Giza/ET)
P-SU-051
Factors related to Sunlight Exposure and the Long-
term Incidence of Cataract and Cataract Surgery
The Blue Mountains Eye Study
Gowri Kanthan, Paul Mitchell, Elena Rochtchina,
Jie Jin Wang (Strathfield/AUS, Sydney/D)
P-SU-052
Global Inequality in Eye Health: Country Level
Analysis from the Global Burden of Disease Study
Koichi Ono, Yoshimune Hiratsuka, Akira Murakami
(Tokyo/J)
P-SU-053
LOXL1 gene polymorphisms and glaucoma
secondary to familial amyloidotic polyneuropathy in
Japanese
Toshiyuki Kyomoto, Takanobu Kikuchi, Teruyoshi
Miyahara, Toshinori Murata, Kana Tojo, Shu-ichi
Ikeda (Matsumoto/J)
P-SU-054
Normal Intraocular Pressure, Corneal diameter, and
Cupping In Newborns
Osama Badeeb (Jeddah/SA)
P-SU-055
Ocular Hypertension Lorraine-France study (HOLF)
Olivier Henckes, Toufic Maalouf, Michel
Helfenstein, Franck May, Jean Luc George (Nancy/F)
P-SU-056
Ophthalmia Neonatorum: Clinical Features,
Outcomes and Under-reported Notification in a
Large UK General Hospital
Manjit Singh Mehat (Birmingham/UK)
S
u
n
d
a
y
,

6

J
u
n
e
P
o
s
t
e
r
s
283
WOC
2010
Epidemiology P14
P-SU-067
An Overview of Shih-Pai Eye Study
Wen-Ming Hsu, Ching-Yu Cheng, Tung-Mei Kuang,
Pei-Yu Lin, Catherine Jui-Ling Liu, Shih-Jen Chen,
Jorn-Horn Liu (Taipei/TJ)
P-SU-068
Burden and severity of ophthalmic zoster in 2007 in
France: a hospital study
Gilles Berrut, Xavier Bresse, Karine Bloch, Jrme
Fernandes, Alexandre Vainchtock (Nantes/F)
P-SU-069
Epidemiology of Primary Glaucoma in the Kyrgyz
Republic
Olzhobai Dzhumagulov (Bishkek/KIS)
P-SU-070
Epidemiology of Pterygium in Aged Population in
Beijing Country, China
Qingfeng Liang, Liang Xu (Beijing/CN)
P-SU-071
Ophthalmic Zoster in the UK: Burden in Secondary
Care (2007)
Ian Power, Xavier Bresse, Azharul Mannan,
Christopher Morgan (Lyon/F)
P-SU-072
Prevalence of HIV-associated ophthalmic disease
among patients enrolling for antiretroviral treat-
ment in India: implications for baseline ophthalmic
screening
Sophia Pathai, Alaka Deshpande, Clare Gilbert,
Stephen Lawn (New York/USA)
P-SU-073
The influence of selected environmental factors on
the frequency of refractive errors among school-
age children.
Magdalena Dalz, Maria Dalz (Pozna /P)
Ethics/Medical History/Traffic Ophthalmology P15
P-SU-074
MR D: A Turkish Ophthalmology Textbook in
XVth Century Anatolia
Do an Ceyhan (Van/TR)
P-SU-075
Albrecht von Graefe - "Father of glaucoma"
Milan Ivanisevic, Lovro Bojic, Robert Stanic,
Petar Ivanisevic (Split/HR)
P-SU-076
Folk Treatment of Eye Diseases using Medicinal
Herbs in Croatia
Vjekoslav Dorn (Zagreb/HR)
P-SU-077
Saints and the Eye
Muhammad Younis, Ahmad Mansour,
Joseph Walsh (Manchester/RL)
P-SU-078
The Fate of Injured and Persecuted Ophthalmo-
logists as well as Persons Closely Related to
Ophthalmology in National Socialism (1933-1945),
Particularly Dealing with those of Jewish Faith or
Heritage.
Udo Hennighausen (Heide/D)
External Disease P16
P-SU-079
A no suture conjunctival graft approach to
pterygium surgery
Aneesur Rahman (Petaling Jaya/MAL)
P-SU-080
Blepharitis therapy with the topical anti-inflamma-
tory macrolide antibiotic Azithromycin 1.5%
Antonio Bergua, Matthias Zenkel, Jeanette Gabel
(Erlangen/D)
P-SU-081
Effective Treatment of Ligneous Conjunctivitis with
Topical Plasminogen Concentrates
P-SU-082
Investigative study of new cases of Acanthamoeba
keratitis: an emergent infection in the management
of external ocular diseases
Denise Freitas, Fabio R. S. Carvalho, Juliana F.
Camargo, Annette S. Foronda (Sao Paulo/BR)
P-SU-083
Long-term assessment of pterygium surgery by
conjunctival autograft with fibrin adhesive.
Eduardo Conesa, Esther Mata, Carlos De Pablo,
Cristina Montn (Madrid/E)
P-SU-084
Morganella Morganii Conjunctivitis: Case Report
Maria Fernanda Abalem de S, Leticia de Castro
Moura Brasil, Marcio Penha Morter Rodrigues,
Daniella Socci da Costa (Rio de Janeiro/BR)
P-SU-085
Ocular rosacea: Glycomics analysis of tear and
saliva for disease biomarkers.
Ana Carolina Vieira, Sureyya Ozcan, Hyun Joo Ann,
Carlito Lebrilla, Mark Mannis (Rio de Janeiro/BR)
P-SU-086
Predictive factors of keratoplasty in keratoconus
Nestor Cortes Mora, David Galarreta, Fernando
Snchez-Mannarelli, Alejandro Portero-Benito,
Belen Carrasco, David Pea, Jesus Merayo-Lloves
(Valladolid/E)
Sunday, 6 June 2010 15:30 - 17:00
S
u
n
d
a
y
,

6

J
u
n
e
P
o
s
t
e
r
s
284
WOC
2010
P-SU-087
Prevention and treatment of meibomian gland
dysfunction
Maria Pimenidi (Moscow/RUS)
P-SU-088
Tear proteomic analysis of dry eye syndrom in type
2 diabetes mellitus patients
Bing Li, Minjie Sheng, Feng Liu, Guoquan Yan,
Anjuan Lin, Weifang Wang, Yanhong Li,
Chunlei Xie, Fei Zhao (Shanghai/CN)
P-SU-089
The effect of vancomycin eye ointment for
MRSA/MRSE ocular surface infection
Masahiko Fukuda, Chie Sotozono, Masao Ohishi,
Keiko Yano, Hideki Orikasa, Yoshikazu Shimomura
(Osaka-Sayama/J)
P-SU-090
The Efficacy of Topical Levofloxacin 0.5% in
Treating Levofloxacin-Resistant Pseudomonas
Aeruginosa Induced Keratitis
Kianti Darusman (Jakarta/RI)
P-SU-091
The Expression of Matrix Metallo Proteinase-1
(MMP-1) in Primary Pterygium After Subconjunc-
tival Injection of Triamcinolone Acetonide and
Mitomycin C
Suhardjo Suhardjo, Ayu Suryaningsih Oetoyo,
Dharmawan M Sophian (Yogyakarta/RI)
P-SU-092
Unilateral epidemic keratoconjunctivitis with
membrane formation
Mentor Gorani, Merita Ilazi, Mentor Ilazi
(Prishtina/KS)
Glaucoma: Basics P17
P-SU-093
Agmatine and oxidative stress-induced cytotoxicity
in primary retinal ganglion cells and Mller glial
cells
Samin Hong, Chan Yun Kim, Yoko Iizuka,
Gong Je Seong (Seoul/ROK)
P-SU-094
Comparison of IgG and IgM Autoantibody Patterns
in Glaucoma Patients
Sabine Beck, Nils Boehm, Marcus Schlich,
Joachim Richter, Karin Pfirrmann, Norbert Pfeiffer,
Franz Grus (Mainz/D)
P-SU-095
FGF plays a regulatory role in the early stages of
the ciliary body development.
Justyna Klos-Rola, Tomasz Zarnowski, Jeanette Hyer
(Lublin/PL)
P-SU-096
Involvement of glutamate in retinal degeneration
induced by pressure elevation in isolated retina
Makoto Ishikawa, Yukitoshi Izumi,
Takeshi Yoshitomi (Akita/J)
P-SU-097
Malignant Melanoma and the Use of Latanoprost:
A Risk Assessment
Charles Tressler, Robert Wiseman, Theresa Dombi,
Bart Jessen, Kui Huang, Kenneth Kwok,
Ken Salatka, Barbara Wirostko (New York/USA)
P-SU-098
Matrix-metalloproteinases and their inhibitors in
the aqueous humor of glaucoma patients: effect of
antiglaucoma drugs
Matthias Zenkel, Jasmina Djordjevic-Jocic,
Piotr Lewczuk, Anita Krysta, Anselm Jnemann,
Friedrich Kruse, Johannes Kornhuber,
P-SU-099
Morphological changes of trabeculectomy
specimens in patients with uveitic glaucoma.
Carsten Heinz, Ozan Tektas, Arnd Heiligenhaus,
Elke Ltjen-Drecoll (Mnster/D, Erlangen/D)
P-SU-100
Plasminogen activator inhibitor-1 in the aqueous
humor of patients with pseudoexfoliation syn-
drome with or without glaucoma
Konstantinos Zinelis, Ioannis Tsinopoulos,
Nikolaos Kopsachilis, Sebastian Wei, Rolf Winter,
Michael Wolfgang Meyer (Hannover/D)
P-SU-101
Possible stress factors working on retinal nerve
fibers at the scleral rim.
Jens Georg Hetland (Oslo/N)
P-SU-102
Pro370Leu mutant myocilin impairs mitochondrial
functions in human trabecular meshwork cells
Yuan He (Xi'an/CN)
P-SU-103
Proteome analyses of HMGB-1 in a rat experimen-
tal glaucoma model and its role in neurodegene-
ration
Maurice Schallenberg, Harut Melkonyan,
Guang-Yu Li, Solon Thanos (Essen/D, Mnster/D)
P-SU-104
Retinal ganglion cells in the Experimental Auto-
immune Glaucoma Model die through apoptosis
Stephanie C. Joachim, Oliver W. Gramlich,
Zacharias Loos, Panagiotis Laspas, Vanessa D. Stahl,
Norbert Pfeiffer, Franz H. Grus (Mainz/D)
Sunday, 6 June 2010 15:30 - 17:00
S
u
n
d
a
y
,

6

J
u
n
e
P
o
s
t
e
r
s
285
WOC
2010
Sunday, 6 June 2010 15:30 - 17:00
S
u
n
d
a
y
,

6

J
u
n
e
P
o
s
t
e
r
s
286
WOC
2010
P-SU-113
Trial of Static program for AMAs Visual Field
Score by Humphrey Custom Program compared to
Goldmann measurement
Junko Kamo, Ryo Harada (Kofu/J)
P-SU-114
Visual outcome of long-term survivors with inborn
error of metabolism
Hideki Oohashi (Isehara/J)
Neuro-Ophthalmology P19
P-SU-115
A case of hypertrophic pachymeningitis with optic
neuritis-like symptoms
Sachi Abe, Akira Sugano, Teiko Yamamoto,
Takeo Kato, Manabu Wada, Takamasa Kayama,
Sunao Takemura, Hidetoshi Yamashita (Yamagata/J)
P-SU-116
A case of Miller Fisher syndrome
Ilona Ryseck (Hamburg/D)
P-SU-117
A case report about mucormycosis in sinus
sphenoidalis misdiagnosed to apical orbital
syndrome result from tumor
P-SU-118
A Case Report: Recurrence of an Orbital Tumor
V. Nandini, Z. A. Zurina, N. Vairavan, V. Waran
(Kuala Lumpur/MAL)
P-SU-119
A proposal about pseudo-Barre-Lieou syndrome
Masayoshi Kajita (Tokyo/J)
P-SU-120
Abducens ocular neuromyotonia in a patient with
nasopharyngeal carcinoma following concurrent
chemo-radiotherapy
Hui-Chuan Kau, Chieh-Chih Tsai (Taipei/TJ)
P-SU-121
Acute zonal occult outer retinopathy presented
with annular scotoma and periphlebitis in a
Japanese girl
Masashi Nishimura, Naohiro Ikeda, Tomohiro Ikeda,
Akiko Masuda, Osamu Mimura (Nishinomiya/J)
P-SU-122
Alpha2-adrenergic receptors ans their core
involvement in the process of axonal regeneration
in the retina
Verena Prokosch, Lambros Panagis, Gerd-Fabian
Volk, Caterina Dermon, Solon Thanos (Mnster/D)
P-SU-105
Substrate elasticity modulates TGF-beta signaling in
human trabecular meshwork cells
Hong Han, Thomas Wecker, Franz Grehn,
Schlunck Gnther (Wuerzburg/D)
P-SU-106
The effect of central corneal thickness on
intraocular pressure measurements by Goldmann
applanation tonometer and non-contact tonometer
in a military hospital
Yener Celik, Levent Ersoy (Istanbul/TR)
Low Vision P18
P-SU-107
Association between quality of life and changes in
visual acuity in Japanese patients with low vision
Meiko Yanagisawa, Satoshi Kato, Shiho Kunimatsu,
Megumi Kobayashi, Makiko Ochiai, Nobuyuki Shoji
(Tokyo/J)
P-SU-108
Development and validation of The Eye Clinic
Opinion Satisfaction (TEC-OS) questionnaire for
Low Vision Aid
Sakshi Mehrotra, Abhas Mehrotra
(Chandigarh/IND)
P-SU-109
Educational Inclusion at a Private University in
Brazil: Accessibility and Pedagogical Aspects in the
Humanities, Economics and Business and Science
and Engineering Courses
M. Cristina de O. Regina (Campinas/BR)
P-SU-110
Efficacy of dexamethasone intravitreal implant for
the treatment of uveitis based on patient-reported
vision function outcome measures
Jonathan W. Kowalski, Heather Gelhorn, Rupali K.
Naik, Anne Rentz, Harry Cui, Careen Lowder,
Rubens Belfort Jr., Steven Foster, Sue Lightman,
Scott M. Whitcup (Irvine/USA, Cologne/D,
So Paulo/BR, London/UK, Irvine/USA)
P-SU-111
First results of the IOL-Vip system Visual rehabili-
tation of patients with low-vision due to severe
Ramin Khoramnia, Christoph Winkler von
Mohrenfels, Josefina Salgado, Barbara Schwaiger,
Michaela Engel, Chris Lohmann (Munich/D)
P-SU-112
Language development in children with retinopathy
of prematurity
Galton Carvalho Vasconcelos, Erika Parlato Oliveira,
Janaina Couto Sacramento,
Silmara de Abreu Melgao (Belo Horizonte/BR)
Sunday, 6 June 2010 15:30 - 17:00
S
u
n
d
a
y
,

6

J
u
n
e
P
o
s
t
e
r
s
287
WOC
2010
P-SU-134
Crossed Quadrant Homonymous Hemianopia Post
Myocardial Infarction: A Case Report
Indira Nadras, Norlelawati Abu, Bethel Livingstone
(Seremban/MAL)
P-SU-135
Demanding treatment of neuromyelitis optica in
Japanese patient
Aya Sakamoto, Masashi Nishimura, Shuhei Kasama,
Keiko Tanaka, Osamu Mimura (Nishinomiya/J)
P-SU-136
Diffusion tensor imaging (DTI)-based white matter
mapping in children with amblyopia: underdevelop-
ment of optic radiation study
Hong Yan, Yongxing Xing, Guangbing Cui,
Junjie Zhi (Xi'an/CN)
P-SU-137
Evaluating visual field states in patients with optic
neuropathy: VEP measurements in relative defect
visual field
Eileen Poloski, Nicole Dettler, Bernhard A. Sabel,
Christoph S. Herrmann, Carolin Gall
(Magdeburg/D)
P-SU-138
Experimental mouse model of optic neuritis
P-SU-139
First report of primitive neuroectodermal tumors
originally in Optic nerve
P-SU-140
Fluorescein angiography in patients with non-
arteritic anterior ischemic optic neuropathy.
Thalia Vasiliou, Marion Kaup, Niklas Plange,
Andreas Remky (Aachen/D)
P-SU-141
High titres of serum anti-aquaporin-4 (AQP4)
antibody after successful plasmapheresis in AQP4-
positive optic neuritis
Eiji Murotani, Shinji Ohkubo, Mayumi Sakurai,
Kazuhisa Sugiyama, Mitsuhiro Kawano,
Mineo Takagi, Keiko Tanaka (Kanazawa/J)
P-SU-142
Idiopathic Bilateral Iris Atrophy
Elizabeth Palkovacs, Karl Golnik (Cincinnati/USA)
P-SU-143
Incidence of cerebral venous sinus thrombosis in
patients with idiopathic intracranial hypertension.
P-SU-123
Analysis of ocular motor dysfunctions related to
multiple sclerosis
P-SU-124
Bilateral vitreous hemorrhages predict poor vision in
Shaken Baby Syndrome in Japan.
Yuri Kobayashi, Makiko Itou, Michiko Tanaka,
Tadashi Yokoi, Sachiko Nishina, Shizuko Ohba,
Makiko Okuyama, Noriyuki Azuma (Tokyo/J)
P-SU-125
Cerebrospinal fluid dynamics between the basal
cisterns and the perioptic space in patients with
papilledema
Hanspeter Killer, Gregor Jaggi, Neil Miller,
Luca Remonda (Aarau/CH)
P-SU-126
Characteristic of Ocular Motor Disorder Patients
in Neuroophthalmology Division, DR Ciptoman-
gunkusumo Hospital, 2006-2008
Syntia Nusanti (Jakarta/RI)
P-SU-127
Clinical analysis of amaurosis fugax caused by
cardiovascular and cerebrovascular disease
P-SU-128
Clinical Analysis of Different Ocular Changes in
Intraocular Anecurysm of Different Locations
P-SU-129
Clinical analysis of mucormycosis 9 A case report
P-SU-130
Clinical analysis of ocular manifestations related to
Takayasu arteritis
P-SU-131
Clinical characteristic and optimization of treatment
of optico-kinetic disadaptation syndrome in
children with perinatal encephalopathy.
Sevinj Salmanova, Elmar Kasimov, Sima Huseynova
(Baku/ASE)
P-SU-132
Comparison of Retinal Nerve Fiber Layer Measure-
ments Using Time Domain and Spectral Domain
Optical Coherence Tomography in Optic Nerve
Head Drusen
Francisco J. Muoz-Negrete, Laura Guerrero,
Gema Rebolleda, Elena Jarrn (Madrid/E)
P-SU-133
Correcting Strabismus in Patients with Central
Nervous System Lesions
Juan Bu, Lejin Wang, Jing Li, Xin Tian (Beijing/CN)
Sunday, 6 June 2010 15:30 - 17:00
S
u
n
d
a
y
,

6

J
u
n
e
P
o
s
t
e
r
s
288
WOC
2010
P-SU-153
Phosphene thresholds during repetitive transorbital
alternating current stimulation (rtACS) relate
to severity of vision loss in patients with optic
neuropathy
Romualda Michalik, Carolin Gall, Anton B. Federov,
Stephan Brandt, Bernhard A. Sabel
(Kleinmachnow/D, Magdeburg/D)
P-SU-154
Pituitary ectopia in a case of bilateral optic nerve
hypoplasia-A case report
Tsui-Kang Hsu (Taipei/TJ)
P-SU-155
Pituitary Tumor Apoplexy Long-term Follow-up
Marketa Machackova, Dagmar Hejcmanova,
Ivan Latr (Hradec Kralove/CZ)
P-SU-156
Preliminary exploration of intracranial aneurysms
with ophthalmic symptoms
P-SU-157
Preliminary report of contrast sensitivity values after
idiopathic optic neuritis
P-SU-158
Relationship between anti-aquaporin-4 antibody
and anti-myelin oligodendrocyte glycoprotein
antibody in patients with optic neuritis
Ryusaku Matsuda, Takeshi Kezuka, Yoshimiti
Matsunaga, Yoshihiko Usui, Naoyuki Yamakawa,
Keiko Tanaka, Hiroshi Goto (Tokyo/J)
P-SU-159
Relationship between Macular Ganglion Cell
Complex Parameters and Visual Field Sensitivity in
Chiasmal Compression
Shinji Ohkubo, Tomomi Higashide, Hisashi Takeda,
Eiji Murotani, Kazuhisa Sugiyama (Kanazawa/J)
P-SU-160
Restoration of vision restoration: training improves
visual fields in glaucoma a double-blind,
randomized, placebo-controlled clinical trial
Bernhard A. Sabel, Julia Gudlin (Magdeburg/D)
P-SU-161
Restoration of vision: Improvements of parafoveal
visual field are associated with increased reading
speed after training of light detection in patients
with homonymous visual field defects
Daniela Komm, Bernhard A. Sabel, Carolin Gall
(Magdeburg/D)
P-SU-162
Restoration of vision: development of a pre-clinical
model for repetitive transorbital alternating current
stimulation after optic nerve crush
Petra Henrich-Noack, Nadine Voigt, Sylvia Prilloff,
Bernhard A. Sabel (Magdeburg/D)
P-SU-144
Internuclear Ophthalmoplegia as an Initial Manifes-
tation of Multiple Sclerosis A Case Report
Filipa Rodrigues, Cludia Costa-Ferreira, Manuela
Amorim, Raquel Soares, Jos Salgado-Borges
(Aveiro/P)
P-SU-145
Lymphocytic hypophysitis presenting as optic
neuritis
Katja Christina Schielke, Sophie Anna Holak,
Linda M. Buchanan, J. Angus Scott (Aalborg/DK,
Berlin/D)
P-SU-146
Multifocal Photopic Negative Response (mfPhNR)
and Visual Field (VF) in patients with optic nerve
lesions
Ari Kamei, Eiichiro Nagasaka (Oshu/J)
P-SU-147
Multiple Meningiomatosis, Mesencephalic Venous
Anomaly and Cerebral Calcifications: Ocular
Manifestations. Clinical Case
Francisco Javier Hernandez Martinez, Purificacion
Pias Garcia, Araceli Trueba Lawand (Sevilla/E)
P-SU-148
Multipotent Neural Progenitor Cells Support
Regeneration Of Axons Within The Rat Optic Nerve
Carolin Chiwitt, Petar Charalambous,
Mirjam Augustin, Solon Thanos (Mnster/D)
P-SU-149
Ocular clinical characteristics in Lymphocytic
hypophysitis
P-SU-150
Ocular complications with acoustic neuroma
surgical resection
Muhammad Amjad, A. Garrick, I. Marsh,
C. Noonan (Manchester/UK)
P-SU-151
Ophthalmic Herpes Zoster: Natural history,
morbidity, treatment and prevention
Peter Wutzler, Arnd Heiligenhaus, Angus Thomson,
Isabelle Bertrand (Jena/D, Mnster/D, Lyon/F)
P-SU-152
Optic Disc Drusen-diagnose, clinical manifestations,
and prognosis
Sonja Cekic, Gordana Stankovic Babic, Jasmina
D - ordevic Jocic, Jovica Mric, Ivan Jovanovic
(Nis/SRB)
Sunday, 6 June 2010 15:30 - 17:00
S
u
n
d
a
y
,

6

J
u
n
e
P
o
s
t
e
r
s
289
WOC
2010
P-SU-174
Vision- and health- related quality of life in stroke
patients with homonymous visual field defects
depend on severity of visual function loss
Caroline Wagenbreth, Gabriele H. Franke,
Bernhard A. Sabel, Carolin Gall (Magdeburg/D)
P-SU-175
Vision- and health-related quality of life before
and after vision restoration training in cerebrally
damaged patients.
Anja Lindig, Bernhard A. Sabel, Carolin Gall
(Oldenburg/D, Magdeburg/D)
P-SU-176
Visual Field Deficit in Patient with the Optic Nerve
Drusen and the Pineal Cyst-case report
Ana Pepic, Biljana Draganic, Jelena Mladenovic,
Dusanka Mrvos-Cobeljic (Belgrade/SRB)
P-SU-177
Visual fields, visual acuity and driving performance
in patients with pituitary adenoma before and after
surgery
Evelin Schneider, Gwendolyn Gramer,
Eugen Gramer (Wuerzburg/D)
P-SU-178
Visual functions assesment in case of functioning
pituitary micraodenomas
Brigita Budiene, Rasa Liutkeviciene,
Rita Lukauskiene, Kestutis Sinkunas (Kaunas/LT)
New Technology, Bioengineering, P20
Nanotechnology
P-SU-179
Classification of Ophthalmic Viscoelastic Devices
using the Weissenberg Number
Bernd-Kristof Mller, Helmut Ritter, Yong Keun
Kim, Dirk-Henning Menz (Duesseldorf/D)
P-SU-180
Comparison Between Simulated and Real Ablations
in Customized Contact Lens
Luciana de Matos, Claudia Francesconi,
Enos de Oliveira, Luis Alberto Vieira de Carvalho
(So Carlos/BR)
P-SU-181
Cultivation of human cornea cells on the surface of
siloxan-gidrogel contact lenses.
Oleg Germanovich Makeev, Sergey Aleksandrovich
Korotkih, Elena Stepanovna Knyazeva,
Maxim Gerasimov, Anastasya Evgenevna Zvereva
(Ekaterinburg/RUS)
P-SU-182
Effects of riboflavin and UV irradiation on sclera
rigidity
Muka Moriyama, Kyoko Oono, Ikuo Morita,
Manabu Motizuki, Sakuya Tamada,
Takuya Kisimoto, Akio Yasuda (Tokyo/J)
P-SU-163
Retrospective analysis of optic neuritis among the
patients of multiple sclerosis
P-SU-164
Study of the threshold defect of branch retinal vein
occlusion
P-SU-165
Study of visual evoked potential with irregular
pattern stimulation in normal human subject
S. M. Shushtarian, Sara Mohammadi,
M. J. Motamedi, T. Davari (Tehran/IR)
P-SU-166
Study of visual function and retinal morphology in
the mice model of experimental optic neuritis
P-SU-167
The analysis of clinic characters of slightly indirect
traumatic optic neuropathy
P-SU-168
The clinical research of correlation factors of
abducens nerve paralysis of 47 hospitalized patients
P-SU-169
The Contribution of Ultrasound to the Diagnosis
and Follow-Up of Giant Cell Arteritis. A Pilot Study
Ana Suelves, J. I. Tembl, Enrique Espaa-Gregori,
Stephanie Rohrweck, Diamar Pardo-Lopez,
Salvador Garcia-Delpech, Patricia Udaondo,
Manuel Daz-Llopis (Xirivella/E, Valencia/E)
P-SU-170
The situation of ocular ischemic diseases cured by
carotid artery endarterectomy
P-SU-171
To analyse the clinical features of The diseases in
occipital lobe
P-SU-172
To analyse the correlation of the of the lesions in
visual pathway posterior to the chiasm with eye
symptom.
P-SU-173
VEP and other visual functions before and after
surgical excision of tumors compressing anterior
visual pathway.
Jawahar Lal Goyal, Lanalyn Thangkhiew,
Usha Yadava (Noida/IND)
Sunday, 6 June 2010 15:30 - 17:00
S
u
n
d
a
y
,

6

J
u
n
e
P
o
s
t
e
r
s
290
WOC
2010
Oculoplasty/Orbita/Lids/Lacrimal System P21
P-SU-191
A case of congenital tarsal kink syndrome treated
with everting sutures
Aristeidis Konstantinidis, Kave Vahdani,
James Benzimra, Khaik Kee Peh, Vladimir Thaller
(Plymouth/UK)
P-SU-192
A case report on the management of an orbital
foreign body
Livia Teo, Audrey Looi, Lay Leng Seah
(Singapore/SGP)
P-SU-193
A Modified Container with Drainage Tube for
Secondary Reconstruction of Severe Contracted Eye
Socket
Ming Lin, Xianqun Fan (Shanghai/CN)
P-SU-194
A novel disease-specific quality of life questionnaire
closely correlates with objective parameters in
Graves orbitopathy
Katharina A. Ponto, George J. Kahaly, Susanne Pitz,
Gerhard Hommel, Norbert Pfeiffer (Mainz/D)
P-SU-195
Amniotic membrane grafting in Epidermal nevus
syndrome
Brahm Guliani, Shreekant Damgude, Anuj Mehta,
Krishan Malik, Vishnu Gupta (Coimbatore/IND)
P-SU-196
An unusual course of a case with orbital cellulitis
Jan Khler, Thomas Bchner, Burkhard Wiechens
(Hannover/D)
P-SU-197
Anthropometry of the Arabian eyes
Amal Bukhari (Jeddah/SA)
P-SU-198
Ascending Nasolacrimal System Obstruction in a
pediatric age patient with Lichen Planus.
Pelin Kaynak-Hekimhan, Serhat Imamoglu,
Can Ozturker, Birsen Gokyigit, Ahmet Demirok,
Omer Faruk Yilmaz (Istanbul/TR)
P-SU-199
Basal Cell Carcinoma of the Eyelid in Young
Woman
Lidija Perez (Bitola/MK)
P-SU-200
Benign fibrous histiocytoma of the eyelid
Stephan Eckert, Gerhard Klaus Lang (Ulm/D)
P-SU-183
Evaluation of conjunctival circulation using
scanning laser ophthalmoscope
Michiya Takamatsu, Takashi Sone, Yoshiaki Kiuchi
(Hiroshima/J)
P-SU-184
FLASH software to improve basic ophthalmological
education: Retinoscopy Trainer and Goldmann
Perimetry Trainer
Heiko Wassill, Birgit Lorenz, Thomas Stoll,
Mini Khler, Thomas Kowarsch (Giessen/D)
P-SU-185
Injectabilty of viscoelastic solutions
Dirk-Henning Menz, Yong Keun Kim, Cora Keil
(Knigsbrunn/D)
P-SU-186
One year experience with a novel tonometer and
contact glass disinfection device (Tonoclean)
Aljoscha Neubauer, Ronald Spaltmann, Werner
Reis, Christoph Hirneiss (Munich/D)
P-SU-187
Optical coherence tomography assisted anterior
segment surgery OCTAASS
Gabor Scharioth (Recklinghausen/D)
P-SU-188
Quantitative proteomic analysis of human aqueous
humor by mass spectrometry
Andreas Pollreisz, Marion Funk, Florian P.
Breitwieser, Stefan Sacu, Andr Mueller,
Melanie Planyavsky, Jacques Colinge, Michael
Georgopoulos, Keiryn L. Bennett, Guilio Superti-
Furga, Ursula Schmidt-Erfurth (Vienna/A)
P-SU-189
Surface Quality Characteristics of Intraocular Lenses
Assessed by Atomic Force Microscopy
Partha Biswas, Koel Choudhury, Subhrangshu
Sengupta, Ajoy Paul, Rashmi Mukherjee
(Kolkata/IND)
P-SU-190
Which physical actuation principles are suitable for
driving the optics of an implantable mechatronic
accommodation system?
Thomas Martin, Ulrich Gengenbach,
Georg Bretthauer, Rudolf Guthoff (Eggenstein-
Leopoldshafen/D, Karlsruhe/D, Rostock/D)
Sunday, 6 June 2010 15:30 - 17:00
S
u
n
d
a
y
,

6

J
u
n
e
P
o
s
t
e
r
s
291
WOC
2010
P-SU-212
How accurate is clinical and radiological evaluation
of orbital lesions in comparison to orbital biopsy?
Antigoni Koukkoulli (Leeds/UK)
P-SU-213
In Vivo Efficacy of Bone Marrow Stromal Cells
Coated Beta-Tricalcium Phosphate for the
Reconstruction of Orbital Defects in the Canine
Huifang Zhou, Xianqun Fan, Caiwen Xiao
(Shanghai/CN)
P-SU-214
Late presentation of congenital nasolacrimal duct
obstruction. Can be cured by simple probing?
Osama Shalaby, M. Ashraf El Desouky (Tanta/ET)
P-SU-215
Lid reconstruction without local blood supply
a new method combining Hughes-flap, skin graft
and tarso-marginal graft for lower lid defects
extending into the canthus
Falk Sommer (Dresden/D)
P-SU-216
Looi Suture Technique for Anchoring the Lateral
Tarsal Strip to the Orbital Wall
Joy Chan, Audrey Looi (Singapore/SGP)
P-SU-217
Management of orbital venous malformation with
intralesional injection of Pingyangmycin:a primary
study
Renbing Jia (Shanghai/CN)
P-SU-218
Metastases in oropharyngeal carcinoma
Lutz Becker (Ulm/D)
P-SU-219
Minimally invasive surgery of blepharoptosis by
short-pulsed CO2 laser irradiation with Mueller
muscle tucking and visual function improvement.
Kazuhiko Dannoue, Nobuyuki Miyata, Eiichi Okada,
Satoki Ueno (Kawasaki/J)
P-SU-220
Minor conjunctivitis expands to fulminant necrotic
fasciitis due to infection with Streptococcus
pyogenes
Inez Brunotte, Sebastian Wei, Konstantinos
Zinelis, Rolf Winter, Michael Meyer (Hannover/D)
P-SU-221
Modified Staged Correction For Blepharophimosis-
Ptosis-Epicanthus Inversus Syndrome
Xin Song, Xianqun Fan (Shanghai/CN)
P-SU-222
Mohs Micrographic Surgery for Chinese Patients
with Eyelid Basal Cell Carcinoma
Terence Goh, David Liu, Kelvin Chong, Ben Wong,
Gary Tse, HK Ng, Dennis Lam (Kowloon/HK)
P-SU-201
Comparative experimental study of biological
integration of different implantation materials used
for orbital surgery
Tatiana Bakaeva, Anatoly Fedorov, Yaroslav Grusha
(Moscow/RUS)
P-SU-202
Conjunctival alterations in ocular pemphigoid:
a confocal laser-scanning microscopy study.
Giulia Renieri, Eva Hecht, Esther von Stebut-
Borschitz, Norbert Pfeiffer, Susanne Pitz (Mainz/D)
P-SU-203
Correction of Telecanthus and ptosis in Patients
with the Blepharophimosis Syndrome
Ashok Grover (New Delhi/IND)
P-SU-204
Dig deeper into the tear proteome: advanced
protein profiling in dry eye patients
Klaus Thomas Ude, Nils Boehm, Michaela Wiegand,
Norbert Pfeiffer, Franz Grus (Mainz/D)
P-SU-205
Dry Eye and Pterygium
Khakima Karim-Zade, Zukhra Akhrorova
(Dushanbe/TAD)
P-SU-206
Dry Eye Disease Activity Log A New Tool in
Management of Patients with Dry Eye Disease
Jayant Venkatramani Iyer, Hak Tien Louis Tong
(Singapore/SGP)
P-SU-207
Early Gold Weight Implants in the management of
paralytic lagophthalmos
Esther Mata, Eduardo Conesa, Carlos De Pablo
(Madrid/E)
P-SU-208
Effects of Botulinum Toxin-A in Orbicularis Oculi
Muscle of Patients with Blepharospasm Pilot
Study
Tammy Osaki, Midori Osaki, Suely Marie,
Rubens Belfort, Jr., Teissy Osaki (Sao Paulo/BR)
P-SU-209
Evaluation of Motility in Primary pegged
anophthalmic implant
Hadi Khazaei (Bangalore/IND)
P-SU-210
Granulocytic sarcoma of lacrimal gland preceding
the blast phase of acute non-lymphoblastic
leukemia.
Jutarat Pomsathit (Bangkok/T)
P-SU-211
Histopathologic evaluation of eyelid lesions:
When to order, when to omit?
Yasser Y. M. Hassan Al-Faky (Riyadh/SA)
Sunday, 6 June 2010 15:30 - 17:00
S
u
n
d
a
y
,

6

J
u
n
e
P
o
s
t
e
r
s
292
WOC
2010
P-SU-234
Reconstruction of Severe Anophthalmic Orbits and
Atresic Eye Sockets after Enucleation and Irradia-
tion of Retinoblastoma by Vascular Anastomosed
Free Dorsal Flap Transplantation and Autogenous
Dermal Fat Implantation
Xiaoping Bi, Xianqun Fan, Huifang Zhou
(Shanghai/CN)
P-SU-235
Recurrent preseptal cellulitis of the upper eye lid
Teresa Wacker, Gerhard K. Lang, Peter Wagner,
Stephan Eckert (Ulm/D)
P-SU-236
Sinus thrombosis as intracranial complication of
phlegmon of orbit.
Darya Zubkova, Pavel Bezditko, Maryna
Shchadnykh, Olesya Zavoloka (Kharkiv/UA)
P-SU-237
Spontaneous lid repair technique for medial canthal
basocelular carcinoma.
Amalia Amadora Ascarza (Cap Fed Bs As/RA)
P-SU-238
Spontaneous recovery of fronto-orbital blow in
fracture in a child
Yefei Wang, Xianqun Fan, Huifang Zhou,
P-SU-239
Surgical correction and prevention of complications
in congenital blepharoptoses complicated by
vertical motility disorders
Svetlana Tronina, Nadiya Bobrova (Odessa/UA)
P-SU-240
Surgical therapy of bilateral upper eyelid ptosis in
a case of Kearns-Sayre syndrome
Christian Flhr, Thomas Bchner,
Burkhard Wiechens (Hannover/D)
P-SU-241
Ten-year follow-up of a case series of primary
epithelial neoplasms of the lacrimal gland: clinical
features, surgical treatment and histopathologic
findings
Renato Damasceno (Erlangen/D)
P-SU-242
The Eyelid and Orbit Nomogram in Indian eyes:
A randomized cross sectional study
Prashant Yadav, Neelam Pushker, Varun Gogia,
Shikha Gupta, Mandeep Bajaj, Bhavna Chawla,
Mahesh Chandra (New Delhi/IND)
P-SU-243
The importance of axial globe projection in
the pathogenesis of involutional lower eyelid
malposition
Renato Damasceno (Erlangen/D)
P-SU-223
Mucosal spread of sebaceous cell carcinoma and
conjunctival melanoma through the lacrimal system
to the ethmoid sinus and nose.
Manpreet Chhabra, Jill Melicher Larson,
Jeffrey Nerad (Cincinnati/USA)
P-SU-224
Myxofibrosarcoma of the orbit
Sharifah Intan Syed Osman (Selangor/MAL)
P-SU-225
New technique for recanalisation of nasolacrimal
duct
Mirsad Ibisevic (Sarajevo/BIH)
P-SU-226
Oculoplastic reconstruction of the periocular region
after severe facial burns a case report
Peter Galambos, Hans-Werner Meyer-Rsenberg,
Ulrich Schaudig (Hamburg/D)
P-SU-227
One-step surgical management of severe
orbito-temporal neurofibromatosis
Jin Li, Xianqun Fan (Shanghai/CN)
P-SU-228
Ophthalmic Complications and their Avoidance
During Functional Endoscopic Sinus Surgery
Imtiaz Chaudhry, Yonca Arat, Waleed Al-Rashed,
Elsanusi Elzaridi, Adel Alsuhaibani, Manal
Bouhaimad, Milton Boniuk (Riyadh/SA,
Houston/USA)
P-SU-229
Orbital apex syndrome in Songklanagarind hospital
Orapan Aryasit (Songkhla/T)
P-SU-230
Primary non-Hodgkin's lymphoma of the lacrimal
sac: a case report
Natha Chongpison (Bangkok/T)
P-SU-231
Profound visual loss in a patient receiving
periorbital treatments of poly-(L)-lactic acid
Steve Roberts, Bryan Arthurs, Mark Gans,
Jean Deschenes, Mashad Darvish (Montreal/CDN)
P-SU-232
Quantitative Morphometry of Orbit in Chinese
Adults by a Three-dimensional Reconstruction
Method
Yongrong Ji (Shanghai/CN)
P-SU-233
Raising the quality of life in an ageing Society by
Oculplastic Surgery challenge and potential for
the Oculoplastic Surgeon
Hseyin Aral, Daniel Martin Handzel (Cologne/D)
Sunday, 6 June 2010 15:30 - 17:00
S
u
n
d
a
y
,

6

J
u
n
e
P
o
s
t
e
r
s
293
WOC
2010
P-SU-253
Effect of ultraviolet A1 and infrared A irradiation
on viability and vascular endothelial growth factor
secretion of retinal pigment epithelial cells.
Stefan Koinzer, Alexa Klettner, Felix Treumer,
Agatha Schwarz, Christian Jantschitsch,
Kirstin Reinecke, Johann Roider (Kiel/D)
P-SU-254
Generation of retinal pigment epithelial cells from
human induced pluripotent stem cells
Tim U. Krohne, Mandy Lehmann, David F.
Friedlander, Alison Dorsey, Wenlin Li, Ding Sheng,
Martin Friedlander (La Jolla/USA)
P-SU-255
Generation of transgenic zebrafish lines with
human rhodopsin mutations
Motokazu Tsujikawa, Yuzuru Sasamoto,
Nagakazu Matsumura, Takeshi Nakao (Suita/J)
P-SU-256
GM-CSF protects rat photoreceptors from death
by activating the SRC-dependent signalling and
elevating anti-apoptotic factors and neurotrophins
Maurice Schallenberg, Petar Charalambos,
Uwe Schrer, Solon Thanos (Essen/D, Mnster/D)
P-SU-257
Involvement of P2X7 receptors in the hypoxia-in-
duced death of rat retinal neurons
Tetsuya Sugiyama, Hidehiro Oku, Maho Shibata,
Masayuki Fukuhara, Shota Kojima, Tsunehiko Ikeda
(Takatsuki/J)
P-SU-258
Laminin and other Basement Membrane Proetins
Alterations in the Mouse Retina of three different
diabetic mouse strains
Elizabeth Abari, Alexander Kunze, Irina Semkova,
Norbert Kociok, Ursula Hartmann, Mats Paulsson,
Antonia M. Joussen (Duesseldorf/D, Berlin/D)
P-SU-259
Linoleic acid stimulates monocyte chemoattractant
factor (MCP)-1 expression through toll-like receptor
4 and NF-kappaB signal transduction pathway in
retinal pigment epithelial cells
Chang-Hao Yang, I-Mor Fang, Chung-May Yang
(Taipei/TJ)
P-SU-260
Macrophage mediated VEGF expression in retinal
neovascularization
Kristina Schmidt, Tina Lucas, Michael Piekarek,
Sabrina Klein, Elizabeth Abari, Irina Semkova,
Norbert Kociok, Sabine A. Eming, Antonia M.
Joussen (Duesseldorf/D, Berlin/D)
P-SU-261
Pharmacological Study of Proliferative Vitreo-
retinopathy
Wu Wen-Chuan (Kaohsiung City/TJ)
P-SU-244
The importance of being earnest
Bipasha Mukherjee (Chennai/IND)
P-SU-245
The management of orbital cavernous
haemangionas a case series study
Morgan Yang, Chai Teck Choo, Audrey Looi,
Lay Leng Seah (Singapore/SGP)
P-SU-246
The role of CD40-CD154 interaction in the
pathogenesis of Graves orbitopathy (GO)
Melissa Thanos, Elena Strher, Erich Gulbins,
Klaus Peter Steuhl, Joachim Esser, Anja Eckstein
(Essen/D)
P-SU-247
The use of Desmarres clamp for controlled
bleeding during excision of lid lesions
Tsiang Ung, Jonathan Chan, Ben While,
Tahir Farooq (Sheffield/UK)
P-SU-248
The use of FloSeal in external DCR
Ralf Ungerechts, Melanie Jger, Hans-Werner
Meyer-Rsenberg, Karl-Heinz Emmerich
(Darmstadt/D, Hagen/D, Giessen/D)
P-SU-249
Transcanalicular diode laser dacryocystorhinostomy
(TDCR) methods, indications and first results
Leonard Holbach, Anselm G. M. Jnemann,
Mansour Tarif, Ludwig M. Heindl, Rudolf Walker,
Reinhard Thyzel, Friedrich Kruse (Erlangen/D)
P-SU-250
Ultrasound Biomicroscopic Evaluation of the
Lacrimal Drainage System
Yasser Y. M. Hassan Al-Faky (Riyadh/SA)
P-SU-277
Psycho-emotional status of vegetative dysfunction
in patients With Sjoegrens Syndrome
Boris Kogan (Odessa/UA)
Retina: Basics P22
P-SU-251
ApoA-I Mimetic Peptide Reduces Lipid Deposition
in Murine Bruchs Membrane after Intravitreal
Injection
Martin Rudolf, Mark E. Clark, Jeffrey D. Messinger,
Salvatore Grisanti, David Garber, Christine A.
Curcio (Lbeck/D, Birmingham/USA)
P-SU-252
Characterisation of Primary Adult Human Retinal
Microglia
Balini Balasubramaniam, Elizabeth Nicholson,
Debra A. Carter, Eric J. Mayer, Andrew D. Randall,
Andrew D. Dick (Bristol/UK)
Sunday, 6 June 2010 15:30 - 17:00
S
u
n
d
a
y
,

6

J
u
n
e
P
o
s
t
e
r
s
294
WOC
2010
P-SU-272
Transdifferentiation and the involvement of Mller
glial cells in epiretinal cell proliferation of idiopathic
macular holes
Ricarda G. Schumann, Markus Schaumberger,
Kirsten Eibl, Christos Haritoglou, Anselm Kampik,
Retina: Trauma/Emergencies P23
P-SU-273
Soccer: one sport, two eye injuries
Gil Calvo-Santos, Joel Ferreira, Joo Chibante,
Antnio Gomes da Rocha, Jos Salgado-Borges
(So Mamede de Infesta/P)
P-SU-274
Subjective and Objective Visual Disability
Assessment in Patients with Open Globe Injuries
Mayuri Bhargava, Usha Vasu (Bangalore/IND)
P-SU-275
Traumatic retinal detachment: our surgical
approach
Volha Yarmak, Tatsiana Imshenetskaya
(Saslauje/BY, Minsk/BY)
P-SU-276
Valsalva Retinopathy after vigorous sexual activity
under the influence of Sildenafil
Andre Schafia, Zisis Gatzioufas, Kouris Ninios,
Ursula Lw, Berthold Seitz (Homburg/D)
P-SU-262
Photoreceptor Cell Death in a Zebrafish Model of
Autosomal Dominant Retinitis Pigmentosa
Takeshi Nakao, Motokazu Tsujikawa (Suita/J)
P-SU-263
Progression of Diabetic Retinopathy and diabetic
nephropathy are they parallel
A Alghadyan (Alkhober/SA)
P-SU-264
Protective Effects of Tempol Against Indocyanine
Green Induced Toxicity In Rats
Tomasz Choragiewicz, Andreas Schatz, Gabriel
Willmann, Bogomil Voykov, Florian Gekeler, Michal
Fiedorowicz, Frank Schuettauf, Tomasz Zarnowski,
Robert Rejdak, Sebastian Thaler (Lublin/PL,
Tbingen/D)
P-SU-265
Regulation of the casein kinase - 2 in retinal
pigment epithelial cells
Stephan Hoffmann, Hans-Sebastian Walter,
Berthold Seitz, Mathias Montenarh (Homburg/D)
P-SU-266
Replacement of photoreceptor cells in dystrophic
adult retinas by cell transplantation
Gila Jung, Gisbert Richard, Xiaoli Yang,
Marius Ader, Udo Bartsch (Hamburg/D)
P-SU-267
Retinal damage in Kimba mouse model
Li Cairui, Ali Rahman Ireni, May Lai Choo (Dali/CN)
P-SU-268
Systemic regulation of renin expression in the reti-
nal pigment epithelium
Olaf Strauss, Marisa Brockmann, Christian Meyer,
Vladimir Todorov, Michael Desch, Armin Kurtz,
Vladimir Milenkovic (Regensburg/D, Bielefeld/D)
P-SU-269
The Diabetic Retinopathy as a Cause of Visual
Acuity Decrease
Ihar Zabarouski, Tatsiana Imshanetskaya,
Galina Semak, Inna Malinouskaya (Minsk/BY)
P-SU-270
The distribution and characteristics of bone mar-
row-derived cells in the retina during physiological
and pathological angiogenesis
Keiko Kataoka, Koji M. Nishiguchi, Shu Kachi,
Hiroko Terasaki (Nagoya-city/J)
P-SU-271
Towards a stem cell-based intraocular delivery
system for therapeutically relevant gene products
Udo Bartsch, Gila Jung, Stephan Linke, Kristoffer
Weber, Boris Fehse, Bettina Petrowitz (Hamburg/D)
Monday, 7 June 2010 15:30 - 17:00
M
o
n
d
a
y
,

7

J
u
n
e
P
o
s
t
e
r
s
295
WOC
2010
P-MO-007
In vivo confocal microscopy of fungal keratitis
a case report
Simon Trpin, Levin Vrhovec, Tomaz Gracner
(Maribor/SI)
P-MO-008
Tear Film Osmolarity and Dry Eye Severity Index
in Patients with Rheumatoid Arthritis or Sjgren
Syndrome
Marc Schargus, Franziska Wolf, Ben Sulivan, Martin
Feuchtenberger, Gerd Geerling (Wuerzburg/D)
P-MO-009
The Effect of Topical Cyclosporine A Compared
with Preservative-free Artificial Tears in Dry Eye
Syndrome
Choun-Ki Joo (Seoul/ROK)
P-MO-010
The effect of wide incision cataract surgery to
corneal sensibility and dry eye
Paramastri Arintawati (Hiroshima/J)
P-MO-011
The Value of Real-Time Polymerase Chain Reaction
for the Diagnosis and Treatment of Acanthamoeba
Keratitis
Yoshifumi IKeda, Keiko Yakura, Ryu Uotani,
Fumie Otani, Atsuko Miyake, Ryoko Ishikura, Dai
Miyazaki, Yoshitsugu Inoue, Tsuyoshi Mito,
Atsushi Shiraishi, Yuichi Ohashi, Yusuke Saeki,
Kenji Yagita (Yonago/J)
Cornea/Eye Bank: Medical Therapy P25
P-MO-012
Antibiotic resistance and clinical outcome in culture
proven cases of microbial keratitis over a 5-year
period
Levin Vrhovec, Simon Trpin, Dusica Pahor
(Maribor/SI)
P-MO-013
Changing trends of bacterial keratitis after
penetrating keratoplasty in Saudi Arabia
Samar Al-Swailem, Michael Wagoner,
M. Bridget Zimmerman, John Sutphin (Riyadh/SA)
P-MO-014
Clinical Performance of an Osmoprotective
Formulation for Dry Eye Therapy
Peter Simmons, Joseph Vehige, Alan Sasai,
Cindy Carlisle-Wilcox, Melissa Blue, Francis Lai
(Irvine/USA)
P-MO-015
Efficacy of postoperative immunosuppression after
keratoplasty in herpetic keratitis
Anna-Karina Maier, Sevil zlgedik, Jessica Rottler,
Matthias Klamann, Sibylle Winterhalter,
Klaudia Huber, Florian Heussen, Antonia Joussen
(Duesseldorf/D)
Poster exhibition of Poster P-MO-001 to P-MO-298.
15:30 to 17:00 hrs.
Moderation Poster sessions on Monday
Chairs:
Gerd U. Auffarth (Heidelberg), Chair
Salvatore Grisanti (Lbeck), Chair
Co-Chairs:
Florian Birnbaum (Freiburg)
Silvia Bopp (Bremen)
Andrea Hassenstein (Hamburg)
Bernhard Jurklies (Essen)
Anja Liekfeld (Potsdam)
Mathias Maier (Munich)
Frank H. W. Tost (Greifswald)
Rainer Guthoff (Wuerzburg)
Hansjrgen T. Agostini (Freiburg)
Cornea/Eye Bank: Diagnostics P24
P-MO-001
A challenging case of perforated corneal ulcer
in Stevens-Johnson syndrome treated with
conjunctival hood
Rajeeb Alam, Syed A. Hassan, Halim Khan,
Rezaul Karim (Dhaka/BD)
P-MO-002
A novel method to detect subclinical keratoconus:
corneal volume measurements with pentacam
system.
Hasan Basri Cakmak, Nagihan Ugurlu, Nurullah
Cagl, Hseyin Simavl, aban im ek (Ankara/TR)
P-MO-003
Bilateral herpetic keratouveitis: a case report with
atypic presentaton
Osman Ceylan, Tugrul Akin, Orhan Ates
(Erzurum/TR)
P-MO-004
Congenital Hereditary Stromal Dystrophy (CHSD):
A diagnostic and management challenge
Rajeeb Alam (Dhaka/BD)
P-MO-005
Determination of significant variables for
keratoconus grading by factor analysis
Nagihan Ugurlu, Hasan Basri Cakmak, Nurullah
Cagl, Elif Damar, aban im ek (Ankara/TR)
P-MO-006
Evaluation of corneal topographic features and
corneal aberrations of keratoconus using ROC
(Receiver Operating Characteristic) curves
Omar Salamanca, Alejandro de la Torre (Cali/CO)
Monday, 7 June 2010 15:30 - 17:00
Glaucoma: Diagnostics P26
P-MO-055
The effect of anterior chamber depth on intraocular
pressure after uneventful phacoemulsification in
nonglaucomatous eyes
Tansu Gonen, Kadircan Keskinbora, Fatih
Horozoglu (Tekirdag/TR)
P-MO-027
A case report of trabeculectomy for high
intraocular pressure with hemodialysis
Yukinobu Okajima, Tetsuo Tochikubo,
Hiroshi Watanabe (Tokyo/J)
P-MO-028
A comparison of clinical diagnostic accuracy
between Octopus standard automated perimetry,
Pulsar perimetry, Moorfields Motion Displacement
Test and Heidelberg Retinal Tomography in
glaucoma detection.
Justyna Oleszczuk, Ciara Bergin, Eamon Sharkawi
(Warsaw/PL)
P-MO-029
Analysis of parapapillary fundus autofluorescence
using modified fundus photography and scanning
laser ophthalmoscopy
Ricarda Wienrich, Achim Langenbucher, Wolfgang
Behrens-Baumann, Arne Viestenz (Magdeburg/D)
P-MO-030
Angle closure glaucoma managed with lens extrac-
tion and viscodissection of the angle: a comparison
of anterior segment OCT and UBM.
Trushar Patel, Imran Masood, TK Jonathan Chan
(Sheffield/UK)
P-MO-031
Clinical Use of Transpalpebral Diaton Tonometry
after Keratophotorefractive Surgeries
Alla Illarionova, Tair Dzafarly (Moscow/RUS)
P-MO-032
Comparison of Fourier Domain Optical Coherence
Tomography (FD-OCT) Measurements in Subjects
With and Without Pupil Dilation
Esther Hoffmann (Mainz/D)
P-MO-033
Comparison of optic disc topographic measure-
ments using Fourier-Domain optical coherence
tomography and confocal scanning laser ophthal-
moscopy in glaucoma patients and normal subjects
Andreas Schulze, Julia Lamparter, Stefan Gnther,
Norbert Pfeiffer, Esther Hoffmann (Mainz/D)
P-MO-034
Correlations of Retinal Nerve Fiber Layer and Gan-
glion Cell Complex Measurements Using Fourier-
Domain Optical Coherence Tomography with Visual
Field Loss in Japanese Glaucoma Patients
Motohiro Shirakashi, Kiyoshi Yaoeda, Haruki Abe
(Niigata/J)
M
o
n
d
a
y
,

7

J
u
n
e
296
WOC
2010
P-MO-016
Immunosuppression with Mycofenolate Mofetil
(MMF) in high-risk keratoplasties
Jessica Rottler, Maier Anna-Karina, Sevil zlgedik,
Florian Heussen, Matthias Klamann, Klaudia
Huber-van der Velden, Sybille Winterhalter,
Antonia Joussen (Essen/D)
P-MO-017
Management of keratopathies by tear substitutes:
the right protocol.
Lorenzo Mannucci (Padova/I)
P-MO-018
Mesenchymal Stem Cells Prolong the Survival of
Corneal Allograft in Rats by Inhibiting Th1-depen-
dent Immune Response
Xiaomin Zhang, Chunna Jiao, Xiaorong Li,
Shaozhen Zhao (Tianjin/CN)
P-MO-019
Optical quality of the cornea following collagen
cross-linking for keratoconus
Martin Baumeister, Jens Bhren, Thomas Kohnen
(Frankfurt/D)
P-MO-020
Photodynamic Therapy of Corneal Neovasculariza-
tion with Verteporfin
P-MO-021
The effect of human and rabbit serum on the
recovery of the wounded corneal surface in the
Ex vivo Eye Irritation test
Norbert Schrage (Cologne/D)
P-MO-022
The influence of 0.15 % hyaluronic acid solution
(OXYAL) treatment on ocular aberrations in dry eye
patients
Anna Rogowska-Godela, Katarzyna Buczak-
Gasinska, Ewa Mrukwa-Kominek (Katowice/PL)
P-MO-023
Topical Gancyclovir 0,15% Ophthalmic Gel for
Herpes Keratitis Treatment
Camila Geraissate, Heloisa Nascimento, Rubens
Belfort Jr, Denise Freitas (Sao Paulo/BR)
P-MO-024
Treatment of dry eye caused by inadequate lid
closure.
Claes Feinbaum (Landskrona/S)
P-MO-025
UVA-Riboflavin Collagen Crosslinking in Corneal
Ulcer
Sebastian Kupferschmid, Gerhard K. Lang (Ulm/D)
P
o
s
t
e
r
s
Monday, 7 June 2010 15:30 - 17:00
P-MO-043
Imaging of Nerve Fiber Layer Defects in Glaucoma
using Speckle Noise-reduced Spectral-domain
Optical Coherence Tomography
Masayuki Nukada, Masanori Hangai, Satoshi Mori,
Noriko Nakano, Yuriko Kotera, Hideo Nakanishi,
Hanako Ikeda, Hajime Nakamura, Atushi Nonaka,
Nagahisa Yoshimura (Anshuyamakawatyo/J)
P-MO-044
Iris Color & Central Corneal Thickness in Glaucoma.
Does Blue Iris portend Thick Cornea?
Sriram Sonty, Sindhura Pisipati, Afzal Ahmad
(Flossmoor/USA)
P-MO-045
Learning Curve of Flicker Defined Form Perimetry
Julia Lamparter, Andreas Schulze, Ann-Christin
Schuff, Norbert Pfeiffer, Esther M. Hoffmann
(Mainz/D)
P-MO-046
Low hysteresis, low pachymetry, low Goldmann
tonometry in healthy and glaucomatous Mexican
patients: comparison of Goldmann, pascal and
ocular response analyzer
Jess Jimnez-Roman, Oscar Albis-Donado,
Daniel de la Torre-Tovar (Mexico City/MEX)
P-MO-047
Macular ganglion cell complex in glaucoma
Jose Javier Garcia-Medina, Manuel Garcia-Medina,
Francisca Fernandez de Benito, Vicente Zanon-
Moreno, Maria Dolores Pinazo-Duran (Huercal-
Overa/E, Almeria/E)
P-MO-048
Normal Tension Glaucoma Mislead Diagnosis;
case presentation
Alina Popa Cherecheanu, Ruxandra Pascu, Mihai
Ghita (Bucharest/RO)
P-MO-049
Optic neuropathy in Alzheimers disease versus
glaucomatous optic neuropathy
Fatmire Berisha, Gilbert T. Feke, Clement L. Trempe,
J. Wallace McMeel, Norbert Pfeiffer,
Charles L. Schepens (Mainz/D)
P-MO-050
Post traumatic 360 degree recession angle
glaucoma
Lus Abego Pinto, Ana Amaral, Paula Leito,
Joana Ferreira, Joo Lisboa (Belas/P)
P-MO-051
Racial Differences in Central Corneal Thickness in
Narrow Angle Glaucoma Patients and correlation
with the Severity of Glaucoma from a Community
Practice
Afzal Ahmad, Sriram Sonty, Sindhura Pisipati
(Flossmoor/USA)
M
o
n
d
a
y
,

7

J
u
n
e
297
WOC
2010
P-MO-035
Dark adaptation and macular blood flow in patients
with primary chronic open-angle glaucoma, pseu-
doexfoliation glaucoma or congenital glaucoma.
Zisis Gkatzioufas, Marilita Moschos, Ursula Lw,
Christian Jonescu-Cuypers, Berthold Seitz (Hom-
burg/D)
P-MO-036
Detection of psychophysical and structural
abnormalities in an outpatient setting using
frequency doubling technology (FDT) perimetry,
scanning laser polarimetry (GDx-VCC), and optical
coherence tomography (Stratus OCT)
Daniel Herzog, Joachim Herzog, Nicola Rauch,
Lorenz Barleon, Norbert Pfeiffer, Esther Hoffmann
(Mainz/D)
P-MO-037
Differences in corneal biomechanics of patients
with unilateral open angle glaucoma
Christoph Hirneiss (Munich/D)
P-MO-038
DynamicContourTonometry, Goldmann Applana-
tion Tonometry and TonoPen vs. intracameral read-
ings A Comparison of three measurement devices
in patients with corneal pathologies
Matthias Neuburger, Philip Maier, Florian Birnbaum,
Juliane Growendt, Sonja Lautebach,
Daniel Bhringer, Thomas Reinhard, Jens F. Jordan
(Freiburg/D)
P-MO-039
EDMAGS (Evonik-Degussa-Mainz-Glaucoma-Study)
IV: The Glaucoma Probability Score of the Heidel-
berg Retina Tomograph (HRT 3.0) as a Screening
Unit for Glaucoma
Lorenz Barleon, Claudia Deters, Esther Hoffmann,
Jochen Wahl, Peter Morfeld, Andrea Lichtme,
Sibylle Haas-Brhler, Rolf Breitstadt, Norbert Pfeiffer
(Mainz/D)
P-MO-040
Electrophysiological Detection of Glaucoma using
Silent Substitution Technique
Patrick Bessler, Sascha Klee, Ulrich Kellner, Jens
Haueisen (Ilmenau/D)
P-MO-041
Evaluation of filtering blebs using the Wuerzburg
bleb classification score compared to other clinical
findings
Sandra Furrer, Marc Tteberg-Harms, Cornelia Hirn,
Peter Paul Ciechanowski, Jens Funk (Zurich/CH)
P-MO-042
Factors Associated with Retinal Nerve Fiber Layer
Thickness Measurements Using Scanning Laser
Polarimetry with Variable Corneal Compensation
and Enhanced Corneal Compensation in Normal
Japanese Subjects
Takayuki Tanaka, Motohiro Shirakashi, Kiyoshi
Yaoeda, Haruki Abe (Niigata/J)
P
o
s
t
e
r
s
Monday, 7 June 2010 15:30 - 17:00
M
o
n
d
a
y
,

7

J
u
n
e
298
WOC
2010
P
o
s
t
e
r
s
P-MO-062
Central Corneal Thickness as a Parameter in
Patients with Glaucoma or Ocular Hypertension:
Results of the German MoviX Survey
Ines Ecke, Claudia Guzy, Richard Stodtmeister
(Rodalben/D)
P-MO-063
Comparison of Latanoprost and Timolol in
Pediatric Glaucoma Patients: a Phase 3, 12-week,
Double-Masked Multicenter Study
Tomoko Maeda, Katherine Chi-Burris, Barbara
Wirostko, PANDA Study Group (San Diego/USA)
P-MO-064
Comparison of the effects of tafluprost and l
atanoprost on intraocular pressure and ocular
surface findings
Katsuyoshi Suzuki, Takeshi Sagara, Hideaki Yoshino,
Masako Nakayama, Miho Enoki, Shinji Hirano,
Norihisa Takahashi, Kayoko Tokuhisa,
Yasuhito Ishida, Shinichiro Teranishi, Rie Matsuda,
Atsuko Tanaka, Teruo Nishida (Ube-city/J)
P-MO-065
Effect of a new audible and visual reminder system
on adherence with topical ocular therapy
Manuel Hermann, Lebriz Ersoy, Michael Diestel-
horst (Cologne/D)
P-MO-066
Efficacy of Selective Laser Trabeculoplasty as first-
line treatment of primary open-angle glaucoma in
Moroccan patients
Youssef Zekraoui, Adil Megzari, Tarik El Alloussi,
Othmane Bourmani, Abdelkarim Boulanouar,
Amina Berraho (Rabat/MA)
P-MO-067
Evaluation of 24-hour post-dose efficacy of travo-
prost-timolol and latanoprost-timolol fixed-combi-
nations in patients with open-angle glaucoma
Navroop Gill, David B. Yan (Toronto/CDN)
P-MO-068
Intravitreal injection of bevacizumab for
neovascular glaucoma post vitrectomy.
Aya Oi, Tetsuo Tochikubo, Yuka Suzuki,
Hiroshi Watanabe (Tokyo/J)
P-MO-069
Mikelan LA 2% ophthalmic solution Phase 4
investigation of the effectiveness and safety
Kazuhide Kawase (Gifu/J)
P-MO-070
Ocular Hypotensive Efficacy of Bimatoprost
(0.03%) over a 64 Hour Period in Patients with
Elevated Intraocular Pressure
Muthusamy Malaravan, Dushyantha Wariyapola
(Dehiwala/CL)
P-MO-052
Role of optical coherence tomography in measuring
retinal nerve fibre thickness in normal subjects and
patients of open angle glaucoma
Arif Adenwala (Sharjah/UAE)
P-MO-053
Screening method for visualisation of a glaucoma-
tous ciliary body condition
Vi tor Morkhat, Maryia Morkhat (Vitebsk/BY)
P-MO-054
Simultaneous GDX & OCT Imaging in Glaucoma-
tous eyes with Disc Hemorrhages showing Visual
Field Defects preceding Disc Damage on Imaging
with minimum 6 Months Follow-up.
Sriram Sonty, Afzal Ahmad (Flossmoor/USA)
P-MO-056
The usefulness of anterior segment optical coher-
ence tomography for evaluation of the iridocorneal
angle width before and after laser peripheral
iridotomy in a cohort of 150 narrow-angle glau-
coma patients
Ewa Mielniczuk, Ewa Mrukwa-Kominek,
Lukasz Drzyzga, Wanda Romaniuk (Katowice/PL)
P-MO-057
The Visual Disability Likelihood Score: Comparison
with Standard Measures of Vision
George L. Spaeth (Philadelphia/USA)
Glaucoma: Medical Therapy P27
P-MO-058
Comparison of the effects of travoprost plus timolol
preserved with either benzalkonium chloride (BAK)
or polyquad (PQ) on cultured human ocular surface
epithelial cells
David A. Ammar, Malik Y. Kahook (Aurora/USA)
P-MO-059
Comparison of the Effects of Travoprost Preserved
with Benzalkonium Chloride (BAK) Versus Polyquad
(PQ) on Cultured Human Ocular Surface Epithelial
Cells
David A. Ammar, Malik Y. Kahook (Aurora/USA)
P-MO-060
A randomized crossover study comparing efficacy
of latanoprost and travoprost in open-angle
glaucoma.
Akira Sawada, Tetsuya Yamamoto (Gifu/J)
P-MO-061
Cataract and ocular hypertension in children on
inhaled corticosteroid therapy
Adel Aljazzaf (Kuwait/KWT)
Monday, 7 June 2010 15:30 - 17:00
M
o
n
d
a
y
,

7

J
u
n
e
299
WOC
2010
P
o
s
t
e
r
s
P-MO-079
Buckling surgery for retinal detachment in Nairobi,
Kenya between 2005 and 2009: case series
K. H. Martin Kollmann, Oscar M. Onyango,
Patrick T. Nyaga, Carl-Ludwig Schnfeld
(Nairobi/EAK, Munich/D)
P-MO-080
Knowledge, skills and productivity of primary eye
care providers in Tanzania
Paul Courtright (Moshi/EAT)
P-MO-081
Ocular multibacillary leprosy profile among Filipinos
released from multi-drug therapy
Ronnie Manaysay, Ian Paredes (Manila/RP)
P-MO-082
Prevalence and Causes of Decreased Vision in a
Tunisian Diabetic Population
Ben Yahia Salim, Messaoud Riadh, Hasnaoui Wafa,
Khochtali Ines, Jenzeri Salah, Moncef Khairallah
(Monastir/TN)
P-MO-083
Prevention of traumatic corneal ulcer an
intervention project in a rural province in Cambodia
Manfred Mrchen, Sun Sarin, M. P. Upadhyay
(Phnom Penh/K)
P-MO-084
Pseudophakic rhegmatogenous retinal detachment
in a large Asian tertiary eye centre a cohort study
Desmond Quek, Shu Yen Lee, Hla Myint Htoon,
Chong Lye Ang (Singapore/SGP)
P-MO-085
Renaissance of the slit-lamp
Marcus-Matthias Gellrich (Kellinghusen/D)
P-MO-086
The Offer of Cataract Surgery: Determinants of
Acceptance following Outreach Eye Clinics in South
India.
David G. Kupitz, Frank G. Holz, Seetha
Chandrasekhar, Bharath Balasubramaniam,
R. V. Ramani, Robert P. Finger (Bonn/D)
P-MO-087
Translating successes at Aravind to sub Saharan
Africa
Susan Lewallen, Thulasiraj Ravilla (Moshi/EAT)
P-MO-088
Vitreoretinal Training program Munich Nairobi:
10 years of experience
Carl-Ludwig Schnfeld, Oscar M. Onyango,
Patrick T. Nyaga, K. H. Martin Kollmann, Volker
Klauss, Anselm Kampik (Munich/D, Nairobi/EAK)
P-MO-071
Patient- and Physician-Reported Satisfaction Follow-
ing Treatment with Bimatoprost 0.01% or Vehicle
in Patients with Glaucoma or Ocular Hypertension
(OHT)
E. Randy Craven, Ton Lin, Thomas K. Mundorf,
Michael Tepedino, Ronald Frenkel, John G. Walt,
Ching-chi Liu, Amy L. Batoosingh (Parker/USA)
P-MO-072
Patient Satisfaction Before and After Changing
Ocular Hypotensive Therapy to Latanoprost/Timolol
Fixed-Combination (LTFC)
Kristian Gerstmeyer, Friedhelm Leverkus, Carsten
Oliver Schmidt, Thomas Kohlmann (Minden/D)
P-MO-073
Prospective, Observational Study of the Long-term
Effect of Latanoprost/Timolol Fixed Combination
(LTFC) in Patients with Glaucoma or Ocular Hyper-
tension
Oliver Schwenn, Barbara Heckmann, Claudia Guzy
(Frankfurt/D)
P-MO-074
Relationship Between Patient Tolerability and
Efficacy When Switching from Dorzolamide/Timolol
to Brimonidine/Timolol Fixed Combination in the
Treatment of Open Angle Glaucoma
Jacqueline Freudenthal, Dan Pericak,
Susan Simonyi, David B. Yan (Toronto/CDN)
P-MO-075
Retrobulbar hemodynamics after oculopression
with and without prior Dorzolamide treatment
Klaudia Huber-van der Velden, Matthias Klamann,
Andreas Remky (Cologne/D, Aachen/D, Berlin/D)
P-MO-076
Toxicological evaluation of preservative-containing
and preservative-free prostaglandin analogs on the
3D-reconstituted corneal epithelium (SkinEthic)
system
Hong Liang (Paris/F)
P-MO-077
Treatment of Glaucomatous Visual Fields by Novel
Nutritional Supplement: Comparison of Group and
Individual Approach.
Meir Gorban (Givataim/IL)
International Ophthalmology P28
P-MO-078
Are wet and dry labs old fashioned?
Jorge Topete-Jimenez, Gerardo Gabriel Perez-
Solorzano, Ivan Dario Sanchez-Amaya
(Guadalajara/MEX)
Monday, 7 June 2010 15:30 - 17:00
M
o
n
d
a
y
,

7

J
u
n
e
300
WOC
2010
P
o
s
t
e
r
s
P-MO-099
Optical visual acuity simulation with a virtual eye
model based on cubic spline reconstruction of the
cornea.
Luis Moreno, Jorge Ali, Antonio Fimia (Alicante/E)
P-MO-100
Prototype for evaluating surgical corneal residual
astigmatism
Liliane Ventura, Homero Schiabel, Jean-Jacques De
Groote, Sidney Julio Faria e Sousa (Sao Carlos/BR)
P-MO-101
Prototype for evaluation of UVA natural protection
of the cornea
Liliane Ventura, Victor A. C. Lincoln, Homero
Schiabel, Sidney Julio Faria e Sousa (Sao Carlos/BR)
P-MO-102
Silicone oil as carrier for drug-delivery interaction
between silicone oil and corticosteroids
Benjamin Braun, Thorsten Lechner, Ulrike Wolf,
Hans Hoerauf, Dirk-Henning Menz (Hipstedt/D,
Gttingen/D)
P-MO-103
The Impact of Free Access on Citations to the
Vision Literature
Pamela Sieving (Bethesda/USA)
P-MO-104
The learning curve on ophthalmologic surgery:
experimental model versus traditional and practical
model
Eglis Esteban Garca Alcolea (Ciudad Habana/C)
P-MO-105
Whether the traditional idea of treatment of the
opening injury of the anterior chamber needs to be
changed?
Zhizhong Ma (Beijing/CN)
Refractive Surgery/Refraction P30
P-MO-131
Personal experience with Toric ARTIFLEX
P-MO-106
Advanced Cataract Surgery with Multifocal IOL
Implantation: Two-Year Follow-Up
P-MO-107
Advanced Surface Ablation in High Myopia at
JoGJA Lasik Center Dr.Yap Eye Hospital
Wasisidi Gunawan (Jogjakarta/RI)
P-MO-108
Bilateral acute angle-closure glaucoma after implan-
tation of an angle-supported anterior chamber lense
Matthias Schmidt, Julia Promesberger, Constantin
E. Uhlig (Mnster/D)
Miscellaneous P29
P-MO-089
A case of mucosa-associated lymphoid tissue
(MALT) lymphoma with difficulties of remove due
to infiltration into extraocular muscles
Yuka Suzuki, Tetsuo Tochikubo, Aya Oi, Hiroshi
Watanabe (Tokyo/J)
P-MO-090
Acupuncture and Chinese herb for Dry Eye disease
Ying-Ling Chen, Mark Chun-Cheng Hou, Lun-
Chien Lo, Chang-Pin Lin (Changhua/TJ)
P-MO-091
Anterior OCT diagnostic possibilities in conjunctival
tumors and filtering blebs
Mykolas Pajaujis, Rimvydas Asoklis,
Donatas Petroska (Vilnius/LT)
P-MO-092
Bibliometric Analysis in Ophthalmology: journal
impact factor change over the last decade
Muhammad Younis, Ahmad Mansour,
George Mollayes (Manchester/RL)
P-MO-093
Central corneal thickness, intraocular pressure
and degree of myopia in a myopic population of
Southeast Spain
Manuel Garcia-Medina, Jose Javier Garcia-Medina,
Francisca Fernandez de Benito, Vicente Zanon-
Moreno, Maria Dolores Pinazo-Duran (Almeria/E)
P-MO-094
Comparison of Intraocular Pressure after Minimal
Incision Cataract Surgery Using the Soft-shell
Technique and various Ophthalmic Viscoelastic
Devices including the dual OVDs Sealing Technique
Takao Tanaka (Tokyo/J)
P-MO-095
Influence of eye concomitant pathology on the
surgery complications frequency at the following
operations
Olga Levanova (Kirow/RUS)
P-MO-096
Isaac Newton on the Eye and Vision
P-MO-097
Lifesaving Ophthalmology Case reports of young
patients with intracerebral tumoration diagnosed
by an ophthalmologist
Stephanie Rohrweck, Ana Suelves, Diamar Pardo,
Salvador Garcia-Delpech, David Salom, Patricia
Udaondo, Manuel Diaz-Llopis (Valencia/E)
P-MO-098
Ocular infections due to Methicillin-resistant
staphylococcus aureus
Cecilia Moeller, M. C. S. Yu, P. Bispo, A. S.
Moriyama, A. C. Pignatari, A. L. Hfling-Lima (So
Paulo/BR)
P
o
s
t
e
r
s
Monday, 7 June 2010 15:30 - 17:00
M
o
n
d
a
y
,

7

J
u
n
e
301
WOC
2010
P
o
s
t
e
r
s
P-MO-118
Effect of the amount of myopic correction on
long-term changes of higher-order wavefront
aberrations after advanced surface ablation-
photorefractive keratectomy (ASA-PRK)
Sang-Bumm Lee, Jin-Seon Kim, Jun-yeup Lee
(Daegu/ROK)
P-MO-119
Effects of Femtosecond Laser-assisted Multilayer
Intrastromal Ablation in the Mid-peripheral Cornea:
Clinical Findings in Two Patients
Zhen-Yong Zhang, Xing-Ru Zhang, Ren-Yuan Chu
(Shanghai/CN)
P-MO-120
Evaluation of Keratometry: Natural corneal
changes, measurement accuracy, influence of
incision sizes and their effect for toric IOL
calculations
Wolfram Wehner (Nrnberg/D)
P-MO-121
Extended depth of focus intra-ocular lens tolerance
to typical corneal aberrations
Alex Zlotnik, Ido Raveh, Shai Ben Yaish, Oren
Yehezkel, Michael Belkin, Zeev Zalevsky
(Hashomer/IL)
P-MO-122
Female/male differences in acceptance and
satisfaction of multifocal IOLs
Magda Rau (Cham/D)
P-MO-123
Femtosecond laser assisted astigmatic keratotomy
(Femto-AK) for high postkeratoplasty astigmatism:
one-year follow-up
Laszlo Kiraly, Anna Sasse, Gernot Duncker (Halle/D)
P-MO-124
First results after the light-adjustable-lens
implantation
Tobias Neuhann, Elisabeth Jakobs (Munich/D)
P-MO-125
Improvement of precise axis marking for TIOLs at
the slit-lamp with the assistance of a special ocular
Wolfram Wehner (Nrnberg/D)
P-MO-126
Intracor Presbyopic Correction Combined with
Cataract Surgery
Carlos Gutierrez-Amoros (La Corua/E)
P-MO-127
Intrastromal Correction of Presbyopia with
Femtosecond Laser
Wilhelm Gromann (Duisburg/D)
P-MO-128
Lasik in High Hyperopia
Diego de Ortueta (Recklinghausen/D)
P-MO-109
Cataract surgery with implantation of the M-FLEX
630F multifocal IOL with +3,0 and +4,0 diopters
addition for near.
Ewa Mrukwa-Kominek, Pawel Stala, Katarzyna
Buczak-Gasinska (Katowice/PL)
P-MO-110
Choosing a proper aspheric IOL designs for an
individual eye
Stefan Pieh, Werner Fiala (Vienna/A)
P-MO-111
Clinical outcomes of LASIK for high hyperopia:
+4.00 to +7.50 D
Dan Reinstein, Timothy Archer, Marine Gobbe
(London/UK)
P-MO-112
Comparison of different presbyopia treatments:
Refractive lens exchange with multifocal intraocular
lens implantation Vs. LASIK Monovision
Ante Barisic, Nikica Gabric, Iva Dekaris, Ivana
Romac, Maja Bohac, Branka Juric, Vlade Glavota
(Zagreb/HR)
P-MO-113
Complications of lamellar keratorefractive surgery
Volodymyr Usov, Elena Dragomyretskaya
(Odessa/UA)
P-MO-114
Correction of corneal astigmatism in cataract and
refractive lens surgery 3-month-results with the
Acri.Comfort 646 TLC
Daniel Martin Handzel, Raimund M. Remmel,
Claudia M. Dardenne, Detlev R. H. Breyer (Bonn/D)
P-MO-115
Correction of irregular astigmatism in post trans-
planted corneas with topography based photore-
fractive keratectomy (Topolink)
G. Macedo, Rossen Hazarbassanov, E. Martinez,
A. L. Hfling-Lima (Sao Paulo/BR)
P-MO-116
Correction of post-keratoplasty astigmatism with
astigmatic keratotomy using the femtosecond laser
Daniel Kook, Jens Bhren, Anna Sophia Bauch,
Oliver Klaproth, Victor Derhartunian, Thomas
Kohnen (Munich/D, Frankfurt/D)
P-MO-117
Effect of mitomycin C on refractive results after
laser-assisted subepithelial keratectomy to correct
myopia.
Montserrat Garcia-Gonzalez, Marta Ibarz-Barbera,
Esther Arranz-Marquez, Laura De Benito-Llopis,
Miguel A. Teus (Madrid/E)
P
o
s
t
e
r
s
Monday, 7 June 2010 15:30 - 17:00
M
o
n
d
a
y
,

7

J
u
n
e
302
WOC
2010
P
o
s
t
e
r
s
P-MO-141
Toric multifocal IOL after twice penetrating injury
Hans-Jrgen Buchwald, Gerhard K. Lang (Ulm/D)
P-MO-142
Up-regulation of the production of interferon-
gamma and the gene expression of the inducible
no-synthase after excimer laser ablation in rat
corneas
Javier Prada, Thanh Ngo-Tu (Berlin/D)
P-MO-143
Visual Recovery After Corneal Enhancement in
Either Femtosecond or Microkeratome Created
Flaps
Marta Ibarz, Montserrat Garcia-Gonzalez,
Laura de Benito, Miguel Teus (Madrid/E)
P-MO-144
Wavefront Analysis of centration in Hyperopic
LASIK: Line of Sight vs. Visual Axis
Uwe Oberheide, Georg Gerten, Karl Schmiedt,
Omid Kermani (Cologne/D)
P-MO-145
What lies Beneath?
Retina/Chorioidea/RPE/Vitreous P31
P-MO-146
One-year follow-up of the treatment of SRH in
AMD with combined 23-gauge core vitrectomy and
injection of rtPA, expansile gas and bevacizumab
Carolin Perz, Julia Konrad, Nikolaus Feucht,
Chris Patrick Lohmann, Mathias Maier (Munich/D)
P-MO-147
Choroidal Folds in Supra venacaval obstruction;
A case Report
Mohamed Naved Abdul Karim, Deepa S. Rathore,
Peter Baranyovits (Kettering/UK)
P-MO-148
Corneal epitheliopathy following Trabeculectomy
with intraoperative 5-Fluorouracil (5FU) or
Mitomycin C (MMC) and postoperative adjunctive
5-Fluorouracil in 381 Patients
Constantin Reiter, S. Wimmer, A. Schultheiss,
Thomas Klink, Franz Grehn, Gerd Geerling
(Wuerzburg/D)
P-MO-149
Differential diagnosis of rod or cone dystrophy
using optical coherence tomography
Midori Yokochi, Shoji Kishi (Maebashi/J)
P-MO-150
Effect of HDAC Inhibitors on Retinal Cells
Shalesh Kaushal (Worcester/USA)
P-MO-129
LASIK with Optimized Prolate Ablation Profile (OPA)
versus LASIK with Conventional Ablation Profile
using NIDEK Platform. 12 Months Results
Alaa El Danasoury (Jeddah/SA)
P-MO-130
Lens Surgery Inclusion Criteria for Glaucoma
Prevention in Eyes with shallow ACD and Narrow
Angle
P-MO-132
PRK and Off Flap Epi-Lasik in Different Age at
JoGJA Lasik Center Dr.Yap Eye Hospital
Rinanto Prabowo (Jogjakarta/RI)
P-MO-133
Quality of vision and quality of life after implanta-
tion with the multifocal Diffractiva Diff-s IOL in
a series of 200 eyes with cataract.
Serge Zaluski (Perpignan/F)
P-MO-134
Refractive Surgery to the Rescue
P-MO-135
ReStor Multifocal Lens in Radial Keratotomy Eyes
P-MO-136
Shape change of crystalline lens of human eyes
after accommodation
Xiaobing Wang, Qinghua Chen, Aizhen Liu,
Ping Liu (Beijing/CN)
P-MO-137
Sudden changes in intraocular pressure during flap
preparation: Comparison between 4 femtosecond
lasers and one microkeratome in porcine eyes
Jan Markus Vetter, Christian Teping, Wolf E.
Weingrnter, David Garcia-Bardon, Adrian Gericke,
Paul R. Preussner, Walter Sekundo (Mainz/D)
P-MO-138
The influence of high order aberrations (HOAs)
on the dynamic visual acuity (DVA) between pre-
and post LASIK.
Futoshi Taketani, Toyoaki Matsuura, Tokuko Hara,
Yoshiaki Hara (Kashihara Nara/J)
P-MO-139
Tilt, Decentration and anterior chamber depth of
ICL: Result of an one year period
Yunwoong Chung, Sung Kun Chung (Seoul/ROK)
P-MO-140
Topographical changes after Myopic LASEK
Diego de Ortueta (Recklinghausen/D)
P
o
s
t
e
r
s
Monday, 7 June 2010 15:30 - 17:00
M
o
n
d
a
y
,

7

J
u
n
e
303
WOC
2010
P
o
s
t
e
r
s
P-MO-160
New genetic approaches to understanding
choroidal neovascularization in relation to Vascular
Endothelial Growth Factor (VEGF) And Brain
Derived Neurotrophic Factor (BDNF) expression in
super p53 mice.
Maria D. Pinazo-Duran, Roberto Gallego-Pinazo,
Vicente Zanon-Moreno, Sheila Pons-Vzquez,
Jose Javier Garcia-Medina, Ignacio Vinuesa Silva,
Manuel Serrano (Valencia/E)
P-MO-161
Photodynamic therapy (PDT) for the treatment of
corneal neovascularization in children
M. Fortunato, Giuseppe Carollo, R. Maggi, A.
Ubaldi, L. Buzzonetti (Palermo/I)
P-MO-162
Picture of macula in optical coherence tomography
in retinal detachment in children with various
etiology description of casus
Erita Filipek, Lidia Nawrocka, Maria Forminska-
Kapuscik, Ewa Mrukwa-Kominek, Ewa Pieczara
(Katowice/PL)
P-MO-163
Retinal nerve fiber layer thickness following pars
plana vitrectomy for rhegmatogenous retinal
detachment
Yuta Ueno, Fumiki Okamoto, Yoshifumi Okamoto,
Tetsuro Oshika (Tsukuba/J)
P-MO-164
Spontaneous closure of postoperative persisting
full thickness macular hole
Karen Schaal, Till Oppermann, Johann Roider,
Stefan Dithmar (Heidelberg/D, Kiel/D)
P-MO-165
Subfoveal choroidal thickness in fellow eyes of
patients with central serous chorioretinopathy
Ichiro Maruko, Yukinori Sugano, Akira Ojima,
Tetsuju Sekiryu, Tomohiro Iida (Fukushima/J)
P-MO-166
Sub-Tenon Injection of Triamcinolone Acetonide
without oral steroid in Vogt-Koyanagi-Harada
syndrome
Mariko Enoki, Shoji Kishi (Maebashi/J)
P-MO-167
The application of silicone saccus lacrimalis
supporting tube in nasal endoscopic
dacryocystorhinostomy (DCR)
Jin Lu Fan, Di Lu (Heng Yang/CN)
P-MO-168
The characteristics of coloboma of the choroid
with optical coherence tomography
Li Juanjuan (Kunming/CN)
P-MO-151
Effects of VEGF-antagonists on RPE cells in vitro
Alexa Klettner, Tim Meyer, Friederike Mhle,
Daniela Wesch, Dieter Kabelitz, Johann Roider
(Kiel/D)
P-MO-152
Evaluation of Ophthalmic complications in type
II diabet mellitus Babol-Iran
Abbas Soleymani, Amin Gorjizadeh, S. R. Hosseini
(Babol/IR)
P-MO-153
Impaired retinal blood flow in patients with type 2
diabetes mellitus and chronic kidney disease
Taiji Nagaoka, Atsushi Takahashi, Eiichi Sato,
Kenji Sogawa, Tsuneaki Omae, Seigo Nakabayashi,
Akihiro Ishibazawa, Ichiro Tanano, Tomofumi Tani,
Akitoshi Yoshida (Asahikawa/J)
P-MO-154
Internal limiting membrane which could be peeled
over the optic nerve head in vitreous surgery for
optic disc pit maculopathy
Toshiyuki Fujiwara (Akita/J)
P-MO-155
Intraocular Worm
Tri Wahyu Widayanti, Angela Nurini Agni
(Yogyakarta/RI)
P-MO-156
Macrophages in the ultrastructure of PDR
membranes and subretinal AMD membranes-
a possible role in neoangiogenesis.
Christina Nicolaeva Vidinova, Pravoslava
Gougoutchkova, Kalin Vidinov (Sofia/BG)
P-MO-157
Modulation of cytokine expression by protein
tyrosine phosphatase inhibition in retinal pigment
epithelial cells
David Arthur Mrker, Renate Foeckler,
Vladimir Milenkovic, Olaf Strauss, Horst Helbig,
Tina Dietrich (Regensburg/D)
P-MO-158
Monitoring Disease Progression in Macular
Telangiectasia Type 2 on Spectral-Domain Optical
Coherence Tomography
Snke Baumller, Peter Charbel Issa, Hendrik P. N.
Scholl, Steffen Schmitz Valckenberg, Frank G. Holz
(Bonn/D)
P-MO-159
Morning Glory Disc anomaly with cystic appear-
ance in orbit and retinal detachment in a premature
infant
Susanne Butros, Gerhard K. Lang, Cecilia Setiobudi,
Hans-Jrgen Buchwald (Ulm/D)
P
o
s
t
e
r
s
Monday, 7 June 2010 15:30 - 17:00
M
o
n
d
a
y
,

7

J
u
n
e
304
WOC
2010
P
o
s
t
e
r
s
P-MO-177
Effect of Intravitreal ranibizumab (Lucentis) in the
treatment of various causes of macular edema.
Hany Elmekawey, Amr Khafagy Amr, Khaled Abo
Elenein Khaled, Safwat Elkady Safwat (Giza/ET)
P-MO-178
Effects of Intravitreal Injection of Anti-VEGF Agents
on Macular edema due to Retinal Vein Occlusion
Eriko Kirii, Teiko Yamamoto, Hitomi Miura,
Hidetoshi Yamashita (Yamagata/J)
P-MO-179
Efficacy of Intravitreal Bevacizumab Combined with
Photodynamic Therapy for Polypoidal Choroidal
Vasculopathy
Fumi Gomi, Miki Sawa, Taku Wakabayashi, Yuzuru
Sasamoto, Mihoko Suzuki, Motokazu Tsujikawa
(Suita/J)
P-MO-180
Efficiency in combined usage of local and general
corticosteroid therapy during acute phase of Vogt-
Koyanagi-Harada diseases
Gunay Rustambayova (Baku/ASE)
P-MO-181
Experience with Avastin (bevacizumab) for
Radiation Maculopathy and Optic Neuropathy
Paul Finger (New York/USA)
P-MO-182
Exsudative Retinal Detachment Associated With
Systemic Scleroderma
Anna Cucera, Gabriele E. Lang, Gerhard K. Lang
(Ulm/D)
P-MO-183
Extended sub retinal hemorrhage secondary to
intravitreus bevacizumab.
Ruben Edel Martnez Serrano, Jose Luis Estrada
Rodrguez (Quertaro/MEX)
P-MO-184
Hemodilution Therapy in Central Retinal Artery
Occlusion
B. A. Ehrhardt, Guido R. K. Krzinger, Gabriele E.
Lang (Ulm/D)
P-MO-185
Intravitreal Bevacicumab injection in ROP
case series of 6 infants
Bjrn Harder, Jost B. Jonas, Frank Schlichtenbrede
(Mannheim/D)
P-MO-186
Intravitreal bevacizumab for the treatment of
macular edema secondary to central retinal vein oc-
clusion
Phalangthep Prapatjukkit, Mansing Rattanasukon
(Bangkok/T)
P-MO-169
The relationship between Peripheral Neuropathy
and Diabetic Retinopathy in an Asian population
(The Singapore Malay Eye Study)
Gavin Tan, Yingfeng Zheng, Chee Weng Fong,
E Shyong Tai, Su Chi Lim, Charumathi
Sabanayagam, Tien Y. Wong (Singapore/SGP)
P-MO-170
The time till ganglion cell death during ischemia
occurs can be extended by vitrectomy with
a neuroprotective irrigation solution
Maximilian Schultheiss, Martin Spitzer, Hannah
Ruschenburg, Hannah Ruschenburg, Peter
Heiduschka, Charlotte Frank, Kai Januschowski,
Karl Ulrich Bartz-Schmidt, Peter Szurman
(Stuttgart/D, Tbingen/D)
P-MO-171
Vasoproliferative retinal tumour Case report
Sarah Pfrommer, Mathias Maier, Christian Mayer,
Verena Engelmann, Chris Patrick Lohmann
(Munich/D)
P-MO-172
Vision-related quality of life and visual function
following vitrectomy and triamcinolone injection
for diabetic macular edema
Ayami Masuda, Fumiki Okamoto, Takahiro Hiraoka,
Tetsuro Oshika (Tsukuba/J)
P-MO-173
Visual outcomes of pleoptics for anisomyopic
amblyopia with myelinated retinal nerve fibers
Fumiko Ikeda, Shoji Kishi (Maebashi/J)
Retina: Medical Therapy P32
P-MO-174
A study of in vivo laser-tissue interaction and
healing response from 20 ms versus 100 ms pulse
Pascal photocoagulation burns
Mahiul Muqit, George R. Marcellino, David B.
Henson, Jane Gray, Lorna B. Young, Niall Patton,
Stephen J. Charles, George S. Turner, Paulo E.
Stanga (Manchester/UK)
P-MO-175
Acute retinal necrosis a case report
Piotr Oleksy, Izabella Karska-Basta, Agnieszka Ku-
bicka-Trz ska, Joanna Kobylarz, Bozena Ro-
manowska-Dixon (Krakow/PL)
P-MO-176
Cellular structure and morphofunctional condition
of corneal epithelium at Zymosan activated
autoserum application in complex treatment of
bacterial keratitis
Tatyana Volkovich (Vitebsk/BY)
P
o
s
t
e
r
s
Monday, 7 June 2010 15:30 - 17:00
M
o
n
d
a
y
,

7

J
u
n
e
305
WOC
2010
P
o
s
t
e
r
s
P-MO-195
Manchester Study of Single-session Pascal
Targeted Retinal Photocoagulation [MTRAP] using
Widefield Optos Angiography in Proliferative
Paulo Stanga, Mahiul Muqit, David Henson,
George Marcellino, Jane Gray, Rita McLauchlan,
Lorna Young, Niall Patton, Stephen Charles,
George Turner (Manchester/UK)
P-MO-196
Micropulse versus bevacizumab in central serous
retinopathy
Isabell Beger, Michael Koss, Frank Koch
(Frankfurt/D)
P-MO-197
Nature or Nurture Retinal Pigment Epithelial
Detachments and Tears Treated with Ranibizumab
Helena Cilliers, Li Ping Chow, Theocharis
Papanikolaou, Douglas Newman (Oxford/UK)
P-MO-198
Open-Label Phase 2 Study of Dexamethasone
Intravitreal Implant for Treatment of Diabetic
Macular Edema (DME) in Vitrectomized Patients:
Interim Results
David S. Boyer, Sunil Gupta, David Faber,
Ching-Chi Liu, Xiao-Yan (Joanne) Li, Scott M.
Whitcup (Los Angeles/USA, Irvine/USA)
P-MO-199
PI3K/Akt mediates the expression of type collagen
induced by TGF- in human retinal pigment
epithelial cells
Katsuhiko Yokoyama, Kenichi Kimoto,
Toshiaki Kubota (Yufu/J)
P-MO-200
Posterior subtenons triamcinolone acetonide
injection in a patient with hypertensive optic
neuropathy
Heeyoon Cho, Insuk Song, Byung Ro Lee
(Kyungggi-do/ROK)
P-MO-201
Posterior vitreous detachment following intravitreal
drug injection
Ulrich Geck, Nicole Pustolla, Husnia Baraki,
P-MO-202
Randomised control trial to evaluate the preferred
method of anaesthesia for intravitreal injections
Sudipto Bhatta, Sakkaf Ahmed Aftab,
Raazia Janjua, Aamir Pasha Siddiqui (Sheffield/UK)
P-MO-203
Safety profile of diabetic macular edema patients
treated over 12 months with ranibizumab in the
RESOLVE study
Justus G. Garweg, on behalf of the RESOLVE study
group (Bern/CH)
P-MO-187
Intravitreal Bevacizumab for treatment of choriodal
neovascularization secondary to Bests disease in a
4-year-old child
Katrin Lorenz, Bernhard Stoffelns, Christina
Kramann, Norbert Pfeiffer, Heike Elflein (Mainz/D)
P-MO-188
Intravitreal bevacizumab treatment of choroidal
neovascularization secondary to pathologic myopia
(PM) in Japanese patients.
Kengo Hayashi, Kyoko Ohno-Matsui, Muka
Moriyama, Noriaki Shimada, Wakako Hayashi,
P-MO-189
Intravitreal Dexamethasone as a Coadjuvant
Therapy with for Ranibizumab Loading Phase in
Choroidal Neovascularization
Cristina Marin-Lambies, Roberto Gallego-Pinazo,
Rosa Dolz-Marco, Andrea Diaz, Sebastian Martinez-
Castillo, Manuel Diaz-Llopis (Valencia/E)
P-MO-190
Intravitreal injections of ranibizumab in patients
with diabetic macular edema resistant to focal/grid
laser treatment.
Sofia Aggeli, Marios Giannakopoulos, Olga Makri,
Panagiotis Vasilakis, Constantine Georgakopoulos,
Nikolaos Pharmakakis (Patras/GR)
P-MO-191
Intravitreal ranibizumab in retinal macroaneurysm
Andrea Wenkstern, Heike Petersen (Uzwil/CH)
P-MO-192
Intravitreal Ranibizumab Treatment for Macular
Diseases: a tertiary eye centre experience
Mary Ho, David T. L. Liu, Vincent Y. W. Lee,
Chi-Lai Li, Dennis S. C. Lam (Hong Kong /HK)
P-MO-193
Levels of intravitreal cytokines in patients with
diabetic retinopathy given injection of anti-vascular
endothelial growth factor antibody prior to
vitrectomy
Yukihiko Suzuki, Kaori Suzuki, Yasuhiro Miyagawa,
Hitoshi Yamazaki, Mitsuru Nakazawa (Hirosaki/J)
P-MO-194
Macular function and photopic negative response
after single injection of intravitreal bevacizumab for
myopic neovascularization
Akiko Takahashi, Kohei Ishikawa, Shinji Ueno,
Yasuki Ito, Mineo Kondo, Hiroko Terasaki
(Nagoya/J)
P
o
s
t
e
r
s
Monday, 7 June 2010 15:30 - 17:00
M
o
n
d
a
y
,

7

J
u
n
e
306
WOC
2010
P
o
s
t
e
r
s
P-MO-213
Therapeutic effect of oral bisphosphonate on
choroidal neovascularization in the human eye.
Shigeru Honda, Takayuki Nagai, Naoshi Kondo,
Masahide Fukuda, Sentaro Kusuhara,
Yasutomo Tsukahara, Akira Negi (Kobe/J)
P-MO-214
Topical use of Ketorolac 0.5% for pain control in
patients undergoing intravitreal administration of
drugs
Olga Makri, Panagiotis Vasilakis, Sofia Aggeli,
Marios Giannakopoulos, Artemis Exarchou,
Nikolaos Pharmakais, Constantine Georgakopoulos
(Patras/GR)
P-MO-215
Transient choroidal thinning after intravitreal
injection for myopic choroidal neovascularization
Yukari Jo, Yasushi Ikuno (Suita/J)
P-MO-216
Treatment of Retinitis Pigmentosa with 9-cis retinal
a Clinical Trial
Ygal Rotenstreich, Aviv Shaish, Gili Ferman-Atar,
Dror Harats, Michael Belkin (Kfar Bilu/IL)
P-MO-217
Warfarin and intra-vitreal injections: Practice in the
United Kingdom
Nishant Kumar, Stathis Liazos, Christopher Baddon
(London/UK)
Retina: Surgical Therapy P33
P-MO-218
Macular pucker surgery with and without
delamination of the internal limiting membrane
Christoph Krger (Cologne/D)
P-MO-219
Anatomic and functional outcome after surgical
removal of idiopathic macular epiretinal membrane
Lee Po-Yen, Wu Wen-Chuan (Kaohsiung/TJ)
P-MO-220
Case report: bullous retinoschisis invading the
macula in a patient with high hyperopia
Maria Heynemann, Stefan Mennel, Walter Sekundo
(Giessen/D)
P-MO-221
Clinical management modalities for premacular
hemorrhages associated with Valsalva retinopathy
Joaquin Castro-Navarro, Ieva Sliesoraityte, Carmen
Gonzlez-Castao (Oviedo/E, Tbingen/D)
P-MO-222
Comparison of anatomical success rate of primary
vitrectomy and scleral buckling procedure in
rhegmatogenous retinal detachment
Christos Haritoglou, Ulrich Brandlhuber,
Carolin Fischer (Munich/D)
P-MO-204
Serum-VEGF-levels in premature infants after
intravitreal application of bevacizumab for
Isabel Oberacher-Velten, Roman Regler,
Viola Radeck, Horst Helbig (Regensburg/D)
P-MO-205
Six months results of intravitreal bevacizumab
versus triamcinolone for the treatment of macular
edema caused by retinal vein occlusion: a
retrospective analysis
Patricia Kook, Eva Schffner, Nikolaus Feucht,
Mathias Maier, Chris P. Lohmann (Munich/D)
P-MO-206
Strategies for successful ex vivo genetic engineering
of pigment epithelial cells
Sandra Johnen, Christiane Stickelmann, Michael
Stcker, Peter Walter, Gabriele Thumann
(Aachen/D)
P-MO-207
The benefit of a therapeutical core Vitrectomy
using the Intrector in exudative AMD
Slawomir Cisiecki, Michael Koss, Katharina
Schramm, Janusz Michalewski, Frank Koch
(Lodz/PL, Frankfurt/D)
P-MO-208
The effect of intravitreal Bevacizumab on the
treatment of central serous chorioretinopathy
Hakyoung Kim (Seoul/ROK)
P-MO-209
The efficiency of intravitreal triamcinolone
acetonide for persistent conventionally treated
diabetic macular edema
Hasan Arzoallxhiu, Isak Jurik (Prizren/KS)
P-MO-210
The Learning Curve for Performing Focal Laser
with the NAVILAS
Michael Ulbig, Michael Ober, Aljoscha Neubauer,
Marcus Kernt, Anselm Kampik, William Freeman,
Igor Kozak (Munich/D)
P-MO-211
The practice of intravitreal triamcinolone acetonide
at a district general hospital in England
Gulrez Ansari, Mehul Damani, Karima Nesnas,
Manju Chandran, Geeta Menon (Fleet/UK)
P-MO-212
The relationship between spectral-domain optical
coherence tomography findings and injection
frequency of bevacizumab in exudative age-related
Kaori Sayanagi (Osaka/J)
P
o
s
t
e
r
s
Monday, 7 June 2010 15:30 - 17:00
M
o
n
d
a
y
,

7

J
u
n
e
307
WOC
2010
P
o
s
t
e
r
s
P-MO-233
Indocyanine Green (ICG) Increases Light-Induced
Oxidative Stress, Senescence, and Accumulation of
Extracellular Matrix Proteins in Human RPE Cells
Johann Rping, Christos Haritoglou, Rafael Liegl,
Christoph Hirneiss, Aljoscha Neubauer,
Arnd Gandorfer, Michael Ulbig, Anselm Kampik,
Marcus Kernt (Munich/D)
P-MO-234
Intraocular pressure changes immediately after
intravitreal injection of Triamcinolone Acetonide
and Ranibizumab
Gul Arikan, A. Osman Saatci, F. Hakan Oner
(Izmir/TR)
P-MO-235
Intraocular Pressure Elevation after Vitrectomy for
Proliferative Diabetic Retinopathy
Fumiki Okamoto, Yumi Hasegawa, Yoshimi Sugiura,
Takahiro Hiraoka, Tetsuro Oshika (Tsukuba/J)
P-MO-236
Macular changes in spectral domain OCT after
membrane peeling
Bernd Junker, Amelie Pielen, Daniel Bhringer,
Hansjrgen T. Agostini, Lutz Lothar Hansen,
Nicolas Feltgen (Freiburg/D, Gttingen/D)
P-MO-237
Management of Submacular Hemorrhage
Associated with Retinal Pigment Epithelial
Detachment
Kwang-Soo Kim, Yu-Cheol Kim (Daegu/ROK)
P-MO-238
New approaches of treatment of rhegmatogenous
retinal detachment with inferior breaks.
Galyna Levytska, Stanislav Rodin, Zoya Rozanova,
Nikolay Umanets, Ivan Levitsky (Odessa/UA)
P-MO-239
Ophthalmodynamometric pressure in eyes
with proliferative diabetic retinopathy
Yoshimi Sugiura, Fumiki Okamoto,
Takahiro Hiraoka, Tetsuro Oshika (Tsukuba/J)
P-MO-240
Perfect mixture? Siluron 2000 The new premium
endotamponade
Hakan Kaymak, Christian Lingenfelder,
Wilfried Kugler, Nadine Hagedorn (Ulm/D)
P-MO-241
Persistent Fetal Vasculature in the last ten years:
what are the surgical outcomes?
Hannah Chiu, Peter Kertes, Wai-ching Lam
(Richmond Hill/CDN)
P-MO-242
Pneumatic retinopexy for the repair of retinal
detachments
Nazmiye Erol, Seyhan Topbas, Ela Gndz
(Eskisehir/TR)
P-MO-223
Comparison of standard and 23g vitrectomy in
the treatment of epiretinal membranes a cross
sectional study
Caroline Gummersbach, Norbert Schrage,
Andreas Cordes (Bergisch Gladbach/D, Cologne/D)
P-MO-224
Correlation between autofluorescence, macular
sensitivity and external limiting membrane structure
after macula-off retinal detachment repair
Mario R. Romano, Vito Romano, Martina Angi,
Ciro Costagliola, Paolo Vinciguerra (Milano/I)
P-MO-225
Correlation between macular hole size and
postoperative visual outcome in eyes with
idiopathic macular holes
Masahiro Ishida, Atsuya Takeuchi, Seiji Takagi,
Goji Tomita, Shinobu Takeuchi (Tokorozawa/J)
P-MO-226
Crosslinked hyaluronic acid as a slow release system
for dexamethasone
Charlotte Frank (Tbingen/D)
P-MO-227
Design and clinical results of the Mirror Telescopic
Implant LMI-SI for the treatment of pseudophakic
eyes that suffer also from AMD.
Isaac Lipshitz, Amar Agarwal (Hertzlia/IL,
Chennai/IND)
P-MO-228
Early emulsification of 2000er silicone oil in minimal
invasiv transconjunctival vitreoretinal surgery
Mathias Maier, Verena Engelmann, Sarah
Pfrommer, Carolin Perz, Chris Patrick Lohmann
(Munich/D)
P-MO-229
Effect of intravitreal bevacizumab injection before
vitrectomy on proliferative diabetic retinopathy
Li Cairui (Dali/CN)
P-MO-230
Effect of vitrectomy for idiopathic macular hole
or epiretinal membrane on peripapillary retinal
nerve fiber layer.
Eiko Tsuiki, Mao Kusano, Kiyoshi Suzuma,
Takeshi Kumagami, Takashi Kitaoka (Nagasaki/J)
P-MO-231
Endogenous fungal endophthalmitis in intravenous
drug abusers
Xhevat Lumi, Mojca Urbancic, Rok Grcar
(Ljubljana/SI)
P-MO-232
Hso as 1st choice in complicated retinal
detachment: Checkmate in two moves!
Cesare Forlini, Paolo Rossini, Matteo Forlini
(Ravenna/I)
P
o
s
t
e
r
s
Monday, 7 June 2010 15:30 - 17:00
M
o
n
d
a
y
,

7

J
u
n
e
308
WOC
2010
P
o
s
t
e
r
s
P-MO-253
Subretinal versus preretinal application of r-TPA to
treat subretinal macular hemorrhage
Stefan Mennel (Marburg/D)
P-MO-254
Surgical and visual outcome after autologous
plasmin assisted vitrectomy for stage5 retinopathy
of prematurity
Yasutomo Tsukahara, Hisanori Imai, Shigeru Honda,
Mizuki Tagami, Sentaro Kusuhara, Akira Negi
(Kobe/J)
P-MO-256
Tear film stability in the early postoperative period
of 23-gauge microincision vitrectomy
Taichi Takahata, Azusa Fujikawa, Kiyoshi Suzuma,
Noritake Miyamura, Takashi Kitaoka (Nagasaki/J)
P-MO-257
The Effect of Intravitreal Bevacizumab Injection in
Diabetic Patients with Macular Edema Receiving
Cataract Surgery
Li-chung John Chi, Wen-Chen Wu (Kaohsiung/TJ)
P-MO-258
The finding of MRI in vitreous humor injected
silicone oil
Hiroshi Watanabe, Aya Ooi, Yuka Suzuki,
Tetuo Tochikubo (Tokyo/J)
P-MO-259
The outcome of primary pneumatic retinopexy
Kaveh Vahdani, Georgios Makrygiannis, Aristeidis
Konstantinidis, Vasant Raman (Plymouth/UK)
P-MO-260
The outcome of TPPV in patients with retinal
detachment with ILM peeling comparing to the
patients with no membrane peeling.
Malgorzata Pietras-Trzpiel, Tomasz Chora giewicz,
Tomasz Z
arnowski, Robert Rejdak (Lublin/PL)

P-MO-261
The Relevant Factors of Macular Holes Closure
Types in Patients of Idiopathic Macular Holes after
Pars Plana Vitrectomy
Junyi Wang, Guoge Han, Haifeng Mei, Yiqiao Xing,
Anhuai Yang (Wuhan/CN)
P-MO-262
Treatment effects in treating diabetic macular
edema by single intravitreal bevacizumab
Jia-Kang Wang (Taipei/TJ)
P-MO-263
Treatment efficiency in serous pigment epithelial
detachment in age related macular degeneration
Matthias Schmidt, Steffi Jeep, Constantin E. Uhlig
(Mnster/D)
P-MO-243
Quantification of Changes in Horizontal Distortion
of Macular Topography after Surgical Removal of
Idiopathic Epiretinal Membranes
Hyeong Gon Yu (Seoul/ROK)
P-MO-244
Retinal Re-Detachment After Primary Buckling
Surgery
Roman Regler, Mohamed Afia, Horst Helbig,
Carsten Framme (Regensburg/D)
P-MO-245
Retinal Re-Detachment after Scleral Buckling
Procedure
Frank Schlichtenbrede, Babara Bort,
Alexander Decker, Jost B. Jonas (Mannheim/D)
P-MO-246
Retrospective review of retinal detachment in
Hong Kong
Cheuk Ki Chan (Hong Kong/HK)
P-MO-247
Rhegmatogenous retinal detachment cases with
decreased visual acuity postoperatively.
Hirofumi Kinoshita, Kiyoshi Suzuma, Noritake
Miyamura, Takeshi Kumagami, Takashi Kitaoka
(Nagasaki/J)
P-MO-248
Scleral buckling for retinal detachment with
subretinal fibrosis
Sofia Androudi, Anna Praidou, Evangelia Tsironi,
Vassilis Konidaris, Evgenia Kanonidou,
P-MO-249
Sequential epiretinal membrane removal with
internal limiting membrane peeling in brilliant blue
G-assisted macular surgery
Ricarda G. Schumann, Arnd Gandorfer,
Kirsten Eibl, Paul B. Henrich, Anselm Kampik,
Christos Haritoglou (Munich/D)
P-MO-250
Siderosis secondary to intraocular foreign body.
Ruben Edel Martnez Serrano, Jose Luis Estrada
Rodrguez (Quertaro/MEX)
P-MO-251
Subclinical choroidal detachment at sclerotomy
sites after 23-gauge vitrectomy analysis with
anterior segment Optical Coherence Tomography
Rainer Guthoff, Heidi Riederle, Berit Kasper,
Winfried Goebel (Wuerzburg/D)
P-MO-252
Subjective auditory perceptions during vitreo-retinal
surgery under local anaesthesia
Fariha Shafi, Randhir Chavan, Mark Hero
(Coventry/UK)
P
o
s
t
e
r
s
Monday, 7 June 2010 15:30 - 17:00
M
o
n
d
a
y
,

7

J
u
n
e
309
WOC
2010
P
o
s
t
e
r
s
Trauma P35
P-MO-272
Anatomical outcome and prognostic factors
following intraocular foreign body removal
Rodney John Morris, Saravanan Veerappan
Rathinasabapathy, Narendran Venkatapathy,
Parag Shah, Dheepha M. (Coimbatore/IND)
P-MO-273
Blunt Trauma Caused by a Tea-towel Is drying
up really this dangerous!
Charalambos Tossounis, Luke Clifford, Mehrdad-
Sam Attaran, David Farnworth (Portsmouth/UK)
P-MO-274
Clinical manifestation of epithelial downgrowth
48 years after penetrating eye trauma
Anne Mellein, Andr Rosentreter, Inga Wedemeyer,
Thomas S. Dietlein (Cologne/D)
P-MO-275
Cluster bomb ocular injuries
Ahmad Mansour, Muhammad Younis, Ayman
Ghaddar, Ahmad Mokaddam, Mohamad Al Hajj-Ali
(Beirut/RL)
P-MO-276
Comparison of ocular trauma indices in grading
severity of injury and predicting visual disability
after open globe injuries
Mayuri Bhargava, Usha Vasu (Bangalore/IND)
P-MO-277
Iatrogen ocular affections after application of
2-Octyl Cyanoacrylate
Birgit Groe, Anna Cucera, Sebastian
Kupferschmid, Gerhard K. Lang (Ulm/D)
P-MO-278
Outcome after severe blunt trauma of the eyeball
due to battery explosion
Katarina Hurtikova, Leonie Troeber, Susanne C.
Goebels, Ursula Lw, Frank Schirra, Berthold Seitz
(Homburg/D)
P-MO-279
Pediatric Ocular Trauma: The Analysis of Causes
and Outcomes from a Tertiary Eye Centre in Eastern
India.
Radha Das, Kumar Saurabh, Sudipta Das,
Deepak Agrawal (Kolkata/IND)
P-MO-280
Predicting visual outcome after an open globe
injury using ocular trauma score (OTS)
Gowri Supramaniam, S. E. Khor, M. M. Choo,
Bethel I. Livingstone (Seremban/MAL)
P-MO-264
Treatment of massive subretinal hematoma
associated with age-related macular degeneration
using pars plana vitrectomy combined with
intentional giant retinal tear formation
Eisuke Ishizaki, Atsuko Nakaizumi, Masanori
Fukumoto, Takaki Sato, Masahiro Minami,
Mari Ueki, Tsunehiko Ikeda (Takatsuki/J)
P-MO-265
Ultra-early histological alteration of the retina
following photocoagulation treatment in diabetic
retinopathy as measured by Spectral domain optical
coherence tomography
Long Su, Hao Kang, Hong Zhang, Xiaorong Li
(Tianjin/CN)
P-MO-266
Vitrectomy in patients with familial amylidotic
polyneuropathy to recover good visual acuity
Akira Imai, Teruyoshi Miyahara, Toshinori Murata
(Matsumoto/J)
P-MO-267
Vitrectomy vs Photocoagulation in Patients with
Optic Disc PIT Associated Maculopathy Case
Reports.
Izabella Karska-Basta, Agnieszka Kubicka-Trza ska,
Piotr Oleksy, Joanna Kobylarz,
Boz
.
ena Romanowska-Dixon (Krakw/PL)
P-MO-268
Vitreoretinal Surgeries with Subconjunctival
Anesthesia in Anticoagulated Patients
Amina Malik (Cincinnati/USA)
Teleophthalmology P34
P-MO-269
Automated detection of hard exudates in retinal
images
Parnian Kasae, Alfredo Ruggeri (Padova/I)
P-MO-270
Integration of a teleophthalmology service
(electronic referrals with imaging) into a regional
ophthalmology unit
James Cameron, Shyamanga Borooah,
Roshini Sanders (Edinburgh/UK)
P-MO-271
Nonmydriatic Screening for Diabetic Retinopathy
by Ultra-Widefield Scanning Laser Ophthalmoscopy
(Optomap) Compared to ETDRS 7-Field Imaging
Indrawati Hadi, Aljoscha Neubauer, Florian Pinter,
Stefanie Guthmann, Christos Haritoglou, Michael
Ulbig, Anselm Kampik, Marcus Kernt (Munich/D)
P
o
s
t
e
r
s
Monday, 7 June 2010 15:30 - 17:00
M
o
n
d
a
y
,

7

J
u
n
e
310
WOC
2010
P
o
s
t
e
r
s
P-MO-290
Myopia Control in Teenager Population by
Corneal Refractive Therapy (CRT): Results of 4 years
Follow-up
Andriy Kovalov, Oksana Averyanova (Kiev/UA)
P-MO-291
Our experience with PDT for the management of
corneal neovascularization in children
Giuseppe Carollo (Palermo/I)
P-MO-292
Outcome of penetrating keratoplasty (PKP) after
fungal keratitis in Middle Delta region of Egypt
Osama Shalaby, Rabab El Seht, M. Sameh El
Shorbagy (Tanta/ET)
P-MO-293
Parameters for personal approval of cornea
donation
Julia Promesberger, Constantin E. Uhlig (Mnster/D)
P-MO-294
Reduced Endothelial Cell Loss following Limbo-
Keratoplasty
Laura Bredow, Daniel Bhringer, Johannes
Schwartzkopff, Thomas Reinhard (Freiburg/D)
P-MO-295
Severe conjunctival cicatrisation with limbal stem
cell failure following bone marrow transplantation
Richard J. Symes, Caroline L. Furness, Bronwen E.
Shaw, Andrena McElvanney (London/UK)
P-MO-296
The changes of the clinical manifestations and tear
cytokines after the treatment with Tears again on
dry eye syndrome
Kwang Sic Joo, Du Hwan Oh, In Ki Park,
Yeoun Sook Chun, Jae Chan Kim (Seoul/ROK)
P-MO-297
The Meibomian glands a hair without a hair
shaft cytokeratin expression of the Human
Meibomian glands
Erich Knop, Milena Ludescher, Nadja Knop
(Berlin/D, Hannover/D)
P-MO-298
Therapeutic Descemet Sparing Anterior Kerato-
plasty:The best choice?
Jayangshu Sengupta, Dipanjan Pal, Archana
Khetan, Suman Saha, Nibaran Gangopadhyay,
Merle Fernandes (Kolkata/IND)
P-MO-281
Severe self-induced ocular mutilation as the first
episode of psychosis
Dagmar Hejcmanova, Lisa Catherine Bytton Daz,
Marketa Machackova, Michaela Hulkova
(Hradec Kralove/CZ)
P-MO-282
Soccer-related ocular trauma in a tertiary ophthal-
mologic center in Brazil
Cristina Miyamoto, Elisabeth Nogueira Martins
(So Paulo/BR)
P-MO-283
Treatment of corneal iron-containing foreign bodies
Volodymyr Usov, Tatyana Zhmud (Odessa/UA)
Cornea/Eye Bank P36
P-MO-284
Analysis of the efficiency of various application
methods of ophthalmic medication
Kwang Sic Joo, Du Hwan Oh, Nam Ju Moon,
Yeoun Sook Chun, Jae Chan Kim (Seoul/ROK)
P-MO-285
Candida Keratitis: The new enemy
Nibaran Gangopadhyay, Jayangshu Sengupta,
Archana Khetan, Suman Saha, Merle Fernandes
(Kolkata/IND)
P-MO-286
Cultivation of rabbit acinar lacrimal gland cells on
denuded and undenuded amniotic membrane with
and without co-cultivation of 3T3 fibroblasts
Karsten Kasper, Stefan Schrader, Doris Deininger,
Gerd Geerling (Wuerzburg/D)
P-MO-287
Effects of bone marrow mesenchymal stem cells
on cell proliferation and growth factors expression
of limbal epithelial cells in vitro
Nan Hu, Xiaohong Mao (Nantong/CN)
P-MO-288
Evaluation of the need for and benefit of a
communication training for consent for cornea
donation by telephone
Stephanie Stiel, Sabine Salla, Andre Steinfeld,
Peter Walter, Lukas Radbruch, Martin Hermel
(Aachen/D)
P-MO-289
Keratoconus coexisting with pigment dispersion
syndrome the cases report
Justyna Izdebska, Anna Kaminska, Agnieszka
Czeszyk-Piotrowicz, Joanna Jedrzejczak-
Mlodziejewska (Warsaw/PL)
P
o
s
t
e
r
s
Tuesday, 8 June 2010 15:30 - 17:00
T
u
e
s
d
a
y
,

8

J
u
n
e
311
WOC
2010
P
o
s
t
e
r
s
P-TU-008
Comparison of Tecnis 1-piece multifocal vs.
monofocal intraocular lenses: a prospective clinical
multicentre study
Tanja M. Rabsilber, Annett Mannsfeld, Julia Villalba,
Il-Joo Limberger, Mike P. Holzer, Gerd U. Auffarth
(Heidelberg/D)
P-TU-009
Defocus Curve Profiles of Patients Implanted
Binocularly with Refractive, Binocularly with
Diffractive, or with a Combination of Diffractive-
Refractive Intraocular Lenses
Phill Buckhurst, Sunil Shah, James Wolffsohn
(Birmingham/UK)
P-TU-010
Differences in reading performance using the
Salzburg Reading Desk (SRD) after multifocal and
monofocal intraocular lens implantation
Max Rasp, Gerhard Nix, Alois Dexl, Ana Belen
Plaza, Jorge Ali, David Pablo Piero Llorens,
Gnther Grabner (Salzburg/A, Alicante/E)
P-TU-011
Effective followability and less BSS consumption
with combined peristaltic and venturi pump during
phaco emulsification
Ekkehard Fabian (Rosenheim/D)
P-TU-012
Endothelial cell integrity, phaco efficiency and
nuclear fragment control using Ellips transversal
phaco with Venturi pump VS longitudinal phaco
with peristaltic pump.
P-TU-013
Factors influencing corneal biomechanical changes
following microincision cataract surgery (MICS) and
standard coaxial phacoemulsification
Jorge Ali, Maria Cecilia Gertrudis Agdeppa,
David Pablo Piero Llorens, Jose Luis Rodriguez
Prats, Francisco Amparo (Alicante/E)
P-TU-014
Functional vision in presbyopia correcting IOLs.
Randomized Double Masked Clinical Trial
comparing Dual optic accommodating IOL vs
multifocal IOL
Ricardo Alarcon, Victor Bohorquez, Ivan Osma
(Bogota/CO)
P-TU-015
Influence of ocular spherical aberration on optical
quality after cataract surgery depending on
intraocular lens asphericity
Christian Hofmann, Oliver Klaproth, Jens Bhren,
Poster exhibition of Poster P-TU-001 to P-TU-265.
15.30 to 17.00 hrs.
Moderation Poster sessions on Tuesday
Chairs:
Katrin Engelmann (Chemnitz)
Sekundo, Walter (Marburg)
Co-Chairs:
Marcus Blum (Erfurt)
Stefan Clemens (Greifswald)
Carl Erb (Berlin)
Hermann O. C. Gmbel (Ulm)
Christos Haritoglou (Munich)
Gerald Langmann (Graz )
Frank Schirra (Homburg/Saar)
Ulrich Mester (Sulzbach)
Daniel Mojon (St. Gallen)
Cataract/Biometry 2 P37
P-TU-001
3-year position stability of an angle-supported
foldable hydrophobic acrylic phakic intraocular lens
evaluated by Scheimpflug photography
Oliver Klaproth, Thomas Kohnen (Frankfurt/D)
P-TU-002
Asymmetric phacobisection
Almazbek Botbaev (Bishkek/KIS)
P-TU-003
Brown Cataract Achallenge to the Ophthalmologist!
Swati Zawar (Nashik/IND)
P-TU-004
Changes in anterior chamber depth and refractive
power after cataract surgery with or without
simultaneous vitreous surgery.
Mao Kusano, Eiko Tsuiki, Kiyoshi Suzuma,
Takeshi Kumagami, Takashi Kitaoka (Nagasaki/J)
P-TU-005
Clinical and functional analysis of the phacoe-
mulsification results in the cataract extraction of
different etiology
Ivanov Gheorghe (Chisinau/MD)
P-TU-006
Clinical impact of spherical aberration on contrast
sensitivity of different intraocular lenses
Hanno Goeppert, Andreas Christian Schroeder,
Welk Stephanie, Frank Schirra, Karin Brueckner,
Achim Langenbucher, Berthold Seitz (Homburg/D)
P-TU-007
Clinical impact of spherical aberration on focal
depth of different intraocular lenses
Sarah Kuehlmeyer, Andreas Christian Schroeder,
Eva Filser, Tobias Hager, Christian Jonescu-Cuypers,
Hans Sebastian Walter, Achim Langenbucher,
P
o
s
t
e
r
s
Tuesday, 8 June 2010 15:30 - 17:00
T
u
e
s
d
a
y
,

8

J
u
n
e
312
WOC
2010
P-TU-025
Oculentis LENTIS Mplus: A new concept of
multifocal intraocular lens technology
Gerd U. Auffarth, Tanja M. Rabsilber, R. Philips,
Jan Novk (Heidelberg/D)
P-TU-026
Optivis Multifocal Progressive Diffractive Lens:
Three Months Clinical Outcomes
P-TU-027
Outcomes with Refractive and Diffractive multifocal
intra ocular lens
P-TU-028
Performance of three biometry devices in patients
with different grades of age-related cataract
Georgios Mylonas, Stefan Sacu, Wolf Bhl, Markus
Ritter, Michael Georgopoulos, Ursula Schmidt-
Erfurth (Vienna/A)
P-TU-029
Postoperative Capsular Block Syndrome Anterior
Segment Optical Coherence Tomography Findings
Amy L. Wong (Hong Kong/HK)
P-TU-030
Postoperative Results after Implantation of a toric
IOL (B1AWTY) for small corneal astigmatism
Andreas K. Cordes, Norbert F. Schrage (Cologne/D)
P-TU-031
Pseudophakic nuclear cataract
Andreas Christian Schroeder, Christian Lingenfelder,
Hans Sebastian Walter, Gregory Dame, Berthold
Seitz (Homburg/D)
P-TU-032
Quality of information about Cataract on the
internet
Markus Groppe, Kwesi Amissah-Arthur, Achmed
El-Amir, Vaughan Tanner (High Wycombe/UK)
P-TU-033
Refractive surprise
Juliana Helou, Anna Cucera, Gerhard K. Lang
(Ulm/D)
P-TU-034
Results of Low Contrast visus in AT.Lisa 366 D
Implantation
Harry Domack (Schweinfurt/D)
P-TU-035
State of art hands on surgical training made easy
Vikas Mahatme (Nagpur/IND)
P-TU-016
Influence of surgically induced corneal spherical
aberration on retinal image quality after cataract
surgery
Thomas Kohnen, Oliver Klaproth,
Christian Hofmann, Jens Bhren (Frankfurt/D)
P-TU-017
Intracameral white mass associated with anterior
uveitis in a patient with anterior polar cataract
Ulrich Brandlhuber, Armin Wolf,
Christos Haritoglou, Daniel Kook (Munich/D)
P-TU-018
Intraocular lens power calculation following
INTRACOR
Tanja M. Rabsilber, Annett Mannsfeld,
Angela Ehmer, Wolfgang Haigis, Gerd U. Auffarth,
P-TU-019
Intraoperative and clinical results of phaco-
emulsification with ultrasound ellips through
2.2mm incision for hard cataract
Ahmed Assaf (Kairo/ET)
P-TU-020
Iris claw (Verisyse/Artisan) intraocular lens
implantation in cases with subluxated lenses due to
Marfan syndrome.
George Voyatzis, Bushra Al-Deiri, Alan Fitt
(Peterborough/UK)
P-TU-021
Long-term results after bilateral congenital cataract
surgery pars plana lensectomy versus ECCE and
IOL implantation
Imad Hakim, Wolfgang Mayer, Daniel Kook,
Guenther Rudolph, Anselm Kampik (Munich/D)
P-TU-022
Misleading axial length measurements due to a
dense posterior vitreous surface membrane in a
diabetic patient case report
Christoph Fidel Mayer, Michaela Velikay-Parel
(Graz/A)
P-TU-023
Morphometric Analysis of Cornea Endothelial Post
Phacoemulsification Viscoadaptive Compare to
Medium Viscosity Combines with Chondroitin
Sulphate
Amir Shidik (Jakarta/IR)
P-TU-024
Near, intermediate and distance vision outcomes
with the Crystalens HD accommodating intraocular
lens
Ana Belen Plaza, Jorge Ali, David Pablo Piero
Llorens (Alicante/E)
P
o
s
t
e
r
s
P
o
s
t
e
r
s
Tuesday, 8 June 2010 15:30 - 17:00
T
u
e
s
d
a
y
,

8

J
u
n
e
313
WOC
2010
P-TU-046
Prophylactic Treatment for Cytosine Arabinoside
(Ara-C) induced Keratoconjunctivitis
William Sheehan, Amit Patel (Bristol/UK)
P-TU-047
Report of our graft-versus-host-disease consultation
hour
Katharina Hauer, Philipp Eberwein, Daniel
Bhringer, Thomas Reinhard, Hans Mittelviefhaus
(Freiburg/D)
P-TU-048
Toxicity of ranibizumab (Lucentis) to cultured
human corneal endothelial cells in vitro
Michael Wolfgang Meyer, Stephan Reichl,
Katharina Bauer, Inez Brunotte, Konstantinos
Zinelis, Sebastian Wei, Rolf Winter (Hannover/D)
P-TU-049
Treatment of traumatic corneal abrasion: A three
arm, prospective, randomized study
Moreno Menghini, Pascal Knecht, Claude
Kaufmann, Ronald Kovacs, Stephanie Watson,
Klara Landau, Martina Bsch (Zurich/CH)
P-TU-050
Update on ocular graft-versus-host-disease (GVHD)
report of the consensus conference on chronic
GVHD
Tina Dietrich, Claus Cursiefen, Daniel Wolff
(Regensburg/D, Erlangen/D)
Glaucoma: Miscellaneous P39
P-TU-051
Analysis of intraocular pressure measurements
influenced by corneal curvatures and thicknesses
among three tonometries.
Sheng-Yao Hsu, Rong-Kung Tsai (Kaohsiung/TJ)
P-TU-052
Assessment of Ciliary body area in pupil block
Peter Good (Birmingham/UK)
P-TU-053
Cerebrospinal Fluid Pressure in Glaucoma.
Ruojin Ren (Beijing/CN)
P-TU-054
Comparison of Cost and Distribution of Patients
after Different Initial Treatments for Primary Open
Angle Glaucoma
Hye Bin Yim, Tong Yun Kwag, Jee Hyun Kwag,
Yeon Deok Kim, Aman Shah B. Abdul Majid,
Kui Dong Kang (Incheon/ROK)
P-TU-055
Correlation of Vision Threatening Glaucoma with
prolonged and unmonitored use of Topical Steroids
Rekha Khandelwal, Shivani Bidaye, Suresh Ughade,
Mohana Majumdar (Nagpur/IND)
P-TU-036
Surgically-induced astigmatism in phacoemulsifi-
cation: 2.2mm versus eleven scalpel blade clear
corneal incisions
Hermelino Oliveira Neto, Israel Cardoso Neto,
Ronald Fonseca Reis, Jos Bessa Jr
(Feira de Santana-Bahia/BR)
P-TU-037
Visual Function in Patients Implanted with the
New Lentis Mplus Multifocal Intraocular Lens
Sunil Shah, Phill Buckhurst, James Wolffsohn
(Birmingham/UK)
P-TU-038
Visual outcomes following microincision cataract
surgery (MICS) in Kuantan, Malaysia
Thevi Thanigasalam (Temerloh/MAL)
P-TU-039
Vizualisation of Anterior Segment Whit Sd-Oct
Rt-100
Lukan Mishev (Sofia/BG)
Cornea/Eye Bank: Miscellaneous P38
P-TU-040
Bilateral Cornea Plana in two siblings: Management
Vishnu Gupta, Anuj Mehta, Shreekant Damgude,
Rupsanchita Das, Brahm Guliani, Krishan Malik
(Coimbatore/IND)
P-TU-041
Bilateral Esclerocornea, case report
Ruben Edel Martnez Serrano, Alejandra Etualin
Gonzlez, Jose Luis Estrada Rodrguez
(Quertaro/MEX)
P-TU-042
Cosmetic corneal tattooing (in corneal opacities)
using new pigment
Chitra Pande, Vikas Mahatme (Nagpur/IND)
P-TU-043
Influencing corneal wound healing after corneal
burn using amniotic membrane and mesenchymal
stem cells.
Philipp Eberwein, Andreas Heidt, Johannes
Schwartzkopff, Yvonne Kern, Daniel Bhringer,
P-TU-044
Keratitis and corneal ulceration due to contact
lenses
Michael R. R. Bhm, Inga Domenghino,
Holger Busse, Ralph-Laurent Mert (Mnster/D)
P-TU-045
Outcomes of amniotic membrane transplantation
in chemical injuries of ocular surface
Swati Tomar (Jaipur/IND)
P
o
s
t
e
r
s
P
o
s
t
e
r
s
Tuesday, 8 June 2010 15:30 - 17:00
T
u
e
s
d
a
y
,

8

J
u
n
e
314
WOC
2010
P-TU-065
Canaloplasty outcome analysis by anterior segment
optical coherence tomography
Thomas Theelen, Cathrien A. Eggink (Nijmegen/NL)
P-TU-066
Capsule exzision and Ologen implantation for
revision after glaucoma drainage device surgery
Andre Rosentreter, Anne C. Mellein, Walter W.
Konen, Thomas S. Dietlein (Hrth/D, Cologne/D)
P-TU-067
Cataract surgery for acute angle closure secondary
to scleral buckling
Kodo Medoruma, Ichiko Medoruma, Hideo
Nakamura, Shoichi Sawaguchi (Nishihara-cho
Okinawa-ken/J)
P-TU-068
Clinical Results of Selective Laser Trabeculoplasty
in Open-Angle Glaucoma in Japanese Eyes:
Comparison of 180 Degree with 360 Degree SLT
Maho Shibata, Tetsuya Sugiyama, Osamu Ishida,
Mari Ueki, Shota Kojima, Takaaki Okuda,
Tsunehiko Ikeda (Takatsuki/J)
P-TU-069
Combined Phaco-Trabeculectomy for Progressive
Normal-Tension Glaucoma Associated with High
Myopia
Atsuya Miki, Aya Terubayashi, Shinichi Usui,
Kenji Matsushita, Yasushi Ikuno (Osaka/J)
P-TU-070
Conditions of preoperative and early postoperative
intraocular pressure for predicting the lower
pressure control in a trabeculectomy.
Satoshi Okimoto, Yoshiaki Kiuchi, Junichi Kawahara
(Hiroshima/J)
P-TU-071
Endoscopic cyclophotocoaguation combined with
phacoemulsification
Zora Ignjatovic, Zoran Kuljaca, Katarina Misailovic,
Maja Beko, Nada Radovic, Andjela Tolic
(Selgrade/SRB)
P-TU-072
Evaluation of Filtering Blebs after Trabeculectomy
using Anterior Segment Optical Coherence
Tomography
Akiko Narita, Jiro Seguchi (Okayama/J)
P-TU-073
Express Shunt in selected glaucoma patients
First results
Claudia Rebel, Mario Matthaei, Johannes
Steinberg, Maren Klemm (Hamburg/D)
P-TU-074
Glaucoma and penetrating keratoplasty after
pseudomonas corneal infection
Carolina Palls (Barcelona/E)
P-TU-056
Depression and sleep disorders in progressed
glaucoma: an indication for melatonergic
antidepressants?
Christos Skevas, Agorastos Agorastos, Mario
Matthaei, Christina-Georg Huber, Oliver Zeitz,
Gisbert Richard, Maren Klemm (Hamburg/D)
P-TU-057
Free floating iris cyst at the anterior eye chamber.
Wolfram Hofmller, Arne Viestenz, Sven Walter,
P-TU-058
Intraocular pressure after phacoemulsification
in eyes with exfoliative glaucoma and primary
open-angle glaucoma
Toma Gracner, Nenad picka, Mojca Hudovernik,
Bojan Gracner, Duica Pahor (Maribor/SI)
P-TU-059
Masked, Randomized, Parallel Comparison of
Physician and Patient Reported Outcomes (PROS)
after Switching to Bimatoprost 0.03% vs
Continuing on Latanoprost 0.05%.
Ehsan Sadri, Ronald Frenkel, Jodi Luchs, Michael
Rotberg, Thomas K. Mundorf, John G. Walt, Ching-
chi Liu, Amy L. Batoosingh (Newport Beach/USA)
P-TU-060
The Humanistic and Economic Burden of
Glaucoma: An Update
Steven M. Kymes, Gail Schwartz, Richard G.
Fiscella, Caroline Burk, Vaishali D. Patel
(St. Louis/USA)
P-TU-061
The Relationship Between Obstructive Sleep Apnea
Syndrome and Glaucoma
Gul Arikan, Mehmet Ozgur Zengin, Ibrahim Oztura,
Uzeyir Gunenc, Mehmet Ergin (Izmir/TR)
P-TU-062
Unusual presentation of unilateral acute angle
closure glaucoma on a child
Karunarathna Rajapaksha, Keembiyage Dayawansa
(Kandy/CL)
Glaucoma: Surgical Therapy P40
P-TU-063
Ahmed valve implantation in refractory glaucoma
secondary to sturge-weber syndrome: case series
Othmaliza Othman, Wan Haslina Wan Abdul Halim,
Norshamsiah Md Din, Ropilah Abdul Rahman
(Kuala Lumpur/MAL)
P-TU-064
Application of gelatin hydrogel and chymase
inhibitor in a canine filtration surgery model
Shota Kojima, Tetsuya Sugiyama, Maho Shibata,
Denan Jin, Shinji Takai, Yasuhiko Tabata, Tsunehiko
Ikeda (Takatsuki/J)
P
o
s
t
e
r
s
P
o
s
t
e
r
s
Tuesday, 8 June 2010 15:30 - 17:00
T
u
e
s
d
a
y
,

8

J
u
n
e
315
WOC
2010
P-TU-075
High-frequency ultrasound evaluation of Schlemms
Canal and suture traction after Canaloplasty
Anne Brggemann, Joshua Torrent Despouy,
Swaantje Peters, Salvatore Grisanti, Maya Mueller
(Lbeck/D)
P-TU-076
Investigation of a modified PNIPAAm hydrogel for
portential use in drug-eluting glaucoma drainage
devices
Hagen Thieme, Robert Roskamp, Maria Wegner,
Norbert Pfeiffer, Lars Choritz (Mainz/D)
P-TU-077
Mid-term outcome of inferior-approch
trabeculotomy
takuro matsuba (Osaka/J)
P-TU-078
Non Penetrating Deep Sclerectomy Between
Safety and Efficacy
Dorin Chiselita, Alina Cantemir, Irina Ilies (Ia i/RO)
P-TU-079
Selective Laser Trabeculoplasty for Uveitis Induced
Elevated Intraocular Pressure
Hyoung Sub Shim, Taehyuk Koh, Hwang Ki Kim,
Yong Ho Sohn (Incheon/ROK)
P-TU-080
Trabeculectomies in Eyes with Glaucoma in a
Patient with Osteogenesis Imperfecta
Julia Rosbach, Norbert Pfeiffer, Katharina A. Ponto,
Katrin Lorenz, Urs Vossmerbaeumer, Hagen Thieme
(Mainz/D)
P-TU-081
Two-years Follow-up of Trabeculectomy with
Biodegradable 3D Porous Collagen-Glycosamino-
glycan Scaffold for Treatment of Refractory Glaucoma
Henry Shen-Lih Chen, Wei-Cherng Hsu (Taipei/TJ)
P-TU-082
YAG-laser-goniopuncture after deep sclerectomy
a morphologic analysis
Matthias Keser, Gisbert Richard, Maren Klemm
(Hamburg/D)
Oncology P41
P-TU-083
Adjuvant topical treatment of recurrent conjunctival
squamous cell carcinoma with Mitomycin C
Orlin Velinov, Holger Busse, Ralph-Laurent Mert
(Mnster/D)
P-TU-084
Adult onset asthma and periocular xanthogranu-
loma associated with reactive lymphoid hyperplasia:
one case report
Rimvydas Asoklis, Laura Butkiene, Ona Garlaite,
Donatas Petroska (Vilnius/LT)
P-TU-085
Breast cancer metastasis to the choroid in a male
patient case report
Arkadiusz Pogrzebielski, Piotr Oleksy,
Izabella Karska-Basta, Bo ena Romanowska-Dixon
(Krakw/P)
P-TU-086
Choroidal Mets. Enucleation?
Jorge Topete-Jimenez, Jorge Topete-Jimenez
(Guadalajara/MEX)
P-TU-087
Clinical and Imaging Features in Metastatic Uveal
Tumors
Xiaoda Bi (Shanghai/CN)
P-TU-088
Combined Treatment T2N0M0 Patients with
Choroidal Melanoma with
106
RU+
106
RH Plaques
and Transpupillary Thermotherapy (TTT)
Larisa Naumenko (Minsk/BY)
P-TU-089
Congenital simple hamartoma of the retinal
pigment epithelium
Gregor Willerding, Hilmar Tillack, Joachim
Wachtlin, Nikolaos E. Bechrakis, Michael H. Foerster
(Berlin/D, Innsbruck/A)
P-TU-090
Conjunctival Melanoma. Origin from primary
acquired melanosis (PAM) and nevus shows less risk
for melanoma-related death than origin de novo.
Carol Shields, Jeremy Markowitz, Irina Belinsky,
Nina George, Hal Schwartzstein, Sara Lally,
Arman Mashayekhi, Jerry Shields (Philadelphia/USA)
P-TU-091
CyberKnife: a new treatment option for uveal
melanomas
Ulrich Christoph Schaller, Martin Nentwich,
Annemarie Klingenstein, Berndt Wowra, Alexander
Muacevic, Anselm Kampik (Munich/D)
P-TU-092
Differential diagnosis of iris and/or ciliary body
melanoma.
Bozena Romanowska-Dixon, Anna Markiewicz,
Barbara Jakubowska (Krakow/P)
P-TU-093
Differential diagnosis of proptosis in childhood
Monica Lang, Andreas Chantzaras, Karl-Heinz
Emmerich (Darmstadt/D)
P-TU-094
Diverse Clinical Spectrum of Bilateral Diffuse Uveal
Melanocytic Proliferation Syndrome.
Camila Simoes, Zelia Correa, James Augsburger
(Cincinnati/USA)
P
o
s
t
e
r
s
P
o
s
t
e
r
s

P
o
s
t
e
r
s
P-TU-095
Endoresection of large choroidal melanoma after
stereotactic radiotherapy
Stefan Christmann (Cologne/D)
P-TU-096
Evaluation of Bulbus Shift after Retrobulbar
Anesthesia in Cyberknife Radiosurgery for the Ther-
apy of Large Uveal Melanoma
Martin M. Nentwich, Christoph Frweger,
Alexander Muacevic, Berndt Wowra, Annemarie
Klingenstein, Anselm Kampik, Ulrich C. Schaller
(Munich/D)
P-TU-097
Expression of Galectin-3 and Epha2 in metastatic
and non-metastatic uveal melanomas
Julia Lke, Vlatka Vukoja, Tim Brandenbusch,
Matthias Lke, Aysegl Tura, Martin Rohrbach,
Salvatore Grisanti (Lbeck/D, Tbingen/D)
P-TU-098
Expression of ocular mucins in conjunctival
melanoma, conjunctival compound naevi and
normal conjunctiva
Vinodh Kakkassery, Claudia Gavranic,
Johannes Holle, Antonia Joussen (Berlin/D)
P-TU-099
Eye manifestation of Waldenstrms macroglobu-
linemia
Antje Zimmermann, Melanie Jger (Linden/D)
P-TU-100
Factors influencing the course of pediatric orbital
malignancy in Third world countries Issues
beyond the therapeutic regimen
Jayanta Das (Guwahati/IND)
P-TU-101
Giant papillary conjunctivis as primary
manifestation of a non-Hodgkin lymphoma
Susanne C. Goebels, Andrea Hasenfus,
Leonie Troeber, Arnulf Schnaidt, Frank Schirra,
P-TU-102
Identification of ionizing radiation-responsive
micro RNAs in uveal melanoma cells
Yixiong Zhou, Xianqun Fan (Shanghai/CN)
P-TU-103
Incidence and Recurrence Rates of Ocular Surface
Squamous Neoplasia in Gaborone, Botswana:
1998 to 2007
Oathokwa Nkomazana (Gaborone/RB)
P-TU-104
Malignant Triton Tumor Without Von Reckling-
hausens Neurofibromatosis in a 16-year-old
Indonesian Girl: A Case Report
Neni Anggraini, Rino Pattiata (Jakarta/RI)
P-TU-105
Masquerade Syndrome Caused by Intraorbital
Lymphoma Two Case Reports
Darko Ler, Jozica Baralic, Senad Pozder,
Jasna Muhovic-Bejtic, Ibrahim Paco (Sarajevo/BIH)
P-TU-106
MicroRNA-200 Is Commonly Repressed in Conjunc-
tival MALT Lymphoma and Potentiates Expression
of Cyclin E2
Jiping Cai (Shanghai/CN)
P-TU-107
Myxoid/Round Cell Conjunctival Liposarcoma:
A Case Report
Giuri Stela, Raica Marius, Munteanu Mihnea,
Munteanu Gheorghe (Timisoara/RO)
P-TU-108
Optical coherence tomographic features of optic
disc melanocytoma in Chinese patients
Jasmine WS Ngai (Hong Kong /HK)
P-TU-109
Optical Coherence Tomography Pathological
Correlation of Optic Disc Melanocytoma
Paul Finger, Sribhargava Natesh, Tatyana Milman
(New York City/USA, Bangalore/IND)
P-TU-110
Orbital metastasis from colorectal cancer
Benjamin Perez, Nicolas Leon-Gonzalez,
Nicolas Leon-Perez, Abelardo Rodriguez-Reyes
(Mexico/MEX)
P-TU-111
Outpatient Cytologic Evaluation of Ocular Surface
Squamous Neoplasia
Ekaterina A. Semenova, Tatyana Milman, Paul T.
Finger, Madhavi Kurli, Susan Schneider, Sribhargava
Natesh, Codrin E. Iacob, Steven A. McCormick
(Moscow/RUS)
P-TU-112
Pars plana lensectomy in External Beam Radio-
therapy induced Cataract in Retinoblastoma
Markus Holdt, Barbara Schaperdoth-Gerlings,
Christine Jurklies, Norbert Bornfeld (Essen/D)
P-TU-113
Photodynamic therapy a novel therapeutic
approach for superficial eyelid basal cell carcinoma
Jan Ricar, Renata Ricarova, P. Cetkovska,
K. Pizinger (Pilsen/CZ)
P-TU-114
Presence of tumor cells in the bloodstream, before
and after surgical intervention in uveal melanoma
Georgios Charitoudis, Vasileios Petousis,
Ronny Schuster, Ulrich Keilholz, Michael H. Foerster,
Nikolaos E. Bechrakis (Berlin/D, Innsbruck/A)
Tuesday, 8 June 2010 15:30 - 17:00
T
u
e
s
d
a
y
,

8

J
u
n
e
316
WOC
2010
P
o
s
t
e
r
s
P
o
s
t
e
r
s
P-TU-115
Recent progress in radiotherapy for optic nerve
tumor
Xiaoda Bi (Shanghai/CN)
P-TU-116
Regression patterns and visual acuity of macular
tumours following chemoreduction for Retino-
blastoma
Christina Weiss, Christine Jurklies, Regina Wieland,
Angelika Eggert, Wolfgang Sauerwein,
P-TU-117
Retinoblastoma in Belarus: today's approach
Hanna Furmanchuk (Minsk/BY)
P-TU-118
Rho-kinases-associated glioma migration effects
on neuronal cell bodies and fibers in vitro
Vera Clemens, Solon Thanos (Mnster/D)
P-TU-119
Serum panel for detection of metastasis in uveal
melanoma patients
Daniela Ssskind, Ayse Tura, Michael Partsch,
Karl Ulrich Bartz-Schmidt, Sigrid Henke Fahle
(Tbingen/D)
P-TU-120
Signet ring cell carcinoma of the lid in a young
woman
Eva Glaser, Christian Mayer, Ramin Khoramnia,
Gregor Weirich, Chris Patrick Lohmann (Munich/D)
P-TU-121
The clinical and histopathological study of
conjunctival and corneal tumors
Pham Thi Khanh Van (Ha Noi/VN)
P-TU-122
The main tumor-associated retinal symptoms,
caused by small uveal melanoma: the correlation
analysis.
Svetlana Saakyan, Natalya Urovskaya
(Moscow/RUS)
P-TU-123
The miR-17-92 gene is amplified and overexpressed
in retinoblastoma
Eva Biewald, Harald Stephan, Pieter Mestdagh,
Johannes Hubertus Schulte, Alexander Schramm,
Angelika Eggert, Norbert Bornfeld (Essen/D)
P-TU-124
The role of HPV serotype 16 and 18 in OSSN
Agus Supartoto, Syenny Budi Handoko, Sri Yuli
Handayani (Yogyakarta/RI)
P-TU-125
The role of transpupillary thermotherapy in
combined treatment of retinoblastoma.
Svetlana V. Saakyan, Ekaterina A. Semenova,
Robert A. Tatzkov, Olga A. Ivanova (Moscow/RUS)
P-TU-126
Treatment of retinal detachment occuring after
brachytherapy of uveal melanomas: triamcinolone
acetonide vs pars plana vitrectomy
Theodora Gkika, Mete Gk, Michael Freisthler,
Harun Akgl, Dirk Flhs, Wolfgang Sauerwein,
P-TU-127
Tumor-Associated Lymphangiogenesis in the
Development of Conjunctival Malignant Melanoma
Ludwig M. Heindl, Carmen Rummelt,
Leonard Holbach, Gottfried Naumann,
Friedrich Kruse, Claus Cursiefen (Erlangen/D)
P-TU-128
UBM in intraocular tumors
Anna Markiewicz, Bozena Romanowska-Dixon,
Barbara Jakubowska (Krakow/P)
Pediatric Ophthalmology & Genetics P42
P-TU-129
A case of aniridia with a unilateral lens malposition
Mayu Sawada, Miho Sato, Akiko Hikoya,
Chunxia Wang, Shinsei Minoshima, Noriyuki
Azuma, Yoshihiro Hotta (Shizuoka/J)
P-TU-130
Analysis of abnormal head postures in pediatric
patients
Steffi Tech, Christina Gerth (Rostock/D)
P-TU-131
Anterior segment dysgenesis, report of Mexican
family.
Ruben Edel Martnez Serrano, Alejandra Etualin
Gonzlez (Quertaro/MEX)
P-TU-132
Beta-blockers as the new treatment method in
capillary orbital and adnexal hemangioma.
Gabriela Gondova (Bratislava/SK)
P-TU-133
Case Series on Phthiriasis Palpebrum in children
Shing Kin Yau, Tak Yau Tam (Kowloon/HK)
P-TU-134
Clinical Characteristics of Taiwanese Children with
optic neuritis
Ming-Hui Sun (Taoyuan/TJ)
P-TU-135
Congenital eye anomalies in children with mixed
cognation of parents
Khakima Karim-Zade, Abdujamil Toshmatov,
Rano Kholmatova, A. Rakhmonov, H. Mirsakhanova
(Khujand/TAD)
Tuesday, 8 June 2010 15:30 - 17:00
T
u
e
s
d
a
y
,

8

J
u
n
e
317 317
WOC
2010
P
o
s
t
e
r
s

P
o
s
t
e
r
s
P-TU-136
Congenital Unilateral Absence of Superior Rectus
without Craniofacial Anomaly
Mohammad Reza Talebnejad, Mahnaz Mosallaei
(Shiraz/IR)
P-TU-137
Development of Ocular Optical Components and
Refractive Error in Infants
Ping Wang (Changsha/CN)
P-TU-138
Endovitreal melphalan as local retinoblastoma (RB)
chemotherapy
Nadiya Bobrova, T. A. Sorochynska (Odessa/UA)
P-TU-139
Epidemiological, clinical and therapeutic aspects of
congenital glaucoma: a report of 159 cases
Adil Megzari, Bencherifa Fatiha, Berraho Amina
(Rabat/MA)
P-TU-140
Etiological Aspects of Congenital Cataract: Case
Study of 107 Cases (179 Eyes)
Tarik El Alloussi, Imane Ahmiti, Sanaa Haddad,
Obaida El Yamouni, Ramzia Sebbah,
Sanaa Idrissi-Alami, Mostapha El Mrabh, Fatiha
Benchrifa, Amina Berraho (Rabat/MA)
P-TU-141
Factors affecting recurrence in successfully treated
cases of anisometropic amblyopia
Shraddha Puranik, Rohit Saxena, Vimla Menon,
Pradeep Sharma, Swati Phuljhele (New Delhi/IND)
P-TU-142
Genetic homogeneity and phenotypic variability in
East Asian patients with achromatopsia
Joo Hyun Choi, Yoon Jeon Kim, Hyun Taek Lim,
Hyejin Lee (Seoul/ROK)
P-TU-143
Lay vision screening: Can the Plusoptix vision
screener replace the LEA symbol chart and random
dot stereotest?
Joannah Vaughan, David Wheeler, Allison Summers
(Portland/USA)
P-TU-144
Long term preservation of visual function in
hereditary mucoepithelial dysplasia
Venkata Avadhanam, Keith Martin (London/UK)
P-TU-145
Morphological and functional outcomes in one-
year-old patients following diode laser photocoagu-
lation for retinopathy of prematurity a prospective
study at ho chi minh city eye hospital
Thao Nguyen Uyen Vo (Ho Chi Minh/VN)
P-TU-146
Myofibroma of the Conjunctiva Invading the
Cornea in Infancy
Gerassimos Lascaratos, Manish Gupta,
Laura Bridges, Mary MacRae (Edinburgh/UK)
P-TU-147
Neonatal Marfan syndrome A rare form with
limited diagnostic and therapeutic opportunities
Nicola Rauch, Daniel Herzog, Heike Elflein,
Pfeiffer Norbert (Mainz/D)
P-TU-148
Nystagmus secondary to drug exposure in utero
Manish Gupta, Gerassimos Lascaratos, Alan
Mulvihill, Brian Fleck, Nick George (Edinburgh/UK)
P-TU-149
Open Globe Injuries in Children
Marlene Schrkhuber, Mona Schneider,
Werner Wackernagel, Andreas Wedrich (Linz/A)
P-TU-150
Outcome of probing or intubation for congenital
naso-lacrimal duct obstruction in NHS Lothian
Six year Audit
Manish Gupta, Gerassimos Lascaratos, Mary
MacRae, Alan Mulvihill, Brian Fleck (Edinburgh/UK)
P-TU-151
Outcomes of ROP treatment in Extremely Low
Birth Weight (ELBW) infants
David Gunn, David Cartwright, Glen A. Gole
(Windsor/AUS)
P-TU-152
Parinaud oculoglandular syndrome
Aneta Skupin, Melanie Jger, Birgit Lorenz
(Giessen/D)
P-TU-153
Penetrating Keratoplasty in a 6 week Child with
Peters anomaly a case report.
Andreas K. Cordes, Axel Schmitz, Norbert Schrage
(Cologne/D)
P-TU-154
Peripapillary choroidal neovascularization (CNV)
associated with optic nerve drusen in 13-year-old
child options for anti-VEGF therapy
Andrzej Dmitriew, Anna Gotz-Wie ckowska,
Joanna Siwiec-Proscinska (Poznan/P)
P-TU-155
Phenotype variability in a family with microph-
thalmia and coloboma
Christina Gerth, Kathy Williamson,
Rudolf F. Guthoff, David R. FitzPatrick,
Veronica van Heyningen (Rostock/D, Edinburgh/UK)
Tuesday, 8 June 2010 15:30 - 17:00
T
u
e
s
d
a
y
,

8

J
u
n
e
318
WOC
2010
P
o
s
t
e
r
s
P
o
s
t
e
r
s
P-TU-156
Primary intraocular lens implantation in pediatric
cataract with posterior lenticonus-case report.
Krystyna Kanigowska, Miroslawa Gralek
(Warsaw/PL)
P-TU-157
Radial pupillotomy for treatment of extreme
pupillary ectopia
Nina Bobisch, Norbert Schrage, Andreas Cordes
(Cologne/D)
P-TU-158
Refraction Anomalies in Children of Kazakhstan
Tursungul Botabekova (Almaty/KZ)
P-TU-159
Screening Results of First Class Primary Schools
Children in Albania
Enno Qerimi (Durres/AL)
P-TU-160
Spectral domain optical coherence tomography
images of serous retinal detachment associated
with optic disc pit in a 7-year-old child
Anu Maudgil, Jonathan Chan (Sheffield/UK)
P-TU-161
Structural and functional outcomes of premature
infants screened for retinopathy of prematurity in
a tertiary-care hospital in Malaysia
May May Choo, U-teng Chan, Nurliza Khaliddin,
Ayu Saad Mas (Kuala Lumpur/MAL)
P-TU-162
The Factors affecting Pattern Visual Evoked Poten-
tial in Amblyopes
Jun-ho Choi, Sun-young Jang, Song-hee Park
(Seoul/ROK)
P-TU-163
The phenomenon of movement perception in
congenital nystagmus: clinical studies and possible
implications concerning the suppression of
oscillopsia
Barbara Ksmann-Kellner, Berthold Seitz
(Homburg/D)
P-TU-164
To know the awareness amongst the children &
their parents regarding the conditions causing
childhood blindness between age-group 0-18
years.
Seema Deshmukh, Vikas Mahatme,
Sanyogita Joshi (Nagpur/IND)
P-TU-165
Treating amblyopia: are we beginning too late?
Carlos Eduardo Resende Gomes, Galton Carvalho
Vasconcelos, Sabrina Cavaglieri, Henderson
Celestino de Almeida (Conselheiro Lafaiete/BR)
P-TU-166
Ultrastructural investigation of cornea wound
healing in full-thickness and 2/3 depth sutures
Nadiya Bobrova, Valeriy Vit, Natalia Dumbrova,
Natalia Molchanyuk, Vasiliy Shevchyk,
Tatiyana Romanova (Odessa/UA)
P-TU-167
Unilateral optic nerve aplasia associated with
microphthalmos A case report
Gordana Stankovic-Babic (Nis/SRB)
P-TU-168
Unproportional microphthalmia in a child with
Hallermann-Streiff syndrome
Werner Schmidt (Giessen/D)
P-TU-169
Use of Spectral Domain OCT to Image Pediatric
Macular and Posterior Pole Pathology
Naz Raoof, Tsiang Ung, Julie Bailey, T. K. Chan
(Sheffield/UK)
Retina: Diagnostics P43
P-TU-170
A comparison between mydriatic digital fundus
photographs and fundus fluorescein angiogram in
the diagnosis of proliferative diabetic retinopathy
early
Shobana Nadarajah (Petaling Jaya/MAL)
P-TU-171
Assessment of the Retinal Nerve Fiber Layer Thick-
ness with Optical Coherence Tomography in Eyes
with Various Degrees of Optic Nerve Head Drusen
Urszula Gajdzik-Gajdecka, Ewa Mrukwa-Kominek,
Wanda Romaniuk (Katowice/PL)
P-TU-172
Association between the ocular involvement and
cardiovascular involvement or the distribution of
skin and mucous membrane lesions in patients with
pseudoxanthoma elasticum.
Hiroshi Tamura, Akitaka Tsujikawa, Hideo
Nakanishi, Kenji Yamashiro, Sotaro Ooto, Atsushi
Otani, Atsushi Utani, Nagahisa Yoshimura (Kyoto/J)
P-TU-173
Atypical retinal changes in sympathetic ophthalmia.
Galina Vashkevich, Olga Sashneva, Tatsiana
Imshenetskaya, Irina Puchkova, Eleonora
Parhovchenko, Arkadyi Puchkov (Minsk/BY)
P-TU-174
Blind spot enlargement syndrome in acute zonal
occult outer retinopathy (AZOOR)
Ramona Verena Neutzner, Melanie Jger,
Tuesday, 8 June 2010 15:30 - 17:00
T
u
e
s
d
a
y
,

8

J
u
n
e
319 319
WOC
2010
P
o
s
t
e
r
s

Tuesday, 8 June 2010 15:30 - 17:00
P
o
s
t
e
r
s
T
u
e
s
d
a
y
,

8

J
u
n
e
320
WOC
2010
P-TU-184
How to Cope with Segmentation Errors in
Measurement of Macular Thickness with Spectral
Domain Optical Coherence Tomography
Byung Ro Lee, Yumi Song, Yong Woon Shin
(Seoul/ROK)
P-TU-185
Influence of lens opacities due to cataract on the
detection of drusen in SD-OCT
Sabine Schriefl, Rupert Menapace, Christian Ahlers,
Eva Stifter, Danielle Boullanger, Isabelle Golbaz,
Ferdinand Schlanitz, Ursula Schmidt-Erfurth
(Vienna/A)
P-TU-186
Interchangeability between different scan protocols
of Spectralis optical coherence tomography in
normal eyes
Yaroslava Chopovska, Stephan Wismann,
Melanie Jger, Birgit Lorenz (Giessen /D)
P-TU-187
In-vivo choroidal thickness imaging after PDT
Lyudmyla Metzger, Horst Helbig, Maria-Andreea
Gamulescu (Zwiesel/D, Regensburg/D)
P-TU-188
Macular Hole: 10 and 20-mhz ULTrasound Images
and Spectral-Domain Optical Coherence
Tomography
Juliana Botts, Virginia Torres, Liliane Kanecadan,
Andrea Martinez, Nilva Moraes, Norma Allemann
(Barcelona/E)
P-TU-189
Myelinated retinal nerve fibers
Kaoutar El Ouazzani Chahdi, Mohamed Benharbit,
Ibtissam Mansouri, Halima Saadiya Mouhdi,
Youssef Amrani, Btissam Ouazzani Tnachri,
Wafae Ibrahimy, Rajae Daoudi (Rabat/MA)
P-TU-190
New screening method using unreflective
transillumination ophthalmoscopy in diagnosis of
chorioretinal pathology
Maryia Morkhat, Vi tor Morkhat (Vitebsk/BY)
P-TU-191
Non-mydriatic Ultra-widefield Scanning Laser
Ophthalmoscopy (Optomap) versus 2 field fundus
photography in diabetic retinopathy
Kristine Kaldefoss, Lala Ceklic, Aljoscha Neubauer,
Stefanie Guthmann, Christos Haritoglou,
Anselm Kampik, Michael Ulbig, Marcus Kernt
(Munich/D)
P-TU-192
OCT signs in refractory diabetic macular oedema.
Ina Malinouskaya, Tatiana Imshanetskaya,
Igor Zaborovski (Minsk/BY)
P-TU-175
Changes of the ocular fundus in patients with
amaurosis fugax
Vakhramova Natalia, Ramazanova Lya
(Moscow/RUS)
P-TU-176
Comparison of Selective Pixel Profiling (SPP) and
Image Tracked Averaging for Signal to Noise
Enhancement in Optical Coherance Tomography
Carl Glittenberg, Ilse Krebs, Kerstin Steindl,
Sarah Moussa, Eva Smretschnig, Susanne Binder
(Vienna/A)
P-TU-177
Correlation of OCT and intraoperative vitreous
characteristics in full-thickness macular holes.
Magdalena Tnz, Stephan Michels, Matthias Becker
(Zurich/CH)
P-TU-178
Correlation of Peripheral Findings in wide-field
Fundusphotography and high-resolution OCT with
the Progression Rate in Areas of Geographic
Atrophy due to dry Age-Related Macular Degenera-
tion
Ute Wolf-Schnurrbusch, Simon Rothenbuehler,
Volker Enzmann, Sebastian Wolf (Bern/CH)
P-TU-179
Does Foveal Thickness Predict Microalbuminuria in
Diabetics ?
Wan Haslina Wah, Muhaya Mohamed
(Kuala Lumpur/MAL)
P-TU-180
Dynamic retinal vessel analysis how different
parameters create a whole picture
Ines Lanzl, Konstantin Kotliar (Munich/D)
P-TU-181
Effects of the intraocular dye brilliant blue mixed
with Glucose on the isolated superfused bovine
retina
Kai Januschowski, Sebastian Mueller, Jolene Hayes,
Matthias Lke, Peter Szurman (Tbingen/D,
Lbeck/D)
P-TU-182
Foveal Thickness and Diabetic Retinopathy in
Type 2 Diabetes Mellitus: A Comparative Study in
Universiti Kebangsaan Malaysia Medical Centre
(UKMMC), Malaysia.
Wan Haslina Wah, Ropilah Abdul Rahman,
Muhaya Mohamed (Kuala Lumpur/MAL)
P-TU-183
Fundus autofluorescence imaging using ultra-wide-
field scanning laser ophthalmoscopy in patients
with geographic atrophy secondary to age-related
Katharina Lammersdorf, Monika Fleckenstein,
Frank G. Holz, Steffen Schmitz Valckenberg
(Bonn/D)
P
o
s
t
e
r
s
Tuesday, 8 June 2010 15:30 - 17:00
P
o
s
t
e
r
s
T
u
e
s
d
a
y
,

8

J
u
n
e
321 321
WOC
2010
P-TU-202
Long-term outcome and risk factors for recurrence
in untreated patients with central serous
chorioretinopathy
Andrew Fok, Poemen Chan, Timothy Lai,
Yolanda Yip, Dennis Lam (Hong Kong/HK)
P-TU-203
Long-term follow-up of extrafoveal retinal holes
following internal limiting membrane peeling
Mira Ruppenstein, Thomas Ach, Stefan Dithmar
(Heidelberg/D)
P-TU-204
Microperimetric assessment of fundus alterations
characteristic for Pseudoxanthoma Elasticum
Nina Peters, Robert P. Finger, Peter Charbel Issa,
Hendrik P. N. Scholl, Frank G. Holz (Bonn/D)
P-TU-205
Morphological and elecrophysiological changes of
retinal structure after treatement with Dipiperon
shown by Fourier Domain OCT
Daria Loos, Jens Huber, Patricia Kook,
Chris P. Lohmann (Munich/D)
P-TU-206
Relationship between retinal nerve fiber layer
thickness and visual field function in HIV-infected
patients without retinitis
Tiago Arantes, Claudio Garcia, Ivan Maynart
Tavares, Paulo Augusto Arruda Mello, Cristina
Muccioli (Sao Paulo/BR)
P-TU-207
Retinal phototoxicity after phacoemulsification
Eva-Maria Lackner, Christoph Fidel Mayer,
Andreas Wedrich (Graz/A)
P-TU-208
Retinal transplantation therapy for rd1 mice
Michiko Mandai, Kohei Homma, Masayo Takahashi
(Kobe/J)
P-TU-209
Risk Factors for Retinal Breaks in Patients with
Symptom of Floaters
Apichart Singalavanija (Bangkok/T)
P-TU-210
Study of vitreoretinal adhesion in exudative
age-related macular degeneration treated with
antiVEGF
Andrea Diaz Barron, M Dolores Pilar Vicente
Fernandez, Cristina Marn Lambies, Rosario Fons
Martinez (Valencia/E)
P-TU-211
Subconjunctival Reflux and Need for Paracentesis
after Intravitreal Injection of 0.1 ml Bevacizumab:
Comparison between 27 gauge and 30 gauge
Needle
Alireza Mirshahi, Katrin Lorenz (Mainz/D)
P-TU-193
Outer photoreceptor layer thickness obtained by
spectral domain optical coherence tomography in
normal eyes and variable macular diseases
Byung Ro Lee, Yong Woon Shin, In Seok Song,
Yumi Song (Seoul/ROK)
P-TU-194
Reproducibility of Fluorescence Lifetime Imaging
(FLIM) at the Human Retina based on Multi-
Exponential Component Fit
Alexander Dietzel, Matthias Klemm, Edgar Nagel,
Dietrich Schweitzer, Jens Haueisen (Ilmenau/D)
P-TU-195
Usefulness of monochromatic conversions to blue
component in digital color photographs in branch
retinal vein occlusion.
Takeya Kohno, Yoshio Okazaki, Manabu
Yamamoto, Norito Miki, Hisashi Iwami, Makoto
Yamaguchi, Shinsuke Ataka, Michiko Hirabayashi,
Kunihiko Shiraki (Osaka/J)
Retina: Miscellaneous P44
P-TU-196
Automatic Dosimetry Control for Gentle Retinal
Photocoagulation
Ralf Brinkmann, Kerstin Schlott, Stefan Koinzer,
Lars Ptaszynski, Marco Bever, Alex Baade, Reginald
Birngruber, Johann Roider (Lbeck/D, Kiel/D)
P-TU-198
Desferrioxamine Related Maculopathy after a single
dose
Mohamed Naved Abdul Karim, Satish Chadha,
Delicia Jayakumar, Trudi Blamires (Kettering/UK)
P-TU-199
Efficacy and ocular drug distribution using the
dexamethasone intravitreal implant in a monkey
model of macula edema
James Burke, Ton Lin, Kai-Ming Zhang, Werhner
Orilla, Clayton Spada, Maria Escobar, Corine
Ghosn, Joan-En Chang Lin, Rhett M. Schiffman,
Larry Wheeler, Scott M. Whitcup (Irvine/USA)
P-TU-200
Endogenous Candida chorioretinitis in a healthy
infant
Makiko Ito, Tadashi Yokoi, Yuri Kobayashi,
Sachiko Nishina, Noriyuki Azuma (Tokyo/J)
P-TU-201
Estimation of the Incidence of Vascular Anomalies
in Eyes with Optic Nerve Head Drusen.
Urszula Gajdzik-Gajdecka, Ewa Mrukwa-Kominek,
Malgorzata Machalska, Jadwiga Pietrzycka,
Magdalena Smuzynska (Katowice/PL)
P
o
s
t
e
r
s

Tuesday, 8 June 2010 15:30 - 17:00
P
o
s
t
e
r
s
T
u
e
s
d
a
y
,

8

J
u
n
e
322
WOC
2010
Retina: Vascular Diseases P46
P-TU-220
Adiponectin suppresses adherent leukocytes in
retinal vessels induced by a high-fat diet.
Yasuhiro Ito, Shintaro Nakao, Yoshihisa Okamoto,
Souska Zandi, Hidenobu Tanihara (Kumamoto/J)
P-TU-221
Bevacizumab (Avastin) for ocular metastasis of
gastric cancer
Thoralf Wecke, Manuela Hinz, Christian Vorwerk,
P-TU-222
Capillary Nonperfusion in Vascularized Retina in
Aggressive Posterior Retinopathy of Prematurity
and Efficacy of Preoperative Laser Photocoagulation
Including Vascularized Retina Posterior to the Ridge
Tadashi Yokoi, Makiko Ito, Sachiko Nishina,
Yuri Kobayashi, Noriyuki Azuma (Tokyo/J)
P-TU-223
Central vein occlusion and hypertensive crisis
caused by a previously unkown renal artery stenosis
in a case of fibromuscular dysplasia
Christian Flhr, Jrg Hattingen, Burkhard Wiechens
(Hannover/D)
P-TU-224
Cilioretinal arteries in diabetic eyes are associated
with increased retinal blood flow velocity and
occurrence of diabetic macular edema
Gennady Landa, Richard Rosen, Wendewesssen
Amde, Jeanne Rosenthal, Joseph Walsh
(New York/USA)
P-TU-225
Clinically significant macular edema in diabetic
patients with hypertension
Noriko Miyamoto, Kazuhiro Ishida, Yasuo Kurimoto
(Kobe/J)
P-TU-226
Coagulation disorders and the risk of retinal vein
occlusion: a subgroup analysis
Claudia Hattenbach, Inge Scharrer,
P-TU-227
Concentrations of unbound bevacizumab in the
aqueous of untreated fellow eyes after a single
intravitreal injection in humans
Carsten H. Meyer, Frank G. Holz, Tim U. Krohne
(Bonn/D)
P-TU-228
Correlation of leaking microaneurysms with retinal
thickening in diabetic retinopathy
Lukas Reznicek, Marcus Kernt, Christos Haritoglou,
Michael Ulbig, Anselm Kampik, Aljoscha Neubauer
(Munich/D)
P-TU-212
The occurrence of ptosis following posterior
subtenons injection of triamcinolone acetonide
Hannah Sharma, Katie Isaac, Samer Elsherbiny
(Birmingham/UK)
P-TU-213
Treatment of peripapillary choroidal neovasculariza-
tions in early childhood
Michael R. R. Bhm, Matthias Schmidt,
Constantin E. Uhlig (Mnster/D)
Retina: RPE Diseases P45
P-TU-214
Changes in Macular Morphology and Function
after Half Dose Verteporfin-PDT for Central Serous
Chorioretinopathy
Ruka Uetani, Kohei Ishikawa, Piao Chang-Hua,
Yasuki Ito, Mineo Kondo, Hiroko Terasaki
(Nagoya/J)
P-TU-215
Characteristics of Vitelliform Macular Dystrophy
in Adults
Stefan J. Lang, Guido R. K. Krzinger,
P-TU-216
Correlation between retinal sensitivity, tested by
microperimetry, and the status of underlying
inner/outer segment junctional photoreceptor layer,
assessed by Spectral Domain Optical Coherence
Tomography in Central Serous Retinopathy
Richard Rosen, Gennady Landa, Joseph Nezgoda,
Emily Su, Patricia Garcia, Alfonso Ponce,
Thomas Muldoon, Ronald Gentile, Joseph Walsh
(New York/USA)
P-TU-217
One-year follow-up of iatrogenic iodate retinopathy
Lars Wagenfeld, Gisbert Richard, Oliver Zeitz
(Hamburg/D)
P-TU-218
Spectral Domain Optical Coherence Tomography
study of morphological features of Stargardts
Disease and its correlation with Central Visual
Function
Mayuri Bhargava, Sribhargava Natesh,
Naresh Kumar Yadav, Anand Vinekar, Rajani Battu,
Shailaja L (Bangalore/IND)
P-TU-219
The effect of acetazolamide treatment on cystoid
macular edema and visual function in retinitis
pigmentosa
Antje S. Bernd, Andreas Schatz, Bogomil Voykov,
M. Dominik Fischer, Martin Wiesen,
Ieva Sliesoraityte, Eberhart Zrenner (Tbingen/D)
P
o
s
t
e
r
s
T
u
e
s
d
a
y
,

8

J
u
n
e Tuesday, 8 June 2010 15:30 - 17:00
P
o
s
t
e
r
s
323 323
WOC
2010
P-TU-238
Intravitreal Bevacizumab in Macular Edema of
Branch Retinal Venous occlusion
Satyen Deka (Guwahati/IND)
P-TU-239
Is iris fixation of IOL in patients with aphakia and
diabetic retinopathy the right indication?
Joerg Christian Schmidt (Marburg/D)
P-TU-240
Low glomerular filtration rate is associated with
more advanced diabetic retinopathy
Vesna Jaksic, Milka Mavija, Svetislav Milenkovic,
Ivan Stefanovic, Dijana Risimic (Beograd/SRB)
P-TU-241
M3 muscarinic acetylcholine receptors mediate
cholinergic responses in murine retinal arterioles
Adrian Gericke, Jan Sniatecki, Evgeny
Goloborodko, Franz Grus, Jrgen Wess, Norbert
Pfeiffer (Mainz/D)
P-TU-242
Monolateral macular hemorrhage in systemic lupus
erythematosus
Orlin Velinov, Michael Frosch, Constantin Uhlig
(Mnster/D)
P-TU-243
Netrin-4 and Its Receptors Have an Impact on
Neoangiogenesis in the Mouse Retina
Sabrina Klein, Liang Yong, Irina Semkova,
Elizabeth Abari, Kristina Schmidt, Norbert Kociok,
Klaus Meyer, Wiliam J. Brunken, Manuel Koch,
Antonia Joussen (Duesseldorf/D, New York/USA)
P-TU-244
Patterns of macular edema in high resolution
OCT scans and response to bevacizumab therapy in
retinal vein occlusion
Mira Ruppenstein, Alexandra Hoeh, Karen Schaal,
Thomas Ach, Stefan Dithmar (Heidelberg/D)
P-TU-245
Predictors for Visual Outcome after Anti-VEGF
Therapy of Central Retinal Vein Occlusion and
Branch Retinal Vein Occlusion
Ute Wolf-Schnurrbusch, Carsten Framme,
Simon Rothenbuehler, Sebastian Wolf (Bern/CH)
P-TU-246
Retinal microglia in the mouse model of oxygen-
induced retinopathy
Franziska Fischer, Gottfried Martin,
Hansjrgen Agostini (Freiburg/D)
P-TU-247
Retinal vasculitis as a paraneoplasic syndrome in
the context of a gastric adenocarcinoma
Purificacion Pias Garcia, Luis Castillon Torre,
Francisco Javier Hernandez Martinez (Sevilla/E)
P-TU-229
Correlation of macular pigment distribution in type
2 idiopathic macular telangiectasia and morpho-
logic abnormalities detected by spectral-domain
OCT
Miki Sawa, Yuzuru Sasamoto, Motokazu Tsujikawa,
Fumi Gomi (Suita/J)
P-TU-230
Diabetic retinopathy and maculopathy in metabolic
syndrome
Milka Mavija, Zoran Mavija, Vesna Jaksic, Svetislav
Milenkovic, Dijana Risimic, Tanja Veselinovic,
Natalija Kosanovic-Jakovic (Banjaluka/BIH,
Beograd/SRB)
P-TU-231
Dysregulation of Bone Marrow Derived Endothelial
Progenitor Cell Bioactivity via VEGF Triggers
Abnormal Vascular Development of Murine
Retinopathy of Prematurity
Yoshihiro Nakagawa, Masuda Haruchika, Rie Ito,
Takahiro Suzuki, Kenji Kawai, Takayuki Asahara
(Isehara/J)
P-TU-232
Effect of Intravitreal Angiogenesis Inhibitors on
Hyperreflective Exudative Foci in Diabetic Macular
Edema Documented by Optical Coherence
Tomography
Christoph Mitsch, Berthold Pemp, Gabor Deak,
Sonja Prager, Gerald Schmidinger, Christoph
Scholda, Matthias Bolz, Ursula Schmidt-Erfurth (Vi-
enna/A)
P-TU-233
Effect of intravitreal bevacizumab on retinal vein
diameter in branch retinal vein occlusion
Tomohiro Otani, Yumiko Yamaguchi, Shoji Kishi
(Maebashi/J)
P-TU-234
Effect of nutrition on development of cataract and
diabetic retinopathy in type II diabetic rat model
Heeyoon Cho, Yunjeong Lee, Yeonhee Noh
(Kyungggi-do/ROK)
P-TU-235
Extensive internal limiting membrane peeling and
gas tamponade for submacular hemorrhage associ-
ated with ruptured retinal arterial macroaneurysm
Shigeki Suzuki (Kounosu/J)
P-TU-236
Haemodilution Therapy in Central Retinal Vein
Occlusion
Jens Ulrich Werner (Ulm/D)
P-TU-237
In vivo OCT characterization of ischemic retina in
diabetic retinopathy
Lukas Reznicek, Marcus Kernt, Christos Haritoglou,
Anselm Kampik, Michael Ulbig, Aljoscha Neubauer
(Munich/D)
P
o
s
t
e
r
s

P
o
s
t
e
r
s
P-TU-248
Risk evaluation in patients with acute non-arteriitic
central retinal artery occlusion
Stefanie Pantenburg, A. Pielen, B. Junker, A. Wolf,
B. Jurklies, K. Kampik, N. Feltgen (Goettingen/D,
Essen/D, Wuerzburg/D)
P-TU-249
Role of Intravitreal Bevacizumab in Diabetic
Vitreous Hemorrhage
Satyen Deka (Guwahati/IND)
P-TU-250
Spontaneous exophthalmus due to a carotid sinus
cavernosus fistula successful interventionell
treatment with GDC coils in three patients
Jrg Hattingen, Jan Khler, Richard Glombik,
Andreas Schwartz, Ekkehard Gmelin, Burkhard
Wiechens (Hannover/D)
P-TU-251
Systemic diseases associated with central retinal
vein occlusion
Marianne Shahsuvaryan (Yerevan/ARM)
P-TU-252
The association between the oxidative stress-
related gene polymorphisms and the diabetic
retinopathy in Type2 Diabetes
Shinko Nakamura, Shigehiko Kitano (Tokyo/J)
P-TU-253
The characteristics of acute retinal necrosis with
optical coherence tomography
Li Juanjuan (Kunming/CN)
P-TU-254
The effect of placental growth factor splice variants
on the neovascularization in the mouse retina
Norbert Kociok, Daniel Hoffmann, Elizabeth Abari,
Sabrina Klein, Kristina Schmidt, Sabine Eming,
Antonia Joussen (Duesseldorf/D, Berlin/D)
P-TU-255
The effects of Intravitreal Bevacizumab for cystoid
macular edema (CME) due to retinal vein occlusions
Mehrdad-Sam Attaran (Hannover/D)
P-TU-256
The Roles of Artery-vein Relation of an Arteriove-
nous Crossing and Vein Bifurcation in Branch
Retinal Vein Occlusion
Qingyuan Liang (Toronto/CDN)
P-TU-257
The use of intravitreal bevacizumab in Coats
patients
Choi Mun Chan (Singapore/SGP)
P-TU-258
Time course of the effect of bavacizumab on
macular edema in central retinal vein occlusion
Mehrdad-Sam Attaran (Hannover/D)
Vision 2020 Prevention of Blindness P47
P-TU-259
Case Study-Short term Impact and lessons of a
systematic eye care development intervention
Kolawole Ogundimu, Elizabeth Elhassan,
Suleiman Buhari (Accra7GH)
P-TU-260
Community eye health of Pediatric age group
in the slums area of one of the Metropolis of
Eastern India
Khandkar Fariduddin (Kolkata/IND)
P-TU-261
Five Year Cataract Surgical Rate in Shanghai,
China from 2005 to 2009
Jianfeng Zhu (Shanghai/CN)
P-TU-262
Outcome of trachoma treatment in chidren and
their families from a public school Barbalha City,
Cear, Brazil
Vitor Luna De Sampaio, Clarice Maria Pinheiro
Callou, Carlos Teixeira Brandt, Luza Stella Correia
Ferreira, Eduardo Jos Pinheiro Callou (Barbalha/BR)
P-TU-263
Preoperative Visual Acuity of Eyes Undergoing
Cataract Surgery in Rural and Urban Nepal
Reeta Gurung, Mohan Krishna Shrestha, Andreas
Mueller, Sanduk Ruit (Kathmandu/NEP)
P-TU-264
Prevention of Diabetic Blindness in Rural China
by Multiple Approaches
Zhizhong Ma (Beijing/CN)
P-TU-265
Tibet's (almost) forgotten children How a blind
person made blind children read
Sibylle Scholtz, Gerd U. Auffarth (Ettlingen/D,
Heidelberg/D)
Tuesday, 8 June 2010 15:30 - 17:00
T
u
e
s
d
a
y
,

8

J
u
n
e
324
WOC
2010
325
WOC
2010
A
d
m
i
n
i
s
t
r
a
t
i
v
e

M
e
e
t
i
n
g
s
Administrative
Meetings
Thursday, 3 June 2010
14:00 16:00 VOL-Sitzung
Salon 21
15:00 17:00 Tropfschulung
Salon 22
17:30 18:30 Initiativkreis Glaukom des BVA
Salon 22
Friday, 4 June 2010
12:15 13:45 Meeting der Initiativgruppe zur Frherkennung
diabetischer Augenerkrankungen (IFdA)
Salon 19
16:00 17:30 Sitzung der Kommission Qualittssicherung
Salon 21
11:30 13:30 Arbeitskreis klinischer Fragen des wissenschaftlichen
Beirats der Pro Retina Deutschland e.V.
Salon 22
14:00 15.30 17. Arbeitstreffen der Sektion DOG-Ophthalmo-
plastische und rekonstruktive Chirurgie
Salon 22
18:00 20:00 Arbeitskreis Psychosomatik in der Augenheilkunde
Salon 22
12:30 14:00 Vorstandsitzung der Retinologischen Gesellschaft
Raum 46
16:30 17:00 Sitzung der Sektion DOG-Neuroophthalmologie
Room 46
14:00 17:00 ICO World Ophthalmology Roundtable on Leadership
Development (WORLD)
and ICO General Assembly
Hall 7
07:15 14:00 AOI Meeting and Luncheon
12:15 13:45 Mitgliederversammlung der Sektion DOG-Kornea
VIP Lounge 1
14:00 15:30 Arbeitsgruppe Internet und medizinische
Informationsverarbeitung
Salon 11/12
16:00 18:00 Sitzung der Sektion DOG-Gewebetransplantation und
Biotechnologie
Salon 11/12
12:30 13:30 Mitgliederversammlung der Bielschowsky-
Gesellschaft
Salon 13/14
12:30 13:45 Sitzung der Sektion DOG-Glaukom
Salon 15/16
16:30 18:00 Meeting der Deutschen Ophthalmologischen
Chefrzte
Room 56
Sunday, 6 June 2010
08:00 11:00 Meeting BVA-Leitlinienkomission
Salon 20
12:00 13:30 Sitzung der Sektion DOG-Internationale
Ophthalmologie
Salon 20
10:00 15:00 Meeting Augenrztegenossenschaft Brandenburg e. G.
Room 24
12:00 14:00 Sitzung der Makulakommission
Salon 22
326
WOC
2010
A
d
m
i
n
i
s
t
r
a
t
i
v
e

M
e
e
t
i
n
g
s
Administrative
Meetings
09:00 10:00 Studientreffen zur FANCY-Studie
Room 45
12:00 13:45 ICO Education Committee
Room 46
Monday, 7 June 2010
06:30 08:15 World Ophthalmic Education Colloquium
Hall 7 (only upon invitation)
12:15 13:45 General Assembly of the DOG
Hall 4/5
12:00 13:45 ICO Fellowships Alumni Reception
Salon 11/12
08:30 10:00 Treffen der Woche des Sehens
Salon 19
10:30 12:30 Treffen der Vision 2020 Initiativgruppe
Salon 19
14:00 15:30 Mitgliederversammlung der Sektion Uveitis der DOG
Salon 19
09:30 12:00 Herausgebersitzung Der Ophthalmologe 2010
Salon 20
14:00 15:30 Kommissionssitzung Refraktive Chirurgie
Salon 20
16:00 17:30 EBO Executive Board
Salon 20
14:30 15:30 Uveitis Award 2010
Salon 21
16:00 17:00 General Assembly European Vision Institute
Salon 21
12:30 13:30 EVICR.net Meeting
Salon 22
14:30 16:00 Meeting Steering Committee European Vision
Institute
Room 37
14:00 16:00 ICO Advisory Group on Sub-Saharan Africa
Room 45
Tuesday. 8 June 2010
14:00 18:00 Meeting der International Agency for the Prevention
of Blindness
Salon 20
11:30 13:00 Award Ceremony and Handover of DOG Presidency
Roof Garden
C
o
m
p
a
n
y

S
y
m
p
o
s
i
a
327
WOC
2010
In Alphabetical Order of Company Names
Aeon Astron Breakfast Symposium
Saturday, 5 June 2010 07:15 08:15
Hall 9
Can MMC be replaced?
ologen for eye tissue repair
Chair:
Julio Lin, VP, Aeon Astron Europe B.V.
07:15 - 07:20
Opening
Michael Lai, CEO, Aeon Astron Europe B.V.
07:20 - 07:35
Introduction of ologen Collagen
Matrix
Jessie Ni, PhD, Aeon Astron Europe B.V.
07:35 - 07:50
500 Experiences with ologen
Collagen Matrix in Trabeculectomy
Prof. Markus Kohlhaas, MD, Germany
07:50 - 08:05
Use of ologen Collagen Matrix in Strabismus Sur-
gery
Prof. Emilio C. Campos, MD, Italy
08:05 - 08:15
General Discussion
Julio Lin, VP, Aeon Astron Europe B.V.
Alcon Lunch Symposium
Saturday, 5 June 2010 12:30 13:30
Hall 2
Changing the Standard of Care in Cataract Surgery
Chair:
Prof. Rudy M.M.A. Nuijts
Prevalence of Astigmatism and Impact on Vision
Prof. James Wolffsohn, United Kingdom
Management of Astigmatism in Cataract Surgery
Prof. Peter Szurman, Germany
Practical Experience with ACRYSOF Toric
Prof. Rudy M.M.A. Nuijts, Netherlands
Integrating ACRYSOF Toric in Your Daily Practice
Dr. Bret Fisher, United States
Changing the Cataract Surgery Standard of Care:
The Belgium Case
Prof. Philippe Kestelyn, Belgium
Alcon Lunch Symposium
Sunday, 6 June 2010 12:30 13:30
Hall 2
Individualizing The Management of Glaucoma
Moderators:
Prof. Kuldev Singh, USA
Prof. Norbert Pfeiffer, Germany
Patient Profiling to Individualize Glaucoma Therapy
Dr. Francisco Goi, Spain
Clinical Trial Results: Travoprost Timolol Fixed
Combination
Prof. Norbert Pfeiffer, Germany
New Fixed Combination Therapeutic offerings
Prof. Gbor Holl, Hungary
Alternative Preservatives in Topical Glaucoma
Medications
Prof. Christophe Baudouin, France
Glaucoma Surgery with Ex-PRESS Mini Glaucoma
Shunt
Prof. Carlo E. Traverso, Italy
Allergan Lunch Symposium
Saturday, 5 June 2010 12:30 13:30
Hall 7
Retina
New Approaches to the Management of Macular
Edema
Chairs:
Prof A. Kampik, MD/ Prof. G. Coscas, MD
12:30 12:32
Introduction and Welcome
Prof. A. Kampik, MD
12:32 12:43
Inflammation A Major Contributor to the Etio-
logy of Macular Edema
Prof. G. Soubrane, MD PhD
12:43 12:54
Steroids in the Management of Macular Edema
Young Hee Yoon, MD
12:54 13:06
New Options for the Management of Macular
Edema
Dr. J. A. Haller, MD
13:06 13:18
Steroids in the Management of Uveitis
Prof. S. Lightman, MD PhD
327
C
o
m
p
a
n
y

S
y
m
p
o
s
i
a
WOC
2010
13:18 13:30
Management of Macular Edema in Clinical
Practice Combination Treatment (an option for
the future)
Dr. A. Loewenstein, MD
Allergan Breakfast Symposium
Monday, 7 June 2010 07:15 08:15
Hall 4/5
Glaucoma Symposium
Optimal Glaucoma Management
Chairs:
Prof. Anders Heijl, MD/ Prof. Remo Susanna Jr, MD
07:15
Introduction and Welcome
Prof. Anders Heijl, MD / Prof. Remo Susanna Jr, MD
07:18
Optimal Glaucoma Management the Patient in
Focus
Prof. Remo Susanna Jr, MD
07:31
Rate of Progression a Measure for Optimal
Management of our Glaucoma Patients
Prof. Anders Heijl, MD
07:44
Successfully Optimizing First Line Therapy in
Glaucoma
Prof. David B. Yan, MD
07:57
Optimal Glaucoma Management is Fixed
combination the Solution for the Progressing
Patients?
Prof. Luca Rossetti, MD
08:10
Closure
Prof. Anders Heijl, MD
Prof. Remo Susanna Jr, MD
Bausch + Lomb Surgical
Saturday, 5 June 2010 12:30 13:30
Bausch+Lomb-Stand, 12 A/16
Meet the expert Meet Stellaris PC
Bausch + Lomb Lunch Symposium
Friday, 4 June 2010 12:30 13:30
Hall 8
Circle of Nutritional Competence
AMD und Mikronhrstoffe: Stand der Wissenschaft
und welchen Einfluss haben sie?
(AMD and micronutrients - status quo in science
andtheir influence)
Chair:
Prof. Dr. Ulrich Welge-Len, Erlangen
1.
"Oxidativer Stress in der Pathogeneseder AMD
und der Einfluss von Mikronhrstoffen"
Prof. Dr. Ulrich Welge-Len, Erlangen
2.
Klinische Evidenz fr den Einsatz von Mikronhr-
stoffen bei AMD ein aktueller berblick
PD Dr. Erdem Ergun, Wien
3.
Welche Rolle spielen genetische Faktoren bei
AMD und knnen Mikronhrstoffe diese positiv
beeinflussen?
Prof. Dr. Andr Reis, Erlangen
Bausch + Lomb Lunch Symposium
Sunday, 6 June 2010 12:30 13:30
Hall 4/5
Inflammation following standard cataract
surgery is it still an issue?
Welcome & Introduction
Chair:
Prof. Dr. Jorge Alio, Spain
Prevention of serious infection and inflammation
following standard cataract surgery
Prof. Dr. Uwe Pleyer, Germany
Early detection and treatment of endophthalmitis
Prevention and treatment of cystoid macular oe-
dema following cataract surgery
David Spalton, UK
Concluding remarks
328
C
o
m
p
a
n
y

S
y
m
p
o
s
i
a
329 329
WOC
2010
BAYER Schering Pharma Lunch Symposium
Sunday, 6 June 2010 12:30 13:30
Hall Oslo
An Update on VEGF Trap-Eye
Chairs:
Frank Holz (Germany), Ursula Schmidt-Erfurth
(Austria)
Introduction
Biology of VEGF Trap-Eye
Georges von Degenfeld (Germany)
Phase II results in AMD
Peter Kaiser (USA)
Phase III trials in AMD
Yuichiro Ogura (Japan)
Development for other indications
Jost B. Jonas (Germany)
Summary
Chibret Lunch Symposium
Friday, 4 June 2010 12:45 13:45
Hall 4/5
Ohne BAC zum Therapiererfolg - die Kunst des
Weglassens
Chair:
Prof. Dr. Gnther K. Krieglstein
Talk 1:
Zur Logik der Konservierungsstoff-Freiheit
Prof. Dr. Gnther K. Krieglstein, Germany
Talk 2:
Vorteile von konservierungsmittelfreien Antiglau-
komatosa fr Augenrzte und Patienten
PD Dr. Elisabeth M. Messmer, Germany
Talk 3:
Konservierungsmittelfreie Glaukomtherapie: fr
wen ist sie notwendig und sinnvoll?
Prof. Dr. Norbert Pfeiffer, Germany
GEUDER LS Lunch-Symposium
Saturday, 5 June 2010 12:30 13:30
Hall Stockholm
GEUDER Lunch-Symposium
1.
Patient-focused refractive Micro-Incisional Cataract
Surgery
Best practices and insider tips to increase patients
satisfaction
Prof. Gerd U. Auffarth, MD
2.
Sutureless Vitrectomy with UnoColorline Trocar
System and Hattenbach Screw-Cut Technique
First encouraging experiences with the new
screw-cut technique for self-sealing transcon-
junctival sclerotomies
Prof. Lars-Olof Hattenbach, MD
3.
Endotamponades: Air, Gas or Silicone Oil?
Indications, Contraindications and Best Practices
Fine-needle aspiration biopsy of intraocular
tumors: new tools
David E. Pelayes MD, PhD
HeidelbergEngineering Lunch Symposium
Sunday, 6 June 2010 12:30 13:30
Hall Stockholm
HeidelbergEngineering Lunch Symposium:
Eye to Eye
Chair:
Dr. Stephan Schulz
Multimodal imaging in wet AMD
Blue Laser Fundus autofluorescence imaging in
advanced dry AMD new concepts for emerging
therapies
Heidelberg Edge Perimeter (HEP) in clinical practice
Definition of glaucomatous progression in
structural and functional imaging
C
o
m
p
a
n
y

S
y
m
p
o
s
i
a
330
WOC
2010
MERCK Lunch Symposium (German)
Friday, 4 June 2010 12:30 13:30
Hall 4/5
Ohne BAC zum Therapiererfolg die Kunst des
Weglassens
Talk 1:
Das eine tun, ohne das andere zu lassen: Erhalt des
Gesichtsfeldes und der Augenoberflche
bei Glaukompatienten"
N.N.
Talk 2:
Konservierungsmittelfreie Glaukomtherapie: fr
welche Patienten sind BAC-freie Prparate sinnvoll?
N.N.
Talk 3:
Vorteile von konservierungsmittelfreien
Antiglaukomatosa fr Augenrzte und Patienten
N.N.
MERCK Lunch Symposium (International)
Saturday, 5 June 2010 12:30 13:30
Hall 3
"Preservative Free Therapy: Addressing Unmet
Needs in the Treatment of Glaucoma"
Chair: Dr. Robert Weinreb, US
Talk 1:
Ocular Surface Disease and the Effects of
Preserved Glaucoma Treatments
Dr. Malik Kahook, US
Talk 2:
Prevalence of Ocular Surface Disease in Glaucoma
Patients
Dr. Robert Weinreb, US
Talk 3:
Introducing a Novel Preservative Free Glaucoma
Treatment
Dr. Carlo Traverso, Italy
Talk 4:
Tafluprost Phase IIIb Clinical Review
Dr. Norbert Pfeiffer, Germany
MERCK Evening Symposium (International)
Sunday, 6 June 2010 18:00 19:00
Hall 3
Current concepts and new data for the
management of glaucoma in the 21
st
century
Chair:
Dr. Norbert Pfeiffer, Germany
Talk 1:
Managing risk factors of the patient with
uncontrolled IOP
Dr. Stefano Miglior, Italy
Talk 2:
Understanding 24-hour IOP fluctuation: new data
on known glaucoma therapies
Dr. Tasos Konstas, Greece
Talk 3:
Predictors of visual field progression
Dr. Antonio Martinez, Spain
Talk 4:
Preserving eye health with preservative-free
glaucoma therapies
Dr. Cindy Hutnick, Canada
MSD Ophthalmics Lunch Symposium
Saturday, 5 June 2010 12:10 - 13:00
Hall 3
Preservative Free Therapy: Addressing Unmet
Needs in the Treatment of Glaucoma
Chair:
Dr. Robert Weinreb, US
Talk 1:
Ocular Surface Disease and the Effects of Preserved
Glaucoma Treatments
Dr. Malik Kahook, US
Talk 2:
Prevalence of Ocular Surface Disease in Glaucoma
Patients
Prof. Dr. Robert Weinreb, US
Talk 3:
Introducing a Novel Preservative Free Glaucoma
Treatment
Dr. Carlo Traverso, Italy
Talk 4:
Tafluprost Phase IIIb Clinical Review
C
o
m
p
a
n
y

S
y
m
p
o
s
i
a
331 331
WOC
2010
MSD Ophthalmics Evening Symposium
Sunday, 6 June 2010 18:00 - 19:30
Hall 3
Current concepts and new data for the manage-
ment of glaucoma in the 21
st
century
Chair:
Talk 1:
Managing risk factors of the patient with
uncontrolled IOP
Dr. Stefano Miglior, Italy
Talk 2:
New Clinical Evidence on 24-Hour IOP Manage-
ment
Prof. Dr. Tasos Konstas, Greece
Talk 3:
Predictors of visual field progression
Dr. Antonio Martinez, Spain
Talk 4:
Preserving eye health with preservative-free
glaucoma therapies
Dr. Cindy Hutnick, Canada
NOVARTIS Lunch Symposium
Sunday, 6 June 2010 12:30 13:30
Hall Abu Dhabi
Improving vision for patients with DME:
New Compelling Evidence
Chair:
Gabriele Lang, Germany
12:30
Epidemiology & current evidence for treatment
success of ranibizumab in diabetic macular edema
patients in the Phase II RESOLVE study (including
Q&A)
Gabriele Lang, Germany
12:40
Improving vision with ranibizumab in patients
with diabetic macular edema in the Phase III
RESTORE study (including Q&A)
Paul Mitchell, Australia
13:05
Further clinical trial evidence of treating patients
with diabetic macular edema (including Q&A)
Neil M. Bressler, USA
NOVARTIS Lunch Symposium
Friday, 4 June 2010 13.00 14.00
Hall Stockholm
Therapie neovaskulrer Erkrankungen:
AMD-Therapie unter real life Bedingungen / DME
und RVO Aufbruch zu neuen Ufern
Vorsitz:
Prof. Anselm Kampik, Mnchen
BOON ein integratives Monitoring-Model fr
intravitreale Injektionstherapien
Prof. Nicole Eter, Bonn
Ranibizumab-Therapie bei neovaskulrer AMD:
Neue Ergebnisse der WAVE-Studie
Dr. Robert Finger, Bonn
Therapie des diabetischen Makuladems aktuelle
Aspekte und Ergebnisse der RESTORE Studie
Prof. Antonia Joussen, Charit Berlin
Anti-VEGF Therapie und Laserkoagulation bei
Venenastverschlssen Beobachtungen aus der
Branch Retinal Vein Occlusion Associated Macular
Edema Studie (R.A.B.A.M.E.S.)
Prof. Lars-Olof Hattenbach*, Ludwigshafen
*Weitere Autoren:
Feltgen N, Pielen A, Hansen LL, Lorenz K, Pfeiffer N,
Hoerauf H, Jnemann C, Hhn F, Kreutzer T,
Priglinger S, Mirshahi A
OCULUS Breakfast Symposium
Sunday, 6 June 2010 07:15 08:15
Hall 7
Corneal measurement for keratoconus detection
New methods of evaluation of anterior segment
data for keratoconus detection, refractive procedu-
res as well as for glaucoma specialists are demons-
trated.
The results of a preliminary study are presented.
Prof. Dr. Renato Ambrsio Jr., Brasil
C
o
m
p
a
n
y

S
y
m
p
o
s
i
a
332
WOC
2010
OCULUS Lunch Symposium
Friday, 4 June 2010 12:45 13:45
Hall 7
Die OCULUS Pentacam und das Nidek OCT
Innovative Diagnostik im tglichen Einsatz
12:45 Uhr:
Premiumdiagnostik mit der OCULUS Pentacam
Dr. Alexander Petzold, Leipzig
13:15 Uhr:
Die optische Kohrenztomografie (OCT) in der
augenrztlichen Praxis
Dr. Gernot Petzold, Kulmbach
Pfizer Breakfast Symposium
Monday, 7 June 2010 07:15 08:15
Hall Sao Paulo
Patient Perspective on DME:
Maximizing Quality of Life in the Management of
Diabetic Macular Edema (DME)
Chair:
Rohit Varma, MD, MPH
07:15 07:25:
Chair's Welcome and Introduction
07:25 07:30:
Living with DME: A Patient Testimony
07:30 07:50:
Evaluating the Whole Patient: OME, Quality of Life
and Associated Comorbidities
Seenu M. Hariprasad, MD
07:50 08:10:
Economic Burden of DME: A UK Perspective
Peter H. Seanlon, MBBS, FRCP, DCH
08:10 08:15: Concluding Remarks and Questions
Pfizer Lunch Symposium
Saturday, 5 June 2010 13:10 14:00
Hall Sao Paulo
Glaucoma The Linkage between Function,
Functioning and Quality of Life
Chair:
Norbert Pfeiffer, MD
12:30 12:35:
Chair's Welcome and Introduction
12:35 - 12:45:
Structure and Function
Robert N. Weinreb, MD
12:45 13:00:
Vision Functioning (Observed)
George l. Spaeth, MD
13:00 13:10:
Patient-Reported Functioning
13:10 - 13:20
Management Decisions
Ivan Goldberg, MB, BS, FRANZCO, FRACS
13:20 13:30
Concludlng Remarks and Questions
Pfizer Evening Symposium
Sunday, 6 June 2010 18:00 19:30
Hall Sao Paulo
A Fresh Look at DME: An Interactive Discussion on
Interdisciplinary Management of Diabetic Macular
Edema (DME)
Chair:
Tien Wong, MD, MPH, PhD
18:00 18:15:
Chairs Welcome and Introduction
18:15 18:35:
Evaluating DME and Associated Comorbidities:
A Comprehensive Clinical Approach
Massimo Porta, MD, PhD
18:35 18:55:
Current Management of DME: Monitoring
Progression
Ursula Schmidt-Erfurth, MD
18:55 - 19:15:
Current Management of DME: Treatment
Considerations
Lloyd P. Aielto, MD. PhD
19:15 19:30:
Is Current Management Effective?
C
o
m
p
a
n
y

S
y
m
p
o
s
i
a
333 333
WOC
2010
SANTEN Lunch Symposium
Sunday, 6 June 2010 12:30 13:30
Hall 3
Progress in Glaucoma Management: where are
we now?
Chair:
Prof. Migdal
Is glaucoma screening effective?
Prof. Dr. N. Pfeiffer
Dry eye, glaucoma and eye drops
Prof. Dr. Christophe Baudouin
Further IOP reduction within the normal range -
the role of prostaglandins in NTG
Prof. Dr. M. Aihara
How do preservative-free prostaglandins
compare? a clinical overview
Prof. Dr. Lutz E. Pillunat
SANTEN Lunch Symposium
Monday, 7 June 2010 12:30 13:30
Hall 7
LEVOFLOXACIN in the Prevention and Treatment
of Ocular Infections
Chair:
Prof. Richard L. Abbott
Ocular Pharmacokinetics: Principles and
Fluorocinolole Related Implications
Prof. Urtti
The treatment of bacterial keratitis
Prof. Richard L. Abbott
The influence of fluoroquinolones on corneal
endothelial cells
Prof. Oshika
Prevention of endophthalmitis in cataract
surgeries
Dr. Chan
Zeiss Breakfast Symposium
Sunday, 6 June 2010 07:15 08:45
Roof Garden
New Frontierts in OCT Imaging
Chair:
Jos Cunha-Vaz, MD, PhD
Change Analysis: Using OCT to manage Macular
Disease"
Jos Cunha-Vaz, MD, PhD
Visualizing the Vitreoretinal Interface with OCT:
Understanding the Role of Epiretinal Membranes
in Retinal Disease.
Alain Gaudric, MD
New OCT Applications for Glaucoma: Optic Nerve
Head Analysis and RNFL Progression
Giacomo Savini, MD
Learn how the experts apply the new features
from Cirrus HD-OCT to optimize daily clinical
care. The panelists will discuss how HD-OCT
is providing more and better information for
the diagnosis and management of retina and
glaucoma disease.
Zeiss Lunch Symposium
Friday, 4 June 2010 12:30 13:30
Roof Garden
AAD/DOG Lunch Symposium Zukunft willkom-
men! Die Grundsulen einer erfolgreichen Augen-
arztpraxis
Chair:
Dr. Martin A. Zeitz, Henning Goebel
Speakers:
Dr. Martin A. Zeitz, optimed GmbH Dsseldorf
Henning Goebel, optimed GmbH Dsseldorf
Der Gesundheitsmarkt ndert sich rasant. Hier-
durch entstehen nicht nur Risiken, sondern auch
Chancen fr die Augenrzte. Die politischen Rah-
menbedingungen und der zunehmende Wettbe-
werb machen es erforderlich, die Weichen jetzt
richtig zu stellen und die eigene Praxis fit fr die
Zukunft zu machen.
Erfahren Sie im Zeiss-Lunchsymposium, wie Sie
Ihre Augenarztpraxis erfolgreich positionieren
knnen:
Strategieentwicklung, Workflow-Optimierung
sowie Marketing und Servicequalitt werden
darber entscheiden, ob Ihr Unternehmen Augen-
arztpraxis in fnf Jahren zu den Gewinnern oder
den Verlierern zhlen wird.
C
o
m
p
a
n
y

S
y
m
p
o
s
i
a
WOC
2010
Saturday, 5 June 2010 12:30 13:30
Roof Garden
Cataract Workflow Innovations
Chair:
Wolfgang Haigis, PhD
Modern Biometry for the Problems of today and
tomorrow
Wolfgang Haigis, PhD
Clinical Experience with the new IOLMaster 500
Oliver Findl, MD
Innovative Management of Astigmatism Cor-
rection with ZEISS Toric Solution
Dominique Pitrini, MD
How to improve Outcomes and optimize Surgical
Workflow with the Monofocal Aspheric CT AS-
PHINA 613P Preloaded IOL and the SkyJet Advanced
Injector in small Incisions
NN
Monday, 7 June 2010 12:30-13:30
Roof Garden
ReLEx and Laser Blended Vision - the start of a new
era in refractive surgery
Chair:
Dan Reinstein, MD
Laser Blended Vision the Safest and Most
Effective Solution for Emmetropic, Myopic and
Hyperopic Presbyopia
Dan Reinstein, MD
Patient Satisfaction after Laser Blended Vision
Peter Brincker, MD
ReLEx a New Method of Laser Vision Correction
Entered the Market
Jesper Hjortdal, MD
Femtosecond Lenticule Extraction in Hyperopic
Cases Where are we today?
Marcus Blum, MD
Minimally Invasive ReLEx Procedures in Low,
Moderate and High Myopia
Rupal Shah, MD
Ocular Wavefront Changes after ReLEx Procedures
Igor Solomatins, MD
Come and see two exciting topics introduced by
Carl Zeiss.
With ReLEx a unique method of vision correction
by femtosecond-only laser application is now avai-
lable. Its current application and also future poten-
tial will be addressed.
Laser Blended Vision provides age optimized treat-
ment as a new option of the MEL 80 / CRS-Master
platform. Very well received by the surgeons, we
will hear about its results
and patient satisfaction.
ZIEMER Breakfast Symposium
Saturday, 5 June 2010 07:15 08:15
Hall 8
GALILEI USER MEETING
Chair:
Dr. Jennifer Lewis
07:15 - 07:30
Highlights of GALILEI Software and Showcase of
GALILEI Presentations at the ASCRS 2010
Jennifer Lewis, PhD
07:30 - 07:45
Clinical Applications of the GALILEI (Keratoconus,
Refractive Surgery and Lamellar Surgery)
Pavol Vesely, MD
07:45 - 08:00
GALILEI in a Refractive Practice: Identification of
Keratoconus Suspects and other risk cases.
Comparison of available methods.
Markus Plzl, MD
08:00 - 08:15
Discussion
The symposium is open for all WOC/DOG atten-
dees interested in the GALILEI Dual Scheimpflug
Analyzer.
334
O
t
h
e
r

S
y
m
p
o
s
i
a
(
i
n

G
e
r
m
a
n
)
335
WOC
2010
Patientensymposium des Deutschen Blinden- und
Sehbehindertenverbandes und des Allgemeinen
Blinden- und Sehbehindertenvereins Berlin:
Risiken, Forschung, Therapien die Augenheil-
kunde im Jahr 2010
This Symposium will be held in German
Raum Stockholm
Donnerstag, 3. Juni 2010 09:00-13:00 Uhr
Patientensymposium
Prof. Dr. Carl Erb, Schlosspark-Klinik Berlin
Prof. Dr. Nicole Eter, Universitts-Augenklinik Bonn
Dr. Robert Finger, Universitts-Augenklinik Bonn
Dr. Christine Stamm, Beratungsstelle fr Sehbehin-
derte Berlin
Kursinhalte
Moderation:
Dr. Christine Stamm
09:00 Uhr
Begrung
09:05 Uhr
Prof. Dr. Carl Erb, Schlosspark-Klinik Berlin
Allgemeinerkrankungen und ihre Auswirkungen
auf das Auge
10:00 Uhr
Dr. Robert Finger, Universitts-Augenklinik Bonn:
Der Weltkongress der Augenheilkunde in Berlin
zum Stand der Forschung zur Verhtung von Blind-
heit im Jahr 2010
10:45 Uhr Pause
11:15 Uhr
Prof. Dr. Nicole Eter, Universitts-
Augenklinik Bonn:
Neue Therapien zur Behandlung der Makula-
Degeneration neue Hoffnung?
12:15 Uhr
Fragen und Antworten
13:00 Uhr
Ende der Veranstaltung
Maximale Teilnehmerzahl: 350
Anmeldung erforderlich unter Tel. 030 / 895 88-0
(Allgemeiner Blinden- und Sehbehindertenverein
Berlin)
Teilnahmegebhren: keine
Symposium FR-01
zur Verleihung des Sicca-Frderpreises 2010 des
Ressorts Trockenes Auge im BVA:
Aktuelle Forschung zum Trockenen Auge
This Symposium will be held in German
Sao Paulo
Friday, 4 June 2010 11:00 - 13:30
Der Sicca-Frderpreis des Ressorts Trockenes Auge
im BVA in einer Gesamthhe von 20.000 Euro
wird nun mittlerweile seit 10 Jahren von Bausch &
Lomb | Dr. Mann Pharma Berlin gestiftet. Er dient
der Untersttzung, Motivation und interdisziplin-
ren Zusammenarbeit junger Forscherinnen und
Forscher im deutschsprachigen Raum auf diesem
Sektor. Im Rahmen des Symposiums werden aktu-
elle Forschungsprojekte zum Trockenen Auge und
Erkrankungen der Augenoberflche prsentiert.
Chairs:
Horst Brewitt (Hannover/D)
Thomas Kaercher (Heidelberg/D)
11:00 IL FR-01-01
Kultivierung und Charakterisierung adulter
Stammzellen der Trnendrse
Philipp Ackermann (Halle/Saale)
11:05 IL FR-01-02
Osmolaritt des Trnenfilms bei Augengesunden
und Patienten mit Trockenem Auge
Meral Bulgen, Elisabeth M. Messmer (Mnchen)
11:10 IL FR-01-03
Behandlung von Patienten mit Keratokonjunktivi-
tis sicca mit Augenakupunktur
Anna Cucera (Ulm)
11:15 IL FR-01-04
Die Relevanz von Harnstoff im Trnenfilm bei der
Pathogenese der Konjunctivitis sicca
Matthias Dunse (Halle/Saale)
11:20 IL FR-01-05
Untersuchungen zur Wirkung von Krften der
extrazellulren Umgebung auf Wachstum und
Differenzierung von humanen Corneazellen
Philipp Eberwein (Freiburg)
11:25 IL FR-01-06
Verbesserung des berlebens allogener Epithel-
transplantate durch Gentherapie
Thomas Armin Fuchsluger, Klaus-Peter Steuhl,
S. Ergun (Boston/USA, Essen)
11:30 IL FR-01-07
Induktion von humoraler und zellulrer Immun-
antwort der Augenoberflche durch lokale Anti-
gen-Applikation
Uta Gehlsen (Lbeck)
335
O
t
h
e
r

S
y
m
p
o
s
i
a
(
i
n

G
e
r
m
a
n
)
WOC
2010
11:35 IL FR-01-08
Epidemiologie der okulren Graft versus Host
Disease und Verlaufsbeobachtung unter immun-
suppressiver Therapie mit der Fragstellung nach
der Rolle der Becherzellen
Eva Jakob (Heidelberg)
11:40 IL FR-01-09
Ist die Replikation von Hornhaut-Endothelzellen
duch lentiviralen Gentransfer induzierbar?
Daniel Kampik (Wrzburg)
11:45 IL FR-01-10
Einfluss potentiell osmoprotektiv wirksamer
Trnenersatzprparate auf die Osmolaritt des
Trnenfilms beim Hund
Regina M. E. Korth, Gwendolyna Romkes,
Corinna Eule (Berlin)
11:50 IL FR-01-11
Pollen-Enzyme schdigen menschliche Trnenfls-
sigkeit und Bindehautzellen Ein Ansatz zum Ver-
stndnis des SNAK (saisonale nicht-allergische
Konjunktivitis)-Syndroms
Dieter Franz Rabensteiner, Eva-Maria Spreitzhofer,
Jutta Horwath-Winter, Otto Schmut (Graz/A)
11:55 IL FR-01-12
iBlink Ein Computer basierter Ansatz zur Diag-
nose und Therapie des Bildschirm-assoziierten
Trockenen Auges
Dieter Franz Rabensteiner, Jutta Horwath-Winter,
Otto Schmut (Graz/A)
12:00 IL FR-01-13
Konzentrationsbestimmung von ausgewhlten
antimikrobiellen Peptiden und Surfactantprotei-
nen in der Trnenflssigkeit von Neugeborenen,
Kindern und Erwachsenen
Gesa Friederike Schfer (Magdeburg)
12:05 IL FR-01-14
Prospektive Studie zur Evaluierung der Trnenfil-
mosmolaritt als Verlaufsparameter des trocknen
Auges bei Patienten mit allogener Stammzell-
transplantation und Graft versus Host Reaktion
(GvHD) mittels der TearLab Osmometrie
Marc Schargus, Gerd Geerling (Wrzburg)
12:10 IL FR-01-15
SP-G und SP-H zwei neue unbekannte Surfactant
Proteine des Trnenfilms
Martin Schicht, Lars Bruer (Halle/Saale)
12:15 IL FR-01-16
Co-Kultur menschlicher Bindehautzellen mit
teilungsfhigen subkonjunktivalen Fibroblasten:
Simulation einer Stammzellnische fr konjunkti-
vale Progenitorzellen
Stefan Schrader, Maria Notara, Michle
Beaconsfield, Stephen J. Tuft, Gerd Geerling,
Julie T. Daniels (Lbeck, London/GB, Wrzburg)
12:20 IL FR-01-17
Eine neue therapeutische Strategie bei entzndli-
chen Erkrankungen der Augenoberflche? Die
gezielte Hemmung antigenprsentierender Zellen
durch Sanglifehrin A.
Johannes Schwartzkopff (Freiburg)
12:25 IL FR-01-18
Konjunktiva-assoziiertes lymphatisches Gewebe
(CALT) ein Epiphnomen?
Sebastian Siebelmann (Lbeck)
12:30 IL FR-01-19
Die Bedeutung von Feinstaub und UV-Licht fr die
Entwicklung eines Umwelt induzierten Trockenen
Auges
Katrin Sturmbauer, Dieter Franz Rabensteiner,
Otto Schmut (Graz/A)
12:35 IL FR-01-20
Modifikation der Expression von Stammzell- und
Pluripotenzmarkern in limbalen epithelialen
Stammzellen durch unterschiedliche Kulturmedien
Henning Thomasen, Klaus-Peter Steuhl,
Daniel Meller (Essen)
12:40 IL FR-01-21
Randomisert kontrollierte Studie zur Verwendung
von autologem Serum zur Prvention einer
Augenoberflchenstrung bei adjuvanter
5-Fluorouracil-Injektion nach filtrierender Glau-
komchirurgie
Jan Darius Unterlauft, Karsten Kasper,
Gerd Geerling (Wrzburg)
336
337
WOC
2010
S
o
c
i
a
l

P
r
o
g
r
a
m
Official Social
Program
Opening Ceremony
Saturday, 5 June 2010, 18:30 - 20:00
ICC, Hall 1
Do not miss the WOC 2010 Opening Ceremony, Saturday 5 June 2010 at 6.30pm
Follow us and discover past, present and future during the Opening Ceremony:
Pay tribute to our ancestor Albrecht von Graefe
Explore the iconic Berlin, the vibrant capital of Germany and its Queen
Look into the future with WOC 2012 to be held in Abu Dhabi, United Arab
Emirates.
Join us in welcoming the Who is Who of ophthalmology marching in and coming
from across the world and be part of the promotion of scientific excellence reflected
throughout the International Award Ceremony.
Featured in HD sequences, the beauty of the Eye will be omnipresent during the
Opening Ceremony and strives to represent the vision and mission of our fascina-
ting profession. Admire the breathtaking pictures of Eyeland Design. Enjoy phantas-
tic music and entertainment.
The WOC Reception is the perfect get-together for the international ophthalmolo-
gist community and allied specialties to meet old friends and make new ones in a
friendly atmosphere.
On behalf of the International Council of Ophthalmology, the German Society of
Ophthalmology, the German Academy of Ophthalmology and both, the WOC 2010
Executive Committee and Scientific Programme Committee, we take pleasure in
welcoming you to this key event.
Prof. Dr. Gerhard K. Lang Bruce E. Spivey, MD, MS, Med
President of the DOG International Council of Ophthalmology
President WOC 2010 President
see also p. 39
WOCReception
Saturday, 5 June 2010, 20:00 - 22:00
ICC, Hall 2
WOC in Concert
Sunday, 6 June 2010, 20:00 - 21:30
Venue: French Church of Friedrichstadt (French
Cathedral)/ Franzsische Friedrichstadtkirche am
Franzsischen Dom, directly at the Gendarmenmarkt.
Tube Station on the U2 Line: Franzsische Str.
Entrance free
No bus transfer
Organizers:
Georg Fischer Varvitsiotis (Conductor)
and Franz Grehn
Ophthalmologists play for Ophthalmologists
The musicians play masterpieces from
Carl Philipp Emmanuel Bach
Lon Bollmann
Leopold Mozart
Wolfgang Amadeus Mozart
Johann Joachim Quantz
Robert Schumann
Louis Vierne
Ludwig van Beethoven
see also p. 41
WOCtoberfest
Monday, 7 June 2010, 7:30- 12:00
WOCtoberfest will be a typical Bavarian-like Oktober-
fest with beer, German food and entertainment.
You should not miss this special social highlight!
We cordially invite you to come and join us for a
Bavarian-style Oktoberfest at the WOCtoberfest in
the Hangar II of Tempelhof Airport. With traditional
Oktoberfest brass band music, beer and Bavarian
specialties, we plan to enjoy a lively, intercultural
evening. Of course, there will also be non-alcoholic
drinks and vegetarian food. We are offering some other
attractions for adults and children so as to celebrate
this WOCtoberfest as a family party.
All participants are also most welcome to wear their
own national dress at this event, as wearing different
and colorful national dresses conveys a sense of
friendly solidarity.
Our motto for the evening is: meet old friends
and make new friends in a relaxed and friendly
atmosphere.
If you are interested in participating in sightseeing tours please go to the congress
website at www.woc2010.org/social-program/sightseeing-tours and contact the
agency Interklassik by quoting "WOC 2010". The Interklassik team will also be
happy to advise you concerning the organisation of pre and post congress tours.
Interklassik Concierge & Event GmbH
E WOC2010@interklassik.de
T +49 (30) 2044 540
F + 49 (30) 2045 2675
Program for
Accompanying
Persons
338
WOC
2010
S
o
c
i
a
l

P
r
o
g
r
a
m
I
n
f
o
r
m
a
t
i
o
n

f
o
r

A
u
t
h
o
r
s
Information for
Authors
Opening hours of the Media Check
The central Media Check is located in Main Lobby, Lobby Level
Thursday, 3 June 2010 7:00 19:00
Friday, 4 June 2010 7:00 18:30
Saturday, 5 June 2010 6:30 18:30
Sunday, 6 June 2010 6:30 18:30
Monday, 7 June 2010 6:30 18:30
Tuesday, 8 June 2010 7:00 18:30
Wednesday, 9 June 2010 7:30 14:00
Speaking Times
Lectures free paper session: 9 minutes
Oral presentation: 7 minutes
In order to guarantee a smooth organization of the entire program, all speakers are
requested to keep to their allocated presentation times. The chairperson of each
session will be entitled to interrupt a presentation if a speaker exceeds the time
allocated.
Videos
Video presentations are an important and effective mean of displaying scientific
results. Therefore, the best seven videos will be displayed and discussed during the
video session on Sunday, 6 June, 14:00 15:30 in the Radio Tower Lounge 2.
The WOC will publish awarded videos on its homepage. Therefore, authors who
would like to make their video available to the WOC are requested to consider that
the videos do not show any data which are subject to payment for copyrights and
technical reproduction.
The WOC 2010 Video Award of the DOG, donated by Carl Zeiss Meditec VG,
will be granted at the end of the Video Session with Presentation of Awards
(Sunday, 6 June, 14:00 15:30).
Poster Presentation
Poster presentations are an important and effective means of displaying scientific
results.
Printed posters will be displayed in indicated sessions and E-posters during the
entire congress.
First authors of posters must be present at their poster at the times indicated
below. Chairpersons will check the presence of poster authors.
Each day three outstanding posters will be awarded an amount of 300 c each.
All posters must be prepared in English.
Standard poster walls will be available in the Poster Exhibition.
The maximum size of a poster is DIN A0 (84.10 cm wide x 118.90 cm high).
Adhesive material and staff will be available to poster authors from the Poster Help
Desk in the poster exhibition area.
The organisers will remove posters that will not have been removed by the times
indicated below.
Poster Presentation
Poster P-SA-001 to P-SA-282 and P-SU-001 to P-SU-277 must be mounted on
Saturday, 5 June 2010, 8:30 and removed on Sunday, 6 June 2010, 17:30.
Poster P-MO-001 to P-MO-298 and to P-TU-001 to P-TU-265 must be mounted on
Monday, 7 June 2010, 8:30 and removed on Tuesday, 8 June 2010, 17:30.
339
WOC
2010
Poster Session with Discussion
First authors are requested to attend their posters for questions and discussions as
follows:
P-SA-001 to P-SA-282
Saturday, 5 June 2010, 15:30 17:00 at the poster
P-SU-001 to P-SU-277
Sunday, 6 June 2010, 15:30 17:00 at the poster
P-MO-001 to P-MO-298
Monday, 7 June 2010, 15:30 17:00 at the poster
P-TU-001 to P-TU-265
Tuesday, 8 June 2010, 15:30 17:00 at the poster
Electronic Posters
In addition to the conventional poster presentation, a facility for all delegates to
view any poster on a LCD display screen during the entire congress will be available.
To optimize the preparation of this presentation, all authors are asked to observe
the following requirements: Maximum five pages (without animation) in Microsoft
PowerPoint. All images and graphics should be. Posters will be displayed in land-
scape format with a screen resolution of 1024 x 768 dpi. (Powerpoint On-Screen
show 4:3)
Projection Facilities
A central Media Check will be available during the entire congress. Own laptops
cannot be connected in the rooms. All presentations must be uploaded in advance
to the network.
All authors will receive a separate e-mail from M Events Cross Media GmbH with
access information and instruction. Presentations that are attached to an email
cannot be processed. Only MS-Powerpoint (XP and higher) and PDF presentations
with video formats as specified on the upload site are permitted for this conference.
Do not forget to bring your video files as they cannot be embedded into the presen-
tation.
Please submit your files at least 2 hours before your talk. If you speak in the first
session in the morning please submit your files the day before or use the internet
upload.
You may check and/or alter your presentation yourself in the Media Check (ICC
Lounge) up to two hours prior to your presentation.
Please note that the M Events staff members cannot revise your presentation.
For the submission of your presentation on site, CDs, USB Sticks, or similar will be
accepted.
After the conference all submitted files will be deleted from all storage media.
Information for
Authors
340
WOC
2010
I
n
f
o
r
m
a
t
i
o
n

f
o
r

A
u
t
h
o
r
s
Publication of Scientific Papers of DOG members
Scientific contributions that have been accepted for oral presentation have to be
handed in in publishable format for peer reviewing no later than 31 October 2010.
Publication is possible in either German or English.
Please send your manuscript to the respective editors:
Contributions in German for review by the journal "Der Ophthalmologe" should be
submitted online only. Full details concerning submission are available at:
www.DerOphthalmologe.de or directly at: www.editorialmanager.com/deop/
Editor-in-Chief
Professor Frank G. Holz
Universitts-Augenklinik Bonn
Ernst-Abbe-Str. 2
53127 Bonn
Contributions in German for review by the journal "Klinische Monatsbltter fr
Augenheilkunde" should be sent online to:
http://mc.manuscriptcentral.com/klimo
Editors-in-Chief
Professor Gerhard K. Lang, Professor Gabriele E. Lang
Universitts-Augenklinik Ulm
Prittwitzstr. 43
89075 Ulm
Contributions in English for review by the journal "Graefes Archive for Clinical
and Experimental Ophthalmology" should be submitted online only. Full details
concerning submission are available at:
www.di-ep.com
or directly at:
http://editorialmanager.com/graefes
Editor-in-Chief
Professor Bernd Kirchhof
Klinikum der Universitt zu Kln
Zentrum fr Augenheilkunde
Kerpener Str. 62
50924 Cologne
Copyright for oral presentations to be made at the congress by DOG members be-
longs to the society. Therefore authors of oral presentations are obliged to submit
their contributions for review and publication to one of the following journals: "Der
Ophthalmologe", "Klinische Monatsbltter fr Augenheilkunde" or "Graefes Archive
for Clinical and Experimental Ophthalmology". Upon request, the presentation may
also be published in another journal. In this case, the author is asked to send an
informal application to the Secretary of the DOG. Contributions published in other
journals shall annotate: "presented at the 108
th
DOG Congress".
All authors are kindly asked to observe the "Instructions for Authors" of the
respective journals. Manuscripts not accepted for publication after the review
process will be returned to the respective author with the reviewers evaluation.
Information for
Authors
341
WOC
2010
I
n
f
o
r
m
a
t
i
o
n

f
o
r

A
u
t
h
o
r
s
DOG Membership
Colleagues who wish to become members of the German Society of Ophthalmology
(DOG) can do so by clicking on membership at www.dog.org. Please complete the
online application form, or download the form, complete it and send it to:
Geschftsstelle der DOG e.V.
Platenstr. 1
80336 Munich
Tel. +49 (89) 5505 768-14
Fax +49 (89) 5505 768-11
E-Mail geschaeftsstelle@dog.org
Opening hours
Monday to Friday: 8:00-12:30
Annual Membership Fees
Consultants / specialists national and international, c 200
who do not belong to any of the following groups
Medical students in training (assistant doctors), c 100
Consultants / specialists and medical students c 100
from neighbouring Eastern European countries
Pensionary members c 100
Paying members of the DOG will automatically receive a copy of the journal Der
Ophthalmologe or alternatively the English language journal Graefes Archive for
Clinical and Experimental Ophthalmology at no extra cost. If Der Ophthalmologe
is chosen, Graefes Archive for Clinical and Experimental Ophthalmology can be
ordered at a reduced annual rate of c 60.
Copies of journals received at reduced rates are exclusively for the personal use
of DOG members and may not be passed on to libraries or institutes.
342
WOC
2010
D
O
G

M
e
m
b
e
r
s
h
i
p
343
WOC
2010
G
r
a
n
t
s

F
r
a
n
c
e

2
0
1
0

Travel and accommodation Grants France 2010
European Symposium
DOG and SFO would like to extend and intensify the scientific cooperation and
exchange between Germany and France. For this purpose, a joint symposium will
be organized at the annual SFO and DOG congress, the topic of this symposium
generally being the topic of the preceding congress in the respective country.
Young physicians in practice and/or research are invited to submit their contributi-
ons, which should be related to the topic of the symposium. The contributions
should possibly be the result of a real German-French cooperation.
A DOG/SFO commission will select up to four articles of all the submitted abstracts.
The first authors will receive from his/her society a travel allowance of c 1000,- to
participate in the congress. In addition, the first author of the respective best
abstract will receive a grant of c 2000,- to be used for a stay of several weeks in a
hospital of the other country. Language skills are welcome, but not an absolute
requirement.
The official languages of the DOG-Congress are German and English, those of the
SFO-Congress French and English.
Applications including a short description (20 25 lines) should be sent to:
geschaeftsstelle@dog.org
You will find more detailed information about application and deadlines on the
DOG-Homepage
http://www.dog.org/foerderung/stipendien.html
Reise und Aufenthaltsstipendium Frankreich 2010
Europisches Symposium
DOG und SFO wollen die Zusammenarbeit und den Austausch zwischen Deutsch-
land und Frankreich auch auf wissenschaftlichem Gebiet weiter intensivieren. Im
Rahmen der Kongresse beider Fachgesellschaften findet dazu jeweils ein gemeinsa-
mes Symposium statt. Thema ist jeweils das Kongressthema des vorausgehenden
Kongresses im jeweils anderen Land.
Junge, klinisch und/oder wissenschaftlich ttige Mitarbeiter/innen werden aufge-
fordert, freie Beitrge einzureichen, die zum Thema des jeweiligen Symposiums
passen sollten. Besonders wnschenswert wre es, falls diese Arbeiten das Ergebnis
einer realen deutsch-franzsischen Zusammenarbeit dokumentieren.
Aus den eingereichten freien Beitrgen whlt die Kommission der DOG/SFO bis zu
vier Beitrge aus.
Die Erstautoren/innen erhalten von ihrer Fachgesellschaft einen Reisekostenzu-
schuss zu dem jeweiligen Kongress in Hhe von c 1.000,-.
Der Erstautor des jeweils besten Beitrags erhlt zustzlich einen Reisekostenzu-
schuss in Hhe von c 2.000,-, der fr einen mehrwchigen Aufenthalt an einer
Klinik des jeweiligen anderen Landes zu verwenden ist. Sprachkenntnisse sind will-
kommen, aber nicht Bedingung.
Die Kongresssprachen der DOG-Kongresse sind Deutsch und Englisch, die der SFO-
Tagungen Franzsisch und Englisch.
Antrge inkl. einer Kurzbeschreibung von max. 20 bis 25 Zeilen Text sind per E-Mail
zu richten an: geschaeftsstelle@dog.org
Details zur Bewerbung, Abgabefristen sowie den genauen Themen der Symposien
werden auf der DOG Homepage
http://www.dog.org/foerderung/stipendien.html
verffentlicht.
Dr. R. Kaden Verlag
Der Ophthalmologe
unter den Verlagen
www.kaden-verlag.de
345
WOC
2010
S
p
o
n
s
o
r
s

a
n
d

E
x
h
i
b
i
t
o
r
s

Sponsors and
Exhibitors
1a Medico GmbH 15 B/38
1st Q Deutschland GmbH & CO. KG 15 A/15
A. R. C. Laser GmbH 15 A/12
AAO American Academy of Ophthalmology EF 08
Aaren Scientific, Inc. 17 B/27
Abbott Medical Optics Inc. 15 A/03
Accutome, Inc. 17 A/10
Aeon Astron Europe B. V. 15 A/26
ADTA 15/02
AKRUS GmbH 12 B/21
ALBOMED GmbH 15 A/34
ALCHIMA 15 A/19
Alcon Laboratories, Inc. 12 B/30
Allergan Inc. 14/07
anteis SA 15 B/48
APAO EF 13
APAO 2011 EF 03
Appasamy Associates 17 B/48
argus Individuell Optic GmbH 17 B/42
asico 15 B/53
Association for Research in Vision and Ophthalmology EF 12
ASCRS Media 17 A/14
Der Augenspiegel 12 A/12
AuroLab 12 B/25
Bausch & Lomb 12 A/16
Bayer Schering Pharma AG 14/09
Biermann Verlag 14/08
BioResonator 15 B/54
Bio Tech 14/04
Block Optic Ltd. 15 A/16
BOD EF/22
Bohus Biotech AB 15 B/51
bon Optic Vertriebsgesellschaft mbH 15 B/50
brumaba GmbH & Co. KG 14/15
Caruso & Freeland 17 B/43
Christoffel-Blindenmission 17 B/56
CCS Pawlowski GmbH 17 A/31
Cochrane Eyes and Vision Group 17 A/22
Chibret GmbH 14/06
Clarity Medical Systems 17 B/34
concept ophthalmologie EF 17
Civilian Research & Development Foundation 17 A/21
CROMA-PHARMA Dtl. GmbH 15 A/04
Cataract & Refractive Surgery Today 17 A/23
CSO Costruzione Strumenti Oftalmici S.r.l. 15 B/50
Deutscher Blinden- und Sehbehindertenverband e.V. 17 B/50
Deutsche Gesellschaft fr Gewebetransplantation gGmbH 12 A/17
Dioptex GmbH 12 B/28
DMG Deutsche Myastenie Gesellschaft e.V. 17 B/74
Dockx Medical B.V. 17 B/67
DOMILENS GmbH 15 B/41
DOMS Eye-Technology GmbH & Co. KG 17 A/31
D.O.R.C. International b.v. 12 B/33
Deutsche Uveitis Arbeitsgemeinschaft e. V. 17 B/63
The WOC 2010 gratefully acknowledges the support of all
Sponsors and Exhibitors
Company Hall Area/Number
Dual Laser Ltd. OY 15 B/52
European Journal of Ophthalmology EF/07
Ellex 14/12
Elektronik & Przisionsbau Saalfeld GmbH 17 A/31
ESCRS EF 05
EVER EF 14
Eyemaginations 12 A/01
Eyemetrics Optic Service AG 15 A/16
Eyetec GmbH 15 A/16
FCI France Chirurgie Instrumentation 12 B/27
Ferrara Ophthalmics 12 B/26
FIDUS 12 B/39
Frastema S.R.L. 17 B/42
Gebauer Medizintechnik GmbH 17 B/77
GEUDER AG 15 A/17
Grner Laser Products GmbH & Co. KG 15 A/05
Haag-Streit International 13/01
Heidelberg Engineering GmbH 15 B/44
Heine Optotechnik GmbH & Co. KG 17 B/70
Albert Heiss GmbH & Co. KG 12 B/20
Heuser Ophthalmologie und Medizintechnik 12 B/31
HEXAL AG 14/03
HOYA Surgical Optics GmbH 14/14, 15 A/01
HumanOptics AG 12 B/22
Icare Finland Oy 15 A/20
ICO International Council of Ophthalmology EF 06
ifa Systems AG 12 A/18
Initiative Auge e.V. Main Foyer ICC
Insight Instruments, Inc. 12 A/06
integration.ag 12 A/18
IOA International Orthoptic Association 17 A/24
IRIDEX Corporation 15 A/07
iVIS Technologies s.r.l. 17 B/45
Jaypee Brothers Medical Publishers Pvt. Ltd. 17 B/29
JCAHPO 17 A/18
Jen-Ophthalmo 17 A/31
Katena Products, Inc. 15 A/02
Keeler Ltd. 15 A/27
Kowa Europe GmbH 15 B/50
Franz Kuschel 17 B/72
LCA Pharmaceutical 15 B/40
Leica Microsystems AG 15 A/32
Lightmed Corporation 17 B/68
LUMENIS (Germany) GmbH 17 B/33
Dieter Mann GmbH 15 A/08
Mani, INC. 15 B/36
MEACO EF 02
Medizingerte + Chirurgiebedarf GmbH 15 A/30
Mathme Eye Bank Eye Hospital India 17 A/20
med_tec Medizintechnik Vertriebs-GmbH 15 A/19
MEDA CO., LTD 17 B/76
Medical Workshop 12 B/42
Medicel AG 15 A/21
Medicontur Medical Engineering Ltd. 15 B/48
Mediphacos 12 A/07
MED-LOGICS, INC. 15 B/43
medways e.V. 17 A/31
Merck Sharp & Dohme 14/06
Metrovision 17 B/47
Sponsors and
Exhibitors
346
WOC
2010
S
p
o
n
s
o
r
s

a
n
d

E
x
h
i
b
i
t
o
r
s

Micro Technologie Ophtalmique SA 15 A/24
MID Labs, Inc. 15 A/29
Morcher GmbH 15 B/37
Moria SA 15 A/19
MSD 14/06
NeoMedix Corporation 17 B/54
NeoVista Inc 17 A/07
New World Medical, Inc. 17 B/75
Nidek Co., Ltd. 15 A/11
Novartis Pharma GmbH 14/11
Novartis Pharma AG 14/11
Ocular Instruments 15 A/06
Ocular Surgery News / SLACK EF 19
Oculentis GmbH 17 A/11
OCULUS Optikgerte GmbH 15 A/10
OD-OS GmbH 12 A/05
Oertli Instrumente AG 15 B/45
OGI Ophthalmologische Gerte und Instrumente 12 B/42
OIS 17 A/15
OmniVision GmbH 12 B/37
OPHTEC BV 17 A/06
Ophthalmic Design GmbH 17 A/04
OphthaSWISS AG 15 A/34
OPKO Instrumentation 15 B/46
Optima Pharmazeutische GmbH 15 B/50
OptiMedica International Pte. Ltd. 17 A/12
Optitech Eye Care 14/02
Opto Global Pty Ltd 15 A/19
Optopol Technology 12 A/09
Optos GmbH 12 A/13
Optovue, Inc. 17 A/35
OTE Ophthalmology Time Europe EF 18
Peschke Medizintechnik GmbH 15 B/56
Pfizer Ophthalmics 12 B/35
Pharma Stulln GmbH 14/01
Plusoptix GmbH 15 A/33
Precision Vision 17 B/52
Prevor GmbH 15 A/22
ProRetina 17 A/17
PXE EF/21
Quantel Medical 12 A/14
Rayner Intraocular Lenses Ltd. 17 A/36
Reichert Ophthalmic Instruments 17 B/44
Right Mfg. Co.Ltd. 15 B/50
Roland Consult 15 B/35
Rowiak GmbH 12 A/17
Fritz Ruck 12 A/10
RUMEX International Co. 15 A/23
S. Karger AG Basel EF 10
Santen 16/01
Schairer 17 A/02
SCHWIND 17 A/03
SFO EF/15
SOE EF 16
SOE 2010 EF 16
Sonomed, Inc. 17 B/53
SOOFT Italia S.p.A. 15 B/50
Stiftung Auge Main Foyer ICC
Surgitrac Co. Ltd. 15 A/25
Sponsors and
Exhibitors
347
WOC
2010
S
p
o
n
s
o
r
s

a
n
d

E
x
h
i
b
i
t
o
r
s

SUZHOU KANGJIE MEDICAL INSTRUMENT CO., LTD. 17 B/28
Synergetics Germany GmbH 12 B/29
T.MED GmbH 12 A/10
Takagi Seiko Co., Ltd. 17 B/41
Tha 15 A/14
Georg Thieme Verlag KG 12 A/02
Thrombogenics 17 A/37
Titan Surgical 15 A/28
Tomey GmbH 15 B/55
Topcon Europe B.V 17 A/05
TRB CHEMEDICA AG 15 B/47
TRIOPTICS GmbH 17 B/49
Trusetal Verbandstoffwerk GmbH 12 B/32
U.S. IOL / Stephens Instruments 17 A/26
UFSK-International OSYS GmbH 12 B/23
Ulrich Zuhnemer KG 12 B/42
URSAPHARM Arzneimittel GmbH & Co. KG 12 A/11
Vision 2020 EF 11
Visiontech Medical Optics Ltda. 12 B/41
Volk Optical Inc. 15 A/27
VRmagic GmbH 15 B/42
W2O Medizintechnik AG 12 B/20
WEFIS GmbH 12 B/40
Wexler Surgical 17 A/38
WGA World Glaucoma Association EF 20
Wirmsberger & Bhm 17 A/01
Wisepress, Ltd. 17 B/73
WOC 2012 EF/01
WOC 2014 EF 04
Carl Zeiss Meditec AG 13/02
ZIEMER OPHTHALMIC SYSTEMS AG 17 B/40
Status: 29 April 2010
E-Posters and Internet Hall 17
Congress Bags Hall 17
Sponsors and
Exhibitors
348
WOC
2010
S
p
o
n
s
o
r
s

a
n
d

E
x
h
i
b
i
t
o
r
s

5aaIebeneUHall level
foyerebeneULobby level
EingangsebeneULntrance level
5aIonebeneUSalon level
5aaI 8
Hall 8
5aaI 9
Hall 9
5aaI 10
Hall 10
5aaI 3
Hall J
5aaI 4l5
Hall 4/S
5aaI 6
Hall 6
5aaI 7
Hall 7
5aaI 1
Hall 1
DachgarIen!oyer
Roofgarden lobby
DachgarIen
Roofgarden
Parkhaus
Car park
Parkhaus
Car park
Parkhaus
Car park
5aaI 2
Hall 2
hne
Stage
HaupIeingang
Main entrance
In!ormaIion
lnfomation
RegisIrierung
Registration
Au!gang 7
Access 7
5aIons 11-20
Salon 11-20
349
WOC
2010
I
n
d
u
s
t
r
i
a
l

E
x
h
i
b
i
t
o
n

P
l
a
n
s

Plan Industrial Exhibition Overview
350
WOC
2010
I
n
d
u
s
t
r
i
a
l

E
x
h
i
b
i
t
o
n

P
l
a
n
s

Hall 12
351
WOC
2010
I
n
d
u
s
t
r
i
a
l

E
x
h
i
b
i
t
o
n

P
l
a
n
s

8 m
H
a
l
l
1
2
C
o
f
f
e
e
S
h
o
p
P
f
i
z
e
r
A
k
r
u
s
A
l
c
o
n
i
f
a
i
n
t
e
g
r
a
t
i
o
n

a
g
M
e
d
i
-
p
h
a
c
o
s
O
D
-
O
S
O
m
n
i
V
i
s
i
o
n
O
p
t
o
p
o
l
O
p
t
o
s
Q
u
a
n
t
e
l
U
r
s
a
p
h
a
r
m
V
i
s
i
o
n
t
e
c
h
W
2
O
A
l
b
e
r
t

H
e
i
s
s
C
A
T
E
R
I
N
G
C
A
T
E
R
I
N
G
C
A
T
E
R
I
N
G
H
u
m
a
n
O
p
t
i
c
s
F
i
d
u
s
D
i
o
p
t
e
x
F
C
I
F
e
r
r
a
r
a
S
y
n
e
r
-
g
e
t
i
c
s
W
E
F
I
S
O
G
I
M
e
d
i
c
a
l

W
o
r
k
s
h
o
p
U
.

Z
u
h
n
e
m
e
r

A
u
r
o
L
a
b
H
e
u
s
e
r
T
r
u
s
e
t
a
l
T
.
M
e
d
F
r
i
t
z

R
u
c
k
H
a
a
g
-
S
t
r
e
i
t
D
O
R
C
D
t
.

G
e
s
.
G
e
w
e
b
e
-
t
r
a
n
s
p
l
a
n
t
.
R
o
w
i
a
k

G
m
b
H
B
a
u
s
c
h

&

L
o
m
b

1
2

A
/
0
5

1
2

A
/
0
6

1
2

A
/
0
7

1
2

A
/
0
9

1
2

A
/
1
0

1
2

A
/
1
2

1
2

A
/
1
3

1
2

A
/
1
1

1
2

A
/
1
6

1
2

A
/
1
4

1
2

A
/
1
7

1
2

A
/
1
8

1
2

B
/
2
5

1
2

B
/
2
6

1
2

B
/
2
7
1
2

B
/
2
8

1
2

B
/
2
9

1
2

B
/
2
2

1
2

B
/
2
3

1
2

B
/
2
0

1
2

B
/
2
1

1
2

B
/
3
0

1
2

B
/
3
9

1
2

B
/
4
0

1
2

B
/
4
1

1
2

B
/
4
2

1
2

B
/
3
7

1
2

B
/
3
5

1
2

B
/
3
1

1
2

B
/
3
2

1
2

B
/
3
3

1
3
/
0
1
U
F
S
K
A
u
g
e
n
-
s
p
i
e
g
e
l
I
n
s
i
g
h
t
I
n
s
t
r
.
1
2

A
/
0
2

T
h
i
e
m
e
E
y
e
m
a
g
i
-
n
a
t
i
o
n
s
1
2

A
/
0
1

H
a
a
g
-
S
t
r
e
i
t
1
3
/
0
1
Hall 15
352
WOC
2010
I
n
d
u
s
t
r
i
a
l

E
x
h
i
b
i
t
o
n

P
l
a
n
s

D
i
e
t
e
r

M
a
n
n
C
r
o
m
a
P
h
a
r
m
a
G
e
u
d
e
r
D
o
m
i
l
e
n
s
T
h
e
a
N
i
d
e
k
O
c
u
l
u
s
A
.
R
.
C
.
1
s
t

Q
b
o
n

O
p
t
i
c
K
o
w
a

E
u
r
o
p
e
O
p
t
i
m
a
C
.
S
.
O
S
.
O
.
O
.
F
:
T
R
i
g
h
t

O
n
E
y
e
t
e
c
/

B
l
o
c
k

O
p
t
i
c

E
y
e
m
e
t
r
i
c
s
H
a
l
l

1
6
S
a
n
t
e
n
C
o
f
f
e
e
S
h
o
p
I
c
e

S
h
o
p
A
l
b
o
m
e
d
O
p
h
t
h
a
S
w
i
s
s
D
u
a
l

L
a
s
e
r
M
a
n
i
M
e
d
-
L
o
g
i
c
s
M
I
D
L
a
b
s
O
e
r
t
l
i
M
o
r
-
c
h
e
r
1
a
M
e
d
i
c
o
B
o
h
u
s
R
o
l
a
n
d
C
o
n
s
u
l
t
T
i
t
a
n
S
u
r
g
.
V
o
l
k
K
e
e
l
e
r
V
R
m
a
g
i
c
H
a
l
l
1
5
O
c
u
l
a
r
I
n
s
t
r
.
I
r
i
d
e
x
T
R
B
C
h
e
m
e
d
i
c
a
G
r
n
e
r
L
a
s
e
r
A
e
o
n
S
u
r
g
i
-
t
r
a
c
H
e
i
d
e
l
b
e
r
g
E
n
g
i
n
e
e
r
i
n
g
M
+
C
L
e
i
c
a
m
e
d
_
t
e
c
O
p
t
o

G
l
o
b
a
l
M
o
r
i
a

/

A
l
c
h
i
m
i
a
M
T
O
M
e
d
i
c
o
n
t
u
r
a
n
t
e
i
s
L
C
A
I
c
a
r
e
T
o
m
e
y
P
r
e
v
o
r
M
e
d
i
c
e
l
1
5

A
/
0
4
1
5

A
/
0
5
1
5

A
/
0
8
1
5

A
/
0
7
1
5

A
/
1
0
1
5

A
/
1
1
1
5

A
/
1
4
1
5

A
/
1
6
1
5

A
/
1
5
1
5

A
/
1
9
1
5

A
/
2
0
1
5

A
/
2
1
1
5

A
/
2
4
1
5

A
/
2
5
1
5

A
/
2
6
1
5

A
/
2
3
1
5

A
/
2
2
1
5

A
/
1
2 1
5

A
/
1
7
1
5

A
/
2
7
1
5

A
/
2
8
1
5

A
/
3
0
1
5

A
/
0
6
1
5

A
/
2
9
1
5

A
/
3
2
1
5

A
/
3
3
1
5

A
/
3
4
1
5

B
/
3
5
1
5

B
/
4
1
1
5

B
/
3
6
1
5

B
/
3
7
1
5

B
/
3
8
1
5

B
/
4
4
1
5

B
/
4
2
1
5

B
/
4
3
1
5

B
/
4
5
1
5

B
/
5
1
1
5

B
/
5
2
1
5

B
/
5
3
1
5

B
/
5
5
1
5

B
/
5
6
1
5

B
/
4
8
1
5

B
/
4
7
1
5

B
/
4
6
1
5

B
/
5
0
1
5

B
/
4
0
1
6
/
0
1
P
l
u
s
o
p
t
i
x
O
P
K
O
R
u
m
e
x
P
e
s
c
h
k
e
a
s
i
c
o
B
i
o
R
e
s
o
-
n
a
t
o
r
1
5

B
/
5
4
A
M
O

A
b
b
o
t
t
K
a
t
e
n
a
1
5

A
/
0
2
1
5

A
/
0
3
Hall 17
353
WOC
2010
I
n
d
u
s
t
r
i
a
l

E
x
h
i
b
i
t
o
n

P
l
a
n
s

Hall 14
354
WOC
2010
I
n
d
u
s
t
r
i
a
l

E
x
h
i
b
i
t
o
n

P
l
a
n
s

M
e
r
c
k
C
h
i
b
r
e
t
N
o
v
a
r
t
i
s
H
a
l
l
1
4
H
a
l
l

1
3
H
o
y
a
B
i
e
r
m
a
n
n
O
p
t
i
-
t
e
c
h
Z
e
i
s
s
A
l
l
e
r
g
a
n
C
o
f
f
e
e
S
h
o
p
H
e
x
a
l
I
C
C
e
l
l
e
x
P
h
a
r
m
a
S
t
u
l
l
n
H
a
a
g
-
S
t
r
e
i
t
H
a
a
g
-
S
t
r
e
i
t
B
a
y
e
r

S
c
h
e
r
i
n
g
1
4
/
0
1
1
3
/
0
1 1
3
/
0
2
1
3
/
0
1
1
4
/
0
2
1
4
/
0
4
1
4
/
0
6
1
4
/
0
7
1
4
/
0
3
1
4
/
0
8
1
4
/
1
1
1
4
/
0
9
1
4
/
1
2
1
4
/
1
4
b
r
u
m
a
b
a
1
4
/
1
5
B
i
o
T
e
c
h
A
l
c
o
n
H
o
y
a
K
a
t
e
n
a
1
5

A
/
0
1
1
5

A
/
0
2
A
D
T
A 1
5

/
0
2
Entrance Foyer ICC
355
WOC
2010
I
n
d
u
s
t
r
i
a
l

E
x
h
i
b
i
t
o
n

P
l
a
n
s

A S I A P A C I F I C A C A D E M Y O F O P H T H A L M O L O G Y C O N G R E S S
20-24 MARCH 2011 SYDNEY CONVENTI ON AND EXHI BI TI ON CENTRE / SYDNEY AUSTRALI A
A N I N T E R N A T I O N A L F O C U S O N O P H T H A L MO L O G Y
W
ith great pleasure, we invite our colleagues and the ophthalmic industry throughout the world to Sydney
for the 2011 Congress of the Asia Pacific Academy of Ophthalmology.
The Scientific Program Committee is assembling an exciting and stimulating scientific program, which will enable
both comprehensive ophthalmologists and sub-specialists the opportunity to update their knowledge and skills.
Australia and New Zealand have a long history of world-class expertise in clinical practice and ophthalmological
research. This, combined with the warm and relaxed Aussie spirit, will ensure your Congress experience is
professionally enhancing and personally rejuvenating.
We encourage our global colleagues and the international ophthalmic industry to join us, to participate and to
experience our unique Australian hospitality. Your journey to Sydney will be more than worthwhile,
professionally and personally.
A/Prof Ivan Goldberg Prof Frank Martin Prof Charles McGhee
Congress President Chairman, Congress Chairman, Scientific
Sponsorship and Exhibition Program Committee
Scientific Program will include: International guest speakers on all subspecialties
Live Cataract and Refractive Surgery Symposia Workshops
Sponsorship and exhibition packages are now available. The
floorplan is also available for preview and space selection. For
more information on sponsorship and exhibition opportunities
please email sponsorship@apaosydney2011.com
Key Dates
Registration and Abstract Submission now open online
Abstract submissions deadline 22 October 2010
Early-bird registrations close 15 January 2011
Your invitation
to Sydney in 2011.
www.apaosydney2011.com
357
WOC
2010
I
n
f
o
r
m
a
t
i
o
n
Information from
A to Z
A
Accommodation/Hotel Reservation
Berlin's hotel landscape is one of the most up-do-date in Europe. In the last 10 years
the number of hotel beds in the city has more than doubled. Berlin now has nearly
100,000 hotel beds at its disposal. Almost all the large hotels chains are already
present on the Spree or plan to come to the German capital.
Hotel rooms in various price categories have been booked for WOC 2010 by HRS,
the worldwide hotel reservation service.
The HRS homepage is available in 32 languages. The list of search result can be
tailored according to different search criteria such as distance to the congress
venue, hotel category, currency etc. You will also find more information by clicking
on the hotels listed after your request. Hotel reservations can be made via HRS at
the congress website www.woc2010.org.
Furthermore, the participants of the WOC 2010 have the possibility to book one of
the three headquarter hotels, Westin Grand, Adlon, Hilton, see also at
www.woc2010.org.
B
Business Center
The Business Center of the ICC is situated in the entrance hall and offers a full range
of services including faxing, copying, printing, telephone cards, etc.
Opening hours during WOC 2010:
From 08:00 to 18:00 (on 9 June until 14:00).
C
Cancellation Policy
Cancellations of registration will only be accepted in writing sent to the PCO by
email or fax. The notification must include all relevant information regarding the
bank account to which a possible refund may be remitted. In case of cancellation
before 10 May 2010 registration fees will be refunded minus a handling fee of c 50.
After this date there will be no refund.
Car Park
A total of 12,000 parking spaces are available on and around the grounds. The par-
king garage of the ICC provides 650 parking spaces. Elevators and cash desk machi-
nes are located at the south entrance of the ICC. Prices are as follows:
Rate per hour: c 2.00 / Rate per day: c 7.50
Climate
Berlin enjoys pleasant, sunny summers when days are long and temperatures can
sometimes exceed 25 to 30C, also in June. However the summer months are also
unpredictable and days can rapidly change from sunshine to cloud. Rain can fall all
year round.
Cloak Room
Services for checking in coats and luggage will be available in the entrance hall of
the ICC.
Clothing
Clothing is informal for all occasions. Raincoat and umbrella might be helpful.
CME Credits/Certification
The congress will be accredited by the respective Accreditation Council for
Continuing Medical Education for Germany and Europe to provide continuing
medical education credits for physicians.
358
WOC
2010
I
n
f
o
r
m
a
t
i
o
n
Information from
A to Z
Congress bags
Every participant will get a voucher for one congress bag which can be picked up in
Hall 17 b.
Congress Organizer
Professional Congress Organizer (PCO)
Please do not hesitate to contact the PCO if you require any additional information
or assistance.
Porstmann Kongresse GmbH (PCO)
Alte Jakobstr. 77
10179 Berlin,Germany
T +49 30 28 44 99 0
F +49 30 28 44 99 11
E pco@woc2010.de
www.porstmann-kongresse.de
Opening Hours of the PCO Counter on site
Wednesday, 2 June 2010 16:00 to 18:00
Thursday, 3 June 2010 07:00 to 19:00
Friday, 4 June 2010 07:00 to 18:30
Saturday, 5 June 2010 06:30 to 18:30
Sunday, 6 June 2010 06:30 to 19:30
Monday, 7 June 2010 06:30 to 18:30
Tuesday, 8 June 2010 07:00 to 18:30
Telefon (on site)
T +49 30 3038-81 800
F +49 30 3038-81 801
Congress program
The final program of the WOC 2010 will be available in the congress bags (Hall 17 b).
Congress Venue
ICC - Internationales Congress Centrum Berlin
Messedamm 22
14055 Berlin
Germany
www.icc-berlin.com
Currency
The currency in Germany is Euro (c).
Please visit www.oanda.com for the latest currency rate.
E
Electricity
In Germany electricity is supplied at 220 V/50 Hz.
Please note that for some devices from foreign countries converters will be needed.
Exhibition
The commercial exhibition will be located in halls 12, 13 and 14, 15, 16 and 17 of the
Berlin Fairground (Messe Berlin). The exhibition area will also house catering areas
and the poster exhibition from Friday through Tuesday.
The opening hours of commercial exhibition are as follows:
Friday, 4 June 2010 09:00 17:00
Saturday, 5 June 2010 09:00 17:00
Sunday, 6 June 2010 09:00 17:00
Monday, 7 June 2010 09:00 17:00
Tuesday, 8 June 2010 09:00 17:00
359
WOC
2010
I
n
f
o
r
m
a
t
i
o
n
Information from
A to Z
H
How to travel to Berlin by plane, by train, by car
By Plane
75 different airlines operate flights to Berlin from112 destinations in 44 countries.
Berlin has two airports:
Tegel Airport (TXL) in the North-West of the city. Distance to City West: 5 km/
to City East: 8 km
Schnefeld Airport (SXF) in the South of Berlin. Distance to City West: 22 km/
to City East: 18 km
By Train
Berlin can by easily reached from all directions by rapid InterCityExpress (ICE),
InterCity (IC), EuroCity (EC) and InterRegio (IR) trains. central stations are Haupt-
bahnhof and Ostbahnhof.
Travel time from... to Berlin (ICE connections)
Departure from Travel time
Amsterdam 6 h
Brussels 7 h 40 min
Dsseldorf 4 h 09min
Frankfurt /Main 3 h 29min
Hamburg 2 h 10min
Cologne 4 h 18min
Copenhagen 7 h 25min
Leipzig 1 h 31min
London 10 h 32min
Munich 6 h 19min
Paris 9 h 09min
Prague 5 h
Warsaw 5 h 49min
Vienna 9 h 49min
Zurich 8 h 17min
More information is available at the counters of the Deutsche Bahn (DB) and on the
homepage www.bahn.de
By Car
The motorway network radiates out of Berlin in the form of a star.
From Munich, Frankfurt/Main and Dortmund use the A 10 Berliner Ring then
the A 115 (Avus) Stadtautobahn (citymotorway).
From Hamburg or Rostock use the A 10 then the A 111.
From Dresden, Cottbus and Frankfurt/Oder use the A 10 then the A 113 and A 100.
Please note that for all cars a special sticker is required to drive into the city centre
since Berlin has been declared as environmental zone on 1st January 2008. The ICC
is located outside of the environmental zone. Further information also in English
available at:
www.berlin.de/umweltzone.e you
360
WOC
2010
I
n
f
o
r
m
a
t
i
o
n
Information from
A to Z
K
Kids Club - Room 35, ICC
In order to support the work life balance, the WOC 2010 is
offering day care for children up to the age of 14 years. Accordingly
furnished rooms will be available in the congress center where
professional and certified educators will offer your children an
attractive and varied program.
As the number of places is limited we recommend you to register
your child in time.
Last minute registration for your children will be possible on site,
please come to the PCO counter in the ICC.
Opening hours
3 June - 9 June 2010, 08:00 am - 06:00 pm
L
Language
The official language of the Congress is English. No simultaneous interpretation will
be offered. AAD in German, WOC in English
Liability
The PCO Porstmann Kongresse GmbH acts solely as an agent and is not liable for
any losses, accidents, injuries to persons or damage to property of any kind. This
does not affect the liability of persons or companies charged with providing the
relevant service. Oral arrangements require a written confirmation. The sole court of
jurisdiction is Berlin.
Delegates accept the above mentioned conditions by registering for the congress.
Local time
Germany is on Central European Time (CET) and is one hour ahead of Greenwich
Mean Time, 6 hours ahead of Eastern Standard Time and 9 hours ahead of Pacific
Standard Time. Summer Time extends from the last Sunday in March to the last
Sunday in October.
P
Parking
A total of 12,000 parking spaces are available on and around the grounds. The
parking garage of the ICC provides 650 parking spaces. Elevators and cash desk
machines are located at the south entrance of the ICC.
Prices are as follows:
Rate per hour: c 2.00
Rate per day: c 7.50
361
WOC
2010
I
n
f
o
r
m
a
t
i
o
n
Information from
A to Z
Press Service
The press office staff welcomes all journalists to the WOC 2010 congress in Berlin,
Germany. Journalists will be admitted free of charge and may participate in all
sessions.
A valid press card is necessary for your registration which will be accomplished in
the press office (rooms 31, 32, 33 on the East Gallery) where you will also receive your
conference badge. All necessary information regarding the conference, its speakers,
press conferences as well as background material will here be available as well. The
press office can be used as a workplace.
On-site Press Office
Our Opening Hours:
Thursday, 3 June 2010 08:00 to 18:00
Friday, 4 June 2010 08:00 to 18:00
Saturday, 5 June 2010 08:00 to 17:00
Sunday, 6 June 2010 07:00 to 18:00
Monday, 7 June 2010 07:15 to 17:00
Tuesday, 8 June 2010 08:15 to 17:00
Our Contact Data on site:
T +49 (0)30 3038-81802
F +49 (0)30 3038-81803
Our Contact Data:
Press Office WOC 2010
Silke Stark/Corinna Spirgat
P.O.B. 30 11 20
70451 Stuttgart, Germany
T +49 (0)711 8931-572 or -293
F +49 (0)711 8931-167
E stark@medizinkommunikation.org, spirgat@medizinkommunikation.org
The WOC 2010 press office staff is available before, during and after the congress.
Journalists who are interested in interviews with speakers or specialists or need
additional background information should contact the press office. Camera crews
are kindly asked to pre-register with the press office as well.
Official WOC 2010 Press Conferences
Press Conference WOC 2010
Date: Thursday, 3 June 2010, 12:00 to 13:00
Room: Radio Tower Lounge 2
(At the radio tower courtyard: entrance Kleiner Stern, access via hall 17)
The press conference is held in German.
International Press Conference WOC 2010
Date: Tuesday, 8 June 2010, 12:15 to 13:15
Room: ICC Berlin, Room 43 (located on the press level on the walkway)
The press conference is held in English.
EuroTimes, official media partner WOC 2010
Mr. Colin Kerr
ESCRS, Temple House
Temple Road
Blackrock, Co Dublin
Ireland
T: +353 12091100
F: +353 12091112
escrs@escrs.org
www.escrs.org
362
WOC
2010
I
n
f
o
r
m
a
t
i
o
n
Information from
A to Z
R
Registration
Membership of the German Society of Ophthalmology (DOG)/Professional Associa-
tion of German Ophthalmologists (BVA) or confirmation of any oral presentation,
video or poster does not automatically include the registration for the WOC 2010.
Therefore, all members of the DOG/BVA and all speakers are requested to register
prior to the congress. Registration can be made solely online. Please note the regis-
tration and payment terms. Bookings that are liable to pay have to be balanced im-
mediately by credit card or direct debit payment (only for German bank accounts) at
the end of the registration. Your billing information including credit card numbers
will be automatically encrypted by SSL and therefore prevent any unauthorized or
unscrupulous persons from prying into the transmission.
Please register via the congress homepage www.woc2010.org.
After having completed your online registration you will automatically receive an
invoice including a booking confirmation and your personal barcode via email.
Please print this barcode. The barcode will enable you to print your name badge at
a self-service terminal on site without having to line up.
Registration Fees On-site registration
fee from 11 May 2010
Entire congress
Delegates c 650
Members of the German Society of Ophthalmology c 325
(DOG)/ Professional Association of
German Ophthalmologists in Practice (BVA)
Residents
1
c 525
(up to 35 years of age)
Students
1
c 70
Accompanying Persons c 70
Industry and Research Attendees c 650
Day Ticket/Pass c 250
(available for one day only)
Day Ticket/Pass for Members of the DOG/BVA c 125
(available for one day only)
WOCtoberfest c 80
Children from 7 to 14 years c 25
(free up to 6 years)
1
Residents/Students: The barcode will not be activated before a valid certificate
(official certificate of thehead of department including the date of birth/ student ID
valid for June 2010) will have been submitted via email (pco@woc2010.de) or fax
(+49 30 284499-11) to Porstmann Kongresse GmbH. Late submission will not be accep-
ted. Please send your certificate at your earliest convenience after online registration.
363
WOC
2010
I
n
f
o
r
m
a
t
i
o
n
Information from
A to Z
Registration of Groups
Registration of groups can be made via the congress website www.woc2010.org
by using the official registration system. Please add new participants via one main
account and use personal email addresses in order to create personal barcodes for
each participant. If you have any question or need assistance, please contact the
PCO via pco@woc2010.de
Restaurants, Bars and Nightlife
Berlin is a dynamic, cosmopolitan and creative city and the capital of Germany. East
meets West, tradition and innovation coexist in the metropolis at the heart of a
changing Europe. Berlin is characterized by its turbulent past and offers today a
multitude of cultural places of interests, restaurants as well as a vibrant nightlife.
Please find several recommendations and addresses on the congress website at
www.woc2010.org
S
Sightseeing
A number of sightseeing tours will be offered by Interklassik Concierge & Event
GmbH, see at www.woc2010.org. or send an email to woc2010@interklassik.de.
Interklassik provides also tickets for theatre, opera or other cultural events.
Sponsorship Opportunities & Exhibition
See the Sponsors and Exhibitors list on page 345.
For details, please contact: Mr. Thomas Hausfeld
Email: th@woc2010.org
Smoking Policy
Please note that smoking is prohibited in the Congress Center.
T
Transportation
Berlin offers excellent public transportation facilities. The BVG, Berlins public trans-
port system, operates Bus, U-Bahn (underground) and S-Bahn (city train). To go to
the ICC from the city it is necessary to use the ticket for the AB zone (single fare
ticket), there are several stops (Bus, U- and S-Bahn) nearby. The ICC is located next to
the city motorway close to the Kaiserdamm in the West of Berlin.
Fare Zone AB
Short trip c 1.30
(up to three stations with U- and S-Bahn or up to six stations with bus and tram)
Single ticket c 2.10
(valid two hours in the same direction, zone AB)
4-Trip Ticket c 8.00
(valid two hours in the same direction, zone AB)
Day ticket c 6.10
(valid to 3:00 hrs at the following day, zone AB)
7-Day Pass c 26.20
(The 7-Day Pass is valid on seven consecutive calendar days. Validity begins on the
first day of the validity period printed on the card or from the time of validation and
ends on the seventh calendar day, at 24:00)
Please note that Schnefeld Airport is out of the fare zone AB. A ticket for the fare
zone ABC (c 2.80) has to be bought in order to get to the congress venue or to the
city center. (Day ticket zone fare ABC, c 6.50).
Further information:www.bvg.de
364
WOC
2010
I
n
f
o
r
m
a
t
i
o
n
Information from
A to Z
Arrival at the venue ICC by using public transportation:
A search function on the BVG website helps you to individually organize your
journey by public transport: www.fahrinfo-berlin.de
U-Bahn / S-Bahn / Bus In the direction of Stop / Station
line number
U2 S+U Pankow <> U Ruhleben Kaiserdamm
S41 Circle line (clockwise) Messe Nord/ICC
S42 Circle line (counterclockwise) Messe Nord/ICC
S46 Knigs Wusterhausen <> Westend Messe Nord/ICC
S75 Wartenberg <> Spandau Messe Sd
(Eichkamp)
S5 Strausberg Nord <> Olympiastadion Messe Sd
(Eichkamp)
BUS M49 Heerstrae/Nennhauser Damm
<> S+U Zoologischer Garten S Messe Nord/ICC
BUS X34 Kladow, Kaserne Hottengrund
<> S+U Zoologischer Garten S Messe Nord/ICC
BUS X49 Staaken, Hahneberg
<> S Messe Nord/ICC S Messe Nord/ICC
BUS 104 Neu-Westend, Brixplatz
<> Stralau, Tunnelstrae Messegelnde/ICC
BUS 139 Hakenfelde, Werderstrae
<> S Messe Nord/ICC S Messe Nord/ICC
365
WOC
2010
366
WOC
2010
Information from
A to Z
Tourist Information Berlin WelcomeCard
This special offer contains a public transport ticket for the City Railway (S-Bahn),
subway (U-Bahn), tram and bus, plus local train services, for 2, 3 or 5 days in Berlin or
in Berlin and Posdam. The WelcomeCard also provides savings of up to 50 % on over
140 top sights and cultural highlights.
Berlin (AB fare zones incl. Tegel Airport) Berlin and Potsdam (ABC fare zones
Valid for one Person incl. Tegel and Schnefeld Airports)
(Children under 6 years travel free) Valid for one adult and max. 3 children
up o 14 years
48 hrs for c 16.50 48 hrs for c 18.50
72 hrs for c 22 72 hrs for c 25
5 Days for c 29.50 5 days for c 34,50
Please find further information at www.berlin-welcomecard.de.
I
n
f
o
r
m
a
t
i
o
n
367
WOC
2010
I
n
f
o
r
m
a
t
i
o
n
Information from
A to Z
V
Venue
The World Ophthalmology Congress 2010 - WOC 2010 will be held at:
ICC Berlin (Internationales Congress Centrum)
Messedamm 22, 14055 Berlin, Germany
For more information, please visit the ICC website www.icc-berlin.com
The ICC Berlin (Internationales Congress Centrum Berlin) ranks among the biggest,
most advanced and most successful congress venues in the world.
With its 80 halls and rooms seating between 20 and 9,100, its versatile facilities,
superb technical installations and comprehensive range of services, ICC Berlin is the
perfect choice for any convention, show or concert.
368
WOC
2010
Adverts Inside Front Cover
Inside Back Cover
Outside Back Cover
2
216
356
44
52
6
90
238
344
62
12
38
128
40
66
20
132
174
264
42
30
236
Bookmark
Allergan Inc.
Pfizer
Carl Zeiss Meditec AG
Alcon Laboratories, Inc.
APAO 2010
APAO 2011
ARVO
Der Augenspiegel
Bausch & Lomb
DGII 2011
DOC 2010
Dr. Kaden Verlag
EVER 2010
Merck Sharp & Dohme
Novartis Pharma GmbH
OCULUS Optikgerte GmbH
Ophthalmology Times Europe
Pifzer
SFO 2011
SIXT
Springer-Verlag GmbH
Star Alliance
WOC 2012
WOC 2014
I
n
f
o
r
m
a
t
i
o
n
369
WOC
2010
A
u
t
h
o
r

I
n
d
e
x A
Abari E. P-SU-258
P-SU-260
P-TU-243
P-TU-254
Abbott R. L. SU-20-01
SU-76
SU-76-06
MO-57
ES-05
ES-05-02
Abboud E. TU-66-07
Abdeen Z. WE-16-04
Abdou A. TU-71-05
Abdul Karim M. N. P-MO-147
P-TU-198
Abdul Majid A. S. B. P-TU-054
Abdul Rahman R. MO-31-04
P-SA-259
P-SA-259
P-TU-063
P-TU-182
Abe H. P-MO-034
P-MO-042
Abe S. P-SU-017
P-SU-115
Abego Pinto L. MO-73-02
P-MO-050
Abiose A. SU-32-03
Abramoff M. SA-24-04
SU-62-04
SU-74
TU-56
TU-56-02
Abrams J. TU-30-06
Abramson D. H. SA-36-02
MO-77-03
WE-24-05
Abramyan A. P-SA-160
Abri S. SU-61-06
Abu A. P-SA-096
Abu El Einen K. G. MO-25-10
WE-40-10
Abu El Ela M. H. P-SA-132
Abu N. P-SU-134
Abuh S. WE-35-01
Acar S. P-SA-057
P-SU-025
Accorinti M. TU-50-01
Ach T. P-SA-177
P-TU-203
P-TU-244
SU-38-02
TU-34-07
Acheampong A. MO-67-02
Acidereli E. MO-79-04
Ackermann P. FR-01-01
Ackland P. MO-62-07
Aclimandos W. MO-55
MO-55-04
Acosta R. MO-62-03
Adamis A. P. MO-63-01
SA-36-04
Adelman R. TU-28-03
Ademola-Popoola D. WE-35-01
Adenis J.-P. TU-06
TU-06-02
TU-41-13
WE-12-03
Adenwala A. P-MO-052
Ader M. P-SU-266
Adhami-Moghadam F. SU-17-05
Afia M. P-MO-244
Aftab S. A. P-MO-202
Agahan A. P-SA-143
Agafonova E. MO-78-06
Agarwal A. SA-07
SA-07-02
SA-32-08
SU-14-01
SU-45-07
TU-39-05
TU-46
WE-17
WE-18-04
P-MO-227
WOC-C-12-07
Agarwal A. SA-07-03
TU-46-02
Agarwal P. MO-74-01
Agarwal R. MO-74-01
TU-30-10
Agdeppa M. C. G. P-TU-013
Aggeli S. P-MO-190
P-MO-214
Agni A. N. P-MO-155
TU-35-10
Agorastos A. P-TU-056
Agostini H. T. TU-48-01
Po-MO
P-SA-070
P-SA-161
P-MO-236
P-TU-246
WOC-C-55
WOC-C-55-01
WOC-C-55-04
Agrawal D. P-MO-279
Agrawal S. S.-M. MO-74-01
Aguilar E. TU-36-05
Ahlers C. MO-27-01
TU-37-06
P-SA-196
P-TU-185
Ahmad A. P-MO-044
P-MO-051
P-MO-054
Ahmad I. MO-17-06
Ahmed I. K. SU-14-07
MO-73
TU-13
TU-13-08
TU-46-03
Ahmiti I. P-TU-140
Aiello L. P. MO-63-02
Aihara LS-17-03
Aisenbrey S. MO-24-07
MO-67-03
Ajaiyeoba A. WE-16-09
WE-41-08
Ajayi B. WE-16-09
WE-41-08
Ajayi B. G. K. SU-74-04
Akahoshi T. WE-18-02
Akar M. SU-81-07
Akesby J. MO-67-03
Akgl H. MO-24-05
MO-77-04
P-TU-126
Akhrorova Z. P-SU-205
Akin T. P-MO-003
Akova Y. SU-27-01
Al Alawi E. K. SU-55-02
Al Arrayed H. SA-26-08
Al Hajj-Ali M. P-MO-275
Al Sawidi K. MO-24-01
Alam R. P-MO-001
P-MO-004
Alarcn I. I. TU-29-05
Alarcon R. P-TU-014
SA-27-03
Albert T. SU-37-05
Albis-Donado O. P-MO-046
Albou-Ganem C. TU-80-09
Al-Deiri B. P-TU-020
Al-Faky Y. Y. M. H. P-SU-211
P-SU-250
Alfayez M. TU-81-06
Alfonso J. F. SU-13-03
MO-15
TU-74
Alge-Priglinger C. P-SA-202
P-SA-205
Alghadyan A. P-SU-263
Ali J. L. SA-01-06
SU-10
SU-10-01
SU-13
SU-20-02
SU-35-07
SU-59-05
MO-15
MO-15-01
MO-39
MO-39-03
MO-57-03
MO-66
MO-66-01
MO-66-04
TU-25-07
TU-39
TU-39-04
TU-41-01
TU-44-06
TU-46-04
TU-75-02
TU-78-02
TU-80-07
TU-80-08
TU-82-07
WE-01
WE-11-04
WE-18
P-MO-099
P-SA-063
P-TU-010
P-TU-013
P-TU-024
WOC-C-12-09
Alipour F. TU-31-08
Aliyeva S. MO-31-07
Aljazzaf A. P-MO-061
Allemann N. P-TU-188
Allen D. MO-20-01
TU-82-05
Allikmets R. SA-32-04
Almazan A. MO-75-07
Alonso Aliste F. WOC-C-63-01
Alonso Mesonero M. SU-42-02
Alp H. P-SA-192
Alqahtani J. P-SA-021
AlRajhi A. SA-19
SU-65-06
MO-30
MO-64
WE-16
P-SA-058
Al-Rashed W. P-SU-228
Alsaeidi R. TU-33-03
Alsuhaibani A. P-SU-228
SU-42-05
Al-Swailem S. P-MO-013
Altaweel M. M. MO-76-04
Alten F. P-SA-197
370
WOC
2010
A
u
t
h
o
r

I
n
d
e
x Al-Turbaq A. P-MO-020
P-SA-056
P-SU-081
Alvarez de Toledo J. P. SU-70-09
SU-70-11
SU-70-18
TU-81-02
Alves M. R. SU-74-01
Alwan A. WE-25-07
Amado D. WE-41-05
Amansakhatov S. SU-35-09
Amar R. TU-80-09
Amaral A. MO-73-02
P-MO-050
Amazigo U. SU-32-04
Amberger R. TU-34-07
Ambrecht A.-A. WE-34-03
Ambrsio Jr. R. SA-04-02
SU-59-03
TU-64-02
BS-04-01
Amde W. P-TU-224
Amina B. P-TU-139
TU-31-05
Amini P. SA-32-09
Amiryan A. MO-77-02
Amissah-Arthur K. P-TU-032
Amjad M. P-SA-261
P-SU-150
Amjadi A. P-SA-061
Ammar D. A. P-MO-058
P-MO-059
Amorim M. P-SU-144
Amouroux-Gicquel N. SU-37-08
Amparo F. P-TU-013
SA-27-11
Amr A. P-MO-177
Amr K. A. P-SU-050
Amrani Y. P-TU-189
Anderson L. D. TU-66
Andrade R. E. MO-32-06
P-SA-271
Andrew E. TU-34-06
Andrews R. TU-65-04
Andrews R. SU-38
MO-47-07
Androudi S. MO-74-03
MO-76-10
P-MO-248
P-SA-012
Ang C. L. P-MO-084
Ang M. P-SA-264
Anggraini N. P-TU-104
Angi M. MO-76-09
P-MO-224
Anglade E. SU-37-03
Ann H. J. P-SU-085
Annaka M. P-SU-037
Ansari G. P-MO-211
Ansari-Astaneh M.-R. SU-36-10
Anticic M. TU-81-03
Antipova J. WE-39-01
Antoniadis M. P-SA-012
Apte R. TU-23-04
Arafa L. SA-28-05
Araie M. MO-22
MO-22-06
TU-16-06
TU-43-06
Arakaki Y. P-SA-120
P-SA-123
Aral H. P-SU-233
Aramberri Agesta J. SU-16-02
Arantes T. P-SA-274
P-TU-206
SU-27-08
Arat Y. P-SU-228
Archer T. C. SA-04-03
TU-80-04
TU-80-10
P-MO-111
Arden G. MO-32-08
Arevalo J. F. SA-41
SA-41-01
SA-41-05
SU-50-05
MO-02-06
MO-72-03
TU-45-01
WE-29
WE-29-01
Arcan G. . P-SA-128
Arikan G. P-MO-234
P-TU-061
Arimura E. P-SA-106
P-SA-109
Arintawati P. P-MO-010
Arliani N. SA-26-10
Armitage J. O. SU-19
SU-19-01
TU-19-01
TU-40-02
TU-81
Arnold A. C. WE-41
Arranz-Marquez E. P-MO-117
Arruda Mello P. A. P-TU-206
Arrufat S. SU-39-02
Artal P. SA-05
SA-05-01
SU-60-02
Arteaga A. P. TU-25
WE-18-05
Artes P. MO-14-03
Arthurs B. P-SU-231
Artini W. P-SA-118
Artunay O. MO-67-03
Aryasit O. P-SU-229
Arzoallxhiu H. P-MO-209
Asahara T. P-TU-231
Asbell P. A. SU-09
Ascarza A. P-SU-237
Ashaye A. O. SU-74-04
WE-16-09
Ashraf El Desouky M. P-SU-214
Aslanova V. TU-29-04
Asoklis R. TU-49-06
P-MO-091
P-SA-181
P-TU-084
Asp S. SU-47-03
Assaf A. P-TU-019
SA-27-09
Astakhov Y. MO-68-06
P-SA-203
SA-28-07
TU-33-07
Asteriades S. MO-75-08
Astle W. F. MO-58
MO-59-03
MO-59-06
TU-66
TU-66-01
TU-66-02
Ataka S. P-TU-195
Ates O. P-MO-003
P-SA-192
Atsushi N. P-SA-126
Attar M. MO-67-02
Attaran M.-S. P-MO-273
P-TU-255
P-TU-258
Attitich M. P-SA-008
Auffarth G. U. SU-10
SU-10-05
SU-15-04
SU-45-05
WE-10-02
Po-MO
P-SA-010
P-TU-008
P-TU-018
P-TU-025
P-TU-265
WOC-C-43
WOC-C-44
WOC-C-45
Augsburger J. J. SU-34-07
MO-77-06
P-TU-094
WOC-C-60-01
Augsten R. P-SA-277
Augustin A. J. MO-16
MO-16-03
MO-72
MO-72-05
SA-34-03
Augustin M. P-SU-148
Aung T. SA-31
SU-08-05
P-SA-140
Auw-Hdrich C. MO-33
MO-33-02
SA-18-06
SU-12-04
P-SA-059
P-SU-007
Avadhanam V. P-TU-144
Averyanova O. P-MO-290
TU-31-02
Avetisov S. P-SA-160
Avni I. P-SA-096
Awe B. TU-03-08
Awh C. C. TU-18-05
Aydin P. SA-38-12
MO-41
MO-41-04
TU-08
TU-08-05
TU-38-02
TU-65
TU-65-01
Aylward G. W. SU-48
SU-51
MO-29-05
TU-23
TU-23-02
TU-69
WOC-C-62
WOC-C-62-02
Ayorinde O. WE-16-09
Azad R. WE-37
WE-38
WE-38-06
WOC-C-58
WOC-C-58-05
Azarpira N. P-SA-278
Aziz R. A. P-SA-272
Azizi S. P-SA-192
Azuara-Blanco A. SU-03
SU-03-03
Azuma N. P-SU-124
P-TU-129
P-TU-200
P-TU-222
371
WOC
2010
A
u
t
h
o
r

I
n
d
e
x B
Baade A. P-TU-196
Babak J. SA-31-08
Babu K. SU-57-03
Babu N. P-MO-255
Bach M. SA-38-10
SU-02-03
SU-11
SU-11-04
WE-20-06
P-SA-088
Bacharach J. TU-30-03
Bachert I. P-SA-224
Bachmann B. MO-17-02
TU-05-02
Baddon C. P-MO-217
Badeeb O. P-SU-054
TU-30-08
Bae E.-h. SU-47-01
Baerveldt G. SU-06
SU-06-05
TU-30
Bagheri A. SU-61-02
Baig N. B. SA-28-03
Baile R. P-SA-082
Bailey J. P-TU-169
Bainbridge J. W. B. SU-25-01
MO-67-04
Baiocchi S. P-SA-071
SU-35-03
Baiyeroju R. WE-16-09
Bajaj M. P-SU-242
Bakaeva T. P-SU-201
Bakunowicz-
Lazarczyk A. P-SU-049
SU-55-07
Balasubramaniam B. P-MO-086
P-SU-252
Baldeschi L. SU-22
SU-22-04
MO-82-03
Baltz J. P-SA-186
Banandur P. SU-74-02
Bandello F. SA-34
SA-34-05
SU-50-06
MO-32-01
MO-32-02
MO-72-04
MO-75-04
MO-75-05
TU-32-01
TU-35
TU-35-01
WOC-C-32-02
Banerjee D. MO-35-02
Banin E. P-SA-096
Banker A. MO-67-03
Bao Y. Z. SU-74-07
Barabino S. SA-20-06
SU-35
SU-37-06
Baradaran-Rafiee A. SU-36-10
Baragan E. P-SA-003
Barajas H. P-SU-003
P-SU-008
Barak A. WE-28
WE-28-06
Baraki H. P-MO-201
Baralic J. P-TU-105
Baran I. TU-31-08
Baranyovits P. P-MO-147
Barbazetto I. MO-77-03
Barbosa C. P. P-SA-102
P-SA-274
Barisani-Asenbauer T. SU-27-02
MO-76-06
TU-50
TU-50-06
Barisic A. P-MO-112
SU-47-06
TU-81-03
Barkana Y. SA-12-05
SA-31-09
Barleon L. P-MO-036
P-MO-039
Barraquer J. SU-70
SU-70-01
SU-70-03
SU-70-04
SU-70-12
SU-70-14
SU-70-16
SU-70-17
SU-70-19
WOC-C-40
WOC-C-40-02
Barraquer M.-E. SU-70
SU-70-02
SU-70-05
SU-70-13
Barraquer R. SU-70
SU-70-07
SU-70-08
SU-70-10
WOC-C-40
WOC-C-40-04
Barreto F. SU-27-08
Barrows J. M. MO-62-06
Barry P. SA-06
SA-06-02
Barton K. SU-06-04
MO-31
MO-65
MO-65-06
MO-65-08
TU-13-07
WOC-C-41-04
Bartsch D.-U. SA-32-09
P-SU-266
P-SU-271
Bartz-Schmidt K. U. SA-06
MO-24-07
MO-75
TU-34-09
P-MO-170
P-SA-155
P-SA-170
P-SA-122
P-TU-119
WOC-C-41
WOC-C-41-02
Basel C. WE-37-07
Batoosingh A. L. P-MO-071
P-TU-059
TU-30-02
TU-30-03
TU-30-05
Batta H. WE-16-04
Battu R. P-TU-218
SU-62-07
Bauch A. S. P-MO-116
Bauchiero L. TU-79-06
Baudouin C. TU-31
TU-49
TU-49-03
WOC-C-47
LS-17-02
Bauer D. MO-76-01
Bauer K. P-TU-048
Bauer L. MO-28-09
Bauer S. MO-26-04
Baumann B. MO-27-01
MO-27-02
TU-37-06
Baumeister M. P-MO-019
Baumgarten S. SU-44-10
Bumler W. TU-32-09
Baumller S. P-MO-158
TU-35-08
Bautista De Lucio V. M.P-SU-024
Bayramoglu S. SA-31-06
Beaconsfield M. FR-01-16
SU-76
SU-76-02
MO-11
TU-41
TU-41-12
WE-32
WE-33
WE-33-03
Bechir J. MO-32-05
P-SA-249
P-SA-270
Bechrakis N. E. MO-03-06
SU-34
SU-43-01
WE-24
WE-24-08
P-TU-089
P-TU-114
Beck S. P-SU-094
SA-28-04
Becker L. P-SU-218
Becker M. P-TU-177
Becker M. D. SU-27
SU-27-02
Bedri A. SA-37-03
TU-42
Beger I. P-MO-196
Behar F. WE-15
WE-15-02
Behrens A. TU-79-07
Behrens-Baumann W. SU-28
SU-28-02
WE-37-06
P-MO-029
P-SA-112
P-SA-146
P-TU-057
P-TU-221
WOC-AAD-C-19
Beiko G. SA-27
SA-27-04
TU-46-03
WE-18-07
Bek T. TU-56-04
Bekibele C. SU-74-05
WE-16-09
WE-41-08
Beko M. P-TU-071
Belfort Jr R. SA-41-02
SU-20-07
SU-34-04
SU-40
SU-64
MO-03
MO-03-03
MO-32
MO-32-01
MO-32-02
MO-32-06
MO-50
MO-50-01
MO-75-04
372
WOC
2010
A
u
t
h
o
r

I
n
d
e
x TU-32-01
TU-35-11
P-SA-271
P-SA-274
P-SU-110
P-SU-208
P-MO-023
WOC-C-41-03
Belfort Neto R. MO-33-06
SU-57-01
Belin M. W. SU-17-11
Belinsky I. P-TU-090
Belkin M. P-MO-121
P-MO-216
SU-38-05
Bell K. P-SA-111
Bellucci R. MO-40-07
Belshi A. SU-42
Beltaief O. P-SA-079
Benchrifa F. P-TU-140
Benelli U. SU-37-05
Bengtsson B. MO-13-04
MO-14-02
Benharbit M. P-TU-189
Bentez del Castillo
Snchez J. M. TU-79-02
Bennett K. L. SA-27-02
P-SU-188
Benz M. S. SU-49-02
Benzimra J. P-SU-191
Berendschot T. T. J. M. TU-33-08
Berger A. SU-36-09
Berger W. P-SA-088
Bergin C. P-MO-028
Bergmanson J. TU-21-06
Bergua A. P-SU-080
Berisha F. P-MO-049
Berit K. P-SA-060
Berna M. J. P-SA-182
P-SA-184
P-SA-185
Bernardes N. SU-74-01
Berna-Thill M. P-SA-184
Bernd A. S. P-TU-219
Bernstein P. TU-30-01
Berraho A. P-MO-066
P-SA-141
P-TU-140
Berrocal A. WE-29-08
Berrut G. P-SU-068
Berta A. P-SU-028
SU-75
SU-75-06
Bertone C. SA-10-03
Bertrand I. P-SU-151
Berzas C. SU-09
Besch D. TU-34-09
Bessa Jr J. P-TU-036
Bessler P. P-MO-040
P-SA-145
Best G. P-SA-177
Beuerman R. MO-35-05
SU-37-04
Bever M. P-TU-196
Bezditko P. P-SA-210
SA-31-08
MO-35-08
P-SA-054
P-SA-156
P-SU-236
Bhandary S. MO-28-05
Bhargava M. MO-67-10
P-MO-276
P-SU-274
P-TU-218
SU-62-07
Bhatta S. P-MO-202
Bhattacharyya B. P-SA-024
Bhisitkul R. B. TU-23
TU-23-06
Bi X. P-SU-234
P-TU-087
P-TU-115
SU-42-10
Bialasiewicz A. A. SA-14
SA-14-05
Po-SU
Bianchi P. E. SA-10-03
Bidaye S. SU-81-06
MO-73-06
P-TU-055
Biewald E. P-SA-239
P-TU-123
Bigdon S. P-SA-182
P-SA-185
Bikbov M. P-SA-085
TU-31-03
Bikbova G. P-SA-085
TU-31-03
Binder C. TU-78-05
Binder S. SA-03
SA-03-02
SA-32
SU-49-07
TU-03-03
TU-45
TU-48
TU-48-04
P-TU-176
Birnbaum F. MO-30
MO-30-04
TU-81
Po-MO
P-MO-038
Birngruber R. SU-38
MO-79-04
TU-36-08
P-SA-186
P-TU-196
Birulya I. SA-28-07
Bischoff G. SA-13-04
SA-14
MO-59
MO-59-07
Bispo P. P-MO-098
Bissen-Miyajima H. SU-14
SU-14-05
P-SA-004
P-SA-037
Bissmann W. P-SA-077
Biswas J. MO-74
MO-74-10
TU-47-05
WE-30
WE-30-03
Biswas P. P-SU-189
WE-34-05
Blakeman A. SU-44-05
Blamires T. P-TU-198
Blanch R. MO-28-04
Blanco-Mateos G. SU-12-01
SU-42-02
Blasiak J. P-SA-099
Bleeker J. C. SU-34-08
Bleich S. SA-28-08
Bloch K. P-SU-068
Blomberg L. SU-75-07
Blondeau F. P-SA-027
Bloomer M. SU-35-02
Blue M. P-MO-014
Blum M. TU-80-02
Po-TU
P-SA-077
Blumenkranz M. S. MO-29-04
MO-32-01
MO-32-02
MO-75-04
TU-32-01
TU-54
TU-54-05
Bobisch N. P-TU-157
Bobrova N. F. SU-55
SU-55-04
P-SA-078
P-SU-239
P-TU-138
P-TU-166
Bock R. SA-29-04
Bodaghi B. SA-08-06
SU-27
SU-33
SU-33-03
MO-76-09
TU-50
TU-50-04
TU-60
TU-60-02
TU-83
WE-09-06
Boehm N. MO-73-10
P-SU-094
P-SU-204
SA-28-04
Boeker T. WOC-C-62-08
Boes T. SU-39-04
Bohac M. P-MO-112
SU-47-02
SU-47-06
Bhm M. R. R. P-TU-044
P-TU-213
Bohorquez V. P-TU-014
SA-27-03
Bhringer D. SU-19
SU-19-02
SU-37-03
TU-19-05
P-MO-038
P-MO-236
P-MO-294
P-SA-068
P-SA-070
P-SU-045
P-TU-043
P-TU-047
Boiko E. V. WE-28-03
Bojic L. P-SU-075
Bker T. WOC-C-62-03
Bokhorst A. G. TU-19-07
Boland M. SU-03-02
SU-05-03
WE-04-02
Bolintineanu C. P-SU-002
P-SU-005
Bolintineanu S. P-SU-002
P-SU-005
Bolz M. MO-27-02
P-TU-232
WOC-C-15-03
Bnig H. P-SU-041
Boniuk M. P-SU-228
Booth A. P. TU-30-09
Bopp S. Po-MO
P-SA-170
Borasio E. MO-19-02
Borderie V. TU-19-06
373
WOC
2010
A
u
t
h
o
r

I
n
d
e
x Bornfeld N. SU-39
SU-39-01
SU-39-04
SU-43-02
MO-24-05
MO-77
MO-77-04
TU-09
TU-22
WE-24-03
P-SA-239
P-TU-112
P-TU-116
P-TU-123
P-TU-126
WOC-C-36
WOC-C-60-05
Borooah S. P-MO-270
Borras T. MO-53-07
Borruat F. SU-29-06
WE-20-04
Bort B. P-MO-245
Bsch M. P-TU-049
Boscia F. TU-28-01
Botabekova T. P-TU-158
Botbaev A. P-TU-002
SA-27-08
Botts J. P-TU-188
Boucard C. SU-44-09
Bouhaimad M. P-SU-228
Boulanouar A. P-MO-066
Boullanger D. P-TU-185
Bourmani O. P-MO-066
Bouzouaya C. SU-37-07
Boyer D. S. P-MO-198
TU-37-07
Bradley J. TU-31-08
Branchevskiy S. P-SU-062
Brandenbusch T. P-TU-097
Brandlhuber U. P-MO-222
P-TU-017
Brandt S. P-SU-153
Bras D. TU-82-02
Bruer L. FR-01-15
Braun B. P-MO-102
Braun J. SA-40-01
P-SA-065
Brazitikos P. SU-48-04
MO-74-03
P-MO-248
P-SA-012
Bredow L. P-MO-294
P-SU-045
Breitstadt R. P-MO-039
Breitwieser F. P. P-SU-188
Brennan M. W. MO-81-02
Bresse X. P-SU-068
P-SU-071
Bretthauer G. SA-27
MO-79-07
MO-79-08
P-SU-190
Brewitt H. FR-01
Breyer D. R. H. SU-80-02
P-SA-018
P-SA-030
P-MO-114
Brezin A. P. MO-11-07
Brian G. WE-16-01
Bridges L. P-TU-146
Brinkmann C. K. P-SA-176
P-SA-197
Brinkmann R. P-SA-186
P-TU-196
TU-36-08
Briszi A. P-SA-011
Brock K. SU-74-01
Brockmann M. P-SU-268
Brodie A. SU-75-10
Bron A. J. SA-20
SA-20-02
SU-63
SU-63-05
Brosius T. P-SA-162
Brucker A. J. SA-33
SU-51-02
MO-45-06
Brueckner K. P-TU-006
Bruggemann A. SA-31-04
P-TU-075
Bruijning J. MO-10-06
Brummeisl W. MO-31-10
Brunken W. J. P-TU-243
Brunner U. TU-34-09
Brunotte I. P-SU-220
P-TU-048
Brx S. P-SA-265
Bu J. P-SA-231
P-SU-133
Bubalo D. P-SA-220
Buchanan L. M P-SU-145
Bchner T. P-SU-196
P-SU-240
Buchwald H. SU-45-03
P-MO-141
P-MO-159
Buckhurst P. P-TU-009
P-TU-037
Buckley E. G. TU-07-02
Buczak-Gasinska K. P-MO-109
P-MO-022
Budenz D. SU-04-01
Budiene B. P-SU-178
Budo C. SU-79-03
MO-40-03
P-MO-131
Buehler A. P-SU-001
Buehler K. J. MO-62
MO-62-01
Buhari S. P-TU-259
SU-74-08
Bhl W. MO-67-07
P-TU-028
Bhren J. SA-13-05
MO-35-07
P-MO-019
P-MO-116
P-SA-157
P-TU-015
P-TU-016
Bukhari A. P-SU-197
Bulgen M. FR-01-02
Burau H. WE-39-08
Burgess B. L. MO-77-05
Burgess G. WE-41-09
Burggraaff M. C. MO-10-02
Burgoyne C. WE-07-07
WE-39
WOC-C-31
WOC-C-31-03
Burian G. MO-68-02
TU-35-01
Burk C. P-TU-060
Burk R. O. W. WOC-C-31
WOC-C-31-04
Burke J. MO-75-07
P-TU-199
Burlutsky G. SU-73-03
Burnier M. N. MO-33
MO-33-01
SU-57
SU-57-02
Burr J. SA-21-06
WOC-C-10-04
Burzer S. SA-32-10
Busch M. MO-76-01
Bschlepp E. P-SA-263
Busin M. SU-78-05
Busse H. P-TU-044
P-TU-083
Butkiene L. P-TU-084
Butros S. P-MO-159
TU-81-02
Buznyk O. TU-81-08
Buzzonetti L. P-MO-161
Bynoe L. MO-67-03
Bytton Daz L. C. P-MO-281
Byun Y. J. SA-25-02
C
Cagl N. P-MO-002
P-MO-005
Cai J. P-TU-106
Cairui L. P-MO-229
P-SU-267
TU-36-10
Cakmak H. B. P-MO-002
P-MO-005
Caligaris L. SU-74-01
Callahan D. SU-27-03
Calvo-Santos G. P-SA-258
P-SU-273
Camargo J. F. P-SU-082
Cameron J. P-MO-270
Campos E. C. SU-55-03
SU-76-04
MO-09-01
Canan G. TU-26-03
Cantemir A. P-TU-078
Cantor L. TU-30-06
Canut I. SU-70-06
SU-70-16
Capo H. MO-78-01
Capone A. MO-29-02
SU-48-06
Caporossi A. P-SA-071
SU-35-03
Caprioli J. TU-30-01
TU-30-03
TU-63
WE-07-03
Caramoy A. P-SA-214
TU-34-04
Cardoso Neto I. P-TU-036
Carlisle-Wilcox C. P-MO-014
Carollo G. P-MO-161
P-MO-291
Carassa R. SA-11-05
Carlton J. SA-47-02
SA-47-03
Carrasco B. P-SU-086
TU-35-09
Carreo E. SU-34-10
SU-34-11
Carriazo C. TU-74
Carter D. A. P-SU-252
Cartwright D. P-TU-151
Carvalho F. R. S. P-SU-082
374
WOC
2010
A
u
t
h
o
r

I
n
d
e
x Carvalho
Vasconcelos G. SU-74-06
P-SU-112
P-TU-165
WOC-C-59
WOC-C-59-02
WOC-C-59-06
Casella A. M. MO-32-06
Caspi R. R. SU-31-01
Cassoux N. SU-67-07
Castilla M. TU-29-05
Castillon Torre L. P-TU-247
Castin R. MO-68-07
Castro-Navarro J. P-MO-221
Castro-Paiz M. MO-75-06
Cate H. SU-05-02
Cavaglieri S. P-TU-165
Cekic S. P-SU-152
Ceklic L. P-TU-191
Celestino de
Almeida H. P-TU-165
Celik Y. P-SU-106
Cernk A. SU-17
TU-19
etin B. P-SA-128
Cetkovska P. P-TU-113
Ceyhan D. P-SU-074
Ceylan O. P-MO-003
P-SA-192
Chadha S. P-TU-198
Chai Teck C. P-SA-217
Chakrabarti A. WOC-C-12
WOC-C-12-01
WOC-C-12-02
WOC-C-12-03
Chakravarthy U. MO-45
Chamot L. SU-34-02
Chan A. S. Y. SU-57-06
Chan C. C. MO-76
TU-53
TU-53-04
P-SA-252
P-SA-260
Chan C. K. P-MO-246
Chan C. K. M. TU-35-07
Chan C. M. L. SA-14-07
SU-37-04
MO-64-04
P-TU-257
Chan C. Y. N. WE-41-06
Chan J. P-SU-216
P-SU-247
P-TU-160
Chan K. Y. P-SU-057
SU-42-04
Chan P. P-TU-202
Chan R. P-SA-260
Chan S. P-SA-093
Chan T. K. P-TU-169
ES-05-04
Chan T. K. J. P-MO-030
Chan U.-t. P-TU-161
Chandra M. P-SU-242
Chandrakumar M. SU-44-05
Chandran M. P-MO-211
Chandra Sekhar S. P-MO-086
Chang L. MO-32-03
Chang S. MO-24-03
Chang-Hua P. P-TU-214
Chantzaras A. P-TU-093
Chanudet E. SU-67-02
Charalambos P. P-SU-256
P-SU-148
Charalel R. WE-40-08
Charbel Issa P. MO-27-06
P-MO-158
P-SA-176
P-TU-204
TU-35-08
Charitoudis G. P-TU-114
Charles S. J. P-MO-195
P-MO-174
Chatziralli I. P-SA-276
P-SU-035
Chaudhri A. TU-37-05
Chaudhry I. P-SU-228
Chauhan A. SU-09-04
Chauhan B. SU-02-04
WOC-C-31
WOC-C-31-01
Chaum E. SU-62-04
Chaumet-Riffaud P. TU-41-07
Chavan R. P-MO-252
Chaves Fernandes L. SU-74-06
Chavez-Mondragon E. SU-79-02
Chawla B. P-SU-242
Chee Chew Y. SA-44
SA-44-04
Chee S. P. MO-50-06
TU-60
TU-60-03
TU-73
TU-73-03
TU-83
P-SA-264
Cheeseman R. SU-40-02
Chen C. P-SA-201
SU-74-09
Chen C.-Y. P-SA-114
Chen D. F. MO-53-01
Chen E. MO-67-03
Chen H. S.-L. P-TU-081
Chen J. SU-38-10
Chen K.-J. P-SA-245
Chen M.-J. P-SA-114
Chen Q. P-MO-136
Chen Rundle A. MO-67-06
TU-29-09
Chen S.-J. P-SU-067
Chen T.-h. MO-24-02
Chen X. SU-36-05
Chen Y. P-SA-216
P-SA-221
Chen Y.-L. P-MO-090
Cheng A. C. SU-60
TU-64-03
Cheng C.-Y. P-SA-105
P-SU-067
Cheng L. SA-32-09
Chentsova E. SU-35-06
Cheung C. SU-41-02
Chew P. SA-30-02
Chhabra M. P-SU-223
Chi L.-c. J. P-MO-257
Chiang F. WE-16-04
Chiang M. SA-29
MO-04-04
Chiang S. P-SA-252
Chibante J. P-SU-273
Chibisova A. N. SU-44-06
Chi-Burris K. P-MO-063
Chin K. TU-35-02
Chiselita D. SA-31
P-TU-078
Chiu H. P-MO-241
WE-37-03
Chiwitt C. P-SU-148
Cho H. P-MO-200
P-TU-234
TU-29-07
Choi J. H. P-TU-142
SU-55-06
P-TU-162
Chomicz L. P-SU-026
Chong K. P-SU-222
Chong L. P. WE-08
Chong X. L. P-SA-140
Chongpison N. P-SU-230
Choo C. T. SA-44-07
P-SU-245
Choo M. L. P-SU-267
Choo M. M. P-MO-280
P-TU-161
Chopovska Y. P-TU-186
Choragiewicz T. P-SU-264
P-MO-260
Choritz L. P-SA-111
P-TU-076
Chou C.-K. P-SA-114
Choudhary R. WE-34-05
Choudhury K. P-SU-189
Chow D. TU-18-06
Chow L. P-MO-197
Christmann S. P-TU-095
Chryssafis C. MO-75-08
Chrzanowska B. P-SU-049
Chu D. SU-27-03
Chu R.-Y. P-MO-119
Chui J. P-SU-032
Chun Y. S. P-MO-284
P-MO-296
Chung H. WE-14-06
Chung S. K. P-MO-139
TU-25-04
Chung Y. P-MO-139
Chunhong G. WE-16-02
Ciechanowski P. P. P-MO-041
WE-39-04
Cilliers H. P-MO-197
Cimbalas A. P-SA-181
Cinatl J. MO-32-10
Ciobanu I. P-SU-005
Cisiecki S. MO-27-05
P-MO-207
Claerhout I. TU-44-04
Claessens D. P-SA-213
Claou C. SU-13
SU-13-02
Claringbold T. WE-02-02
Clark A. WE-40-09
Clark M. E. P-SU-251
Clarke J. C. K. SA-21-05
Clemens C. P-SA-195
TU-33-02
Clemens S. SA-29-02
SU-80-04
Po-TU
Clemens V. P-TU-118
Clifford L. P-MO-273
Coady P. MO-76-08
Cochener B. SU-36
SU-36-01
TU-41
TU-76-04
WE-32
Cohen J. S. MO-08-05
TU-30-05
Cohn H. C. MO-13
Colangelo L. SU-42
WE-12-07
Colenbrander A. MO-23
MO-23-01
375
WOC
2010
A
u
t
h
o
r

I
n
d
e
x Colin J. SU-36
SU-58
MO-40
MO-40-05
TU-46-04
Colinge J. P-SU-188
SA-27-02
Collin J. R. O. SA-42
SA-42-05
TU-68-04
WE-12
WE-12-06
WE-33
WE-33-06
Colvard M. SU-10-06
Conesa E. P-SU-083
P-SU-207
Congdon N. G. MO-51
MO-51-07
WE-36
WE-36-01
Conlon J. MO-62-04
Constable I. MO-56
TU-54-06
Contarini P. TU-31-09
Conte M. SA-28-02
Conzelmann I. SU-79-07
Coral-Ghanem C. WE-21-01
Corcostegui B. WOC-C-07
WOC-C-07-02
Cordeiro M. F. SU-01-03
TU-15
TU-15-02
Cordes A. K. TU-27-03
TU-27-06
P-MO-223
P-TU-157
P-TU-030
P-TU-153
Cornelissen F. SU-44-09
Corra Z. M. SU-34-07
Correa de Carvalho C. SU-74-06
Correa Z. MO-77-06
P-TU-094
Correia Ferreira L. S. P-TU-262
Corriveau C. MO-77-08
Cortes M. TU-34-11
Cortes Mora N. P-SU-086
TU-35-09
Cortese M. SU-17-11
Coscas F. WOC-C-61-01
Coscas G. J. TU-29
TU-67-07
TU-71
TU-71-01
WE-11
WE-11-02
WOC-C-61
WOC-C-61-04
LS-08
Coskun C. P-SA-143
Costa E. SU-73-04
Costa V. P. TU-16-05
Costa-Ferreira C. P-SU-144
Costagliola C. P-MO-224
Coupland S. E. SU-12-05
SU-39-09
SU-67
SU-67-04
MO-18
MO-33-03
TU-40-02
TU-53
TU-53-01
Couroucli X. SU-55-09
Courtney R. SU-55-05
Courtright P. SA-37-07
SU-74-03
MO-51-06
P-MO-080
Couto Sacramento J. P-SU-112
Couturier J. SU-39-02
Crabb D. P. MO-14-04
Craig J. TU-43-01
Crane I. J. SU-31-04
Craven E. R. P-MO-071
TU-30-02
Cremer C. P-SA-177
Creuzot-Garcher C. MO-55-02
TU-49-04
Cristvo L. M. SU-73-04
Crossland M. D. MO-10-05
Crowston J. TU-30-04
Croxatto J. O. TU-70-05
WOC-C-47-03
Cruysberg J. R. M. TU-33-08
Cucera A. FR-01-03
P-MO-182
P-MO-277
P-TU-033
Cui G. P-SU-136
Cui H. P-SU-110
TU-35-11
Cui H.-P. WE-39-06
Cullen J. MO-26-06
Cumberland P. SU-73-07
Cummings A. TU-64-05
Cummings T. J. SU-12-02
TU-70-06
TU-70-07
Cunha J. P. WE-41-05
Cunha-Vaz J. MO-45
MO-45-04
MO-61
MO-61-02
TU-44
TU-44-01
Cunnigham E. T. MO-46-05
TU-60-01
Cuny C. SA-28-06
TU-36-03
Curcio C. A. P-SA-187
P-SU-251
Curnow S. J. SU-31-03
TU-17
Cursiefen C. SU-78
TU-41-05
Po-SU
P-SA-065
P-TU-050
P-TU-127
WOC-AAD-C-11
Cvenkel B. TU-30-04
Cvintal V. SU-45-01
Czepita D. P-SU-061
P-SU-063
Czeszyk-Piotrowicz A. P-MO-289
D
da Silva J. MO-67-04
Daftari I. P-SA-211
Dahl P. TU-19-02
Dai Y. SU-74-09
Daito M. P-SA-150
Dalz M. P-SU-073
P-SU-073
Damani M. P-MO-211
Damar E. P-MO-005
Damasceno R. P-SU-241
P-SU-243
Damato B. D. SU-12-05
SU-39-09
MO-18-02
MO-44-02
TU-22
TU-40-02
TU-40-03
WE-23-07
Dame G. P-TU-031
Damgude S. P-SU-195
P-TU-040
D'Amico D. J. SA-36
MO-29
TU-45
Damico L. A. MO-68-05
Dana R. SU-38-06
Danieliene E. SU-36-02
Danielius R. SU-36-02
Daniels J. T. FR-01-16
Daniil Z. MO-76-10
Danilova D. P-SA-045
SU-35-06
Daniyar D. P-SA-262
Dannoue K. P-SU-219
Daoudi R. P-TU-189
Dapena I. TU-31-01
Dar K. A. P-SA-128
Dardenne C. M. P-MO-114
Dart J. K. G. SU-28
SU-28-01
MO-35
MO-49-06
TU-49-02
Darusman K. P-SU-090
Darvish M. P-SU-231
Das J. P-TU-100
WE-40-03
Das R. P-MO-279
P-TU-040
Das S. P-MO-279
Das T. P. MO-56-05
SA-03-06
Dashevsky A. SU-35-11
Dauletbekov D. P-SA-262
Davari T. P-SU-165
Davies S. P-SU-032
Dawczynski J. P-SA-277
Daxer A. SU-35-08
P-SA-055
WOC-C-39
Day S. H. MO-42-08
Dayawansa K. SU-80-01
MO-25-09
P-SA-273
P-TU-062
de Abreu Melgao S. P-SU-112
De Benito-Llopis L. P-MO-117
P-MO-143
de Boer J. MO-74-05
De Carvalho J. H. SU-74-06
de Castro Moura
Brasil L. P-SU-084
de Faber J.-T. SU-52-06
MO-69
MO-69-04
de Freitas D. MO-50-07
MO-57
MO-57-01
TU-31-09
P-MO-023
P-SU-082
de Groot J. TU-83
De Groote J.-J. P-MO-100
376
WOC
2010
A
u
t
h
o
r

I
n
d
e
x de Juan, Jr. E. TU-45-03
de Keizer R. J. W. SU-34-08
SU-42-09
de Klein A. SU-39-05
de la Cruz J. P-SA-073
de Laey J.-J. TU-11
de la Torre A. P-MO-006
de la Torre-Tovar D. P-MO-046
de la Paz M. SU-70-18
de Matos L. P-SU-180
De Moraes G. V. MO-13-05
MO-31-11
SA-12-02
de O. Regina M. C. P-SU-109
SU-40-04
de Oliveira E. P-SU-180
de Ortueta D. P-MO-128
P-MO-140
De Pablo C. P-SU-083
P-SU-207
de Paula Fiod Costa E. P-SU-011
de S M. F. P-SU-084
De Smedt S. SU-38-04
de Smet M. D. MO-46-03
SU-33-02
de Souza Pena A. WE-21-06
Deak G. P-TU-232
Decaudin D. MO-76
TU-53-05
Decker A. P-MO-245
Deeg C. A. TU-17-05
P-SA-251
DeForge L. MO-68-05
Deininger D. P-MO-286
Deissler H. TU-36-07
Dejiao L. SA-31-05
Deka S. P-TU-238
P-TU-249
Dekaris I. P-MO-112
SU-47-02
SU-47-06
TU-81-03
Dekel I. SA-31-09
Del Amo Freire J. P-SA-023
Del Monte M. A. SU-52
Dembovetskaya A. SU-55-04
Demirok A. P-SU-198
Denaro R. P-SA-071
SU-35-03
Deng L. P-SA-134
Denisova E. SU-41-07
Derhartunian V. P-MO-116
Dermon C. P-SU-122
Desai P. TU-81-07
Desch M. P-SU-268
Deschenes J. P-SU-231
Deshmukh S. P-TU-164
SU-55-08
Deshpande A. P-SU-072
Desjardins L. SA-09
SA-09-04
SU-39
SU-39-02
MO-75-01
TU-41-08
WE-23
WE-24
WE-24-01
WE-37
Deters C. P-MO-039
Dettbarn M. C. P-SA-166
Dettler N. P-SU-137
Deuter C. M. E. SU-27-04
MO-46-04
TU-53
TU-53-06
WE-30-06
Po-SA
P-SA-254
Deva J. SA-15-04
Devgan U. TU-46-02
P-SA-028
P-SA-035
Dexl A. P-SA-044
P-TU-010
SA-26-06
Dharmasena A. SU-35-05
Dhibi H. A. MO-70-01
Dhillon B. SU-44-04
WE-34-03
Di Girolamo N. MO-64-02
P-SU-032
Diaz A. P-MO-189
Diaz Barron A. P-TU-210
Diaz-Llopis M. MO-11-09
P-MO-097
P-MO-189
P-SA-243
P-SA-266
P-SU-169
Dib E. MO-32-09
Dichtl M. SU-17-07
Dick A. D. P-SU-252
Dick H. B. SA-19-04
SU-45
MO-19
MO-19-03
MO-66-06
TU-25-07
WE-01-06
WE-02
Po-SA
WOC-C-43
WOC-C-45
Dickenson A. J. SU-22-02
MO-82
Dieckow J. P-SU-012
Diedrichs-Mhring M. P-SA-251
Diesenberger D. SU-17-07
Diestelhorst M. Po-SA
P-MO-065
Dietlein T. S. P-SA-013
P-MO-274
P-TU-066
WOC-AAD-C-02
Dietrich T. P-MO-157
P-SA-124
P-TU-050
Dietzel A. P-TU-194
Diez-Andino P. SU-34-10
Dimaras H. SU-41-11
SU-74-02
WE-37-03
Diniz B. P-SA-271
P-SA-274
Dirisamer M. SU-17-07
Dithmar S. SA-43
SA-43-03
SU-38-02
MO-03
TU-34-07
P-MO-164
P-SA-177
P-SA-255
P-TU-203
P-TU-244
Djordjevic-Jocic J. P-SU-098
Dmitriew A. P-TU-154
Do D. MO-01-04
MO-75-06
WE-38-01
WOC-C-57-01
Dobner B. P-SA-255
SU-27-02
Dobrowolski D. MO-35-03
SA-31-03
SU-35-10
Doga A. MO-26-05
SU-36-04
Dogra M. WOC-C-58
WOC-C-58-04
Dolgoff R. MO-08-02
Dolgopolov I. WE-35-02
Dolz-Marco R. P-MO-189
Domack H. P-TU-034
Dombi T. P-SU-097
Domenghino I. P-TU-044
Domingues I. MO-73-02
Dominika J. MO-35-03
SA-31-03
Dong C. SA-32-03
Dong G. SU-67-02
Donner R. TU-37-06
Donshik P. MO-59-02
TU-26-02
D- ordevic J. P-SU-152
Dorecka M. TU-36-09
Dorn V. P-SU-076
Dorrell M. I. TU-36-05
Dorsey A. P-SU-254
Dou H. WE-35-10
Doubal F. SU-44-04
Doudou A. P-SA-012
Doughty M. J. SU-75-04
Douglas R. TU-06-04
Downie R. SU-74-02
WE-37-03
Doycheva D. P-SA-254
Draca N. TU-81-03
Draeger J. A. SA-31-10
Draganic B. P-SU-176
Dragomyretskaya E. P-MO-113
Drenser K. A. WE-29-07
Drexler W. MO-61
MO-61-03
Dridi M. J. P-SA-101
Drnovek-Olup B. MO-28-11
MO-78
Droggina G. P-SA-078
Droutsas K. TU-31-01
Drozhyna G. P-SA-053
P-SA-098
Dryja T. P. SU-27-03
Drzyzga L. P-MO-056
Du M.-Q. SU-67-02
Dua H. S. SU-35
SU-75-10
MO-17
MO-17-03
TU-81-07
Duarte Silva E. J. SU-42-02
Dubovy S. MO-77-08
Ducournau D. TU-01
TU-01-03
Duerksen R. SU-64-07
SU-65-04
TU-57-05
Dugel P. TU-34-10
WE-38-04
Duker J. S. WOC-C-15-01
Dumbrova N. P-TU-166
Dunavlgyi R. MO-67-07
377
WOC
2010
A
u
t
h
o
r

I
n
d
e
x Duncker G. I. W. SU-47
TU-21
TU-61-03
TU-61-06
P-MO-123
WOC-C-06
WOC-C-21
WOC-C-22
Dunse M. FR-01-04
Dupps Jr. W. J. SU-59-01
MO-39
MO-39-01
WE-03-01
Duquesnoy R. J. SU-19
SU-19-03
Dutton G. SA-10
SA-10-01
SU-44-04
Dydykina S. TU-32-09
Dzafarly T. P-MO-031
Dzhumagulov O. P-SU-069
Dziegielewski K. MO-27-05
E
Eagle Jr R. C. SU-34-05
MO-33-04
Eberwein P. FR-01-05
P-TU-043
P-TU-047
Ebner R. WE-40-01
WE-40-01
Eckardt A. MO-78-03
Eckardt C. P-SA-170
Ecke I. P-MO-062
Eckert S. Po-SA
P-SU-200
P-SU-235
Eckert T. P-SA-170
Eckstein A. K. MO-82-03
SU-22
SU-22-03
P-SU-246
Edelman J. L. MO-75-06
Edirisooriya J. P-SA-273
Edmond J. C. SU-52-07
Edward D. P. MO-43
MO-43-03
MO-43-07
MO-43-09
TU-40-04
Eggert A. P-TU-116
P-TU-123
Eggink C. A. P-TU-065
Eghtedari M. P-SA-238
P-SA-238
Egidio R. P-SA-090
P-SA-094
Eguchi H. P-SA-232
TU-31-10
Eha J. TU-41-10
Ehlers W. H. MO-43-05
MO-44-07
MO-59-01
MO-59-06
TU-21
Ehlken C. P-SA-161
Ehmer A. P-TU-018
Ehrhardt B. A. P-MO-184
Ehrlich R. TU-30-06
Ehrt O. SA-47
SA-47-05
SU-18-04
MO-51
Po-SU
Eibl K. P-MO-249
P-SA-173
P-SA-202
P-SA-205
P-SU-272
TU-25-08
Eid Farah M. MO-32-09
P-SU-011
Einolahi B. SU-36-10
Eisenbarth W. P-SA-208
Eisenkoelbl S. MO-68-03
P-SA-200
El Alloussi T. P-MO-066
P-SA-141
P-TU-140
El Danasoury M. A. SA-01-08
SA-26
SA-26-01
SU-59
SU-59-06
TU-39-06
TU-64-04
P-MO-129
El Defrawy H. H. E. D. WE-40-10
El Hage S. TU-21-06
El Mrabh M. P-TU-140
El Ouazzani Chahdi K. P-TU-189
El Seht R. P-MO-292
El Shorbagy M. S. P-MO-292
El Yamouni O. P-TU-140
El-Amir A. P-TU-032
El-Ashry M. WE-34-03
El-Awady H. P-SA-142
El-Baz A. SA-28-05
Elboraey M. G. E. WE-40-10
Elfakey Y. SU-42-05
Elflein H. P-MO-187
P-TU-147
WE-41-02
Elhassan E. P-TU-259
Elizabeth Hale J. TU-25-01
Elizalde J. WOC-C-40-03
Elizondo A. SU-09-07
El-Lakkany R. TU-32-02
Ellis-Behnke R. G. MO-47-05
MO-53-05
TU-15-06
Ells A. WE-09-02
El-Maghraby A. WE-16
Elmekawey H. P-MO-177
P-SU-050
WE-40-10
El-Shabrawi Y. P-SA-135
Elsherbiny S. P-TU-212
Elshiwy H. E. MO-25-10
Elzaridi E. P-SU-228
Eming S. A. P-TU-254
P-SU-260
Emmerich K.-H. SU-71
SU-71-06
MO-78
MO-78-10
P-SU-248
P-TU-093
WOC-C-13
Enders C. P-SA-208
Endl E. MO-79-01
Endo T. TU-32-08
Engel M. P-SU-111
Engelbert M. MO-24-03
Engelmann K. TU-19-08
Po-TU
Engelmann V. P-MO-171
P-MO-228
Engin A. P-SA-165
Engin K. N. P-SA-128
P-SA-143
SA-31-06
Engle E. SA-45
SA-45-02
MO-71-02
Enikeev A. P-SA-042
Enoki M. P-MO-064
P-MO-166
Enzmann V. P-TU-178
Eppelin A. MO-48-05
Epstein D. TU-76-07
TU-78
TU-78-01
Epstein D. MO-45-01
Erb C. SU-46-06
TU-13
Po-TU
P-SA-148
P-SA-149
Erben A. P-SA-263
Ergin M. P-TU-061
Ergun S. FR-01-06
Ermilov V. MO-68-08
Ernest P. H. TU-75-05
Erol N. P-MO-242
Errais K. P-SA-079
Ersoy L. P-MO-065
P-SU-106
Escobar M. P-TU-199
Eshmambetov A. SA-27-08
Eskelin S. MO-77-08
Esmaeli B. SU-67-05
TU-40-05
Espaa-Gregori E. P-SU-169
Espinoza R. MO-23-06
Esser J. SU-22-05
P-SU-246
Essig H. MO-78-03
SU-38-09
Estermann S. P-SU-027
Estrada Rodrguez J. L. P-MO-183
P-MO-250
P-TU-041
Estu D. P-SA-118
Eter N. MO-79-01
TU-33-02
TU-69
WE-34
WE-34-04
P-SA-188
P-SA-195
Etualin Gonzlez A. P-TU-041
P-TU-131
Etya'ale D. SA-37-02
SA-48
SA-48-01
SU-65-03
Eule C. FR-01-10
Eun-kyoung K. TU-25-02
Exarchou A. P-MO-214
F
Faal H. SA-37-02
SA-48-04
Faber D. P-MO-198
Fabian E. WE-10-04
P-TU-011
Fahmy I. P-SA-132
Fain J. P-SA-100
Falk N. SU-27-03
Fan J. L. P-MO-167
Fan L. TU-66-04
378
WOC
2010
A
u
t
h
o
r

I
n
d
e
x Fan X. SU-17-09
SU-42-06
SU-42-10
MO-25-07
P-SU-060
P-SU-193
P-SU-213
P-SU-221
P-SU-227
P-SU-234
P-SU-238
P-TU-102
Fan X.Q. SA-44
SA-44-08
Fan Y. C. P-SU-066
Fang I.-M. P-SU-259
Fang S. K. SA-30
SA-30-07
Fantes F. SA-11
SA-11-02
Farah M. E. MO-32-06
Farah O. P-SA-089
Faria e Sousa S. J. P-MO-100
P-MO-101
Fariduddin K. P-TU-260
Farkas A. SU-75-02
TU-31-07
Farnworth D. P-MO-273
Farooq T. P-SU-247
Farrar J. WE-15
WE-15-03
Farvili E. SA-27-07
Farzavandi S. MO-69-06
P-SA-217
Faschinger C. MO-12-04
P-SA-135
Fasina O. WE-16-09
Fass O. N. SU-81-01
Fatiha B. P-TU-139
Fauser S. P-SA-214
Faust M. P-SA-043
Fazelipour S. SU-17-05
Fazzi E. SA-10
SA-10-03
Fechtner R. MO-13-06
WE-07
WE-07-05
Federov A. P-SU-153
Federowicz A. P-SA-091
Fedorov A. P-SU-201
SU-44-06
Fedorov A. B. SU-44-08
Fehse B. P-SU-271
Feinbaum C. P-MO-024
P-SA-075
WOC-C-46
WOC-C-46-04
WOC-C-46-05
WOC-C-46-08
Feiner L. MO-67-06
Feke G. T. P-MO-049
Felix C. TU-30-05
Feltgen N. P-MO-236
P-TU-248
TU-29-08
WOC-C-55
WOC-C-55-03
Feng X. WE-35-10
Fengyuan S. SA-44-01
Ferman-Atar G. P-MO-216
Fernandes J. P-SU-068
Fernandes L. C. WOC-C-59-05
WOC-C-59-06
Fernandes M. P-MO-285
P-MO-298
P-SU-030
Fernandez A. P. MO-15-06
Fernandez de Benito F. P-MO-047
P-MO-093
Fernelius C. TU-40-06
Ferrara D. SA-32-04
Ferreira J. MO-73-02
P-MO-050
P-SA-258
P-SU-273
WE-41-05
Ferrone P. TU-18-09
Ferry J. SU-67-02
Feucht N. P-MO-146
P-MO-205
P-SA-208
P-SA-233
SA-32-10
TU-35-05
Feuchtenberger M. P-MO-008
Fiala W. P-MO-110
Fichter N. MO-34-04
Fiedorowicz M. P-SU-264
Fielder A. MO-04-06
TU-66
Figueroa M. S. LS-08-03
TU-48-02
Filipek E. P-MO-162
Filipi H. MO-44-06
Filser E. P-TU-007
Fimia A. P-MO-099
TU-82-07
Fimmers R. SU-73-08
Findl O. SU-16
SU-16-01
MO-43-04
TU-75-06
TU-76-01
Finger P. T. MO-77-08
TU-35
TU-35-02
TU-40
TU-40-01
P-MO-181
P-TU-109
P-TU-111
Finger R. P. SU-64
SU-73-08
SU-74
MO-27-06
TU-14-04
TU-35-08
P-MO-086
P-SA-176
P-SU-058
P-TU-204
Fingerle V. SU-24-03
Fintelmann R. SU-35-02
Fiol-Silva Z. SA-16
TU-26-05
Fiscella R. G. P-TU-060
Fischer C. P-MO-222
P-SA-194
Fischer E.-M. P-SA-148
Fischer F. P-TU-246
Fischer M. D. P-TU-219
Fischer-Harder K. WE-16-01
Fishkind W. J. SA-05
SA-05-06
TU-25-09
Fitt A. P-TU-020
Fitzke F. W. TU-55-06
FitzPatrick D. R. P-TU-155
Flammer J. SA-12
SA-12-04
SA-21-02
MO-31
MO-73-03
WE-11-03
Flanagan J. G. MO-14-01
Fleck B. P-TU-148
P-TU-150
Fleckenstein M. P-SA-176
P-SA-197
P-TU-183
WE-34-08
Fleming A. SU-62-06
Fleming A. D. TU-29-03
TU-56-05
Fletcher D. C. TU-14
TU-14-02
Flhr C. P-SU-240
P-TU-223
Flohr F. TU-67-04
Flores-Limas S. SU-61-04
Flhs D. MO-77-04
P-TU-126
Foeckler R. P-MO-157
Foerster A. M. H. TU-34-04
Foerster J. P-SA-214
Foerster M. H. SA-35
SU-43-03
MO-24
WE-23-06
WOC-C-60
WOC-C-60-04
P-TU-089
P-TU-114
Fok A. P-TU-202
Fong C. W. P-MO-169
Fons Martinez R. P-TU-210
Forlini C. SU-45-06
MO-24-10
TU-02-02
WE-26-03
WE-27-06
P-MO-232
Forlini M. MO-24-10
P-MO-232
Forminska-
Kapuscik M. P-MO-162
Foronda A. S. TU-31-09
P-SU-082
Forrester J. V. SU-19-05
SU-31
SU-31-05
MO-01-06
Frster C. MO-28-10
Fortunato M. P-MO-161
Foster A. SU-65-01
Foster C. S. SU-27-03
Foster P. SU-08
SU-08-01
SU-08-06
Foster S. P-SU-110
TU-35-11
Foulks G. SU-63
SU-63-03
WE-22
Fox K. SU-62-04
Framme C. SA-32
SA-32-02
P-MO-244
P-TU-245
Franceschetti A. SA-15
SA-15-01
SU-46
SU-46-03
379
WOC
2010
A
u
t
h
o
r

I
n
d
e
x Francesconi C. P-SU-180
Francis A. P-SA-134
Francis P. J. SU-25-02
Franco E. P-SA-090
P-SA-094
Franco I. P-SA-217
Francuz T. TU-36-09
Frank C. P-MO-170
P-MO-226
Franke G. H. P-SU-174
Frech M. SU-56-04
Freedman S. SU-41-03
SU-55-05
Freeman W. R. P-MO-210
TU-34-11
SA-32-09
SU-38-01
Freisthler M. MO-24-05
MO-77-04
P-TU-126
Freitas H. SU-74-01
Frenkel R. P-MO-071
P-TU-059
TU-30-03
Frentz M. MO-28-08
SU-17-02
SU-17-08
Fresina M. SU-55-03
Freudenthal J. P-MO-074
Freund K. B. SA-32-04
Frezzotti P. P-SA-137
Friberg T. MO-63-03
Friedlander D. P-SU-254
Friedlander M. P-SU-254
TU-36-05
Friedman D. SA-23
SA-23-02
SA-24
SA-24-05
WOC-C-10-03
Frhlich S. J. WE-36
WE-36-07
Fronius M. P-SA-224
Frosch M. P-TU-242
Fruschelli M. P-SA-137
Frutos J. M. SU-34-10
Fu T. SU-44-05
Fu Y. SU-17-09
Fuchsluger T. FR-01-06
SU-38-06
Fujikado T. WE-14-03
Fujikawa A. P-MO-256
Fujiki K. P-SA-087
Fujimaki T. P-SA-087
Fujimoto J. G. MO-61-05
Fujiwara T. P-MO-154
SA-32-06
Fukuda M. MO-35-01
P-MO-213
P-SU-089
Fukuhara M. P-SU-257
Fukumoto A. SA-31-07
Fukumoto M. P-MO-264
Funk J. MO-31-02
P-MO-041
WE-39-04
Funk M. P-SU-188
SA-27-02
Furmanchuk H. P-TU-117
Furness C. L. P-MO-295
Furrer S. P-MO-041
Furuta M. SU-34-09
TU-22-01
Frweger C. P-TU-096
Fyodorov A. MO-78-07
G
Gabel J. P-SU-080
Gabel V.-P. MO-42
TU-34-09
Gabela G. WOC-C-50-03
Gabric N. P-MO-112
SU-47-02
SU-47-06
TU-02-04
TU-81-03
Gabryte E. SU-36-02
Gajdzik-Gajdecka U. P-TU-171
P-TU-201
Galambos P. P-SU-226
Galand A. P-SA-240
Galarreta D. P-SU-086
TU-35-09
Gall C. P-SU-137
P-SU-153
P-SU-161
P-SU-174
P-SU-175
SU-44-06
SU-44-08
Gallego-Pinazo R. P-MO-160
P-MO-189
Gallenga P. E. TU-41
WE-32
Gallie B. L. SU-41-11
SU-74-02
MO-77
WE-24
WE-24-06
WE-37-03
Gamaly T. SU-47-10
Gamulescu M.-A. SA-32-02
P-TU-187
Gandhi R. WE-04
WE-04-03
Gandolfi S. SA-11
SA-11-01
Gandorfer A. SU-49-01
WE-34-06
P-MO-233
P-MO-249
P-SA-173
P-SU-272
WOC-AAD-C-
01-03
WOC-AAD-C-
01-04
Ganesh S. WOC-C-12-05
Gangopadhyay N. P-MO-285
P-MO-298
P-SU-030
Ganguly A. SU-81-02
MO-31-03
P-MO-145
TU-13-06
Gans M. P-SU-231
Ganssauge M. MO-67-03
Gao L. P-SA-095
SA-32-03
Gao X.-R. WE-39-06
Garber D. P-SU-251
Garcia C. P-TU-206
SU-27-08
Garcia P. MO-27-03
P-SA-180
P-TU-216
TU-37-09
Garca Alcolea E. E. P-MO-104
Garca-Alvarez C. SU-34-10
SU-34-11
Garca Arum J. MO-29-06
SU-50-07
TU-48
TU-48-05
Garca-Barbern I. SU-70-14
Garcia-Bardon D. P-MO-137
Garca-Delpech S. TU-41
TU-41-06
WE-32
P-MO-097
P-SA-243
P-SA-266
P-SU-169
Garca-Feijo J. MO-66-07
Garcia Filho C. A. P-SA-271
Garcia-Gonzalez M. P-MO-117
P-MO-143
Garcia-Marcos M. WOC-C-63
WOC-C-63-04
Garcia-Medina J. J. P-MO-047
P-MO-093
P-MO-160
P-SA-119
Garcia-Medina M. P-MO-047
P-MO-093
Garczorz W. TU-36-09
Garg P. SU-28-04
Garg S. SU-62-04
Garip A. P-SA-251
Garlaite O. P-TU-084
Garms C. WE-25
Garrett Q. SU-17-04
Garrick A. P-SU-150
Garway-Heath T. SU-01
SU-01-02
MO-14
MO-14-06
WE-07-04
Garweg J. G. SU-24
SU-24-02
MO-25-05
MO-74
TU-50-03
P-MO-203
Gatinel D. SA-01-07
SU-47
MO-37-03
Gatzioufas Z. SU-69
P-SA-081
P-SU-276
Gaudric A. SU-48
SU-49
Gavranic C. P-TU-098
Gavrilenko A. P-SA-160
Gayathri R. MO-74-10
Gaydamaka T. P-SA-053
P-SA-078
P-SA-098
Ge J. MO-22-07
Geck U. P-MO-201
Gedde S. SA-21-03
Geerling G. FR-01-14
FR-01-16
FR-01-21
SU-63-07
MO-64
MO-64-05
TU-79
TU-79-09
Po-SA
P-MO-008
P-MO-148
P-MO-286
P-SA-060
WOC-C-14
WOC-C-14-05
380
WOC
2010
A
u
t
h
o
r

I
n
d
e
x Gehlsen U. FR-01-07
P-SU-023
P-SU-031
P-SU-034
Geinoz J. SU-38-04
Gekeler F. P-SA-155
P-SU-264
TU-34-09
Gelhorn H. P-SU-110
Geller S. TU-34-02
Gellrich M.-M. P-MO-085
Gellrich N.-C. MO-78-03
SU-38-09
Gengenbach U. MO-79-07
MO-79-08
P-SU-190
Gentile R. MO-27-03
P-SA-180
P-TU-216
Georgakopoulos C. P-MO-190
P-MO-214
George J. L. P-SU-055
George N. P-TU-090
P-TU-148
George T. M. P-SA-272
Georgiou T. SU-35-01
Georgopoulos M. P-SU-188
P-TU-028
SA-27-02
Geraissate C. P-MO-023
Gerasimov M. P-SU-181
Gerding H. TU-37-04
WOC-AAD-C-29
Gericke A. P-MO-137
P-TU-241
Gerinec A. SU-41
MO-05-04
MO-73
MO-73-01
Gerstmeyer K. P-MO-072
Gerten G. P-MO-144
SA-27-07
Gerth C. P-TU-130
P-TU-155
Ghaddar A. P-MO-275
Ghanem A. P-SA-142
SA-28-05
Gheorghe I. P-TU-005
Gheorghe M. P-TU-107
Ghita M. P-MO-048
Ghosn C. MO-75-07
P-TU-199
Giancardo L. SU-62-04
Giannakopoulos M. P-MO-190
P-MO-214
Giblin M. TU-22-02
WOC-C-60
WOC-C-60-06
Gicquel J.-J. SU-37-08
SU-75-10
TU-81-07
Giebel A. SU-78-08
Giegengack M. SU-79-06
MO-79-03
Giers U. WE-40-06
Gilbert C. MO-07
MO-07-01
MO-51
MO-51-01
WE-16-06
P-SU-064
P-SU-072
Gilbert S. TU-57
TU-57-06
Gill N. P-MO-067
Gillies M. MO-32-02
MO-75-04
MO-75-05
TU-32-01
Gini G. TU-01-06
TU-27
TU-27-05
TU-27-06
WE-27-07
Girkin C. A. MO-13-01
Giuliari G. P. MO-35-09
Gkatzioufas Z. P-MO-035
Gkika T. MO-24-05
MO-77-04
P-TU-126
Glnzel W. MO-45-02
Glaser E. P-SA-263
P-TU-120
Glasser A. MO-39-02
Glaus E. P-SA-088
Glavota V. P-MO-112
Glekov I. WE-35-02
Glittenberg C. P-TU-176
Globocnik Petrovic M. P-SA-206
Glombik R. P-TU-250
Gloor B. P. SU-46-02
TU-65
Gmelin E. P-TU-250
Gminski J. TU-36-09
Goatman K. SU-62-06
TU-29-03
TU-56-06
Gobbe M. P-MO-111
TU-80-04
TU-80-10
Gbel A. P. WE-34-08
Gbel K. P-SA-149
Goebel W. P-MO-251
Goebels S. C. P-MO-278
P-SA-081
P-TU-101
Goeppert H. P-TU-006
Goerig M. SU-40-05
Goes F. J. TU-75
TU-75-04
Goetz A. E. SU-40-05
Gogia V. P-SU-242
TU-32-04
Goh M. MO-26-06
Goh S. Y. MO-74-08
Goh T. P-SU-222
Gk M. MO-24-05
P-TU-126
Gokyigit B. P-SU-198
Golbaz I. MO-27-01
P-SA-196
P-TU-185
Goldberg I. SA-30
MO-08-03
TU-30-04
TU-43-03
Goldberg R. SU-42-05
Goldstein M. H. TU-26
Gole G. A. P-TU-151
Golnik K. SU-40
MO-41
MO-41-01
MO-41-07
MO-42-05
MO-44-05
MO-59-05
P-SU-142
Goloborodko E. P-TU-241
Gologorsky D. MO-77-08
Golovin A. WE-39-01
Golshahi A. TU-33-09
Goltz C. SA-29-02
Goltz H. SU-44-05
Gomes da Rocha A. P-SU-273
Gomez L. SA-32-09
Gomez de Liano R. MO-09-06
TU-59-05
Gomi F. P-MO-179
P-SA-163
P-TU-229
SA-25-04
Goncalves J. TU-21-05
Gondova G. P-TU-132
Gonen T. P-MO-055
Gong H. P-SA-134
Goi Foncillas F. J. MO-54
MO-54-01
Gonnermann J. P-SU-046
Gonzlez-Castao C. P-MO-221
Good P. P-TU-052
Goodale M. SA-10-02
Gopovtzova O. WE-35-02
Gorani M. P-SU-092
Gorban M. P-MO-077
Gorby M. MO-08-07
Gordillo L. MO-51-02
Gordon I. WOC-C-10-02
Gorjizadeh A. P-MO-152
Gos R. MO-68-09
Gosho T. P-SA-121
Goswami M. K. MO-67-05
Gothwal V. K. MO-23-04
Goto H. SU-57-05
TU-73-04
P-SA-247
P-SU-158
Gotoh N. P-SA-167
Gottlieb C. MO-76-08
Gottlob I. SU-23
SU-23-01
SU-55
MO-06
MO-06-02
Gottsch J. D. TU-81
Gottschling P. F. SA-28-06
TU-36-03
Gotz- Wie ckowska A. P-TU-154
Gtzinger E. MO-27-01
TU-37-06
Gougoutchkova P. P-MO-156
Gourgoulianis K. MO-76-10
Goyal J. L. P-SU-173
Grabner G. SA-02-01
SA-26-06
SU-47
MO-38
MO-38-01
P-SA-044
P-SA-067
P-TU-010
Gracner B. P-TU-058
Gracner T. P-MO-007
P-TU-058
Grf M. SA-38-06
SA-47-04
SU-18
SU-18-03
TU-59
WE-41
Gragoudas E. S. MO-63
Graham E. MO-03
MO-03-02
Grajewski R. MO-11-02
P-SA-248
381
WOC
2010
A
u
t
h
o
r

I
n
d
e
x Gralek M. P-TU-156
Gramer E. TU-16
P-SU-177
Gramer G. P-SU-177
Gramlich O. W. SA-28-06
TU-36-03
TU-36-06
P-SU-104
Grandin J. TU-81-05
Graneros G. P-SA-269
Gray J. P-MO-174
P-MO-195
Gray S. MO-67-06
TU-29-09
Grcar R. P-MO-231
Grechko S. P-SA-053
Gregor Z. J. MO-02
MO-02-01
MO-67-04
Gregory D. G. SA-17-04
Grehn F. SA-11-05
SU-06-02
SU-07
SU-07-02
MO-08
P-MO-148
P-SU-105
WOC-C-14
WOC-C-14-01
WOC-AAD-C-20
Greveniotis P. SU-35-01
Grieb P. TU-77-03
Griebel M. P-SA-253
Grierson R. P-SA-184
P-SA-185
Grigg M. SU-24-01
MO-76-08
Grisan E. SU-62-01
Grisanti S. SA-31-04
SU-51-04
MO-79-04
Po-MO
P-SA-166
P-SA-170
P-SA-187
P-SU-023
P-SU-031
P-SU-251
P-TU-075
P-TU-097
Grobelny A. P-SU-063
Groll J. MO-79-01
Groppe M. P-TU-032
Groe B. P-MO-277
Groe Darrelmann B. SA-25-08
Gromann W. P-MO-127
Grossniklaus H. E. SA-43
SA-43-02
SU-43-04
SU-57-04
MO-33
TU-22-03
TU-70-03
Growendt J. P-MO-038
Group the AJCC-UICC
Study TU-40-07
Grover A. SA-44
SA-44-05
MO-78-05
P-SU-203
Grucha Y. MO-78-07
Grnert A. P-SA-113
Grupcheva C. SA-14-04
Grus F. H. SA-28-04
SA-28-06
MO-22
MO-22-05
MO-73-10
Po-SU
P-SA-111
P-SU-094
P-SU-204
P-TU-241
P-SU-104
TU-36-03
TU-36-06
Grusha Y. MO-78-04
MO-78-06
MO-78-08
P-SU-201
Grterich M. MO-35-04
P-SA-051
Grzybowski A. SU-46-07
Gu H. MO-75-09
Gudlin J. P-SU-160
Gell J. L. SA-05-02
SU-77
MO-40-01
TU-76
TU-76-02
Guenther T. WE-41-03
Guerrero L. P-SU-132
Guichard M. M. P-SA-161
Guilherme-Monteiro J.P-SA-258
Gul A. SA-40
SA-40-06
MO-74
Gulani A. SU-80-03
P-MO-134
P-MO-135
Gulbins E. P-SU-246
Guliani B. P-SU-195
P-TU-040
Gmbel H. O. C. TU-09-03
WE-28-01
Po-TU
WOC-C-37-04
Gummersbach C. P-MO-223
Gunawan W. P-MO-107
Gundlach E. P-SA-059
Gundorova R. P-SA-045
Gndz E. P-MO-242
Gndz . U. TU-21-02
Gunenc U. P-TU-061
Gunn D. P-TU-151
Gnther S. P-MO-033
P-SU-105
Gupta A. K. SU-44-07
Gupta M. P-TU-146
P-TU-148
P-TU-150
Gupta N. MO-53-04
TU-15
TU-15-03
WE-13-01
Gupta S. MO-79-06
P-MO-198
P-SU-242
TU-30-10
Gupta S. K. MO-74-01
Gupta V. P-SU-195
P-TU-040
Grel E. P-SA-128
Gurung R. P-TU-263
Gusek-Schneider G. P-SA-036
SU-41-09
Gustiene O. P-SA-204
Guth H. MO-79-07
Guthmann S. P-MO-271
P-TU-191
Guthoff R. Po-MO
P-MO-251
P-SA-253
Guthoff R. F. SA-16
SA-46
SA-46-09
SU-32
SU-38
SU-56-04
MO-34
MO-34-05
MO-79-05
MO-79-07
MO-79-08
WE-12
WE-12-01
P-SA-077
P-SU-190
P-TU-155
WOC-C-47
WOC-C-47-01
Gutierrez-Amoros C. P-MO-126
Guymer R. TU-37-03
Guyton D. P-SA-226
Guzy C. P-MO-062
P-MO-073
Gyasi M. P-SA-134
H
Haas A. WE-08-02
Haas-Brhler S. P-MO-039
Haase V. H. TU-36-05
Habela M. SA-16-05
Haddad D. TU-71-04
WE-25-04
Haddad S. P-TU-140
Hadi I. P-MO-271
Hadipour Jahromy M. SU-17-05
Hadjiraftis S. P-SA-139
Haefliger E. A. TU-03
TU-75
TU-75-01
Hafez M. SU-42-07
Hafezi F. SU-59
SU-59-04
Hagedorn N. P-MO-240
Hager A. MO-67-09
Hager T. P-SA-066
P-TU-007
Hahn I. MO-79-01
Hahn U. TU-03-08
Haigis W. MO-20-02
TU-10
TU-10-02
TU-82
TU-82-03
P-TU-018
Hakim I. P-TU-021
WE-34-06
Halberstadt M. MO-25-05
Haldipurkar S. WE-17-02
Halfter W. TU-34-06
Halle M. TU-33-06
Haller J. A. SU-50-03
MO-32-01
MO-32-02
MO-75-04
TU-32-01
LS-08-04
Ham L. TU-31-01
Hamoudi R. A. SU-67-02
382
WOC
2010
A
u
t
h
o
r

I
n
d
e
x Hampejskov L. SU-41-11
SU-74-02
Hamrah P. WOC-C-47-06
Hamsley N. P-SA-064
Han G. P-MO-261
P-SA-201
Han H. P-SU-105
Han J.-F. Su-54-04
Handayani S. Y. P-TU-124
Handoko S. B. P-TU-124
Handzel D. M P-SU-233
P-MO-114
Hangai M. P-MO-043
P-SA-126
Hansen L. L. TU-29-08
WE-34
P-MO-236
Hara T. P-MO-138
P-SU-037
Hara Y. P-MO-138
P-SU-037
Harada R. P-SU-113
Harats D. P-MO-216
Harder B. P-MO-185
Hardy S. P-SU-057
Haritoglou C. SU-38-01
SU-49-03
TU-25-08
TU-33-03
WE-34-06
Po-TU
P-MO-222
P-MO-233
P-MO-249
P-MO-271
P-SA-188
P-SU-272
P-TU-017
P-TU-191
P-TU-228
P-TU-237
Haritoglou I. SU-34-06
Harris A. TU-16
TU-16-01
TU-30-06
Hartmann K. SA-32-09
SU-38-01
TU-34-11
Hartmann U. P-SU-258
Hartnett M. E. SU-41-03
Haruchika M. P-TU-231
Hasegawa Y. P-MO-235
Hasenfus A. P-SA-066
P-TU-101
Hasenfus D. P-SU-043
Hashad Y. MO-68-02
TU-35-01
Hashim H. P-SA-272
Hashimoto S. P-SA-106
P-SA-109
Hasnain S. P-SA-104
Hass P. E. MO-68-05
Hassan A. O. SA-37-03
SA-37-05
SA-37-06
TU-42-01
Hassan S. A. P-MO-001
Hassan T. S. MO-72-06
TU-18
TU-18-01
TU-45-04
Hassenstein A. SA-25-08
Po-MO
Hathaway M. MO-27-03
Hattenbach C. P-TU-226
Hattenbach L.-O. MO-28-07
TU-29
TU-29-08
Po-SA
P-TU-226
WOC-C-30
WOC-C-36-04
WOC-C-48
Hattingen J. P-TU-223
P-TU-250
Haueisen J. P-MO-040
P-SA-145
P-SA-147
P-TU-194
Hauer K. P-TU-047
Haughney P. MO-68-05
Haustein M. P-SA-139
Hawlina M. SU-11
SU-11-03
MO-42
MO-42-02
MO-55
MO-55-07
TU-02-05
Hayashi H. P-SA-097
P-SA-167
Hayashi K. P-MO-188
P-SA-229
Hayashi W. P-MO-188
Hayes J. P-TU-181
Hazarbassanov R. M. SU-17-03
P-MO-115
Hazarika M. MO-28-05
He M. SU-08-07
MO-52-04
WE-36-04
He Y. P-SU-102
Healey P. SA-30-06
TU-43
Hecht E. P-SU-202
Heckmann B. P-MO-073
Hediger A. MO-31-02
Hedges T. R. SA-38-11
WE-20
WE-20-02
Heegaard S. SU-12-06
SU-34
SU-67-01
TU-70
TU-70-04
Hefner L. TU-37-04
Hegde K. SU-74-02
Heidt A. P-TU-043
Heiduschka P. MO-36-06
P-MO-170
Heier J. MO-32-01
MO-32-02
MO-75-04
TU-32-01
Heijl A. SU-02
SU-02-01
MO-14
TU-43-02
BS-09-01
BS-09-03
Heiligenhaus A. SU-27
SU-27-02
SU-27-06
SU-27-07
MO-11-06
MO-21
MO-21-05
MO-49
MO-74-04
MO-74-07
MO-76-01
TU-50
TU-50-02
P-SA-248
P-SA-256
P-SU-099
P-SU-151
Heimann H. SU-48-03
TU-23
TU-23-03
WE-35
Heindl L. M. SA-29-01
P-SU-249
TU-40-07
P-TU-127
Heinrich M. A. P-SA-112
Heinz C. SU-27-02
MO-11-05
MO-74-04
MO-74-07
TU-60
TU-60-07
P-SA-248
P-SU-099
Heinzelmann S. U. TU-19-09
P-SA-068
Hejcmanova D. P-MO-281
P-SU-155
Helb H.-M. SA-25-07
MO-43-02
MO-67-09
WE-34-04
P-SA-158
Helbig H. SA-32-02
SU-79
TU-09-04
TU-23-05
TU-32
P-MO-157
P-MO-204
P-MO-244
P-SA-011
P-SA-124
P-TU-187
Helfenstein M. P-SU-055
Hellebrand H. SU-61-03
Hellmich M. P-SA-013
Hellstrom A. MO-04-01
Helou J. P-TU-033
Helvestone E. SU-52-04
TU-59
TU-59-02
Henckes O. P-SU-055
Hendrikse F. SU-48-05
Hengerer F. SU-15-05
Henke Fahle S. P-TU-119
P-SA-122
Hennig A. TU-24-04
Hennig M. MO-76-01
Hennighausen U. P-SU-078
Henrich P. B. MO-24-06
P-MO-249
Henrich-Noack P. P-SU-162
Henson D. B. P-MO-195
P-MO-174
Hepper D. TU-80-06
Herbort C. P. SA-08-04
SU-33-05
Hergeldzhieva-
Fileva T. SU-17-01
SU-62-09
SU-64-03
SU-81-04
P-SA-076
Heriot W. WE-08-06
383
WOC
2010
A
u
t
h
o
r

I
n
d
e
x Herman W. SU-81-01
Hermann M. P-MO-065
Hermel M. P-MO-288
P-SA-064
Hernaez-Ortega M. C. MO-75-02
Hernandez
Martinez F. P-SU-147
Hernandez
Martinez F. J. P-TU-247
Hernndez Silva J. R. P-SA-023
P-SA-033
Hernandez-
Boussard T. WE-40-08
Herndon L. W. TU-13-03
Hernowo A. SU-44-09
Hero M. P-MO-252
Herrmann C. SU-44-08
Herrmann C. S. P-SU-137
Herrmann W. P-SA-011
SA-32-02
Herwig M. C. P-SU-006
Herzog D. MO-31-07
P-MO-036
P-TU-147
Herzog J. P-MO-036
Hessler F. P-SA-265
Hetland J. P-SU-101
Hetzel A. WOC-C-55-02
WOC-C-55-06
Heuen F. M. A. P-SA-113
P-MO-015
P-MO-016
Heynemann M. P-MO-220
Higashide T. P-SU-159
Hikoya A. A. P-SA-215
P-TU-129
Hilgers R.-D. TU-32-05
Hillebrand S. P-SA-165
P-SA-198
Hillenkamp J. P-SA-186
TU-32-09
TU-36-08
Hingst V. MO-34-03
Hintschich C. SA-42
SA-42-04
MO-82
WE-33
WE-33-05
Hinz M. P-TU-221
Hirabayashi M. P-TU-195
Hirai K. P-SA-131
P-SA-154
Hirakata A. SA-25-05
Hirano S. P-MO-064
Hiraoka T. P-MO-172
P-MO-235
P-MO-239
P-SA-150
Hiratsuka Y. P-SU-052
Hirn C. MO-31-02
P-MO-041
WE-39-04
Hirneiss C. P-MO-037
P-MO-233
P-SA-202
P-SU-186
Hirota A. SU-38-07
Hirsch-Kauffmann
Jokl D. SU-46
SU-46-04
Hisatomi T. SA-43-01
Hitzenberger C. MO-27-01
MO-27-02
MO-61-04
TU-37-06
Hjortdal J. SU-47-03
TU-72-02
Hn M. MO-74-10
Ho M. P-MO-192
Ho T.-Y. P-SA-105
Hoang-Xuan T. MO-49-05
Hoeh A. E. P-TU-244
SU-38-02
TU-34-07
Hoerauf H. TU-12
TU-29-08
P-MO-102
P-MO-201
WOC-C-32-03
WOC-C-37-03
WOC-C-49
WOC-C-57
Hoffmann D. P-TU-254
Hoffmann E. M. SU-01
SU-01-01
MO-13
MO-31-07
TU-41-10
P-MO-032
P-MO-033
P-MO-036
P-MO-039
P-MO-045
Hoffmann M. P-SA-146
Hoffmann P. TU-82-04
Hoffmann S. P-SU-043
P-SU-265
Hfling-Lima A. L. P-MO-098
P-MO-115
Hofmann C. P-TU-015
P-TU-016
Hofmller W. P-TU-057
Hohensinn M. P-SA-044
P-SA-067
SA-26-06
SA-26-09
Hoh S. T. MO-13-02
Hohman T. C. WE-34-08
P-SA-197
Hhn F. MO-28-07
TU-29-08
Holak H. P-SA-072
P-SA-072
SU-44-10
SU-44-10
Holak N. P-SA-072
SU-44-10
Holak S. A. P-SU-145
Holbach L. M. SU-57
MO-18
MO-18-03
TU-40-07
P-SU-249
P-TU-127
Holbroook J. T. MO-76-04
Holden B. A. WE-36-02
Holder G. E. SU-11
SU-11-05
Holdt M. P-TU-112
Holladay J. T. SA-01-02
MO-39-04
TU-10
TU-10-01
TU-80
TU-80-01
Holland D. TU-80-06
Holland G. N. MO-21-01
MO-76-08
TU-60-04
Hollander D. TU-30-06
Holle J. P-TU-098
Holl G. MO-60
MO-60-05
Holmstrm G. WE-09
WE-09-01
Holopainen J. M. SU-37
TU-80-05
Holz E. R. TU-45-08
Holz F. G. SA-25-07
SA-33
SA-43-04
SU-50-04
SU-51-03
SU-73-08
MO-27-06
MO-45
MO-45-03
MO-68
MO-68-02
TU-29-10
TU-33-02
TU-35-08
WE-34-08
WE-38-05
P-MO-158
P-MO-086
P-SA-158
P-SA-176
P-SA-195
P-SA-197
P-SU-006
P-SU-058
P-TU-183
P-TU-204
Holzchuh N. WE-21-03
WE-22
Holzer M. P. SA-02-03
SU-45-05
SU-80
TU-62-03
P-SA-010
P-TU-008
P-TU-018
Home S. WE-34-05
Homma K. P-TU-208
Hommel G. P-SU-194
Hommer A. B. MO-12
MO-12-02
MO-54-03
Honda S. P-MO-213
P-MO-254
Hong L. Su-54-04
Hong S. P-SU-093
Hong S.-M. MO-67-08
Hooper C. P-SA-236
Hooymans J. SU-44-09
Hopkins A. D. SU-32
SU-32-06
TU-57-07
Hopkinson A. SU-75-10
Hori N. P-SA-107
Hornegger J. TU-56
Hornykewycz K. WE-39
WE-39-05
Horozoglu F. P-MO-055
Horwath-Winter J. FR-01-11
FR-01-12
Hosseini S. R. P-MO-152
Hosseini H. MO-67-03
Hotta Y. P-SA-215
P-TU-129
Hou M. C.-C. P-MO-090
Hou X. R. SU-74-07
Hovakimyan M. MO-79-05
SU-56-04
384
WOC
2010
A
u
t
h
o
r

I
n
d
e
x Hovanesian J. TU-46-01
Hoyng C. B. TU-33-08
Hsieh Y.-T. TU-32-06
Hsu S.-Y. P-TU-051
Hsu T.-K. P-SU-154
Hsu W.-C. P-TU-081
Hsu W.-M. P-SU-067
Hsueh S. SA-32-09
Htoon H. M. P-MO-084
TU-81-09
Hu N. P-MO-287
Hu W. K. SU-17-10
Hu X.-W. SU-54-04
Hu Y. WE-35-10
Huang B. TU-82-01
Huang J. P-SA-138
Huang K. P-SU-097
Huang P. MO-73-09
Huang S. TU-18-08
Huang Y. SU-67-02
Huang Z.-L. MO-67-03
Huber C.-G. P-TU-056
Huber J. P-SA-101
P-TU-205
Huber K. P-MO-015
P-SA-113
Huber-van der
Velden K. P-MO-016
P-MO-075
Hudovernik M. P-TU-058
Huf W. P-SA-200
Hulkova M. P-MO-281
Humayun M. TU-18
TU-18-03
TU-45-05
WE-14-01
WE-15-05
Hungerford J. WE-23
WE-24-04
Hunter D. G. SA-45-03
MO-71
Hunter M. SU-68-01
Huo Y.-J. MO-73-09
Hurtikova K. P-MO-278
Huseynova S. P-SU-131
Hutauruk J. P-SA-069
Httmann G. MO-79-01
MO-79-04
MO-79-05
P-SU-031
P-SU-034
Hwang L.-J. WE-41-09
Hyer J. P-SU-095
Hyndrak M. P-SA-049
SU-75-02
Hyvrinen L. SA-10-04
I
Iacob C. E. P-TU-111
Iakymenko S. SU-35-04
TU-81-08
Ibarz-Barbera M. P-MO-117
P-MO-143
Ibisevic M. P-SU-225
SU-27-09
Ibrahim M. WE-37-01
Ibrahim O. SA-26-03
Ibrahimy W. P-TU-189
Ichimura K. SU-67-02
Ideguchi K. SU-38-07
Idrissi-Alami S. P-TU-140
Ignjatovic Z. P-TU-071
Iida T. P-MO-165
P-SA-097
P-SA-191
Iijima H. MO-27-10
Iizuka Y. P-SU-093
Ikeda F. P-MO-173
Ikeda H. P-MO-043
P-SA-126
Ikeda N. P-SU-121
Ikeda S.-i. P-SU-053
Ikeda T. P-SU-121
Ikeda T. P-SU-257
P-MO-264
P-TU-064
P-TU-068
Ikeda Y. TU-54-04
P-MO-011
P-SA-279
Ikuno Y. P-MO-215
P-TU-069
SA-25-04
Ilako D. R. SA-37
SA-37-03
SA-37-06
Ilazi M. P-SU-092
P-SU-092
Ilginis T. P-SA-174
Ilies I. P-TU-078
Illarionova A. P-MO-031
Ilyina E. P-SA-054
Imai A. P-MO-266
Imai H. P-MO-254
Imaizumi M. SU-56-03
Imamoglu S. P-SU-198
Imamura Y. SA-32-04
SA-32-06
Imshanetskaya T. MO-24
MO-24-04
MO-27-08
P-SU-275
P-SU-269
P-TU-192
P-TU-173
Inatomi T. WE-05-04
Ines K. P-MO-082
Ing M. WE-37-02
Inoue M. SA-25-05
Inoue Y. MO-35-01
P-MO-011
P-SA-279
Investigators for the
LUMINATE MO-76-03
Iomdina E. MO-26-04
Iranmanesh R. MO-77-03
Ireni A.-R. P-SU-267
Irkec M. MO-60
MO-60-04
Irsch K. P-SA-226
Irschick E. MO-35-04
Isa H. P-SU-009
Isaac K. P-TU-212
Isaacson P. G. SU-67-02
Ishibashi T. SA-43
TU-54-04
Ishibazawa A. P-MO-153
Ishida K. P-TU-225
Ishida M. P-MO-225
Ishida O. P-TU-068
Ishida Y. P-MO-064
Ishikawa K. P-MO-194
P-SA-131
P-SA-154
P-SA-175
P-TU-214
Ishikawa M. P-SU-096
Ishiko S. P-SA-267
P-SA-282
Ishikura R. P-MO-011
Ishizaki E. P-MO-264
Iskandar E. P-SA-087
Ismailova D. MO-78-06
MO-78-08
Isquierdo Jr. L. MO-57-05
Ito M. P-TU-200
P-TU-222
SU-47-09
Ito R. P-TU-231
Ito Y. P-MO-194
P-SA-175
P-TU-214
P-TU-220
Itou M. P-SU-124
Ivanchenko Y. MO-78-06
MO-78-07
Ivandic B. P-SA-130
Ivandic T. P-SA-130
Ivanisevic M. P-SU-075
Ivanisevic P. P-SU-075
Ivanova N. P-SA-235
Ivanova O. A. P-TU-125
Ivanovskaya E. V. P-SA-078
Ivarsen A. SU-47-03
Iwami H. P-TU-195
Iwata D. P-SA-257
Iyer J. V. P-SU-206
Izdebska J. P-MO-289
TU-31-06
Izquierdo L. MO-15-07
TU-74-01
Izquierdo N. MO-81-03
J
Jaafar M. SU-52
SU-52-02
Jabs D. A. MO-76-04
Jackson M. L. MO-23-08
Jackson T. TU-34-10
Jacob M. P-SA-205
Jacobi C. SA-16-03
Jacobs D. S. TU-31-08
Jacobson L. SA-10-05
Jafarinasab M.-R. P-SU-039
Jaffe G. J. P-SA-197
Jger M. P-TU-152
P-SA-246
P-SU-248
P-TU-099
P-TU-174
P-TU-186
Jager M. J. SA-35
SU-53-02
Jaggi G. MO-73-03
P-SU-125
Jgle H. SU-72
SU-72-04
Jaki Mekjavic P. P-SA-206
Jakob E. FR-01-08
P-SA-241
P-SA-255
Jakobs E. P-MO-124
Jakobsen J. E. SU-07
SU-07-01
Jaksic V. P-TU-230
P-TU-240
Jakubowska B. P-TU-092
P-TU-128
James D. K. SU-75-10
385
WOC
2010
A
u
t
h
o
r

I
n
d
e
x Jan J. MO-58
TU-56-01
Jang S.-y. P-TU-162
Janjua R. P-MO-202
Jankov M. R. MO-57-06
TU-64
Jansonius N. M. SA-31
SA-31-02
SU-44-09
Jantschitsch C. P-SU-253
Januleviciene I. TU-16-02
P-SA-116
Januschowski K. P-MO-170
P-TU-181
Jap A. P-SA-264
Jarrn E. P-SU-132
Jarsch C. P-SU-045
Jasek M. C. TU-30-04
Jasielska M. P-SA-168
Jasinskas V. P-SA-204
Javadi M.-A. P-SU-039
Javate R. M. SA-44-06
SU-71
SU-71-05
TU-06-05
Jaworska M. P-SA-072
Jayakumar D. P-TU-198
Jedrzejczak-
Mlodziejewska J. P-MO-289
Jeep S. P-MO-263
Jeng B. SU-35-02
Jenkins A. TU-29-02
Jennane N. P-SA-141
Jepsen C. P-SA-010
Jeremy W. TU-34-06
Jessen B. P-SU-097
Ji J. MO-25-07
Ji Y. P-SU-232
Jia H. P-SA-095
Jia R. P-SU-217
SU-42-03
Jia Y. P-SA-231
Jiang L. SU-44-02
Jiang T. P-SA-216
P-SA-221
Jiang W. SU-55-09
Jiao C. P-MO-018
Jiao J. MO-32-01
MO-32-02
MO-75-04
TU-32-01
Jimenez-
Martinez M. d. C. P-SU-024
Jimenez R. SA-27-11
Jimnez-Roman J. P-MO-046
Jin X.-y. TU-31-04
Jin D. P-TU-064
Jin E.-H. MO-67-08
Jo Y. P-MO-215
Joachim S. C. P-SU-104
SA-28-06
TU-36-03
TU-36-06
Job O. TU-08-01
TU-08-05
Jobke S. SU-44-06
Johnen S. P-MO-206
TU-37-08
Johnson R. S. TU-36-05
Johnston S. TU-66-06
Jhrens K. P-SA-263
Jonas J. B. SA-12
SA-12-03
SU-73-06
MO-47-02
TU-16-03
WE-07-01
P-MO-185
P-MO-245
Jonasson F. MO-60-01
Jonescu-Cuypers C.-P. SU-68-06
SU-69-04
P-MO-035
P-TU-007
Jonuscheit S. SU-75-04
Joo C.-K. P-MO-009
TU-25-02
Joo K. S. P-MO-284
P-MO-296
P-SA-219
Jordan J. F. TU-63
TU-63-06
P-MO-038
Joshi L. TU-65-07
P-SA-244
P-SA-268
Joshi S. P-TU-164
Josifova T. TU-34-03
Josselin P. M. SU-36-01
Joussen A. M. SU-27-07
MO-01
MO-72-08
TU-32-05
TU-33
Po-SU
P-SA-113
P-SA-168
P-SU-258
P-SU-260
P-MO-015
P-MO-016
P-TU-098
P-TU-243
P-TU-254
Jovanovic I. P-SU-152
Juanjuan L. P-MO-168
P-SA-019
P-TU-253
WE-41-04
Jnemann A. G. M. SA-28-08
MO-12
MO-12-01
TU-37-05
TU-77
TU-77-02
WE-39-09
Po-SU
P-SA-036
P-SU-098
P-SU-249
Jnemann C. TU-29-08
Jung G. P-SU-266
P-SU-271
Junker B. P-MO-236
P-SA-070
P-TU-248
Jrgens C. SA-29-03
Juric B. P-MO-112
Jurik I. P-MO-209
Jurklies B. Po-MO
P-SA-239
P-TU-248
Jurklies C. P-TU-112
P-TU-116
Jurkunas U. SU-38-06
Jurowski P. MO-68-09
Jyothi S. MO-32-08
K
Ka Fat, Thomas T. MO-68-10
Kabasele P. M. B. P-SA-236
Kabelitz D. P-MO-151
Kaaniku G. SU-64-01
Kachalina G. MO-27-07
SU-36-04
Kachi S. P-SU-270
Kadinskaya M. SA-28-07
Kador P. TU-82-02
Kaercher T. FR-01
WE-22
Kahaly G. J. P-SU-194
Kahlert C. P-SA-255
Kahook M. Y. P-MO-058
P-MO-059
Kaiser P. K. SA-22-02
SU-34-04
TU-18
TU-18-02
TU-37
TU-37-01
WE-38
WE-38-03
WOC-C-57
WOC-C-57-03
Kaiserling E. P-SA-170
Kajita M. SA-15-06
P-SU-119
Kakizaki H. SA-44-02
Kakkassery V. P-TU-098
Kaldefoss K. P-TU-191
Kalinina Ayuso V. MO-74-05
Kalogeropoulos C. MO-74-03
Kalua K. TU-57-04
Kaluzny B. J. WOC-C-47-05
Kalyani P. MO-76-08
Kamei A. P-SU-146
Kamei I. P-SA-004
Kamei M. TU-30-07
Kaminska A. P-MO-289
TU-31-06
Kammann J. TU-25
Kmmerling S. P-SA-224
Kamo J. P-SU-113
Kampik A. SU-38-01
SU-50
SU-51
MO-11
MO-31-10
MO-35-04
MO-66-02
MO-75-03
TU-25-08
TU-33-03
TU-34-11
TU-41
TU-41-02
TU-42
WE-11
WE-11-01
WE-16-03
WE-32
WE-34-06
P-SA-051
P-SA-173
P-SA-178
P-SA-188
P-SA-194
P-SA-202
P-SA-205
P-SU-272
P-MO-088
P-MO-210
386
WOC
2010
A
u
t
h
o
r

I
n
d
e
x P-MO-233
P-MO-249
P-MO-271
P-TU-021
P-TU-091
P-TU-096
P-TU-191
P-TU-228
P-TU-237
WOC-AAD-C-03
LS-08
LS-08-01
Kampik D. FR-01-09
Kampik K. P-TU-248
Kampmeier J. Po-SU
P-SA-050
Kanamori A. MO-73-05
Kandelman S. SU-75-03
TU-74-05
Kandori M. P-SA-279
Kanecadan L. P-TU-188
Kaneda K. SU-38-07
Kaneko M. P-SA-121
Kang H. P-MO-265
Kang J. H. WE-40-02
Kang K. D. P-TU-054
Kang S. TU-25-04
Kanigowska K. P-TU-156
Kann G. P-SA-060
Kanonidou C. P-SA-276
P-SU-035
Kanonidou E. P-MO-248
P-SA-012
P-SA-276
P-SU-035
Kanpolat A. SA-13
TU-21-01
Kanthan G. P-SU-051
SU-73-03
Kao S.-C. P-SU-015
Kapica A. MO-68-09
Kaplan J. MO-07-05
Kar D. MO-24-03
Karacorlu M. TU-08-03
TU-08-05
WE-37
Karadenizli S. P-SA-128
Karagiannis D. P-SA-168
Karahan E. SA-31-06
Karam E. SA-38-05
SU-18-02
Karim R. P-MO-001
Karimian F. P-SU-039
Karim-Zade K. P-SA-042
P-SU-205
P-TU-135
Kara-Jos N. SA-14-02
Karliychuk M. P-SA-171
Karnowski T. SU-62-04
Karska-Basta I. P-SA-183
P-MO-175
P-MO-267
P-TU-085
Kartasasmita A. P-SA-087
Kasae P. P-MO-269
Kasama S. P-SU-135
Kashii S. SU-29
SU-29-02
SU-40
WE-04-06
Kashiwagi K. MO-22-03
Kasimov E. P-SU-131
Kaskaloglu M. TU-02
TU-02-03
Ksmann-Kellner B. SU-68-02
SU-69-02
WE-37-07
P-TU-163
Kasmiya M. TU-25-01
Kasparov A. MO-78-08
Kasper B. P-MO-251
Kasper K. FR-01-21
P-MO-286
Kassel J. MO-08-06
Katada T. P-SA-136
Kataev M. WE-12-02
Katalin G. P-SA-133
Katalin Z. P-SA-133
Kataoka K. P-SU-270
Katargina L. A. SU-41-07
Kato S. P-SU-107
Kato T. P-SU-115
Kato Y. P-SA-267
Katowitz J. A. MO-34
MO-34-06
Katschke Jr. K. J. MO-68-05
Katz L. J. TU-30-05
Katz T. P-SA-082
SU-75-05
Kau H.-C. P-SU-015
P-SU-120
Kaufmann C. P-TU-049
Kaulen P. TU-63-08
Kaup M. P-SU-140
TU-63-05
Kaushal S. P-MO-150
WE-35-05
Kawahara J. P-TU-070
Kawai K. P-TU-231
Kawano M. P-SU-141
Kawasaki A. SU-29-05
WE-20-05
Kawasaki R. TU-29-02
Kawase K. P-MO-069
Kayama T. P-SU-115
Kaymak H. P-MO-240
Kaynak-Hekimhan P. P-SU-198
Kayode SA-37-05
Kazakova D. TU-63-01
Kazanskaya O. TU-37-08
Kazaryan A. P-SA-151
Kazlauskas A. SU-38-06
Keane P. A. P-SA-165
Kedar S. WE-04-04
Kee C. SA-28-09
Keeffe J. MO-52
MO-52-05
WOC-C-59
WOC-C-59-03
WOC-C-59-04
WOC-C-59-06
Keeley S. WE-40-07
Keenan T. WE-16-04
Keil C. P-SU-185
Keilholz U. P-TU-114
Keindl T. K. SU-61-06
Kelley R. F. MO-68-05
Kellner S. TU-33-09
Kellner U. SU-11-01
TU-33-09
P-MO-040
Kempen J. H. MO-76-04
Kermani O. P-MO-144
SA-27-07
TU-82-09
Kern T. SA-34-02
Kern Y. P-SU-045
P-TU-043
Kernt M. P-MO-210
P-MO-233
P-MO-271
P-SA-173
P-SA-178
P-SA-194
P-SA-202
P-SA-205
P-TU-191
P-TU-228
P-TU-237
SU-38-01
TU-25-08
Kersten D. P-SA-162
Kertes P. P-MO-241
Keser M. P-TU-082
Keskinbora K. MO-23-07
P-MO-055
Ketring K. TU-82-02
Kettesy B. P-SU-028
Keuchel S. MO-48-01
Keul H. MO-79-01
Key J. E. SA-14
SA-14-01
Kezirian G. M. TU-78
TU-78-04
Kezuka T. P-SA-247
P-SU-158
Khairallah M. MO-32-05
TU-60-05
P-MO-082
P-SA-089
P-SA-249
P-SA-250
P-SA-270
Khaireddin R. P-SA-082
Khakpour S. SU-17-05
Khaled A. E. P-MO-177
Khaled A. K. G. P-SU-050
Khaliddin N. P-TU-161
Khalifa M. SU-47-08
Khalilia N. WE-16-04
Khan A. P-SA-244
Khan H. P-MO-001
Khan M. D. TU-42-03
Khan S. MO-77-08
Khan W. MO-35-10
Khandelwal P. SA-20-04
Khandelwal R. SU-81-06
MO-73-06
P-TU-055
Kharoubi A. TU-33-06
Khatana A. K. TU-30-02
Khaw P. T. SU-06
SU-06-01
SU-72-02
MO-07-03
MO-53
MO-53-06
Khazaei H. P-SU-209
Khetan A. MO-35-02
P-MO-285
P-MO-298
P-SU-029
P-SU-030
Khetan V. WE-24-02
Kholmatova R. P-TU-135
Khoo C. Y. SA-15
SA-15-05
Khor S. E. P-MO-280
P-SA-199
Khoramnia R. P-SU-111
P-TU-120
Ki C. S. SA-28-09
387
WOC
2010
A
u
t
h
o
r

I
n
d
e
x Kibata Githeko A. MO-62
MO-62-05
MO-62-08
Kikkawa D. O. SU-22
SU-22-06
Kikuchi T. P-SU-053
Kilangalanga N. J. SA-37-07
Kilic E. SU-39-05
Killer H. MO-73-03
P-SU-125
Kim I. MO-63-04
Kim Y. M. SA-25-02
Kim C. S. SA-28-09
Kim C. Y. P-SU-093
SA-28-09
Kim D. S. WE-40-02
Kim H. P-MO-208
Kim H. J. SA-28-09
Kim H. K. P-TU-079
Kim J. C. P-MO-284
P-MO-296
Kim J. S. SA-32-09
SU-38-01
TU-34-11
Kim J.-o. SU-47-01
Kim J.-S. P-MO-118
Kim K.-S. P-MO-237
Kim R. SU-27-03
Kim Y. D. P-TU-054
Kim Y. J. P-TU-142
SU-55-06
Kim Y. K. P-SU-179
P-SU-185
Kim Y. Y. SA-28-09
Kim Y.-C. P-MO-237
Kimoto K. P-MO-199
TU-32-03
Kimura H. SA-31-07
King A. J. MO-31-08
Kinoshita H. P-MO-247
Kinoshita S. SA-16
SA-16-01
SU-38
SU-78-09
MO-17-01
MO-49
MO-49-01
MO-66-08
TU-05-08
Kinouchi R. P-SA-267
P-SA-282
Kiraly L. P-MO-123
WOC-C-08
Kirchhof B. SA-36-07
MO-16-04
MO-27
MO-48
MO-48-06
MO-70
MO-70-05
TU-03
TU-32-05
TU-34-04
WE-08
P-SA-165
P-SA-170
P-SA-198
P-SA-213
P-SA-214
WOC-AAD-C-18
Kirii E. P-MO-178
Kirilova Y. P-SA-076
SU-17-01
SU-62-09
Kiseleva T. P-SA-160
SA-25-01
WE-34-09
Kishi S. P-MO-149
P-MO-166
P-MO-173
P-SA-242
P-TU-233
Kishimoto F. P-SA-222
Kisimoto T. P-SU-182
Kiss C. TU-37-10
MO-68-03
P-SA-164
P-SA-200
WOC-C-15-04
Kitano S. P-TU-252
Kitaoka T. P-MO-230
P-MO-247
P-MO-256
P-TU-004
Kiuchi T. P-SA-150
Kiuchi Y. P-SA-121
P-SU-183
P-TU-070
SU-38-07
Kivel T. SU-34
MO-33-05
MO-55-06
MO-60-07
MO-77-08
TU-22-04
TU-40
WE-23
WOC-C-60
WOC-C-60-02
Kiyosaki K. SU-56-03
Klamann M. P-MO-015
P-MO-016
P-MO-075
P-SA-113
Klancnik J. MO-77-03
MO-32-03
Klaproth O. MO-25-02
P-MO-116
P-TU-001
P-TU-015
P-TU-016
Klassen H. MO-53-02
Klatt C. SA-25-06
Klauss V. SA-37-05
SU-65
SU-74
TU-57
TU-57-03
WE-16-03
P-MO-088
WOC-AAD-C-28
Klaver C. TU-14-05
Klee S. P-MO-040
P-SA-145
P-SA-147
Klein H. SA-32-09
Klein M. L. MO-63-05
Klein S. P-SU-260
P-TU-243
P-TU-254
Klemm M. P-TU-056
P-TU-073
P-TU-082
P-TU-194
WE-39-02
Klett A. SA-42
SA-42-01
Klettner A. MO-28-01
P-MO-151
P-SA-186
P-SU-253
TU-32-09
TU-36-08
Klevering B. J. TU-33-08
Klingenstein A. P-TU-091
P-TU-096
SU-34-06
Klink T. SU-07-03
SU-45
P-MO-148
WOC-C-14-03
Klintworth G. SU-12
TU-70
TU-70-01
Klos-Rola J. P-SU-095
WE-39-09
Klyce S. D. SA-16-04
WE-03-06
Knecht P. P-TU-049
Knobloch J. P-SA-166
Knop E. SA-20
SA-20-01
SU-63-01
P-MO-297
Knop N. SA-20
SA-20-03
P-MO-297
Knorr M. P-SA-265
Knorz M. C. SA-26
SA-26-05
SU-13-06
MO-38
MO-38-05
TU-03-06
TU-82-06
WE-01
WE-03-03
Knyazeva E. S. P-SU-181
Ko Y.-C. P-SA-105
Kobayashi A. SA-18-04
P-SA-047
Kobayashi M. P-SU-107
Kobayashi Y. P-SU-124
P-TU-200
P-TU-222
Kobylarz J. P-MO-175
P-MO-267
Kocabora S. P-SA-128
Koch D. D. SU-10-04
SU-16
MO-37
MO-37-02
Koch F. MO-32-10
TU-01-08
TU-77-07
P-MO-196
P-MO-207
WOC-C-36
WOC-C-36-02
WOC-C-37
WOC-C-37-02
Koch H.-R. WE-17
WE-17-06
Koch M. P-TU-243
Kociok N. P-SA-168
P-SU-258
P-SU-260
P-TU-243
P-TU-254
Kocur I. SU-65
SU-65-07
TU-71-02
388
WOC
2010
A
u
t
h
o
r

I
n
d
e
x Koffler B. H. SU-09
SU-09-06
WE-22-03
Kofoed P. MO-67-03
Kogan B. P-SA-078
P-SU-277
Koh A. MO-56-03
Koh H. J. SA-25-02
Koh T. P-TU-079
Kohl S. MO-06-03
Khler J. P-SU-196
P-TU-250
Khler M. P-SU-184
Kohlhaas M. SA-13
SA-13-01
Kohli S. P-SA-052
Kohlmann T. P-MO-072
Kohnen S. SU-14-06
WE-10-01
WOC-C-56-03
Kohnen T. SA-07
SA-07-01
SU-15
SU-15-01
MO-25-02
MO-35-07
MO-40
MO-40-02
TU-03-05
TU-09-01
TU-46-01
TU-61
TU-61-02
TU-61-06
WE-03-07
WE-10
WE-10-03
P-MO-019
P-MO-116
P-SA-157
P-TU-001
P-TU-015
P-TU-016
WOC-C-05
WOC-AAD-C-16
WOC-C-56-02
Kohno T. P-TU-195
Koinzer S. P-SU-253
P-TU-196
Koizumi I. SU-74-01
Kojima S. P-SU-257
P-TU-064
P-TU-068
Kok H. S. P-SU-020
Kokemueller H. SU-38-09
MO-78-03
Koler E. P-SA-050
Koleva-Georgieva D. SA-25-10
Kolker A. SU-38-05
Koller T. SU-58
Kollmann K. H. M. SA-37
SA-37-01
SA-37-02
SA-37-05
SA-37-08
P-MO-079
P-MO-088
Kolodziejska U. P-SA-099
TU-31-06
Komatsu N. P-SA-279
Komm D. P-SU-161
Komori S. P-SA-107
P-SA-136
Kompella U. B. MO-47-04
Kondo M. P-MO-194
P-SA-175
P-TU-214
Kondo N. P-MO-213
Konen W. MO-65-05
P-TU-066
Kong S. J. TU-25-04
Konidaris V. P-MO-248
P-SA-276
P-SU-035
Knigsdrffer E. P-SA-277
Konrad J. P-MO-146
Konstantinidis A. P-MO-259
P-SU-191
TU-30-09
Konstas A. MO-12-06
SU-69-05
Konstas A. G. P. MO-60-06
WE-13
Kook D. MO-35-04
MO-35-07
P-MO-116
P-SA-051
P-TU-017
P-TU-021
Kook M. S. SA-28-09
MO-22-04
Kook P. P-MO-205
P-TU-205
Koop N. P-SU-031
P-SU-034
Kopayenko G. P-SA-235
Kopp K. P-SU-033
Kopsachilis N. P-SU-100
Korber N. TU-13-01
Kornhuber J. P-SU-098
SA-28-08
Korobelnik J.-F. SA-06-03
Korotkih S. A. P-SU-181
Korth R. M. E. FR-01-10
Korwitz U. MO-48
MO-48-04
Kosanovic-Jakovic N. P-TU-230
Kose D. SU-81-06
Koshitz I. MO-26-04
Kosinska J. P-SA-091
Koss M. J. MO-32-10
TU-77-08
P-MO-196
P-MO-207
WOC-C-37
Kostenko P. TU-63-09
Kotak S. P-SA-100
Kotamarthi V. P-SA-261
Kotb Ali K. P-SA-039
Kotera Y. P-MO-043
P-SA-126
Kothari M. P-SA-225
SU-61-05
Kotliar K. MO-26-04
P-TU-180
SU-35-11
TU-33-06
TU-35-05
Kotoula M. MO-76-10
Koukkoulli A. P-SU-212
Kovacs R. P-TU-049
Kovalov A. P-MO-290
TU-31-02
Kowalski J. W. MO-75-05
P-SU-110
WE-35-04
Kowarsch T. P-SU-184
Kozak I. P-MO-210
P-MO-210
SU-38-01
TU-34-11
Kozeis N. SU-69-01
Kozobolis V. SU-69-03
Kracht J. P-SA-224
Kramann C. MO-73-10
P-MO-187
P-SA-190
Kramar E. SU-61-06
Kramp H. P-SA-265
Kranebitter N. MO-35-04
Krantz K. MO-78-01
Kranz-Opgen-Rhein B. SU-17-02
Krappe A. P-SA-162
Kraut A. P-SA-206
Kravchuk E. SA-25-01
WE-34-09
Krawczyk A. SU-41-10
Krebs I. P-TU-176
Kreil D. P-SA-164
Kreiner C. F. WE-12
WE-12-05
Kreissig I. WOC-C-62
WOC-C-62-01
WOC-C-62-07
Krema H. MO-35-09
Kreutzer T. TU-33-03
TU-29-08
Kriechbaum K. MO-32-07
Krieglstein G. K. SA-11
SA-11-06
SA-21
SA-28
SU-05
SU-05-01
TU-03-01
Krishna P. V. MO-05-03
Krogmann F. SU-46
SU-46-05
Krohne T. U. TU-29-10
TU-36-05
P-SU-254
P-TU-227
Kroisamer J.-S. TU-37-10
Krueger R. R. MO-39-05
SA-01-03
SA-02
SU-60-01
TU-39-02
Krug M. MO-79-04
Krger A. MO-79-05
Krger C. P-MO-218
Krger H. WOC-C-36
Krger N. P-SA-184
P-SA-185
Kruglova G. P-SA-210
Krupin T. MO-12
MO-12-05
SA-12-07
Kruse F. E. SA-28-08
SU-17
SU-77
SU-78-07
MO-17
MO-17-04
MO-18-06
TU-05-06
TU-37-05
TU-40-07
WE-05-06
P-SA-065
P-SU-098
P-SU-249
P-TU-127
389
WOC
2010
A
u
t
h
o
r

I
n
d
e
x Kruse K. TU-35-08
Krysta A. P-SU-098
Ksiazek S. MO-42-07
MO-43-08
Kuang T.-M. P-SU-067
Kubicka-Trzaska A. P-SA-183
P-MO-175
P-MO-267
Kubota A. SU-17-06
Kubota T. P-MO-199
SU-56-03
TU-32-03
Kuchenbecker J. WE-10-06
Kchle M. P-SA-031
Kuchynka P. TU-31-07
Kudou A. P-SA-015
Kuehlmeyer S. P-TU-007
Kugler W. P-MO-240
Kuhn D. SA-15
SA-15-02
Kuhn F. TU-01-07
TU-28
TU-28-08
WE-26
WE-26-02
WE-26-06
WE-27
WE-27-01
WE-28
WE-28-08
WOC-C-50
WOC-C-50-05
Kujala E. TU-40-08
Kuklin A. P-SA-160
Kuljaca Z. P-TU-071
Kulkarni U. V. P-SA-199
Kumagami T. P-MO-230
P-MO-247
P-TU-004
Kumar A. MO-06-05
TU-32-04
Kumar N. P-MO-217
SU-40-02
Kumar S. SU-30-02
SU-62-07
MO-58-05
TU-56
Kumaramanickavel G. TU-55-03
Kumaran S. MO-79-06
SU-44-07
Kunert K. TU-80-02
Kunimatsu S. P-SU-107
Kunst F. P-SA-184
P-SA-185
Knster A. SU-74-10
Kunze A. P-SU-258
Kuoliene K. P-SA-181
Kuper H. WE-16-04
Kupferschmid S. SU-45-03
P-MO-025
P-MO-277
Kupitz D. G. P-MO-086
Kuppermann B. D. SA-22
SA-22-01
MO-68-04
TU-18-04
TU-47
Kuri J. V. MO-15-09
Kurihara T. TU-36-05
Kurimoto Y. P-TU-225
Kuriyama S. P-SA-097
Kurli M. P-TU-111
Kuroda S. SA-31-07
Kurtenbach A. P-SA-152
Kurtz A. P-SU-268
Kuruca S. E. P-SA-128
Kurup S. K. SU-79-06
MO-67-03
MO-79-03
Kurz H. SU-17-08
Krzinger G. R. K. P-SA-193
P-MO-184
P-TU-215
Kusano M. P-MO-230
P-TU-004
Kstner M. SU-80-04
Kusuhara S. P-MO-213
P-MO-254
Kuwahara T. P-SA-232
Kuznetsova T. P-SA-203
Kwag J. H. P-TU-054
Kwag T. Y. P-TU-054
Kwok K. P-SU-097
Kyari F. P-SU-064
Kychenthal A. WE-29-04
Kymes S. M. MO-52-03
P-TU-060
Kyomoto T. P-SU-053
L
Labb A. WOC-C-47-02
Lacey J. SU-05
SU-05-02
Lackerbauer C.-A P-SA-051
P-SA-202
Lackner E.-M. P-TU-207
Laganovska G. MO-25
P-SA-209
Lagrze W. A. SA-47-01
SU-72
SU-72-03
P-SA-088
WOC-C-55-02
WOC-C-55-05
Lagua M. TU-82-07
Lai F. P-MO-014
Lai M.-S. P-SU-065
Lai T. MO-02-03
MO-56
MO-56-08
P-SA-252
P-SA-260
P-TU-202
Lai W. W. MO-43-06
Laidlaw D. A. H. SU-49-04
Lala C. P-SU-048
Lally S. P-TU-090
Lam W. C. SU-41-02
P-MO-241
Lamard M. SU-36-01
Lambert S. R. TU-07-03
Lammer J. MO-27-02
Lammersdorf K. P-TU-183
Lamminen H. SU-30
SU-30-03
Lamoureux E. P-SA-140
Lamparter J. P-MO-033
P-MO-045
Lan C. P-SA-252
Landa G. MO-27-03
P-SA-180
P-TU-216
P-TU-224
TU-37-09
Landau K. SA-38
SA-38-01
SU-23-03
SU-61-08
TU-08
TU-08-05
WE-11-06
P-TU-049
Landgren B. P-SA-102
Lang G. E. MO-02
MO-02-08
SA-43-05
TU-11
TU-36-07
TU-46
TU-81-02
P-MO-182
P-SA-193
P-TU-215
WOC-AAD-C-
01-01
WOC-AAD-C-
01-01
WOC-AAD-C-
01-04
WOC-AAD-C-
01-05
WOC-C-32
WOC-C-32-01
Lang G. K. SU-45-03
SU-53
SU-53-03
SU-54
SU-56
SU-79-07
TU-46
TU-81-02
P-MO-025
P-MO-141
P-MO-159
P-MO-182
P-MO-277
P-SA-050
P-SU-200
P-SU-235
P-TU-033
WOC-C-51
Lang G. L. P-MO-184
Lang M. P-TU-093
Lang S. P-TU-215
Lange C. MO-67-04
Langenbucher A. SA-19-01
WE-03-04
P-SA-146
P-MO-029
P-SA-112
P-TU-006
P-TU-007
Langer P. D. TU-27
TU-27-01
TU-27-06
Langman M. E. SU-37-08
Langmann A. SU-23-04
Langmann G. Po-TU
Langwinska-Wosko E. P-SA-091
Lankenau E. MO-79-04
Lanzetta P. P-SA-212
Lanzl I. M. MO-26
MO-26-03
MO-26-04
P-TU-180
TU-33-06
TU-35-05
Lappas A. TU-34-04
Larkin D. F. P. TU-20
TU-20-02
390
WOC
2010
A
u
t
h
o
r

I
n
d
e
x LaRoche R. SU-52-03
Lascaratos G. P-TU-148
P-TU-150
P-TU-146
WE-34-03
Laspas P. P-SU-104
SA-28-06
Laties A. M. WE-41-09
Latinovic S. P-SU-048
TU-02-01
Latr I. P-SU-155
Lautebach S. P-MO-038
Lavinsky D. P-SA-274
Lawn S. P-SU-072
Lawrence L. WOC-C-59-01
WOC-C-59-06
Lay Leng S. SA-44-03
P-SA-217
Lazutina E. TU-81-07
SU-75-10
Leach N. TU-21-06
Lebrilla C. P-SU-085
Lebuisson D. A. TU-80-09
Lechner T. P-MO-102
Lee A. G. SA-38
SA-38-04
SU-29
SU-29-04
MO-41-06
MO-42
MO-42-01
MO-42-04
TU-08-02
TU-08-05
Lee B. R. SU-45-02
SU-80-07
SU-81-05
P-MO-200
P-TU-184
P-TU-193
TU-29-07
Lee H. P-TU-142
Lee J. P. MO-09
MO-09-04
TU-59-03
Lee J.-y. P-MO-118
Lee P. MO-52
MO-52-01
Lee P.-J. P-SA-105
Lee S. Y. P-MO-084
Lee S.-B. P-MO-118
Lee S.-M. P-SA-105
P-SA-114
P-SU-015
Lee T. MO-77-03
Lee V. Y. W. WE-19-08
P-MO-192
Lee W.-K. MO-56-04
Lee Y. P-TU-234
Leese G. P. TU-29-03
Lehmann M. P-SU-254
LeHoang P. MO-76-09
Leito P. MO-73-02
P-MO-050
Lekskul A. P-SA-223
P-SA-223
Le Mesurier R. WE-16-02
Lemke J. P-SA-088
Lemmen K.-D. SU-76
SU-76-05
TU-09
TU-34
Lemp M. A. WE-22-05
Lenz B. SA-28-08
Leon-Gonzalez N. P-TU-110
Leon-Perez N. P-TU-110
Leonardi M. WE-13-06
Ler D. P-TU-105
Lerner F. TU-43-05
Lesauskaite V. P-SA-204
Leung D. Y.-l. SA-28-03
Leung Y. L. D. SA-12-06
Levanova O. P-MO-095
Leverkus F. P-MO-072
Levinson R. D. SA-40-04
TU-47-04
Levitsky I. P-MO-238
Levold F. MO-79-01
Levy C. SA-09-05
Levytska G. P-MO-238
Lewallen S. SA-37-04
SA-48-03
P-MO-087
Lewando-Hundt G. WE-40-07
Lewczuk P. P-SU-098
Leys A. MO-02
MO-02-02
Li B. P-SU-088
SU-41-04
Li C. TU-36
Li C.-L. P-MO-192
Li G.-Y. P-SU-103
Li H. MO-73-09
Li J. P-SA-231
P-SU-133
P-SU-227
Li Q. WE-39-06
Li R. SU-47-04
Li W. P-SU-254
Li X. SA-34
SA-34-07
MO-56
MO-56-06
Li X. MO-74-02
P-MO-018
P-MO-265
SU-37-04
Li X. X. SU-74-07
Li X.-Y. MO-32-01
Li X.-Y. MO-32-02
MO-68-04
Li X.-Y. MO-75-04
P-MO-198
TU-32-01
Li X.-Y. TU-35-11
Li Y. MO-75-07
P-SU-088
Li Y. SU-56-01
SU-62-04
Li Z. MO-67-06
Liakopoulos S. P-SA-165
P-SA-198
Liang H. P-MO-076
Liang Q. P-SU-070
P-TU-256
TU-31-04
Liang S. P-SA-001
P-SA-007
Liao X. WE-39-06
Liazos S. P-MO-217
Lichtenberg S. P-SA-148
Lichter P. SU-20
SU-20-04
SU-21
Lichtme A. P-MO-039
Lieb W. E. Po-SU
Liebmann J. M. MO-13
MO-31-11
Liegl R. P-MO-233
P-SA-173
P-SA-202
TU-25-08
Liehneova K. P-SA-048
P-SA-049
SU-75-02
Liekfeld A. Po-MO
WOC-C-56-01
Liesegang T. J. MO-21
MO-21-06
Lietman T. M. TU-71-06
Liggett P. TU-45
Lightman S. TU-35-11
TU-65
TU-65-02
P-SA-236
P-SA-244
P-SA-268
P-SA-281
P-SU-009
P-SU-110
LS-08-05
Lim H. T. P-TU-142
SU-55-06
Lim L. SA-15-03
Lim L. MO-35-05
P-SU-047
Lim L. TU-81-09
Lim S. MO-65-02
Lim S. C. P-MO-169
Lim T. H. MO-32-04
Lima L. H. P-SA-172
SA-32-04
Limberger I.-J. P-TU-008
Lin X. P-SA-221
Lin A. P-SU-088
Lin C.-P. TU-78-03
P-MO-090
Lin J.-C. P-SU-065
Lin J.-E. C. MO-67-02
P-TU-199
Lin M. P-SU-193
Lin P.-Y. P-SU-067
Lin T. MO-75-07
P-MO-071
P-TU-199
Lin X. P-SA-216
Lincoff H. WOC-C-62
WOC-C-62-05
Lincoln V. A. C. P-MO-101
Lindell J. SU-38-04
Lindfield R. WE-16-04
WE-16-06
Lindig A. P-SU-175
Lindsell B. MO-08-08
Lingenfelder C. P-MO-240
P-TU-031
Link D. P-SA-145
P-SA-147
Linke S. P-SA-082
P-SU-271
Linke S. SU-75-05
Lipener C. TU-21-04
Lipshitz I. SA-05-03
SA-32
SA-32-08
P-MO-227
Lisboa J. MO-73-02
P-MO-050
Lisch W. SA-18
TU-81-02
Lisochkina A. MO-68-06
P-SA-203
TU-33-07
391
WOC
2010
A
u
t
h
o
r

I
n
d
e
x Little B. TU-46-02
Liu A. MO-76-08
P-MO-136
Liu C. MO-22-08
MO-75-05
P-MO-198
Liu C. J.-L. P-SA-105
P-SA-114
P-SU-067
Liu C.-C. MO-68-04
Liu C.-c. P-MO-071
P-TU-059
TU-30-02
TU-30-03
Liu C.-M. P-SU-059
Liu D. P-SA-093
P-SU-222
Liu D. T. L. P-MO-192
Liu F. P-SU-088
Liu H. MO-74-09
Liu J. WE-13-02
Liu J.-H. P-SU-059
P-SU-067
Liu N. MO-75-09
Su-54-04
Su-54-04
Liu N. P. SA-25-03
Liu P. P-MO-136
Liu Q. P-SA-092
SU-56-05
Liu R. SU-17-10
Liu S. SA-20-04
Liu W. SA-32-03
TU-47-06
Liu X. P-SA-138
Liu Y. TU-24-05
Liu Z. WE-35-08
Liutkeviciene R. P-SA-204
P-SU-178
Livchits L. P-SA-098
Liveikiene A. P-SA-181
Livingstone B. I. P-SU-134
P-MO-280
P-SA-199
Ljutica M. P-SA-220
Lo L.-C. P-MO-090
Loewenstein A. MO-16-05
MO-32
MO-32-02
MO-50
MO-50-02
MO-68-04
MO-32-01
MO-75-04
TU-32-01
WE-35-04
LS-08-06
Lffler K. U. SU-12
MO-43
MO-44
P-SU-006
Lohmann C. P. SA-32-10
SU-35
MO-27-04
TU-35-05
P-MO-146
P-MO-171
P-MO-205
P-SA-101
P-SA-233
P-SA-263
P-SU-111
P-MO-228
P-TU-120
P-TU-205
Lohmann D. SA-09
SA-09-01
Lohr A. P-SA-256
Lommatzsch A. TU-09-05
Lommatzsch P. K. SU-43-05
Longstaff S. MO-73-04
Looi A. P-SU-192
P-SU-216
P-SU-245
Loos D. P-TU-205
Loos Z. P-SU-104
Lopes M. d. F. SU-74-01
Lopez Galvez M. I. TU-35-09
Lopez-Lara F. J. SU-34-10
Lpez-Lizcano R. P-SA-266
Lopez-Prats M. J. P-SA-243
Lopez-Star E. P-SU-024
Lorenz B. SA-10
SA-45-01
SU-41
MO-04
MO-05
MO-06
MO-06-01
MO-07
MO-07-06
TU-07
TU-07-05
TU-55
TU-55-04
P-SA-246
P-SU-184
P-TU-152
P-TU-174
P-TU-186
Lorenz K. MO-73-10
P-MO-187
P-SA-190
P-TU-080
P-TU-211
TU-29-08
Lossbrandt U. SA-28-04
SA-28-04
Lotfi A. TU-81-04
Lou J. MO-68-04
Lou M. P-SU-022
Loukopoulos V. TU-37-04
Lovisolo C. F. SA-04-01
Lw U. P-MO-035
P-MO-278
P-SA-081
P-SU-276
Lowder C. Y. SA-41-04
MO-50-05
TU-35-11
P-SU-110
Loyet K. MO-68-05
Lu D. P-MO-167
Lu J. MO-25-07
Lu J.-m. P-SU-044
Lu N. TU-34-08
Lu W. SU-17-09
Lubatschowski H. SU-75-07
MO-38-03
Lubimova N. V. SU-41-07
Lucas T. P-SU-260
Luchs J. P-TU-059
Lchtenberg M. P-SA-224
Lucke K. TU-01
TU-01-02
P-SA-170
WOC-C-36-06
WOC-C-37-06
Luco C. SA-38
SA-38-03
SU-18
MO-81
MO-81-04
Ludescher M. P-MO-297
Ludgate M. SU-22-01
MO-82
Luedtke H. P-SA-002
Luhmann U. MO-67-04
Lukas J. SU-56-04
Lukauskiene R. P-SU-178
Lke J. P-TU-097
Lke M. MO-36-05
P-TU-097
P-TU-181
Lumbroso B. WOC-C-61-06
Lumi X. P-MO-231
Luna de Sampaio V. P-TU-262
Luna E. SU-74-01
Lundstrm M. SU-16
SU-16-05
MO-79-02
Luo M. MO-25-07
Luthert P. J. P-SU-009
Ltjen-Drecoll E. P-SU-099
Luyten G. SU-34-08
Lyia R. SU-40-06
P-TU-175
Lyngholm M. SU-47-03
Lynn W. A. P-SA-244
M
M. Dheepa P-MO-272
M. Chibisova J. SU-44-06
Ma K. P-SA-095
SA-25-03
Ma L.-b. MO-24-02
Ma Z. P-MO-105
P-TU-264
Maalouf T. P-SU-055
Maar B. MO-77-03
Macedo G. P-MO-115
Machackova M. P-MO-281
P-SU-155
Machalska M. P-TU-201
MacKeben M. P-SA-208
Mackensen F. SA-40
SA-40-05
SU-27-02
SU-27-07
MO-27-09
MO-76-03
TU-50-05
P-SA-241
Mackenzie G. E. WE-36-05
Mackert M. MO-35-04
Mackey D. MO-71-04
Mackiewicz J. P-SA-168
MacLaren R. E. SA-03
SA-36-06
TU-36
WE-14
WE-14-04
MacRae M. P-TU-146
P-TU-150
Madrigal R. TU-82-07
Mady S. P-SA-142
Maeda N. WE-21-05
Maeda T. P-MO-063
Maeda-Chubachi T. SU-55-05
Magalhaes Jr. O. MO-32-09
Magauran D. WE-16-04
392
WOC
2010
A
u
t
h
o
r

I
n
d
e
x Maggi R. P-MO-161
Mahajan s. P-SA-074
Mahatme V. P-TU-035
P-TU-042
P-TU-164
SU-41-08
SU-55-08
Mahendra M. SU-80-06
P-SA-005
P-SA-032
Mahendradas P. MO-67-03
Maher L. WE-16-01
Mahmood H. WOC-C-39
Mahmoud T. MO-24-09
Maia M. MO-32-09
P-SU-011
Maier A.-K. SU-27-07
P-SA-113
P-MO-015
P-MO-016
Maier M. MO-27-04
P-MO-146
P-MO-171
P-MO-205
P-MO-228
Po-MO
P-SA-101
P-SA-208
P-SA-233
P-SA-263
P-TU-205
SA-32-10
TU-35-05
Maier P. MO-30-01
SU-78-03
TU-19
TU-72-04
Po-SU
P-MO-038
P-SA-068
Majdanik E. P-SU-061
Majumdar M. SU-81-06
P-TU-055
Makeev O. G. P-SU-181
Maklakova I. SU-35-06
Makri O. P-MO-190
P-MO-214
Makrygiannis G. P-MO-259
Malaravan M. P-MO-070
TU-35-03
Malbrn E. SU-20-05
Malik A. P-MO-268
Malik K. P-SU-195
P-TU-040
Malinouskaya I. P-SU-269
P-TU-192
Malinowska U. SU-41-10
Mallipatna A. SU-41-11
SU-74-02
TU-40-09
Malov I. P-SU-062
Malyugin B. SU-14
SU-14-04
SU-45-04
SU-64-02
TU-46-04
TU-82
TU-82-11
WOC-C-12-06
Manaysay R. P-MO-081
Mandai M. P-TU-208
Mandal A. K. TU-43-04
Mandic Z. MO-25
WE-39-07
Manku K. P-SA-244
Mannan A. P-SU-071
Mannis M. P-SU-085
Mannsfeld A. P-TU-008
P-TU-018
Mannucci L. P-MO-017
P-SU-021
Manquez M. E. MO-77-09
TU-22-05
Mansberger S. L. SU-03-01
Mansour A. SU-81-07
MO-50-03
MO-67-03
P-MO-092
P-MO-275
P-SU-077
Mansouri I. P-TU-189
Manzanas L. TU-35-09
Mao X. P-MO-287
Marcellino G. R. P-MO-195
P-MO-174
Mardekian J. P-SA-100
Marie S. P-SU-208
Marn Lambies C. P-TU-210
Marnez-Giralt O. TU-29-05
Marinho A. A. P. MO-40-06
Marinkovic M. SU-34-08
Marin-Lambies C. P-MO-189
Marioneaux S. J. MO-81-06
Mariotti S. P. TU-71-02
Marius R. P-TU-107
Mark H. WOC-C-38
WOC-C-38-01
WOC-C-38-02
WOC-C-38-03
WOC-C-38-04
WOC-C-38-05
P-MO-096
Mrker D. A. P-MO-157
Markiewicz A. MO-78-02
P-TU-092
P-TU-128
Markowitz J. P-TU-090
Marsh I. P-SU-150
Marshall J. WE-02
Martin F. MO-69
MO-69-01
Martin G. P-SA-161
P-TU-246
Martin K. MO-53-03
P-TU-144
Martin L. TU-66-03
Martin T. SA-40-02
TU-17-01
P-SU-190
Martinez A. P-TU-188
Martinez E. P-MO-115
Martinez M. R. SA-25-09
Martnez Serrano R. E. P-MO-183
P-MO-250
P-TU-041
P-TU-131
Martinez-Castillo S. P-MO-189
Martinez-Castro F. P-SU-024
Martinova L. P-SA-151
Martins E. N. P-MO-282
Martius P. P-SA-077
Maruko I. P-MO-165
Marx-Gross S. TU-25-10
Mas A. S. P-TU-161
Masaki T. P-SA-047
Masayoshi K. TU-21-07
Mashayekhi A. P-TU-090
SU-34-09
Mason I. SA-37-06
Masood I. MO-73-04
P-MO-030
Massin P. MO-29-01
SU-50-02
Masuda A. P-MO-172
P-SU-121
Mata E. P-SU-083
P-SU-207
Mathenge W. SA-37-04
SA-37-06
SU-74-03
Matsuba T. P-TU-077
Matsuda R. P-MO-064
P-SU-158
Matsumoto C. P-SA-106
P-SA-109
Matsumura N. P-SU-255
Matsunaga Y. P-SU-158
Matsuoka M. P-SA-159
Matsushita K. P-TU-069
TU-30-07
Matsuura T. P-MO-138
P-SU-037
Matsuyama K. P-SA-159
Matt G. MO-67-07
Matthaei M. P-TU-056
P-TU-073
WE-39-02
Matu C. P-SU-005
Matveeva I. WE-35-02
Maudgil A. P-TU-160
Maumenee I. H. TU-55
TU-55-01
Mavija M. P-TU-230
P-TU-240
Mavija Z. P-TU-230
Max R. MO-27-09
SU-27-02
May F. P-SU-055
Maychuk N. SU-36-04
Mayer C. P-MO-171
P-TU-120
Mayer C. F. P-TU-022
P-TU-207
Mayer E. J. P-SU-252
Mayer W. MO-35-04
P-SA-051
P-SA-178
P-TU-021
WE-34-06
Maynart Tavares I. P-TU-206
Mayorga Argaaraz E. MO-41-02
MO-42-06
MO-44
MO-44-01
Mazzotta C. P-SA-071
SU-35-03
McCannel C. A. MO-44-08
McCannel T. MO-77-05
McCluskey P. TU-65-05
TU-73
TU-73-07
McCluskey P. P-SA-244
McCormick S. A. P-TU-111
McCranor L. TU-30-06
McDonald M. MO-38-06
WE-02
WE-02-07
McDonnell P. TU-78-07
TU-80
McElvanney A. P-MO-295
McKeown C. MO-78-01
McLauchlan R. P-MO-195
McMeel J. W. P-MO-049
McNamee P. TU-29-03
393
WOC
2010
A
u
t
h
o
r

I
n
d
e
x McRae S. SU-60
Md Din N. P-SU-020
P-TU-063
Medeiros F. A. MO-22
Medina N. H. SU-74-01
Medoruma I. P-SA-120
P-SA-123
P-TU-067
Medoruma K. P-TU-067
Megzari A. P-MO-066
P-SA-141
P-TU-139
TU-31-05
Mehat M. S. P-SU-056
Mehdizadeh M. MO-73-08
Mehriar M. P-SA-278
Mehrotra A. P-SU-108
Mehrotra S. P-SU-108
Mehta A. P-SU-195
P-TU-040
Mehta K. R. TU-46-01
Mei H. P-MO-261
Mei L. P-SA-138
Meier M. MO-58-04
Meier P. TU-28-07
Meigen T. SU-11-02
Meindl A. SU-61-03
Melamed S. SU-38-05
TU-13-04
Melicher Larson J. P-SU-223
Melki S. A. WE-13-07
Melkonyan H. P-SU-103
Mellein A. C. P-MO-274
P-TU-066
Meller D. FR-01-20
SA-17
MO-49-04
WE-05
WE-05-07
P-SU-038
P-SU-042
Melles G. R. J. SU-78-04
TU-05-07
TU-31-01
Meltendorf S. WE-37-06
Mly R. SA-14-06
TU-26
TU-26-04
Menapace R. SA-05
SA-05-04
MO-60-08
TU-03-02
P-TU-185
Mendoza C. SA-38-13
WE-20-01
Menghini M. P-TU-049
Menke M. SU-61-08
Mennel S. MO-67-09
P-MO-220
P-MO-253
Menon G. P-MO-211
Menon V. MO-79-06
P-TU-141
SU-44-07
Mensink H. W. SU-39-05
Mentkevich G. WE-35-02
Menz D.-H. P-MO-102
P-SU-179
P-SU-185
Merayo-Lloves J. TU-79-03
P-SU-086
Merchant A. SU-74-02
Merle H. TU-27-06
Mermoud A. SU-38-04
Merriam J. SA-32-04
Mert R.-L. P-TU-044
P-TU-083
Messias A. P-SA-144
Messinger J. D. P-SU-251
Messmer E. M. FR-01-02
SU-12-03
MO-35-04
TU-49
TU-49-05
TU-70
TU-70-02
WOC-AAD-C-24
P-SA-044
P-SA-067
Mestdagh P. P-TU-123
Mester U. WE-19
WE-19-07
Po-TU
Metz C. P-SA-239
Metzger L. P-TU-187
Meyer C. P-SU-268
Meyer C. H. SA-25-07
TU-29-10
MO-32-09
MO-67-09
Po-SU
P-SA-158
P-SU-011
P-TU-227
Meyer K. P-TU-243
Meyer M. MO-75-10
P-SU-220
Meyer M. W. P-SU-100
P-TU-048
Meyer T. P-MO-151
Meyer-Rsenberg B. P-SA-182
P-SA-184
P-SA-185
P-SA-189
Meyer-
Rsenberg H.-W. SU-42
MO-78-10
TU-06
TU-06-03
P-SU-226
P-SU-248
WOC-C-52
Meyer-ter-Vehn T. P-SU-013
Michael S. SU-35-01
Michaelis M. MO-32-10
Michalewska Z. MO-27-05
TU-33-10
Michalewski J. MO-27-05
P-MO-207
TU-33-10
Michalik R. P-SU-153
Michalik-Wjcik A. MO-78-02
Michalke B. TU-37-05
Michelle T. SU-44-04
Michels R. SU-61-08
TU-29-06
Michels S. MO-67-09
P-SU-027
P-TU-177
TU-29-06
Michelson G. SA-29
SA-29-05
SU-62
MO-53
Midelfart A. P-SU-016
Midena E. MO-18-04
WE-23-04
Midori Yabiku M. P-SA-271
Mieler W. F. SA-25
SA-35
SA-41-08
SU-20-09
MO-02-04
MO-16
MO-16-02
MO-72-02
WOC-C-62-04
Mielniczuk E. P-MO-056
Migdal C. MO-54
LS-17
Mihnea M. P-TU-107
Miki A. P-TU-069
TU-30-07
Miki N. P-TU-195
Milenkovic S. P-TU-230
P-TU-240
Milenkovic V. P-MO-157
P-SU-268
Miliauskaite L. P-SA-116
Miller J. MO-63-06
Miller M. SU-55
Miller N. MO-73-03
P-SU-125
Miller W. TU-21-06
Milman T. P-TU-109
P-TU-111
Milojcic C. P-SA-195
TU-33-02
WE-34-04
Mimura O. P-SU-121
P-SU-135
Minami M. P-MO-264
Minavi A. TU-21-06
Minoshima S. P-TU-129
Mintz-Hittner H. A. MO-04-07
Miraglia O. TU-21-03
Mira-Lorenzo X. P-SU-024
Miranda Hernandez I. P-SA-023
Mirlay R. P-SA-016
Mironow A. MO-73-03
Mirsakhanova H. P-TU-135
Mirshahi A. MO-28-07
P-TU-211
TU-29-08
TU-63-10
Mirsoev S. P-SA-042
Misailovic K. P-TU-071
Misefari W. SA-10-03
Miserocchi E. SA-08-07
Mishev L. P-TU-039
Mitchell P. SA-12-01
SU-73-03
MO-03-01
MO-56-09
TU-35
WE-36-03
WE-38
WE-38-02
WE-40
P-SU-051
Mito T. P-MO-011
Mitra A. K. WE-15-04
Mitsch C. P-TU-232
Mittelviefhaus H. SU-81
P-TU-047
Mittica P. P-SA-137
Mittica V. P-SA-137
Miura H. P-MO-178
Miura Y. P-SA-186
TU-36-08
Miyagawa Y. P-MO-193
Miyahara T. P-MO-266
P-SU-053
394
WOC
2010
A
u
t
h
o
r

I
n
d
e
x Miyake A. P-MO-011
Miyake K. SU-20-08
Miyamoto C. P-MO-282
Miyamoto N. P-TU-225
Miyamoto T. P-SA-232
TU-31-10
Miyamura N. P-MO-247
P-MO-256
Miyata N. SU-80-05
P-SU-219
Miyazaki D. P-MO-011
P-SA-279
Mizariene V. P-SA-204
Mizoguchi T. P-SA-103
Mizokami J. P-SA-131
P-SA-154
Mladenovic J. P-SU-176
Mbius H. MO-28-09
Mochizuki K. P-SA-107
P-SA-136
Mochizuki M. TU-47-03
TU-60-06
P-MO-188
P-SA-097
P-SA-229
Mdis L. TU-72
TU-72-05
Moeller C. P-MO-098
Mohamad C. M. P-SA-275
Mohamed A. M. P-SU-050
Mohamed M. MO-74-08
P-TU-179
P-TU-182
Mohamed S. TU-35-07
Mohammadi S. P-SU-165
Mohammed I. TU-81-07
SU-75-10
Mohan R. R. MO-47-03
Mohd Rawi N. A. P-SA-275
Mhle F. P-MO-151
Mohney B. SU-55-10
Mojon D. SU-23
SU-72
SU-72-01
MO-66
MO-66-01
MO-66-03
WE-20
Po-TU
Mokaddam A. P-MO-275
Molchanyuk N. P-TU-166
Mollayes G. P-MO-092
Monnet D. MO-11-01
Montemagno C. MO-47-09
Montenarh M. P-SU-265
Montn C. P-SU-083
Montuoro A. P-SA-164
Moon N. J. P-MO-284
P-SA-219
Moore A. T. WE-35
Moorthy B. SU-55-09
Mooy C. M. SA-43-06
Moraes N. P-TU-188
Morales P. H. SU-64-04
Morawski K. P-SA-183
Morax S. MO-34-07
Mrchen M. P-MO-083
Moreno L. P-MO-099
TU-80-08
TU-82-07
Moreno-Nadal M. A. P-SA-119
Morfeld P. P-MO-039
Morgan C. P-SU-071
Mori S. P-MO-043
P-SA-126
Morita H. TU-32-03
Morita I. P-SU-182
Moriyama A. S. P-MO-098
Moriyama M. P-MO-188
P-SA-229
P-SU-182
SU-56-03
Morkhat M. P-MO-053
P-TU-190
Morkhat V. P-MO-053
P-TU-190
Morlet N. WE-40-09
Morris R. J. P-MO-272
SU-62-03
Morse L. P-SA-211
Morsy M. TU-25-06
Mortada H. MO-70-02
SU-68-04
TU-01-05
WE-28
WE-28-05
Morton J. WE-40-08
Mosallaei M. P-SA-278
P-TU-136
Mosca L. P-SA-062
Moschos M. P-MO-035
Moshfeghi A. WE-40-08
Moshfeghi D. TU-54-03
WE-40-08
WOC-C-57-02
Mosqueda P. SA-25-09
Mossbck G. P-SA-135
Moster M. MO-65-04
Mosuro A. WE-16-08
Motamedi M. J. P-SU-165
Motizuki M. P-SU-182
Motolese E. P-SA-137
Motolese I. P-SA-137
Motschmann M. P-SA-162
Mouhdi H. S. P-TU-189
Moussa S. P-TU-176
Moustafa M. P-SA-230
Moutsouris K. TU-31-01
Mrochen M. SU-60
SU-60-06
MO-38-04
Mrsic J. P-SU-152
Mrukwa-Kominek E. SU-75-01
P-MO-022
P-MO-056
P-MO-109
P-MO-162
P-TU-171
P-TU-201
WOC-C-46
WOC-C-46-02
WOC-C-46-03
Mrvos-Cobeljic D. P-SU-176
Muacevic A. P-TU-091
P-TU-096
Muccioli C. SU-27-08
MO-32-06
WE-30-01
P-TU-206
Mucke E. P-SU-010
P-SU-018
Mucke H. P-SU-010
P-SU-018
Mucke P. M. P-SU-010
P-SU-018
Mueller A. P-SU-188
P-TU-263
SU-74-03
WE-16-02
Mueller I. WE-41-03
Mueller M. P-SU-023
P-TU-075
Mueller S. P-TU-181
Muhd Zafran bin
Shamsudin M. Z. TU-35-10
Muhit M. MO-51-04
Muhovic-Bejtic J. P-TU-105
Mukherjee B. P-SU-244
SU-37-09
Mukherjee R. P-SU-189
Muldoon T. MO-27-03
P-SA-180
P-TU-216
TU-37-09
Mller A. SA-27-02
Mller A. M. P-SU-006
Mller B.-K. P-SU-179
Mller H. MO-48-03
Mller M. SA-31-04
MO-79-04
WE-10-05
WOC-C-14
WOC-C-14-04
WOC-C-37-05
Mulvihill A. P-TU-150
P-TU-148
Munana J. SU-74-03
Munch I. C. SA-32-05
Mundorf T. K. P-MO-071
P-TU-059
TU-30-02
Mundt H. W. TU-57-01
Munier F. SA-09-02
SA-18
SA-18-01
Munk M. MO-68-03
P-SA-200
Muoz M. F. SU-34-11
Muoz-Negrete F. P-SU-132
Muqit M. P-MO-174
P-MO-195
Muraine M. TU-04-03
Murakami A. P-SA-087
P-SU-052
Murakami Y. TU-54-04
Murata T. P-MO-266
P-SU-053
Murenzi J. SU-74-03
Murillo-Correa C. SU-61-04
Murjaneh S. TU-25-01
Murotani E. P-SU-141
P-SU-159
Murray A. MO-69-02
TU-67-06
TU-68-03
Murray P. I. MO-11-08
TU-47
TU-83
WE-30
WE-30-05
Murray T. G. SA-25
MO-77-08
TU-22-06
TU-45-06
Murta J. N. MO-57-02
TU-76-03
WE-11-07
Murthy G. V. S. SU-74-05
Murube del
Castillo D. J. TU-41-09
TU-79
TU-79-01
Mylonas G. MO-32-07
P-TU-028
395
WOC
2010
A
u
t
h
o
r

I
n
d
e
x N
Nadal J. WOC-C-40
WOC-C-40-01
WOC-C-40-02
WOC-C-40-05
Nadarajah S. P-TU-170
Nadras I. P-SU-134
Nafie I. P-SA-142
Nagai T. P-MO-213
Nagaoka T. P-MO-153
Nagasaka E. P-SU-146
Nagata M. SA-31-07
Nagel E. P-TU-194
Nagel J. MO-79-07
Nagel J. A. MO-79-08
Nagori S. SU-34-09
Nagpal P. N. SU-20-06
Nagy A. P-SU-028
Nagy Z. Z. TU-72-03
Nahen K. WOC-C-31-02
Nahra D. P-SA-006
Naidoo K. SA-37-02
SA-48-05
WE-36
WE-36-06
Naik R. K. P-SU-110
Najm-Tehrani N. SU-74-02
Naka M. MO-73-05
P-SA-131
P-SA-154
Nakabayashi S. P-MO-153
Nakada C. SU-56-03
Nakagawa Y. P-TU-231
Nakaizumi A. P-MO-264
Nakamoto H. SU-38-07
Nakamoto K. P-SA-115
Nakamura H. P-MO-043
P-SA-126
P-TU-067
Nakamura K. P-SA-037
Nakamura M. MO-73-05
P-SA-131
P-SA-154
Nakamura S. P-TU-252
Nakamura Y. P-SA-123
Nakanishi H. P-MO-043
P-SA-097
P-SA-126
P-SA-167
P-TU-172
Nakano N. P-MO-043
P-SA-126
Nakao S. P-TU-220
Nakao T. P-SU-255
P-SU-262
Nakata I. P-SA-097
P-SA-167
Nakayama M. P-MO-064
Nakazawa M. P-MO-193
P-SA-015
Nan B. WE-40-02
Naranjo-Tackman R. SA-02-02
Nardi M. SU-37-05
Narendran K. WOC-C-58-06
Narendran V. WOC-C-58
WOC-C-58-01
WOC-C-58-03
Narita A. P-TU-072
Nasaruddin R. A. P-SA-259
Nascimento H. P-MO-023
Nasri A. SU-81-07
Nasser Z. SU-41-02
Natalia V. P-TU-175
Natarajan S. MO-81-05
WE-28-04
Natesh S. MO-67-10
P-TU-109
P-TU-111
P-TU-218
Nau J. TU-34-10
Naumann G. O. H. SU-56
TU-68
P-TU-127
Naumenko L. P-TU-088
Naus N. SU-39-05
Naval C. I. WE-34-07
Nawrocka L. P-MO-162
Nawrocki J. MO-27-05
TU-01-04
TU-33-10
TU-77-10
Naycheva L. P-SA-155
Nechiporenko P. MO-68-06
P-SA-203
TU-33-07
Nefedova D. SA-28-07
Negi A. MO-73-05
P-MO-213
P-MO-254
P-SA-131
P-SA-154
Negishi T. P-SA-215
Neidhardt J. P-SA-088
Neira W. TU-80-05
Nelson S. F. MO-77-05
Nmeth J. SU-28
SU-37
TU-02
TU-02-06
Nentwich M. M. P-TU-091
SU-34-06
SU-61-03
WE-16-03
P-TU-096
Neophytou P. SU-35-01
Nerad J. P-SU-223
Nesnas K. P-MO-211
Ness T. SU-27-07
MO-50
MO-50-04
Netto C. SA-28-02
Netukova M. P-SA-048
TU-31-07
Neubauer A. MO-75-03
MO-75-08
P-MO-210
P-MO-233
P-MO-271
P-SA-173
P-SA-202
P-SU-186
P-TU-191
P-TU-228
P-TU-237
SU-38-01
TU-33-03
TU-34-11
Neuburger M. P-MO-038
TU-63-06
Neudorfer B. SU-61-06
Neugebauer A. SA-45
SA-45-04
Neuhann I. MO-16-06
Neuhann T. P-MO-124
SU-47-05
Neuhann T. F. SA-13
SA-19-03
SA-26
SU-13
SU-13-01
MO-37
MO-37-01
TU-03-04
TU-24
TU-46-01
TU-75-03
Neutzner R. V. P-TU-174
Newman D. P-MO-197
Nezgoda J. P-TU-216
Ng H. K. P-SU-222
Ng J. WE-40-09
Ngah N. F. P-SA-272
Ngai J. W. S. P-TU-108
Ngo-Tu T. P-MO-142
Nguyen N. X. TU-14
TU-14-01
Nguyen Q. D. SU-27-03
MO-01
MO-03-04
MO-32-09
MO-46-02
MO-75-06
TU-29-09
WE-35
Nguyen T. P-SU-036
Nicholson E. P-SU-252
Nikolic S. WOC-C-36-05
Ninios K. P-SU-276
Nischal K. K MO-05
MO-05-02
Nishi M. MO-57-04
Nishi O. TU-75
Nishida K. SU-17-06
Nishida T. P-MO-064
Nishiguchi K. M. P-SU-270
Nishikawa N. P-SA-282
Nishimura M. P-SU-121
P-SU-135
Nishina S. P-SU-124
P-TU-200
P-TU-222
Nitta N. TU-32-03
Nix G. P-SA-044
P-SA-067
P-TU-010
SA-26-06
Nkomazana O. P-TU-103
Nkumbe H. SA-37
SA-37-01
SA-37-04
SA-37-07
Nobrega M. J. MO-32-06
Noh Y. P-TU-234
Nlle B. SU-27-10
Nomoto H. P-SA-020
Nonaka A. P-MO-043
Noonan C. P-SU-150
Norbert P. P-TU-147
Noske W. WE-39-08
Notara M. FR-01-16
Novk J. P-TU-025
Novak Laus K. WE-39-07
Nowak M. MO-68-09
Nowinska A. MO-35-03
SA-31-03
Ntountas Y. SU-71-04
Nuijts R. SU-15
SU-15-02
SU-58-04
TU-82-10
396
WOC
2010
A
u
t
h
o
r

I
n
d
e
x Nukada M. P-MO-043
P-SA-126
Nusanti S. P-SU-126
TU-36-04
Nussenblatt R. SU-31
SU-31-06
MO-46
MO-46-01
MO-76-08
TU-17
TU-17-03
Nutheti R. SU-34-09
Nyaga P. T. P-MO-079
P-MO-088
O
Ober M. MO-75-03
P-MO-210
Oberacher-Velten I. MO-58
MO-58-01
P-MO-204
P-SA-124
Oberheide U. P-MO-144
SA-27-07
TU-82-09
Obholzer K. P-SA-173
TU-25-08
O'Brien T. SA-06
SA-06-01
Obstbaum S. A. TU-04
TU-04-01
Ochiai M. P-SU-107
Ocklenburg C. TU-32-05
Odrobina D. MO-27-05
Oehler S. TU-80-03
Oelckers S. MO-79-04
Oestreicher J. SU-71
SU-71-01
MO-78-09
Oetoyo A. S. P-SU-091
Ofner J. TU-37-06
Oganesyan O. P-SA-045
Ogata N. P-SA-159
Ogun O. A. WE-16-09
WE-41-08
Ogundimu K. SA-37-06
SU-74-08
P-TU-259
Ogundipe B. WE-16-09
Ogura Y. MO-01
TU-37-02
Oh D. H. P-MO-284
P-MO-296
Ohashi Y. P-MO-011
Ohba S. P-SU-124
Ohishi M. P-SU-089
Ohji M. SU-48-07
Ohkubo S. P-SU-141
P-SU-159
Ohno K. P-SA-097
Ohno S. TU-73
TU-73-05
WE-30-02
Ohno-Matsui K. MO-01-01
MO-24
P-MO-188
P-SA-229
Ohrloff C. P-SU-041
Ohtsuki H. P-SA-222
Oi A. P-MO-068
P-MO-089
P-SA-017
Ojima A. P-MO-165
Okada A. A. TU-73-08
Okada E. SU-80-05
P-SU-219
Okajima Y. P-MO-027
Okamoto F. P-MO-163
P-MO-172
P-MO-235
P-MO-239
P-SA-150
Okamoto Y. P-MO-163
P-TU-220
Okazaki Y. P-TU-195
OKeefe M. MO-07-02
Oki S. P-SA-004
P-SA-037
Okimoto S. P-TU-070
Oku H. P-SU-257
Okuda T. P-TU-068
Okunuki Y. P-SA-247
Okuyama M. P-SU-124
Okuyama S. P-SA-106
P-SA-109
Olali C. MO-31-08
Olawoye S. WE-16-09
Oldak M. P-SA-091
Ole dzka G. P-SU-026
Oleksy P. P-MO-175
P-MO-267
P-TU-085
Oleszczuk J. P-MO-028
Olfa H. T. P-SA-249
Oli Mohamed S. P-SA-272
Olivares C. Q. WE-34-07
Oliveira Neto H. MO-32-06
P-TU-036
Olivier J. MO-31-05
Olivier M. M. G. MO-81-01
Olsen T. TU-10
TU-10-04
Olson J. SA-29
Olson J. SU-62-06
Olson J. A. TU-29-03
Olson R. J. MO-25-04
TU-68
TU-68-06
Oluleye T. WE-16-09
Olusanya B. SU-74-04
WE-16-09
Omae T. P-MO-153
Omarganova I. P-SA-160
Omran M. S. SU-55-02
Ondas B. P-SA-192
Ondiveeran V. R. TU-14
TU-14-03
Oner F. H. P-MO-234
Ong L. MO-26-06
Ono K. P-SU-052
Onyango O. M. P-MO-079
P-MO-088
Oohashi H. P-SU-114
Ooi A. P-MO-258
Oono K. P-SU-182
Ooto S. P-SA-167
P-TU-172
Ophir A. SA-25-09
Ophthalmic PDT
study group P-SA-191
Oppermann T. P-MO-164
Orapiriyakul L. P-SA-117
Orgl S. TU-16
WE-13-05
Orikasa H. P-SU-089
Orilla W. P-TU-199
Orozco M. SU-42-07
Orzekowsky-
Schroeder R. P-SU-031
P-SU-034
Osaki M. P-SU-208
Osaki T. P-SU-208
P-SU-208
Osborne N. N. TU-15-01
Oshika T. P-MO-163
P-MO-172
P-MO-235
P-MO-239
P-SA-150
ES-05-03
Oshima Y. TU-30-07
Osma I. P-TU-014
Ossma-Gomez I. L. MO-15
MO-15-03
SU-13-05
Oster S. SU-38-01
TU-34-11
Otani A. P-SA-167
P-TU-172
Otani F. P-MO-011
Otani T. P-SA-242
P-TU-233
Othman O. MO-74-08
P-SA-275
P-SU-020
P-TU-063
Otsuji T. P-SA-159
Otterbach F. P-SU-042
Ouazzani Tnachri B. P-TU-189
Owoaje E. SU-74-04
Owoeye F. WE-35-01
Ozaki M. P-SA-097
Ozawa S. P-SA-175
Ozcan S. P-SU-085
zkan S. B. MO-09
MO-09-05
zlgedik S. P-MO-015
P-MO-016
Oztura I. P-TU-061
ztrk C. SA-31-06
Ozturker C. P-SU-198
zyurt O. SA-31-06
P
Paco I. P-TU-105
Paetzold J. P-SA-106
Pahor D. MO-26
MO-26-02
Po-SA
P-MO-012
P-TU-058
Pajaujis M. P-MO-091
Pakalnis V. A. TU-28-02
Pal D. SU-81-02
MO-31-03
P-MO-145
P-MO-298
TU-13-06
Palanker D. TU-54-01
Palis G. MO-41-05
MO-42-03
MO-44-04
Palkovacs E. P-SU-142
Palls C. P-TU-074
TU-63-02
Pallerla S. SU-73-09
Pallikaris I. G. TU-76-06
WE-02-04
Palomino C. MO-15-04
Pampucha V. P-SA-098
397
WOC
2010
A
u
t
h
o
r

I
n
d
e
x Pan Y. MO-25-07
Panagakis G. SA-32-02
Panagis L. P-SU-122
Pande C. P-TU-042
Pande M. SU-13-04
Pandova M. SU-73-01
Pang C. P-SA-093
Pang C.-P. MO-56-02
P-SA-252
Panidou E. P-SA-253
Panos L. TU-36-06
Pantenburg S. P-TU-248
Papanikolaou T. P-MO-197
Paques M. SU-01-04
Paranhos J. P-SA-046
P-SA-086
Paranhos Jr. A. P-SA-102
Pardo D. P-MO-097
Pardo-Lopez D. P-SU-169
P-SA-266
Paredes I. P-MO-081
Parhovchenko E. P-TU-173
Paridaens D. SU-39-05
Paris V. TU-59
Park C. K. SA-28-09
Park I. K. P-MO-296
Park K. H. SA-28-09
SA-30-04
Park K.-u. SU-47-01
Park S. P-SA-211
TU-32-07
Park S. C. SA-28-09
MO-47-08
Park S.-h. P-TU-162
Parlato Oliveira E. P-SU-112
Parrozzani R. WE-23-08
Parsa C. F. WE-41-01
Partsch M. P-TU-119
Parviz B. A. MO-47-01
Pascu R. P-MO-048
Pasiechnikova N. P-SA-098
Paskaleva D. SU-81-04
Pasquale L. R. MO-71-06
TU-16-04
WE-40-02
Pastuszka M. MO-68-09
Patel A. P-TU-046
Patel S. TU-80-07
WOC-C-46
WOC-C-46-01
WOC-C-46-06
WOC-C-46-07
WOC-C-46-08
Patel T. MO-73-04
P-MO-030
Patel V. D. P-TU-060
Patelli F. TU-01-01
TU-45-09
Paterson C. A. TU-27-06
Pathai S. P-SU-066
P-SU-072
Pattiata R. P-TU-104
Patton N. P-MO-174
P-MO-195
Pauk M. TU-81-03
Pauklin M. SA-17-07
P-SU-038
P-SU-042
Paul A. P-SU-189
WE-34-05
Pauleikhoff D. TU-09-05
TU-37
Paulig S. SA-27-05
Paulin Huerta J. M. SU-79-02
MO-15-08
Paulsen F. SU-63-02
P-SU-012
Paulsson M. P-SU-258
Paulus D. SU-30
SU-30-04
Pavesio C. SA-08
SA-08-02
MO-76-02
Pavlin C. J. MO-35-09
Pavlovskaya A. WE-35-02
Peckham C. SU-73-07
Pedanova E. MO-27-07
Pe'er J. SA-46
SA-46-01
SU-39
SU-39-07
SU-67
SU-67-08
MO-18-05
TU-22-07
Pefkianaki M. MO-76-10
Peh K. K. P-SU-191
Pelayes D. SU-43-06
WE-27
WE-27-04
WOC-C-50-01
Pellegrini G. MO-17
WE-05-02
Pemp B. P-TU-232
Pea D. P-SU-086
Pealoza-Roman I. P-SU-024
Peng J. Su-54-04
Penha F. M. MO-32-09
P-SU-011
Penha Morter
Rodrigues M. P-SU-084
Pepic A. P-SU-176
Pereyra-Munoz N. SU-61-04
SU-79-02
Perez B. MO-77-07
P-TU-110
Perez L. P-SU-199
Perez V. L. SA-17-02
Prez-Arteaga A. P-SA-009
TU-82-08
Perez Fernandez C. TU-35-09
Perez-Solorzano G. G. P-MO-078
Pericak D. P-MO-074
Perros P. MO-82
MO-82-01
Pertile G. P-SA-170
Perulasamy N. SA-24
SA-24-03
Peruzzi S. P-SA-137
Perz C. P-MO-146
P-MO-228
Pesavento R. MO-67-03
Pester A. P-SU-042
Pesudovs C. WE-01-03
Peters A. MO-28-01
Peters N. P-TU-204
Peters S. SA-31-04
MO-36-04
P-TU-075
Peters T. N. TU-62-01
TU-62-06
Petersen H. P-MO-191
Peto T. SU-62-01
TU-44-05
P-SU-064
Petousis V. P-TU-114
Petrarca R. TU-34-10
Petric Vickovic I. WE-39-07
Petroska D. P-MO-091
P-TU-084
Petrovski B. WE-35-09
Petrowitz B. P-SU-271
Petzold A. LS-04
LS-04-01
Petzold G. LS-04
LS-04-02
Pezzente M. SU-41-11
SU-74-02
Pfeifenbring S. SU-44-10
Pfeiffer N. SA-23
SA-24
SA-28-04
SA-28-06
SU-03
SU-03-04
SU-73
MO-13-07
MO-31-07
MO-73-10
TU-29-08
TU-36-03
TU-36-06
TU-41-10
TU-44
TU-44-03
WE-13
P-MO-033
P-MO-036
P-MO-039
P-MO-045
P-MO-049
P-MO-187
P-SA-111
P-SA-190
P-SU-094
P-SU-104
P-SU-194
P-SU-202
P-SU-204
P-TU-076
P-TU-080
P-TU-241
WOC-C-34
WOC-C-35
LS-17-01
Pfenninger L. TU-29-06
Pfirrmann K. P-SU-094
Pfister M. MO-32-10
Pfrommer S. P-MO-171
P-MO-228
SA-32-10
TU-35-05
WE-35-06
Pham D.-T. SU-14
SU-14-02
TU-82
WE-10
P-SA-026
Phamonvaechavan P. P-SA-226
Pharmakakis N. P-MO-214
P-MO-190
Philip S. SU-62-06
TU-29-03
Philipp W. P-SA-034
Philips R. P-TU-025
Phillips T. P-SA-211
Phuljhele S. P-TU-141
Pieczara E. P-MO-162
Pieh C. SU-23
SU-23-07
Pieh S. P-MO-110
SA-26-04
Piekarek M. P-SU-260
Pielen A. P-MO-236
P-SA-070
P-TU-248
TU-29-08
398
WOC
2010
A
u
t
h
o
r

I
n
d
e
x Pietras-Trzpiel M. P-MO-260
Pietrzycka J. P-TU-201
Pignatari A. C. P-MO-098
Pikulski Z. MO-27-05
Pilavas J. TU-37-09
Pillunat L. E. MO-73
WE-07
WE-07-08
WE-39-05
P-SA-139
LS-17-04
Pimenidi M. P-SU-087
Pias Garcia P. P-SU-147
P-TU-247
Pinazo-Duran M. D. P-SA-119
P-MO-047
P-MO-093
P-MO-160
Pinchuk L. SU-42-07
Piero Llorens D. P. P-SA-063
P-TU-010
P-TU-013
P-TU-024
SA-27-11
SU-35-07
Pinheiro Callou C. M. P-TU-262
Pinheiro Callou E. P-TU-262
Pinies J. A. MO-75-02
Pinter F. P-MO-271
Pinto L. A. WE-41-05
Piotrowski J. SU-55-10
Piovella M. TU-25-03
TU-41-04
TU-76-05
P-MO-106
P-MO-130
P-TU-012
P-TU-026
Piperno-Neumann S. SU-39-02
Pircher M. MO-27-01
MO-27-02
Pircher M. TU-37-06
Pisipati S. P-MO-044
P-MO-051
Pitz S. MO-82-03
WE-40
WE-40-01
WE-41-02
Po-SU
P-SU-194
P-SU-202
WOC-AAD-C-27
Pivetti P. TU-50-01
Pizinger K. P-TU-113
Plager D. A. TU-07-04
Plange N. P-SU-140
TU-63-05
Plant G. SA-38-07
SU-18
SU-18-06
SU-44
TU-08-04
TU-08-05
Planyavsky M. P-SU-188
SA-27-02
Plaza A. B. P-TU-010
P-TU-024
SA-27-11
TU-82-07
Pleyer U. MO-11-04
MO-74-06
SU-24
SU-24-04
SU-27-07
SU-33
SU-33-04
TU-20
TU-20-03
TU-38
TU-38-03
TU-47
P-SA-263
WOC-AAD-C-23
Ploski R. P-SA-091
Poelzl M. TU-80-06
Pogrzebielski A. MO-78-02
P-TU-085
Pojda-Wilczek D. P-SA-153
WE-37-05
Polling J. R. TU-59-06
Pollock A. SU-44-04
Pollreisz A. P-SU-188
SA-27-02
Poloschek C. P-SA-088
Poloski E. P-SU-137
Polyakov V. WE-35-02
Pomsathit J. P-SU-210
Ponce A. TU-37-09
MO-27-03
P-SA-180
P-TU-216
Ponomareva E. P-SA-151
Pons-Vzquez S. P-MO-160
Ponto K. A. P-SU-194
P-TU-080
Ponzin D. TU-19-03
Pop E. P-SU-005
Popa Cherecheanu A. P-MO-048
Poposka D. TU-29-05
Poposki V. TU-29-05
Portero-Benito A. P-SU-086
SU-34-10
SU-34-11
Porz G. P-SU-058
Posarelli C. SU-37-05
Pttgen J. SA-25-08
Pournaras C. J. SU-48-01
TU-34
TU-48
TU-48-03
Power I. P-SU-071
Po-Yen L. P-MO-219
Pozder S. P-TU-105
Prabowo R. P-MO-132
Prada J. P-MO-142
Prager S. G. P-TU-232
MO-32-07
Praidou A. MO-74-03
P-MO-248
P-SA-012
P-SA-276
P-SU-035
Prajna N. V. TU-24
TU-24-06
TU-57-02
Prakoso H. WE-17-05
Prapatjukkit P. P-MO-186
Pras E. P-SA-096
Prasad S. WOC-C-12-08
Prata T. S. P-SA-102
Prause J. U. SA-46
SA-46-06
SU-67-01
Preen D. WE-40-09
Prescott G. J. TU-29-03
Preuss M. WE-41-03
Preussner P.-R. SA-04
TU-82-04
P-MO-137
Price F. W. SU-78
SU-78-01
Price M. O. TU-05-05
Priglinger Jr. S. G. SU-17-07
SU-61-06
TU-25-07
TU-29-08
WE-27-02
Priglinger-Alge C. P-SA-178
Prilloff S. P-SU-162
Proena R. SU-73-04
Prokofyeva E. SU-73-05
Prokosch V. P-SU-122
Promesberger J. P-MO-108
P-MO-293
P-SA-052
Prnte C. TU-37-10
MO-67-07
P-SA-164
P-SA-196
WOC-C-15-05
Ptaszynski L. P-TU-196
Puccioni M. WE-33-01
Puchkov A. P-TU-173
Puchkova I. P-TU-173
Puech M. TU-10-03
Pulido J. S. SU-67-09
TU-53-02
Puranik S. P-TU-141
Pusey C. P-SA-268
Pushker N. P-SU-242
Pustolla N. P-MO-201
Q
Qerimi E. P-TU-159
Qu C. P-SU-040
Quaranta-Leoni F. SA-42-03
Quek D. P-MO-084
Quellec G. TU-56-03
Quinn A. TU-25-01
Quinn G. SU-41-03
Quiroz-Mercado H. WE-29-06
Qureshi M. B. TU-42
TU-42-04
R
Rabensteiner D. F. FR-01-11
FR-01-12
FR-01-19
Raber S. SU-55-05
Rabsilber T. M. SU-45-05
P-SA-010
P-TU-008
P-TU-018
P-TU-025
Rad F. M. MO-28-10
Radbruch L. P-MO-288
Radeck V. P-MO-204
Radecka L. MO-68
P-SA-209
Radford J. SU-67-02
Radovic N. P-TU-071
Rahi J. WE-40-07
Rahi J. S. SU-07
SU-07-04
SU-73-07
399
WOC
2010
A
u
t
h
o
r

I
n
d
e
x Rahman A. P-SU-079
Rainer G. MO-32-07
Rajan M. TU-46-03
Rajapaksha K. P-TU-062
Rakhmonov A. P-TU-135
Ralfkiaer E. SU-67-01
Rama P. MO-17-05
Ramaesh K. SU-75-04
Ramamurthy C. SA-26-07
Ramamurthy D. P-TU-027
SA-26-02
Raman V. P-MO-259
Ramani R. V. SU-64-06
MO-10
P-MO-086
Ramke J. WE-16-01
Ramos F. TU-31-09
Ramos Lopz M. P-SA-033
Ramulu P. MO-08-01
Randall A. D. P-SU-252
Randleman J. B. SU-59
SU-59-02
MO-38
MO-38-07
Rao G. N. SA-37-03
SU-65-02
WE-25
WE-25-02
Rao K. MO-28-05
Rao L. MO-28-05
Rao N. A. SU-24
SU-24-06
SU-57
TU-73-01
Rao N. P. MO-77-05
Rao S. K. TU-24-01
WE-19
WE-19-04
Raoof N. P-TU-169
Rasmussen M. L. R. SA-46-05
Rasp M. P-TU-010
Rathore D. S. P-MO-147
Rattanasukon M. P-MO-186
Rau M. P-MO-122
Rauch N. P-MO-036
P-TU-147
Raum C. P-SA-036
Raus P. P. M. SU-37-07
TU-79-08
Raut R. MO-77-08
Ravech S. P-SA-096
Raveh I. P-MO-121
Ravilla T. P-MO-087
Razzaq L. SU-34-08
Read R. P-SA-187
Realini A. WE-13-04
P-SA-129
Rebel C. P-TU-073
WE-39-02
Rebolleda G. P-SU-132
Reed D. M. WE-40-02
Rees G. P-SA-140
Reese J. MO-31-01
Regler R. P-MO-204
P-MO-244
P-SA-124
Regoda V. P-SA-220
Rehder J. R. C. L. SU-45-01
Reichard M. SU-56-04
Reichl S. P-TU-048
Rein D. B. MO-52-02
Reinecke K. P-SU-253
Reinhard T. SA-19
SA-19-02
SU-37-03
SU-78
TU-20-05
TU-31
TU-63-06
P-MO-038
P-MO-294
P-SA-059
P-SA-068
P-SA-070
P-SU-045
P-TU-043
P-TU-047
Reinstein D. Z. SA-04
SA-04-04
TU-62-03
TU-80
TU-80-04
TU-80-10
P-MO-111
Reis A. Po-SA
Reis R. F. P-TU-036
Reis W. P-SU-186
Reiter C. P-MO-148
Reitsamer H. SA-28
MO-12-03
Rejdak R. SA-28-08
TU-37-05
TU-77
TU-77-01
P-MO-260
P-SU-264
Reka K. P-SA-133
Remeijer L. MO-21-04
SU-28-05
Remky A. P-MO-075
P-SU-140
TU-63-05
Remmel R. M. P-MO-114
Remonda L. MO-73-03
P-SU-125
Ren R. P-SU-004
P-TU-053
Ren X. MO-74-02
Renieri G. P-SU-202
Rentz A. MO-75-05
P-SU-110
WE-35-04
Repka M. X. SA-47
SA-47-06
SU-52
SU-52-05
Resende Gomes C. E. P-TU-165
Reupsch J. P-SA-146
Revicki D. MO-75-05
WE-35-04
Rezaei-Kanavi M. P-SU-039
Reznicek L. P-TU-228
P-TU-237
Rheinschmitt L. MO-79-08
Riadh M. MO-32-05
P-MO-082
P-SA-270
Ricar J. P-TU-113
Ricardo P. WE-21-04
WE-22-02
Ricarova R. P-TU-113
Richard G. SU-75-05
MO-61
MO-61-01
TU-32
P-SA-082
P-SA-182
P-SA-184
P-SA-185
P-SA-189
P-SU-266
P-TU-056
P-TU-082
P-TU-217
WOC-C-07
WOC-C-07-01
Richards F. SU-32-05
Richards J. E. WE-40-02
Richards S. SA-20-04
Richter J. P-SU-094
Rieck P. SA-05-05
Riedel K. G. WOC-C-33
Riederle H. P-MO-251
Riemann C. D. TU-45-07
Riese J. TU-37-04
Riha W. P-SA-044
P-SA-067
SA-26-06
Ringens P. J. MO-55-01
Rio Torres M. SU-64-05
P-SA-023
P-SA-033
Rios R. SU-75-09
Risimic D. P-TU-230
P-TU-240
Ristau T. P-SA-165
P-SA-198
Ritch R. SA-12
SA-21
MO-31-11
MO-47
MO-60-03
TU-43-07
TU-68-02
Ritter F. MO-79-08
Ritter H. P-SU-179
Ritter M. P-TU-028
Rizk H. I. R. WE-40-10
Rizk A. SU-61-09
Rizzo R. TU-14-06
Rizzo S. MO-16
MO-16-01
Rizzuto P. R. MO-81-07
Roberts P. SU-42-04
Roberts S. P-SU-231
Roberts T. WE-17-01
Robinson M. MO-67-02
MO-75-06
TU-35-11
Robles-Contreras A. P-SU-024
Roca J. SA-41
WE-29
WE-29-02
Rochtchina E. P-SU-051
Rck T. P-SA-155
Rodin S. P-MO-238
TU-29-04
Rodrigues F. P-SA-090
P-SA-094
Rodrigues E. MO-32-09
P-SU-011
Rodrigues E. B. MO-67-09
Rodrigues F. P-SU-144
Rodriguez de la Rua E. TU-35-09
Rodriguez Prats J. L. P-TU-013
SA-27-11
400
WOC
2010
A
u
t
h
o
r

I
n
d
e
x Rodriguez-Reyes A. P-TU-110
Rogers J. MO-27-03
Roggia M. P-SA-226
Rogmann J.-P. SU-40-05
Rogowska-Godela A. P-MO-022
Rohit S. TU-59-01
Rohrbach J. M. TU-81-02
P-TU-097
Rohrschneider K. MO-23
MO-23-03
MO-27-09
Rohrweck S. P-MO-097
P-SA-243
P-SA-266
P-SU-169
Roider J. SA-25
SA-25-06
SU-27-10
SU-45
MO-28-01
MO-36
MO-36-03
TU-32-09
TU-36-08
P-MO-151
P-MO-164
P-SA-186
P-SU-253
P-TU-196
WOC-C-57-05
Rojanapongpun P. SA-30
SA-30-03
Rojas-Diaz A. P-SU-024
Rolfs A. SU-56-04
Romac I. P-MO-112
Romaniuk W. P-MO-056
P-SA-153
P-TU-171
TU-36-09
Romano M. R. P-MO-224
Romano V. P-MO-224
Romanova T. P-TU-166
Romanowska-Dixon B. MO-77
MO-78-02
P-SA-183
P-MO-175
P-MO-267
P-TU-085
P-TU-092
P-TU-128
Romanowski E. G. MO-21-02
Roman-Roman S. SU-39-02
Romkes G. FR-01-10
Rootman J. TU-40-02
Rosbach J. P-TU-080
Rose G. MO-34
MO-34-01
SA-46-07
Rsel M. MO-74-04
MO-74-07
P-SA-248
P-SA-256
Rosen E. S. MO-19
MO-19-01
MO-37
MO-37-04
Rosen R. P-SA-180
P-TU-216
P-TU-224
TU-37-09
MO-27-03
Rosenbaum J. T. SA-40
SA-40-03
Rosenthal J. TU-37-09
P-SA-180
P-TU-224
Rosenthal P. TU-31-08
Rosentreter A. P-MO-274
P-SA-013
P-TU-066
Roskamp R. P-TU-076
Rosman M. WE-40-04
Rosner M. SA-46-02
Rossetti L. BS-09-05
Rossi T. WE-26-04
Rossini P. SU-45-06
MO-24-10
P-MO-232
Rosu L. P-SU-002
Rotberg M. P-TU-059
Rotchord A. MO-31-08
Rotenstreich Y. P-MO-216
P-SA-096
SU-38-05
Rothenbuehler S. P-TU-178
P-TU-245
WE-34-10
Rothova A. MO-74-05
TU-47-01
TU-83
Rothweiler F. MO-32-10
Rottler J. P-MO-015
P-MO-016
Rovner B. MO-68-07
Roy S. SU-38-04
Rozanova Z. P-MO-238
Rozenberg F. MO-76-09
Rubin G. S. MO-10
MO-10-04
Rubio R. G. MO-67-06
TU-29-09
WOC-C-63-02
Rubis V. MO-27-08
Rcker I. MO-28-10
SU-38-09
Rcker M. MO-78-03
SU-38-09
Rdiger H. SU-34-06
Rudnitzki F. MO-79-01
Rudolf M. P-SA-166
P-SA-187
P-SU-251
Rudolph G. SU-61
SU-61-03
TU-33-03
P-TU-021
Rfer F. MO-28-01
Ruggeri A. P-MO-269
SU-62-01
Ruit S. P-TU-263
Ruiz Rodrguez Y. P-SA-023
Ruksenas O. SU-36-02
Rummelt C. P-SA-065
P-TU-127
Rping J. P-MO-233
P-SA-188
P-SA-194
Ruppenstein M. P-SA-177
P-TU-203
P-TU-244
SU-38-02
TU-34-07
Ruschenburg H. P-MO-170
P-MO-170
Russ D. P-SA-050
Rustambayova G. P-MO-180
Ruttig A. MO-74-04
Ryan S. J. TU-46
Rybakova E. SA-14-03
Rym K. MO-32-05
P-SA-250
Ryseck I. P-SU-116
S
Saad A. SA-01-07
Saakyan S. V. P-TU-122
P-TU-125
SU-34-03
Saatci A. O. P-MO-234
Sabanayagam C. P-MO-169
Sabel B. A. P-SU-153
P-SU-175
SU-44-06
P-SU-137
P-SU-160
P-SU-161
P-SU-162
P-SU-174
SU-44-08
WE-41-03
Saburina I. SU-35-06
Sachdev A. P-SA-261
Sachdev M. S. TU-46-03
Sachs H. TU-34-09
Sacko D. SA-37-03
Sacu S. MO-67-07
MO-68-03
P-SA-164
P-SA-207
P-SU-188
P-TU-028
SA-27-02
Sadda S. R. P-SA-165
P-SA-198
Sadri E. P-TU-059
TU-30-03
Sadun A. MO-03-05
Saeger M. SA-25-06
SU-27-10
Saeki Y. P-MO-011
Safwat E. P-MO-177
Sagara T. P-MO-064
Saha S. MO-35-02
P-MO-285
P-MO-298
P-SU-029
P-SU-030
Sahel J.-A. SU-25
SU-25-04
MO-75
TU-41-07
TU-44
TU-44-02
WE-11-08
Saif Y. S. S. WE-40-10
Saito M. P-SA-097
Sakai H. P-SA-120
P-SA-123
Sakai J.-I. P-SA-247
Sakamoto A. P-SU-135
Sakurai M. P-SU-141
Sala E. TU-80-08
Salah J. P-MO-082
P-SA-249
Salahim S. P-SA-014
Salama A. P-SA-268
Salamanca O. P-MO-006
Salatka K. P-SU-097
Salgado-Borges J. P-SA-258
P-SU-111
P-SU-144
P-SU-273
Salim B. Y. P-MO-082
P-SA-089
P-SA-250
Salla S. P-MO-288
P-SA-064
Sallam A. P-SA-244
401
WOC
2010
A
u
t
h
o
r

I
n
d
e
x Salma G. P-SA-250
Salmanova S. P-SU-131
Salom D. MO-11-03
TU-41-11
P-MO-097
P-SA-243
Salvi M. G. MO-82-02
Samaan M. SU-70-15
Samanta S. K. WE-16-07
Sampaio P. C. SU-45-01
Samson C. M. SU-27-03
Sanchez M. J. SU-45-05
Sanchez Sanchez M. T. TU-35-09
Sanchez-Amaya I. D. P-MO-078
Snchez-Mannarelli F. P-SU-086
SU-34-11
Sanders R. P-MO-270
Sandhu J. P-SU-057
SU-42-04
Sandkull P. MO-77-08
Snger J. MO-48-02
Sano K. SA-25-05
Santini R. SU-81-07
Santos-Jimenez S. MO-23-05
Santos-Prez J. SU-42-02
Sanz-Solana P. P-SA-119
Saornil M. A. SU-12
SU-34-10
SU-34-11
Sapieha M. MO-01-03
Saragoussi J.-J. TU-80-09
Sargan I. P-SU-002
Sargent N. WE-16-04
Sarin S. P-MO-083
Saroj N. MO-67-06
TU-29-09
Sasai A. P-MO-014
Sasamoto Y. P-MO-179
P-SU-255
P-TU-229
TU-30-07
Sashneva O. P-TU-173
Sasongko M. B. TU-29-02
Sasse A. P-MO-123
Sato E. P-MO-153
P-SA-267
TU-31-09
Sato G. TU-14-06
Sato M. MO-69-05
P-SA-215
P-TU-129
Sato T. P-MO-264
Satoh H. TU-32-03
Sauder G. MO-31-06
Sauerbrey M. SU-32-02
Sauerwein W. MO-77-04
P-TU-116
P-TU-126
Saule S. SU-39-06
Saurabh K. P-MO-279
Saveleva A. SA-31-08
Saw S. M. P-SU-047
WE-40-04
Sawa M. SA-25-04
TU-26-01
P-MO-179
P-SA-163
P-TU-229
Sawada A. P-MO-060
P-SA-107
P-SA-136
Sawada M. P-SA-215
P-TU-129
Sawaguchi S. P-SA-120
P-SA-123
P-TU-067
Sawant S. D. MO-74-10
Sawatzki B. TU-20
TU-20-04
Saxena R. MO-74-01
MO-79-06
P-TU-141
SU-44-07
TU-30-10
Saxena S. SA-25-07
Sayanagi K. P-MO-212
SU-34-04
Sayegh R. G. TU-37-10
P-SA-164
Scarpi M. SA-28-02
Schaaf G. P-SA-061
Schaal K. P-MO-164
P-TU-244
Schfer G. F. FR-01-13
Schaefer T. WE-21
WE-21-02
Schaeffer K. SU-61-08
Schffner E. P-MO-205
Schafia A. P-SU-276
Schalenbourg A. SU-34-02
Schallenberg M. P-SU-103
P-SU-256
Schaller U. C. P-TU-091
P-TU-096
SU-34-06
WE-16-03
Schallhorn S. C. SA-01-01
Schaperdoth-
Gerlings B. P-TU-112
Schargus M. FR-01-14
P-MO-008
Scharioth G. TU-63-03
TU-63-10
WE-18
P-SA-022
P-SA-170
P-SU-187
Scharrer A. TU-03
Scharrer I. P-TU-226
Schatz A. P-SA-144
P-SA-155
P-SU-264
P-TU-219
Schaudig U. P-SU-226
WOC-AAD-C-26
Schaumberger M. P-SU-272
SU-34-06
Schefler A. MO-77-08
Scheler R. P-SA-173
Schepens C. L. P-MO-049
Scheschy U. TU-37-10
P-SA-164
Scheuerle A. F. P-SA-241
WOC-C-54
Schiabel H. P-MO-100
P-MO-101
Schiavi C. MO-09
MO-09-03
MO-69
MO-69-03
Schicht M. FR-01-15
Schiefer U. SU-02
SU-02-02
MO-14
MO-14-07
TU-08
TU-08-05
P-SA-106
WOC-AAD-C-25
Schielke K. C. P-SA-072
P-SA-174
P-SU-145
Schiestl C. SU-61-08
Schiffman R. M. P-TU-199
TU-30-01
TU-30-05
TU-35-11
Schilcher K. SU-17-07
Schild A. P-SA-013
Schill M. WOC-C-37-01
Schippling S. SA-25-08
Schirra F. SA-20-05
Po-TU
P-MO-278
P-SA-081
P-TU-006
P-TU-101
Schittkowski M. P. WE-12-04
Schlanitz F. G. P-SA-196
P-TU-185
MO-27-01
Schlich M. MO-73-10
P-SU-094
SA-28-04
Schlichtenbrede F. P-MO-185
P-MO-245
Schlote H.-W. P-SA-162
Schlott K. P-TU-196
Schltzer-
Schrehardt U. SA-28-08
SU-56-08
MO-60
MO-60-02
TU-37-05
P-SA-065
P-SU-098
Schmetterer L. MO-22-01
MO-58-03
Schmickler S. TU-03-08
Schmid K. W. P-SU-042
Schmid R. P-SA-002
Schmidinger G. P-TU-232
SA-26-04
Schmidt C. O. P-MO-072
Schmidt D. SU-40-07
Schmidt J. C. MO-67-09
WE-26-05
P-TU-239
Schmidt K. P-SA-168
P-SU-260
P-TU-243
P-TU-254
Schmidt M. P-MO-108
P-MO-263
P-SA-052
P-TU-213
Schmidt W. P-TU-168
Schmidt-Erfurth U. SA-27-02
SA-34
SA-34-04
MO-27-01
MO-27-02
MO-32-07
MO-67-07
MO-68-03
MO-72-07
MO-75
TU-37-06
TU-37-10
WE-08-03
P-SA-164
P-SA-196
P-SA-200
P-SA-207
P-SU-188
402
WOC
2010
A
u
t
h
o
r

I
n
d
e
x P-TU-028
P-TU-185
P-TU-232
WOC-C-15
WOC-C-15-02
Schmidt-Trucksss A. TU-33-06
Schmiedl J. P-SA-060
Schmiedt K. P-MO-144
SA-27-07
Schmitz A. P-TU-153
Schmitz
Valckenberg S. P-MO-158
P-TU-183
WE-34-08
P-SA-176
P-SA-197
Schmut O. FR-01-11
FR-01-12
FR-01-19
Schnaidt A. G. P-TU-101
P-SA-081
Schneider E. P-SU-177
Schneider M. P-TU-149
Schneider S. P-TU-111
Schnyder C. SU-38-04
Scholda C. P-TU-232
Scholl H. P. N. SU-51-05
SU-73-08
MO-27
MO-27-06
TU-35-08
P-SU-058
P-MO-158
P-TU-204
Scholtz S. P-TU-265
Schnfeld C.-L. P-MO-079
P-MO-088
Schpfer K. SU-36-09
Schor P. TU-64-01
P-SA-086
Schorderet D. SA-18-02
Schrkhuber M. P-TU-149
Schossau T. SU-79-06
MO-79-03
Schrader S. FR-01-16
P-MO-286
Schrader W. F. SU-80
MO-28
TU-28
TU-28-06
WE-26
WE-27
WE-27-05
WOC-C-50-02
Schraermeyer U. WE-15
WE-15-01
Schrage N. F. SU-17-02
SU-17-08
SU-62
SU-62-08
MO-28-08
TU-27
TU-27-04
TU-27-06
TU-32-05
P-MO-021
P-MO-223
P-SA-061
P-TU-153
P-TU-157
P-TU-030
WOC-C-08
WOC-C-08-02
WOC-C-08-03
Schramm A. MO-78-03
P-TU-123
Schramm K. P-MO-207
Schranz E. MO-67-07
Schriefl S. MO-27-01
P-SA-196
P-TU-185
Schrder A. C. P-SA-081
P-TU-006
P-TU-007
P-TU-031
Schrder S. P-SA-214
Schrer U. P-SU-256
Schroeter J. WOC-AAD-C-04
Schubert C. SA-32-04
Schuchard R. A. TU-14-06
Schuemie M. J. SU-54-01
Schuettauf F. MO-36-07
TU-77-04
P-SU-264
Schuff A.-C. P-MO-045
Schuknecht B. P-SU-027
Schulte J. H. P-TU-123
Schultheiss A. P-MO-148
Schultheiss M. P-MO-170
Schultz G. P-SA-025
Schulz S. P-SA-241
Schulze A. P-MO-033
P-MO-045
Schulze U. P-SU-012
Schumacher C. MO-74-04
P-SA-256
Schumann R. G. TU-25-08
P-MO-249
P-SU-272
Schuster R. P-TU-114
Schtze C. P-SA-196
TU-37-06
Schwaiger B. P-SU-111
Schwartz A. P-TU-250
Schwartz G. P-SA-100
P-TU-060
Schwartz R. SA-25-08
Schwartz S. TU-18-07
Schwartzkopff J. FR-01-17
P-MO-294
P-SU-045
P-TU-043
Schwartzstein H. P-TU-090
Schwarz A. P-SU-253
Schwarz T. SU-74-10
Schwechheimer H. SU-53
SU-53-01
Schweitzer D. P-TU-194
Schwenn O. P-MO-073
Scotland G. TU-29-03
Scott J. A. P-SU-145
Scott R. A. H. MO-28-04
WE-28-02
Seah L. L. P-SU-192
P-SU-245
Sebbah R. P-TU-140
Seeliger B. SU-62-08
Seeliger M. SU-25-06
Po-SA
Seguchi J. P-TU-072
Seibel B. S. SU-16-03
Seifert B. U. P-SA-147
Seiff S. TU-06
TU-06-01
TU-68-01
Seigel G. P-SA-111
Seiler T. SU-58-06
SU-60-04
MO-38-02
MO-39
TU-39
TU-62
TU-62-05
TU-64
WE-01-05
WE-03-05
Seiple W. P-SA-180
Seira P. SU-38-04
Seitz B. SA-18-05
SA-19
SA-19-06
SU-68
SU-68-07
SU-69
MO-30-02
MO-35
TU-12
WE-03
WE-21
WE-37-07
P-MO-035
P-MO-278
P-SA-066
P-SA-081
P-SU-043
P-SU-265
P-SU-276
P-TU-006
P-TU-007
P-TU-031
P-TU-031
P-TU-101
P-TU-163
Sekiryu T. P-MO-165
Sekundo W. SA-02
SU-36-09
TU-80-02
Po-TU
P-MO-137
P-MO-220
P-SA-043
WOC-C-56-04
Selma G. P-SA-270
Semak G. P-SU-269
Semenova E. A. P-TU-111
P-TU-125
SU-34-03
Semkova I. P-SA-168
P-SU-258
P-SU-260
P-TU-243
Sen H. N. MO-76-08
Seneadza A. SA-37-04
SA-37-07
Senft S. P-SA-080
Sengupta J. MO-35-02
P-MO-285
P-MO-298
P-SU-029
P-SU-030
Sengupta S. P-SU-189
WE-34-05
Seong G. J. P-SU-093
Serbes U. P-SA-128
Seregard S. SU-39-08
SU-75
MO-18
MO-18-01
MO-77-08
MO-81-09
TU-40
TU-40-02
WE-23-01
Serova N. WE-04-05
Serrano M. P-MO-160
Setiobudi C. P-MO-159
Seyam N. WE-16-04
403
WOC
2010
A
u
t
h
o
r

I
n
d
e
x Seyeddain O. P-SA-044
P-SA-067
SA-26-06
Shaarawy T. M. SU-06
SU-06-03
SU-08-04
MO-54-04
TU-13
TU-13-06
Shafi F. P-MO-252
Shah K. MO-73-06
Shah P. P-MO-272
Shah P. K. WOC-C-58-02
Shah R. SU-36-03
Shah R. S. SA-01-05
SA-02-04
Shah S. P-TU-009
P-TU-037
WE-16-06
Shahin M. TU-32-02
TU-33-05
Shahsuvaryan M. P-TU-251
Shaikh S. MO-76-07
Shaish A. P-MO-216
Shalaby M. H. MO-25-10
Shalaby O. P-MO-292
P-SU-214
Shami M. MO-67-03
Shandurkov I. SU-62-09
SU-81-04
Shao C. SU-17-09
Shao-Min Zhang S. MO-14-05
Sharkawi E. P-MO-028
Sharma H. P-TU-212
Sharma P. MO-79-06
P-TU-141
SU-44-07
SU-44-07
Sharon D. P-SA-096
Sharp P. F. SU-62-06
TU-29-03
Shaw B. E. P-MO-295
Shaw J. TU-29-02
Shchadnykh M. MO-35-08
P-SA-156
P-SU-236
Shchypun S. TU-81-08
Sheehan W. P-TU-046
Sheng D. P-SU-254
Sheng M. P-SU-088
Sherwood M. SU-06-06
Shetta S. SU-68
SU-68-03
MO-70
MO-70-04
Shetty B. MO-67-10
SU-62-07
Shetty R. MO-67-10
Shevchyk V. P-TU-166
Shi D. SU-17-06
Shi W. SU-74-09
Shi X. P-SA-168
Shibata M. P-SU-257
P-TU-064
P-TU-068
Shibata Y. P-SA-229
Shidik A. P-TU-023
Shields C. L. SA-36-03
SA-41-03
SU-34-05
SU-34-09
SU-39-10
SU-39-11
MO-77-07
TU-22-08
TU-32
TU-34
WE-23-09
WOC-C-60-03
P-TU-090
Shields J. SA-09-03
SA-41-07
SU-12-07
SU-34-05
SU-34-09
SU-39-10
MO-02-05
MO-33-07
MO-77-07
TU-22
P-TU-090
Shih S. SU-17-04
Shim H. s. P-TU-079
Shimada N. P-MO-188
P-SA-097
P-SA-229
Shimajiri S. TU-32-03
Shimizu K. SU-47-09
Shimomura Y. MO-35-01
P-SA-106
P-SA-109
P-SU-089
Shimonura Y. WE-22-06
Shin Y. W. SU-80-07
SU-81-05
P-TU-193
P-TU-184
Shinoda K. P-SA-170
Shiraishi A. P-MO-011
Shirakashi M. P-MO-034
P-MO-042
Shiraki K. P-TU-195
Shoji M. P-SA-109
P-SU-107
Shoshani Y. TU-30-06
Shpak A. MO-27-07
Shrestha M. K. P-TU-263
Shriver E. SU-81-03
MO-78-01
Shu V. TU-30-05
Shushtarian S. M. P-SU-165
Shusterov Y. SU-36-06
Siddig M. MO-28-02
TU-25-05
Siddiqui A. P. P-MO-202
Sidik M. WE-41-07
Siebelmann S. FR-01-18
P-SU-023
P-SU-031
P-SU-034
Siesky B. TU-30-06
Sieving P. A. MO-71-01
P-MO-103
Signorini S. G. SA-10-03
Sihota R. SA-30-01
Sikivou B. WE-16-01
Silva E. SA-09
SA-09-06
Simader C. TU-37-10
P-SA-164
P-SA-196
P-SA-207
Simavl H. P-MO-002
Simmet U. P-SA-233
Simmons P. P-MO-014
SU-17-04
Simes C. C. SU-34-07
MO-77-06
P-TU-094
Simon M. C. TU-36-05
Simons B. SU-55-05
Simonyi S. P-MO-074
Simonyte S. P-SA-204
Simpson E. R. SU-43-07
MO-35-09
TU-40-10
S ims ek S . P-MO-002
P-MO-005
Simsonsen F. SU-62-08
Singalavanija A. P-TU-209
Singer M. MO-68-04
WE-34
WE-34-02
Singh A. SU-34-04
Singh A. D. SA-46-04
SU-43
SU-43-08
MO-66-09
WE-23-03
Singh J. TU-65-06
P-SA-236
P-SA-281
Singh K. SU-08-02
MO-65-01
TU-43
Singh P. WOC-C-36-03
Sinkunaite G. P-SA-204
Sinkunas K. P-SU-178
Sinyavsky O. WE-39-01
Sirtautiene R. P-SA-181
Sisu A. P-SU-002
Sit A. J. WE-13-03
Sitnik H. SU-75
P-SA-083
Sivaprasad S. MO-32-08
Sivasubramaniam S. P-SU-064
Sivekova D. P-SA-048
P-SA-049
SU-75-02
TU-31-07
Sivkova N. MO-28
MO-28-03
SA-25-10
Siwiec-Proscinska J. P-TU-154
Sjahreza E. WE-41-07
Sjo L. D. SU-67-01
Skaat A. SU-38-05
Skevas C. P-SA-185
P-TU-056
Skorpik C. SA-26-04
Skupin A. P-TU-152
Slade S. G. SU-36
SU-36-08
SU-60-05
TU-39-07
TU-61-06
TU-75-07
Slakter J. MO-32-03
Sliesoraityte I. P-MO-221
P-SA-152
P-TU-219
Sloper J. MO-09-02
Smailhodzic D. P-SA-198
Smetanina M. P-SA-045
Smigielski J. MO-68-09
Smiles J. SU-79-01
Smith J. R. SU-67-06
TU-17-02
TU-53-03
Smith R. E. WE-30
WE-30-04
Smretschnig E. P-TU-176
Smuzynska M. P-TU-201
Snead D. R. J. MO-28-04
Sniatecki J. P-TU-241
Soares R. P-SU-144
Sobaci G. WE-28-07
Socci da Costa D. P-SU-084
404
WOC
2010
A
u
t
h
o
r

I
n
d
e
x Soderberg P. TU-68-05
Sodi A. WE-40-01
Sogawa K. P-MO-153
Sohn Y.-h. P-TU-079
Soleymani A. P-MO-152
Soliman M. SU-68-05
Soliman W. MO-67-03
Solonina S. WE-39-01
Solorzano A. O. TU-74-07
Sommer A. SA-23-01
SA-48-02
SU-04
SU-04-04
Sommer F. P-SU-215
Sone T. P-SU-183
SU-38-07
Song H. P-SA-038
Song I. P-MO-200
P-TU-193
Song S. P-SA-216
Song X. P-SU-221
Song X.-j. P-SU-044
Song Y. SU-45-02
SU-80-07
P-TU-184
P-TU-193
Sonia A. MO-32-05
P-SA-089
P-SA-249
Sonia C. P-SA-089
Sonia N. P-SA-089
Sonia Z. P-SA-249
P-SA-250
P-SA-270
Sonty S. P-MO-044
P-MO-051
P-MO-054
Soon Phaik C. P-SA-217
Sophian D. M. P-SU-091
Sorenson J. MO-32-03
Sorochynska T. A. P-TU-138
Soroush M.-R. P-SU-039
Soto-Pedre E. MO-75-02
Sotozono C. P-SU-089
Soubrane G. SA-33
MO-67
WE-08-01
WOC-C-57-04
WOC-C-61-05
LS-08-02
Sourlas V. MO-76-10
Sousa A. K. S. P-SA-102
Sovani I. P-SA-087
Spada C. P-TU-199
Spaeth G. L. P-MO-057
TU-30-01
TU-43-08
Spahn K. WE-25
WE-25-01
Spaide R. F. MO-32-03
SA-32-06
SA-32-04
Spaide T. C. SA-32-06
Spalek T. MO-27-01
Spaltmann R. P-SU-186
Spalton D. SU-15-03
Sparholt J. SU-09-01
Speeg-Schatz C. SU-23-02
Speicher L. P-SA-034
S
picka N. P-TU-058
Spiegel D. SA-21-07
SA-28
TU-13-02
Spierer A. MO-19-04
Spierings E. SU-19-04
MO-35
Spitzer M. S. MO-36
MO-36-02
P-MO-170
Spivey B. E. TU-46
WE-16
Spoerl E. SA-13-03
WE-07-06
WE-39-05
P-SA-139
Spler F. MO-28-08
SU-17-08
Sponer U. P-SA-179
P-SA-207
Spors F. P-SA-146
Spreitzhofer E.-M. FR-01-11
Springer C. MO-27-09
Sprunger D. SU-52-01
MO-69
Sreekantam S. P-SA-169
Sriharanathan P. TU-63-07
Srinivasan K. P-MO-255
Srivastava S. MO-74-01
TU-30-10
Stachs O. MO-79-05
P-SA-077
SU-56-04
Stadler S. P-SU-007
Stahl V. D. P-SU-104
TU-36-03
TU-36-06
Stala P. P-MO-109
Stalmans P. TU-33-04
Stana L. P-SU-002
Standefer J. E. SA-24-02
Stanford M. R. TU-47-02
P-SA-281
Stanga P. E. P-MO-195
P-MO-174
Stanic R. P-SU-075
Stankov B. P-SA-220
Stankovic Babic G. P-SU-152
P-TU-167
Stanzel B. SA-03-05
Starikova A. V. SU-41-07
Stark W. MO-25
MO-25-01
Staurenghi G. SU-38-02
WOC-C-61-03
Stavrakas P. MO-67-04
Stefanovic I. P-TU-240
Stefnsson E. SA-34-01
SU-50-01
SU-53
SU-54
SU-54-02
TU-38-01
Steffen H. SU-23-06
Po-SA
Stegmann R. MO-05-05
MO-31-05
WE-19
WE-19-01
Stehr F. WE-37-09
Stein J. D. SU-04-02
MO-22-02
MO-31
WE-40-02
Steinberg J. P-TU-073
WE-39-02
Steindl K. SA-03-03
P-TU-176
Steinert R. MO-66-05
TU-46-04
P-SA-003
Steinfeld A. P-MO-288
P-SA-064
Steinhuber B. P-SA-034
Steinkogler F. J. SU-71-02
Stela G. P-TU-107
Stephan H. P-TU-123
Stephanie W. P-TU-006
Stern M. SU-37-04
Steuhl K.-P. FR-01-06
FR-01-20
SU-81
MO-41
P-SU-246
P-SU-038
P-SU-042
Steven P. MO-79-04
MO-79-05
P-SU-023
P-SU-031
P-SU-034
Stevens J. D. SA-01-04
Stewart J. A. TU-30-04
Stewart W. C. TU-30-04
Stickelmann C. P-MO-206
Stieger K. MO-06-06
TU-55-05
Stiel S. P-MO-288
P-SA-064
Stifter E. P-TU-185
Stitt A. MO-01-05
Stcker M. P-MO-206
Stodtmeister R. P-MO-062
WE-39-05
Stodulka P. TU-25-07
Stoffelns B. M. P-MO-187
P-SA-190
SU-36-09
Stojanovic A. TU-64-06
WE-02-03
Stojkovic R. P-SA-220
Stoll T. P-SU-184
Stone E. MO-71-03
Stonecipher K. G. SU-60-03
Stopa P. TU-37-05
Stopper S. P-SA-050
Stout T. SU-25
SU-25-05
TU-29
Straatsma B. R. MO-77-05
TU-67
TU-67-02
Strack C. MO-79-01
Stratmann N. P-SA-197
Strauss O. P-MO-157
P-SU-268
Strau R. SU-17-07
Strher E. P-SU-246
Struck H. G. WOC-C-08
WOC-C-08-01
WOC-C-08-03
Studeny P. SU-75-02
SU-78-06
TU-31-07
P-SA-048
P-SA-049
Study Group
Rotterdam Ocular 39-05
Study Group HSV Kit MO-35-01
Study Group on
behalf of the DENALI TU-37-01
Study Group on
behalf of the
LUMINATE MO-76-05
SU-27-04
Study Group on
behalf of the
MONT BLANC P-SA-212
Study Group on
behalf of the RESTOREWE-38-02
405
WOC
2010
A
u
t
h
o
r

I
n
d
e
x Study Group on
behalf of the SECURE TU-37-03
Study Group PANDA P-MO-063
Study Group The
Nigeria National
Blindness and Visual
Impairment P-SU-064
Study Group on
behalf of the EVEREST MO-32-04
Stuebiger N. P-SA-254
Stulting A. MO-02-07
Stulting R. D. WE-01-04
Sturm T. TU-40-07
Sturm V. SU-61-08
Sturmbauer K. FR-01-19
Su E. P-SA-180
P-TU-216
Su L. P-MO-265
Suarez E. MO-15
MO-15-02
Subramani S. P-SA-199
Subramanian P. WE-04
WE-04-02
Sudharshan S. MO-74-10
Suelves A. P-MO-097
P-SU-169
Suelves-Cogollos A. M. P-SA-266
Sugano A. P-SU-115
Sugano Y. P-MO-165
Sugar E. A. MO-76-04
Sugiura Y. P-MO-235
P-MO-239
Sugiyama K. P-SA-047
P-SU-141
P-SU-159
Sugiyama T. P-SU-257
P-TU-064
P-TU-068
Suh W. SA-28-09
Suhardjo S. P-SU-091
SA-26-10
Suleman H. SU-75-10
TU-81-07
Sulivan B. P-MO-008
Sullivan D. A. SA-20-04
SU-63
SU-63-04
Sullivan P. TU-28
TU-28-04
WOC-C-41
WOC-C-41-01
Sullivan T. WE-33-02
Sulzbacher F. MO-68
MO-68-03
P-SA-200
Summers A. P-TU-143
Sun C.-b. WE-35-08
Sun J. P-SA-001
P-SA-007
P-SU-060
Sun L. SU-61-10
Sun M. P-SA-231
Sun M.-H. P-SA-245
P-TU-134
Sunaric-Megevand G. MO-55-03
Sundari S. SA-26-10
Sunder-Plassmann G. WE-40-01
Suntay A. T. WE-34-07
Supartoto A. P-TU-124
Superti-Furga G. P-SU-188
SA-27-02
Supiandi E. P-SA-118
Supramaniam G. P-MO-280
Surchev N. P-SA-076
SU-17-01
SU-62-09
Suryono A. TU-63-04
Susanna, Jr R. BS-09-01
BS-09-02
MO-13-03
TU-43
Ssskind D. MO-24-07
P-TU-119
Sutphin J. P-MO-013
Suwan Y. P-SA-029
Suzuki K. P-MO-064
P-MO-193
P-SA-015
Suzuki M. P-MO-179
P-SA-163
Suzuki S. P-TU-235
Suzuki T. P-TU-231
Suzuki Y. P-MO-068
P-MO-089
P-MO-193
P-MO-258
P-SA-015
Suzuma K. P-MO-230
P-MO-247
P-MO-256
P-TU-004
Syed Osman S. I. P-SU-224
Symes R. J. P-MO-295
Synowiec E. P-SA-099
Szaflik J. P-SA-091
P-SA-099
P-SU-026
SU-41-10
TU-31-06
Szaflik J. P. SA-16-02
SU-41-10
TU-31-06
TU-72-01
P-SA-091
P-SA-099
P-SU-026
Szetu J. WE-16-01
Szulborski K. P-SA-091
Szuminski M. SU-55-07
Szurman P. MO-36
MO-36-01
TU-09-02
TU-28-05
WE-08-05
WE-26-01
P-MO-170
P-TU-181
P-TU-181
T
Tabata Y. P-TU-064
Tabbara K. F. TU-73-02
Tabin G. SA-27
TU-24-02
WE-25-06
Tadayoni R. SU-49-05
Tadic V. WE-40-07
Tagami M. P-MO-254
Tai E. S. P-MO-169
Takada S. P-SA-106
P-SA-109
Takagi M. P-SU-141
Takagi S. P-MO-225
Takahashi A. P-MO-153
P-MO-194
Takahashi K. P-SA-159
Takahashi M. WE-14-05
P-TU-208
Takahashi N. P-MO-064
P-SA-107
P-SA-136
Takahata T. P-MO-256
Takai S. P-TU-064
Takamatsu M. P-SU-183
Takeda H. P-SU-159
Takeda N. TU-36-05
Takemura S. P-SU-115
Takenaka J. P-SA-121
Taketani F. P-MO-138
P-SU-037
Takeuchi A. P-MO-225
Takeuchi M. P-SA-247
Takeuchi S. P-MO-225
Takhchidi E. K. TU-02-07
Takhchidi K. P. MO-26
MO-26-05
P-SU-062
SU-47-07
Talamo J. H. SA-27-10
SU-58-02
Talebnejad M. R. P-TU-136
Talwar N. WE-40-02
Tam P. P-SA-252
Tam T. Y. P-TU-133
Tamada S. P-SU-182
Tamayo G. TU-39-01
Tamosiunas A. P-SA-204
Tamura H. P-SA-167
P-TU-172
Tan L. T. P-SU-009
Tan D. T. H. SU-78-02
MO-35-05
MO-64
MO-64-06
TU-05-03
TU-81-09
Tan G. P-MO-169
Tanabe F. P-SA-106
P-SA-109
Tanaka A. P-MO-064
P-SA-229
Tanaka K. P-SA-017
P-SU-135
P-SU-141
P-SU-158
Tanaka M. P-SU-124
Tanaka T. P-MO-042
P-MO-094
Tanaka Y. SU-17-06
Tanano I. P-MO-153
Taneri S. TU-80-03
Tang X. P-SA-038
Tani T. P-MO-153
Tanihara H. P-TU-220
Taniuchi S. SA-25-05
Tanner V. P-TU-032
Tanyildizi Y. MO-35-06
Tao H. SU-56-02
Tao J. P-SA-092
SU-56-05
Tappeiner C. MO-74-07
Tarassoly K. MO-78-09
Tarif M. P-SU-249
Tartak D. P-SA-080
Tartak M. P-SA-080
Taryam M. O. MO-70
MO-70-03
MO-81-08
Tasman W. MO-68-07
Tassignon M.-J. SU-20-03
MO-05
MO-05-01
MO-20
406
WOC
2010
A
u
t
h
o
r

I
n
d
e
x MO-20-04
MO-55
MO-55-05
TU-68
TU-76
TU-76-09
WE-11-05
WE-17-03
Tatar O. P-SA-170
Tatzkov R. A. P-TU-125
Tavassol F. MO-78-03
SU-38-09
Tawara A. TU-32-03
Tay W. T. WE-40-04
Taylor D. MO-07
MO-41-03
Taylor H. R. SU-65
SU-65-05
MO-64-01
TU-71-03
WE-25-05
WE-40-09
Taylor S. TU-65-03
P-SA-268
P-SA-281
Taylor S. R. J. P-SA-236
P-SU-009
Tech S. P-TU-130
Tehrani N. SU-41-02
Teimann U. TU-81-02
Teixeira Brandt C. P-TU-262
Tektas O. P-SU-099
Tello C. MO-31-11
Tembl J. P-SU-169
Temprano J. SU-70-19
ten Cate H. MO-74-05
Tennant M. SU-62-04
Teo L. P-SU-192
Tepedino M. P-MO-071
TU-30-05
Teping C. P-MO-137
Teranishi S. P-MO-064
Terasaki H. P-MO-194
P-SA-175
P-SU-270
P-TU-214
Terubayashi A. P-TU-069
Tervo T. TU-80-05
Tetz M. SU-16-04
TU-04
TU-04-02
WE-10-07
Teus M. A. P-MO-143
P-MO-117
Teutloff H. P-SA-265
Thaler S. TU-77-06
P-SU-264
Thaller V. P-SU-191
Tham C. C. Y. SA-21-04
SA-30-05
SU-08
SU-08-03
MO-08
Thangappan A. SU-34-09
Thangkhiew L. P-SU-173
Thanigasalam T. P-TU-038
Thanos M. P-SU-246
Thanos S. SU-69
SU-69-06
MO-76-01
WE-35-06
P-SU-103
P-SU-122
P-SU-148
P-SU-256
P-TU-118
Theelen T. TU-33
TU-33-08
P-TU-065
Thei B. P-SA-277
Theodoridou A. MO-74-03
Therese L. K. MO-74-10
Thi Khanh Van P. P-TU-121
Thieme H. MO-65
MO-65-03
TU-63
WOC-C-42
P-TU-076
P-TU-080
Thiemeyer D. MO-27-09
Thill M. P-SA-185
Thomas S. SU-39-04
Thomasen H. FR-01-20
SA-17-05
P-SU-038
P-SU-042
Thomson A. P-SU-151
Thouvenin D. SA-47
Thulasiraj R. D. SA-48
TU-42-02
TU-52-05
Thumann G. SA-03-04
TU-37
TU-37-08
P-MO-206
Thurau S. SA-08
TU-17
WE-09
WE-09-05
P-SA-251
Thygesen J. MO-54
MO-54-02
Thyzel R. P-SU-249
TU-25-07
Tian F. P-SA-040
Tian L. SU-47-04
Tian X. P-SU-133
Tilikete C. SA-38-09
SU-18-05
Tillack H. P-TU-089
Timmermann M. TU-37-04
Ting D. WE-40-09
Ting S. J. SU-44-04
Ting S. W. SU-44-04
Tinh N. X. MO-04-03
Tint N. L. TU-81-07
Tjia K. F. MO-20-03
WE-18-03
Tobin K. SU-62-04
Tochikubo T. P-MO-027
P-MO-068
P-MO-089
P-MO-258
P-SA-017
Toda R. SU-38-07
Todorov V. P-SU-268
Tojo K. P-SU-053
Toker E. SU-09-03
WE-22-01
Tokoro T. P-SA-229
Tokuhisa K. P-MO-064
Toledo de Paula C. H. SU-74-06
Tolic A. P-TU-071
Tomalla M. MO-31-01
TU-25-11
Tomar S. P-TU-045
SA-32-07
Tomita G. P-MO-225
Tomoyose E. P-SA-120
P-SA-123
Tong H. T. L. P-SU-206
Tong L. SU-37-04
WE-40-04
Tnz M. S. P-TU-177
TU-29-06
P-SU-027
Topbas S. P-MO-242
Topete-Jimenez J. P-MO-078
P-SA-127
P-TU-086
P-TU-086
Torrent Despouy J. P-SA-187
P-TU-075
SA-31-04
Torres Suarez E. TU-33-09
Torres V. P-TU-188
Torun Acar B. P-SA-057
P-SU-025
Toshmatov A. P-TU-135
Toshniwal N. SU-38-08
SU-79-04
Tossounis C. P-MO-273
Tost F. H. W. SA-29
SA-29-02
SU-80-04
TU-26
TU-26-06
Po-MO
Tteberg-Harms M. MO-31-02
P-MO-041
WE-39-04
Tou N. TU-32-03
Touge C. P-SA-279
Toyokawa N. SA-31-07
Trajanoski Z. SA-27-02
Tranos P. MO-75-08
Trauzettel-Klosinski S. TU-14-01
WE-04
WE-04-01
Traverso C. E. SA-11-03
Trempe C. L. P-MO-049
Trese M. T. SU-49
SU-49-08
SU-50
SU-72-05
MO-29-03
WE-09
WE-09-03
WE-29-05
Tressler C. P-SU-097
WE-41-09
Treumer F. MO-28-01
P-SA-186
P-SU-253
SA-25-06
TU-32-09
TU-36-08
Trevino A. SA-25-09
Trimmel J. MO-62
MO-62-02
WE-25-03
Troeber L. P-MO-278
P-TU-101
Trger E. MO-27-06
P-SA-152
SU-73-05
Tronina S. P-SU-239
Troyanovsky R. WE-39-01
Trpin S. P-MO-007
P-MO-012
Trueba Lawand A. P-SU-147
Tsai C.-C. P-SU-015
P-SU-120
Tsai H. Y. TU-04-04
Tsai J. C MO-65
MO-65-07
SU-05-04
407
WOC
2010
A
u
t
h
o
r

I
n
d
e
x Tsai R. J.-F. WE-05
WE-05-03
Tsai R.-K. P-TU-051
Tsai S. MO-75-07
Tse D. SU-42-07
SU-81-03
MO-78
MO-78-01
Tse G. P-SU-222
Tse J. MO-78-01
Tseng S. C. G. SA-17
SA-17-03
MO-64-03
TU-74
TU-74-02
TU-74-04
WE-05-01
Tsinopoulos I. P-SU-100
Tsirbas A. SA-42-02
SU-42-08
Tsironi E. MO-74-03
MO-76-10
P-MO-248
Tso M. O. M. MO-43
MO-43-01
MO-44
MO-44-01
Tsuchiya Y. P-SA-215
Tsuiki E. P-MO-230
P-TU-004
Tsujikawa A. P-SA-167
P-TU-172
Tsujikawa M. P-MO-179
P-SA-163
P-SU-255
P-SU-262
P-TU-229
SA-25-04
Tsukahara Y. P-MO-213
P-MO-254
Tsukiyama J. WE-22-07
Tsumura T. P-SA-020
Tu E. SU-28-03
Tuchen S. WE-37-06
Tudor C. P-SA-110
Tufail A. SU-51-01
Tuft S. J. FR-01-16
Tuisku I. SA-04-05
Tulidowicz-Bielak M. WE-39-09
Tung W. T.-H. P-SU-059
Tuomi L. WE-34-02
Tura A. P-SA-122
P-TU-097
P-TU-119
Turan N. SA-31-06
Turbin R. TU-27-02
TU-27-06
Trkeli E. P-SU-038
Turner G. S. P-MO-195
P-MO-174
Tuulonen A. MO-58
MO-58-02
TU-52
U
Ubaida Mohien C. SA-27-02
Ubaldi A. P-MO-161
Udaondo P. TU-41-03
P-MO-097
P-SA-243
P-SU-169
Ude K. T. P-SU-204
Ueki M. P-MO-264
P-TU-068
Uemura A. MO-01-02
Ueno S. P-MO-194
P-SU-219
Ueno Y. P-MO-163
Uetani R. P-TU-214
Ughade S. MO-73-06
P-TU-055
Ughi G. SU-62-01
Ugurbas S. H. TU-79
TU-79-05
Ugurlu N. P-MO-002
P-MO-005
Uhlig C. E. P-SA-059
P-TU-242
P-MO-108
P-MO-263
P-MO-293
P-SA-052
P-TU-213
Ukety T. SU-32-01
Ulbig M. MO-75-03
P-MO-210
P-MO-233
P-MO-271
P-SA-173
P-SA-194
P-SA-202
P-TU-191
P-TU-228
P-TU-237
SU-38-01
TU-33-03
WE-34-06
Umanets N. P-MO-238
Unal M. WE-33-04
Ung T. P-SU-247
P-TU-169
Ungerechts R. MO-78-10
P-SU-248
Unterlauft J. FR-01-21
P-SA-060
Uotani R. P-MO-011
Upadhyay M. P. P-MO-083
Updike J. P-SA-165
P-SA-198
Urbancic M. P-MO-231
P-SA-206
Urovskaya N. P-TU-122
Urtti A. ES-05-01
WE-15-06
Ushakova T. WE-35-02
Usov V. P-MO-113
P-MO-283
Usui S. P-TU-069
Usui Y. P-SA-247
P-SU-158
Utani A. P-TU-172
Uthoff D. SU-79-05
TU-80-06
Uwaydat S. MO-67-03
Ux M. SU-70-12
SU-70-17
Uy H. TU-25-09
MO-24-08
P-SA-280
V
Vahdani K. P-MO-259
P-SU-191
TU-30-09
Vaiceliunaite A. SU-36-02
Vaida M. P-SU-005
Vainchtock A. P-SU-068
Vajaranant T. P-SA-073
Vakalis A. MO-75-08
Valdez-Gonzalez T. P-SU-024
Valet V. MO-27-04
Valsky V. V. SU-34-03
Valverde-Collar C. SU-34-10
van den Does P. MO-74-05
van der Wees J. TU-31-01
van Gils W. SU-39-05
van Heyningen V. P-TU-155
van Lookeren
Campagne M. MO-68-05
van Meurs J. SA-36
SU-51-06
TU-03-07
van Nispen R. M. A. MO-10-01
van Rens G. MO-10
MO-10-03
MO-23
MO-23-02
van Rij G. MO-20
MO-79
TU-05-04
van Setten G. TU-79-04
van Son M. P-SU-027
Vanchakova N. P-SA-203
VandenHoven C. SU-41-11
SU-74-02
Vani A. WE-34-03
Vargas A. B. P-SA-023
Vargas J. M. MO-15-05
TU-74
TU-74-03
TU-74-06
Varma R. TU-52-01
Vasconcelos
Santos D. V. SU-24-05
Vashkevich G. MO-27-08
P-TU-173
Vasilakis P. P-MO-190
P-MO-214
Vasiliou T. P-SU-140
Vasold R. TU-32-09
Vassileva P. I. SU-17-01
SU-62-09
SU-64
SU-81-04
TU-02
TU-02-08
P-SA-076
Vasu U. P-MO-276
P-SU-274
Vaughan J. P-TU-143
Vazquez
Membrillo M. A. P-SU-024
Veckeneer M. A. SA-36-05
Veerappan
Rathinasabapathy S. P-MO-272
Vgh M. SU-09-02
Vehige J. P-MO-014
SU-17-04
Vejarano L. F. SU-38-03
WE-18-06
Velikay-Parel M. P-TU-022
Velinov O. P-TU-083
P-TU-242
Vemuganti G. SA-46-03
SU-67
SU-67-03
Vengris M. SU-36-02
Venkatapathy N. P-MO-272
SU-62-03
Venter J. WE-01-02
Ventura L. P-MO-100
P-MO-101
Verdaguer J. SU-20
408
WOC
2010
A
u
t
h
o
r

I
n
d
e
x SU-21
SU-21-01
TU-67
TU-67-01
TU-67-05
Vergs C. TU-61
TU-61-05
TU-61-06
Verjans G. M. G. M. MO-21
MO-21-03
Verolli K. P-SA-090
P-SA-094
Verstraeten T. C. SU-51-08
Veselinovic T. P-TU-230
Vetter J. M. P-MO-137
P-SA-043
Vicente Fernandez
M. D. P. P-TU-210
Vicente Rodriguez J. WOC-C-63-03
Vidinov K. P-MO-156
Vidinova C. N. P-MO-156
Vieira A. C. P-SU-085
Vieira de Carvalho
L. A. P-SU-180
TU-31-09
Viestenz A. WE-37-06
P-MO-029
P-SA-112
P-SA-146
P-TU-057
WOC-C-50
WOC-C-50-04
VIEW 2 investigators TU-37-02
Vijayalakshmi P. MO-07-04
MO-51-05
Vilaplana D. TU-29-05
Villada J. R. TU-82-03
Villalba J. P-TU-008
Villani G. M. TU-14-06
Villarrubia A. WOC-C-63-05
Vilupuru A. MO-75-07
Vinciguerra P. SU-58-03
TU-78
TU-78-08
WE-02-01
P-MO-224
Vinekar A. SU-62-07
MO-04
MO-04-05
P-TU-218
Vinuesa Silva I. P-MO-160
Virgili G. WOC-C-10
WOC-C-10-05
Visser N. TU-82-10
Vit V. P-SA-098
P-TU-166
Vitovska O. P-SA-125
Vlasov S. P-SA-160
WE-34-09
Vo T. N. U. P-TU-145
Vogt S. P-SA-187
Vogt U. SU-09-05
Voigt N. P-SU-162
Voigt U. P-SA-277
Vokrojova M. P-SA-048
P-SA-049
TU-31-07
Vlcker H. E. SU-56
WOC-AAD-C-09
Vold S. D. TU-13-05
Volk G.-F. P-SU-122
Volkovich T. P-MO-176
von Hanno T. MO-67-03
von Holstein S. L. SA-46-08
von Jagow B. P-SU-041
von Stebut-
Borschitz E. P-SU-202
Vorwerk C. K. TU-15
TU-15-04
P-TU-221
Vossmerbaeumer U. P-TU-080
TU-80-02
Voyatzis G. P-TU-020
Voykov B. P-SA-152
P-SU-264
P-TU-219
Vrhovec L. P-MO-007
P-MO-012
Vucic D. SU-45-05
Vukoja V. P-TU-097
W
Wabbels B. K. SU-23-05
Wachtlin J. P-TU-089
Wacker T. P-SU-235
Wackernagel W. SU-43-09
P-TU-149
Wada M. P-SU-115
Wafa A. MO-32-05
P-SA-270
Wafa H. P-MO-082
P-SA-250
Wagenbreth C. P-SU-174
Wagenfeld L. P-TU-217
WOC-C-07-03
Wagner A. P-SA-187
Wagner C. WOC-C-36-01
Wagner N. P-SA-256
Wagner P. SU-79
SU-79-07
P-SA-050
P-SU-235
Wagoner M. P-MO-013
Wah W. H. MO-74-08
P-SA-259
P-TU-179
P-TU-182
Wahab T. A. SU-47-08
Wahl J. P-MO-039
TU-41-10
TU-82-04
Wakabayashi T. P-MO-179
TU-30-07
Wakefield D. SA-08
SA-08-01
P-SU-032
Walch A. P-SA-173
Waldstein S. P-SA-207
Walker R. P-SU-249
TU-25-07
Wallace D. SU-41-03
Walsh A. C. P-SA-165
P-SA-198
Walsh J. MO-27-03
P-SA-180
P-SU-077
P-TU-216
P-TU-224
TU-37-09
Walsh M. SA-28-10
Walt J. G. P-MO-071
P-TU-059
Walter A. SA-32-02
Walter H. S. P-SU-043
P-TU-007
P-TU-031
P-SU-265
Walter P. MO-27
TU-37-08
P-MO-206
P-MO-288
P-SA-064
WOC-AAD-C
-01-02
WOC-AAD-C
-01-04
Walter S. P-SA-146
P-TU-057
WE-37-06
Wan Abdul
Halim W. H. P-SA-275
P-TU-063
Wang C. P-TU-129
WE-35-10
Wang D. P-SA-138
wang F. SU-73-02
Wang F. WE-39-06
Wang J. P-MO-261
P-SA-201
Wang J. J. P-SU-051
SU-73-03
TU-29-02
Wang J.-K. P-MO-262
Wang K. SU-74-07
Wang L. P-SA-231
P-SU-133
Wang N. SU-56-05
TU-34-08
P-SA-092
P-SA-095
Wang N. SA-30-08
TU-52-02
Wang P. P-TU-137
Wang Q. P-SA-221
Wang W. P-SU-088
Wang X. P-MO-136
SU-36-07
Wang Y. P-SU-238
SU-42-10
SU-74-09
Wang Z. Su-54-04
SU-61-07
SU-61-07
Wangsupadilok B. P-SA-117
Waqar S. TU-25-01
Waran V. P-SU-118
Waring G. MO-37-05
TU-25-07
TU-62-02
TU-78-06
WE-02-06
Wariyapola D. P-MO-070
TU-35-03
Wasfy T. P-SA-194
Wasielica-Poslednik J. MO-31-07
Wasmuth S. MO-76-01
Wassill H. P-SU-184
Watanabe H. P-MO-027
P-MO-068
P-MO-089
P-MO-258
P-SA-017
Watkins M. SU-40-03
TU-66-06
Watson P. G. SU-20
SU-21-02
Watson S. P-TU-049
Webb T. TU-82-02
Weber A. TU-63-05
Weber B. H. F. SU-25-03
Weber K. P-SU-271
Weber S. SU-39-04
409
WOC
2010
A
u
t
h
o
r

I
n
d
e
x Wecke T. P-TU-221
WE-37-06
Wecker T. P-SU-105
Wedemeyer I. P-MO-274
Wedrich A. WE-08
SU-17-07
P-TU-149
P-TU-207
Weger M. P-SA-135
Wegner A. P-SA-101
Wegner M. P-TU-076
Wehner W. P-MO-120
P-MO-125
TU-25-07
Wei M. P-SU-066
Wei S. SU-44
SU-44-01
SU-44-03
P-SA-108
P-SU-117
P-SU-123
P-SU-127
P-SU-128
P-SU-129
P-SU-130
P-SU-138
P-SU-139
P-SU-143
P-SU-149
P-SU-156
P-SU-157
P-SU-163
P-SU-164
P-SU-166
P-SU-167
P-SU-168
P-SU-170
P-SU-171
P-SU-172
Wei Y.-h. SU-55-09
Weichselberger A. MO-68-02
TU-35-01
Weidemann A. TU-36-05
Weikert M. P. MO-39-06
Weil D. WE-12-08
Weimer P. MO-27-09
Weinberger D. MO-68-04
Weindler J. WE-39-03
Weingrnter W. E. P-MO-137
Weinitz S. TU-33-09
Weinreb R. N. SA-21-01
MO-13-08
WE-13
WE-13-08
P-SA-129
Weirich G. P-TU-120
Weiss C. P-TU-116
Wei S. MO-75-10
P-SU-100
P-SU-220
P-TU-048
SU-37-03
Weitz R. MO-27-03
Welch J. MO-67-03
Welge-Len U. MO-31-10
MO-73-07
Welkoborsky H.-J. MO-28-09
Weller K. P-SA-060
Welty D. MO-67-02
Wen J. MO-24-02
Wen-Chuan W. P-MO-219
P-SU-261
Weng N. P-SA-092
SU-56-05
Wenkstern A. P-MO-191
Werner J. U. P-TU-236
Werner L. SU-15
SU-15-06
Wesch D. P-MO-151
Wess J. P-TU-241
West S. TU-52-04
WE-40-05
Westekemper H. SA-17-06
Wetzel B. MO-27-02
Wheeler D. P-TU-143
Wheeler L. MO-75-07
P-TU-199
While B. P-SU-247
Whitcup S. M. MO-32-01
MO-32-02
MO-67-02
MO-68-04
MO-75-04
MO-75-05
MO-75-07
P-MO-198
P-SU-110
P-TU-199
TU-32-01
TU-35-11
WE-35-04
White V. A. TU-40-02
Wiafe B. MO-59-04
TU-66-05
Wickham L. SU-48-02
Wickstrom K. SU-63-06
Widayanti T. P-MO-155
Widyawati S. P-SA-069
Wiechens B. MO-28-09
MO-28-10
P-SU-196
P-SU-240
P-TU-223
P-TU-250
Wiedemann P. SA-36
SU-45
MO-02-09
MO-29
TU-36
Wiegand M. P-SU-204
Wieland E. MO-45-05
Wieland R. P-TU-116
Wienrich R. P-MO-029
Wiermann A. P-SA-182
P-SA-184
P-SA-185
Wiesen M. P-TU-219
Wiesmann C. MO-68-05
Wiggs J. L. MO-71
MO-71-05
WE-40-02
Wildner G. SA-08-05
SU-31
SU-31-02
TU-17-04
P-SA-251
Wilensky J. P-SA-073
Wilhelm B. TU-34-09
Wilhelm F. WE-27-03
Wilhelm H. SA-38-08
SU-29
SU-29-03
SU-44
MO-44-03
Wilke M. WE-16-03
Wilke R. MO-27-06
P-SA-144
SU-73-05
TU-34-09
Wilkens L. MO-28-10
Wilkinson C. P. SA-41
SA-41-09
TU-69
WOC-C-41-06
Will F. SU-75-07
Willcox M. SU-17-04
Wille D. TU-81-10
Willerding G. P-TU-089
Willert A. SA-19-04
Williams G. J. SU-62-06
TU-29-03
Williams J. TU-30-06
Williams K. A. SA-18-03
TU-19-04
Williamson K. P-TU-155
Willmann G. P-SA-155
P-SU-264
Wilson P. WE-40-01
Wilson S. E. WE-01-01
WE-03
WE-03-02
Wimmer S. P-MO-148
Windischbauer E. SU-61-06
Winkler von
Mohrenfels C. P-SU-111
SA-32-10
Winter K. WE-16-03
Winter R. MO-75-10
P-SU-100
P-SU-220
P-TU-048
SU-75-07
Winterhalter S. P-MO-015
P-MO-016
P-SA-113
SU-27-07
Wirbelauer C. WE-10-08
P-SA-026
Wirostko B. P-MO-063
P-SU-097
SU-55-05
WE-41-09
Wirtz C. WE-35-07
Wiseman R. P-SU-097
Wismann S. P-TU-186
Wissen A. SA-25-06
SU-27-10
Witt M. SU-56-04
Wittekind C. TU-40-07
Wiyogo I. WE-39-10
Wodong S. MO-28-06
Wlbert M.-K. SA-25-08
Wolf A. MO-35-04
P-SA-051
P-SA-173
P-SA-178
P-SA-188
P-SA-194
P-SA-202
P-SA-205
P-TU-017
P-TU-248
TU-25-08
WE-34-06
Wolf F. P-MO-008
WE-41-03
Wolf S. TU-11
WE-34-10
P-TU-178
P-TU-245
WOC-C-57
WOC-C-57-06
WOC-C-61-02
Wolf U. P-MO-102
410
WOC
2010
A
u
t
h
o
r

I
n
d
e
x Wolfensberger T. J. SU-49-06
MO-29
MO-29-07
MO-67
TU-45-02
Wolff D. P-TU-050
Wolff J. WOC-C-56
Wolffsohn J. P-TU-009
P-TU-037
Wolfram C. SU-73
TU-52
Wolf-Schnurrbusch U. P-TU-178
P-TU-245
WE-34-10
Wollensak G. SU-46-01
Wolter-Roessler M. P-SA-031
Wong H. S. MO-31-04
Wong A. L. P-TU-029
Wong A. M. F. SU-44-05
Wong B. P-SU-222
Wong D. SU-48-08
Wong D. S. H. SA-34-06
WOC-C-07
WOC-C-07-04
WOC-C-41
WOC-C-41-05
Wong H. S. MO-74-08
Wong J. P-SA-073
Wong P. WE-34-02
Wong T. Y. MO-56-01
TU-29-02
WE-40-04
P-MO-169
Wong V. P-SA-260
Wong W. L. P-SA-140
Woo C.-m. SU-47-01
Wormald R. SA-21
SU-04
SU-04-03
SU-76-01
TU-23-01
TU-30
WOC-C-10
WOC-C-10-01
WOC-C-10-02
Wotherspoon A. C. SU-67-02
Wowra B. P-TU-091
P-TU-096
Wree A. SU-56-04
Wrobel W. TU-34-09
Wu L. SA-41-06
MO-72
MO-72-01
WE-29
WE-29-03
Wu P. MO-68-05
Wu W.-C. P-MO-257
TU-36-01
WuDunn D. TU-30-06
Wulff A. J. SA-25-08
Wutzler P. P-SU-151
Wykes W. TU-29-03
Wylegala E. SA-31-03
SU-35-10
MO-30
MO-30-03
MO-35-03
WE-05
WE-05-05
WOC-C-47
WOC-C-47-04
Wyman M. TU-82-02
X
Xiang N. SU-17-10
Xiao C. SU-42-06
MO-79
MO-79-09
P-SU-213
P-SU-238
Xie C. P-SU-088
Xie G. P-SU-014
Xie L. TU-36-02
Xie T. MO-47-06
TU-39-03
Xing X. P-SA-038
Xing Y. P-MO-261
P-SA-201
P-SU-136
Xu J. MO-75-09
Xu L. P-SA-216
P-SU-070
SU-73-06
Xu X. MO-77-10
Y
Yadav N. K. MO-67-10
P-TU-218
Yadav P. P-SU-242
Yadava U. P-SU-173
Yagita K. P-MO-011
Yaish S. B. P-MO-121
Yakura K. P-MO-011
P-SA-279
Yamada K. P-SA-121
Yamada R. P-SA-097
Yamada Y. P-SA-131
P-SA-154
Yamaguchi M. P-TU-195
Yamaguchi Y. P-SA-242
P-TU-233
Yamaji H. P-SA-020
Yamakawa N. P-SA-247
P-SU-158
Yamamoto M. P-TU-195
Yamamoto T. P-MO-060
P-MO-178
P-SA-107
P-SA-136
P-SU-115
Yamamoto S. WOC-C-62-06
Yamashiro K. P-SA-097
P-SA-167
P-TU-172
Yamashita H. P-MO-178
P-SU-115
Yamashita M. P-SA-229
Yamazaki H. P-MO-193
Yan D. B. P-MO-067
P-MO-074
BS-09-04
Yan G. P-SU-088
Yan H. P-SU-014
P-SU-136
SU-61-10
Yan X. P-SA-216
P-SA-221
Yanagisawa M. P-SU-107
Yanai R. WE-22-04
Yang Q. P-SA-095
Yang A. P-MO-261
Yang A. h. P-SA-201
Yang C.-H. WE-08-04
P-SU-259
Yang C.-M. P-SU-259
Yang J.-Y. MO-67-08
Yang M. P-SU-245
Yang P. TU-73-06
Yang X. P-SU-266
Yang Y. P-SA-138
Yang Y.-S. MO-67-08
Yannuzzi L. MO-32-03
SA-32-04
Yano K. P-SU-089
Yao K. WE-35-08
Yaoeda K. P-MO-034
P-MO-042
Yarmak V. MO-24-04
MO-27-08
P-SU-275
Yasuda A. P-SU-182
Yasuda N. P-SA-115
Yasuno Y. SA-25-04
MO-61-06
Yau S. K. P-TU-133
Yee Murahashi W. MO-67-06
TU-29-09
Yehezkel O. P-MO-121
Yemis ci B. P-SA-128
P-SA-143
SA-31-06
Yetik H. SU-41
Yeung A. M. TU-81-07
Yigit U. P-SA-143
Yilmaz O. F. P-SU-198
Yim H. B. P-TU-054
Ying H. P-SA-226
Yip Y. P-TU-202
Yiu S. C. SA-17-01
Yoeruek E. P-SA-170
Yogesan K. SU-30
SU-30-01
Yokochi M. P-MO-149
Yokogawa H. P-SA-047
Yokoi T. P-SU-124
P-TU-200
P-TU-222
Yokoyama K. P-MO-199
Yokoyama T. TU-59-04
Yonahara M. P-SA-123
Yong L. P-TU-243
Yoon J. U. SA-25-02
Yoon Y. MO-32-01
Yoon Y.-H. SU-45-02
MO-32-02
MO-75-04
MO-75-05
TU-32-01
Yoshida A. P-MO-153
P-SA-267
P-SA-282
Yoshikawa T. P-SA-159
Yoshimura N. P-MO-043
P-SA-097
P-SA-126
P-SA-167
P-TU-172
Yoshino H. P-MO-064
Yoshino M. P-SA-004
P-SA-037
Yoshitake S. P-SA-097
You Q. SU-73-06
Younesian M. SU-17-05
Young L. P-MO-195
Young L. B. P-MO-174
Young M. J. TU-15-05
TU-30
Younis M. P-MO-092
P-MO-275
P-SU-077
411
WOC
2010
A
u
t
h
o
r

I
n
d
e
x Yu A. MO-31-10
Yu F. MO-76-08
Yu H. SA-32-03
Yu H. G. P-MO-243
Yu M. SU-74-09
Yu M. C. S. P-MO-098
Yuan J. SU-17-10
Yuen H. K. L. SU-71-03
Yuen J. WE-40-09
Yuen L. MO-26-06
TU-81-09
Yukawa E. P-SU-037
Yung C. W. TU-30-06
Yuzawa M. MO-56-07
Z
Za Z. P-SU-118
Zabarouski I. P-SU-269
Zaborovski I. P-TU-192
Zagrski Z. SU-37
TU-49
TU-49-01
TU-67
TU-67-03
Zaidman G. W. SU-79-06
MO-79-03
Zakynthinos E. MO-76-10
Zaldivar R. MO-40
MO-40-04
TU-61
TU-61-04
TU-61-06
Zalevsky Z. P-MO-121
Zaliaduonyte-
Peksiene D. P-SA-204
Zaliuniene D. P-SA-204
Zaluski S. P-MO-133
Zandi S. P-TU-220
Zanon-Moreno V. P-MO-047
P-MO-093
P-MO-160
P-SA-119
Zapata J. SU-79-02
Zarbin M. SA-03
SA-03-01
MO-47
MO-79
Zare M. SU-36-10
Zarei-Ghanavati M. P-SA-041
P-SA-084
Zarei-Ghanavati S. P-SA-041
P-SA-084
P-SU-039
SU-36-10
Zarnowski T. TU-77-05
WE-39-09
P-SU-095
P-SU-264
P-MO-260
Zavoloka O. MO-35-08
P-SA-156
P-SU-236
Zawar S. P-TU-003
Zegans M. MO-76-08
Zeimer R. SU-62-02
Zeitz C. MO-06
MO-06-04
Zeitz O. SU-61
P-SA-182
P-SA-185
P-TU-056
P-TU-217
Zekraoui Y. P-MO-066
P-SA-141
Zeng Y. P-SA-138
Zengin M. O. P-TU-061
Zenkel M. P-SU-080
P-SU-098
Zenteno Ruiz J. C. SU-61-04
Zeschnigk M. SU-39
SU-39-03
SU-39-04
Zetterstrm C. TU-07-06
TU-25
TU-76
TU-76-08
Zeyen T. WE-07
WE-07-02
Zhaboedov G. P-SA-235
Zhang C. MO-73-09
Zhang F. P-SA-218
SA-25-03
Zhang H. P-MO-265
P-SA-040
Zhang J. SU-47-04
Zhang J.-d. MO-24-02
Zhang K.-M. P-TU-199
Zhang S. S.-M. MO-73-09
Zhang W. P-SA-228
SU-61-01
Zhang X. MO-74-02
P-MO-018
Zhang X.-R. P-MO-119
Zhang Z.-Y. P-MO-119
Zhao B. P-SA-092
SU-56-05
Zhao F. P-SU-088
Zhao J. WE-37-04
Zhao J. SA-23
SA-23-04
SU-73
TU-52
TU-52-03
Zhao L. TU-34-08
Zhao S. MO-74-02
P-MO-018
SU-37-04
Zhekov O. SU-55-04
Zhen Kiat T. MO-26-06
Zheng Y. P-MO-169
Zhi J. P-SU-136
Zhivov A. P-SA-077
Zhmud T. P-MO-283
Zhng Z. MO-24-02
Zhou H. P-SU-213
P-SU-234
P-SU-238
Zhou J. P-SU-060
Zhou L. SU-37-04
Zhou Y. P-SA-216
P-TU-102
Zhou Y.-h. SU-47-04
Zhu J. P-TU-261
Zhutdieva M. SU-35-09
Ziakas N. P-SA-276
P-SU-035
Ziemssen F. SA-22
SA-22-04
MO-67-03
Zierhut M. SA-08-03
SU-27-07
MO-46
MO-49-03
MO-76
MO-76-05
TU-83
WE-42
P-SA-254
WOC-C-14-02
WOC-AAD-C-17
Zillikens D. MO-49-02
Zimmer-Galler I. E. SU-62-02
Zimmerman M. B. P-MO-013
Zimmermann A. P-TU-099
Zimmermann C. P-SA-135
Zin A. SU-61
MO-04
MO-04-02
MO-51-03
Zinelis K. MO-75-10
P-SU-100
P-SU-220
P-TU-048
SU-75-07
Zivkovic M. P-SA-234
Zlatanovic M. P-SA-237
Zlotnik A. P-MO-121
Zografos L. SU-34-02
TU-22-09
WE-23-05
WE-24-07
Zoric Geber M. WE-39-07
Zorn C. P-SA-263
P-TU-205
Zotta P. P-SA-276
P-SU-035
Zrenner E. SA-38
SA-38-02
SU-25
SU-73-05
TU-34-09
TU-37-05
TU-77-11
WE-14
WE-14-02
WE-20
WE-41
P-SA-144
P-SA-152
P-SA-155
P-TU-219
Zsolt B. WE-17-04
Zubkova D. MO-35-08
P-SA-156
P-SU-236
Zurek-Imhoff B. MO-76-01
P-SA-248
Zvereva A. E. P-SU-181
Zweifel S. A. MO-31-02
SA-32-06
Zwiener I. P-SA-190
Responsible for the Content
WOC 2010 Congress President
Professor Gerhard K. Lang, Ulm, Germany
WOC 2010 Program Director
Professor Gabriele E. Lang, Ulm, Germany
Content handling and adverts
Professional Congress Organizer (PCO)
Monika Porstmann
Porstmann Kongresse GmbH
Alte Jakobstr. 77
10179 Berlin, Germany
T: +49 30 28 44 99 0
F: +49 30 28 44 99 11
pco@woc2010.de
www.porstmann-kongresse.de
Credits
Page 34, 35: Roman Lorenz
Page 39: www.fotolibrary.de
Page 39: Eyeland Design Network
Page 41: Torsten George
Page 43: Herbert Spichtinger/Corbis
Page 367: ICC
Design
Bro Roman Lorenz
design alliance
Munich
www.designalliance.de
Production and Printing
MediaService GmbH
BrenDruck und Werbung
Franz-Mehring-Platz 1
10243 Berlin
Disclaimer
The titles and contents of the presentations as well as the authors names as
listed on the following pages have been printed according to the files sent by the
presenters themselves. The organizer is not responsible for spelling mistakes.
World Ophthalmology Congress and WOC 2010 are registered trade names of the
International Council of Ophthalmology (ICO).
The WOC 2010 logo design and corporate identity are protected by copyright.
The rights of use lie with the German Ophthalmology Society (DOG). The use by a
third party requires the express approval of the DOG.
Subject to alteration without notice.
Status as per April 2010
Last minute changes of the scientific program will be included in the online version
at www.woc2010.org.
Imprint
413
WOC
2010
414
WOC
2010
Notes
415
WOC
2010
Notes
416
WOC
2010
Notes
We see whats coming.
Pzer Ophthalmics is advancing the future of eye health. Exploring
new molecular entities designed to address unmet medical needs.
Investing in stem cell therapies. Developing innovative polymer-based
drug delivery. Creating a diverse portfolio that delivers a promising
outlook for the future of eye care.
OUR VISION IS CLEAR.
Visit us at booth 12 B/35
2010 Pzer Inc. All rights reserved.
XLU01040
>
through innovation
Look forward. Envision.
As a committed pioneer in the eld of ophthalmology, we supply
innovative technologies and application-oriented solutions which
enable doctors to improve the quality of life of their patients.

An ophthalmic world with Carl Zeiss as your partner supporting your goals with ...

Sharply focused solutions for growing patient demands.
Higher efciency and faster process support.
Better quality of care.

Visit our booth in Hall 13 and envision new opportunities in the world to see.
Get more information at our website: www.meditec.zeiss.com/woc
Carl Zeiss Meditec AG
Phone: +49 36 41 22 00
Fax: +49 36 41 22 01 12
www.meditec.zeiss.com
info@meditec.zeiss.com

WOC2010 FinalProgram

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

WOC2010 FinalProgram

Uploaded by

Copyright:

Available Formats

See you WOC

0.5% Eye Drops, Suspension Abbreviated Prescribing

0.005% w/v eye drops solution Prescribing Information

PIA Stadt Frankfurt am Main

arnowski, Robert Rejdak (Lublin/PL)

You might also like